PT J
AU Aoki, H
   Higashi, M
   Okita, M
   Ando, N
   Murayama, S
   Ishikawa, K
   Yokota, T
AF Aoki, Hanako
   Higashi, Miwa
   Okita, Michi
   Ando, Noboru
   Murayama, Shigeo
   Ishikawa, Kinya
   Yokota, Takanori
TI Thymidine Kinase 2 and Mitochondrial Protein COX I in the Cerebellum of Patients with Spinocerebellar Ataxia Type 31 Caused by Penta-nucleotide Repeats (TTCCA)<sub>n</sub>
SO CEREBELLUM
LA English
DT Article
DE Spinocerebellar ataxia type 31 (SCA31); Thymidine kinase 2 (TK2); Mitochondrial DNA depletion syndrome (MDS); Purkinje cell; Mitochondria; Cytochrome-c oxidase (COX)
ID dna depletion; natural-history; mutations; cloning; gene; deficiency; expression; myopathy; diseases; adca
AB Spinocerebellar ataxia type 31 (SCA31), an autosomal-dominant neurodegenerative disorder characterized by progressive cerebellar ataxia with Purkinje cell degeneration, is caused by a heterozygous 2.5-3.8 kilobase penta-nucleotide repeat of (TTCCA)(n) in intron 11 of the thymidine kinase 2 (TK2) gene. TK2 is an essential mitochondrial pyrimidine-deoxyribonucleoside kinase. Bi-allelic loss-of-function mutations of TK2 lead to mitochondrial DNA depletion syndrome (MDS) in humans through severe (similar to 70%) reduction of mitochondrial electron-transport-chain activity, and tk2 knockout mice show Purkinje cell degeneration and ataxia through severe mitochondrial cytochrome-c oxidase subunit I (COX I) protein reduction. To clarify whether TK2 function is altered in SCA31, we investigated TK2 and COX I expression in human postmortem SCA31 cerebellum. We confirmed that canonical TK2 mRNA is transcribed from exons far upstream of the repeat site, and demonstrated that an extended version of TK2 mRNA ("TK2-EXT"), transcribed from exons spanning the repeat site, is expressed in human cerebellum. While canonical TK2 was conserved among vertebrates, TK2-EXT was specific to primates. Reverse transcription-PCR demonstrated that both TK2 mRNAs were preserved in SCA31 cerebella compared with control cerebella. The TK2 proteins, assessed with three different antibodies including our original polyclonal antibody against TK2-EXT, were detected as similar to 26 kilodalton proteins on western blot; their levels were similar in SCA31 and control cerebella. COX I protein level was preserved in SCA31 compared to nuclear DNA-encoded protein. We conclude that the expression and function of TK2 are preserved in SCA31, suggesting a mechanism distinct from that of MDS.
C1 [Aoki, Hanako; Higashi, Miwa; Okita, Michi; Yokota, Takanori] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Ando, Noboru] Tokyo Med & Dent Univ, Grad Sch, Dept Pathol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Brain Bank Aging Res, Itabashi Ku, 35-2 Sakae Chou, Tokyo 1730015, Japan.
   [Murayama, Shigeo] Inst Gerontol, Itabashi Ku, 35-2 Sakae Chou, Tokyo 1730015, Japan.
   [Ishikawa, Kinya] Tokyo Med & Dent Univ, Ctr Personalized Med Hlth Aging, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Murayama, Shigeo] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Brain Bank Neurodev Neurol & Psychiat Disorders, Suita, Osaka 5650871, Japan.
C3 Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU); Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Gerontology; Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU); Osaka University
RP Ishikawa, K (corresponding author), Tokyo Med & Dent Univ, Ctr Personalized Med Hlth Aging, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
EM pico.nuro@tmd.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [15K09335, 18H02715, 21K07432]; Research Committee of Ataxia, Health Labour Sciences Research Grant, the Ministry of Health, Labour and Welfare, Japan [JPMH20FC1041]; Grants-in-Aid for Scientific Research [22H04923, 22K07538, 22K07550, 21K07432, 18H02715, 15K09335] Funding Source: KAKEN
CR Artuch R, 2006, J NEUROL SCI, V246, P153, DOI 10.1016/j.jns.2006.01.021
   Ayhan F, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201899023
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Corral-Juan M, 2018, BRAIN, V141, P1981, DOI 10.1093/brain/awy137
   Fecher C, 2019, NAT NEUROSCI, V22, P1731, DOI 10.1038/s41593-019-0479-z
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Ishiguro T, 2017, NEURON, V94, P108, DOI 10.1016/j.neuron.2017.02.046
   Ishikawa K, 2011, NEUROLOGY, V77, P1853, DOI 10.1212/WNL.0b013e3182377e3a
   Ishikawa K, 2006, NEUROPATHOLOGY, V26, P352, DOI 10.1111/j.1440-1789.2006.00719.x
   Ishikawa K, 2010, NEUROPATHOLOGY, V30, P490, DOI 10.1111/j.1440-1789.2010.01142.x
   Ishiura H, 2018, NAT GENET, V50, P581, DOI 10.1038/s41588-018-0067-2
   Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244
   Kim S, 2015, EXP MOL MED, V47, P0, DOI 10.1038/emm.2015.33
   Mancini C, 2019, NEUROBIOL DIS, V124, P14, DOI 10.1016/j.nbd.2018.10.018
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   McFarland KN, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0135906
   Montero R, 2007, CEREBELLUM, V6, P118, DOI 10.1080/14734220601021700
   Nakamura K, 2017, CEREBELLUM, V16, P518, DOI 10.1007/s12311-016-0833-6
   Niimi Y, 2013, NEUROPATHOLOGY, V33, P600, DOI 10.1111/neup.12032
   Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2
   Quinzii CM, 2007, MITOCHONDRION, V7, PS122, DOI 10.1016/j.mito.2007.03.004
   Rodríguez-Labrada R, 2020, CEREBELLUM, V19, P446, DOI 10.1007/s12311-020-01109-7
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sakai H, 2010, NEUROGENETICS, V11, P409, DOI 10.1007/s10048-010-0245-6
   Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019
   Schmitz A, 2021, FRONT CELL NEUROSCI, V15, P0, DOI 10.3389/fncel.2021.637548
   Shibata T, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20487-4
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
   Yoshida K, 2014, NEUROPATHOLOGY, V34, P261, DOI 10.1111/neup.12090
NR 42
TC 6
Z9 6
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1473-4222
EI 1473-4230
J9 CEREBELLUM
JI Cerebellum
PD FEB 15
PY 2023
VL 22
IS 1
BP 70
EP 84
DI 10.1007/s12311-021-01364-2
EA JAN 2022
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 8K2CW
UT WOS:000749072900002
PM 35084690
DA 2024-11-01
ER

PT J
AU Garcia-Gaona, E
   García-Gregorio, A
   García-Jiménez, C
   López-Olaiz, M
   Mendoza-Ramírez, P
   Fernandez-Guzman, D
   Pillado-Sánchez, R
   Soto-Pacheco, A
   Yareni-Zuñiga, L
   Sánchez--Parada, M
   González-Santiago, A
   Román-Pintos, L
   Castañeda-Arellano, R
   Hernández-Ortega, L
   Mercado-Sesma, A
   Orozco-Luna, F
   Villa-Angulo, C
   Villa-Angulo, R
   Baptista-Rosas, RC
AF Garcia-Gaona, Enrique
   Garcia-Gregorio, Alheli
   Garcia-Jimenez, Camila
   Alejandra Lopez-Olaiz, Mildred
   Mendoza-Ramirez, Paola
   Fernandez-Guzman, Daniel
   Alberto Pillado-Sanchez, Rolando
   David Soto-Pacheco, Axel
   Yareni-Zuniga, Laura
   Guadalupe Sanchez-Parada, Maria
   Elizabeth Gonzalez-Santiago, Ana
   Miguel Roman-Pintos, Luis
   Castaneda-Arellano, Rolando
   Daniel Hernandez-Ortega, Luis
   Roldan Mercado-Sesma, Arieh
   de Jesus Orozco-Luna, Felipe
   Villa-Angulo, Carlos
   Villa-Angulo, Rafael
   Baptista-Rosas, Raul C.
TI mtDNA Single-Nucleotide Variants Associated with Type 2 Diabetes
SO CURRENT ISSUES IN MOLECULAR BIOLOGY
LA English
DT Article
DE mtDNA; mitogenome; type 2 diabetes; variant; polymorphism
ID human skeletal-muscle; beta-cell mitochondria; insulin-resistance; proteome analysis; lipid-content; dysfunction; gene; heteroplasmy; mellitus; sequence
AB Type 2 diabetes (T2D) is a chronic systemic disease with a complex etiology, characterized by insulin resistance and mitochondrial dysfunction in various cell tissues. To explore this relationship, we conducted a secondary analysis of complete mtDNA sequences from 1261 T2D patients and 1105 control individuals. Our findings revealed significant associations between certain single-nucleotide polymorphisms (SNPs) and T2D. Notably, the variants m.1438A>G (rs2001030) (controls: 32 [27.6%], T2D: 84 [72.4%]; OR: 2.46; 95%CI: 1.64-3.78; p < 0.001), m.14766C>T (rs193302980) (controls: 498 [36.9%], T2D: 853 [63.1%]; OR: 2.57, 95%CI: 2.18-3.04, p < 0.001), and m.16519T>C (rs3937033) (controls: 363 [43.4%], T2D: 474 [56.6%]; OR: 1.24, 95%CI: 1.05-1.47, p = 0.012) were significantly associated with the likelihood of developing diabetes. The variant m.16189T>C (rs28693675), which has been previously documented in several studies across diverse populations, showed no association with T2D in our analysis (controls: 148 [13.39] T2D: 171 [13.56%]; OR: 1.03; 95%CI: 0.815-1.31; p = 0.83). These results provide evidence suggesting a link between specific mtDNA polymorphisms and T2D, possibly related to association rules, topological patterns, and three-dimensional conformations associated with regions where changes occur, rather than specific point mutations in the sequence.
C1 [Garcia-Gaona, Enrique] Benemerita Univ Autonoma Puebla, Fac Med, Puebla 72420, Mexico.
   [Garcia-Gregorio, Alheli] Univ Veracruzana, Fac Enfermeria Reg Poza R Tuxpan, Tuxpan 91700, Veracruz, Mexico.
   [Garcia-Jimenez, Camila] Univ Michoacana, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia 58000, Mexico.
   [Alejandra Lopez-Olaiz, Mildred] Univ Valle Atemajac, Escuela Nutr, Leon 37330, Mexico.
   [Mendoza-Ramirez, Paola] Benemerita Univ Autonoma Puebla, Fac Ciencias Biol, Puebla 72420, Mexico.
   [Fernandez-Guzman, Daniel] Univ Cient Sur, Carrera Med Humana, Lima 15067, Peru.
   [Alberto Pillado-Sanchez, Rolando; David Soto-Pacheco, Axel] Univ Autonoma Sinaloa, Fac Med Extens Los Mochis, Sinaloa 81223, Mexico.
   [Yareni-Zuniga, Laura; Miguel Roman-Pintos, Luis; Roldan Mercado-Sesma, Arieh; Baptista-Rosas, Raul C.] Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Salud Enfermedad como Proc Individua, Tonala 45425, Mexico.
   [Guadalupe Sanchez-Parada, Maria; Elizabeth Gonzalez-Santiago, Ana; Castaneda-Arellano, Rolando; Daniel Hernandez-Ortega, Luis] Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Biomed, Tonala 45425, Mexico.
   [Guadalupe Sanchez-Parada, Maria; Elizabeth Gonzalez-Santiago, Ana; Miguel Roman-Pintos, Luis; Castaneda-Arellano, Rolando; Daniel Hernandez-Ortega, Luis; Roldan Mercado-Sesma, Arieh; Baptista-Rosas, Raul C.] Univ Guadalajara, Ctr Invest Multidisciplinaria Salud, Tonala 45425, Mexico.
   [de Jesus Orozco-Luna, Felipe] Univ Guadalajara, Ctr Anal Datos & Supercomputo, Tonala 45425, Mexico.
   [Villa-Angulo, Carlos; Villa-Angulo, Rafael] Univ Autonoma Baja California, Inst Ingn, Lab Bioinformat & Biofoton, Mexicali 21100, Mexico.
   [Baptista-Rosas, Raul C.] Secretaria Salud Jalisco, Hosp Gen Occidente, Zapopan 45170, Mexico.
C3 Benemerita Universidad Autonoma de Puebla; Universidad Veracruzana; Universidad Michoacana de San Nicolas de Hidalgo; Benemerita Universidad Autonoma de Puebla; Universidad Cientifica del Sur (CIENTIFICA); Universidad Autonoma de Sinaloa; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad Autonoma de Baja California
RP Baptista-Rosas, RC (corresponding author), Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Salud Enfermedad como Proc Individua, Tonala 45425, Mexico.; Baptista-Rosas, RC (corresponding author), Univ Guadalajara, Ctr Invest Multidisciplinaria Salud, Tonala 45425, Mexico.; Baptista-Rosas, RC (corresponding author), Secretaria Salud Jalisco, Hosp Gen Occidente, Zapopan 45170, Mexico.
EM enrique.garciaga@alumno.buap.mx; zs18005332@estudiantes.uv.mx; 1593027a@umich.mx; milyolaiz@gmail.com; paola.mendozaramirez1@gmail.com; dfernandezg@cientifica.edu.pe; rolandops20@ms.uas.edu.mx; axelsoto.fm@uas.edu.mx; lauray.zuniga@academicos.udg.mx; maria.sparada@academicos.udg.mx; ana.gonzalez@academicos.udg.mx; luis.roman@acaemicos.udg.mx; rolando.castaneda@academicos.udg.mx; luis.hortega@academicos.udg.mx; arieh.mercado@academicos.udg.mx; felipe.orozco@academicos.udg.mx; villac@uabc.edu.mx; rafael.villa@uabc.edu.mx; raul.baptista@academicos.udg.mx
FU University of Guadalajara
CR Ahmad E, 2022, LANCET, V400, P1803, DOI 10.1016/S0140-6736(22)01655-5
   Alwehaidah MS, 2021, BIOMED REP, V14, P0, DOI 10.3892/br.2021.1417
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Chen ZZ, 2020, CIRC RES, V126, P1613, DOI 10.1161/CIRCRESAHA.120.315898
   Cooper AJ, 2021, CURR OBES REP, V10, P458, DOI 10.1007/s13679-021-00453-x
   Cousin E, 2022, LANCET DIABETES ENDO, V10, P655, DOI 10.1016/S2213-8587(22)00186-3
   Czibula G, 2012, EVOL BIOINFORM, V8, P181, DOI 10.4137/EBO.S9376
   Dela F, 2013, INT J BIOCHEM CELL B, V45, P11, DOI 10.1016/j.biocel.2012.09.019
   Diaz-Morales N, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7080220
   Fex M, 2018, J ENDOCRINOL, V236, PR145, DOI 10.1530/JOE-17-0367
   Floris M, 2020, BMC CANCER, V20, P0, DOI 10.1186/s12885-020-06749-w
   Galicia-Garcia U, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21176275
   Gaona EG, 2022, PREPRINTS, V0, PP2022100025, DOI 10.20944/preprints202210.0025.v1
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Hallgrimsson B, 2019, SEMIN CELL DEV BIOL, V88, P67, DOI 10.1016/j.semcdb.2018.05.019
   He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817
   Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104
   Hittel DS, 2005, DIABETES, V54, P1283, DOI 10.2337/diabetes.54.5.1283
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375
   Justino JR, 2021, GENET MOL BIOL, V44, P0, DOI 10.1590/1678-4685-GMB-2021-0109
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   Kronenberg F, 2022, CLIN J AM SOC NEPHRO, V17, P942, DOI 10.2215/CJN.05820522
   Kruszynska YT, 1998, DIABETES, V47, P1107, DOI 10.2337/diabetes.47.7.1107
   Kwak SH, 2016, FRONT BIOSCI-LANDMRK, V21, P1151, DOI 10.2741/4447
   Kwak SH, 2010, J DIABETES INVEST, V1, P161, DOI 10.1111/j.2040-1124.2010.00047.x
   Lamolle G, 2018, AN FAC MED-UNIV REPU, V5, P12, DOI 10.25184/anfamed2018v5n2a10
   Langenberg C, 2018, LANCET, V391, P2463, DOI 10.1016/S0140-6736(18)31132-2
   Leung KS, 2010, NUCLEIC ACIDS RES, V38, P6324, DOI 10.1093/nar/gkq500
   Li CH, 2022, INT J DIABETES DEV C, V42, P713, DOI 10.1007/s13410-021-01031-6
   Li JR, 2019, FEBS LETT, V593, P2525, DOI 10.1002/1873-3468.13546
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lin XL, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-71908-9
   Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552
   Liu JL, 2020, BMC PUBLIC HEALTH, V20, P0, DOI 10.1186/s12889-020-09502-x
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Mallik S, 2015, IEEE T NANOBIOSCI, V14, P59, DOI 10.1109/TNB.2014.2359494
   Martín-Jiménez R, 2020, DNA CELL BIOL, V39, P1421, DOI 10.1089/dna.2020.5398
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Mkaouar-Rebai E, 2008, BIOCHEM BIOPH RES CO, V369, P849, DOI 10.1016/j.bbrc.2008.02.107
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Moody L, 2022, PLOS COMPUT BIOL, V18, P0, DOI 10.1371/journal.pcbi.1010109
   Moody Laura, 2019, J BIOMED INFORM, V100S, P100001, DOI 10.1016/j.yjbinx.2018.100001
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   Morino K, 2006, DIABETES, V55, PS9, DOI 10.2337/db06-S002
   Mulder H, 2017, MOL METAB, V6, P1040, DOI 10.1016/j.molmet.2017.05.014
   Nahili H, 2010, INT J PEDIATR OTORHI, V74, P1071, DOI 10.1016/j.ijporl.2010.06.008
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Nissanka N, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949612
   Oellrich A, 2014, BIOINFORMATICS, V30, P52, DOI 10.1093/bioinformatics/btu260
   Parsons MJ, 2004, BIOL PSYCHIAT, V56, P406, DOI 10.1016/j.biopsych.2004.06.020
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087
   Ptitsyn A, 2006, BMC GENOMICS, V7, P0, DOI 10.1186/1471-2164-7-318
   Rambani Vibhuti, 2022, ENDOCR REGUL, V56, P232, DOI 10.2478/enr-2022-0025
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sangwung P, 2020, ENDOCRINOLOGY, V161, P0, DOI 10.1210/endocr/bqaa017
   Santander-Lucio H, 2023, ARCH MED RES, V54, P113, DOI 10.1016/j.arcmed.2022.12.014
   Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Sikhayeva N, 2017, BMC MED GENET, V18, P0, DOI 10.1186/s12881-017-0443-2
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Soini Heidi K, 2012, BMC RES NOTES, V5, P350, DOI 10.1186/1756-0500-5-350
   Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100
   Sudoyo H, 2003, ADV EXP MED BIOL, V531, P19
   Swan EJ, 2015, DIABETIC MED, V32, P1104, DOI 10.1111/dme.12763
   Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Umetsu Kazuo, 2005, LEGAL MEDICINE, V7, P259, DOI 10.1016/j.legalmed.2005.01.005
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vringer E, 2023, CELL DEATH DIFFER, V30, P304, DOI 10.1038/s41418-022-01094-w
   Wang D, 2001, EXP CLIN ENDOCR DIAB, V109, P361, DOI 10.1055/s-2001-17407
   Weksler-Zangen S, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11101617
   Wong MH, 2015, IEEE ACM T COMPUT BI, V12, P142, DOI 10.1109/TCBB.2014.2343952
   Wu HM, 2018, NEUROBIOL DIS, V114, P17, DOI 10.1016/j.nbd.2018.02.015
   Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 93
TC 0
Z9 0
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1467-3037
EI 1467-3045
J9 CURR ISSUES MOL BIOL
JI Curr. Issues Mol. Biol.
PD NOV 15
PY 2023
VL 45
IS 11
BP 8716
EP 8732
DI 10.3390/cimb45110548
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA Z1DT3
UT WOS:001109562800001
PM 37998725
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Obstetric involvement in mitochondrial disorders: A review
SO MEDICINE
LA English
DT Review
DE eclampsia; mitochondrial disorder; motherhood; mtDNA; oxidative phosphorylation; polyhydramnion; premature delivery; stillbirth
ID stroke-like episodes; lactic-acidosis; mtdna mutation; pregnancy; encephalopathy; myopathy
AB This is the first review about obstetric involvement in mitochondrial disorders (MIDs). The purpose of the review was to discuss recent advances and knowledge about the type and frequency of obstetric complications in MIDs. A narrative review for preferred reporting items was performed in MEDLINE, Current Contents, EMBASE, Web of Science, Web of Knowledge, LILACS, SCOPUS, and Google Scholar. The author searched for studies examining obstetric complications in patients with a definite MID. Obstetric complications described in MIDs include eclampsia, preeclampsia, intra uterine growth retardation, polyhydramnion, oligoamnion, decreased fetal movements, premature delivery, stillbirth, blow weakness, dystocia, breech presentation, retained placenta, postnatal hemorrhage, low birth weight, and early postnatal death. The most common of these complications are polyhydramnion, stillbirth, premature delivery, and low birth weight. The data show that some obstetric complications are more common in MIDs than in healthy females. MIDs can be associated with various obstetric complications. Some of these complications are more common in pregnant females with MID compared with healthy pregnant females. Obstetricians should be aware of MIDs and should know that pregnant females with a MID have an increased risk of developing complications during pregnancy or delivery.
C1 [Finsterer, Josef] Neurol & Neurophysiol Ctr, Postfach 20, A-1180 Vienna, Austria.
RP Finsterer, J (corresponding author), Neurol & Neurophysiol Ctr, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Aggarwal P, 2000, HUM HERED, V51, P114
   Arnon S, 2002, PRENATAL DIAG, V22, P34, DOI 10.1002/pd.232
   Bell JD, 2017, A A CASE REP, V9, P38, DOI 10.1213/XAA.0000000000000520
   BERKOWITZ K, 1990, AM J OBSTET GYNECOL, V162, P146, DOI 10.1016/0002-9378(90)90837-W
   Chandra SR, 2015, J POSTGRAD MED, V61, P200, DOI 10.4103/0022-3859.150905
   Chou YJ, 2004, PRENATAL DIAG, V24, P367, DOI 10.1002/pd.876
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Chuang LM, 1996, PANCREAS, V12, P243, DOI 10.1097/00006676-199604000-00006
   Cunningham F G, 1993, WILLIAMS OBSTETRICS, V19th, P763
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   Ewart RM, 1997, AM J PERINAT, V14, P293, DOI 10.1055/s-2007-994147
   Faris AS, 2014, KOREAN J ANESTHESIOL, V67, P283, DOI 10.4097/kjae.2014.67.4.283
   Finsterer J, 2019, Z RHEUMATOL, V78, P875, DOI 10.1007/s00393-018-0551-1
   Gabbe S G, 1991, OBSTETRICS: NORMAL AND PROBLEM PREGNANCIES, V2nd, P0
   Göpel W, 2014, BMC PEDIATR, V14, P0, DOI 10.1186/1471-2431-14-210
   Guitart-Mampel M, 2019, J CELL MOL MED, V23, P3962, DOI 10.1111/jcmm.14282
   Inbar-Feigenberg M, 2018, METAB BRAIN DIS, V33, P1369, DOI 10.1007/s11011-018-0218-2
   Khan IA, 2015, SAUDI J BIOL SCI, V22, P243, DOI 10.1016/j.sjbs.2014.11.001
   Kuleva M, 2019, BJOG-INT J OBSTET GY, V126, P1372, DOI 10.1111/1471-0528.15515
   Lin L, 2019, EXP THER MED, V17, P1855, DOI 10.3892/etm.2018.7143
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   Sikdar S, 2007, NEUROL INDIA, V55, P82
   TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902
   van Rij MC, 2016, CLIN CASE REP, V4, P425, DOI 10.1002/ccr3.511
   Velez DR, 2008, MITOCHONDRION, V8, P130, DOI 10.1016/j.mito.2007.10.007
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Yanagawa T, 1998, INTERNAL MED, V37, P780, DOI 10.2169/internalmedicine.37.780
NR 27
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD MAR 17
PY 2023
VL 102
IS 11
BP 
EP 
DI 10.1097/MD.0000000000033336
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA J6WE8
UT WOS:001010994900016
PM 36930069
DA 2024-11-01
ER

PT J
AU Herbst, A
   Aiken, JM
   Kim, C
   Gushue, D
   McKenzie, D
   Moore, TM
   Zhou, J
   Hoang, AN
   Choi, S
   Wanagat, J
AF Herbst, Allen
   Aiken, Judd M.
   Kim, Chiye
   Gushue, Danielle
   McKenzie, Debbie
   Moore, Timothy M.
   Zhou, Jin
   Hoang, Austin N.
   Choi, Solbie
   Wanagat, Jonathan
TI Age- and time-dependent mitochondrial genotoxic and myopathic effects of beta-guanidinopropionic acid, a creatine analog, on rodent skeletal muscles
SO GEROSCIENCE
LA English
DT Article
DE Guanidinopropionic acid; Aging; Skeletal muscle; Mitochondria; Genetics; Creatine
ID abnormality; disability; mutations; depletion; entry
AB Beta-guanidinopropionic acid (GPA) is a creatine analog suggested as a treatment for hypertension, diabetes, and obesity, which manifest primarily in older adults. A notable side effect of GPA is the induction of mitochondrial DNA deletion mutations. We hypothesized that mtDNA deletions contribute to muscle aging and used the mutation promoting effect of GPA to examine the impact of mtDNA deletions on muscles with differential vulnerability to aging. Rats were treated with GPA for up to 4 months starting at 14 or 30 months of age. We examined quadriceps and adductor longus muscles as the quadriceps exhibits profound age-induced deterioration, while adductor longus is maintained. GPA decreased body and muscle mass and mtDNA copy number while increasing mtDNA deletion frequency. The interactions between age and GPA treatment observed in the quadriceps were not observed in the adductor longus. GPA had negative mitochondrial effects in as little as 4 weeks. GPA treatment exacerbated mtDNA deletions and muscle aging phenotypes in the quadriceps, an age-sensitive muscle, while the adductor longus was spared. GPA has been proposed for use in age-associated diseases, yet the pharmacodynamics of GPA differ with age and include the detrimental induction of mtDNA deletions, a mitochondrial genotoxic stress that is pronounced in muscles that are most vulnerable to aging. Further research is needed to determine if the proposed benefits of GPA on hypertension, diabetes, and obesity outweigh the detrimental mitochondrial and myopathic side effects.
C1 [Herbst, Allen; Aiken, Judd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Herbst, Allen] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA.
   [Kim, Chiye; Gushue, Danielle; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.
   [Moore, Timothy M.] UCLA, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA.
   [Zhou, Jin] UCLA, Dept Med, Stat Core, Los Angeles, CA 90024 USA.
   [Zhou, Jin] UCLA, Dept Biostat, Los Angeles, CA USA.
   [Hoang, Austin N.; Choi, Solbie; Wanagat, Jonathan] UCLA, Dept Med, Div Geriatr, 10945 Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.
   [Wanagat, Jonathan] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
C3 University of Alberta; United States Department of the Interior; United States Geological Survey; University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System
RP Wanagat, J (corresponding author), UCLA, Dept Med, Div Geriatr, 10945 Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.; Wanagat, J (corresponding author), Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
EM jwanagat@mednet.ucla.edu
FU National Institutes of Health [R56AG060880, R01AG055518, K02AG059847, R21AR072950]; UCLA CFAR [P30AI028697]
CR Acin-Perez R, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019104073
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   DALY MM, 1980, ARCH BIOCHEM BIOPHYS, V203, P317, DOI 10.1016/0003-9861(80)90182-4
   den Ouden MEM, 2013, MATURITAS, V74, P89, DOI 10.1016/j.maturitas.2012.10.011
   den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008
   DETATA V, 1993, INT J EXP PATHOL, V74, P501
   Dorigatti JD, 2021, GEROSCIENCE, V43, P1497, DOI 10.1007/s11357-021-00372-8
   FITCH CD, 1968, J BIOL CHEM, V243, P2024
   FITCH CD, 1974, J BIOL CHEM, V249, P1060
   GORI Z, 1988, BRIT J EXP PATHOL, V69, P639
   Herbst A, 2021, GEROSCIENCE, V43, P1253, DOI 10.1007/s11357-021-00351-z
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Herbst A, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1884-7
   Herbst A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059006
   Karamat FA, 2017, BRIT J CLIN PHARMACO, V83, P2626, DOI 10.1111/bcp.13390
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921
   Mayhew AJ, 2020, J GERONTOL A-BIOL, V75, P147, DOI 10.1093/gerona/glz122
   MEGLASSON MD, 1993, J PHARMACOL EXP THER, V266, P1454
   Oudman I, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0052879
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Ross TT, 2017, PHYSIOL REP, V5, P0, DOI 10.14814/phy2.13192
   Shea CA, 2018, AM J PHYS MED REHAB, V97, P426, DOI 10.1097/PHM.0000000000000889
   SHIELDS RP, 1973, CAN J BIOCHEM CELL B, V51, P1046, DOI 10.1139/o73-136
   Strong R, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13269
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Turturro A, 1999, J GERONTOL A-BIOL, V54, PB492, DOI 10.1093/gerona/54.11.B492
   Virani SS, 2021, CIRCULATION, V143, Pe254, DOI 10.1161/CIR.0000000000000950
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
NR 34
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD FEB 15
PY 2023
VL 45
IS 1
BP 555
EP 567
DI 10.1007/s11357-022-00667-4
EA SEP 2022
PG 13
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 8R9OV
UT WOS:000862216000001
PM 36178599
DA 2024-11-01
ER

PT J
AU Hautakangas, MR
   Widgren, P
   Korpelainen, P
   Kangas, SM
   Komulainen, T
   Vieira, P
   Rahikkala, E
   Pylkäs, K
   Tuominen, H
   Kokkonen, H
   Miinalainen, I
   Nadaf, J
   Majewski, J
   Hinttala, R
   Uusimaa, J
AF Hautakangas, Milla-Riikka
   Widgren, Paula
   Korpelainen, Paavo
   Kangas, Salla M.
   Komulainen, Tuomas
   Vieira, Paivi
   Rahikkala, Elisa
   Pylkas, Katri
   Tuominen, Hannu
   Kokkonen, Hannaleena
   Miinalainen, Ilkka
   Nadaf, Javad
   Majewski, Jacek
   Hinttala, Reetta
   Uusimaa, Johanna
TI Infantile onset encephalomyopathy, retinopathy, optic atrophy, and mitochondrial DNA depletion associated with a novel pathogenic <i>DHX16</i> variant
SO CLINICAL GENETICS
LA English
DT Article
DE DHX16; encephalomyopathy; mitochondrial DNA depletion; optic atrophy; retinopathy
AB We studied a patient with mitochondrial DNA depletion in skeletal muscle and a multiorgan phenotype, including fatal encephalomyopathy, retinopathy, optic atrophy, and sensorineural hearing loss. Instead of pathogenic variants in the mitochondrial maintenance genes, we identified previously unpublished variant in DHX16 gene, a de novo heterozygous c.1360C>T (p. Arg454Trp). Variants in DHX16 encoding for DEAH-box RNA helicase have previously been reported only in five patients with a phenotype called as neuromuscular oculoauditory syndrome including developmental delay, neuromuscular symptoms, and ocular or auditory defects with or without seizures. We performed functional studies on patient-derived fibroblasts and skeletal muscle revealing, that the DHX16 expression was decreased. Clinical features together with functional data suggest, that our patient's disease is associated with a novel pathogenic DHX16 variant, and mtDNA depletion could be a secondary manifestation of the disease.
C1 [Hautakangas, Milla-Riikka; Widgren, Paula; Korpelainen, Paavo; Kangas, Salla M.; Komulainen, Tuomas; Vieira, Paivi; Rahikkala, Elisa; Kokkonen, Hannaleena; Hinttala, Reetta; Uusimaa, Johanna] Univ Oulu, Med Res Ctr, Res Unit Clin Med, Oulu, Finland.
   [Hautakangas, Milla-Riikka; Widgren, Paula; Korpelainen, Paavo; Kangas, Salla M.; Komulainen, Tuomas; Vieira, Paivi; Rahikkala, Elisa; Tuominen, Hannu; Uusimaa, Johanna] Oulu Univ Hosp, Oulu, Finland.
   [Pylkas, Katri; Miinalainen, Ilkka; Hinttala, Reetta] Univ Oulu, Bioctr Oulu, Oulu, Finland.
   [Pylkas, Katri; Kokkonen, Hannaleena] Northern Finland Lab Ctr Oulu, Oulu, Finland.
   [Nadaf, Javad] McGill Univ, Montreal Neurol Inst Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada.
   [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ, Canada.
C3 University of Oulu; University of Oulu; University of Oulu; McGill University; McGill University
RP Hautakangas, MR (corresponding author), Univ Oulu, Med Res Ctr, Res Unit Clin Med, Oulu, Finland.
EM milla-riikka.hautakangas@oulu.fi
FU Academy of Finland [266498, 273790, 303996, 311934, 331436]; Pediatric Research Foundation, Finland; StateGrants for Health Research, Clinic for Childrenand Adolescents, Oulu University Hospital; University of Oulu Scholarship Foundation; Alma and K.A. Snellman Foundation; Paeivi andSakari Sohlberg Foundation; Arvo and LeaYlppoe Foundatio; Academy of Finland (AKA) [273790, 331436, 303996] Funding Source: Academy of Finland (AKA)
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Alli Z, 2006, EXP MOL PATHOL, V81, P245, DOI 10.1016/j.yexmp.2006.07.005
   Archana A, 2022, ANN INDIAN ACAD NEUR, V25, P780, DOI 10.4103/aian.aian_67_22
   Becchetti A, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00022
   Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fjaer R, 2015, EUR J MED GENET, V58, P624, DOI 10.1016/j.ejmg.2015.10.005
   Gencheva M, 2010, BIOCHEM J, V429, P25, DOI 10.1042/BJ20100266
   Hikiami R, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-20405-2
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P202, DOI 10.1016/j.spen.2013.10.010
   Komulainen T, 2015, JIMD REP, V23, P91, DOI 10.1007/8904_2015_438
   Paine I, 2019, AM J HUM GENET, V105, P302, DOI 10.1016/j.ajhg.2019.06.001
   Paysan-Lafosse T, 2023, NUCLEIC ACIDS RES, V51, PD418, DOI 10.1093/nar/gkac993
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Uhlen M, 2015, SCIENCE, V347, P0, DOI 10.1126/science.1260419
NR 15
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD DEC 15
PY 2023
VL 104
IS 6
BP 686
EP 693
DI 10.1111/cge.14416
EA AUG 2023
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA X8UA0
UT WOS:001047357500001
PM 37574199
DA 2024-11-01
ER

PT J
AU Vinciguerra, C
   Di Fonzo, A
   Monfrini, E
   Ronchi, D
   Cuoco, S
   Piscosquito, G
   Barone, P
   Pellecchia, MT
AF Vinciguerra, C.
   Di Fonzo, A.
   Monfrini, E.
   Ronchi, D.
   Cuoco, S.
   Piscosquito, G.
   Barone, P.
   Pellecchia, M. T.
TI Case report: Asp194Ala variant in MFN2 is associated with ALS-FTD in an Italian family
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitofusin 2-gene (MFN2); amyotrophic lateral sclerosis (ALS); frontotemporal dementia (FTD); whole exom sequencing; charcot marie tooth (CMT)
ID charcot-marie-tooth; amyotrophic-lateral-sclerosis; neuropathy; mutations
AB Background: MFN2 gene encodes the protein Mitofusin 2, involved in essential mitochondrial functions such as fusion, trafficking, turnover, and cellular interactions. We describe a family carrying a novel MFN2 mutation associated with ALS-frontotemporal dementia (FTD) clinical phenotype in the mother and Charcot-Marie-Tooth disease type 2A (CMT2A) in her son.Case presentation: The mother, a 67-year-old woman, referred to us for a three year-history of mood disturbance and gait impairment, and a more recent hypophonia, dysarthria, dysphagia, and diffuse muscle wasting. Family history was positive for psychiatric disorders and gait disturbances. Brain 18F-FDG PET showed severe hypometabolism in the fronto-temporal brain cortex bilaterally. Electrodiagnostic studies (EDX) showed severe motor axonopathy in the bulbar, cervical and lumbosacral districts. Her 41-year-old son had a history of mood depression and sensory disturbances in the limbs, along with mild muscle wasting, weakness, and reduced reflexes. Nerve conduction studies revealed a moderate sensory-motor polyneuropathy, while brain MRI was normal. Whole exome sequencing of the patients' DNA identified the novel MFN2 (NM_014874.4) variant c.581A>C p.(Asp194Ala).Conclusion: Our findings provide evidence of heterogenous clinical manifestations in family members sharing the same MFN2 molecular defect. Additionally, we present the first documented case of ASL-FTD associated with an MFN2 mutation, thereby expanding the range of MFN-related disorders. Further research involving larger cohorts of patients will be needed to better understand the role of MFN2 as a contributing gene in the development of ALS-FTD.
C1 [Vinciguerra, C.; Cuoco, S.; Piscosquito, G.; Barone, P.; Pellecchia, M. T.] Univ Salerno, Ctr Neurodegenerat Dis CEMAND, Surg & Odontol Scuola Med Salernitana, Dept Med, Salerno, Italy.
   [Di Fonzo, A.; Monfrini, E.; Ronchi, D.] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Di Fonzo, A.; Monfrini, E.; Ronchi, D.] IRCCS Fdn CaGranda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
C3 University of Salerno; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Vinciguerra, C (corresponding author), Univ Salerno, Ctr Neurodegenerat Dis CEMAND, Surg & Odontol Scuola Med Salernitana, Dept Med, Salerno, Italy.
EM claudiavinci@hotmail.it
CR Abati E, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-10220-0
   Abramzon YA, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.00042
   Auranen M, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000003
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Cho HJ, 2007, CLIN GENET, V71, P267, DOI 10.1111/j.1399-0004.2007.00763.x
   Davis SA, 2018, NEUROSCI LETT, V678, P8, DOI 10.1016/j.neulet.2018.04.053
   Gao J, 2017, ANTIOXIDANTS-BASEL, V6, P0, DOI 10.3390/antiox6020025
   Gaweda-Walerych K, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.676478
   Gentile F, 2019, FRONT NEUROSCI-SWITZ, V13, P0, DOI 10.3389/fnins.2019.00601
   Ludolph A, 2015, AMYOTROPH LAT SCL FR, V16, P291, DOI 10.3109/21678421.2015.1049183
   Marchesi C, 2011, NEUROMUSCULAR DISORD, V21, P129, DOI 10.1016/j.nmd.2010.09.009
   Mou YC, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.727552
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2015, BRAIN, V138, PE372, DOI 10.1093/brain/awu384
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Shammas MK, 2023, BIOCHEM SOC T, V51, P797, DOI 10.1042/BST20221365
   Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768
   Turner MR, 2017, J NEUROL NEUROSUR PS, V88, P1042, DOI 10.1136/jnnp-2017-315995
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Zhu D, 2005, NEUROLOGY, V65, P496, DOI 10.1212/01.wnl.0000171345.62270.29
NR 25
TC 3
Z9 3
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JUL 20
PY 2023
VL 14
IS 
BP 
EP 
DI 10.3389/fgene.2023.1235887
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA O2NH6
UT WOS:001042233900001
PM 37547466
DA 2024-11-01
ER

PT J
AU Ripolone, M
   Zanotti, S
   Napoli, L
   Ronchi, D
   Ciscato, P
   Comi, GP
   Moggio, M
   Sciacco, M
AF Ripolone, Michela
   Zanotti, Simona
   Napoli, Laura
   Ronchi, Dario
   Ciscato, Patrizia
   Comi, Giacomo Pietro
   Moggio, Maurizio
   Sciacco, Monica
TI MERRF Mutation A8344G in a Four-Generation Family without Central Nervous System Involvement: Clinical and Molecular Characterization
SO JOURNAL OF PERSONALIZED MEDICINE
LA English
DT Article
DE MERRF; lipoma; central nervous system
ID ragged-red fibers; merrf/melas overlap syndrome; stroke-like episodes; mitochondrial-dna; myoclonic epilepsy; transfer rnalys; g8363a mutation; mtdna mutation; disease; gene
AB A 53-year-old man approached our Neuromuscular Unit following an incidental finding of hyperckemia. Similar to his mother who had died at the age of 77 years, he was diabetic and had a few lipomas. The patient's two sisters, aged 60 and 50 years, did not have any neurological symptoms. Proband's skeletal muscle biopsy showed several COX-negative fibers, many of which were "ragged red". Genetic analysis revealed the presence of the A8344G mtDNA mutation, which is most commonly associated with a maternally inherited multisystem mitochondrial disorder known as MERRF (myoclonus epilepsy with ragged-red fibers). The two sisters also carry the mutation. Family members on the maternal side were reported healthy. Although atypical phenotypes have been reported in association with the A8344G mutation, central nervous system (CSN) manifestations other than myoclonic epilepsy are always reported in the family tree. If present, our four-generation family manifestations are late-onset and do not affect CNS. This could be explained by the fact that the mutational load remains low and therefore prevents tissues/organs from reaching the pathologic threshold. The fact that this occurs throughout generations and that CNS, which has the highest energetic demand, is clinically spared, suggests that regulatory genes and/or pathways affect mitochondrial segregation and replication, and protect organs from progressive dysfunction.
C1 [Ripolone, Michela; Zanotti, Simona; Napoli, Laura; Ciscato, Patrizia; Comi, Giacomo Pietro; Moggio, Maurizio; Sciacco, Monica] Fdn IRCCS CaGranda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, I-20122 Milan, Italy.
   [Ronchi, Dario; Comi, Giacomo Pietro] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Sciacco, M (corresponding author), Fdn IRCCS CaGranda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, I-20122 Milan, Italy.
EM monica.sciacco@policlinico.mi.it
FU Italian Ministry of Health (Ministero della Salute Ricerca Corrente) [245]
CR BOULET L, 1992, AM J HUM GENET, V51, P1187
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Guallar JP, 2006, MOL GENET METAB, V89, P283, DOI 10.1016/j.ymgme.2006.03.001
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Jeeva-Patel T, 2021, BMJ CASE REP, V14, P0, DOI 10.1136/bcr-2020-240463
   Lamperti C, 2010, CURR PHARM DESIGN, V16, P978, DOI 10.2174/138161210790883471
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   LARSSON NG, 1995, MUSCLE NERVE, V0, PS102
   LERTRIT P, 1992, HUM GENET, V90, P251
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   PICCOLO G, 1993, ACTA NEUROL SCAND, V88, P406, DOI 10.1111/j.1600-0404.1993.tb05368.x
   Ripolone M, 2015, JAMA NEUROL, V72, P666, DOI 10.1001/jamaneurol.2015.0178
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Zeviani M, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11040637
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
NR 36
TC 2
Z9 2
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-4426
J9 J PERS MED
JI J. Pers. Med.
PD JAN 15
PY 2023
VL 13
IS 1
BP 
EP 
DI 10.3390/jpm13010147
PG 7
WC Health Care Sciences & Services; Medicine, General & Internal
SC Health Care Sciences & Services; General & Internal Medicine
GA 8D4EX
UT WOS:000918249200001
PM 36675808
DA 2024-11-01
ER

PT J
AU Chen, BS
   Harvey, JP
   Gilhooley, MJ
   Jurkute, N
   Yu-Wai-Man, P
AF Chen, Benson S.
   Harvey, Joshua P.
   Gilhooley, Michael J.
   Jurkute, Neringa
   Yu-Wai-Man, Patrick
TI Mitochondria and the eye-manifestations of mitochondrial diseases and their management
SO EYE
LA English
DT Review
ID progressive external ophthalmoplegia; dominant optic atrophy; macular dystrophy; opa1 mutations; dna; retinopathy; strabismus; prevalence; deafness; myopathy
AB Historically, distinct mitochondrial syndromes were recognised clinically by their ocular features. Due to their predilection for metabolically active tissue, mitochondrial diseases frequently involve the eye, resulting in a range of ophthalmic manifestations including progressive external ophthalmoplegia, retinopathy and optic neuropathy, as well as deficiencies of the retrochiasmal visual pathway. With the wider availability of genetic testing in clinical practice, it is now recognised that genotype-phenotype correlations in mitochondrial diseases can be imprecise: many classic syndromes can be associated with multiple genes and genetic variants, and the same genetic variant can have multiple clinical presentations, including subclinical ophthalmic manifestations in individuals who are otherwise asymptomatic. Previously considered rare diseases with no effective treatments, considerable progress has been made in our understanding of mitochondrial diseases with new therapies emerging, in particular, gene therapy for inherited optic neuropathies.
C1 [Chen, Benson S.; Yu-Wai-Man, Patrick] Univ Cambridge, John van Geest Ctr Brain Repair, Dept Clin Neurosci, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Chen, Benson S.; Yu-Wai-Man, Patrick] Cambridge Univ Hosp, Addenbrookes Hosp, Cambridge Eye Unit, Cambridge, England.
   [Harvey, Joshua P.; Gilhooley, Michael J.; Jurkute, Neringa; Yu-Wai-Man, Patrick] Moorfields Eye Hosp NHS Fdn Trust, London, England.
   [Harvey, Joshua P.; Gilhooley, Michael J.; Jurkute, Neringa; Yu-Wai-Man, Patrick] UCL, Inst Ophthalmol, London, England.
   [Gilhooley, Michael J.; Jurkute, Neringa] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Queen Sq, London, England.
C3 University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Yu-Wai-Man, P (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Dept Clin Neurosci, MRC Mitochondrial Biol Unit, Cambridge, England.; Yu-Wai-Man, P (corresponding author), Cambridge Univ Hosp, Addenbrookes Hosp, Cambridge Eye Unit, Cambridge, England.; Yu-Wai-Man, P (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, London, England.; Yu-Wai-Man, P (corresponding author), UCL, Inst Ophthalmol, London, England.
EM py237@cam.ac.uk
FU Cambridge-Rutherford Memorial Scholarship; Royal Society Te Aparangi-Rutherford Foundation; Cambridge Commonwealth, European & International Trust; Bushell Travelling Fellowship in Medicine or the Allied Sciences; Royal Australasian College of Physicians (RACP) Foundation; NIHR; Academy of Medical Sciences [SGL023\1051]; Moorfields Eye Charity [GR001376]; ProRetina Foundation Deutschland [NIHR301696]; UK National Institute of Health and Care Research (NIHR); Fight for Sight (UK); Isaac Newton Trust (UK); Addenbrooke's Charitable Trust; National Eye Research Centre (UK); International Foundation for Optic Nerve Disease (IFOND); NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]; NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bacman SR, 2020, METHOD CELL BIOL, V155, P441, DOI 10.1016/bs.mcb.2019.12.004
   Barboni P, 2022, AM J OPHTHALMOL, V0, P0
   Birtel J, 2022, OPHTHALMOL RETINA, V6, P65, DOI 10.1016/j.oret.2021.02.017
   Bucelli RC, 2016, J NEURO-OPHTHALMOL, V36, P270, DOI 10.1097/WNO.0000000000000384
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Catarino CB, 2020, J NEURO-OPHTHALMOL, V40, P558, DOI 10.1097/WNO.0000000000001023
   Chen BS, 2022, CURR NEUROL NEUROSCI, V22, P881, DOI 10.1007/s11910-022-01246-y
   Del Dotto V, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.681326
   Eshaghi M, 2021, EUR J OPHTHALMOL, V31, P2064, DOI 10.1177/1120672120952344
   Farruggia P, 2018, EXPERT REV HEMATOL, V11, P239, DOI 10.1080/17474086.2018.1426454
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Goto Y, 1993, NIHON RINSHO, V51, P2373
   Graefe VON, 1868, BERL KLIN WSCHR, V5, P125
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jankauskaite E, 2020, J APPL GENET, V61, P195, DOI 10.1007/s13353-020-00550-y
   KEARNS THOMAS P, 1965, TRANS AMER OPHTHALMOL SOC, V63, P559
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kerrison JB, 2000, ARCH OPHTHALMOL-CHIC, V118, P298
   LANE CM, 1987, BRIT J OPHTHALMOL, V71, P290, DOI 10.1136/bjo.71.4.290
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Lefevere E, 2017, MITOCHONDRION, V36, P66, DOI 10.1016/j.mito.2017.03.006
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Liu Y, 2022, GENE THER, V29, P368, DOI 10.1038/s41434-022-00333-6
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Mejia-Vergara AJ, 2020, CURR NEUROL NEUROSCI, V20, P0, DOI 10.1007/s11910-020-01032-8
   Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Muench NA, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071593
   Müller PL, 2020, AM J OPHTHALMOL, V213, P134, DOI 10.1016/j.ajo.2020.01.013
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Newman NJ, 2023, BRAIN, V146, P1328, DOI 10.1093/brain/awac421
   Newman NJ, 2023, LANCET NEUROL, V22, P172, DOI 10.1016/S1474-4422(22)00174-0
   Newman NJ, 2021, OPHTHALMOLOGY, V128, P649, DOI 10.1016/j.ophtha.2020.12.012
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Ovens CA, 2020, NEURO-OPHTHALMOLOGY, V44, P168, DOI 10.1080/01658107.2019.1653935
   Park RB, 2023, ORBIT-ABINGDON, V42, P11, DOI 10.1080/01676830.2022.2122514
   Pass T, 2021, FRONT MOL BIOSCI, V8, P0, DOI 10.3389/fmolb.2021.676187
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Ritchie AE, 2010, BRIT J OPHTHALMOL, V94, P1165, DOI 10.1136/bjo.2009.165639
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   Sanchez MIGL, 2021, AM J HUM GENET, V108, P2159, DOI 10.1016/j.ajhg.2021.09.015
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Shinkai A, 2021, MITOCHONDRION, V56, P47, DOI 10.1016/j.mito.2020.11.003
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sorkin JA, 1997, AM J OPHTHALMOL, V123, P235, DOI 10.1016/S0002-9394(14)71041-4
   Tinley C, 2010, STRABISMUS, V18, P41, DOI 10.3109/09273971003758388
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wan X, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep21587
   Weisschuh N, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0253987
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2022, EYE, V36, P818, DOI 10.1038/s41433-021-01535-9
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Yu-Wai-Man P, 2014, INVEST OPHTH VIS SCI, V55, P0
   Yu-Wai-Man P, 2013, OPHTHALMOLOGY, V120, P1712, DOI 10.1016/j.ophtha.2013.04.022
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zeviani M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23010210
NR 79
TC 8
Z9 8
U1 1
U2 6
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0950-222X
EI 1476-5454
J9 EYE
JI Eye
PD AUG 15
PY 2023
VL 37
IS 12
BP 2416
EP 2425
DI 10.1038/s41433-023-02523-x
EA APR 2023
PG 10
WC Ophthalmology
SC Ophthalmology
GA N6UN8
UT WOS:000989668500001
PM 37185957
DA 2024-11-01
ER

PT J
AU Restrepo-Vera, JL
   Rovira-Moreno, E
   Ramón, J
   Codina-Sola, M
   Llauradó, A
   Salvadó, M
   Sánchez-Tejerina, D
   Sotoca, J
   Martínez-Sáez, E
   Martí, R
   García-Arumí, E
   Juntas-Morales, R
AF Restrepo-Vera, Juan Luis
   Rovira-Moreno, Eulalia
   Ramon, Javier
   Codina-Sola, Marta
   Llaurado, Arnau
   Salvado, Maria
   Sanchez-Tejerina, Daniel
   Sotoca, Javier
   Martinez-Saez, Elena
   Marti, Ramon
   Garcia-Arumi, Elena
   Juntas-Morales, Raul
TI Identification of two novel <i>RRM2B</i> variants associated with autosomal recessive progressive external ophthalmoplegia in a family with pseudodominant inheritance pattern
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID mitochondrial disease; mutations; diagnosis; replication; adults; p53r2
AB RRM2B encodes the p53-inducible small subunit (p53R2) of ribonucleotide reductase, a key protein for mitochondrial DNA (mtDNA) synthesis. Pathogenic variants in this gene result in familial mitochondrial disease in adults and children, secondary to a maintenance disorder of mtDNA. This study describes two patients, mother and son, with early-onset chronic progressive external ophthalmoplegia (PEO). Skeletal muscle biopsy from the latter was examined: cytochrome c oxidase (COX)-negative fibres were shown, and molecular studies revealed multiple mtDNA deletions. A next-generation sequencing gene panel for nuclear-encoded mitochondrial maintenance genes identified two unreported heterozygous missense variants (c.514 G > A and c.682 G > A) in the clinically affected son. The clinically affected mother harboured the first variant in homozygous state, and the clinically unaffected father harboured the remaining variant in heterozygous state. In silico analyses predicted both variants as deleterious. Cell culture studies revealed that patients' skin fibroblasts, but not fibroblasts from healthy controls, responded to nucleoside supplementation with enhanced mtDNA repopulation, thus suggesting an in vitro functional difference in patients' cells. Our results support the pathogenicity of two novel RRM2B variants found in two patients with autosomal recessive PEO with multiple mtDNA deletions inherited with a pseudodominant pattern.
C1 [Restrepo-Vera, Juan Luis; Llaurado, Arnau; Salvado, Maria; Sanchez-Tejerina, Daniel; Sotoca, Javier; Juntas-Morales, Raul] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, Neuromuscular Dis Unit,European Reference Network, Barcelona, Spain.
   [Rovira-Moreno, Eulalia; Codina-Sola, Marta; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Clin & Mol Genet, Barcelona, Spain.
   [Rovira-Moreno, Eulalia; Codina-Sola, Marta] Univ Autonoma Barcelona, Vall dHebron Res Inst, Med Genet Grp, Barcelona, Spain.
   [Ramon, Javier; Marti, Ramon; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromusc & Mitochondrial Dis, Barcelona, Spain.
   [Ramon, Javier; Marti, Ramon; Garcia-Arumi, Elena] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Martinez-Saez, Elena] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Pathol, Barcelona 08035, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron
RP Juntas-Morales, R (corresponding author), Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, Neuromuscular Dis Unit,European Reference Network, Barcelona, Spain.; García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Clin & Mol Genet, Barcelona, Spain.; García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromusc & Mitochondrial Dis, Barcelona, Spain.; García-Arumí, E (corresponding author), Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
EM e.garcia@vhebron.net; rjuntas@vhebron.net
FU Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias; ERDF funds [FIS PI19/01772]
CR Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   [Anonymous], 2020, MUSCLE BIOPSY, V0, P408
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blázquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Hadjigeorgiou GM, 2002, NEUROMUSCULAR DISORD, V12, P824, DOI 10.1016/S0960-8966(02)00028-7
   Hou Y, 2022, MOL GENET GENOM MED, V10, P0, DOI 10.1002/mgg3.1921
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Liu HY, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.952
   Miles L, 2012, HUM PATHOL, V43, P1249, DOI 10.1016/j.humpath.2011.09.016
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wilichowski EKG, 2014, NEUROMUSCULAR DISORD, V24, P866, DOI 10.1016/j.nmd.2014.06.244
NR 26
TC 1
Z9 1
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD AUG 15
PY 2023
VL 68
IS 8
BP 527
EP 532
DI 10.1038/s10038-023-01144-2
EA MAR 2023
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA M5NV5
UT WOS:000955716400001
PM 36959467
DA 2024-11-01
ER

PT J
AU Durrleman, C
   Grevent, D
   Aubart, M
   Kossorotoff, M
   Roux, CJ
   Kaminska, A
   Rio, M
   Barcia, G
   Boddaert, N
   Munnich, A
   Nabbout, R
   Desguerre, I
AF Durrleman, Chloe
   Grevent, David
   Aubart, Melodie
   Kossorotoff, Manoelle
   Roux, Charles-Joris
   Kaminska, Anna
   Rio, Marlene
   Barcia, Giulia
   Boddaert, Nathalie
   Munnich, Arnold
   Nabbout, Rima
   Desguerre, Isabelle
TI Clinical and radiological description of 120 pediatric stroke-like episodes
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE children; energy deficit; mitochondrial disorder; neuronal hyperexcitability; stroke-like episodes
ID reversible encephalopathy syndrome; familial hemiplegic migraine; lactic-acidosis; mitochondrial myopathy; congenital disorder; status epilepticus; blood-vessels; melas; diffusion; epilepsy
AB Background and purpose Stroke-like episodes (SLEs) are defined as acute onset of neurological symptoms mimicking a stroke and radiological lesions non-congruent to vascular territory. We aimed to analyze the acute clinical and radiological features of SLEs to determine their pathophysiology.Methods We performed a monocenter retrospective analysis of 120 SLEs in 60 children over a 20-year period. Inclusion criteria were compatible clinical symptoms and stroke-like lesions on brain magnetic resonance imaging (MRI; performed for all 120 events) with focal hyperintensity on diffusion-weighted imaging in a non-vascular territory.Results Three groups were identified: children with mitochondrial diseases (n = 22) involving mitochondrial DNA mutations (55%) or nuclear DNA mutations (45%); those with other metabolic diseases or epilepsy disorders (n = 22); and those in whom no etiology was found despite extensive investigations (n = 16). Age at first SLE was younger in the group with metabolic or epilepsy disorders (18 months vs. 128 months; p < 0.0001) and an infectious trigger was more frequent (69% vs. 20%; p = 0.0001). Seizures occurred in 75% of episodes, revealing 50% episodes of SLEs and mainly leading to status epilepticus (90%). Of the 120 MRI scans confirming the diagnosis, 28 were performed within a short and strict 48-h period and were further analyzed to better understand the underlying mechanisms. The scans showed primary cortical hyperintensity (n = 28/28) with decreased apparent diffusion coefficient in 52% of cases. Systematic hyperperfusion was found on spin labeling sequences when available (n = 18/18).Conclusion Clinical and radiological results support the existence of a vicious circle based on two main mechanisms: energy deficit and neuronal hyperexcitability at the origin of SLE.
C1 [Durrleman, Chloe; Aubart, Melodie; Kossorotoff, Manoelle; Nabbout, Rima; Desguerre, Isabelle] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Pediat Neurol Dept, Paris, France.
   [Grevent, David; Roux, Charles-Joris; Boddaert, Nathalie] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Pediat Imaging Dept, Paris, France.
   [Grevent, David; Boddaert, Nathalie] Univ Paris Cite, Lumiere Platform, Paris, France.
   [Kaminska, Anna] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Neurophysiol Dept, Paris, France.
   [Rio, Marlene; Barcia, Giulia; Munnich, Arnold] Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Genet Dept, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP
RP Durrleman, C (corresponding author), Univ Paris Cite, APHP, Necker Enfants Malad Hosp, Pediat Neurol Dept, Paris, France.
EM chloe.durrleman@aphp.fr
CR Al-Hassnan ZN, 2008, J NEUROL SCI, V264, P187, DOI 10.1016/j.jns.2007.08.003
   Auvin S, 2012, EUR J PAEDIATR NEURO, V16, P413, DOI 10.1016/j.ejpn.2012.01.007
   Barcia G, 2013, DEV MED CHILD NEUROL, V55, P1150, DOI 10.1111/dmcn.12233
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   Demarest ST, 2014, J CHILD NEUROL, V29, P1249, DOI 10.1177/0883073814538511
   Dinopoulos A, 2007, PEDIATRICS, V119, PE768, DOI 10.1542/peds.2006-0763
   Forkert ND, 2016, AM J NEURORADIOL, V37, P1738, DOI 10.3174/ajnr.A4772
   Fugate JE, 2015, LANCET NEUROL, V14, P914, DOI 10.1016/S1474-4422(15)00111-8
   Funakawa I, 1997, ELECTROEN CLIN NEURO, V103, P370, DOI 10.1016/S0013-4694(97)00020-9
   Garcelon N, 2018, J BIOMED INFORM, V80, P52, DOI 10.1016/j.jbi.2018.02.019
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Gropman AL, 2007, J INHERIT METAB DIS, V30, P865, DOI 10.1007/s10545-007-0709-5
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Iizuka T, 2015, J NEUROL NEUROSUR PS, V86, P344, DOI 10.1136/jnnp-2014-307731
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD
   Kastrup O, 2015, CLIN NEURORADIOL, V25, P161, DOI 10.1007/s00062-014-0293-7
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Koepp MJ, 2010, EPILEPSY BEHAV, V19, P127, DOI 10.1016/j.yebeh.2010.06.036
   Kunz WS, 2000, ANN NEUROL, V48, P766, DOI 10.1002/1531-8249(200011)48:5<766::AID-ANA10>3.0.CO;2-M
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Li R, 2017, J MAGN RESON IMAGING, V45, P199, DOI 10.1002/jmri.25354
   Li YX, 2019, CLIN NEURORADIOL, V29, P321, DOI 10.1007/s00062-018-0662-8
   Liman TG, 2012, J NEUROL, V259, P155, DOI 10.1007/s00415-011-6152-4
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Ohshita T, 2000, NEURORADIOLOGY, V42, P651, DOI 10.1007/s002340000335
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Prasun P, 2015, J CHILD NEUROL, V30, P782, DOI 10.1177/0883073814535490
   Rahman S, 2015, EPILEPSY BEHAV, V49, P71, DOI 10.1016/j.yebeh.2015.05.003
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Russell MB, 2011, LANCET NEUROL, V10, P457, DOI 10.1016/S1474-4422(11)70048-5
   Thomsen LL, 2003, NEUROLOGY, V60, P595, DOI 10.1212/01.WNL.0000046524.25369.7D
   Todd RB, 2005, EPILEPSIA, V46, P995
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tzoulis C, 2017, MITOCHONDRION, V32, P10, DOI 10.1016/j.mito.2016.11.004
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   van Baalen A, 2009, BRAIN DEV-JPN, V31, P183, DOI 10.1016/j.braindev.2008.08.014
   Whitehead MT, 2017, NEURORADIOLOGY, V59, P813, DOI 10.1007/s00234-017-1866-3
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
NR 49
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD JUL 15
PY 2023
VL 30
IS 7
BP 2051
EP 2061
DI 10.1111/ene.15821
EA MAY 2023
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA I1CO0
UT WOS:000985802900001
PM 37046408
DA 2024-11-01
ER

PT J
AU DeFoor, N
   Paul, S
   Li, S
   Basso, EKG
   Stevenson, V
   Browning, JL
   Prater, AK
   Brindley, S
   Tao, G
   Pickrell, AM
AF DeFoor, Nicole
   Paul, Swagatika
   Li, Shuang
   Basso, Erwin K. Gudenschwager
   Stevenson, Valentina
   Browning, Jack L.
   Prater, Anna K.
   Brindley, Samantha
   Tao, Ge
   Pickrell, Alicia M.
TI Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID mitochondrial-dna depletion; antiretroviral therapy; azt; fialuridine; liver; ace2; rat; expression; infection; myopathy
AB SARS-CoV-2 causes the severe respiratory disease COVID-19. Remdesivir (RDV) was the first fast-tracked FDA approved treatment drug for COVID-19. RDV acts as an antiviral ribonucleoside (adenosine) analogue that becomes active once it accumulates intracellularly. It then diffuses into the host cell and terminates viral RNA transcription. Previous studies have shown that certain nucleoside analogues unintentionally inhibit mitochondrial RNA or DNA polymerases or cause mutational changes to mitochondrial DNA (mtDNA). These past findings on the mitochondrial toxicity of ribonucleoside analogues motivated us to investigate what effects RDV may have on mitochondrial function. Using in vitro and in vivo rodent models treated with RDV, we observed increases in mtDNA copy number in Mv1Lu cells (35.26% increase +/- 11.33%) and liver (100.27% increase +/- 32.73%) upon treatment. However, these increases only resulted in mild changes to mitochondrial function. Surprisingly, skeletal muscle and heart were extremely resistant to RDV treatment, tissues that have preferentially been affected by other nucleoside analogues. Although our data suggest that RDV does not greatly impact mitochondrial function, these data are insightful for the treatment of RDV for individuals with mitochondrial disease.
C1 [DeFoor, Nicole; Browning, Jack L.; Prater, Anna K.; Brindley, Samantha; Pickrell, Alicia M.] Virginia Tech, Sch Neurosci, Life Sci Room 217,970 Washington St SW, Blacksburg, VA 24061 USA.
   [Paul, Swagatika] Virginia Maryland Coll Vet Med, Grad Program Biomed & Vet Sci, Blacksburg, VA 24061 USA.
   [Li, Shuang; Tao, Ge] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.
   [Basso, Erwin K. Gudenschwager] Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
   [Stevenson, Valentina] Virginia Maryland Coll Vet Med, Virginia Tech Anim Lab Serv, Blacksburg, VA 24061 USA.
C3 Virginia Polytechnic Institute & State University; Medical University of South Carolina
RP Pickrell, AM (corresponding author), Virginia Tech, Sch Neurosci, Life Sci Room 217,970 Washington St SW, Blacksburg, VA 24061 USA.
EM alicia.pickrell@vt.edu
FU NIH [R21AI162775]
CR Afgan E, 2019, FUTURE GENER COMP SY, V94, P802, DOI 10.1016/j.future.2018.04.037
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barrientos Antoni, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1903s63
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bjork JA, 2021, TOXICOL APPL PHARM, V433, P0, DOI 10.1016/j.taap.2021.115783
   Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002
   Cazzalini O, 2001, BIOCHEM PHARMACOL, V62, P893, DOI 10.1016/S0006-2952(01)00713-4
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401
   FOUREL I, 1992, J MED VIROL, V37, P122, DOI 10.1002/jmv.1890370209
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679
   Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056
   Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V176, P87, DOI 10.1016/0006-291X(91)90893-C
   Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798
   Herbst A, 2022, PLOS ONE, V17, P0, DOI 10.1371/journal.pone.0271850
   HERSKOWITZ A, 1992, ANN INTERN MED, V116, P311, DOI 10.7326/0003-4819-116-4-311
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Humeniuk R, 2021, CLIN PHARMACOKINET, V60, P569, DOI 10.1007/s40262-021-00984-5
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   Justo R, 2005, AM J PHYSIOL-CELL PH, V289, PC372, DOI 10.1152/ajpcell.00035.2005
   Kang L, 2021, CELL, V184, P4392, DOI 10.1016/j.cell.2021.07.007
   Kwok M, 2022, CARDIOVASC RES, V118, P2652, DOI 10.1093/cvr/cvab311
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   Lewis W, 1996, P NATL ACAD SCI USA, V93, P3592, DOI 10.1073/pnas.93.8.3592
   Lewis W, 1997, LAB INVEST, V76, P77
   Masini A, 1999, J NEUROL SCI, V166, P131, DOI 10.1016/S0022-510X(99)00126-4
   MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702
   Meyerholz DK, 2018, LAB INVEST, V98, P844, DOI 10.1038/s41374-018-0057-0
   MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096
   MODICANAPOLITANO JS, 1993, BIOCHEM BIOPH RES CO, V194, P170, DOI 10.1006/bbrc.1993.1800
   Mossel EC, 2005, J VIROL, V79, P3846, DOI 10.1128/JVI.79.6.3846-3850.2005
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Poirier MC, 1999, J ACQ IMMUN DEF SYND, V22, P477
   Poirier MC, 2015, CURR OPIN PEDIATR, V27, P233, DOI 10.1097/MOP.0000000000000193
   Pruijssers AJ, 2020, CELL REP, V32, P0, DOI 10.1016/j.celrep.2020.107940
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Ross AC, 2012, HIV MED, V13, P98, DOI 10.1111/j.1468-1293.2011.00945.x
   Saffran HA, 2007, EMBO REP, V8, P188, DOI 10.1038/sj.embor.7400878
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sheahan TP, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.abb5883
   Sheahan TP, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal3653
   Shi CS, 2014, J IMMUNOL, V193, P3080, DOI 10.4049/jimmunol.1303196
   Silaidos C, 2018, BIOL SEX DIFFER, V9, P0, DOI 10.1186/s13293-018-0193-7
   STASCHKE KA, 1994, J VIROL, V68, P8265, DOI 10.1128/JVI.68.12.8265-8269.1994
   Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959
   Tchesnokov EP, 2019, VIRUSES-BASEL, V11, P0, DOI 10.3390/v11040326
   Thoolen B, 2010, TOXICOL PATHOL, V38, P5S, DOI 10.1177/0192623310386499
   USFDAAdministration, 2020, UPDATE: FDA ISSUES EMERGENCY USE OF AUTHORIZATION FOR POTENTIAL COVID-19 TREATMENT, V0, P0
   van Dorp L, 2020, INFECT GENET EVOL, V83, P0, DOI 10.1016/j.meegid.2020.104351
   Wang X, 2011, MOL ONCOL, V5, P399, DOI 10.1016/j.molonc.2011.07.008
   WEISSMAN JD, 1992, NEUROLOGY, V42, P619, DOI 10.1212/WNL.42.3.619
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   WHO Solidarity Trial Consortium, 2022, LANCET, V399, P1941, DOI 10.1016/S0140-6736(22)00519-0
   Wu KE, 2020, CELL SYST, V11, P102, DOI 10.1016/j.cels.2020.06.008
   Xu YL, 2021, ANTIMICROB AGENTS CH, V65, P0, DOI 10.1128/AAC.02237-20
   Young MJ, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00074
NR 68
TC 2
Z9 2
U1 0
U2 0
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD SEP 15
PY 2023
VL 13
IS 1
BP 
EP 
DI 10.1038/s41598-023-42704-y
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LC7Y8
UT WOS:001184658500013
PM 37714940
DA 2024-11-01
ER

PT J
AU Diniz, G
   Yavascan, O
   Sarkis, UB
   Yildirim, Z
   Alparslan, C
   Öztürk, C
   Berdeli, A
AF Diniz, Gulden
   Yavascan, Onder
   Sarkis, Umit Basak
   Yildirim, Zubeyde
   Alparslan, Caner
   Ozturk, Can
   Berdeli, Afig
TI A Childhood Inflammatory Myopathy with Cytochrome Oxidase Deficiency: Which Came First, the Chicken or the Egg?
SO JOURNAL OF BEHCET UZ CHILDRENS HOSPITAL
LA English
DT Article
DE Childhood inflammatory myopathy; polymyositis with COX-negative myofibers; ATP6 synthase gene; ND4 gene; CytB gene; mitochondrial myopathy
ID mutations
AB Inflammatory myopathies are autoimmune disorders rarely seen in childhood. Normally high-dose corticosteroid is the current treatment for inflammatory myopathies. For a specific subgroup of patients with inflammatory myopathy with cytochrome oxidase (COX)-negative myofibers that do not typically respond to corticosteroid treatment, and methotrexate (MTX) is used for therapy. Herein we present a 10-year-old girl who initially received clinical diagnosis of juvenile inflammatory myopathy which did not respond to corticosteroid treatment. Examination of her muscle biopsy specimen showed the presence of COX-negative muscle fibers which are very rarely seen in childhood inflammatory myopathies, and she was diagnosed as inflammatory myopathy characterized with COX-negative myofibers. The patient, who recovered with MTX therapy underwent genetic examination 3 years after the treatment was terminated. The sequence analyses of mitochondrial DNA (mtDNA) identified 19 variants in the rRNA, ND2, ND4, ND5, COX1, COX3, and CytB genes of the mtDNA of the patient and her mother. These mutations generally induce the production of synonym amino acids. However, four missense mutations on the ND4, ATP6, and CytB genes have caused structural changes in amino acids. None of these mutations have been previously reported as pathogenic variants. We have thought that these variations in such essential genes might destabilize mtDNA and could probably affect the ATP synthesis in our patient. Our final diagnosis was established based on abnormal inflammatory response induced by a hereditary mtDNA defect in a child with mitochondrial myopathy, rather than an inflammatory myopathy with COX deficiency.
C1 [Diniz, Gulden] Izmir Democracy Univ, Buca Seyfi Demirsoy Training & Res Hosp, Dept Pathol, Izmir, Turkiye.
   [Yavascan, Onder] Istanbul Medipol Univ, Dept Pediat, Fac Med, Istanbul, Turkiye.
   [Sarkis, Umit Basak; Ozturk, Can] Univ Hlth Sci Turkey, Izmir Tepecik Training & Res Hosp, Pediat Clin, Izmir, Turkiye.
   [Yildirim, Zubeyde] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Clin Pathol, Izmir, Turkiye.
   [Alparslan, Caner] Izmir Democracy Univ, Buca Seyfi Demirsoy Training & Res Hosp, Dept Pediat, Izmir, Turkiye.
   [Berdeli, Afig] Ege Univ, Dept Pediat, Mol Med Lab, Fac Med, Izmir, Turkiye.
C3 Izmir Democracy University; Istanbul Medipol University; Izmir Tepecik Training & Research Hospital; Izmir Ataturk Training & Research Hospital; Izmir Katip Celebi University; Izmir Democracy University; Ege University
RP Diniz, G (corresponding author), Izmir Democracy Univ, Buca Seyfi Demirsoy Training & Res Hosp, Dept Pathol, Izmir, Turkiye.
EM gulden.diniz@idu.edu.tr
CR Felhi R, 2016, BIOCHEM BIOPH RES CO, V473, P61, DOI 10.1016/j.bbrc.2016.03.050
   Habbane M, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9101364
   Kaphan E, 2018, REV NEUROL-FRANCE, V174, P731, DOI 10.1016/j.neurol.2018.03.014
   Kleefeld F, 2022, NEUROLOGY, V99, PE2212, DOI 10.1212/WNL.0000000000201103
   Papadimas GK, 2019, RHEUMATOL INT, V39, P1459, DOI 10.1007/s00296-019-04314-8
   Rider LG, 2016, J INTERN MED, V280, P24, DOI 10.1111/joim.12444
   Schänzer A, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11010109
   Stenzel W, 2021, NEUROMUSCULAR DISORD, V31, P1051, DOI 10.1016/j.nmd.2021.08.007
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 9
TC 0
Z9 0
U1 0
U2 0
PU GALENOS PUBL HOUSE
PI ISTANBUL
PA Kacamak Sokak 21/1, ISTANBUL, Findikzade, TURKIYE
SN 
EI 2822-4469
J9 J BEHCET UZ CHILD
JI J Behcet Uz Child. Hosp.
PD JUN 15
PY 2023
VL 13
IS 3
BP 198
EP 202
DI 10.4274/jbuch.galenos.2023.45556
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA LU0X0
UT WOS:001189207200008
DA 2024-11-01
ER

PT J
AU Ueda, S
   Yagi, M
   Tomoda, E
   Matsumoto, S
   Ueyanagi, Y
   Do, Y
   Setoyama, D
   Matsushima, Y
   Nagao, A
   Suzuki, T
   Ide, T
   Mori, Y
   Oyama, N
   Kang, D
   Uchiumi, T
AF Ueda, Saori
   Yagi, Mikako
   Tomoda, Ena
   Matsumoto, Shinya
   Ueyanagi, Yasushi
   Do, Yura
   Setoyama, Daiki
   Matsushima, Yuichi
   Nagao, Asuteka
   Suzuki, Tsutomu
   Ide, Tomomi
   Mori, Yusuke
   Oyama, Noriko
   Kang, Dongchon
   Uchiumi, Takeshi
TI Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID wobble modification deficiency; atp synthase; transcription termination; protein-synthesis; lactic-acidosis; biogenesis; myopathy; patient; cells; mtdna
AB The 3243A > G in mtDNA is a representative mutation in mitochondrial diseases. Mitochondrial protein synthesis is impaired due to decoding disorder caused by severe reduction of 5-taurinomethyluridine (& tau;m(5)U) modification of the mutant mt-tRNA(Leu(UUR)) bearing 3243A > G mutation. The 3243A > G heteroplasmy in peripheral blood reportedly decreases exponentially with age. Here, we found three cases with mild respiratory symptoms despite bearing high rate of 3243A > G mutation (>90%) in blood mtDNA. These patients had the 3290T > C haplotypic mutation in addition to 3243A > G pathogenic mutation in mt-tRNA(Leu(UUR)) gene. We generated cybrid cells of these cases to examine the effects of the 3290T > C mutation on mitochondrial function and found that 3290T > C mutation improved mitochondrial translation, formation of respiratory chain complex, and oxygen consumption rate of pathogenic cells associated with 3243A > G mutation. We measured & tau;m(5)U frequency of mt-tRNA(Leu(UUR)) with 3243A > G mutation in the cybrids by a primer extension method assisted with chemical derivatization of & tau;m(5)U, showing that hypomodification of & tau;m(5)U was significantly restored by the 3290T > C haplotypic mutation. We concluded that the 3290T > C is a haplotypic mutation that suppresses respiratory deficiency of mitochondrial disease by restoring hypomodified & tau;m(5)U in mt-tRNA(Leu(UUR)) with 3243A > G mutation, implying a potential therapeutic measure for mitochondrial disease associated with pathogenic mutations in mt-tRNAs.
C1 [Ueda, Saori; Yagi, Mikako; Matsumoto, Shinya; Ueyanagi, Yasushi; Do, Yura; Setoyama, Daiki; Matsushima, Yuichi; Kang, Dongchon; Uchiumi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
   [Yagi, Mikako; Uchiumi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
   [Tomoda, Ena; Nagao, Asuteka; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, 7-3-1 Hongo,Bunkyo ku, Tokyo 1138656, Japan.
   [Matsushima, Yuichi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka 5600043, Japan.
   [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
   [Mori, Yusuke] Kitakyushu City Yahata Hosp, Dept Internal Med, 2-6-2 Ogura,Yahatahigashi ku, Kitakyushu 8058534, Japan.
   [Oyama, Noriko] Fukuoka Childrens Hosp, Dept Endocrinol & Metab, 5-1-1 Kashiiteriha,Higashi ku, Fukuoka 8130017, Japan.
C3 Kyushu University; Kyushu University; University of Tokyo; Osaka University; Kyushu University
RP Uchiumi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.; Uchiumi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, 3-1-1 Maidashi,Higashi ku, Fukuoka 8128582, Japan.
EM uchiumi.takeshi.008@m.med.kyushu-u.ac.jp
CR Amornvit Jakkrit, 2014, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V97, P467
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   Bakare AB, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126263
   Brunner V, 2016, BIOTECHNOL BIOENG, V113, P2394, DOI 10.1002/bit.26003
   Chang KC, 2002, HONG KONG MEDICAL JOURNAL, V8, P137
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chomyn A, 1996, METHODS ENZYMOL, V264, P334, DOI 10.1016/S0076-6879(96)64031-2
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   El Meziane A, 1998, NAT GENET, V18, P350
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Holman KM, 2017, RNA, V23, P1685, DOI 10.1261/rna.061069.117
   Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744
   KAMAKURA K, 1995, J NEUROL, V242, P253, DOI 10.1007/BF00919602
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Kunz TC, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00617
   Lavie L, 2003, J MOL NEUROSCI, V21, P57, DOI 10.1385/JMN:21:1:57
   Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002
   Lin H, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04250-4
   Liu GL, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116562
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072
   Momiyama Y, 1999, JPN CIRC J, V63, P130, DOI 10.1253/jcj.63.130
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9
   Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013
   Pan XL, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00780
   Pascucci B, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22137123
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Saito T, 2017, CARDIOVASC RES, V113, P1173, DOI 10.1093/cvr/cvx095
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Setoyama D, 2022, J CACHEXIA SARCOPENI, V13, P355, DOI 10.1002/jcsm.12889
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Suzuki T, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18068-6
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   Tomoda E, 2023, NUCLEIC ACIDS RES, V51, P7563, DOI 10.1093/nar/gkad139
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   Veeresh P, 2019, ANN NY ACAD SCI, V1457, P41, DOI 10.1111/nyas.14212
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Worley B, 2016, CURR METABOL, V4, P97, DOI 10.2174/2213235X04666160613122429
   Yagi M, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020105268
   Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774
   Yang CC, 1998, J FORMOS MED ASSOC, V97, P715
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zhu HY, 2009, CLIN CHIM ACTA, V410, P64, DOI 10.1016/j.cca.2009.09.023
NR 69
TC 1
Z9 1
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD AUG 11
PY 2023
VL 51
IS 14
BP 7480
EP 7495
DI 10.1093/nar/gkad591
EA JUL 2023
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA O5OX4
UT WOS:001024276700001
PM 37439353
DA 2024-11-01
ER

PT J
AU Peng, X
   Ma, LX
   Xiao, C
   Zhang, ZZ
   Zhu, M
   Hong, DJ
   Zhan, YA
AF Peng, Xiong
   Ma, Li-xiu
   Xiao, Ce
   Zhang, Zhi-zhe
   Zhu, Min
   Hong, Dao-jun
   Zhan, Yi-an
TI Weaning difficulty after severe pneumonia in adult-onset mitochondrial myopathy with A3243G mutation in the mitochondrial tRNA gene: A case report
SO HELIYON
LA English
DT Article
DE Mitochondrial myopathy; Severe pneumonia; Acute respiratory failure; Difficulty in weaning; A3243G mutation
ID respiratory insufficiency
AB Background: Mitochondrial myopathy is a group of diseases caused by abnormal mitochondrial structure or function. The mitochondrial myopathy impacts muscles of the whole body and exhibits variable symptoms. Respiratory muscle deficits deteriorate pulmonary function in patients with severe pneumonia. Case presentation: We report the case of a male patient with severe pneumonia-induced respiratory failure. He was abnormally dependent invasive ventilator-assisted ventilation after his condition had improved. Then we found abnormal ventilator waveform and a decline in muscle strength of him. Mitochondrial myopathy was ultimately confirmed by muscle pathological biopsy and body fluid genetic testing. Vitamin B complex, coenzyme Q10, Neprinol AFD, L-arginine, and MITOTONIC were used to improve mitochondrial function and muscle metabolism. After treatment, discomfort associated with chest tightness, fatigue, cough, and sputum disappeared, and the patient was discharged. Conclusion: This case presented an uncommon cause of difficult weaning and extubation-acute onset of mitochondrial myopathy. Muscle biopsy and genetic testing of body fluid are essential for diagnosing mitochondrial myopathy. The A3243G mutation in the MT-TL1 gene of mitochondrial DNA contributes to pathogenesis of this case.
C1 [Peng, Xiong; Ma, Li-xiu; Xiao, Ce; Zhang, Zhi-zhe; Zhan, Yi-an] Nanchang Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
   [Zhu, Min; Hong, Dao-jun] Nanchang Univ, Dept Neurol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.
C3 Nanchang University; Nanchang University
RP Zhan, YA (corresponding author), Nanchang Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
EM ndyfy02169@ncu.edu.cn
FU National Natural Science Foundation of China [82060345]; Natural Science Foundation of Jiangxi Province [20192BAB205057]
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Amornvit Jakkrit, 2014, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V97, P467
   BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Chang KC, 2002, HONG KONG MEDICAL JOURNAL, V8, P137
   Chotmongkol Verajit, 2001, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V84, P445
   CROS D, 1992, CHEST, V101, P824, DOI 10.1378/chest.101.3.824
   Fan HC, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11111111
   Heunks LM, 2010, CRIT CARE, V14, P0, DOI 10.1186/cc9296
   Hutchinson David, 2008, PRACT NEUROL, V8, P229, DOI 10.1136/pn.2008.152611
   Jeong BH, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0122810
   Karaa A, 2023, NEUROLOGY, V101, PE238, DOI 10.1212/WNL.0000000000207402
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   KIM G W, 1991, YONSEI MEDICAL JOURNAL, V32, P184
   Murayama A, 2019, J NEUROL SCI, V396, P216, DOI 10.1016/j.jns.2018.11.023
   Naddaf E, 2017, MUSCLE NERVE, V56, P881, DOI 10.1002/mus.25602
   Ortí-Pareja M, 1999, REV NEUROLOGIA, V29, P735, DOI 10.33588/rn.2908.99307
   Padilla F, 1999, NEUROLOGIA, V14, P368
   Pan X, 2019, FRONT NEUROL, V10, P0
   Pan XL, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00780
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Shibasaki H, 1973, RINSHO SHINKEIGAKU, V13, P45
   Thille AW, 2013, CURR OPIN CRIT CARE, V19, P57, DOI 10.1097/MCC.0b013e32835c5095
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 24
TC 0
Z9 0
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 
EI 2405-8440
J9 HELIYON
JI Heliyon
PD DEC 15
PY 2023
VL 9
IS 12
BP 
EP 
DI 10.1016/j.heliyon.2023.e23300
EA DEC 2023
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4Q7
UT WOS:001134316900001
PM 38149187
DA 2024-11-01
ER

PT J
AU Bagyinszky, E
   Hulme, J
   An, SSA
AF Bagyinszky, Eva
   Hulme, John
   An, Seong Soo A.
TI Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
SO CELLS
LA English
DT Review
DE amyotrophic lateral sclerosis; biomarkers; genetic factors; proteomic markers; therapy; diagnosis
ID antisense oligonucleotide tofersen; frontotemporal lobar degeneration; neurofilament light-chain; motor-neuron degeneration; dipeptide-repeat proteins; copy-number variation; cerebrospinal-fluid; matrix metalloproteinases; adenoassociated virus; hexanucleotide repeat
AB Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease affecting the upper and lower motor neurons, leading to muscle weakness, motor impairments, disabilities and death. Approximately 5-10% of ALS cases are associated with positive family history (familial ALS or fALS), whilst the remainder are sporadic (sporadic ALS, sALS). At least 50 genes have been identified as causative or risk factors for ALS. Established pathogenic variants include superoxide dismutase type 1 (SOD1), chromosome 9 open reading frame 72 (c9orf72), TAR DNA Binding Protein (TARDBP), and Fused In Sarcoma (FUS); additional ALS-related genes including Charged Multivesicular Body Protein 2B (CHMP2B), Senataxin (SETX), Sequestosome 1 (SQSTM1), TANK Binding Kinase 1 (TBK1) and NIMA Related Kinase 1 (NEK1), have been identified. Mutations in these genes could impair different mechanisms, including vesicle transport, autophagy, and cytoskeletal or mitochondrial functions. So far, there is no effective therapy against ALS. Thus, early diagnosis and disease risk predictions remain one of the best options against ALS symptomologies. Proteomic biomarkers, microRNAs, and extracellular vehicles (EVs) serve as promising tools for disease diagnosis or progression assessment. These markers are relatively easy to obtain from blood or cerebrospinal fluids and can be used to identify potential genetic causative and risk factors even in the preclinical stage before symptoms appear. In addition, antisense oligonucleotides and RNA gene therapies have successfully been employed against other diseases, such as childhood-onset spinal muscular atrophy (SMA), which could also give hope to ALS patients. Therefore, an effective gene and biomarker panel should be generated for potentially "at risk" individuals to provide timely interventions and better treatment outcomes for ALS patients as soon as possible.
C1 [Bagyinszky, Eva; Hulme, John] Gachon Univ, Grad Sch Environm Dept Ind & Environm Engn, Seongnam Si 13120, South Korea.
   [An, Seong Soo A.] Gachon Univ, Dept Bionano Technol, Seongnam Si 13120, South Korea.
C3 Gachon University; Gachon University
RP Hulme, J (corresponding author), Gachon Univ, Grad Sch Environm Dept Ind & Environm Engn, Seongnam Si 13120, South Korea.; An, SSA (corresponding author), Gachon Univ, Dept Bionano Technol, Seongnam Si 13120, South Korea.
EM eva85@gachon.ac.kr; johnhulme21@gmail.com; seong.an@gmail.com
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2020R1A2B5B01002463, 2021R1A6A1A03038996]
CR Abramzon YA, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.00042
   Aluri KC, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-60431-6
   An HY, 2019, ACTA NEUROPATHOL COM, V7, P0, DOI 10.1186/s40478-019-0658-x
   An YR, 2014, MOL CELL TOXICOL, V10, P127, DOI 10.1007/s13273-014-0014-y
   Antonyuk S, 2005, PROTEIN SCI, V14, P1201, DOI 10.1110/ps.041256705
   Arnold Carrie, 2019, NAT MED, V0, P0, DOI DOI 10.1038/d41591-019-00021-w
   Ayloo S, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5807
   Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4
   Banack SA, 2022, J NEUROL SCI, V442, P0, DOI 10.1016/j.jns.2022.120396
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Barbo M, 2023, GENES-BASEL, V14, P0, DOI 10.3390/genes14020325
   Beghi E, 2007, CURR MED CHEM, V14, P3185, DOI 10.2174/092986707782793862
   Behzadi A, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-01499-6
   Beijer D, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.148363
   Benatar M, 2022, NEUROTHERAPEUTICS, V19, P1248, DOI 10.1007/s13311-022-01237-4
   Benatar M, 2022, BRAIN, V145, P27, DOI 10.1093/brain/awab404
   Benatar M, 2019, AMYOTROPH LAT SCL FR, V20, P303, DOI 10.1080/21678421.2019.1587634
   Benatar M, 2018, ANN NEUROL, V84, P130, DOI 10.1002/ana.25276
   Benatar M, 2012, NEUROLOGY, V79, P1732, DOI 10.1212/WNL.0b013e31826e9b1d
   Benigni M, 2016, NEUROMOL MED, V18, P551, DOI 10.1007/s12017-016-8396-8
   Bertolin C, 2018, EUR J NEUROL, V25, PE41, DOI 10.1111/ene.13559
   Beyer L, 2021, ANN CLIN TRANSL NEUR, V8, P271, DOI 10.1002/acn3.51256
   Blasco H, 2017, CAN J NEUROL SCI, V44, P90, DOI 10.1017/cjn.2016.284
   Blauw HM, 2012, HUM MOL GENET, V21, P2497, DOI 10.1093/hmg/dds064
   Blauw HM, 2010, HUM MOL GENET, V19, P4091, DOI 10.1093/hmg/ddq323
   Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6
   Boehringer A, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14924-6
   Boutry M, 2019, COMMUN BIOL, V2, P0, DOI 10.1038/s42003-019-0615-z
   Bradshaw WJ, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep41996
   Brenner D, 2016, BRAIN, V139, PCP14, DOI 10.1093/brain/aww033
   Brockmann SJ, 2018, HUM MOL GENET, V27, P706, DOI 10.1093/hmg/ddx436
   Broom HR, 2015, PROTEIN SCI, V24, P2081, DOI 10.1002/pro.2803
   Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003
   Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195
   Cadoni MPL, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010164
   Campos-Melo D, 2018, MOL BRAIN, V11, P0, DOI 10.1186/s13041-018-0386-3
   Campos-Melo D, 2013, MOL BRAIN, V6, P0, DOI 10.1186/1756-6606-6-26
   Cano A, 2023, INT J BIOL SCI, V19, P721, DOI 10.7150/ijbs.79063
   Cao MC, 2022, BMC NEUROL, V22, P0, DOI 10.1186/s12883-022-02730-1
   Capponi S, 2016, HUM MUTAT, V37, P1202, DOI 10.1002/humu.23062
   Castellanos-Montiel MJ, 2020, FRONT CELL NEUROSCI, V14, P0, DOI 10.3389/fncel.2020.594975
   Chang L, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0130162
   Chen C, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24081622
   Chen PC, 2020, J NEUROL SCI, V418, P0, DOI 10.1016/j.jns.2020.117070
   Chen YZ, 2006, NEUROBIOL DIS, V23, P97, DOI 10.1016/j.nbd.2006.02.007
   Chen Y, 2019, FRONT NEUROSCI-SWITZ, V13, P0, DOI 10.3389/fnins.2019.00574
   Chen YP, 2016, FRONT MOL NEUROSCI, V9, P0, DOI 10.3389/fnmol.2016.00069
   Cheng C, 2019, TRANSL NEURODEGENER, V8, P0, DOI 10.1186/s40035-019-0152-1
   Chernyshova K, 2019, INVEST OPHTH VIS SCI, V60, P3625, DOI 10.1167/iovs.19-27184
   Chiò A, 2014, J NEUROL NEUROSUR PS, V85, P478, DOI 10.1136/jnnp-2013-305546
   Chiò A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824
   Chitiprolu M, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-05273-7
   Choi YS, 2014, MOL CELL TOXICOL, V10, P1, DOI 10.1007/s13273-014-0001-3
   Corcia P, 2006, NEUROLOGY, V67, P1147, DOI 10.1212/01.wnl.0000233830.85206.1e
   Corcia P, 2020, REV NEUROL-FRANCE, V176, P166, DOI 10.1016/j.neurol.2019.07.027
   Corrado L, 2019, NEUROL SCI, V40, P2537, DOI 10.1007/s10072-019-04001-3
   Corrado L, 2011, NEUROBIOL AGING, V32, P0, DOI 10.1016/j.neurobiolaging.2010.02.011
   Calvo AC, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/629630
   Cronin S, 2008, HUM MOL GENET, V17, P3392, DOI 10.1093/hmg/ddn233
   DANESHMANDPOUR Y, 2023, AMYOTROPH LAT SCL FR, V24, P148, DOI 10.1080/21678421.2022.2100263
   De Felice B, 2014, NEUROGENETICS, V15, P243, DOI 10.1007/s10048-014-0420-2
   De Marchi F, 2021, NEUROSCI BIOBEHAV R, V127, P958, DOI 10.1016/j.neubiorev.2021.06.027
   De Schaepdryver M, 2018, J NEUROL NEUROSUR PS, V89, P367, DOI 10.1136/jnnp-2017-316605
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Demestre M, 2005, J NEUROIMMUNOL, V159, P146, DOI 10.1016/j.jneuroim.2004.09.015
   Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353
   Deng H, 2014, NAT REV NEUROL, V10, P337, DOI 10.1038/nrneurol.2014.78
   Deng X, 2022, J CELL BIOL, V221, P0, DOI 10.1083/jcb.202103033
   Deng ZQ, 2020, AUTOPHAGY, V16, P917, DOI 10.1080/15548627.2019.1644076
   Deshaies JE, 2018, BRAIN, V141, P1320, DOI 10.1093/brain/awy062
   Deshimaru M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22083985
   Dhasmana S, 2022, LIFE SCI, V288, P0, DOI 10.1016/j.lfs.2021.120156
   Dierick I, 2007, HUM MUTAT, V28, P830, DOI 10.1002/humu.9503
   Ding XB, 2015, ONCOTARGET, V6, P24178, DOI 10.18632/oncotarget.4680
   Dreser A, 2017, CELL DEATH DIFFER, V24, P1655, DOI 10.1038/cdd.2017.88
   Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320
   Fang T, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11132066
   Farrawell NE, 2023, HUM MOL GENET, V32, P2386, DOI 10.1093/hmg/ddad063
   Ferrari V, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23041939
   Forgrave LM, 2019, ALZH DEMENT-DADM, V11, P730, DOI 10.1016/j.dadm.2019.08.009
   Fratta P, 2018, BRAIN, V141, P1236, DOI 10.1093/brain/awy091
   Fukunaga K, 2015, J PHARMACOL SCI, V127, P36, DOI 10.1016/j.jphs.2014.12.012
   Gaiani A, 2017, JAMA NEUROL, V74, P525, DOI 10.1001/jamaneurol.2016.5398
   Gaur N, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00377
   Gendron TF, 2017, ANN NEUROL, V82, P139, DOI 10.1002/ana.24980
   Gendron TF, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aai7866
   Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z
   Genin EC, 2018, NEUROBIOL DIS, V119, P159, DOI 10.1016/j.nbd.2018.07.027
   Gertsman I, 2019, JCI INSIGHT, V4, P0, DOI 10.1172/jci.insight.122768
   Ghasemi M, 2018, CSH PERSPECT MED, V8, P0, DOI 10.1101/cshperspect.a024125
   Gijselinck I, 2016, MOL PSYCHIATR, V21, P1112, DOI 10.1038/mp.2015.159
   Gille B, 2019, J NEUROL NEUROSUR PS, V90, P1338, DOI 10.1136/jnnp-2018-319586
   Goode A, 2016, AUTOPHAGY, V12, P1094, DOI 10.1080/15548627.2016.1170257
   Goyal NA, 2020, MUSCLE NERVE, V62, P156, DOI 10.1002/mus.26801
   Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200
   Haeusler AR, 2016, NAT REV NEUROSCI, V17, P383, DOI 10.1038/nrn.2016.38
   Haidar M, 2019, AUTOPHAGY, V15, P1051, DOI 10.1080/15548627.2019.1569930
   Hand CK, 2003, ARCH NEUROL-CHICAGO, V60, P1768, DOI 10.1001/archneur.60.12.1768
   Harding O, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2025053118
   Hayashi N, 2020, NEUROSCI RES, V160, P43, DOI 10.1016/j.neures.2019.10.010
   Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036
   Heilman PL, 2017, EXP NEUROL, V297, P101, DOI 10.1016/j.expneurol.2017.08.002
   Hensley K, 2006, ANTIOXID REDOX SIGN, V8, P2075, DOI 10.1089/ars.2006.8.2075
   Ho WY, 2021, ACTA NEUROPATHOL COM, V9, P0, DOI 10.1186/s40478-020-01111-4
   Holmoy T, 2007, EUR NEUROL, V58, P57, DOI 10.1159/000102170
   Honda H, 2015, NEUROPATHOLOGY, V35, P37, DOI 10.1111/neup.12153
   Hu Y, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-09097-1
   Huai JS, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00527
   Hulisz D, 2018, AM J MANAG CARE, V24, P0
   Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505
   Irwin KE, 2023, BIORXIV, V0, P0
   Jamerlan AM, 2023, ALZHEIMERS DEMENT, V19, P4020, DOI 10.1002/alz.13127
   Jankovic M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22189832
   Jiang L, 2022, METABOLITES, V12, P0, DOI 10.3390/metabo12080709
   Jo M, 2020, EXP MOL MED, V52, P1652, DOI 10.1038/s12276-020-00513-7
   Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264
   Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036
   Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688
   Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319
   Kamelgarn M, 2018, P NATL ACAD SCI USA, V115, PE11904, DOI 10.1073/pnas.1810413115
   Kapeli K, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12143
   Karch CM, 2018, JAMA NEUROL, V75, P860, DOI 10.1001/jamaneurol.2018.0372
   Kasai T, 2009, ACTA NEUROPATHOL, V117, P55, DOI 10.1007/s00401-008-0456-1
   Kaur SJ, 2016, GENE, V577, P109, DOI 10.1016/j.gene.2015.11.049
   Kenna KP, 2016, NAT GENET, V48, P1037, DOI 10.1038/ng.3626
   Khani M, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1240
   Kim H, 2023, MOL CELL TOXICOL, V19, P789, DOI 10.1007/s13273-022-00309-y
   Kim J, 2021, J CELL BIOL, V220, P0, DOI 10.1083/jcb.202007112
   King AE, 2012, BRAIN RES, V1465, P90, DOI 10.1016/j.brainres.2012.05.018
   King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016
   Kojima Y, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0260323
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Kon T, 2014, NEUROPATHOLOGY, V34, P19, DOI 10.1111/neup.12056
   Kondori NR, 2018, FRONT MOL BIOSCI, V5, P0, DOI 10.3389/fmolb.2018.00008
   Koppers M, 2015, ANN NEUROL, V78, P426, DOI 10.1002/ana.24453
   Koppers M, 2012, NEUROBIOL AGING, V33, P0, DOI 10.1016/j.neurobiolaging.2011.10.006
   Kreilaus F, 2020, GENES BRAIN BEHAV, V19, P0, DOI 10.1111/gbb.12604
   Krishnan G, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-30387-4
   Kueffner R, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-36873-4
   Landers JE, 2008, NEUROLOGY, V70, P1179, DOI 10.1212/01.wnl.0000289760.85237.4e
   Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319
   Lejman J, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24021130
   Leoni E, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-40632-4
   Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601
   Lim LZ, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002338
   Liu CY, 2022, J CLIN NEUROL, V18, P41, DOI 10.3988/jcn.2022.18.1.41
   Liu JM, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11030572
   Liu W, 2021, ROY SOC OPEN SCI, V8, P0, DOI 10.1098/rsos.210160
   Liu YJ, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-21112-8
   Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525
   Lu CH, 2016, NEUROL-NEUROIMMUNOL, V3, P0, DOI 10.1212/NXI.0000000000000244
   Lu CH, 2015, J NEUROL NEUROSUR PS, V86, P565, DOI 10.1136/jnnp-2014-307672
   Lukaszewicz-Zajac M, 2014, J NEURAL TRANSM, V121, P1387, DOI 10.1007/s00702-014-1205-3
   Ma LM, 2018, BRAIN BEHAV, V8, P0, DOI 10.1002/brb3.1066
   Magen I, 2021, NAT NEUROSCI, V24, P1534, DOI 10.1038/s41593-021-00936-z
   Malik AM, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.143948
   Månberg A, 2021, NAT MED, V27, P0, DOI 10.1038/s41591-021-01295-9
   Martier R, 2019, MOL THER-NUCL ACIDS, V16, P26, DOI 10.1016/j.omtn.2019.02.001
   Martier R, 2019, MOL THER-NUCL ACIDS, V14, P593, DOI 10.1016/j.omtn.2019.01.010
   Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971
   Masrori P, 2020, EUR J NEUROL, V27, P1918, DOI 10.1111/ene.14393
   May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4
   McCluskey G, 2023, LIFE-BASEL, V13, P0, DOI 10.3390/life13010121
   Mead RJ, 2023, NAT REV DRUG DISCOV, V22, P185, DOI 10.1038/s41573-022-00612-2
   Mejzini R, 2019, FRONT NEUROSCI-SWITZ, V13, P0, DOI 10.3389/fnins.2019.01310
   Michaelson N, 2017, CYTOKINE GROWTH F R, V37, P81, DOI 10.1016/j.cytogfr.2017.05.001
   Miller T, 2020, NEW ENGL J MED, V383, P109, DOI 10.1056/NEJMoa2003715
   Miller TM, 2022, NEW ENGL J MED, V387, P1099, DOI 10.1056/NEJMoa2204705
   Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107
   Mitsuzawa Shio, 2018, ENEUROLOGICALSCI, V11, P20, DOI 10.1016/j.ensci.2018.04.001
   Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800
   Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z
   Moisse M, 2021, ANN NEUROL, V89, P686, DOI 10.1002/ana.26009
   Mol MO, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000596
   Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927
   Mueller C, 2020, NEW ENGL J MED, V383, P151, DOI 10.1056/NEJMoa2005056
   Nahm M, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aax3993
   Nakaya T, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-33964-0
   Nekoua MP, 2022, MICROORGANISMS, V10, P0, DOI 10.3390/microorganisms10040768
   Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214
   Nicholson G, 2011, BRAIN, V134, P1959, DOI 10.1093/brain/awr148
   Niebroj-Dobosz I, 2010, EUR J NEUROL, V17, P226, DOI 10.1111/j.1468-1331.2009.02775.x
   Orrell RW, 2000, NEUROMUSCULAR DISORD, V10, P63, DOI 10.1016/S0960-8966(99)00071-1
   Osmanovic A, 2017, EUR J HUM GENET, V25, P324, DOI 10.1038/ejhg.2016.186
   Paladino P, 2009, EUR J NEUROL, V16, P257, DOI 10.1111/j.1468-1331.2008.02405.x
   Pasetto L, 2021, MOL NEURODEGENER, V16, P0, DOI 10.1186/s13024-021-00470-3
   Peggion C, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11040614
   Peng C, 2020, NAT REV NEUROL, V16, P199, DOI 10.1038/s41582-020-0333-7
   Pesiridis GS, 2009, HUM MOL GENET, V18, PR156, DOI 10.1093/hmg/ddp303
   Porter L, 2020, FRONT MOL BIOSCI, V7, P0, DOI 10.3389/fmolb.2020.574133
   Pradat PF, 2012, NEURODEGENER DIS, V9, P38, DOI 10.1159/000329723
   Pregnolato F, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11081220
   Quaegebeur A, 2020, ACTA NEUROPATHOL COM, V8, P0, DOI 10.1186/s40478-020-01036-y
   Rademakers R, 2014, NEURON, V84, P241, DOI 10.1016/j.neuron.2014.10.002
   Raghunathan R, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23169299
   Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd
   Rayner SL, 2024, NEUROSCIENTIST, V30, P214, DOI 10.1177/10738584221120182
   Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
   Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113
   Rinchetti P, 2018, MOL NEUROBIOL, V55, P2617, DOI 10.1007/s12035-017-0537-z
   Robelin L, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/525097
   Robertson J, 2003, J CELL BIOL, V160, P939, DOI 10.1083/jcb.200205027
   Romano R, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232315416
   Ruan Y, 2022, CELL DEATH DIS, V13, P0, DOI 10.1038/s41419-022-04602-5
   Saeed M, 2009, NEUROLOGY, V72, P1634, DOI 10.1212/01.wnl.0000343509.76828.2a
   Sama RRK, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-00091-1
   Scarafino A, 2018, J NEUROL, V265, P2353, DOI 10.1007/s00415-018-9008-3
   Schmidt EJ, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2024605118
   Scotter EL, 2015, NEUROTHERAPEUTICS, V12, P352, DOI 10.1007/s13311-015-0338-x
   Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115
   de Souza PVS, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-01993-0
   Shang YL, 2016, BRAIN RES, V1647, P65, DOI 10.1016/j.brainres.2016.03.036
   Shaw CE, 2010, NEURON, V68, P812, DOI 10.1016/j.neuron.2010.11.040
   Silverman JM, 2016, CELL MOL NEUROBIOL, V36, P377, DOI 10.1007/s10571-015-0294-3
   Singh Abhay Kumar, 2020, ONCOTARGET, V11, P2647, DOI 10.18632/oncotarget.27663
   Smeyers J, 2021, FRONT CELL NEUROSCI, V15, P0, DOI 10.3389/fncel.2021.661447
   Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027
   Smukowski SN, 2022, NEUROL-GENET, V8, P0, DOI 10.1212/NXG.0000000000000669
   Sokolowska B, 2009, J PHYSIOL PHARMACOL, V60, P117
   Sproviero D, 2022, FRONT AGING NEUROSCI, V14, P0, DOI 10.3389/fnagi.2022.785741
   Sproviero D, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22052737
   Sproviero W, 2017, NEUROBIOL AGING, V51, P0, DOI 10.1016/j.neurobiolaging.2016.11.010
   Steinacker P, 2018, J NEUROL NEUROSUR PS, V89, P239, DOI 10.1136/jnnp-2017-317138
   Stoica L, 2016, ANN NEUROL, V79, P687, DOI 10.1002/ana.24618
   Straub IR, 2021, HUM MOL GENET, V30, P687, DOI 10.1093/hmg/ddab078
   Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393
   Sturmey E, 2022, ACTA NEUROL SCAND, V146, P375, DOI 10.1111/ane.13698
   Sun J, 2020, EUR J NEUROL, V27, P2125, DOI 10.1111/ene.14409
   Sun QH, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00919
   Sung W, 2022, BRAIN COMMUN, V4, P0, DOI 10.1093/braincomms/fcac299
   Takahashi Y, 2013, AM J HUM GENET, V93, P900, DOI 10.1016/j.ajhg.2013.09.008
   Tan RH, 2017, ACTA NEUROPATHOL, V133, P177, DOI 10.1007/s00401-016-1666-6
   Tarasiuk J, 2012, J NEURAL TRANSM, V119, P747, DOI 10.1007/s00702-012-0806-y
   Tazelaar GSHP, 2019, NEUROBIOL AGING, V74, P0, DOI 10.1016/j.neurobiolaging.2018.09.012
   Testa D, 2004, AMYOTROPH LATERAL SC, V5, P208, DOI 10.1080/14660820410021311
   Teyssou E, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23105694
   Thapa S, 2023, ACTA NEUROL SCAND, V2023, P0, DOI 10.1155/2023/2791622
   Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004
   Thompson AG, 2019, J NEUROL NEUROSUR PS, V90, P1215, DOI 10.1136/jnnp-2019-320442
   Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158
   Tortelli R, 2015, EUR J NEUROL, V22, P215, DOI 10.1111/ene.12421
   Tortelli R, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.552295
   Toth RP, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.01017
   Traynor BJ, 2014, J NEUROL NEUROSUR PS, V85, P476, DOI 10.1136/jnnp-2013-305726
   Ugbode C, 2021, NEUROBIOL DIS, V147, P0, DOI 10.1016/j.nbd.2020.105144
   Vacchiano V, 2021, FRONT AGING NEUROSCI, V13, P0, DOI 10.3389/fnagi.2021.753242
   Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100
   van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244
   Verde F, 2019, J NEUROL NEUROSUR PS, V90, P157, DOI 10.1136/jnnp-2018-318704
   Vilariño-Güell C, 2009, NEUROLOGY, V72, P2024, DOI 10.1212/WNL.0b013e3181a92c4c
   Walhout R, 2018, AMYOTROPH LAT SCL FR, V19, P21, DOI 10.1080/21678421.2017.1386688
   Walker C, 2017, NAT NEUROSCI, V20, P1225, DOI 10.1038/nn.4604
   Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200
   Waller R, 2017, NEUROBIOL AGING, V55, P123, DOI 10.1016/j.neurobiolaging.2017.03.027
   Wang F, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.865264
   Wang LQ, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-31240-4
   Wang P, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1007947
   Wang XB, 2014, J NEUROL SCI, V340, P63, DOI 10.1016/j.jns.2014.02.026
   Wang Y, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.886887
   Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405
   Williams KL, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11253
   Winer L, 2013, JAMA NEUROL, V70, P201, DOI 10.1001/jamaneurol.2013.593
   Witzel S, 2022, CURR OPIN NEUROL, V35, P699, DOI 10.1097/WCO.0000000000001094
   Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280
   Wu JJ, 2020, P NATL ACAD SCI USA, V117, P15230, DOI 10.1073/pnas.1917371117
   Xiao YC, 2017, J EXP MED, V214, P1493, DOI 10.1084/jem.20161524
   Xiao Y, 2021, PROG NEUROBIOL, V201, P0, DOI 10.1016/j.pneurobio.2021.102022
   Yang CX, 2016, P NATL ACAD SCI USA, V113, PE6209, DOI 10.1073/pnas.1605964113
   Yao L, 2017, CANCER GENET-NY, V211, P1, DOI 10.1016/j.cancergen.2016.12.002
   Ye JQ, 2019, P NATL ACAD SCI USA, V116, P24517, DOI 10.1073/pnas.1915732116
   Yu M, 2022, J NEUROPATH EXP NEUR, V81, P172, DOI 10.1093/jnen/nlac004
   Yu YJ, 2019, HUM MOL GENET, V28, P3486, DOI 10.1093/hmg/ddz119
   Zhou YQ, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003895
   Zou ZY, 2016, AMYOTROPH LAT SCL FR, V17, P610, DOI 10.1080/21678421.2016.1199698
NR 274
TC 3
Z9 3
U1 5
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG 15
PY 2023
VL 12
IS 15
BP 
EP 
DI 10.3390/cells12151948
PG 39
WC Cell Biology
SC Cell Biology
GA O7CF4
UT WOS:001045337600001
PM 37566027
DA 2024-11-01
ER

PT J
AU Gharti, P
   Fletcher, JF
   Chapman, KE
AF Gharti, Prashamsa
   Fletcher, Jessica F.
   Chapman, Katherine E.
TI Evaluation of endpoints for the study and diagnosis of mitochondrial toxicity and disease: a narrative review
SO MUTAGENESIS
LA English
DT Review
ID oxidative damage; atp synthesis; dna; lymphoblast; disorders; biomarker; nuclear; fgf-21; respiration; management
AB Mitochondrial DNA mutation and toxicity have been linked to several inherited and acquired diseases; however, these are challenging to diagnose and characterize due to clinical and genetic heterogeneity. This review investigates current techniques for the analysis of mitochondrial perturbations, and novel, emerging endpoints for routine application within the clinical setting. Particular focus is given to the biochemistry of the mitochondria influencing each endpoint and the relation of these to toxicity. Current approaches such as the use of metabolic markers (e.g. lactate production), and muscle biopsies to measure mitochondrial proteins were found to lack specificity. Newly emerging identified endpoints were: fibroblast growth factor-21, glucose uptake, mitochondrial membrane potential, mitochondrial morphology, mtDNA heteroplasmy, and mutation of mtDNA and nuclear DNA. Owed to the advancement in genetic analysis techniques, it is suggested by this review that genotypic endpoints of mtDNA mutation and heteroplasmy show particular promise as indicators of mitochondrial disease. It is, however, acknowledged that any single endpoint in isolation offers limited information; therefore, it is recommended that analysis of several endpoints simultaneously will offer the greatest benefit in terms of disease diagnosis and study. It is hoped that this review further highlights the need for advancement in understanding mitochondrial disease.
C1 [Gharti, Prashamsa; Fletcher, Jessica F.; Chapman, Katherine E.] Swansea Univ, Med Sch, Swansea SA2 8PP, Wales.
   [Chapman, Katherine E.] Swansea Univ, Med Sch, Inst Life Sci 1, Swansea SA2 8PP, Wales.
C3 Swansea University; Swansea University
RP Chapman, KE (corresponding author), Swansea Univ, Med Sch, Inst Life Sci 1, Swansea SA2 8PP, Wales.
EM K.E.Chapman@swansea.ac.uk
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Almannai M, 2020, MOL GENET METAB, V131, P1, DOI 10.1016/j.ymgme.2020.10.002
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Battelli MG, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/3527579
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Cai CY, 2019, MODERN PATHOL, V32, P462, DOI 10.1038/s41379-018-0164-x
   Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Fernández-Vizarra E, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00134
   Finsterer J, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7020016
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Konno T, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10020233
   Kuna L, 2018, CURR DRUG METAB, V19, P830, DOI 10.2174/1389200219666180523095355
   Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lu YW, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00003
   Maeda R, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67686-z
   Mayorov Vladimir I, 2008, BMC BIOCHEMISTRY, V9, P9, DOI 10.1186/1471-2091-9-22
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Missiroli S, 2020, EBIOMEDICINE, V59, P0, DOI 10.1016/j.ebiom.2020.102943
   Mitrofanov KY, 2018, RUSS J GENET+, V54, P121, DOI 10.1134/S1022795417100064
   Moindijie H, 2021, CANCERS, V13, P1
   Morava E, 2015, J INHERIT METAB DIS, V38, P387, DOI 10.1007/s10545-015-9852-6
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   Muraresku CC, 2018, CURR GENET MED REP, V6, P62, DOI 10.1007/s40142-018-0138-9
   Naini A, 2020, METHOD CELL BIOL, V155, P383, DOI 10.1016/bs.mcb.2019.11.009
   Navaratnarajah T, 2021, INT J BIOCHEM CELL B, V134, P0, DOI 10.1016/j.biocel.2021.105951
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Perez-Albert Paula, 2018, JIMD REP, V42, P61, DOI 10.1007/8904_2017_78
   Pino RM, 2021, ANESTHESIOLOGY, V134, P637, DOI 10.1097/ALN.0000000000003655
   Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094
   Rana P, 2019, CHEM RES TOXICOL, V32, P156, DOI 10.1021/acs.chemrestox.8b00246
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Sabouny R, 2020, TRENDS BIOCHEM SCI, V45, P564, DOI 10.1016/j.tibs.2020.03.009
   Salehi MH, 2013, MOL BIOL REP, V40, P6495, DOI 10.1007/s11033-013-2767-0
   Singh S, 2017, INFLAMMOPHARMACOLOGY, V25, P383, DOI 10.1007/s10787-017-0347-y
   Sofronova JK, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1031, DOI 10.1134/S0006297916100011
   Steele HE, 2017, BRAIN, V140, P2530, DOI 10.1093/brain/awx168
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142
   Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003
   Van Bergen NJ, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021347
   Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491
   White EJ, 2017, BIORXIV, V222109, P0
   Xie LL, 2018, CANCER SCI, V109, P3686, DOI 10.1111/cas.13830
   Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274
   Zhang BB, 2015, FAM CANCER, V14, P19, DOI 10.1007/s10689-014-9757-9
   Zhao M, 2021, THERANOSTICS, V11, P1845, DOI 10.7150/thno.50905
   Zhu CL, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-03739-0
   Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 62
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0267-8357
EI 1464-3804
J9 MUTAGENESIS
JI Mutagenesis
PD JUN 20
PY 2023
VL 38
IS 3
BP 132
EP 138
DI 10.1093/mutage/gead010
EA MAY 2023
PG 7
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA J2OJ3
UT WOS:000992061500001
PM 37144479
DA 2024-11-01
ER

PT J
AU Liu, YQ
   Zhao, S
   Chen, XL
   Bian, YH
   Cao, YZ
   Xu, PW
   Zhang, CM
   Zhang, JT
   Zhao, SG
   Zhao, H
AF Liu, Yuqing
   Zhao, Shuai
   Chen, Xiaolei
   Bian, Yuehong
   Cao, Yongzhi
   Xu, Peiwen
   Zhang, Changming
   Zhang, Jiangtao
   Zhao, Shigang
   Zhao, Han
TI Variations in mitochondrial DNA coding and d-loop region are associated with early embryonic development defects in infertile women
SO HUMAN GENETICS
LA English
DT Article
ID lactic-acidosis; mutation; mtdna; encephalopathy; aminoacylation; competence; variants; myopathy; deafness; oocytes
AB Mitochondrial DNA (mtDNA) plays a critical role in oocyte maturation, fertilization, and early embryonic development. Defects in mtDNA may determine the alteration of the mitochondrial function, affecting cellular oxidative phosphorylation and ATP supply, leading to impaired oocyte maturation, abnormal fertilization, and low embryonic developmental potential, ultimately leading to female infertility. This case-control study was established to investigate the correlation between mtDNA variations and early embryonic development defects. Peripheral blood was collected for next-generation sequencing from women who suffered the repeated failures of in vitro fertilization (IVF) and/or intracytoplasmic sperm injection (ICSI) cycles due to early embryonic development defects as well as in-house healthy controls, and the sequencing results were statistically analyzed for all subjects. This study found that infertile women with early embryonic development defects carried more mtDNA variants, especially in the d-loop region, ATP6 gene, and CYTB gene. By univariate logistic regression analysis, 16 mtDNA variants were associated with an increased risk of early embryonic development defects (OR > 1, p < 0.05). Furthermore, we identified 16 potentially pathogenic mtDNA variants only in infertile cases. The data proved that mtDNA variations were associated with early embryonic development defects in infertile Chinese women.
C1 [Liu, Yuqing; Zhao, Shuai; Chen, Xiaolei; Bian, Yuehong; Cao, Yongzhi; Xu, Peiwen; Zhang, Changming; Zhang, Jiangtao; Zhao, Shigang; Zhao, Han] Shandong Univ, Ctr Reprod Med, 157 Jingliu Rd, Jinan 250021, Shandong, Peoples R China.
   [Liu, Yuqing; Zhao, Shuai; Chen, Xiaolei; Bian, Yuehong; Cao, Yongzhi; Xu, Peiwen; Zhang, Changming; Zhang, Jiangtao; Zhao, Shigang; Zhao, Han] Shandong Univ, Key Lab Reprod Endocrinol, Minist Educ, Jinan 250012, Shandong, Peoples R China.
   [Liu, Yuqing; Zhao, Shuai; Chen, Xiaolei; Bian, Yuehong; Cao, Yongzhi; Xu, Peiwen; Zhang, Changming; Zhang, Jiangtao; Zhao, Shigang; Zhao, Han] Shandong Key Lab Reprod Med, Jinan 250012, Shandong, Peoples R China.
   [Liu, Yuqing; Zhao, Shuai; Chen, Xiaolei; Bian, Yuehong; Cao, Yongzhi; Xu, Peiwen; Zhang, Changming; Zhang, Jiangtao; Zhao, Shigang; Zhao, Han] Shandong Prov Clin Res Ctr Reprod Hlth, Jinan 250012, Shandong, Peoples R China.
   [Liu, Yuqing; Zhao, Shuai; Chen, Xiaolei; Bian, Yuehong; Cao, Yongzhi; Xu, Peiwen; Zhang, Changming; Zhang, Jiangtao; Zhao, Shigang; Zhao, Han] Shandong Technol Innovat Ctr Reprod Hlth, Jinan 250012, Shandong, Peoples R China.
   [Liu, Yuqing; Zhao, Shuai; Chen, Xiaolei; Bian, Yuehong; Cao, Yongzhi; Xu, Peiwen; Zhang, Changming; Zhang, Jiangtao; Zhao, Shigang; Zhao, Han] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University
RP Zhao, H (corresponding author), Shandong Univ, Ctr Reprod Med, 157 Jingliu Rd, Jinan 250021, Shandong, Peoples R China.; Zhao, H (corresponding author), Shandong Univ, Key Lab Reprod Endocrinol, Minist Educ, Jinan 250012, Shandong, Peoples R China.; Zhao, H (corresponding author), Shandong Key Lab Reprod Med, Jinan 250012, Shandong, Peoples R China.; Zhao, H (corresponding author), Shandong Prov Clin Res Ctr Reprod Hlth, Jinan 250012, Shandong, Peoples R China.; Zhao, H (corresponding author), Shandong Technol Innovat Ctr Reprod Hlth, Jinan 250012, Shandong, Peoples R China.; Zhao, H (corresponding author), Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250012, Shandong, Peoples R China.
EM hanzh80@sdu.edu.cn
FU National Key Research and Development Program of China [2021YFC2700400, 2018YFC1004303]; Basic Science Center Program of NSFC [31988101]; National Natural Science Foundation of China [82192874, 31871509, 82071606]; Shandong Provincial Key Research and Development Program [2020ZLYS02]; Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences [2020RU001]; Taishan Scholars Program of Shandong Province [ts20190988]; Fundamental Research Funds of Shandong University
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Au HK, 2005, ANN NY ACAD SCI, V1042, P177, DOI 10.1196/annals.1338.020
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Clayton D A, 2000, HUM REPROD, V15 Suppl 2, P11
   Demain LAM, 2017, CLIN GENET, V91, P199, DOI 10.1111/cge.12896
   Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8
   Duranthon V, 2001, THERIOGENOLOGY, V55, P1277, DOI 10.1016/S0093-691X(01)00482-4
   Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Jancic J, 2020, MITOCHONDRION, V50, P132, DOI 10.1016/j.mito.2019.10.011
   Ji LC, 2020, J ASSIST REPROD GEN, V37, P2181, DOI 10.1007/s10815-020-01893-5
   Ji YC, 2016, INVEST OPHTH VIS SCI, V57, P2377, DOI 10.1167/iovs.16-19243
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Keefe D, 2015, FERTIL STERIL, V103, P317, DOI 10.1016/j.fertnstert.2014.12.115
   Lee LN, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8081207
   Li XY, 2020, J ASSIST REPROD GEN, V37, P2171, DOI 10.1007/s10815-020-01853-z
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007
   Maybury BD, 2013, ANTICANCER RES, V33, P3543
   Poincenot L, 2020, OPHTHALMOLOGY, V127, P679, DOI 10.1016/j.ophtha.2019.11.014
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Seyedhassani SM, 2010, J ASSIST REPROD GEN, V27, P641, DOI 10.1007/s10815-010-9435-2
   Shamsi MB, 2013, MITOCHONDRION, V13, P96, DOI 10.1016/j.mito.2013.01.002
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240
   Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726
   YANAGISAWA K, 1995, DIABETOLOGIA, V38, P809, DOI 10.1007/s001250050357
NR 34
TC 0
Z9 1
U1 2
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD FEB 15
PY 2023
VL 142
IS 2
BP 193
EP 200
DI 10.1007/s00439-022-02505-1
EA NOV 2022
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 9C8IY
UT WOS:000880534400001
PM 36352239
DA 2024-11-01
ER

PT J
AU Vandiver, AR
   Hoang, AN
   Herbst, A
   Lee, CC
   Aiken, JM
   McKenzie, D
   Teitell, MA
   Timp, W
   Wanagat, J
AF Vandiver, Amy R.
   Hoang, Austin N.
   Herbst, Allen
   Lee, Cathy C.
   Aiken, Judd M.
   McKenzie, Debbie
   Teitell, Michael A.
   Timp, Winston
   Wanagat, Jonathan
TI Nanopore sequencing identifies a higher frequency and expanded spectrum of mitochondrial DNA deletion mutations in human aging
SO AGING CELL
LA English
DT Article
DE aging; DNA sequencing; human; mitochondrial DNA; skeletal muscle; substantia nigra
ID human skeletal-muscle; age; regions; genome
AB Mitochondrial DNA (mtDNA) deletion mutations cause many human diseases and are linked to age-induced mitochondrial dysfunction. Mapping the mutation spectrum and quantifying mtDNA deletion mutation frequency is challenging with next-generation sequencing methods. We hypothesized that long-read sequencing of human mtDNA across the lifespan would detect a broader spectrum of mtDNA rearrangements and provide a more accurate measurement of their frequency. We employed nanopore Cas9-targeted sequencing (nCATS) to map and quantitate mtDNA deletion mutations and develop analyses that are fit-for-purpose. We analyzed total DNA from vastus lateralis muscle in 15 males ranging from 20 to 81 years of age and substantia nigra from three 20-year-old and three 79-year-old men. We found that mtDNA deletion mutations detected by nCATS increased exponentially with age and mapped to a wider region of the mitochondrial genome than previously reported. Using simulated data, we observed that large deletions are often reported as chimeric alignments. To address this, we developed two algorithms for deletion identification which yield consistent deletion mapping and identify both previously reported and novel mtDNA deletion breakpoints. The identified mtDNA deletion frequency measured by nCATS correlates strongly with chronological age and predicts the deletion frequency as measured by digital PCR approaches. In substantia nigra, we observed a similar frequency of age-related mtDNA deletions to those observed in muscle samples, but noted a distinct spectrum of deletion breakpoints. NCATS-mtDNA sequencing allows the identification of mtDNA deletions on a single-molecule level, characterizing the strong relationship between mtDNA deletion frequency and chronological aging.
C1 [Vandiver, Amy R.] UCLA, Dept Med, Div Dermatol, Los Angeles, CA USA.
   [Vandiver, Amy R.; Lee, Cathy C.; Wanagat, Jonathan] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Hoang, Austin N.; Lee, Cathy C.; Wanagat, Jonathan] UCLA, Dept Med, Div Geriatr, Los Angeles, CA USA.
   [Herbst, Allen] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA.
   [Aiken, Judd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.
   [Teitell, Michael A.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, Dept Bioengn, Calif NanoSyst Inst, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA.
   [Teitell, Michael A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA USA.
   [Timp, Winston] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD USA.
   [Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA.
   [Timp, Winston] Johns Hopkins Univ, Dept Genet Med, Sch Med, Baltimore, MD USA.
   [Wanagat, Jonathan] Univ Calif Los Angeles, Dept Med, Div Geriatr, 650 Charles E Young Dr South,RM 34-115, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; United States Department of the Interior; United States Geological Survey; University of Alberta; University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles
RP Wanagat, J (corresponding author), Univ Calif Los Angeles, Dept Med, Div Geriatr, 650 Charles E Young Dr South,RM 34-115, Los Angeles, CA 90095 USA.
EM jwanagat@mednet.ucla.edu
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases [T32 AR071307]; National Institute on Aging [K02AG059847, R01AG055518, R01AG069924, R56AG060880]; Dermatology Foundation
CR Albayrak L, 2016, BMC GENOMICS, V17, P0, DOI 10.1186/s12864-016-3375-x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   Devall M, 2015, BIOTECHNIQUES, V59, P241, DOI 10.2144/000114343
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Herbst A, 2021, GEROSCIENCE, V43, P1253, DOI 10.1007/s11357-021-00351-z
   Herbst A, 2021, AGING CLIN EXP RES, V33, P1811, DOI 10.1007/s40520-020-01698-7
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Keraite I, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-33530-3
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, P0, DOI 10.1371/journal.pcbi.1003118
   Lee Cathy C, 2020, J CYTOL HISTOL, V11, P0, DOI 10.37421/jch.2020.11.553
   LEE CM, 1994, MECH AGEING DEV, V75, P69, DOI 10.1016/0047-6374(94)90029-9
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sanchez-Contreras M, 2022, FRONT AGING-LAUSANNE, V2, P0, DOI 10.3389/fragi.2021.805126
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   Wei W, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15336-3
   Weissensteiner H, 2021, GENOME RES, V31, P309, DOI 10.1101/gr.256545.119
   Wheeler Joel H, 2019, CURR PROTOC TOXICOL, V80, Pe75, DOI 10.1002/cptx.75
   Yang C, 2017, GIGASCIENCE, V6, P0, DOI 10.1093/gigascience/gix010
   Yao Y, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-53449-y
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 39
TC 8
Z9 8
U1 3
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN 15
PY 2023
VL 22
IS 6
BP 
EP 
DI 10.1111/acel.13842
EA MAY 2023
PG 12
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA I9NV0
UT WOS:000981568100001
PM 37132288
DA 2024-11-01
ER

PT J
AU Dabravolski, SA
AF Dabravolski, Siarhei A.
TI Mitochondria-derived peptides in healthy ageing and therapy of age-related diseases
SO SENESCENCE, SENOTHERAPEUTICS AND MITOCHONDRIA, VOL. 136
LA English
DT Article; Book Chapter
ID amyloid-beta-peptide; synaptic plasticity; skeletal-muscle; humanin; homeostasis; colivelin; memory; neuroprotection; impairments; protects
AB Mitochondrial-derived peptides (MDPs) are small bioactive peptides encoded by mitochondrial DNA and involved in various stress-protecting mechanisms. To date, eight mitochondrial-derived peptides have been identified: MOTS-c sequence is hidden in the 12 S rRNA gene (MT-RNR1), and the other 7 (humanin and small humanin-like peptides 1-6) are encoded by the 16 S rRNA (MT-RNR2) gene. While the anti-apoptotic, anti-inflammatory and cardioprotective activities of MDPs are well described, recent research suggests that MDPs are sensitive metabolic sensors, closely connected with mtDNA mutation-associated diseases and age-associated metabolic disorders. In this chapter, we focus on the recent progress in understanding the metabolo-protective properties of MDPs, their role in maintenance of the cellular and mitochondrial homeostasis associated with age-related diseases: Alzheimer's disease, cognitive decline, macular degeneration and cataracts. Also, we will discuss MDPs-based and MDPs-targeted interventions to treat age-related diseases and extend a healthy lifespan.
C1 [Dabravolski, Siarhei A.] Braude Acad Coll Engn, Dept Biotechnol Engn, IL-2161002 Karmiel, Israel.
C3 Braude Academic College of Engineering
RP Dabravolski, SA (corresponding author), Braude Acad Coll Engn, Dept Biotechnol Engn, IL-2161002 Karmiel, Israel.
EM sergedobrowolski@gmail.com
CR Alsanousi N, 2016, BIOCHEM BIOPH RES CO, V477, P647, DOI 10.1016/j.bbrc.2016.06.114
   Atayik MC, 2022, BIOGERONTOLOGY, V23, P401, DOI 10.1007/s10522-022-09973-y
   Benayoun BA, 2019, BIOESSAYS, V41, P0, DOI 10.1002/bies.201900046
   Blasiak J, 2020, CELL MOL LIFE SCI, V77, P789, DOI 10.1007/s00018-019-03420-x
   Boguszewska K, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25122857
   Bohovych I, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00109
   Campos-Peña V, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232012092
   Capt C, 2016, MITOCHONDRIAL DNA A, V27, P3098, DOI 10.3109/19401736.2014.1003924
   Carmona-Gutierrez D, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08555-w
   Chai GS, 2014, NEUROSCI BULL, V30, P923, DOI 10.1007/s12264-014-1479-3
   Chiba T, 2005, J NEUROSCI, V25, P10252, DOI 10.1523/JNEUROSCI.3348-05.2005
   Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943
   Conte M, 2021, GEROSCIENCE, V43, P985, DOI 10.1007/s11357-020-00287-w
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   Zárate SC, 2019, FRONT AGING NEUROSCI, V11, P0, DOI 10.3389/fnagi.2019.00123
   DSouza RF, 2020, AGING-US, V12, P5244, DOI 10.18632/aging.102944
   Dabravolski SA, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22168770
   Zuccato CF, 2019, EXPERT OPIN THER TAR, V23, P117, DOI 10.1080/14728222.2019.1559300
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gong Zhenwei, 2018, ONCOTARGET, V9, P10832, DOI 10.18632/oncotarget.24396
   Gong ZW, 2018, J CELL BIOL, V217, P635, DOI 10.1083/jcb.201606095
   Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   Hyatt JPK, 2022, PHYSIOL REP, V10, P0, DOI 10.14814/phy2.15377
   Jiang JH, 2021, ACS CHEM NEUROSCI, V12, P1506, DOI 10.1021/acschemneuro.0c00782
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Kim Jihye, 2021, J LIFESTYLE MED, V11, P13, DOI 10.15280/jlm.2021.11.1.13
   Kim KH, 2018, CELL METAB, V28, P516, DOI 10.1016/j.cmet.2018.06.008
   Kim SJ, 2022, BBA-GEN SUBJECTS, V1866, P0, DOI 10.1016/j.bbagen.2021.130017
   Kim SJ, 2021, GEROSCIENCE, V43, P1113, DOI 10.1007/s11357-020-00262-5
   Kim SJ, 2018, AGING-US, V10, P1239, DOI 10.18632/aging.101463
   Kim SJ, 2016, ONCOTARGET, V7, P46899, DOI 10.18632/oncotarget.10380
   Klionsky DJ, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2021108863
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee C, 2014, AGING CELL, V13, P958, DOI 10.1111/acel.12243
   Li H, 2018, INT J CARDIOL, V268, P40, DOI 10.1016/j.ijcard.2018.03.031
   Li Z, 2020, NANOMED-NANOTECHNOL, V24, P0, DOI 10.1016/j.nano.2019.102111
   Logan IS, 2017, PSEUDOGENIZATION OF THE HUMANIN GENE IS COMMON IN THE MITOCHONDRIAL DNA OF MANY VERTEBRATES, V38, P198, DOI 10.24272/j.issn.2095-8137.2017.049
   Ma ZW, 2018, ACTA PHARMACOL SIN, V39, P1012, DOI 10.1038/aps.2017.169
   Matsunaga D, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0165150
   Mendelsohn AR, 2018, REJUV RES, V21, P369, DOI 10.1089/rej.2018.2114
   Merry TL, 2020, AM J PHYSIOL-ENDOC M, V319, PE659, DOI 10.1152/ajpendo.00249.2020
   Meyer A, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.00536
   Mortz M, 2020, GENOMICS, V112, P1120, DOI 10.1016/j.ygeno.2019.06.026
   Murakami M, 2017, NEUROPEPTIDES, V66, P90, DOI 10.1016/j.npep.2017.10.002
   Murakami M, 2017, NEUROPEPTIDES, V62, P65, DOI 10.1016/j.npep.2016.10.008
   Nascimento CM, 2019, FREE RADICAL BIO MED, V132, P42, DOI 10.1016/j.freeradbiomed.2018.08.035
   Nashine S, 2022, AGING-US, V14, P4247, DOI 10.18632/aging.204074
   Nashine S, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9051102
   Nashine S, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-33290-5
   Nashine S, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2017.348
   Njomen E, 2015, PROTEIN PEPTIDE LETT, V22, P869, DOI 10.2174/0929866522666150728114955
   Ogborn DI, 2015, AM J PHYSIOL-REG I, V308, PR734, DOI 10.1152/ajpregu.00005.2014
   Okada AK, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-08372-5
   Qian K, 2022, ACS NANO, V16, P11455, DOI 10.1021/acsnano.2c05795
   Qin QQ, 2018, BIOCHEM BIOPH RES CO, V497, P292, DOI 10.1016/j.bbrc.2018.02.071
   Rao M, 2019, ANDROLOGY-US, V7, P859, DOI 10.1111/andr.12614
   Reynolds JC, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20790-0
   Shah M, 2012, PROTEIN SCI, V21, P743, DOI 10.1002/pro.2063
   Sreekumar PG, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101663
   Sreekumar PG, 2016, INVEST OPHTH VIS SCI, V57, P1238, DOI 10.1167/iovs.15-17053
   Thiankhaw K, 2022, BBA-GEN SUBJECTS, V1866, P0, DOI 10.1016/j.bbagen.2022.130097
   Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119
   Wang YY, 2021, ENDOCRINOLOGY, V162, P0, DOI 10.1210/endocr/bqab056
   Woodhead JST, 2020, J APPL PHYSIOL, V128, P1346, DOI 10.1152/japplphysiol.00032.2020
   Wu MN, 2015, HIPPOCAMPUS, V25, P363, DOI 10.1002/hipo.22378
   Wu MN, 2017, J ALZHEIMERS DIS, V59, P1067, DOI 10.3233/JAD-170307
   Yang BY, 2021, BBA-MOL BASIS DIS, V1867, P0, DOI 10.1016/j.bbadis.2021.166126
   Yang H, 2020, MOL MED REP, V22, P1467, DOI 10.3892/mmr.2020.11202
   Yen K, 2020, AGING-US, V12, P11185, DOI 10.18632/aging.103534
   Yen K, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-32616-7
   Yu WD, 2021, MITOCHONDRION, V58, P135, DOI 10.1016/j.mito.2021.02.010
   Yuan L, 2016, NEUROSCI BULL, V32, P374, DOI 10.1007/s12264-016-0041-x
   Zhu Y, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-29361-x
NR 75
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1876-1623
EI 
J9 ADV PROTEIN CHEM STR
JI Adv. Protein Chem. Struct. Biol.
PD JUN 15
PY 2023
VL 136
IS 
BP 197
EP 215
DI 10.1016/bs.apcsb.2023.02.015
PG 19
WC Biochemistry & Molecular Biology; Cell Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Cell Biology; Pharmacology & Pharmacy
GA BW0GQ
UT WOS:001096267800007
PM 37437978
DA 2024-11-01
ER

PT J
AU Tang, S
   You, JY
   Liu, L
   Ouyang, HJ
   Jiang, N
   Duan, JQ
   Li, CL
   Luo, YH
   Zhang, WT
   Zhan, MZ
   Liu, CX
   Lyu, GZ
   Zhang, VW
   Zhao, HM
AF Tang, Shuo
   You, Jieyu
   Liu, Li
   Ouyang, Hongjuan
   Jiang, Na
   Duan, Jiaqi
   Li, Canlin
   Luo, Yanhong
   Zhang, Wenting
   Zhan, Meizheng
   Liu, Chenxi
   Lyu, Gui-Zhen
   Zhang, Victor Wei
   Zhao, Hongmei
TI Expanding the mutational spectrum of ZTTK syndrome: A de novo variant with global developmental delay and malnutrition in a Chinese patient
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE genetics; global developmental delay; multiple phylogenetic disorders; muscle weakness; SON; Zhu-Tokita-Takenouchi-Kim syndrome
ID intellectual-disability; son
AB BackgroundZhu-Tokita-Takenouchi-Kim (ZTTK, OMIM 617140) syndrome is a severe multisystem developmental disorder characterized by intellectual disability, developmental delay, cortical malformations, epilepsy, visual problems, musculoskeletal abnormalities, and congenital malformations. ZTTK syndrome is caused by a heterozygous pathogenic variant of the SON gene (NM_138927) at chromosome 21q22.1. The purpose of this study was to investigate the pathogenesis of a 6-month-old Chinese child who exhibited global developmental delay, muscle weakness, malnutrition, weight loss, and strabismus, brain abnormality, immunological system abnormalities. MethodsThe little girl was tested for medical exome sequencing (MES) and mtDNA sequencing in trio. And, the mutation was validated by Sanger sequencing. ResultsA novel de novo frameshift variant, c.1845_1870del26 (p.G616Sfs*61), in the SON gene was found in the proband. ConclusionWe described a 6-month-old Chinese child with global developmental delay caused by pathogenic de novo mutation c.1845_1870del26 (p.G616Sfs*61) in the SON. Apart from a founder mutation, we reviewed the phenotypic abnormalities and genotypes in 79 individuals. The data showed that global developmental delay is accompanied by other system disorders. Our findings expanded the mutational spectrum of ZTTK syndrome and provide genetic counseling of baby with global developmental delay.
C1 [Tang, Shuo; You, Jieyu; Liu, Li; Ouyang, Hongjuan; Jiang, Na; Duan, Jiaqi; Li, Canlin; Luo, Yanhong; Zhang, Wenting; Zhan, Meizheng; Liu, Chenxi; Zhao, Hongmei] Hunan Childrens Hosp, Dept Digest Syst Dis, Changsha, Peoples R China.
   [Lyu, Gui-Zhen; Zhang, Victor Wei] AmCare Genom Lab, Guangzhou, Guangdong, Peoples R China.
   [Zhao, Hongmei] Hunan Childrens Hosp, Dept Digest Syst Dis, 86 Ziyuan Rd, Changsha 410007, Peoples R China.
RP Zhao, HM (corresponding author), Hunan Childrens Hosp, Dept Digest Syst Dis, 86 Ziyuan Rd, Changsha 410007, Peoples R China.
EM 364875977@foxmail.com
CR Ahn EEY, 2013, J BIOL CHEM, V288, P5381, DOI 10.1074/jbc.M112.447227
   Dingemans AJM, 2022, EUR J HUM GENET, V30, P271, DOI 10.1038/s41431-021-00960-4
   Gilissen C, 2014, NATURE, V511, P344, DOI 10.1038/nature13394
   Indelicato E, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02218-8
   Kim JH, 2019, KIDNEY INT, V95, P1494, DOI 10.1016/j.kint.2019.01.025
   Kim JH, 2016, AM J HUM GENET, V99, P711, DOI 10.1016/j.ajhg.2016.06.029
   Kushary ST, 2021, AM J MED GENET A, V185, P3740, DOI 10.1002/ajmg.a.62445
   Mahler EA, 2019, DTSCH ARZTEBL INT, V116, P197, DOI 10.3238/arztebl.2019.0197
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, PD200, DOI 10.1093/nar/gkw1129
   Mena R, 2020, AM J MED GENET C, V184, P996, DOI 10.1002/ajmg.c.31859
   Meng LY, 2017, JAMA PEDIATR, V171, P0, DOI 10.1001/jamapediatrics.2017.3438
   Mithyantha R, 2017, ARCH DIS CHILD, V102, P1071, DOI 10.1136/archdischild-2016-311271
   Ouyang XJ, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.725259
   Peng F, 2021, IDENTIFICATION FRAME, V0, P0, DOI DOI 10.21203/rs.3.rs-191620/v1
   Qi QW, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11121397
   Qiao F, 2020, COMPREHENSIVE EVALUA, V0, P0
   Castanedo LQ, 2020, PEDIATR DERMATOL, V37, P517, DOI 10.1111/pde.14113
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sharma A, 2011, J CELL SCI, V124, P4286, DOI 10.1242/jcs.092239
   Slezak R, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1432
   Takenouchi T, 2016, AM J MED GENET A, V170, P2587, DOI 10.1002/ajmg.a.37761
   Tan Y, 2020, J CLIN LAB ANAL, V34, P0, DOI 10.1002/jcla.23326
   Tokita MJ, 2016, AM J HUM GENET, V99, P720, DOI 10.1016/j.ajhg.2016.06.035
   Xin H, 2022, J MED GENET, V39, P316
   Yang LL, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1496
   Yang Y, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.953
   Yi Z, 2022, INT J DEV NEUROSCI, V82, P271, DOI 10.1002/jdn.10170
   Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191
NR 28
TC 0
Z9 0
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD AUG 15
PY 2023
VL 11
IS 8
BP 
EP 
DI 10.1002/mgg3.2188
EA JUL 2023
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA FO9G9
UT WOS:001032165900001
PM 37488749
DA 2024-11-01
ER

PT J
AU Lou, XT
   Zhou, YW
   Liu, ZM
   Xie, YJ
   Zhang, LY
   Zhao, SZ
   Gong, S
   Zhuo, XW
   Wang, JL
   Dai, LF
   Ren, XT
   Tong, X
   Jiang, LL
   Fang, HZ
   Fang, F
   Lyu, J
AF Lou, Xiaoting
   Zhou, Yuwei
   Liu, Zhimei
   Xie, Yaojun
   Zhang, Luyi
   Zhao, Suzhou
   Gong, Shuai
   Zhuo, Xiuwei
   Wang, Junling
   Dai, Lifang
   Ren, Xiaotun
   Tong, Xiao
   Jiang, Liangliang
   Fang, Hezhi
   Fang, Fang
   Lyu, Jianxin
TI <i>De</i><i> novo</i> frameshift variant in<i> MT-ND1</i> causes a mitochondrial complex I deficiency associated with MELAS syndrome
SO GENE
LA English
DT Article
DE MELAS syndrome; MT-ND1; m; 3571_3572insC; De novo; Heteroplasmic
ID oxidative-phosphorylation; dna mutations; nd1; gene; diagnosis
AB Background: The variant m.3571_3572insC/MT-ND1 thus far only reported in oncocytic tumors of different tis-sues. However, the role of m.3571_3572insC in inherited mitochondrial diseases has yet to be elucidated. Methods: A patient diagnosed with MELAS syndrome was recruited, and detailed medical records were collected and reviewed. The muscle was biopsied for mitochondrial respiratory chain enzyme activity. Series of fibroblast clones bearing different m.3571_3572insC variant loads were generated from patient-derived fibroblasts and subjected to functional assays. Results: Complex I deficiency was confirmed in the patient's muscle via mitochondrial respiratory chain enzyme activity assay. The m.3571_3572insC was filtered for the candidate variant of the patient according to the guidelines for mitochondrial mRNA variants interpretation. Three cell clones with different m.3571_3572insC variant loads were generated to evaluate mitochondrial function. Blue native PAGE analysis revealed that m.3571_3572insC caused a deficiency in the mitochondrial complex I. Oxygen consumption rate, ATP produc-tion, and lactate assays found an impairment of cellular bioenergetic capacity due to m.3571_3572insC. Mito-chondrial membrane potential was decreased, and mitochondrial reactive oxygen species production was increased with the variant of m.3571_3572insC. According to the competitive cell growth assay, the mutant cells had impaired cell growth capacity compared to wild type. Conclusions: A novel variant m.3571_3572insC was identified in a patient diagnosed with MELAS syndrome, and the variant impaired mitochondrial respiration by decreasing the activity of complex I. In conclusion, the genetic spectrum of mitochondrial diseases was expanded by including m.3571_3572insC/MT-ND1.
C1 [Lou, Xiaoting] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Reprod Med,Dept Genet & Genom Med, Hangzhou 310014, Zhejiang, Peoples R China.
   [Lou, Xiaoting; Lyu, Jianxin] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Lab Med Ctr,Dept Clin Lab, Hangzhou 310014, Zhejiang, Peoples R China.
   [Zhou, Yuwei; Xie, Yaojun; Zhang, Luyi; Fang, Hezhi; Lyu, Jianxin] Wenzhou Med Univ, Coll Lab Med & Life Sci, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet,Minist Educ, Wenzhou 325035, Zhejiang, Peoples R China.
   [Liu, Zhimei; Gong, Shuai; Zhuo, Xiuwei; Dai, Lifang; Ren, Xiaotun; Tong, Xiao; Fang, Fang] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, Beijing 100069, Peoples R China.
   [Zhao, Suzhou] Fujungenet Technol Co Ltd, Beijing 100176, Peoples R China.
   [Wang, Junling] Third Affiliated Hosp Zhengzhou Univ, Dept Pediat, Zhengzhou 450052, Henan, Peoples R China.
   [Jiang, Liangliang] Anhui Prov Childrens Hosp, Pediat Neurol, Hefei 230022, Anhui, Peoples R China.
C3 Hangzhou Medical College; Zhejiang Provincial People's Hospital; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Wenzhou Medical University; Capital Medical University; Zhengzhou University
RP Lyu, J (corresponding author), Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Lab Med Ctr,Dept Clin Lab, Hangzhou 310014, Zhejiang, Peoples R China.; Lyu, J (corresponding author), Wenzhou Med Univ, Coll Lab Med & Life Sci, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet,Minist Educ, Wenzhou 325035, Zhejiang, Peoples R China.; Fang, F (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, Beijing 100069, Peoples R China.
EM fangfang@bch.com.cn; jxlu313@163.com
FU National Natural Science Foundation of China [81830071]; Zhejiang Provincial Natural Science Foundation of China [LR20H200001]; R & D Program of Beijing Municipal Education Commission [KZ202210025033]; Beijing Municipal Hospital Scientific Research Cultivation Program [PX2021048]; Key Discipline of Zhejiang Province in Medical Technology
CR Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Campbell T, 2021, HUM MUTAT, V42, P177, DOI 10.1002/humu.24143
   Campos Y, 1997, BIOCHEM BIOPH RES CO, V238, P323, DOI 10.1006/bbrc.1997.7166
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fernandez-Vizarra E, 2021, FEBS LETT, V595, P1062, DOI 10.1002/1873-3468.13995
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104
   Gasparre G, 2011, CANCER RES, V71, P6220, DOI 10.1158/0008-5472.CAN-11-1042
   Gu JK, 2022, NAT STRUCT MOL BIOL, V29, P172, DOI 10.1038/s41594-022-00722-w
   Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horváth R, 2008, NEUROMUSCULAR DISORD, V18, P553, DOI 10.1016/j.nmd.2008.05.002
   Ikeda T, 2018, HUM GENOME VAR, V5, P0, DOI 10.1038/s41439-018-0026-6
   Iommarini L, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19030764
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Lim SC, 2016, FASEB J, V30, P2236, DOI 10.1096/fj.201500137R
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Liu ZM, 2022, J MED GENET, V59, P351, DOI 10.1136/jmedgenet-2020-107383
   Liu ZM, 2021, MITOCHONDRION, V57, P222, DOI 10.1016/j.mito.2020.12.014
   Lou XT, 2018, J HUM GENET, V63, P1269, DOI 10.1038/s10038-018-0505-0
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   McKenzie M, 2014, HUM MUTAT, V35, P1476, DOI 10.1002/humu.22694
   Oyama M, 2020, BMC NEUROL, V20, P0, DOI 10.1186/s12883-020-01748-7
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wong LJC, 2020, HUM MUTAT, V41, P1783, DOI 10.1002/humu.24082
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
   Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051
NR 42
TC 5
Z9 5
U1 1
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD APR 15
PY 2023
VL 860
IS 
BP 
EP 
DI 10.1016/j.gene.2023.147229
EA FEB 2023
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA C9LH5
UT WOS:000965045100001
PM 36717040
DA 2024-11-01
ER

PT J
AU Shastry, A
   Dunham-Snary, K
AF Shastry, Abhishek
   Dunham-Snary, Kimberly
TI Metabolomics and mitochondrial dysfunction in cardiometabolic disease
SO LIFE SCIENCES
LA English
DT Article
DE Metabolomics; Metabolic profiling; Cardiometabolic disease; Circulating metabolites; Mitochondria; Redox balance
ID skeletal-muscle cells; fatty-acid oxidation; atmospheric-pressure photoionization; mass-spectrometry data; chain amino-acids; insulin-resistance; cardiovascular-disease; s-adenosylhomocysteine; cellular-metabolism; human-plasma
AB Circulating metabolites are indicators of systemic metabolic dysfunction and can be detected through contemporary techniques in metabolomics. These metabolites are involved in numerous mitochondrial metabolic processes including glycolysis, fatty acid beta-oxidation, and amino acid catabolism, and changes in the abundance of these metabolites is implicated in the pathogenesis of cardiometabolic diseases (CMDs). Epigenetic regulation and direct metabolite-protein interactions modulate metabolism, both within cells and in the circulation. Dysfunction of multiple mitochondrial components stemming from mitochondrial DNA mutations are implicated in disease pathogenesis. This review will summarize the current state of knowledge regarding: i) the interactions between metabolites found within the mitochondrial environment during CMDs, ii) various metabolites' effects on cellular and systemic function, iii) how harnessing the power of metabolomic analyses represents the next frontier of precision medicine, and iv) how these concepts integrate to expand the clinical potential for translational cardiometabolic medicine.
C1 [Shastry, Abhishek; Dunham-Snary, Kimberly] Queens Univ, Dept Med, Botterell Hall 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.
   [Dunham-Snary, Kimberly] Queens Univ, Dept Biomed & Mol Sci, Botterell Hall 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.
C3 Queens University - Canada; Queens University - Canada
RP Dunham-Snary, K (corresponding author), Queens Univ, Dept Med, Botterell Hall 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.; Dunham-Snary, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.
EM Kimberly.DunhamSnary@queensu.ca
FU Canadian Institutes of Health Research [202303PJT-495854]; Canada Research Chairs Program [CRC -2020-00192]; Canada Foundation for Innovation-John R. Evans Leaders Fund [41511]; Banting Research Foundation and Mitacs [6035577]; Faculty of Health Sciences [6032495]; Department of Medicine at Queen's University [6034430]
CR Abedpoor N, 2018, NUTR METAB, V15, P0, DOI 10.1186/s12986-018-0298-3
   Abu Aboud O, 2013, CLIN CHEM, V59, P138, DOI 10.1373/clinchem.2012.184598
   Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737
   Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754
   Adant I, 2022, MOL METAB, V63, P0, DOI 10.1016/j.molmet.2022.101537
   Adav SS, 2021, AGING DIS, V12, P646, DOI 10.14336/AD.2020.0909
   Adriouch S, 2007, J IMMUNOL, V179, P186, DOI 10.4049/jimmunol.179.1.186
   Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901
   Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Akbaraly T, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-26441-1
   Al-Amrani Safa, 2021, WORLD J BIOL CHEM, V12, P57, DOI 10.4331/wjbc.v12.i5.57
   Alarcon-Barrera JC, 2022, DRUG DISCOV TODAY, V27, P1763, DOI 10.1016/j.drudis.2022.02.018
   Alonso A, 2015, FRONT BIOENG BIOTECH, V3, P0, DOI 10.3389/fbioe.2015.00023
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   Anderson R, 2023, CANCERS, V15, P0, DOI 10.3390/cancers15020484
   Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041
   Arany Z, 2018, CURR DIABETES REP, V18, P0, DOI 10.1007/s11892-018-1048-7
   Audrito V, 2020, FRONT ONCOL, V10, P0, DOI 10.3389/fonc.2020.00358
   AVOGARO A, 1989, J LIPID RES, V30, P1811
   Balage M, 2011, J NUTR BIOCHEM, V22, P219, DOI 10.1016/j.jnutbio.2010.02.001
   Bandara AB, 2021, BMC MOL CELL BIOL, V22, P0, DOI 10.1186/s12860-021-00370-w
   Berthiaume JM, 2019, ANTIOXID REDOX SIGN, V30, P375, DOI 10.1089/ars.2017.7415
   Bhinderwala F, 2018, J PROTEOME RES, V17, P4017, DOI 10.1021/acs.jproteome.8b00567
   Bian XL, 2022, TRENDS CELL BIOL, V32, P786, DOI 10.1016/j.tcb.2022.02.003
   Bierla K, 2020, FRONT CHEM, V8, P0, DOI 10.3389/fchem.2020.612387
   Binder E, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074705
   Bingol K, 2015, ANAL CHEM, V87, P3864, DOI 10.1021/ac504633z
   Bishop CA, 2022, NUTR DIABETES, V12, P0, DOI 10.1038/s41387-022-00200-8
   Bjune MS, 2021, BBA-MOL CELL BIOL L, V1866, P0, DOI 10.1016/j.bbalip.2021.158887
   Boesl U, 2017, MASS SPECTROM REV, V36, P86, DOI 10.1002/mas.21520
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   BROOKS GA, 1986, FASEB J, V45, P2924
   Brown JA, 2020, REDOX BIOL, V36, P0, DOI 10.1016/j.redox.2020.101568
   Bruzzone S, 2001, FASEB J, V15, P10
   Bui D, 2019, NEUROCHEM RES, V44, P2301, DOI 10.1007/s11064-019-02759-8
   Cabre N, 2020, ALIMENT PHARM THER, V51, P374, DOI 10.1111/apt.15606
   Cai WB, 2021, FREE RADICAL BIO MED, V173, P7, DOI 10.1016/j.freeradbiomed.2021.06.033
   Carthew RW, 2021, TRENDS GENET, V37, P389, DOI 10.1016/j.tig.2020.09.018
   Castagneto-Gissey L, 2022, EBIOMEDICINE, V76, P0, DOI 10.1016/j.ebiom.2022.103864
   Castelli FA, 2022, ANAL BIOANAL CHEM, V414, P759, DOI 10.1007/s00216-021-03586-z
   Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700
   Charidemou E, 2022, BMC BIOL, V20, P0, DOI 10.1186/s12915-021-01225-8
   Chen JJ, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep05855
   Chen YL, 2018, MICROVASC RES, V119, P13, DOI 10.1016/j.mvr.2018.03.010
   Cheng LL, 2001, FEBS LETT, V494, P112, DOI 10.1016/S0014-5793(01)02329-8
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Chu XG, 2022, METABOLISM, V126, P0, DOI 10.1016/j.metabol.2021.154923
   Clement J, 2019, REJUV RES, V22, P121, DOI 10.1089/rej.2018.2077
   Clendinen CS, 2014, ANAL CHEM, V86, P9242, DOI 10.1021/ac502346h
   Cobb J, 2016, DIABETES CARE, V39, P988, DOI 10.2337/dc15-2752
   Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494
   Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k
   Constantin-Teodosiu D, 2013, DIABETES METAB J, V37, P301, DOI 10.4093/dmj.2013.37.5.301
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Costanzo M, 2022, BIOL SEX DIFFER, V13, P0, DOI 10.1186/s13293-022-00440-4
   Rosa SCD, 2020, PHYSIOL REP, V8, P0, DOI 10.14814/phy2.14607
   David J, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11020355
   de Koning L, 2013, CLIN CHIM ACTA, V415, P54, DOI 10.1016/j.cca.2012.09.002
   DeFronzo RA, 2009, DIABETES CARE, V32, PS157, DOI 10.2337/dc09-S302
   Demetriadou C, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1487-3
   Desfontaine V, 2017, SUPERCRITICAL FLUID CHROMATOGRAPHY, V0, PP213, DOI 10.1016/B978-0-12-809207-1.00008-2
   Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490
   Diebold LP, 2019, NAT METAB, V1, P158, DOI 10.1038/s42255-018-0011-x
   Dietrich S, 2016, HYPERTENSION, V68, P471, DOI 10.1161/HYPERTENSIONAHA.116.07292
   Dunham-Snary KJ, 2018, EBIOMEDICINE, V36, P316, DOI 10.1016/j.ebiom.2018.08.036
   Dyar KA, 2017, FRONT NEUROSCI-SWITZ, V11, P0, DOI 10.3389/fnins.2017.00369
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emwas AH, 2019, METABOLITES, V9, P0, DOI 10.3390/metabo9070123
   Emwas AH, 2018, METABOLOMICS, V14, P0, DOI 10.1007/s11306-018-1321-4
   Emwas Abdul-Hamid M, 2015, METHODS MOL BIOL, V1277, P161, DOI 10.1007/978-1-4939-2377-9_13
   Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400
   Lopes AFC, 2020, CLIN EPIGENETICS, V12, P0, DOI 10.1186/s13148-020-00976-5
   Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012
   Fernandes J, 2022, METABOLITES, V12, P0, DOI 10.3390/metabo12100932
   Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707
   Ferreira AP, 2007, J PEDIAT-BRAZIL, V83, P21, DOI 10.2223/JPED.1562
   Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029
   Fiehn O, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015234
   Figlia G, 2020, DEV CELL, V54, P156, DOI 10.1016/j.devcel.2020.06.036
   Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358
   Fromentin S, 2022, NAT MED, V28, P303, DOI 10.1038/s41591-022-01688-4
   Fujita Y, 2007, MITOCHONDRION, V7, P80, DOI 10.1016/j.mito.2006.11.003
   Fukai T, 2000, J AM SOC MASS SPECTR, V11, P458, DOI 10.1016/S1044-0305(00)00109-4
   FULFORD JE, 1980, J VAC SCI TECHNOL, V17, P829, DOI 10.1116/1.570570
   Gaffney DO, 2020, CELL CHEM BIOL, V27, P206, DOI 10.1016/j.chembiol.2019.11.005
   Gall WE, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010883
   Gao RX, 2023, HEPATOLOGY, V78, P1800, DOI 10.1097/HEP.0000000000000279
   Gathungu RM, 2020, MASS SPECTROM REV, V39, P35, DOI 10.1002/mas.21575
   Geffroy G, 2018, BBA-MOL BASIS DIS, V1864, P1596, DOI 10.1016/j.bbadis.2018.02.005
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Giorgi-Coll S, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-01149-w
   Giskeodegård GF, 2019, ANAL CHIM ACTA, V1081, P93, DOI 10.1016/j.aca.2019.07.026
   Glendenning P, 2006, ANN CLIN BIOCHEM, V43, P23, DOI 10.1258/000456306775141650
   Go SM, 2021, APOPTOSIS, V26, P38, DOI 10.1007/s10495-020-01648-8
   Gouellec AL, 2023, FRONT ANAL SCI, V3, P0, DOI 10.3389/frans.2023.1142606
   Grebe Stefan Kg, 2011, CLIN BIOCHEM REV, V32, P5
   Greco V, 2018, EXPERT REV PROTEOMIC, V15, P683, DOI 10.1080/14789450.2018.1505510
   Grimsditch DC, 2000, ATHEROSCLEROSIS, V151, P389, DOI 10.1016/S0021-9150(99)00400-1
   Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012
   Guijas C, 2018, ANAL CHEM, V90, P3156, DOI 10.1021/acs.analchem.7b04424
   Guo FJ, 2014, OBESITY, V22, P110, DOI 10.1002/oby.20585
   Guo KY, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-57
   Halket John M, 2005, JOURNAL OF EXPERIMENTAL BOTANY, V56, P219
   Hamade AK, 2008, ENVIRON HEALTH PERSP, V116, P1033, DOI 10.1289/ehp.10689
   Hamade AK, 2009, AM J PHYSIOL-REG I, V296, PR1202, DOI 10.1152/ajpregu.90808.2008
   Hanold KA, 2004, ANAL CHEM, V76, P2842, DOI 10.1021/ac035442i
   Hao J, 2012, BIOINFORMATICS, V28, P2088, DOI 10.1093/bioinformatics/bts308
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   Harrison SL, 2009, JOURNAL OF RURAL AND TROPICAL PUBLIC HEALTH, V8, P53
   Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, PE1237, DOI 10.1152/ajpendo.00594.2005
   Hasin Y, 2017, GENOME BIOL, V18, P0, DOI 10.1186/s13059-017-1215-1
   Hatazawa Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0091006
   Haufe S, 2017, NUTR METAB CARDIOVAS, V27, P858, DOI 10.1016/j.numecd.2017.07.001
   Hayen H, 2003, J CHROMATOGR A, V1000, P549, DOI 10.1016/S0021-9673(03)00505-3
   Heiles S, 2021, ANAL BIOANAL CHEM, V413, P5927, DOI 10.1007/s00216-021-03425-1
   Heux S, 2017, CURR OPIN BIOTECH, V43, P104, DOI 10.1016/j.copbio.2016.10.010
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Ho JE, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148361
   Hoffmann MA, 2022, NAT BIOTECHNOL, V40, P411, DOI 10.1038/s41587-021-01045-9
   Holecek M, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24021724
   Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777
   HORNING EC, 1971, CLIN CHEM, V17, P802
   Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498
   Huang WH, 2023, METABOLITES, V13, P0, DOI 10.3390/metabo13050647
   Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075
   Iliou A, 2021, HEART, V107, P1123, DOI 10.1136/heartjnl-2019-315615
   Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171
   Jacob KJ, 2019, J NUTR, V149, P959, DOI 10.1093/jn/nxz038
   Jacobs RA, 2013, AM J PHYSIOL-ENDOC M, V304, PE686, DOI 10.1152/ajpendo.00476.2012
   Janda M, 2021, ANAL CHEM, V93, P8399, DOI 10.1021/acs.analchem.0c04720
   Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057
   Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650
   Jones TE, 2019, SURGERY, V166, P861, DOI 10.1016/j.surg.2019.04.017
   Joseph JJ, 2022, CIRCULATION, V145, PE722, DOI 10.1161/CIR.0000000000001040
   Jung HS, 2020, J LIPID RES, V61, P33, DOI 10.1194/jlr.RA119000256
   Junot C, 2010, ANALYST, V135, P2203, DOI 10.1039/c0an00021c
   Kaklamanos G, 2020, CHEM ANAL FOOD, VSecond, P525, DOI 10.1016/B978-0-12-813266-1.00011-5
   Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002
   Kauppila TJ, 2017, MASS SPECTROM REV, V36, P423, DOI 10.1002/mas.21477
   Kell DB, 2016, METABOLOMICS, V12, P0, DOI 10.1007/s11306-016-1108-4
   Kemper MF, 2014, EUR J PHARMACOL, V723, P322, DOI 10.1016/j.ejphar.2013.11.009
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5
   Kesterson Robert A, 2016, BIO PROTOC, V6, P0
   Kim EY, 2012, J LIPID RES, V53, P1864, DOI 10.1194/jlr.M026567
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Kosmides AK, 2013, METABOLOMIC FINGERPRINTING: CHALLENGES AND OPPORTUNITIES, V41, P205, DOI 10.1615/CritRevBiomedEng.2013007736
   Krijt J, 2009, J CHROMATOGR B, V877, P2061, DOI 10.1016/j.jchromb.2009.05.039
   Kryukov EV, 2021, DIS MARKERS, V2021, P0, DOI 10.1155/2021/7686374
   Krzywanski DM, 2016, CIRC-CARDIOVASC GENE, V9, P26, DOI 10.1161/CIRCGENETICS.115.001308
   Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95
   Kulkarni H, 2013, HYPERTENSION, V62, P621, DOI 10.1161/HYPERTENSIONAHA.113.01396
   Kumar V, 2017, CIRC-CARDIOVASC IMAG, V10, P0, DOI 10.1161/CIRCIMAGING.117.005447
   LaBarre JL, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13103365
   Leamy LJ, 2009, BMC GENET, V10, P0, DOI 10.1186/1471-2156-10-58
   Lee CC, 2016, DIABETES CARE, V39, P582, DOI 10.2337/dc15-2284
   Lee Seo Yeon, 2016, J CANCER PREV, V21, P164
   Leiter LA, 2011, CAN J CARDIOL, V27, P0, DOI 10.1016/j.cjca.2010.12.054
   Lerin C, 2016, MOL METAB, V5, P926, DOI 10.1016/j.molmet.2016.08.001
   Li HR, 2022, MOL OMICS, V18, P196, DOI 10.1039/d1mo00416f
   Li J, 2004, EXP MOL PATHOL, V77, P210, DOI 10.1016/j.yexmp.2004.08.005
   Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005
   Liang CZ, 2014, J NUTR METAB, V2014, P0, DOI 10.1155/2014/239750
   Lin HT, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060874
   Lin YT, 2020, ARTERIOSCL THROM VAS, V40, Pe227, DOI 10.1161/ATVBAHA.120.314356
   Lin YJ, 2022, DIABETES, V71, P637, DOI 10.2337/db21-0535
   Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W
   Liu CY, 2022, GEN PSYCHIAT, V35, P0, DOI 10.1136/gpsych-2021-100662
   Liu H, 2014, AMINO ACIDS, V46, P1971, DOI 10.1007/s00726-014-1752-9
   Liu R, 2021, MOLECULES, V26, P0, DOI 10.3390/molecules26113311
   Liu WP, 2021, ANAL METHODS-UK, V13, P3127, DOI 10.1039/d1ay00821h
   Liu XL, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.972020
   Lowe R, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005457
   Lu WY, 2018, ANTIOXID REDOX SIGN, V28, P167, DOI 10.1089/ars.2017.7014
   Lund J, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8091101
   Lustgarten MS, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0084034
   Mai M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082459
   Marco-Ramell A, 2018, BMC BIOINFORMATICS, V19, P0, DOI 10.1186/s12859-017-2006-0
   Mardinoglu A, 2018, EBIOMEDICINE, V27, P151, DOI 10.1016/j.ebiom.2017.12.008
   Marion D, 2013, MOL CELL PROTEOMICS, V12, P3006, DOI 10.1074/mcp.O113.030239
   Maschari D, 2022, FRONT PHYSIOL, V13, P0, DOI 10.3389/fphys.2022.951390
   McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x
   McCormick KC, 2019, QUANTUM SCI TECHNOL, V4, P0, DOI 10.1088/2058-9565/ab0513
   McGarrah RW, 2018, CIRC RES, V122, P1238, DOI 10.1161/CIRCRESAHA.117.311002
   Menni C, 2016, OBESITY, V24, P1380, DOI 10.1002/oby.21488
   Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024
   Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100
   Moco S, 2022, FRONT MOL BIOSCI, V9, P0, DOI 10.3389/fmolb.2022.882487
   Moghei M, 2016, AM J PHYSIOL-CELL PH, V311, PC518, DOI 10.1152/ajpcell.00062.2016
   Molina-Serrano D, 2016, EMBO REP, V17, P1829, DOI 10.15252/embr.201642540
   Monteiro MS, 2013, CURR MED CHEM, V20, P257, DOI 10.2174/092986713804806621
   Moodley N, 2015, J CLIN PATHOL, V68, P258, DOI 10.1136/jclinpath-2014-202672
   Nair R, 2012, J PHARMACOL PHARMACO, V3, P118, DOI 10.4103/0976-500X.95506
   Nassan FL, 2021, ENVIRON HEALTH-GLOB, V20, P0, DOI 10.1186/s12940-020-00683-x
   Naviaux RK, 2008, CANCER BIOL THER, V7, P1191, DOI 10.4161/cbt.7.8.6741
   Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002
   Ngo DTM, 2019, AM J PHYSIOL-ENDOC M, V316, PE168, DOI 10.1152/ajpendo.00227.2018
   Nikolaev EN, 2016, MASS SPECTROM REV, V35, P219, DOI 10.1002/mas.21422
   Nilsen MS, 2020, DIABETES, V69, P1903, DOI 10.2337/db19-1174
   Nolting D, 2019, MASS SPECTROM REV, V38, P150, DOI 10.1002/mas.21549
   Oberacher H, 2013, J MASS SPECTROM, V48, P487, DOI 10.1002/jms.3184
   Olson KC, 2014, OBESITY, V22, P1212, DOI 10.1002/oby.20691
   Onuh JO, 2020, CLIN HYPERTENS, V26, P0, DOI 10.1186/s40885-020-00157-9
   Ormazabal V, 2018, CARDIOVASC DIABETOL, V17, P0, DOI 10.1186/s12933-018-0762-4
   Ouyang Y, 2020, CELL PROLIFERAT, V53, P0, DOI 10.1111/cpr.12891
   Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298
   Palermo A, 2023, DRUG DISCOV TODAY, V28, P0, DOI 10.1016/j.drudis.2022.103460
   Palmer ND, 2015, J CLIN ENDOCR METAB, V100, PE463, DOI 10.1210/jc.2014-2357
   Schätzlein MP, 2018, ANAL BIOANAL CHEM, V410, P2793, DOI 10.1007/s00216-018-0961-6
   Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, PW388, DOI 10.1093/nar/gkab382
   Paul BD, 2018, TRENDS PHARMACOL SCI, V39, P513, DOI 10.1016/j.tips.2018.02.007
   Paul W, 1953, ANORG. CHEM., V0, P0
   Perng W, 2014, OBESITY, V22, P2570, DOI 10.1002/oby.20901
   Peters SJ, 2001, AM J PHYSIOL-ENDOC M, V281, PE1151, DOI 10.1152/ajpendo.2001.281.6.E1151
   Petersen AK, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-120
   Petersen C, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-13298-z
   Picard M, 2015, P NATL ACAD SCI USA, V112, PE6614, DOI 10.1073/pnas.1515733112
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Pluskal T, 2010, BMC BIOINFORMATICS, V11, P0, DOI 10.1186/1471-2105-11-395
   Poole CF, 2018, CHROMATOGRAPHIA, V81, P365, DOI 10.1007/s10337-017-3400-5
   Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059
   Pretz D, 2021, FASEB J, V35, P0, DOI 10.1096/fj.202001147R
   Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870
   Putri SP, 2013, J BIOSCI BIOENG, V116, P9, DOI 10.1016/j.jbiosc.2013.01.004
   Py G, 2002, METABOLISM, V51, P807, DOI 10.1053/meta.2002.33343
   Rahme M, 2018, METABOLISM, V89, P1, DOI 10.1016/j.metabol.2018.09.003
   Rasmussen P, 2009, J APPL PHYSIOL, V107, P1799, DOI 10.1152/japplphysiol.00468.2009
   Remie CME, 2020, AM J CLIN NUTR, V112, P413, DOI 10.1093/ajcn/nqaa072
   Ribel-Madsen A, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.13044
   Rivera ME, 2020, BIOCHIMIE, V168, P124, DOI 10.1016/j.biochi.2019.10.017
   Robb DB, 2000, ANAL CHEM, V72, P3653, DOI 10.1021/ac0001636
   Roberts Lee D, 2012, CURR PROTOC MOL BIOL, VChapter 30, P0, DOI 10.1002/0471142727.mb3002s98
   Röst HL, 2016, NAT METHODS, V13, P741, DOI 10.1038/nmeth.3959
   Rosca MG, 2012, DIABETES, V61, P2074, DOI 10.2337/db11-1437
   Rothman KJ, 2008, INT J OBESITY, V32, PS56, DOI 10.1038/ijo.2008.87
   Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Rutkai I, 2015, AM J PHYSIOL-HEART C, V309, PH1490, DOI 10.1152/ajpheart.00231.2015
   Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, PE1378, DOI 10.1152/ajpendo.00656.2013
   Saccenti E, 2014, METABOLOMICS, V10, P361, DOI 10.1007/s11306-013-0598-6
   Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870
   Sammy MJ, 2021, AM J PHYSIOL-ENDOC M, V321, PE521, DOI 10.1152/ajpendo.00069.2021
   Sampey BP, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038812
   Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
   San-Millán I, 2018, SPORTS MED, V48, P467, DOI 10.1007/s40279-017-0751-x
   Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264
   Santos-Silva MA, 2013, ARQ BRAS CARDIOL, V100, P157, DOI 10.5935/abc.20130029
   Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Scigelova M, 2011, MOL CELL PROTEOMICS, V10, P0, DOI 10.1074/mcp.M111.009431
   Segers K, 2019, BIOANALYSIS, V11, P2297, DOI 10.4155/bio-2019-0014
   Semmler A, 2008, CLIN CHEM LAB MED, V46, P1398, DOI 10.1515/CCLM.2008.277
   Serena C, 2018, ISME J, V12, P1642, DOI 10.1038/s41396-018-0068-2
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003
   Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078
   Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982
   Shirley MK, 2019, EUR J CLIN NUTR, V73, P1164, DOI 10.1038/s41430-018-0362-0
   Si XY, 2017, ANAL CHEM, V89, P2275, DOI 10.1021/acs.analchem.6b03390
   Sidoli S, 2019, METHODS MOL BIOL, V1928, P125, DOI 10.1007/978-1-4939-9027-6_9
   Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043
   Skinner SC, 2023, J PROTEOME RES, V22, P2319, DOI 10.1021/acs.jproteome.3c00070
   Skovierová H, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17101733
   Sleno L, 2004, J MASS SPECTROM, V39, P1091, DOI 10.1002/jms.703
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Smith CD, 2021, AM J PHYSIOL-ENDOC M, V320, PE938, DOI 10.1152/ajpendo.00010.2021
   Sousa AP, 2021, METABOLITES, V11, P0, DOI 10.3390/metabo11120835
   STANLEY WC, 1988, METABOLISM, V37, P850, DOI 10.1016/0026-0495(88)90119-9
   Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005
   STEINBERGER J, 1995, J PEDIATR-US, V126, P690, DOI 10.1016/S0022-3476(95)70394-2
   Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009
   Suhre K, 2016, ARCH BIOCHEM BIOPHYS, V589, P168, DOI 10.1016/j.abb.2015.09.023
   Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110
   Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025
   Sylow L, 2021, CELL METAB, V33, P758, DOI 10.1016/j.cmet.2021.03.020
   Sysoev A, 1983, THE PHYSICS AND ENGINEERING OF MASS SPECTROMETRY DEVICES AND ELECTROMAGNETIC SETUPS, V0, P0
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taysi S, 2015, EUR REV MED PHARMACO, V19, P154
   Thapa D, 2017, AM J PHYSIOL-HEART C, V313, PH265, DOI 10.1152/ajpheart.00752.2016
   Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017
   Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z
   Tremblay F, 2005, CURR OPIN CLIN NUTR, V8, P457, DOI 10.1097/01.mco.0000172589.55434.03
   Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104
   Tricò D, 2017, J CLIN ENDOCR METAB, V102, P2473, DOI 10.1210/jc.2017-00475
   Tse MCL, 2017, DIABETES, V66, P1858, DOI 10.2337/db16-0270
   Tymoczko J, 2011, BIOCHEMISTRY: A SHORT COURSE, V0, P0
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003
   Varner EL, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200187
   Varvel SA, 2014, BMJ OPEN DIAB RES CA, V2, P0, DOI 10.1136/bmjdrc-2014-000038
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Vieira JPP, 2023, METABOLITES, V13, P0, DOI 10.3390/metabo13070874
   Vignoli A, 2022, J PROTEOME RES, V21, P1061, DOI 10.1021/acs.jproteome.1c00935
   Villanueva-Carmona T, 2023, CELL METAB, V35, P0, DOI 10.1016/j.cmet.2023.03.004
   Vinaixa M, 2016, TRAC-TREND ANAL CHEM, V78, P23, DOI 10.1016/j.trac.2015.09.005
   Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753
   Walford GA, 2014, DIABETES CARE, V37, P2508, DOI 10.2337/dc14-0560
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   Wang ZM, 2019, EXP CELL RES, V378, P51, DOI 10.1016/j.yexcr.2019.03.001
   Webster BR, 2014, BBA-MOL CELL BIOL L, V1841, P525, DOI 10.1016/j.bbalip.2014.02.001
   Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097
   WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514
   Winkler H, 1920, VERBREITUNG UND URSACHE DER PARTHENOGENESIS IM PFLANZEN- UND TIERREICHE, V0, P0
   Wishart DS, 2022, NUCLEIC ACIDS RES, V50, PD622, DOI 10.1093/nar/gkab1062
   Wishart DS, 2019, PHYSIOL REV, V99, P1819, DOI 10.1152/physrev.00035.2018
   Wu YM, 2016, J CHROMATOGR A, V1430, P80, DOI 10.1016/j.chroma.2015.12.007
   Wyness SP, 2015, CLIN BIOCHEM, V48, P1089, DOI 10.1016/j.clinbiochem.2015.08.005
   Xu FG, 2013, J CLIN ENDOCR METAB, V98, PE1060, DOI 10.1210/jc.2012-4132
   Xu TF, 2021, ANAL CHEM, V93, P3072, DOI 10.1021/acs.analchem.0c03684
   Yamazaki Y, 2008, J GASTROEN HEPATOL, V23, P276, DOI 10.1111/j.1440-1746.2007.05150.x
   Yang J, 2021, ANAL CHIM ACTA, V1181, P0, DOI 10.1016/j.aca.2021.338873
   YangLiu, 2012, J LIPID RES, V53, P358, DOI 10.1194/jlr.M019257
   Yea SS, 2011, SCIENCE, V332, P1270, DOI 10.1126/science.1208071
   Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012
   Yoon MS, 2016, EXP MOL MED, V48, P0, DOI 10.1038/emm.2015.93
   Yu DY, 2021, CELL METAB, V33, P905, DOI 10.1016/j.cmet.2021.03.025
   Yu HX, 2022, BIOINFORMATICS, V38, P3429, DOI 10.1093/bioinformatics/btac355
   Yu WW, 2019, MOL CELL, V75, P1147, DOI 10.1016/j.molcel.2019.06.039
   Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484
   Yu ZH, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021230
   Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1
   Zhang H, 2022, J NUTR BIOCHEM, V100, P0, DOI 10.1016/j.jnutbio.2021.108919
   Zhang HP, 2016, MOL MED REP, V14, P289, DOI 10.3892/mmr.2016.5230
   Zhang QB, 2016, J CHROMATOGR B, V1038, P101, DOI 10.1016/j.jchromb.2016.10.025
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
   Zheng DM, 2021, LIPIDS HEALTH DIS, V20, P0, DOI 10.1186/s12944-021-01576-9
   Zhou B, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040096
   Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5
NR 334
TC 0
Z9 1
U1 3
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD NOV 15
PY 2023
VL 333
IS 
BP 
EP 
DI 10.1016/j.lfs.2023.122137
EA OCT 2023
PG 27
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA Y2ZF0
UT WOS:001103992500001
PM 37788764
DA 2024-11-01
ER

PT J
AU Sonkodi, B
AF Sonkodi, Balazs
TI Miswired Proprioception in Amyotrophic Lateral Sclerosis in Relation to Pain Sensation (and in Delayed Onset Muscle Soreness)-Is Piezo2 Channelopathy a Principal Transcription Activator in Proprioceptive Terminals Besides Being the Potential Primary Damage?
SO LIFE-BASEL
LA English
DT Article
DE amyotrophic lateral sclerosis; Piezo2 channelopathy; transcription; pain; WDR neuron; aging
ID oxidative stress; mechanical hyperalgesia; analyses identify; neural-control; mitochondrial; exercise; granules; mechanotransduction; phosphorylation; classification
AB Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative multisystem disease, with an unknown pathomechanism, resulting in progressive motoneuron loss. In 90-95% of cases, ALS is sporadic, but close to 10% of ALS is familial with inherited gene mutations from family members. Recently, a non-contact dying-back injury mechanism theory of ALS postulated that irreversible intrafusal proprioceptive terminal degeneration induces the non-resolving progressive impairment of the proprioceptive circuitry, leading to motoneuron loss, progressive overloading and depletion of the central nervous system, and eventually to death. The current manuscript proposes that irreversible Piezo2 channelopathy of this proprioceptive terminal degeneration induces constantly activated and dysregulated transcription process in ALS, providing access to underlying pathogenic gene variants and letting the cell-type-specific noncoding DNA mutations become more apparent. This opinion piece proposes that ALS genes are associated with the Piezo2 channelopathy mechanism both downstream and upstream, and their mutations, along with the aging process, could explain the non-contact dying-back injury mechanism theory of ALS. Moreover, irreversible microinjury of the Piezo2 ion channel could be the primary damage or the root cause of death in ALS. Finally, the current manuscript also depicts the pathomechanism as to why ALS is considered a painless disease.
C1 [Sonkodi, Balazs] Hungarian Univ Sports Sci, Dept Hlth Sci & Sport Med, H-1123 Budapest, Hungary.
RP Sonkodi, B (corresponding author), Hungarian Univ Sports Sci, Dept Hlth Sci & Sport Med, H-1123 Budapest, Hungary.
EM bsonkodi@gmail.com
CR ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P380, DOI 10.1113/jphysiol.1952.sp004755
   Aguiar P, 2010, J NEUROPHYSIOL, V104, P1155, DOI 10.1152/jn.00834.2009
   Bennett GJ, 2011, EUR J NEUROSCI, V33, P1667, DOI 10.1111/j.1460-9568.2011.07652.x
   BEREGI E, 1987, ACTA MORPHOL HUNG, V35, P219
   Bewick GS, 2021, J PHYSIOL-LONDON, V599, P2781, DOI 10.1113/JP281624
   Borghi SM, 2022, FRONT PHARMACOL, V12, P0, DOI 10.3389/fphar.2021.734091
   Borghi SM, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0162267
   Brownstone RM, 2018, J NEUROPHYSIOL, V119, P1782, DOI 10.1152/jn.00331.2017
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   CAMUS G, 1994, INTENS CARE MED, V20, P602, DOI 10.1007/BF01705731
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Case LK, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-20939-5
   Cashman CR, 2015, NEUROSCI LETT, V596, P33, DOI 10.1016/j.neulet.2015.01.048
   Chang WP, 2020, J NEUROPHYSIOL, V124, P1824, DOI 10.1152/jn.00502.2020
   Chen YX, 2020, CELL PROLIFERAT, V53, P0, DOI 10.1111/cpr.12781
   Cheng YR, 2018, J BIOMED SCI, V25, P0, DOI 10.1186/s12929-018-0448-y
   CHUNG JM, 1986, J NEUROPHYSIOL, V56, P308, DOI 10.1152/jn.1986.56.2.308
   Close GL, 2004, EUR J APPL PHYSIOL, V91, P615, DOI 10.1007/s00421-003-1012-2
   Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x
   Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812
   Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Del Rosario JS, 2021, BIORXIV, V0, P0, DOI DOI 10.1085/jgp.202213164
   Devlin AC, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms6999
   dos Santos RS, 2020, J NEUROCHEM, V155, P29, DOI 10.1111/jnc.15006
   Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014
   Duchateau J, 2016, J EXP BIOL, V219, P197, DOI 10.1242/jeb.123158
   Duchateau J, 2014, J APPL PHYSIOL, V116, P1418, DOI 10.1152/japplphysiol.00002.2013
   Eijkelkamp N, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2673
   Ellefsen KL, 2019, COMMUN BIOL, V2, P0, DOI 10.1038/s42003-019-0514-3
   Espino CM, 2022, ELIFE, V11, P0, DOI 10.7554/eLife.79917
   Fang Y, 2022, FRONT CARDIOVASC MED, V9, P0, DOI 10.3389/fcvm.2022.842885
   Fernández-Trillo J, 2020, J NEUROSCI, V40, P8976, DOI 10.1523/JNEUROSCI.0247-20.2020
   GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Guo YSR, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.33660
   Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949
   Held A, 2019, J NEUROSCI, V39, P2347, DOI 10.1523/JNEUROSCI.1771-18.2019
   Hentilä J, 2018, ACTA PHYSIOL, V224, P0, DOI 10.1111/apha.13069
   Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194
   Hody S, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00536
   Holt JR, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.65415
   HORTOBAGYI T, 1990, EUR J APPL PHYSIOL, V60, P395, DOI 10.1007/BF00713506
   Hu X, 2021, FRONT MOL BIOSCI, V8, P0, DOI 10.3389/fmolb.2021.770808
   Huang JQ, 2021, J TRANSL MED, V19, P0, DOI 10.1186/s12967-021-02954-8
   Izumikawa K, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-06953-y
   Jagaraj CJ, 2021, FRONT CELL NEUROSCI, V14, P0, DOI 10.3389/fncel.2020.581950
   Janes K, 2013, PAIN, V154, P2432, DOI 10.1016/j.pain.2013.07.032
   Jia ZF, 2016, J BIOL CHEM, V291, P9087, DOI 10.1074/jbc.M115.692384
   Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Komka Z, 2022, PLOS ONE, V17, P0, DOI 10.1371/journal.pone.0277978
   Kubo A, 2012, NEUROSCI RES, V73, P56, DOI 10.1016/j.neures.2012.02.005
   Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896
   Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5
   Lee W, 2014, P NATL ACAD SCI USA, V111, PE5114, DOI 10.1073/pnas.1414298111
   Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701
   Martins JR, 2016, PFLUG ARCH EUR J PHY, V468, P1197, DOI 10.1007/s00424-016-1811-z
   Mason S, 2017, FRONT NEUROSCI-SWITZ, V11, P0, DOI 10.3389/fnins.2017.00043
   Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007
   McGaraughty S, 2008, J NEUROPHYSIOL, V100, P3158, DOI 10.1152/jn.90768.2008
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971
   Mendelsohn AI, 2015, NEURON, V87, P111, DOI 10.1016/j.neuron.2015.05.045
   Metodiewa D, 1999, NEUROTOX RES, V1, P197, DOI 10.1007/BF03033290
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012
   Mukhtar E, 2014, MOL CANCER THER, V13, P275, DOI 10.1158/1535-7163.MCT-13-0791
   Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010
   Narayanan P, 2018, ELIFE, V7, P0, DOI 10.7554/elife.32346
   Nicolas A, 2018, NEURON, V97, P1268, DOI 10.1016/j.neuron.2018.02.027
   Nilsson MI, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020040
   Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724
   Onate J, 2019, RETURN SPORT ACL REC, V0, P0
   Oswald DJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044574
   Ota H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065751
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Pidoux L, 2022, FRONT MOL NEUROSCI, V15, P0, DOI 10.3389/fnmol.2022.880651
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   PRICE DD, 1977, J INVEST DERMATOL, V69, P167, DOI 10.1111/1523-1747.ep12497942
   Puja G, 2021, FRONT PHARMACOL, V12, P0, DOI 10.3389/fphar.2021.764396
   Radwani H, 2016, J PHYSIOL-LONDON, V594, P6607, DOI 10.1113/JP272725
   Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038
   Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980
   Ridone P, 2020, J GEN PHYSIOL, V152, P0, DOI 10.1085/jgp.201912515
   Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430
   Rode B, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00429-3
   Roh J, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21113834
   Romero LO, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-16816-2
   Ryan M, 2019, JAMA NEUROL, V76, P1367, DOI 10.1001/jamaneurol.2019.2044
   Sabado J, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/852163
   Scuteri A, 2009, NEUROTOXICOLOGY, V30, P312, DOI 10.1016/j.neuro.2009.01.003
   Seki S, 2019, J NEUROSCI, V39, P8798, DOI 10.1523/JNEUROSCI.1214-19.2019
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sonkodi B, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms231911940
   Sonkodi B, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms231911117
   Sonkodi B, 2022, METABOLITES, V12, P0, DOI 10.3390/metabo12090857
   Sonkodi B, 2022, BIOMOLECULES, V12, P0, DOI 10.3390/biom12091207
   Sonkodi B, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23169046
   Sonkodi B, 2022, J FUNCT MORPHOL KIN, V7, P0, DOI 10.3390/jfmk7020043
   Sonkodi B, 2022, J MOL NEUROSCI, V72, P1598, DOI 10.1007/s12031-022-02015-9
   Sonkodi B, 2022, OPEN MED-WARSAW, V17, P397, DOI 10.1515/med-2022-0444
   Sonkodi B, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10081867
   Sonkodi B, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11050443
   Sonkodi B, 2021, BRAIN SCI, V11, P0, DOI 10.3390/brainsci11010108
   Sonkodi B, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9030212
   Suchyna TM, 2017, PROG BIOPHYS MOL BIO, V130, P244, DOI 10.1016/j.pbiomolbio.2017.07.011
   Szczot M, 2021, ANNU REV BIOCHEM, V90, P507, DOI 10.1146/annurev-biochem-081720-023244
   Szczot M, 2018, SCI TRANSL MED, V10, P0, DOI 10.1126/scitranslmed.aat9892
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778
   van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622
   Vaughan SK, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-34510-8
   Vaughan SK, 2015, J COMP NEUROL, V523, P2477, DOI 10.1002/cne.23848
   Vina J, 2006, FREE RADICAL RES, V40, P111, DOI 10.1080/10715760500405778
   Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019
   Vincent JA, 2016, NEUROBIOL DIS, V95, P54, DOI 10.1016/j.nbd.2016.07.004
   Vincent JA, 2015, J ANAT, V227, P221, DOI 10.1111/joa.12312
   Vogler TO, 2018, NATURE, V563, P508, DOI 10.1038/s41586-018-0665-2
   Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z
   Walczak J, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14964-y
   Wang AL, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201797452
   Wilkinson KA, 2022, CURR OPIN NEUROBIOL, V74, P0, DOI 10.1016/j.conb.2022.102542
   Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406
   Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162
   Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251
   Xu X, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126429
   Ye YY, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-31103-y
   Zechini L, 2022, CURR BIOL, V32, P3584, DOI 10.1016/j.cub.2022.06.041
   Zeng WZ, 2018, SCIENCE, V362, P464, DOI 10.1126/science.aau6324
   Zhang S, 2022, NEURON, V110, P992, DOI 10.1016/j.neuron.2021.12.019
NR 133
TC 12
Z9 12
U1 0
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD MAR 15
PY 2023
VL 13
IS 3
BP 
EP 
DI 10.3390/life13030657
PG 18
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA C0AQ1
UT WOS:000958655100001
PM 36983813
DA 2024-11-01
ER

PT J
AU Chen, L
   Zhou, MN
   Li, H
   Liu, DL
   Liao, P
   Zong, Y
   Zhang, CQ
   Zou, WG
   Gao, JJ
AF Chen, Long
   Zhou, Mengnan
   Li, Hao
   Liu, Delin
   Liao, Peng
   Zong, Yao
   Zhang, Changqing
   Zou, Weiguo
   Gao, Junjie
TI Mitochondrial heterogeneity in diseases
SO SIGNAL TRANSDUCTION AND TARGETED THERAPY
LA English
DT Review
ID nonalcoholic fatty liver; ketoglutarate dehydrogenase complex; superoxide-dismutase 2; human skeletal-muscle; one-carbon metabolism; ovarian-cancer cells; diet-induced obesity; oxygen species ros; oxidative stress; adipose-tissue
AB As key organelles involved in cellular metabolism, mitochondria frequently undergo adaptive changes in morphology, components and functions in response to various environmental stresses and cellular demands. Previous studies of mitochondria research have gradually evolved, from focusing on morphological change analysis to systematic multiomics, thereby revealing the mitochondrial variation between cells or within the mitochondrial population within a single cell. The phenomenon of mitochondrial variation features is defined as mitochondrial heterogeneity. Moreover, mitochondrial heterogeneity has been reported to influence a variety of physiological processes, including tissue homeostasis, tissue repair, immunoregulation, and tumor progression. Here, we comprehensively review the mitochondrial heterogeneity in different tissues under pathological states, involving variant features of mitochondrial DNA, RNA, protein and lipid components. Then, the mechanisms that contribute to mitochondrial heterogeneity are also summarized, such as the mutation of the mitochondrial genome and the import of mitochondrial proteins that result in the heterogeneity of mitochondrial DNA and protein components. Additionally, multiple perspectives are investigated to better comprehend the mysteries of mitochondrial heterogeneity between cells. Finally, we summarize the prospective mitochondrial heterogeneity-targeting therapies in terms of alleviating mitochondrial oxidative damage, reducing mitochondrial carbon stress and enhancing mitochondrial biogenesis to relieve various pathological conditions. The possibility of recent technological advances in targeted mitochondrial gene editing is also discussed.
C1 [Chen, Long; Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Univ Chinese Acad Sci,State Key Lab Cell Biol, Shanghai 200031, Peoples R China.
   [Zhou, Mengnan] China Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Shenyang 110001, Peoples R China.
   [Li, Hao; Liu, Delin; Liao, Peng; Zhang, Changqing; Gao, Junjie] Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Dept Orthopaed, Sch Med, Shanghai 200233, Peoples R China.
   [Zong, Yao] Univ Western Australia, Ctr Orthopaed Res, Med Sch, Nedlands, WA 6009, Australia.
   [Zou, Weiguo; Gao, Junjie] Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Inst Microsurg Extrem, Sch Med, Shanghai 200233, Peoples R China.
   [Zou, Weiguo; Gao, Junjie] Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Sch Med, Dept Orthoped Surg, Shanghai 200233, Peoples R China.
   [Gao, Junjie] Shanghai Sixth Peoples Hosp Fujian, 16 Luoshan Sect,Jinguang Rd,Luoshan St, Quanzhou, Fujian, Peoples R China.
C3 Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Center for Excellence in Molecular Cell Science, CAS; China Medical University; University of Western Australia
RP Zou, WG (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Univ Chinese Acad Sci,State Key Lab Cell Biol, Shanghai 200031, Peoples R China.; Zhang, CQ; Gao, JJ (corresponding author), Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Dept Orthopaed, Sch Med, Shanghai 200233, Peoples R China.; Zou, WG; Gao, JJ (corresponding author), Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Inst Microsurg Extrem, Sch Med, Shanghai 200233, Peoples R China.; Zou, WG; Gao, JJ (corresponding author), Shanghai Peoples Hosp Shanghai Jiao Tong Univ 6, Sch Med, Dept Orthoped Surg, Shanghai 200233, Peoples R China.; Gao, JJ (corresponding author), Shanghai Sixth Peoples Hosp Fujian, 16 Luoshan Sect,Jinguang Rd,Luoshan St, Quanzhou, Fujian, Peoples R China.
EM zhangcq@sjtu.edu.cn; zouwg94@sibcb.ac.cn; colingjj@163.com
FU National Natural Science Foundation of China [82002339, 81820108020]; Shanghai Frontiers Science Center of Degeneration and Regeneration in Skeletal System [BJ1-9000-22-4002]; Shanghai Municipal Hospital Orthopedic Specialist Alliance; Shanghai Municipal Health Commission key priority discipline project; Shanghai Spinal Disease and Trauma Orthopedics Research Center
CR Abdelmegeed MA, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep39764
   Abdullahi A, 2017, ENDOCR REV, V38, P538, DOI 10.1210/er.2017-00163
   Abuaita BH, 2018, CELL HOST MICROBE, V24, P625, DOI 10.1016/j.chom.2018.10.005
   Ahmad T, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2012.213
   Ahn CS, 2015, CANCER METAB, V3, P0, DOI 10.1186/s40170-015-0128-2
   Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029
   Albert CJ, 2007, FRONT BIOSCI, V12, P2750, DOI 10.2741/2269
   Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Area-Gomez E, 2019, J CLIN INVEST, V129, P34, DOI 10.1172/JCI120848
   Arguello T, 2021, CELL REP, V37, P0, DOI 10.1016/j.celrep.2021.110139
   Asif S, 2022, MOL METAB, V61, P0, DOI 10.1016/j.molmet.2022.101494
   Aung LHH, 2021, MOL THER-NUCL ACIDS, V25, P416, DOI 10.1016/j.omtn.2021.06.006
   Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006
   Bak S, 2013, J PROTEOME RES, V12, P4327, DOI 10.1021/pr400281r
   Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560
   Bao FX, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abk2376
   Barbosa PO, 2021, BIOMED PHARMACOTHER, V139, P0, DOI 10.1016/j.biopha.2021.111627
   Barcena B, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10101535
   BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Beck SJ, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11483
   Begum HM, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-47593-8
   Benador IY, 2018, CELL METAB, V27, P869, DOI 10.1016/j.cmet.2018.03.003
   Berenguer-Escuder C, 2020, HUM MOL GENET, V29, P1353, DOI 10.1093/hmg/ddaa066
   Bhatia D, 2022, KIDNEY INT, V101, P963, DOI 10.1016/j.kint.2022.01.030
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013
   Blokhuis AM, 2016, ACTA NEUROPATHOL, V132, P175, DOI 10.1007/s00401-016-1575-8
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bond ST, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00543
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Bosch A, 2019, METHODS MOL BIOL, V2040, P99, DOI 10.1007/978-1-4939-9686-5_6
   Boufroura FZ, 2018, HUM MOL GENET, V27, P3417, DOI 10.1093/hmg/ddy254
   Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914
   Bozi LHM, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.100836
   BRANDT JT, 1974, BIOCHEM BIOPH RES CO, V59, P1097, DOI 10.1016/S0006-291X(74)80091-4
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Brea-Calvo G, 2015, AM J HUM GENET, V96, P309, DOI 10.1016/j.ajhg.2014.12.023
   Brown AD, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.727585
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200
   Bruton JD, 2008, J PHYSIOL-LONDON, V586, P175, DOI 10.1113/jphysiol.2007.147470
   Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107
   Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214
   Bulthuis EP, 2019, ANTIOXID REDOX SIGN, V30, P2066, DOI 10.1089/ars.2018.7534
   Burke PJ, 2017, TRENDS CANCER, V3, P857, DOI 10.1016/j.trecan.2017.10.006
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Butterick TA, 2016, BASIC RES CARDIOL, V111, P0, DOI 10.1007/s00395-016-0555-4
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cao W, 2017, BIOMED PHARMACOTHER, V85, P611, DOI 10.1016/j.biopha.2016.11.071
   Carley AN, 2021, CIRCULATION, V143, P1797, DOI 10.1161/CIRCULATIONAHA.120.052671
   Carrasco P, 2012, J BIOL CHEM, V287, P21224, DOI 10.1074/jbc.M111.337493
   Carruthers NJ, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-96995-0
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Cervantes-Silva MP, 2021, EMBO REP, V22, P0, DOI 10.15252/embr.202153086
   Chae S, 2018, EXP MOL MED, V50, P0, DOI 10.1038/s12276-018-0154-6
   Chandhok G, 2018, BIOL REV, V93, P933, DOI 10.1111/brv.12378
   Chen FQ, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/9565545
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen M, 2015, CANCER SCI, V106, P1075, DOI 10.1111/cas.12710
   Chen XL, 2014, THERANOSTICS, V4, P1164, DOI 10.7150/thno.8502
   Chen X, 2019, REDOX BIOL, V21, P0, DOI 10.1016/j.redox.2018.101068
   Chen Y, 2013, FOOD CHEM TOXICOL, V60, P38, DOI 10.1016/j.fct.2013.07.008
   Chen Y, 2007, HEPATOLOGY, V45, P1118, DOI 10.1002/hep.21635
   Cho SI, 2022, CELL, V185, P1764, DOI 10.1016/j.cell.2022.03.039
   Choi J, 2020, REDOX BIOL, V30, P0, DOI 10.1016/j.redox.2020.101437
   Choi KM, 2022, ENDOCRINOLOGY, V163, P0, DOI 10.1210/endocr/bqac018
   Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399
   Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909
   Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212
   CHRISTIANSEN EG, 1949, NATURE, V163, P361, DOI 10.1038/163361a0
   Chung SJ, 2017, NEUROBIOL AGING, V49, P0, DOI 10.1016/j.neurobiolaging.2016.09.017
   Cluntun AA, 2021, CELL METAB, V3, P629, DOI 10.1016/j.cmet.2020.12.003
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388
   Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028
   Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7
   Crimi M, 2008, INT J NANOMED, V3, P51
   dAvignon DA, 2018, JCI INSIGHT, V3, P0, DOI 10.1172/jci.insight.99762
   DSouza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   Dabravolski SA, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23020952
   Dabravolski SA, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094459
   Dahl ES, 2019, MOL CANCER RES, V17, P1710, DOI 10.1158/1541-7786.MCR-18-1233
   Dai ZQ, 2010, PROTEOMICS, V10, P3789, DOI 10.1002/pmic.200900685
   Das S, 2012, PFLUG ARCH EUR J PHY, V464, P101, DOI 10.1007/s00424-012-1100-4
   Rodrigues PMD, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-94474-0
   De Blasio MJ, 2015, FREE RADICAL BIO MED, V87, P137, DOI 10.1016/j.freeradbiomed.2015.04.028
   De Souza AI, 2010, J MOL CELL CARDIOL, V49, P851, DOI 10.1016/j.yjmcc.2010.07.008
   De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064
   Delaunay S, 2022, NATURE, V607, P593, DOI 10.1038/s41586-022-04898-5
   Demarest TG, 2020, ACTA NEUROPATHOL, V140, P25, DOI 10.1007/s00401-020-02152-8
   Deng LD, 2022, STEM CELL RES THER, V13, P0, DOI 10.1186/s13287-022-02836-w
   Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200
   Deng Y, 2021, BIOMED PHARMACOTHER, V140, P0, DOI 10.1016/j.biopha.2021.111689
   Deshmukh AS, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20556-8
   Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0
   Di Francesco A, 2020, NPJ AGING MECH DIS, V6, P0, DOI 10.1038/s41514-020-00051-6
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Ding F, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059825
   Ding MG, 2018, J PINEAL RES, V65, P0, DOI 10.1111/jpi.12491
   Ding YY, 2021, BIOENGINEERED, V12, P5440, DOI 10.1080/21655979.2021.1967032
   Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007
   Doll S, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-01747-2
   Donega V, 2019, ACTA NEUROPATHOL COM, V7, P0, DOI 10.1186/s40478-019-0736-0
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   E QK, 2013, ACTA BIOCH BIOPH SIN, V45, P129, DOI 10.1093/abbs/gms098
   Eccleston HB, 2011, ANTIOXID REDOX SIGN, V15, P447, DOI 10.1089/ars.2010.3395
   del Dedo JE, 2021, J CELL BIOL, V220, P0, DOI 10.1083/jcb.202010016
   Faas MM, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165845
   Fais M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22147630
   Faitg J, 2021, CELL REP, V36, P0, DOI 10.1016/j.celrep.2021.109509
   Fatehi F, 2020, EUR J NEUROL, V27, P2257, DOI 10.1111/ene.14402
   Favaro G, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-10226-9
   Fecher C, 2019, NAT NEUROSCI, V22, P1731, DOI 10.1038/s41593-019-0479-z
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   Field CS, 2020, CELL METAB, V31, P422, DOI 10.1016/j.cmet.2019.11.021
   Filali-Mouncef Y, 2022, AUTOPHAGY, V18, P50, DOI 10.1080/15548627.2021.1895658
   Fischer CA, 2020, ISCIENCE, V23, P0, DOI 10.1016/j.isci.2020.101601
   Fogarty MJ, 2020, J APPL PHYSIOL, V128, P70, DOI 10.1152/japplphysiol.00644.2019
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014
   Francis BM, 2014, J ALZHEIMERS DIS, V39, P347, DOI 10.3233/JAD-131499
   Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fritsch M, 2015, AM J CLIN NUTR, V102, P1051, DOI 10.3945/ajcn.115.107599
   Fu QH, 2020, J PROTEOMICS, V223, P0, DOI 10.1016/j.jprot.2020.103821
   Fu R, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/3527809
   Galera-Monge T, 2019, J CELL PHYSIOL, V234, P19511, DOI 10.1002/jcp.28549
   Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gao S, 2018, MITOCHONDRION, V38, P41, DOI 10.1016/j.mito.2017.08.002
   Gao ZJ, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-01919-0
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Gauba E, 2021, NEUROBIOL AGING, V98, P63, DOI 10.1016/j.neurobiolaging.2020.09.018
   Gauba E, 2019, NEUROBIOL DIS, V121, P138, DOI 10.1016/j.nbd.2018.09.020
   Geltink RIK, 2020, NAT METAB, V2, P703, DOI 10.1038/s42255-020-0256-z
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52
   Giebelstein J, 2012, DIABETOLOGIA, V55, P1114, DOI 10.1007/s00125-012-2456-x
   Giedt RJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep32985
   Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413
   Giovannoni MP, 2003, MINI-REV MED CHEM, V3, P576, DOI 10.2174/1389557033487890
   Goh KY, 2019, REDOX BIOL, V21, P0, DOI 10.1016/j.redox.2019.101100
   Goldsmith J, 2022, AUTOPHAGY, V18, P2003, DOI 10.1080/15548627.2022.2056865
   Gómez-Serrano M, 2017, REDOX BIOL, V11, P415, DOI 10.1016/j.redox.2016.12.013
   Gómez-Serrano M, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25756
   Gómez-Valadés AG, 2021, CELL METAB, V33, P1820, DOI 10.1016/j.cmet.2021.07.008
   Gonzalez-Rodríguez P, 2021, NATURE, V599, P650, DOI 10.1038/s41586-021-04059-0
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grabowski P, 2019, MOL CELL PROTEOMICS, V18, P760, DOI 10.1074/mcp.RA118.001141
   Graham LC, 2017, MOL NEURODEGENER, V12, P0, DOI 10.1186/s13024-017-0221-9
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Gumucio JP, 2019, FASEB J, V33, P7863, DOI 10.1096/fj.201802457RR
   Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8090392
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   He L, 2012, CIRCULATION, V126, P1705, DOI 10.1161/CIRCULATIONAHA.111.075978
   He QF, 2021, J BIOL CHEM, V297, P0, DOI 10.1016/j.jbc.2021.100960
   Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444
   Heerdt BG, 1998, CANCER RES, V58, P2869
   Heine KB, 2020, BIOL REV, V95, P730, DOI 10.1111/brv.12584
   Hesse R, 2019, ACTA NEUROPATHOL COM, V7, P0, DOI 10.1186/s40478-019-0847-7
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745
   Holmquist L, 2007, PHARMACOL THERAPEUT, V113, P154, DOI 10.1016/j.pharmthera.2006.07.001
   Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Horton JL, 2016, JCI INSIGHT, V1, P0, DOI 10.1172/jci.insight.84897
   Hou TT, 2019, CELL RES, V29, P754, DOI 10.1038/s41422-019-0208-x
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Hsieh CH, 2019, CELL METAB, V30, P1131, DOI 10.1016/j.cmet.2019.08.023
   Hu C, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-03152-y
   Hu FF, 2020, EUR J PHARMACOL, V883, P0, DOI 10.1016/j.ejphar.2020.173286
   Huang J, 2021, CELL DEATH DIFFER, V28, P1174, DOI 10.1038/s41418-020-00641-7
   Huang YS, 2014, LIVER INT, V34, P931, DOI 10.1111/liv.12533
   Huang ZL, 2019, TOXICOLOGY, V428, P0, DOI 10.1016/j.tox.2019.152307
   Huttunen HJ, 2007, FEBS LETT, V581, P1688, DOI 10.1016/j.febslet.2007.03.056
   Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214
   Iannetti EF, 2016, NAT PROTOC, V11, P1693, DOI 10.1038/nprot.2016.094
   Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429
   Iozzo P, 2010, GASTROENTEROLOGY, V139, P846, DOI 10.1053/j.gastro.2010.05.039
   Itsumi M, 2015, CELL DEATH DIFFER, V22, P1837, DOI 10.1038/cdd.2015.38
   Jaberi E, 2020, EBIOMEDICINE, V57, P0, DOI 10.1016/j.ebiom.2020.102868
   Jacob KJ, 2021, FRONT NUTR, V7, P0, DOI 10.3389/fnut.2020.619216
   Jiao HF, 2021, CELL, V184, P2896, DOI 10.1016/j.cell.2021.04.027
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Jusic A, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-0783-5
   Kalyanaraman B, 2018, REDOX BIOL, V14, P316, DOI 10.1016/j.redox.2017.09.020
   Kanno T, 2021, CELL REP, V37, P0, DOI 10.1016/j.celrep.2021.109921
   Kaurov I, 2018, CURR BIOL, V28, P3393, DOI 10.1016/j.cub.2018.09.008
   Kawamata H, 2017, J CELL BIOL, V216, P3917, DOI 10.1083/jcb.201709172
   Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035
   Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x
   Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027
   Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P811, DOI 10.1074/mcp.M113.035501
   Kleele T, 2021, NATURE, V593, P435, DOI 10.1038/s41586-021-03510-6
   Ko LW, 2001, J MOL NEUROSCI, V17, P361, DOI 10.1385/JMN:17:3:361
   Koenen M, 2021, CIRC RES, V128, P951, DOI 10.1161/CIRCRESAHA.121.318093
   Kojima R, 2019, CELL REP, V26, P518, DOI 10.1016/j.celrep.2018.12.070
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095
   Komakula SSB, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-33151-1
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198
   Kopecky J, 2001, BIOCHEM SOC T, V29, P791, DOI 10.1042/bst0290791
   Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, PC1074, DOI 10.1152/ajpcell.00391.2004
   Kras KA, 2018, METABOLISM, V89, P18, DOI 10.1016/j.metabol.2018.09.006
   Kraus F, 2021, NATURE, V590, P57, DOI 10.1038/s41586-021-03214-x
   Krishnan KC, 2021, NAT METAB, V3, P1552, DOI 10.1038/s42255-021-00481-w
   Kristián T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x
   Kruse R, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21155374
   Ku HJ, 2015, FREE RADICAL BIO MED, V80, P84, DOI 10.1016/j.freeradbiomed.2014.12.018
   Kukreja L, 2014, MOL NEURODEGENER, V9, P0, DOI 10.1186/1750-1326-9-16
   Kummer E, 2021, NAT REV MOL CELL BIO, V22, P307, DOI 10.1038/s41580-021-00332-2
   Kuwahara Y, 2016, INT J RADIAT ONCOL, V96, P556, DOI 10.1016/j.ijrobp.2016.07.002
   Kuznetsov AV, 2004, MOL CELL BIOCHEM, V256, P359, DOI 10.1023/B:MCBI.0000009881.01943.68
   Kuznetsov AV, 1998, J CELL BIOL, V140, P1091, DOI 10.1083/jcb.140.5.1091
   Lahiri V, 2017, AUTOPHAGY, V13, P1259, DOI 10.1080/15548627.2017.1327512
   LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Latorre-Muro P, 2021, CELL METAB, V3, P598, DOI 10.1016/j.cmet.2021.01.013
   LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555
   Lefebvre AEYT, 2021, NAT METHODS, V18, P1091, DOI 10.1038/s41592-021-01234-z
   Lei ZX, 2022, NATURE, V606, P804, DOI 10.1038/s41586-022-04836-5
   Li CF, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.698679
   Li L, 2021, NAT METAB, V3, P1242, DOI 10.1038/s42255-021-00443-2
   Li M, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010121
   Li N, 2020, MASS SPECTROM REV, V39, P471, DOI 10.1002/mas.21618
   Li N, 2019, AGING-US, V11, P6449, DOI 10.18632/aging.102199
   Li N, 2018, GYNECOL ONCOL, V150, P343, DOI 10.1016/j.ygyno.2018.06.013
   Li WM, 2012, J CELL MOL MED, V16, P59, DOI 10.1111/j.1582-4934.2011.01336.x
   Li X, 2018, INT J CANCER, V143, P1143, DOI 10.1002/ijc.31395
   Li Y, 2020, THERANOSTICS, V10, P2897, DOI 10.7150/thno.40495
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Lihavainen E, 2012, BIOINFORMATICS, V28, P1050, DOI 10.1093/bioinformatics/bts073
   Lim D, 2021, CELL CALCIUM, V98, P0, DOI 10.1016/j.ceca.2021.102453
   Lindinger PW, 2015, J PROTEOMICS, V124, P79, DOI 10.1016/j.jprot.2015.03.037
   Linscheid N, 2021, PLOS BIOL, V19, P0, DOI 10.1371/journal.pbio.3001144
   Liu JP, 2012, BMC MED GENOMICS, V5, P0, DOI 10.1186/1755-8794-5-62
   Liu W, 2020, CELL DEATH DIFFER, V27, P2014, DOI 10.1038/s41418-019-0482-7
   Liu X, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.713729
   Liu X, 2020, SCI CHINA LIFE SCI, V63, P1429, DOI 10.1007/s11427-020-1631-9
   Liu YY, 2019, ACTA PHARM SIN B, V9, P745, DOI 10.1016/j.apsb.2019.02.006
   Longo M, 2021, METABOLISM, V117, P0, DOI 10.1016/j.metabol.2021.154708
   Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013
   Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448
   Luo J, 2019, TRENDS BIOCHEM SCI, V44, P273, DOI 10.1016/j.tibs.2018.10.001
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Maeda R, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67686-z
   Malpartida AB, 2021, TRENDS BIOCHEM SCI, V46, P329, DOI 10.1016/j.tibs.2020.11.007
   Mardinoglu A, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4083
   Neila PM, 2016, NEUROINFORMATICS, V14, P235, DOI 10.1007/s12021-015-9288-z
   Mårtensson CU, 2017, TRENDS CELL BIOL, V27, P700, DOI 10.1016/j.tcb.2017.08.006
   Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094
   Martínez-Reyes I, 2014, CANCER DISCOV, V4, P1371, DOI 10.1158/2159-8290.CD-14-1228
   Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239
   McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028
   McWilliams TG, 2019, NATURE, V565, P296, DOI 10.1038/d41586-019-00093-1
   Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001
   Merkley ED, 2014, MASS SPECTROM REV, V33, P98, DOI 10.1002/mas.21382
   Merry TL, 2016, DIABETOLOGIA, V59, P2632, DOI 10.1007/s00125-016-4084-3
   Mewton N, 2010, J AM COLL CARDIOL, V55, P1200, DOI 10.1016/j.jacc.2009.10.052
   Michurina SS, 2021, MITOCHONDRION, V59, P157, DOI 10.1016/j.mito.2021.05.001
   Miele L, 2003, AM J GASTROENTEROL, V98, P2335, DOI 10.1111/j.1572-0241.2003.07725.x
   Migliavacca E, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13694-1
   Miliara X, 2015, EMBO REP, V16, P824, DOI 10.15252/embr.201540229
   Miller KE, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00435
   Mills EL, 2022, CELL METAB, V34, P140, DOI 10.1016/j.cmet.2021.11.003
   Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064
   Mitchell TW, 2007, EXP GERONTOL, V42, P1053, DOI 10.1016/j.exger.2007.09.004
   Miyata M, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12061898
   MIZUNO Y, 1994, ANN NEUROL, V35, P204, DOI 10.1002/ana.410350212
   Modi S, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12382-4
   Mohamed BA, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0898-5
   Mohs A, 2021, J HEPATOL, V74, P638, DOI 10.1016/j.jhep.2020.09.037
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Molnar M, 1996, ACTA NEUROPATHOL, V91, P654, DOI 10.1007/s004010050480
   Moore AS, 2021, NATURE, V591, P659, DOI 10.1038/s41586-021-03309-5
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Morgenstern M, 2021, CELL METAB, V33, P2464, DOI 10.1016/j.cmet.2021.11.001
   Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034
   Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174
   Murphy SR, 2013, MOL THER, V21, P1497, DOI 10.1038/mt.2013.118
   Nahon P, 2009, HEPATOLOGY, V50, P1484, DOI 10.1002/hep.23187
   Nakamura T, 2009, MOL NEURODEGENER, V4, P0, DOI 10.1186/1750-1326-4-35
   Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160
   Nastasi C, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-020-80933-7
   Neupert W, 2015, J MOL BIOL, V427, P1135, DOI 10.1016/j.jmb.2015.02.001
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008
   Nie Y, 2022, ACTA NEUROPATHOL, V143, P687, DOI 10.1007/s00401-022-02423-6
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Nikolaisen J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0101365
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Ogando J, 2019, J IMMUNOTHER CANCER, V7, P0, DOI 10.1186/s40425-019-0628-7
   Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237
   Otsuka H, 2020, J INHERIT METAB DIS, V43, P960, DOI 10.1002/jimd.12243
   Ouellet M, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005612
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Parakh S, 2021, SEMIN CELL DEV BIOL, V112, P105, DOI 10.1016/j.semcdb.2021.02.002
   Park H, 2019, J CLIN INVEST, V129, P694, DOI 10.1172/JCI120606
   Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863
   Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587
   Pataky MW, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-12682-z
   Patterson RE, 2016, AM J PHYSIOL-ENDOC M, V310, PE484, DOI 10.1152/ajpendo.00492.2015
   Pekkurnaz G, 2022, NAT METAB, V4, P802, DOI 10.1038/s42255-022-00594-w
   Peng JY, 2011, PLOS COMPUT BIOL, V7, P0, DOI 10.1371/journal.pcbi.1002212
   Peng W, 2020, P NATL ACAD SCI USA, V117, P19266, DOI 10.1073/pnas.2003236117
   Peng YH, 2022, FREE RADICAL BIO MED, V179, P11, DOI 10.1016/j.freeradbiomed.2021.12.264
   Peralta S, 2018, J CELL SCI, V131, P0, DOI 10.1242/jcs.217075
   Pérez-Pérez R, 2012, J PROTEOMICS, V75, P783, DOI 10.1016/j.jprot.2011.09.016
   Pérez-Treviño P, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165761
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524
   POLLISTER ARTHUR W, 1941, PHYSIOL ZOOL, V14, P268
   Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155
   Pound KM, 2009, CIRC RES, V104, P805, DOI 10.1161/CIRCRESAHA.108.189951
   Prasetyanti PR, 2017, MOL CANCER, V16, P0, DOI 10.1186/s12943-017-0600-4
   Qian XL, 2021, AGING-US, V13, P8960, DOI 10.18632/aging.202717
   Rackham O, 2022, NAT REV GENET, V23, P606, DOI 10.1038/s41576-022-00480-x
   Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720
   Rangel-Azevedo C, 2022, J NUTR BIOCHEM, V105, P0, DOI 10.1016/j.jnutbio.2022.109002
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Reamy AA, 2011, J NEUROCHEM, V118, P388, DOI 10.1111/j.1471-4159.2011.07312.x
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Renkema GH, 2015, EUR J HUM GENET, V23, P202, DOI 10.1038/ejhg.2014.80
   Rensvold JW, 2022, NATURE, V606, P382, DOI 10.1038/s41586-022-04765-3
   Ribeiro RF, 2018, FREE RADICAL BIO MED, V117, P18, DOI 10.1016/j.freeradbiomed.2018.01.012
   Rieusset J, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-0416-1
   Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009
   Rohani A, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-75899-5
   Ron-Harel N, 2018, P NATL ACAD SCI USA, V115, P13347, DOI 10.1073/pnas.1804149115
   Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007
   Rossi M, 2022, NATURE, V605, P747, DOI 10.1038/s41586-022-04758-2
   Rubio-Gozalbo ME, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P521, DOI 10.1016/j.mam.2004.06.007
   Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135
   Ruiz A, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00003
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Safiulina D, 2019, EMBO J, V38, P0, DOI 10.15252/embj.201899384
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377
   Scharwey M, 2013, J CELL SCI, V126, P5317, DOI 10.1242/jcs.134130
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schilf P, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22031006
   Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076
   Schmidt NM, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-22967-7
   Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shah SI, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0223014
   Shaltouki A, 2018, ACTA NEUROPATHOL, V136, P607, DOI 10.1007/s00401-018-1873-4
   Shami GJ, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-82884-z
   Shamseldin HE, 2016, HUM GENET, V135, P21, DOI 10.1007/s00439-015-1608-8
   Shao D, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-05362-7
   Sharma S, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101740
   SHEU KFR, 1994, ANN NEUROL, V35, P312, DOI 10.1002/ana.410350311
   Shi JR, 2015, LIFE SCI, V141, P170, DOI 10.1016/j.lfs.2015.09.022
   Shi QL, 2011, J BIOL CHEM, V286, P17640, DOI 10.1074/jbc.M110.203018
   Shi XJ, 2020, J CELL MOL MED, V24, P13151, DOI 10.1111/jcmm.15921
   Shin CS, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20597-z
   Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502
   Siebers EM, 2018, J NEUROPATH EXP NEUR, V77, P665, DOI 10.1093/jnen/nly042
   SIERRA MF, 1973, P NATL ACAD SCI USA, V70, P3155, DOI 10.1073/pnas.70.11.3155
   Sim WC, 2020, METABOLISM, V102, P0, DOI 10.1016/j.metabol.2019.154000
   Simoes ICM, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22136848
   Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9080743
   Sinha D, 2014, MOL CELL BIOL, V34, P1757, DOI 10.1128/MCB.01527-13
   Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5
   Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023
   Sonn SK, 2022, REDOX BIOL, V51, P0, DOI 10.1016/j.redox.2022.102275
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Stauch KL, 2014, J PROTEOME RES, V13, P2620, DOI 10.1021/pr500295n
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Sun WQ, 2016, TOXICOL SCI, V151, P193, DOI 10.1093/toxsci/kfw035
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Szeto HH, 2016, KIDNEY INT, V90, P997, DOI 10.1016/j.kint.2016.06.013
   Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010
   Tan MJ, 2020, CELL DEATH DIFFER, V27, P2143, DOI 10.1038/s41418-020-0491-6
   Tan YQ, 2021, BBA-REV CANCER, V1876, P0, DOI 10.1016/j.bbcan.2021.188534
   Tang ZJ, 2022, MOL BIOL EVOL, V39, P0, DOI 10.1093/molbev/msac090
   Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793
   Tews D, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101286
   Thelen MP, 2020, ACTA NEUROPATHOL COM, V8, P0, DOI 10.1186/s40478-020-01101-6
   Towers CG, 2021, DEV CELL, V56, P2029, DOI 10.1016/j.devcel.2021.06.003
   Tracy TE, 2022, CELL, V185, P712, DOI 10.1016/j.cell.2021.12.041
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Ubaida-Mohien C, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.49874
   Ubaida-Mohien C, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00312
   Uchihashi M, 2017, CIRC-HEART FAIL, V10, P0, DOI 10.1161/CIRCHEARTFAILURE.117.004417
   Unni S, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-47018-6
   Dietz JV, 2021, REDOX BIOL, V46, P0, DOI 10.1016/j.redox.2021.102125
   Vaillant-Beuchot L, 2021, ACTA NEUROPATHOL, V141, P39, DOI 10.1007/s00401-020-02234-7
   Vairetti M, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10030364
   Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001
   van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Villarroya J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029691
   Virmani A, 2015, MOL NEUROBIOL, V52, P826, DOI 10.1007/s12035-015-9238-7
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Völgyi K, 2015, J PROTEOMICS, V120, P142, DOI 10.1016/j.jprot.2015.03.005
   von Montfort C, 2012, J HEPATOL, V57, P852, DOI 10.1016/j.jhep.2012.05.024
   Walker JM, 2022, ACTA NEUROPATHOL COM, V10, P0, DOI 10.1186/s40478-022-01324-9
   Wang G, 2016, J AGR FOOD CHEM, V64, P1610, DOI 10.1021/acs.jafc.5b05897
   Wang GX, 2019, MOL CELL, V74, P844, DOI 10.1016/j.molcel.2019.03.021
   Wang PW, 2014, ANTIOXID REDOX SIGN, V20, P2572, DOI 10.1089/ars.2013.5334
   Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324
   Wang X, 2022, NATURE AGING, V2, P155, DOI 10.1038/s43587-021-00164-x
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wang Y, 2020, J CARD FAIL, V26, P243, DOI 10.1016/j.cardfail.2019.09.003
   Wang YH, 2020, CANCERS, V12, P0, DOI 10.3390/cancers12071797
   Wang ZC, 2020, MOL THER-NUCL ACIDS, V21, P751, DOI 10.1016/j.omtn.2020.07.013
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weber M, 2020, FASEB J, V34, P11816, DOI 10.1096/fj.202000678R
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Weinheimer EM, 2007, AM J PHYSIOL-REG I, V292, PR2241, DOI 10.1152/ajpregu.00718.2006
   Wenes M, 2022, CELL METAB, V34, P731, DOI 10.1016/j.cmet.2022.03.013
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Willcox JAL, 2022, AM J HUM GENET, V109, P961, DOI 10.1016/j.ajhg.2022.03.011
   Wong CO, 2017, CELL HOST MICROBE, V21, P719, DOI 10.1016/j.chom.2017.05.002
   Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486
   Wu NN, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/9825061
   Wu ZJ, 2020, MOL THER-NUCL ACIDS, V20, P801, DOI 10.1016/j.omtn.2020.04.017
   Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004
   Xu L, 2022, ACTA PHARMACOL SIN, V43, P316, DOI 10.1038/s41401-021-00658-9
   Xu ZS, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28557-5
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
   Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863
   Yang LC, 2009, NEUROBIOL DIS, V36, P320, DOI 10.1016/j.nbd.2009.07.023
   Ye J, 2017, P NATL ACAD SCI USA, V114, P292, DOI 10.1073/pnas.1618605114
   Yin C, 2019, ANN ONCOL, V30, P953, DOI 10.1093/annonc/mdz105
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zahedi A, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-34455-y
   Zekonyte U, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-23561-7
   Zhang S, 2021, PROG NEUROBIOL, V204, P0, DOI 10.1016/j.pneurobio.2021.102089
   Zhang X, 2020, ARCH TOXICOL, V94, P2691, DOI 10.1007/s00204-020-02785-4
   Zhanghao K, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-19747-0
   Zhao QY, 2022, DIABETES, V71, P233, DOI 10.2337/db21-0173
   Zhao QY, 2020, CELL, V183, P76, DOI 10.1016/j.cell.2020.08.009
   Zhao W, 2021, FRONT AGING NEUROSCI, V13, P0, DOI 10.3389/fnagi.2021.713819
   Zhao Y, 2019, THERANOSTICS, V9, P1510, DOI 10.7150/thno.29620
   Zheng YX, 2018, CELL, V175, P1546, DOI 10.1016/j.cell.2018.09.041
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
   Zou Y, 2017, BIOMED PHARMACOTHER, V94, P140, DOI 10.1016/j.biopha.2017.07.074
   Zuliani I, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22073746
NR 476
TC 10
Z9 10
U1 13
U2 39
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2095-9907
EI 2059-3635
J9 SIGNAL TRANSDUCT TAR
JI Signal Transduct. Target. Ther.
PD AUG 23
PY 2023
VL 8
IS 1
BP 
EP 
DI 10.1038/s41392-023-01546-w
PG 27
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA P8BF3
UT WOS:001052862100003
PM 37607925
DA 2024-11-01
ER

PT J
AU Gonzalez-Chapa, JA
   Macêdo, MB
   Lood, C
AF Gonzalez-Chapa, Jorge Armando
   Macedo, Marina Barguil
   Lood, Christian
TI The Emerging Role of Mitochondrial Dysfunction in the Pathogenesis of Idiopathic Inflammatory Myopathies
SO RAMBAM MAIMONIDES MEDICAL JOURNAL
LA English
DT Review
DE Dermatomyositis; inclusion body myositis; mitochondria; muscular diseases
ID amyloid precursor protein; inclusion-body myositis; human skeletal-muscle; antimitochondrial antibody; dna deletions; oxidative-phosphorylation; sequence polymorphisms; diagnostic-value; animal-models; loop region
AB Increasing evidence points towards mitochondria as crucial players in the initiation and progression of auto-immune and degenerative disorders, to which impaired cell metabolism is but a facet of the subjacent etiopathogenesis. This review aims to introduce the reader to essential concepts of mitochondrial abnor-malities in idiopathic inflammatory myopathy (IIM), underscoring inclusion-body myositis and dermato-myositis. Far surpassing the initial simplistic view of being responsible for energy generation, mitochondria have gathered attention regarding their role in inflammatory processes, being able to fuel autoimmunity, as shown by the presence of anti-mitochondrial antibodies (AMAs) in up to 10% of IIM patients. As cellular respiration takes place, mitochondrial metabolites might help to shape the pro-inflammatory milieu in affected muscle, beyond generating reactive oxygen species, which are well-recognized inducers of damage -associated molecular patterns. A series of mitochondrial components might facilitate the sterile activation of pro-inflammatory cells and the production of several cytokines responsible for enhancing auto-immune responses. Marked variation in the mitochondrial genome has also been reported in IIM patients. As such, we summarize key historical and recent advances linking aberrations and instabilities of mitochondrial DNA to impaired muscle function. Besides discussing mitochondrial dysfunction as an essential part of IIM development, we also highlight possible associations between presence of AMAs and a particular phenotype of IIM, with its own characteristic clinical and radiological pattern. Finally, we present promising treatment approaches targeting mitochondria, while briefly discussing experimental models for gaining deeper insight into the disease process, and ultimately leading to novel drug development.
C1 [Gonzalez-Chapa, Jorge Armando; Macedo, Marina Barguil; Lood, Christian] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle
RP Lood, C (corresponding author), Univ Washington, Div Rheumatol, Seattle, WA 98195 USA.
EM Loodc@uw.edu
CR Afzali AM, 2017, AUTOIMMUN REV, V16, P478, DOI 10.1016/j.autrev.2017.03.001
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Akhtar M, 2021, BIOLOGY-BASEL, V10, P0, DOI 10.3390/biology10060501
   Albayda J, 2018, SEMIN ARTHRITIS RHEU, V47, P552, DOI 10.1016/j.semarthrit.2017.06.004
   Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barbieri Elena, 2012, J SIGNAL TRANSDUCT, V2012, P982794, DOI 10.1155/2012/982794
   Becker YLC, 2022, NAT REV RHEUMATOL, V18, P621, DOI 10.1038/s41584-022-00834-z
   Betteridge Z, 2019, J AUTOIMMUN, V101, P48, DOI 10.1016/j.jaut.2019.04.001
   Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Brunn A, 2012, J NEUROPATH EXP NEUR, V71, P855, DOI 10.1097/NEN.0b013e31826bf7f3
   Bujo S, 2019, CAN J CARDIOL, V35, P0, DOI 10.1016/j.cjca.2019.07.002
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Cenini G, 2016, MOL BIOL CELL, V27, P3257, DOI 10.1091/mbc.E16-05-0313
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chang ML, 2022, FRONT IMMUNOL, V13, P0, DOI 10.3389/fimmu.2022.869018
   Chen JT, 2001, MAGNET RESON MED, V46, P870, DOI 10.1002/mrm.1271
   Colapietro F, 2022, CLIN REV ALLERG IMMU, V63, P166, DOI 10.1007/s12016-021-08904-y
   Conte M, 2020, SEMIN IMMUNOPATHOL, V42, P607, DOI 10.1007/s00281-020-00813-0
   Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Danielsson O, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0239176
   Davis MA, 2019, P NATL ACAD SCI USA, V116, P5061, DOI 10.1073/pnas.1818598116
   De Luna N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-09309-8
   De Paepe B, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9010015
   De Paepe B, 2017, ANN TRANSL MED, V5, P0, DOI 10.21037/atm.2016.12.68
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Duvvuri B, 2021, J AUTOIMMUN, V119, P0, DOI 10.1016/j.jaut.2021.102630
   Duvvuri Bhargavi, 2021, IMMUNOMETABOLISM, V3, P0, DOI 10.20900/immunometab20210008
   Elpeleg O, 2002, J MOL MED-JMM, V80, P389, DOI 10.1007/s00109-002-0343-5
   EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402
   Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355
   Ghirardello A, 2014, AUTOIMMUN HIGHLIGHTS, V5, P69, DOI 10.1007/s13317-014-0060-4
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Greenberg Steven A, 2010, CURR RHEUMATOL REP, V12, P198, DOI 10.1007/s11926-010-0101-6
   Guo ZJ, 2016, MITOCHONDRIAL DNA A, V27, P4244, DOI 10.3109/19401736.2014.1003920
   Hagen CM, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0208828
   Hargreaves M, 2020, NAT METAB, V2, P817, DOI 10.1038/s42255-020-0251-4
   Hedberg-Oldfors C, 2022, NEUROPATH APPL NEURO, V48, P0, DOI 10.1111/nan.12841
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Herman AM, 2011, BRAIN RES, V1386, P191, DOI 10.1016/j.brainres.2011.02.052
   Hesselstrand R, 2022, ARTHRITIS RHEUMATOL, V12, P0, DOI 10.3389/fimmu.2021.785275
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hoffmann RF, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-51517-x
   Hojgaard P, 2021, OXF MED CASE REP, V0, PP89, DOI 10.1093/omcr/omaa150
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Hou Y, 2019, NEUROMUSCULAR DISORD, V29, P5, DOI 10.1016/j.nmd.2018.11.004
   Hu SL, 2014, CLIN CHEM LAB MED, V52, P1533, DOI 10.1515/cclm-2013-0926
   Huntley ML, 2019, LAB INVEST, V99, P1041, DOI 10.1038/s41374-019-0233-x
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Javed F, 2010, AM J CLIN NUTR, V91, P907, DOI 10.3945/ajcn.2009.28512
   Jiang D, 2014, ACTA PHARMACOL SIN, V35, P135, DOI 10.1038/aps.2013.144
   Kadosaka T, 2020, ESC HEART FAIL, V7, P4315, DOI 10.1002/ehf2.12984
   Katsumata Y, 2008, CURR OPIN RHEUMATOL, V20, P681, DOI 10.1097/BOR.0b013e328310e0ac
   KEMP GJ, 1994, MAGNET RESON MED, V31, P248, DOI 10.1002/mrm.1910310303
   KEMP GJ, 1995, CLIN SCI, V89, P581, DOI 10.1042/cs0890581
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Khorramizadeh MReza, 2020, ANIM BIOTECHNOL, V0, PP153, DOI 10.1016/B978-0-12-811710-1.00008-2
   Kim GT, 2010, CLIN RHEUMATOL, V29, P273, DOI 10.1007/s10067-009-1316-7
   Kim Hyeonhui, 2018, LAB ANIM RES, V34, P147
   Koo JH, 2019, GERONTOLOGY, V65, P240, DOI 10.1159/000494723
   Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lahoria R, 2016, BRAIN, V139, P1891, DOI 10.1093/brain/aww122
   Lai RX, 2021, ARCH RHEUMATOL, V36, P375, DOI 10.46497/ArchRheumatol.2021.8101
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Leclair V, 2021, CURR OPIN RHEUMATOL, V33, P537, DOI 10.1097/BOR.0000000000000837
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lightfoot AP, 2015, ANN RHEUM DIS, V74, P1340, DOI 10.1136/annrheumdis-2014-207172
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lindor KD, 2019, HEPATOLOGY, V69, P394, DOI 10.1002/hep.30145
   Liu DL, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-020-00440-z
   Liu ZH, 2022, CELL BIOSCI, V12, P0, DOI 10.1186/s13578-022-00805-7
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468
   Maeda MH, 2012, BRAIN, V135, P1767, DOI 10.1093/brain/aws106
   Mahler M, 2021, DIAGNOSTICS, V11, P0, DOI 10.3390/diagnostics11122246
   Malik A, 2016, FRONT NEUROL, V7, P0, DOI 10.3389/fneur.2016.00064
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, PH2726, DOI 10.1152/ajpheart.00376.2007
   Mauhin W, 2018, JOINT BONE SPINE, V85, P375, DOI 10.1016/j.jbspin.2017.04.004
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Melki I, 2021, SCI TRANSL MED, V13, P0, DOI 10.1126/scitranslmed.aav5928
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Michailidou D, 2022, ARTHRITIS RES THER, V24, P0, DOI 10.1186/s13075-022-02849-z
   Milkiewicz M, 2012, AUTOIMMUN HIGHLIGHTS, V3, P105, DOI 10.1007/s13317-012-0038-z
   Minamiyama S, 2020, MUSCLE NERVE, V61, P81, DOI 10.1002/mus.26731
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Muravchick S, 2006, ANESTHESIOLOGY, V105, P819, DOI 10.1097/00000542-200610000-00029
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Naddaf E, 2018, NEUROTHERAPEUTICS, V15, P995, DOI 10.1007/s13311-018-0658-8
   Nagaraju K, 2000, J IMMUNOL, V164, P5459, DOI 10.4049/jimmunol.164.10.5459
   Nakashima Ran, 2018, IMMUNOL MED, V41, P103, DOI 10.1080/25785826.2018.1531188
   Nelke C, 2022, ACTA NEUROPATHOL COM, V10, P0, DOI 10.1186/s40478-022-01389-6
   Oikawa Y, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0231064
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Paradies G, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070728
   Park SY, 2014, AM J PHYSIOL-HEART C, V307, PH346, DOI 10.1152/ajpheart.00227.2014
   Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363
   Perenthaler E, 2019, FRONT CELL NEUROSCI, V13, P0, DOI 10.3389/fncel.2019.00352
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Pham-Huy Lien Ai, 2008, INT J BIOMED SCI, V4, P89
   Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0
   Pirkmajer S, 2022, FRONT PHYSIOL, V13, P0, DOI 10.3389/fphys.2022.1113860
   Platteel ACM, 2019, J TRANSL AUTOIMMUN, V2, P0, DOI 10.1016/j.jtauto.2019.100013
   Qiu MQ, 2021, RHEUMATOLOGY, V60, P2826, DOI 10.1093/rheumatology/keaa721
   Qualls AE, 2021, AM J PHYSIOL-CELL PH, V320, PC681, DOI 10.1152/ajpcell.00462.2020
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Riley JS, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949799
   Rodríguez-Nuevo A, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201796553
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sabbagh SE, 2021, CLIN RHEUMATOL, V40, P4095, DOI 10.1007/s10067-021-05730-7
   Sakellariou GK, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33944
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001
   Shi J, 2021, FRONT IMMUNOL, V12, P0, DOI 10.3389/fimmu.2021.783616
   Shokolenko Inna N, 2014, WORLD J EXP MED, V4, P46
   Singh B, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0139846
   Song JY, 2021, NAT REV MOL CELL BIO, V22, P54, DOI 10.1038/s41580-020-00300-2
   Souza Fernando Henrique Carlos de, 2012, REV BRAS REUMATOL, V52, P642
   Stribl C, 2014, J BIOL CHEM, V289, P10769, DOI 10.1074/jbc.M113.515940
   Sugarman MC, 2006, NEUROBIOL AGING, V27, P423, DOI 10.1016/j.neurobiolaging.2005.02.011
   Suk TR, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00397-1
   Sun JY, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abp9245
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suzuki T, 2015, TOHOKU J EXP MED, V236, P225, DOI 10.1620/tjem.236.225
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka A, 2002, CELL MOL BIOL, V48, P295
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6
   Uenaka T, 2017, EUR NEUROL, V78, P290, DOI 10.1159/000481503
   Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang CH, 2014, MOD RHEUMATOL, V24, P865, DOI 10.3109/14397595.2013.874741
   Wang F, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.675465
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
   Yamada T, 2022, ARTHRITIS RES THER, V24, P0, DOI 10.1186/s13075-022-02846-2
   Yamanaka Tetsuo, 2017, BMJ CASE REP, V2017, P0, DOI 10.1136/bcr-2016-218469
   Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200
   Yin X, 2016, CHINESE MED J-PEKING, V129, P1047, DOI 10.4103/0366-6999.180528
   Yokokawa T, 2021, INTERNAL MED, V60, P201, DOI 10.2169/internalmedicine.5422-20
   Yusoff AAM, 2019, ONCOL REV, V13, P54, DOI 10.4081/oncol.2019.409
   Zhang L, 2021, SEMIN ARTHRITIS RHEU, V51, P741, DOI 10.1016/j.semarthrit.2021.05.019
   Zhang YC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0128624
   Zhao YD, 2009, CALCIFIED TISSUE INT, V85, P267, DOI 10.1007/s00223-009-9271-5
   Zhao YF, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-09943-x
   Zhou ZJ, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00770
NR 166
TC 7
Z9 7
U1 0
U2 3
PU RAMBAM HEALTH CARE CAMPUS
PI HAIFA
PA 6 HA ALIYA ST, HAIFA, 31096, ISRAEL
SN 2076-9172
EI 
J9 RAMBAM MAIMONIDES ME
JI Rambam Maimonides Med. J.
PD APR 15
PY 2023
VL 14
IS 2
BP 
EP 
DI 10.5041/RMMJ.10493
PG 18
WC Medicine, General & Internal
SC General & Internal Medicine
GA F9KV4
UT WOS:000985472800005
PM 37116066
DA 2024-11-01
ER

PT J
AU Salvador, CL
   Oppeboen, M
   Vassli, AO
   Pfeiffer, HCV
   Varhaug, KN
   Elgstoen, KBP
   Yazdani, M
AF Salvador, Cathrin Lytomt
   Oppeboen, Mari
   Vassli, Anja Osteby
   Pfeiffer, Helle Cecilie Viekilde
   Varhaug, Kristin Nielsen
   Elgstoen, Katja Benedikte Presto
   Yazdani, Mazyar
TI Increased Sphingomyelin and Free Sialic Acid in Cerebrospinal Fluid of Kearns-Sayre Syndrome: New Findings Using Untargeted Metabolomics
SO PEDIATRIC NEUROLOGY
LA English
DT Article
DE Kearns -Sayre syndrome; Sialic acid; 5-Methyltetrahydrofolate; Tau protein; Sphingomyelin; Mitochondrial DNA; CAFSA; Metabolomics
ID n-acetylneuraminic acid; mitochondrial-dna; lipid rafts; tau; diagnosis; glycosylation; deletions; diseases; ataxia
AB Background: Kearns-Sayre syndrome (KSS) is caused by duplications and/or deletions of mitochondrial DNA (mtDNA) and is typically diagnosed based on a classic triad of symptoms with chronic progressive external ophthalmoplegia (CPEO), retinitis pigmentosa, and onset before age 20 years. The present study aimed to diagnose two patients, on suspicion of KSS.Methods: One of the patients went through a diagnostic odyssey, with normal results from several mtDNA analyses, both in blood and muscle, before the diagnosis was confirmed genetically.Results: Two patients presented increased tau protein and low 5-methyltetrahydrofolate (5-MTHF) levels in the cerebrospinal fluid (CSF). Untargeted metabolomics on CSF samples also showed an increase in the levels of free sialic acid and sphingomyelin C16:0 (d18:1/C16:0), compared with four control groups (patients with mitochondrial disorders, nonmitochondrial disorders, low 5-MTHF, or increased tau proteins).Conclusions: It is the first time that elevated sphingomyelin C16:0 (d18:1/C16:0) and tau protein in KSS are reported. Using an untargeted metabolomics approach and standard laboratory methods, the study could shed new light on metabolism in KSS to better understand its complexity. In addition, the findings may suggest the combination of elevated free sialic acid, sphingomyelin C16:0 (d18:1/C16:0), and tau protein as well as low 5-MTHF as new biomarkers in the diagnostics of KSS.(c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Salvador, Cathrin Lytomt; Vassli, Anja Osteby; Elgstoen, Katja Benedikte Presto; Yazdani, Mazyar] Oslo Univ Hosp, Rikshosp, Dept Med Biochem, Oslo, Norway.
   [Oppeboen, Mari; Pfeiffer, Helle Cecilie Viekilde] Oslo Univ Hosp, Rikshosp, Dept Pediat, Oslo, Norway.
   [Pfeiffer, Helle Cecilie Viekilde] Copenhagen Univ Hosp Hvidovre, Dept Pediat, Hvidovre, Denmark.
   [Varhaug, Kristin Nielsen] Univ Bergen, Dept Clin Med, Mitochondrial Med & Neurogenet MMN Grp, Bergen, Norway.
   [Varhaug, Kristin Nielsen] Haukeland Hosp, Dept Neurol, Bergen, Norway.
   [Salvador, Cathrin Lytomt] Oslo Univ Hosp, Dept Med Biochem, PB 4950, N-0424 Oslo, Norway.
C3 University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Copenhagen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo
RP Salvador, CL (corresponding author), Oslo Univ Hosp, Dept Med Biochem, PB 4950, N-0424 Oslo, Norway.
EM catsal@ous-hf.no
FU Oslo University Hospital
CR Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Amador MD, 2018, J INHERIT METAB DIS, V41, P447, DOI 10.1007/s10545-017-0134-3
   BERENBAUM F, 1990, NEUROLOGY, V40, P193, DOI 10.1212/WNL.40.1.193
   Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, PE1, DOI 10.1152/ajpendo.2002.282.1.E1
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   Cho A, 2017, HUM MOL GENET, V26, P3081, DOI 10.1093/hmg/ddx192
   DAndrea G, 2001, J HEADACHE PAIN, V2, Ps57, DOI 10.1007/s101940170011
   Diniz AG, 2009, TURK J PATHOL, V25, P53, DOI 10.5146/tjpath.2009.00974
   Ditiatkovski M, 2020, J BIOL CHEM, V295, P13377, DOI 10.1074/jbc.RA120.014642
   Dugger BN, 2017, CSH PERSPECT BIOL, V9, P0, DOI 10.1101/cshperspect.a028035
   Finsterer J, 2020, CASE REP NEUROL MED, V2020, P0, DOI 10.1155/2020/7368527
   Grangeon L, 2016, J ALZHEIMERS DIS, V51, P905, DOI 10.3233/JAD-151111
   Gupta SN, 2008, J NEUROL SCI, V264, P173, DOI 10.1016/j.jns.2007.07.023
   Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hicks DA, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00189
   Idland AV, 2017, J ALZHEIMERS DIS, V55, P371, DOI 10.3233/JAD-160461
   Kamei H, 2001, PROTEINS, V45, P285, DOI 10.1002/prot.1149
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Kontou M, 2009, BIOL CHEM, V390, P575, DOI 10.1515/BC.2009.058
   Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031
   Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7
   Maceluch Jaros Aw, 2006, PEDIATR ENDOCRINOL REV, V4, P117
   Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x
   Mochel F, 2009, BRAIN, V132, P801, DOI 10.1093/brain/awn355
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Nagamine S, 2016, NEUROPATHOLOGY, V36, P333, DOI 10.1111/neup.12277
   Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088
   Obeid R, 2007, CLIN CHEM, V53, P1129, DOI 10.1373/clinchem.2006.085241
   Pavone P, 2017, ITAL J PEDIATR, V43, P0, DOI 10.1186/s13052-016-0325-9
   Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Polanco JC, 2018, NAT REV NEUROL, V14, P22, DOI 10.1038/nrneurol.2017.162
   Pritchard SM, 2011, J CELL MOL MED, V15, P1621, DOI 10.1111/j.1582-4934.2011.01273.x
   Quntanilla RA, 2020, CURR NEUROPHARMACOL, V18, P1076, DOI 10.2174/1570159X18666200525020259
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Schraen-Maschke S, 2008, BIOMARK MED, V2, P363, DOI 10.2217/17520363.2.4.363
   Shemesh A, 2021, KEARNS SAYRE SYNDROM, V0, P0
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Skogvold HB, 2021, J PROTEOME RES, V20, P4010, DOI 10.1021/acs.jproteome.1c00326
   Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00314
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Szalardy L, 2016, FOLIA NEUROPATHOL, V54, P9, DOI 10.5114/fn.2016.58911
   Tapia-Rojas C, 2019, PROG NEUROBIOL, V175, P54, DOI 10.1016/j.pneurobio.2018.12.005
   THOMAS GH, 1985, PEDIATR RES, V19, P451, DOI 10.1203/00006450-198505000-00009
   Walter J, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-34
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, PD521, DOI 10.1093/nar/gkl923
   Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017
   Yu M, 2016, CHINESE MED J-PEKING, V129, P2519, DOI 10.4103/0366-6999.191855
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang L, 2018, CIRCULATION, V137, P1374, DOI 10.1161/CIRCULATIONAHA.117.031139
NR 52
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD JUN 15
PY 2023
VL 143
IS 
BP 68
EP 76
DI 10.1016/j.pediatrneurol.2023.02.016
EA APR 2023
PG 9
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA E1LD1
UT WOS:000973226500001
PM 37018879
DA 2024-11-01
ER

PT J
AU Huang, G
   Wang, YM
   Yao, DY
AF Huang, Gang
   Wang, Yanmei
   Yao, Dongyuan
TI Myoclonic epilepsy with ragged red fibers syndrome associated with mitochondrial 3302A&gt;G mutation in the MT-TL1 gene: A case report
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE myoclonic epilepsy with ragged red fibers syndrome; mitochondrial DNA; gene mutation; MT-TL1 gene; mitochondrial encephalomyopathy
ID a3302g mutation
AB A 37-year-old woman presented with proximal limb weakness, an unstable gait, tiredness and paroxysmal jitters. Neurological examination showed decreased deep tendon reflexes and positive signs indicating damage to the cerebellum. The patient's children reported no symptoms but were found to have the mitochondrial 3302A>G mutation in the mitochondrially encoded tRNA-Leu (UUA/G) 1 gene. The patient presented with increased blood lactic acid and lactic acid dehydrogenase levels, myopathy-related limb muscle electromyographic activities, ragged red fibers (RRFs), cytochrome oxidase-negative muscle fibers and mitochondrial 3302A>G mutation. Inverted lactic acid peaks in the basal ganglia, an atrophied cerebellum and multiple electroencephalographic spike waves were also observed. Therefore, myoclonic epilepsy with RRFs syndrome with the 3302A>G mutation was considered.
C1 [Huang, Gang; Wang, Yanmei; Yao, Dongyuan] Jiangxi Prov Peoples Hosp, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China.
   [Huang, Gang; Wang, Yanmei; Yao, Dongyuan] Nanchang Med Coll, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.
   [Huang, Gang; Wang, Yanmei; Yao, Dongyuan] Jiangxi Prov Peoples Hosp, Neurol Inst Jiangxi Prov, Nanchang 330006, Jiangxi, Peoples R China.
   [Yao, Dongyuan] Jiangxi Prov Peoples Hosp, Dept Neurol, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.
   [Yao, Dongyuan] Nanchang Med Coll, Affiliated Hosp 1, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.
RP Yao, DY (corresponding author), Jiangxi Prov Peoples Hosp, Dept Neurol, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.; Yao, DY (corresponding author), Nanchang Med Coll, Affiliated Hosp 1, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.
EM yao9000@gmail.com
FU Jiangxi Provincial People's Hospital [2019-009]
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bornstein R, 2020, MITOCHONDRION, V54, P72, DOI 10.1016/j.mito.2020.07.007
   Ding Y, 2016, REPROD SCI, V23, P228, DOI 10.1177/1933719115602777
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V0, P21
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Goto M, 2014, BRAIN DEV-JPN, V36, P180, DOI 10.1016/j.braindev.2013.03.001
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   Lopriore P, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232113216
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727
   Rahman S, 2018, EPILEPSIA, V59, P70, DOI 10.1111/epi.14485
   Siira SJ, 2017, INT J BIOCHEM CELL B, V85, P106, DOI 10.1016/j.biocel.2017.02.003
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Veenin K, 2022, FRONT PEDIATR, V10, P0, DOI 10.3389/fped.2022.876436
   Wong LJC, 2020, GENET MED, V0, P0, DOI DOI 10.1038/s41436-019-0746-0
NR 18
TC 2
Z9 2
U1 0
U2 0
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD FEB 15
PY 2023
VL 25
IS 2
BP 
EP 
DI 10.3892/etm.2023.11786
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 7X2GN
UT WOS:000914021500001
PM 36684660
DA 2024-11-01
ER

PT J
AU San-Millan, I
AF San-Millan, Inigo
TI The Key Role of Mitochondrial Function in Health and Disease
SO ANTIOXIDANTS
LA English
DT Review
DE mitochondrial dysfunction; cellular bioenergetics; diabetes; cardiovascular disease; cancer; Alzheimer's disease; metabolic flexibility; exercise
ID fatty-acid-metabolism; human skeletal-muscle; brain insulin-resistance; physical-activity; oxidative stress; alzheimers-disease; cardiovascular-disease; in-vivo; diabetes-mellitus; respiratory-chain
AB The role of mitochondrial function in health and disease has become increasingly recognized, particularly in the last two decades. Mitochondrial dysfunction as well as disruptions of cellular bioenergetics have been shown to be ubiquitous in some of the most prevalent diseases in our society, such as type 2 diabetes, cardiovascular disease, metabolic syndrome, cancer, and Alzheimer's disease. However, the etiology and pathogenesis of mitochondrial dysfunction in multiple diseases have yet to be elucidated, making it one of the most significant medical challenges in our history. However, the rapid advances in our knowledge of cellular metabolism coupled with the novel understanding at the molecular and genetic levels show tremendous promise to one day elucidate the mysteries of this ancient organelle in order to treat it therapeutically when needed. Mitochondrial DNA mutations, infections, aging, and a lack of physical activity have been identified to be major players in mitochondrial dysfunction in multiple diseases. This review examines the complexities of mitochondrial function, whose ancient incorporation into eukaryotic cells for energy purposes was key for the survival and creation of new species. Among these complexities, the tightly intertwined bioenergetics derived from the combustion of alimentary substrates and oxygen are necessary for cellular homeostasis, including the production of reactive oxygen species. This review discusses different etiological mechanisms by which mitochondria could become dysregulated, determining the fate of multiple tissues and organs and being a protagonist in the pathogenesis of many non-communicable diseases. Finally, physical activity is a canonical evolutionary characteristic of humans that remains embedded in our genes. The normalization of a lack of physical activity in our modern society has led to the perception that exercise is an "intervention". However, physical activity remains the modus vivendi engrained in our genes and being sedentary has been the real intervention and collateral effect of modern societies. It is well known that a lack of physical activity leads to mitochondrial dysfunction and, hence, it probably becomes a major etiological factor of many non-communicable diseases affecting modern societies. Since physical activity remains the only stimulus we know that can improve and maintain mitochondrial function, a significant emphasis on exercise promotion should be imperative in order to prevent multiple diseases. Finally, in populations with chronic diseases where mitochondrial dysfunction is involved, an individualized exercise prescription should be crucial for the "metabolic rehabilitation" of many patients. From lessons learned from elite athletes (the perfect human machines), it is possible to translate and apply multiple concepts to the betterment of populations with chronic diseases.
C1 [San-Millan, Inigo] Univ Colorado, Dept Human Physiol & Nutr, Colorado Springs, CO 80198 USA.
   [San-Millan, Inigo] Univ Colorado Anschutz Med Campus, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA.
   [San-Millan, Inigo] Univ Colorado Anschutz Med Campus, Dept Med, Div Med Oncol, Aurora, CO 80045 USA.
C3 University of Colorado System; University of Colorado at Colorado Springs; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus
RP San-Millan, I (corresponding author), Univ Colorado, Dept Human Physiol & Nutr, Colorado Springs, CO 80198 USA.; San-Millan, I (corresponding author), Univ Colorado Anschutz Med Campus, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA.; San-Millan, I (corresponding author), Univ Colorado Anschutz Med Campus, Dept Med, Div Med Oncol, Aurora, CO 80045 USA.
EM isanmill@uccs.edu
FU IS-M Cellular Metabolism Laboratory funds.
CR Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1
   Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25
   Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042
   Alam MM, 2016, CLIN TRANSL MED, V5, P0, DOI 10.1186/s40169-016-0082-9
   Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, PE752, DOI 10.1152/ajpendo.00590.2009
   Alonso A, 1997, ELECTROPHORESIS, V18, P682, DOI 10.1002/elps.1150180504
   Amara CE, 2008, METHODS, V46, P312, DOI 10.1016/j.ymeth.2008.10.001
   Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221
   Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333
   Arismendi-Morillo G, 2017, ULTRASTRUCT PATHOL, V41, P234, DOI 10.1080/01913123.2017.1300618
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Arnold Dominguez Y, 2017, REV CUB ENDOCRINOL, V28, P1
   Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185
   Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200
   Aubert G, 2013, BBA-MOL CELL RES, V1833, P840, DOI 10.1016/j.bbamcr.2012.08.015
   Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174
   Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
   Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012
   Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x
   Benedict FG, 1938, VITAL ENERGETICS STU, V0, P0
   Bergman BC, 2012, DIABETOLOGIA, V55, P1140, DOI 10.1007/s00125-011-2419-7
   Bergman BC, 2020, DIABETES, V69, P848, DOI 10.2337/dbi18-0042
   Bergman BC, 2018, AM J PHYSIOL-ENDOC M, V314, PE152, DOI 10.1152/ajpendo.00142.2017
   Bergouignan A, 2006, PLOS CLIN TRIALS, V1, P0, DOI 10.1371/journal.pctr.0010027
   Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011
   BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012
   Bismuth J, 2008, ATHEROSCLEROSIS, V196, P497, DOI 10.1016/j.atherosclerosis.2007.09.018
   Blaak EE, 2000, DIABETES, V49, P2102, DOI 10.2337/diabetes.49.12.2102
   Blair SN, 2009, BRIT J SPORT MED, V43, P1
   Blake R, 2014, BBA-GEN SUBJECTS, V1840, P1404, DOI 10.1016/j.bbagen.2013.11.007
   Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Boutagy NE, 2015, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/53216
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brooks GA, 2020, J SPORT HEALTH SCI, V9, P446, DOI 10.1016/j.jshs.2020.02.006
   Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008
   Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6
   Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Campbell MD, 2016, BBA-MOL BASIS DIS, V1862, P716, DOI 10.1016/j.bbadis.2015.12.019
   Campos JC, 2017, AUTOPHAGY, V13, P1304, DOI 10.1080/15548627.2017.1325062
   Carter HN, 2018, J APPL PHYSIOL, V124, P1605, DOI 10.1152/japplphysiol.01110.2017
   Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014
   Casademont Jordi, 2002, HEART FAIL REV, V7, P131, DOI 10.1023/A:1015372407647
   Cass SP, 2017, CURR SPORT MED REP, V16, P19, DOI 10.1249/JSR.0000000000000332
   Chatfield KC, 2022, J INHERIT METAB DIS, V45, P111, DOI 10.1002/jimd.12459
   Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002
   Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93
   Chen YN, 2021, HUM BRAIN MAPP, V42, P4671, DOI 10.1002/hbm.25575
   Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, PC33, DOI 10.1152/ajpcell.00243.2006
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988
   Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728
   Colombini M, 2017, J BIOENERG BIOMEMBR, V49, P57, DOI 10.1007/s10863-016-9646-z
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   COYLE EF, 1985, J APPL PHYSIOL, V59, P853, DOI 10.1152/jappl.1985.59.3.853
   Cuezva JM, 2002, CANCER RES, V62, P6674
   Cui Hang, 2012, J SIGNAL TRANSDUCT, V2012, P646354, DOI 10.1155/2012/646354
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Daussin FN, 2008, J APPL PHYSIOL, V104, P1436, DOI 10.1152/japplphysiol.01135.2007
   Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d
   de Boer E, 2022, AM J RESP CRIT CARE, V205, P126, DOI 10.1164/rccm.202108-1903LE
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   de la Maza MP, 2015, J NUTR HEALTH AGING, V19, P389, DOI 10.1007/s12603-014-0548-7
   De la Rosa A, 2020, J SPORT HEALTH SCI, V9, P394, DOI 10.1016/j.jshs.2020.01.004
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   DeBerardinis RJ, 2020, NAT METAB, V2, P127, DOI 10.1038/s42255-020-0172-2
   DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000
   DeFronzo RA, 2009, DIABETES CARE, V32, PS157, DOI 10.2337/dc09-S302
   Dembitskaya Y, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2212004119
   Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344
   Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002
   Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415
   DOLKAS CB, 1977, J APPL PHYSIOL, V43, P1033, DOI 10.1152/jappl.1977.43.6.1033
   Drochioiu G, 2008, BIOL SYSTEMS STRUCTU, V0, P0
   Dubé JJ, 2016, MED SCI SPORT EXER, V48, P472, DOI 10.1249/MSS.0000000000000789
   Dudek J, 2017, FRONT CELL DEV BIOL, V5, P0, DOI 10.3389/fcell.2017.00090
   Durstine JL, 2013, J SPORT HEALTH SCI, V2, P3, DOI 10.1016/j.jshs.2012.07.009
   Farina N, 2014, INT PSYCHOGERIATR, V26, P9, DOI 10.1017/S1041610213001385
   Fernández AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001
   Fields JA, 2016, NEUROBIOL DIS, V86, P154, DOI 10.1016/j.nbd.2015.11.015
   Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967
   Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177
   Friedenreich CM, 2021, MOL ONCOL, V15, P790, DOI 10.1002/1878-0261.12772
   Fritzen AM, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8030237
   Fritzen AM, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9103113
   Ganji R, 2021, FRONT AGING NEUROSCI, V12, P0, DOI 10.3389/fnagi.2020.614650
   Gatti P, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.578599
   Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9
   Glushakova LG, 2011, MOL GENET METAB, V104, P255, DOI 10.1016/j.ymgme.2011.07.023
   GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107
   GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312
   GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502
   Gonzalez-Franquesa A, 2017, ADV EXP MED BIOL, V982, P465, DOI 10.1007/978-3-319-55330-6_25
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755
   Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015
   Gornik I, 2010, J CRIT CARE, V25, P263, DOI 10.1016/j.jcrc.2009.10.002
   Grill S, 2017, ARCH GYNECOL OBSTET, V296, P1135, DOI 10.1007/s00404-017-4546-y
   Gu CP, 2022, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.788505
   Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154
   Guntur VP, 2022, METABOLITES, V12, P0, DOI 10.3390/metabo12111026
   Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500
   Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6
   HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B
   Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288
   Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681
   Hammond Tyler C, 2022, J CELL IMMUNOL, V4, P15
   Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harris JAB, 1919, SCI MON, V8, P385
   Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370
   Hashimoto T, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002915
   Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI 10.1249/mss.0b013e31815fcb04
   Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, PE1237, DOI 10.1152/ajpendo.00594.2005
   Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086
   HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   HOUMARD JA, 1992, INT J SPORTS MED, V13, P572, DOI 10.1055/s-2007-1024567
   HOUSTON ME, 1979, ACTA PHYSIOL SCAND, V105, P163, DOI 10.1111/j.1748-1716.1979.tb06328.x
   HOYER S, 1992, MOL CHEM NEUROPATHOL, V16, P207, DOI 10.1007/BF03159971
   Hsu CC, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8122186
   Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021
   Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008
   Huang CC, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087095
   Intlekofer KA, 2013, NEUROBIOL DIS, V57, P47, DOI 10.1016/j.nbd.2012.06.011
   Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   JANSSON E, 1987, J APPL PHYSIOL, V62, P999, DOI 10.1152/jappl.1987.62.3.999
   Jayaraman A, 2014, CURR DIABETES REP, V14, P0, DOI 10.1007/s11892-014-0476-2
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Jenner P, 2003, ANN NEUROL, V53, PS26, DOI 10.1002/ana.10483
   Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7010013
   Jiang HK, 2014, INT J MOL SCI, V15, P5304, DOI 10.3390/ijms15045304
   Jones DP, 2015, ANTIOXID REDOX SIGN, V23, P734, DOI 10.1089/ars.2015.6247
   Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509
   Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997
   Karwi QG, 2018, FRONT CARDIOVASC MED, V5, P0, DOI 10.3389/fcvm.2018.00068
   Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677
   Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, P0
   Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758
   KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603
   Kemp GJ, 2015, ACTA PHYSIOL, V213, P107, DOI 10.1111/apha.12307
   Khosravi M, 2019, J ALZHEIMERS DIS, V70, P1197, DOI 10.3233/JAD-190220
   KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Kim SJ, 2013, PLOS PATHOG, V9, P0, DOI 10.1371/journal.ppat.1003285
   Kirkman DL, 2021, AM J PHYSIOL-HEART C, V320, PH2080, DOI 10.1152/ajpheart.00917.2020
   KIRKWOOD SP, 1986, AM J PHYSIOL, V251, PC395, DOI 10.1152/ajpcell.1986.251.3.C395
   Kirwan JP, 2013, DIABETES, V62, P352, DOI 10.2337/db12-1427
   KLAUSEN K, 1981, ACTA PHYSIOL SCAND, V113, P9, DOI 10.1111/j.1748-1716.1981.tb06854.x
   Kohl HW, 2001, MED SCI SPORT EXER, V33, PS472, DOI 10.1097/00005768-200106001-00017
   Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095
   Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004
   Koziel R, 2013, BIOCHEM J, V452, P231, DOI 10.1042/BJ20121778
   Krssak M, 2000, J CLIN ENDOCR METAB, V85, P748, DOI 10.1210/jc.85.2.748
   Kuehn BM, 2020, JAMA-J AM MED ASSOC, V323, P297, DOI 10.1001/jama.2019.20939
   LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Law BA, 2018, FASEB J, V32, P1403, DOI 10.1096/fj.201700300R
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Le CH, 2020, J BIOL CHEM, V295, P12485, DOI 10.1074/jbc.RA119.011229
   Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950
   Leibson CL, 1997, AM J EPIDEMIOL, V145, P301
   Li WJ, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/823071
   Lim AY, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232012559
   Lin ML, 2021, THROMB HAEMOSTASIS, V121, P900, DOI 10.1055/s-0040-1722191
   Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Ljubicic V, 2009, AGING-US, V1, P818, DOI 10.18632/aging.100083
   Lombardi AM, 1999, AM J PHYSIOL-ENDOC M, V276, PE922, DOI 10.1152/ajpendo.1999.276.5.E922
   Long QQ, 2019, METHODS MOL BIOL, V1966, P237, DOI 10.1007/978-1-4939-9195-2_19
   Lopez X, 2013, J PEDIATR ENDOCR MET, V26, P995, DOI 10.1515/jpem-2012-0407
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87
   Lutwak L, 1959, CLIN. RES, V7, P143
   MACOVSCHI E, 1982, REV ROUM BIOCHIM, V19, P177
   Macovschi E, 1969, BIOSTRUCTURA, VVolume 57, P0
   Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177
   Mah M, 2021, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.684448
   Mandolesi L, 2018, FRONT PSYCHOL, V9, P0, DOI 10.3389/fpsyg.2018.00509
   Mankowski RT, 2019, INTENS CARE MED, V45, P78, DOI 10.1007/s00134-018-5173-1
   Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323
   Marcus C, 2014, CLIN NUCL MED, V39, PE413, DOI 10.1097/RLU.0000000000000547
   Martín-Timón I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444
   McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7
   McGurk KA, 2021, ATHEROSCLEROSIS, V327, P18, DOI 10.1016/j.atherosclerosis.2021.04.021
   McTiernan A, 2019, MED SCI SPORT EXER, V51, P1252, DOI 10.1249/MSS.0000000000001937
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   MIKINES KJ, 1991, J APPL PHYSIOL, V70, P1245, DOI 10.1152/jappl.1991.70.3.1245
   Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a
   Monlun M, 2017, J MOL BIOL, V429, P1, DOI 10.1016/j.jmb.2016.10.028
   MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719
   Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143
   Murariu M, 2012, BIOSYSTEMS, V109, P126, DOI 10.1016/j.biosystems.2012.02.006
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nelson MAM, 2021, ELIFE, V10, P0, DOI 10.7554/elife.63104
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Newington Jordan T, 2013, J NEURODEGENER DIS, V2013, P234572, DOI 10.1155/2013/234572
   Newman LA, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028427
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5
   Ou YN, 2019, ALZHEIMERS RES THER, V11, P0, DOI 10.1186/s13195-019-0512-1
   Paradies G, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070728
   Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324
   Peng HL, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.626047
   Perreault L, 2018, JCI INSIGHT, V3, P0, DOI 10.1172/jci.insight.96805
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Petrocelli JJ, 2020, J GERONTOL A-BIOL, V75, P1663, DOI 10.1093/gerona/glaa072
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0
   Potenza MA, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10081257
   POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.pu.08.050187.001345
   Poznyak AV, 2020, BIOLOGY-BASEL, V9, P0, DOI 10.3390/biology9060137
   PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033
   Rahmel T, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-78195-4
   RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026
   Rolland Y, 2008, J AM MED DIR ASSOC, V9, P390, DOI 10.1016/j.jamda.2008.02.007
   Rome S, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00929
   Rossin F, 2015, CELL DEATH DIFFER, V22, P408, DOI 10.1038/cdd.2014.106
   Rudwill F, 2018, J CLIN ENDOCR METAB, V103, P1910, DOI 10.1210/jc.2017-02267
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Safeliu C, 2001, NEUROTOXICOLOGY, V22, P317, DOI 10.1016/S0161-813X(01)00015-8
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   San-Millan I, 2022, FRONT NUTR, V9, P0, DOI 10.3389/fnut.2022.809485
   San-Millán I, 2020, FRONT ONCOL, V9, P0, DOI 10.3389/fonc.2019.01536
   San-Millán I, 2018, SPORTS MED, V48, P467, DOI 10.1007/s40279-017-0751-x
   San-Millán I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127
   Sangwung P, 2020, ENDOCRINOLOGY, V161, P0, DOI 10.1210/endocr/bqaa017
   Santos-Lozano A, 2016, MAYO CLIN PROC, V91, P999, DOI 10.1016/j.mayocp.2016.04.024
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6934394
   Schaar CE, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1004972
   Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009
   Sergi D, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00532
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035
   Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907
   Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531
   Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11
   Sokolowska E, 2019, FRONT ENDOCRINOL, V10, P0, DOI 10.3389/fendo.2019.00577
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Stephen R, 2017, J GERONTOL A-BIOL, V72, P733, DOI 10.1093/gerona/glw251
   STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2
   Bon RS, 2021, FRONT PSYCHIATRY, V12, P0, DOI 10.3389/fpsyt.2021.669725
   Sulaiman N, 2018, BMJ OPEN DIAB RES CA, V6, P0, DOI 10.1136/bmjdrc-2017-000489
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P1434, DOI 10.1089/ars.2011.4149
   Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Talbot K, 2014, NEURODEGENER DIS MAN, V4, P31, DOI 10.2217/nmt.13.73
   Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007
   Tan-Chen S, 2020, FRONT ENDOCRINOL, V11, P0, DOI 10.3389/fendo.2020.00491
   Tang XQ, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00175
   Tauffenberger A, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1877-6
   Terzo S, 2021, J DIABETES COMPLICAT, V35, P0, DOI 10.1016/j.jdiacomp.2021.108026
   Thanan R, 2015, INT J MOL SCI, V16, P193, DOI 10.3390/ijms16010193
   Tiku V, 2020, TRENDS CELL BIOL, V30, P263, DOI 10.1016/j.tcb.2020.01.006
   Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429
   Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141
   Toledo FGS, 2006, J CLIN ENDOCR METAB, V91, P3224, DOI 10.1210/jc.2006-0002
   Tran DH, 2019, J AM HEART ASSOC, V8, P0, DOI 10.1161/JAHA.119.012673
   TURCOTTE LP, 1992, AM J PHYSIOL, V262, P0
   Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001
   Turpin-Nolan SM, 2020, NAT REV ENDOCRINOL, V16, P224, DOI 10.1038/s41574-020-0320-5
   Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, PH1876, DOI 10.1152/ajpheart.00375.2009
   van Loon LJC, 2003, J PHYSIOL-LONDON, V553, P611, DOI 10.1113/jphysiol.2003.052431
   Vasile VC, 2021, ARTERIOSCL THROM VAS, V41, P1558, DOI 10.1161/ATVBAHA.120.315530
   Verma M, 2003, NAT REV CANCER, V3, P789, DOI 10.1038/nrc1192
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Vorkas PA, 2015, J PROTEOME RES, V14, P1389, DOI 10.1021/pr5009898
   Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang D, 2022, J DIABETES RES, V2022, P0, DOI 10.1155/2022/3780156
   Wang W, 2016, ANTIOXID REDOX SIGN, V25, P534, DOI 10.1089/ars.2016.6739
   Warburg O, 1923, JOURNAL OF MOLECULAR MEDICINE, V2, P776, DOI 10.1007/BF01712130
   Warburg O, 1925, J CANCER RES CLIN, V9, P148, DOI 10.1158/JCR.1925.148
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820
   WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004
   Xia WQ, 2013, PSYCHONEUROENDOCRINO, V38, P2493, DOI 10.1016/j.psyneuen.2013.05.012
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Yetkin-Arik B, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-48676-2
   Yetkin-Arile B, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-46503-2
   Yoshizumi T, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5713
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yuan Huiping, 2018, ONCOTARGET, V9, P6718, DOI 10.18632/oncotarget.22961
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1
   Zhang LX, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101284
   Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014
   Zhao Y, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/316523
   Zhou J, 2018, EXP MOL MED, V50, P0, DOI 10.1038/s12276-018-0113-2
   Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504
NR 327
TC 55
Z9 58
U1 24
U2 54
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD APR 15
PY 2023
VL 12
IS 4
BP 
EP 
DI 10.3390/antiox12040782
PG 30
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology
GA E7MO4
UT WOS:000977344100001
PM 37107158
DA 2024-11-01
ER

PT J
AU Hobson, S
   Arefin, S
   Witasp, A
   Hernandez, L
   Kublickiene, K
   Shiels, PG
   Stenvinkel, P
AF Hobson, S.
   Arefin, S.
   Witasp, A.
   Hernandez, L.
   Kublickiene, K.
   Shiels, P. G.
   Stenvinkel, P.
TI Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel Therapies
SO CIRCULATION RESEARCH
LA English
DT Article
DE aging; biology; inflammation; oxidative stress; progeria; renal insufficiency; chronic
ID smooth-muscle-cell; vitamin-k supplementation; matrix gla protein; clonal hematopoiesis; oxidative stress; senescent cells; dna-damage; mitochondrial dysfunction; endothelial dysfunction; chronic inflammation
AB The pathophysiology of vascular disease is linked to accelerated biological aging and a combination of genetic, lifestyle, biological, and environmental risk factors. Within the scenario of uncontrolled artery wall aging processes, CKD (chronic kidney disease) stands out as a valid model for detailed structural, functional, and molecular studies of this process. The cardiorenal syndrome relates to the detrimental bidirectional interplay between the kidney and the cardiovascular system. In addition to established risk factors, this group of patients is subjected to a plethora of other emerging vascular risk factors, such as inflammation, oxidative stress, mitochondrial dysfunction, vitamin K deficiency, cellular senescence, somatic mutations, epigenetic modifications, and increased apoptosis. A better understanding of the molecular mechanisms through which the uremic milieu triggers and maintains early vascular aging processes, has provided important new clues on inflammatory pathways and emerging risk factors alike, and to the altered behavior of cells in the arterial wall. Advances in the understanding of the biology of uremic early vascular aging opens avenues to novel pharmacological and nutritional therapeutic interventions. Such strategies hold promise to improve future prevention and treatment of early vascular aging not only in CKD but also in the elderly general population.
C1 [Hobson, S.; Arefin, S.; Witasp, A.; Hernandez, L.; Kublickiene, K.; Stenvinkel, P.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden.
   [Shiels, P. G.] Univ Glasgow, Sch Mol Biosci, MVLS, Glasgow, Lanark, Scotland.
C3 Karolinska Institutet; University of Glasgow
RP Stenvinkel, P (corresponding author), Karolinska Univ Hosp Stockholm, Dept Renal Med M99, Stockholm, Sweden.
EM peter.stenvinkel@ki.se
FU Hjaert-lungfonden; CIMED; Swedish Research Council [2018-00932, 2021-01102]; Stiftelsen Stig och Gunborg Westman; Njurfonden; EU Innovative Training Network CaReSyAn [764474]; Swedish Research Council [2018-00932, 2021-01102] Funding Source: Swedish Research Council; Vinnova [2021-01102] Funding Source: Vinnova
CR Afanasev I, 2010, AGING DIS, V1, P75
   Aghagolzadeh P, 2017, ATHEROSCLEROSIS, V265, P78, DOI 10.1016/j.atherosclerosis.2017.08.012
   Agrawal M, 2022, BLOOD, V140, P1094, DOI 10.1182/blood.2022015384
   Alexander Y, 2021, CARDIOVASC RES, V117, P29, DOI 10.1093/cvr/cvaa085
   Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798
   Arefin S, 2020, CLIN CHIM ACTA, V505, P108, DOI 10.1016/j.cca.2020.02.026
   Arnold R, 2016, JRSM CARDIOVASC DIS, V5, P0, DOI 10.1177/2048004016677687
   Asai K, 2000, ARTERIOSCL THROM VAS, V20, P1493, DOI 10.1161/01.ATV.20.6.1493
   Asenjo-Bueno A, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10081308
   Avesani CM, 2022, J REN NUTR, Vs1051-2276, P00161
   Axelsson AS, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aah4477
   Bailey MJ, 2020, GUT MICROBES, V11, P1188, DOI 10.1080/19490976.2020.1749754
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Sandoval SB, 2010, MUTAGENESIS, V25, P603, DOI 10.1093/mutage/geq047
   Bhattacharya R, 2022, STROKE, V53, P788, DOI 10.1161/STROKEAHA.121.037388
   Bisbal F, 2020, J AM COLL CARDIOL, V75, P222, DOI 10.1016/j.jacc.2019.11.013
   Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434
   Boraldi F, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10010131
   Briet M, 2012, CLIN SCI, V123, P399, DOI 10.1042/CS20120074
   Brunner AM, 2017, BLOOD ADV, V1, P2032, DOI 10.1182/bloodadvances.2017010165
   Bruno RM, 2021, ARTERY RES, V27, P59, DOI 10.2991/artres.k.201124.001
   Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200
   Cagan A, 2022, NATURE, V604, P517, DOI 10.1038/s41586-022-04618-z
   Carafa V, 2016, CLIN EPIGENETICS, V8, P0, DOI 10.1186/s13148-016-0224-3
   Cardozo LFMF, 2021, NUTR REV, V79, P1204, DOI 10.1093/nutrit/nuaa129
   Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x
   Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181
   Chang J, 2013, AM J PHYSIOL-RENAL, V304, PF348, DOI 10.1152/ajprenal.00568.2012
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen SC, 2018, KIDNEY BLOOD PRESS R, V43, P1388, DOI 10.1159/000492953
   Chirinos JA, 2019, J AM COLL CARDIOL, V74, P1237, DOI 10.1016/j.jacc.2019.07.012
   Chowdhury A, 2022, PHARMACEUTICALS-BASE, V15, P0, DOI 10.3390/ph15050493
   Chung AWY, 2009, CIRCULATION, V120, P792, DOI 10.1161/CIRCULATIONAHA.109.862565
   Clarkson MT, 2019, AM J PHYSIOL-RENAL, V316, PF856, DOI 10.1152/ajprenal.00317.2018
   Cobo G, 2018, NEPHROL DIAL TRANSPL, V33, P35, DOI 10.1093/ndt/gfy175
   Cobo G, 2016, CLIN SCI, V130, P1147, DOI 10.1042/CS20160047
   Corredor Z, 2020, MUTAT RES-GEN TOX EN, V852, P0, DOI 10.1016/j.mrgentox.2020.503167
   Csiszar A, 2004, PHYSIOL GENOMICS, V17, P21, DOI 10.1152/physiolgenomics.00136.2003
   Cunha PG, 2017, CURR HYPERTENS REV, V13, P8, DOI 10.2174/1573402113666170413094319
   Dai L, 2021, CLIN SCI, V135, P1251, DOI 10.1042/CS20201452
   Dai L, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0247623
   Dai L, 2020, NEPHROL DIAL TRANSPL, V35, P31, DOI 10.1093/ndt/gfaa006
   Dai L, 2019, COMPUT STRUCT BIOTEC, V17, P721, DOI 10.1016/j.csbj.2019.06.015
   Dawoud AAZ, 2022, LEUKEMIA, V36, P507, DOI 10.1038/s41375-021-01382-3
   De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9
   de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Dihingia A, 2018, FOOD FUNCT, V9, P450, DOI 10.1039/c7fo01491k
   Disthabanchong Sinee, 2012, WORLD J NEPHROL, V1, P43, DOI 10.5527/wjn.v1.i2.43
   Düsing P, 2021, J MOL MED, V99, P335, DOI 10.1007/s00109-021-02037-7
   Ebert T, 2022, MOL ASPECTS MED, V86, P0, DOI 10.1016/j.mam.2022.101099
   Ebert T, 2020, TOXINS, V12, P0, DOI 10.3390/toxins12040227
   Ellaway A, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0214380
   Erlandsson H, 2022, J INTERN MED, V291, P813, DOI 10.1111/joim.13459
   Esgalhado M, 2020, FOOD FUNCT, V11, P2617, DOI 10.1039/c9fo02939g
   Evenepoel P, 2015, J CLIN ENDOCR METAB, V100, P4669, DOI 10.1210/jc.2015-3056
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2
   Foreman KJ, 2018, LANCET, V392, P2052, DOI 10.1016/s0140-6736(18)31694-5
   Fougère B, 2017, J GERONTOL A-BIOL, V72, P1218, DOI 10.1093/gerona/glw240
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, PS4, DOI 10.1093/gerona/glu057
   Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034
   Gamboa JL, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.12780
   Gerdes EOW, 2021, MECH AGEING DEV, V200, P0, DOI 10.1016/j.mad.2021.111591
   Grabowska W, 2017, BIOGERONTOLOGY, V18, P447, DOI 10.1007/s10522-017-9685-9
   Guedj A, 2020, GUT, V69, P1064, DOI 10.1136/gutjnl-2019-318491
   Ha CM, 2014, VASC PHARMACOL, V63, P29, DOI 10.1016/j.vph.2014.06.007
   Hamczyk MR, 2020, J AM COLL CARDIOL, V75, P919, DOI 10.1016/j.jacc.2019.11.062
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harvey A, 2016, CAN J CARDIOL, V32, P659, DOI 10.1016/j.cjca.2016.02.070
   Heather LC, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026326
   Herman Allison B, 2021, J CARDIOVASC AGING, V1, P0, DOI 10.20517/jca.2021.16
   Hernandez L, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-08387-7
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Heyde A, 2021, CELL, V184, P1348, DOI 10.1016/j.cell.2021.01.049
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hobson S, 2019, TOXINS, V11, P0, DOI 10.3390/toxins11020082
   Holden RM, 2023, NEPHROL DIAL TRANSPL, V38, P746, DOI 10.1093/ndt/gfac191
   Imai T, 2016, NEUROBIOL DIS, V89, P136, DOI 10.1016/j.nbd.2016.02.001
   Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005
   Jaiswal S, 2019, SCIENCE, V366, P586, DOI 10.1126/science.aan4673
   Jaiswal S, 2020, NAT REV CARDIOL, V17, P137, DOI 10.1038/s41569-019-0247-5
   Jaminon A, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20225694
   Jaminon AMG, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-63013-8
   Jankowski J, 2021, CIRCULATION, V143, P1157, DOI 10.1161/CIRCULATIONAHA.120.050686
   Ji HW, 2022, CIRC RES, V130, P566, DOI 10.1161/CIRCRESAHA.121.319902
   Jin DH, 2022, FASEB J, V36, P0, DOI 10.1096/fj.202100625RR
   Jin KL, 2019, AGING DIS, V10, P676, DOI 10.14336/AD.2019.0315
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jung J, 2022, BMC NEPHROL, V23, P0, DOI 10.1186/s12882-022-02918-0
   Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208
   Khashan AS, 2019, PLOS MED, V16, P0, DOI 10.1371/journal.pmed.1002875
   King KY, 2020, EXP HEMATOL, V83, P66, DOI 10.1016/j.exphem.2019.12.005
   Kirkman DL, 2018, AM J PHYSIOL-RENAL, V314, PF423, DOI 10.1152/ajprenal.00321.2017
   Kobayashi EH, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11624
   Kooman JP, 2017, AM J PHYSIOL-RENAL, V313, PF938, DOI 10.1152/ajprenal.00256.2017
   Kooman JP, 2017, EXP GERONTOL, V87, P156, DOI 10.1016/j.exger.2016.02.003
   Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Kyriakidis NC, 2021, TOXINS, V13, P0, DOI 10.3390/toxins13010026
   Lacolley P, 2018, CARDIOVASC RES, V114, P513, DOI 10.1093/cvr/cvy009
   Lanzer P, 2021, J AM COLL CARDIOL, V78, P1145, DOI 10.1016/j.jacc.2021.06.049
   Laurent S, 2019, HYPERTENSION, V74, P218, DOI 10.1161/HYPERTENSIONAHA.119.12655
   Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190
   Leloup AJA, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00375
   Lerner H, 2017, FRONT VET SCI, V4, P0, DOI 10.3389/fvets.2017.00163
   Levy-Schousboe K, 2021, CLIN KIDNEY J, V14, P2114, DOI 10.1093/ckj/sfab017
   Liabeuf S, 2022, NEPHROL DIAL TRANSPL, V37, P33, DOI 10.1093/ndt/gfab223
   Libby P, 2021, NATURE, V592, P524, DOI 10.1038/s41586-021-03392-8
   Liu YZ, 2021, FRONT CELL DEV BIOL, V09, P0, DOI 10.3389/fcell.2021.648639
   London GM, 2016, J AM SOC NEPHROL, V27, P1837, DOI 10.1681/ASN.2015060617
   Lopez-Otin C, 2022, CELL, VS0092-8674, P01377
   Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760
   Luttropp K, 2016, TRANSPLANT DIRECT, V2, P0, DOI 10.1097/TXD.0000000000000629
   M Nilsson Peter, 2015, EUR ENDOCRINOL, V11, P26, DOI 10.17925/EE.2015.11.01.26
   Ma WQ, 2021, FREE RADICAL BIO MED, V165, P229, DOI 10.1016/j.freeradbiomed.2021.01.033
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Mafra D, 2021, NAT REV NEPHROL, V17, P153, DOI 10.1038/s41581-020-00345-8
   Mafra D, 2019, MITOCHONDRION, V47, P206, DOI 10.1016/j.mito.2018.11.006
   MALACHI T, 1993, KIDNEY INT, V44, P385, DOI 10.1038/ki.1993.256
   Marnell CS, 2021, J MOL CELL CARDIOL, V161, P98, DOI 10.1016/j.yjmcc.2021.07.004
   Marton A, 2021, NAT REV NEPHROL, V17, P65, DOI 10.1038/s41581-020-00350-x
   Matsushita K, 2015, J AM SOC NEPHROL, V26, P439, DOI 10.1681/ASN.2014020173
   Mayer O, 2016, J HUM HYPERTENS, V30, P418, DOI 10.1038/jhh.2015.55
   Mazumder MK, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-37935-3
   McClelland R, 2016, AGING-US, V8, P1135, DOI 10.18632/aging.100948
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Melnyk BM, 2020, AM J HEALTH PROMOT, V34, P929, DOI 10.1177/0890117120920451
   Mimura J, 2015, FREE RADICAL BIO MED, V88, P221, DOI 10.1016/j.freeradbiomed.2015.06.019
   Mishima E, 2022, NATURE, V608, P778, DOI 10.1038/s41586-022-05022-3
   Missailidis C, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0141738
   Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075
   Moore L, 2021, NATURE, V597, P381, DOI 10.1038/s41586-021-03822-7
   Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001
   Mudrovcic N, 2017, PHARMACOL RES, V119, P48, DOI 10.1016/j.phrs.2017.01.011
   Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98
   Nelson AJ, 2020, JACC-BASIC TRANSL SC, V5, P398, DOI 10.1016/j.jacbts.2020.02.002
   Neradova A, 2022, NEPHROL DIAL TRANSPL, V37, P652, DOI 10.1093/ndt/gfab314
   Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319
   Nilsson PM, 2014, AGING DIS, V5, P109, DOI 10.14336/AD.2014.0500109
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Opdebeeck B, 2019, J AM SOC NEPHROL, V30, P751, DOI 10.1681/ASN.2018060609
   Packer M, 2022, CIRCULATION, V146, P1383, DOI 10.1161/CIRCULATIONAHA.122.061732
   Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684
   Phadwal K, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.611922
   Pongsuwan K, 2022, J CELL PHYSIOL, V237, P4369, DOI 10.1002/jcp.30891
   Querfeld U, 2020, CLIN SCI, V134, P1333, DOI 10.1042/CS20200279
   Raffaele M, 2022, LANCET HEALTH LONGEV, V3, PE67, DOI 10.1016/S2666-7568(21)00300-7
   Raggi P, 2020, CIRCULATION, V141, P728, DOI 10.1161/CIRCULATIONAHA.119.044195
   Rapp N, 2020, TOXINS, V12, P0, DOI 10.3390/toxins12100624
   Raschenberger J, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep11887
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Ridker PM, 2021, LANCET, V397, P2060, DOI 10.1016/S0140-6736(21)00520-1
   Ridker PM, 2021, CIRC RES, V128, P1728, DOI 10.1161/CIRCRESAHA.121.319077
   Ridker PM, 2018, J AM COLL CARDIOL, V71, P2405, DOI 10.1016/j.jacc.2018.03.490
   Robertson NA, 2019, CURR BIOL, V29, PR786, DOI 10.1016/j.cub.2019.07.011
   Rodríguez-Ribera L, 2015, INT J RADIAT BIOL, V91, P172, DOI 10.3109/09553002.2015.959670
   Rojas-Rueda D, 2019, LANCET PLANET HEALTH, V3, PE469, DOI 10.1016/S2542-5196(19)30215-3
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Santos L, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/9831825
   Saritas T, 2022, CLIN KIDNEY J, V15, P2300, DOI 10.1093/ckj/sfac184
   Savage CD, 2012, FRONT IMMUNOL, V3, P0, DOI 10.3389/fimmu.2012.00288
   Schafer MJ, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14532
   Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7
   Shah AV, 2017, EUR J PHARMACOL, V816, P116, DOI 10.1016/j.ejphar.2017.03.050
   Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216
   Shiels PG, 2021, BIOCHEM J, V478, P2889, DOI 10.1042/BCJ20200958
   Shiels PG, 2019, BIOCHEM SOC T, V47, P1165, DOI 10.1042/BST20190110
   Shiels PG, 2017, NAT REV NEPHROL, V13, P471, DOI 10.1038/nrneph.2017.78
   Shiels PG, 2012, BRIT MED J, V344, P0, DOI 10.1136/bmj.e1415
   Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794
   Short S, 2019, EBIOMEDICINE, V41, P683, DOI 10.1016/j.ebiom.2019.01.056
   Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191
   Singh RR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26777
   Speer T, 2022, NAT REV NEPHROL, V18, P762, DOI 10.1038/s41581-022-00621-9
   Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747
   Steinbach EJ, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.797503
   Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x
   Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x
   Stenvinkel P, 2021, KIDNEY INT REP, V6, P1775, DOI 10.1016/j.ekir.2021.04.023
   Stenvinkel P, 2019, BIOCHEM SOC T, V47, P1157, DOI 10.1042/BST20190105
   Stenvinkel P, 2020, NEPHROL DIAL TRANSPL, V35, P2036, DOI 10.1093/ndt/gfz120
   Stenvinkel P, 2018, NAT REV NEPHROL, V14, P265, DOI 10.1038/nrneph.2017.169
   Stenvinkel P, 2017, AGING-US, V9, P494, DOI 10.18632/aging.101173
   Stopper H, 2001, AM J KIDNEY DIS, V38, P296, DOI 10.1053/ajkd.2001.26094
   Sturmlechner I, 2017, NAT REV NEPHROL, V13, P77, DOI 10.1038/nrneph.2016.183
   Thijssen DHJ, 2016, J PHYSIOL-LONDON, V594, P2275, DOI 10.1113/JP270597
   Thompson AM, 2014, AM J PHYSIOL-HEART C, V307, PH533, DOI 10.1152/ajpheart.00871.2013
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646
   Versari D, 2009, DIABETES CARE, V32, PS314, DOI 10.2337/dc09-S330
   Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571
   Vlasschaert C, 2022, J AM SOC NEPHROL, V33, P985, DOI 10.1681/ASN.2021060774
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Walaszczyk A, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12945
   Wang HH, 2022, LIFE SCI, V306, P0, DOI 10.1016/j.lfs.2022.120780
   Wang PW, 2022, ATHEROSCLEROSIS, V346, P36, DOI 10.1016/j.atherosclerosis.2022.02.007
   Wang QW, 2015, CIRC RES, V116, P600, DOI 10.1161/CIRCRESAHA.116.304899
   Wang R, 2017, AGING CELL, V16, P564, DOI 10.1111/acel.12587
   Wang W, 2018, CIRC RES, V123, PE35, DOI 10.1161/CIRCRESAHA.118.313283
   Weber T, 2018, EUR HEART J, V39, P3847, DOI 10.1093/eurheartj/ehy346
   Wu FN, 2020, FREE RADICAL BIO MED, V158, P171, DOI 10.1016/j.freeradbiomed.2020.06.038
   Wu SJ, 2019, CANCER MED-US, V8, P2252, DOI 10.1002/cam4.2101
   Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733
   Xie Y, 2022, NAT MED, V28, P583, DOI 10.1038/s41591-022-01689-3
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu M, 2016, PHARMACOL RES, V111, P152, DOI 10.1016/j.phrs.2016.05.015
   Ye YZ, 2022, KIDNEY INT, V102, P1259, DOI 10.1016/j.kint.2022.07.034
   Young GH, 2012, KIDNEY INT, V81, P611, DOI 10.1038/ki.2011.461
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Yu B, 2021, J AM COLL CARDIOL, V78, P42, DOI 10.1016/j.jacc.2021.04.085
   Yuan H, 2021, MOL CELL BIOCHEM, V476, P247, DOI 10.1007/s11010-020-03901-9
   Yuille S, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0201073
   Zhang Y, 2022, MOLECULES, V27, P0, DOI 10.3390/molecules27175422
   Zhu H, 2021, FRONT IMMUNOL, V12, P0, DOI 10.3389/fimmu.2021.714943
   Zhu Q, 2015, J VASC RES, V52, P291, DOI 10.1159/000442980
NR 220
TC 11
Z9 12
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD APR 14
PY 2023
VL 132
IS 8
BP 950
EP 969
DI 10.1161/CIRCRESAHA.122.321751
PG 20
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Hematology
GA D7EM3
UT WOS:000970321200005
PM 37053277
DA 2024-11-01
ER

PT J
AU Wang, JW
   Yuan, XB
   Chen, HF
AF Wang, Jian-Wei
   Yuan, Xiao-Bo
   Chen, Hong-Fang
TI Late-onset mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome with mitochondrial DNA 3243A>G mutation masquerading as autoimmune encephalitis: A case report
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE MELAS; Mitochondrial DNA mutation; Encephalitis; Case report
ID herpes-simplex encephalitis; melas; encephalopathy; myopathy; cohort
AB BACKGROUND Here, we present a unique case of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, which initially appeared to be autoimmune encephalitis and was ultimately confirmed as MELAS with the mitochondrial DNA 3243A>G mutation.CASE SUMMARY A 58-year-old female presented with acute-onset speech impediment and auditory hallucinations, symmetrical bitemporal lobe abnormalities, clinical and laboratory findings, and a lack of relevant prodromal history, which suggested diagnosis of autoimmune encephalitis. Further work-up, in conjunction with the patient's medical history, family history, and lactate peak on brain lesions on magnetic resonance imaging, suggested a mitochondrial disorder. Mitochondrial genome analysis revealed the m.3243A>G variant in the MT-TL1 gene, which led to a diagnosis of MELAS syndrome.CONCLUSION This case underscores the importance of considering MELAS as a potential cause of autoimmune encephalitis even if patients are over 40 years of age, as the symptoms and signs are atypical for MELAS syndrome.
C1 [Wang, Jian-Wei; Chen, Hong-Fang] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Neurol, Sch Med, Jinhua 321000, Zhejiang, Peoples R China.
   [Yuan, Xiao-Bo] First Peoples Hosp Yongkang, Dept Neurol, Jinhua 321300, Zhejiang, Peoples R China.
   [Chen, Hong-Fang] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Neurol, Sch Med, 356 Renmin East Rd, Jinhua 321000, Zhejiang, Peoples R China.
C3 Zhejiang University; Zhejiang University
RP Chen, HF (corresponding author), Zhejiang Univ, Affiliated Jinhua Hosp, Dept Neurol, Sch Med, 356 Renmin East Rd, Jinhua 321000, Zhejiang, Peoples R China.
EM jhchf894@163.com
FU Science and Technology Plan of Jinhua City [2020-3-026]
CR Bhatia KD, 2020, AM J NEURORADIOL, V41, P167, DOI 10.3174/ajnr.A6325
   Chow FC, 2015, CLIN INFECT DIS, V60, P1377, DOI 10.1093/cid/civ051
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Farrar MA, 2010, PEDIATRICS, V126, PE734, DOI 10.1542/peds.2009-2930
   Geberhiwot T, 2006, NEW ENGL J MED, V354, P1096
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hsu Yu-Chuan, 2012, J EMERG MED, V43, Pe163, DOI 10.1016/j.jemermed.2009.10.021
   Ienco EC, 2016, MITOCHONDRION, V30, P148, DOI 10.1016/j.mito.2016.07.008
   JOHNS DR, 1993, NEUROLOGY, V43, P2471, DOI 10.1212/WNL.43.12.2471
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Miyahara H, 2019, NEUROPATHOLOGY, V39, P212, DOI 10.1111/neup.12551
   Pauli W, 2013, POL J RADIOL, V78, P61, DOI 10.12659/PJR.884010
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yokota Y, 2020, BMC NEUROL, V20, P0, DOI 10.1186/s12883-020-01818-w
   Zhang Z, 2018, J NEUROL SCI, V385, P151, DOI 10.1016/j.jns.2017.12.033
NR 26
TC 0
Z9 0
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
EI 
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD MAY 16
PY 2023
VL 11
IS 14
BP 3275
EP 3281
DI 10.12998/wjcc.v11.i14.3275
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA I6JI2
UT WOS:001003823300018
PM 37274040
DA 2024-11-01
ER

PT J
AU Tran, NQ
   Phan, CC
   Vuong, TB
   Tran, TV
   Ma, PT
AF Tran, Nam Quang
   Phan, Chien Cong
   Vuong, Tran Bao
   Tran, Thang Viet
   Ma, Phat Tung
TI Acute onset of diabetes and rapid cognitive decline in a patient with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome
SO ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS
LA English
DT Article
DE Adult; Female; White; United States; Pancreas; Diabetes; Unique; unexpected symptoms or presentations of a disease; April; 2023
ID dna mutation; encephalopathy; myopathy; melas; mellitus
AB Mitochondrial diseases are a group of rare diseases presenting with heterogeneous clinical, biochemical, and genetic disorders caused by mutations in the mitochondrial or nuclear genome. Multiple organs can be affected, particularly those with high energy demand. Diabetes is a common endocrine manifestation of mitochondrial diseases. The onset of mitochondrial diabetes can be latent or acute, and the presenting phenotype can be type 1- or type 2-like. Studies show that diabetes ais associated with latent progression of cognitive decline in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Herein, we report a case of rapid cognitive decline after the acute onset of diabetes in a patient with MELAS syndrome. The patient was a 36-year-old woman who was hospitalized due to hyperglycemic crisis and seizures. She was diagnosed with MELAS syndrome two years previously, and had gradually progressing dementia and hearing loss. However, following the acute onset of diabetes, she developed rapid cognitive decline and loss of ability to perform daily activities. In conclusion, the acute onset of diabetes could be an associated risk factor for rapid cognitive decline in patients with MELAS syndrome. Thus, these patients as well as healthy carriers with related genetic mutations should undergo diabetes education and screening tests. Moreover, clinicians should be aware of the possibility for acute onset of hyperglycemic crisis, particularly in the presence of triggering factors. Learning points Diabetes is a common endocrine manifestation of mitochondrial diseases, presenting with a type 1- or type 2-like phenotype depending on the level of insulinopenia. Metformin should be avoided in patients with mitochondrial diseases to prevent metformin-induced lactic acidosis. Mitochondrial diabetes can manifest before or after the onset of MELAS syndrome. In patients with MELAS syndrome, diabetes can initially manifest with a life-threatening severe hyperglycemic crisis and can cause rapid cognitive decline. Diabetes screening tests (e.g. hemoglobin A1c, oral glucose tolerance test, or random blood glucose level measurement) should be performed either systematically or in the presence of symptoms, particularly after triggering events. Genetic testing and counseling should be provided to patients and their families for the purpose of better understanding the inheritance, progression, and possible outcomes of the disease.
C1 [Tran, Nam Quang; Vuong, Tran Bao; Tran, Thang Viet; Ma, Phat Tung] Univ Med & Pharm Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.
   [Tran, Nam Quang; Tran, Thang Viet; Ma, Phat Tung] Univ Med Ctr Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.
   [Phan, Chien Cong] Univ Med Ctr Ho Chi Minh City, Dept Imaging, Ho Chi Minh City, Vietnam.
C3 Hochiminh City University of Medicine & Pharmacy
RP Ma, PT (corresponding author), Univ Med & Pharm Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.; Ma, PT (corresponding author), Univ Med Ctr Ho Chi Minh City, Dept Endocrinol, Ho Chi Minh City, Vietnam.
EM matungphat@ump.edu.vn
CR Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Murakami T, 2016, TOHOKU J EXP MED, V238, P311, DOI 10.1620/tjem.238.311
   Nakamura S, 2000, DIABETES METAB, V26, P407
   Reed EM, 2020, AM J FOREN MED PATH, V41, P331, DOI 10.1097/PAF.0000000000000563
   Simoncini C, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/803942
   Stefano GB, 2016, EUR J NUTR, V55, P2339, DOI 10.1007/s00394-016-1212-2
   Toki T, 2021, PEDIATR NEUROL, V114, P1, DOI 10.1016/j.pediatrneurol.2020.09.013
   Vento JM, 2013, NEUROTHERAPEUTICS, V10, P243, DOI 10.1007/s13311-012-0173-2
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 13
TC 1
Z9 1
U1 1
U2 1
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 
EI 2052-0573
J9 ENDOCR DIAB MET C R
JI Endocrinol. Diabetes Metab. Case Rep.
PD APR 1
PY 2023
VL 2023
IS 2
BP 
EP 
DI 10.1530/EDM-22-0416
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA N9ZA5
UT WOS:001040495300001
PM 37073829
DA 2024-11-01
ER

PT J
AU Liu, L
   Yang, JH
   Otani, Y
   Shiga, T
   Yamaguchi, A
   Oda, Y
   Hattori, M
   Goto, T
   Ishibashi, S
   Kawashima-Sonoyama, Y
   Ishihara, T
   Matsuzaki, Y
   Akamatsu, W
   Fujitani, M
   Taketani, T
AF Liu, Lu
   Yang, Jiahao
   Otani, Yoshinori
   Shiga, Takahiro
   Yamaguchi, Akihiro
   Oda, Yasuaki
   Hattori, Miho
   Goto, Tsukimi
   Ishibashi, Shuichi
   Kawashima-Sonoyama, Yuki
   Ishihara, Takaya
   Matsuzaki, Yumi
   Akamatsu, Wado
   Fujitani, Masashi
   Taketani, Takeshi
TI MELAS-Derived Neurons Functionally Improve by Mitochondrial Transfer from Highly Purified Mesenchymal Stem Cells (REC)
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE MELAS; rapidly expanding clones (RECs); mesenchymal stem cells (MSCs); mitochondrial transfer
ID lactic-acidosis; tunneling nanotubes; dna; encephalopathy; mutation; differentiation; biomarker; myopathy; therapy; stress
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode (MELAS) syndrome, caused by a single base substitution in mitochondrial DNA (m.3243A>G), is one of the most common maternally inherited mitochondrial diseases accompanied by neuronal damage due to defects in the oxidative phosphorylation system. There is no established treatment. Our previous study reported a superior restoration of mitochondrial function and bioenergetics in mitochondria-deficient cells using highly purified mesenchymal stem cells (RECs). However, whether such exogenous mitochondrial donation occurs in mitochondrial disease models and whether it plays a role in the recovery of pathological neuronal functions is unknown. Here, utilizing induced pluripotent stem cells (iPSC), we differentiated neurons with impaired mitochondrial function from patients with MELAS. MELAS neurons and RECs/mesenchymal stem cells (MSCs) were cultured under contact or non-contact conditions. Both RECs and MSCs can donate mitochondria to MELAS neurons, but RECs are more excellent than MSCs for mitochondrial transfer in both systems. In addition, REC-mediated mitochondrial transfer significantly restored mitochondrial function, including mitochondrial membrane potential, ATP/ROS production, intracellular calcium storage, and oxygen consumption rate. Moreover, mitochondrial function was maintained for at least three weeks. Thus, REC-donated exogenous mitochondria might offer a potential therapeutic strategy for treating neurological dysfunction in MELAS.
C1 [Liu, Lu; Yang, Jiahao; Oda, Yasuaki; Hattori, Miho; Goto, Tsukimi; Kawashima-Sonoyama, Yuki; Taketani, Takeshi] Shimane Univ, Fac Med, Dept Pediat, 89-1 Enya Cho, Izumo 6938501, Japan.
   [Otani, Yoshinori; Fujitani, Masashi] Shimane Univ, Fac Med, Dept Anat & Neurosci, 89-1 Enya Cho, Izumo 6938501, Japan.
   [Shiga, Takahiro; Yamaguchi, Akihiro; Akamatsu, Wado] Juntendo Univ, Ctr Genom & Regenerat Med, Sch Med, Tokyo 1138421, Japan.
   [Goto, Tsukimi] Shimane Univ Hosp, Clin Lab Div, 89 1 Enya Cho, Izumo 6938501, Japan.
   [Ishibashi, Shuichi] Shimane Univ, Fac Med, Dept Digest & Gen Surg, 89-1 Enya Cho, Izumo 6938501, Japan.
   [Ishihara, Takaya; Matsuzaki, Yumi] Shimane Univ, Fac Med, Dept Life Sci, 89-1 Enya Cho, Izumo, 6938501, Japan.
C3 Shimane University; Shimane University; Juntendo University; Shimane University; Shimane University; Shimane University
RP Taketani, T (corresponding author), Shimane Univ, Fac Med, Dept Pediat, 89-1 Enya Cho, Izumo 6938501, Japan.
EM m209432@med.shimane-u.ac.jp; jiahao@med.shimane-u.ac.jp; yotani@med.shimane-u.ac.jp; t-shiga@juntendo.ac.jp; a.yamaguchi.fm@juntendo.ac.jp; y-oda@med.shimane-u.ac.jp; mhatt001@med.shimane-u.ac.jp; t.goto@med.shimane-u.ac.jp; shuichi466@gmail.com; yuki.kawashima@med.shimane-u.ac.jp; ishitky@med.shimane-u.ac.jp; ymatsuzak@gmail.com; awado@juntendo.ac.jp; fujitani@med.shimane-u.ac.jp; ttaketani@med.shimane-u.ac.jp
FU JSPS Grants-in-Aid for Scientific Research (KAKENHI); Shimane University, Japan; Otsuka Toshimi Scholarship Foundation
CR Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279
   Austefjord Magnus Wiger, 2014, COMMUN INTEGR BIOL, V7, Pe27934, DOI 10.4161/cib.27934
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Fujimori K, 2017, STEM CELL REP, V9, P1675, DOI 10.1016/j.stemcr.2017.09.024
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gunnewiek TMK, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107538
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557
   Ljubojevic N, 2021, TRENDS CELL BIOL, V31, P130, DOI 10.1016/j.tcb.2020.11.008
   Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001
   Madreiter-Sokolowski CT, 2020, REDOX BIOL, V36, P0, DOI 10.1016/j.redox.2020.101678
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Paliwal S, 2018, J BIOMED SCI, V25, P0, DOI 10.1186/s12929-018-0429-1
   Pei LM, 2018, BIOL PSYCHIAT, V83, P722, DOI 10.1016/j.biopsych.2017.11.018
   PESKIN AV, 1986, FEBS LETT, V194, P317, DOI 10.1016/0014-5793(86)80109-0
   Prigione Alessandro, 2015, METHODS MOL BIOL, V1265, P349, DOI 10.1007/978-1-4939-2288-8_24
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Taketani T, 2015, CELL TRANSPLANT, V24, P1931, DOI 10.3727/096368914X685410
   Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987
   Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Yan CJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040379
   Yang JH, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms241210294
   Yang JH, 2023, STEM CELL RES THER, V14, P0, DOI 10.1186/s13287-023-03274-y
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang YL, 2016, STEM CELL REP, V7, P749, DOI 10.1016/j.stemcr.2016.08.009
   Zhou T, 2021, J HEMATOL ONCOL, V14, P0, DOI 10.1186/s13045-021-01037-x
   Zhou XY, 2023, J EXTRACELL VESICLES, V12, P0, DOI 10.1002/jev2.12320
NR 46
TC 1
Z9 1
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC 15
PY 2023
VL 24
IS 24
BP 
EP 
DI 10.3390/ijms242417186
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DN3N2
UT WOS:001132686500001
PM 38139018
DA 2024-11-01
ER

PT J
AU Protasoni, M
   Serrano, M
AF Protasoni, Margherita
   Serrano, Manuel
TI Targeting Mitochondria to Control Ageing and Senescence
SO PHARMACEUTICS
LA English
DT Review
DE ageing; cellular senescence; mitochondrial targeting; novel therapeutic approaches
ID permeability transition pore; protein-kinase activity; life-span; cellular senescence; oxidative stress; skeletal-muscle; nlrp3 inflammasm; human fibroblasts; dna methylation; point mutations
AB Ageing is accompanied by a progressive impairment of cellular function and a systemic deterioration of tissues and organs, resulting in increased vulnerability to multiple diseases. Here, we review the interplay between two hallmarks of ageing, namely, mitochondrial dysfunction and cellular senescence. The targeting of specific mitochondrial features in senescent cells has the potential of delaying or even reverting the ageing process. A deeper and more comprehensive understanding of mitochondrial biology in senescent cells is necessary to effectively face this challenge. Here, we discuss the main alterations in mitochondrial functions and structure in both ageing and cellular senescence, highlighting the differences and similarities between the two processes. Moreover, we describe the treatments available to target these pathways and speculate on possible future directions of anti-ageing and anti-senescence therapies targeting mitochondria.
C1 [Protasoni, Margherita; Serrano, Manuel] Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.
   [Serrano, Manuel] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain.
   [Serrano, Manuel] Cambridge Inst Sci, Altos Labs, Granta Pk, Cambridge CB21 6GP, England.
C3 Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA
RP Serrano, M (corresponding author), Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.; Serrano, M (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain.; Serrano, M (corresponding author), Cambridge Inst Sci, Altos Labs, Granta Pk, Cambridge CB21 6GP, England.
EM mserrano@altoslabs.com
FU Commission under Marie Sklodowska-Curie Actions', Individual Fellowship [MitoSen-101060172]; IRB; "laCaixa" Foundation; Spanish Ministry of Science - European Regional Development Fund (ERDF) [SAF2017-82613-R]; European Research Council [ERC-2014-AdG/669622]; Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia [2017 SGR 282]
CR Adashek JJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8080860
   Adlimoghaddam A, 2022, MOL NEUROBIOL, V59, P6009, DOI 10.1007/s12035-022-02937-w
   Afshordel S, 2015, PROSTAG LEUKOTR ESS, V92, P23, DOI 10.1016/j.plefa.2014.05.008
   Ahmed EK, 2010, AGING CELL, V9, P252, DOI 10.1111/j.1474-9726.2010.00555.x
   Alcázar-Fabra M, 2016, BBA-BIOENERGETICS, V1857, P1073, DOI 10.1016/j.bbabio.2016.03.010
   Anisimov VN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1329, DOI 10.1134/S0006297908120055
   Anisimov VN, 2011, AGING-US, V3, P1110, DOI 10.18632/aging.100404
   [Anonymous], 1900, DOI 10.1101/2022.07.08.499319V1.FULL DOI 10.1101/2022.07.08.499319V1.FULL, V0, P0
   Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200
   Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498
   Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x
   Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877
   Blagosklonny MV, 2019, AGING-US, V11, P8048, DOI 10.18632/aging.102355
   Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003
   Bordi M, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1752-5
   Borrás C, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21020418
   Borras C, 2016, AGING-US, V8, P3185, DOI 10.18632/aging.101078
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942
   Busch L, 2022, BIOL CHEM, V403, P27, DOI 10.1515/hsz-2021-0258
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Capell BC, 2016, GENE DEV, V30, P321, DOI 10.1101/gad.271882.115
   Carroll B, 2017, J CELL BIOL, V216, P1949, DOI 10.1083/jcb.201610113
   Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004
   Champigny CM, 2018, MAR DRUGS, V16, P0, DOI 10.3390/md16110453
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen G, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00200
   Chinnaiyan Arul M, 1999, NEOPLASIA (NEW YORK), V1, P5
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Chung KW, 2019, CELL METAB, V30, P784, DOI 10.1016/j.cmet.2019.08.003
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x
   DAmico D, 2019, MOL CELL, V73, P775, DOI 10.1016/j.molcel.2018.11.034
   de Barcelos IP, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020028
   García-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932
   De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004
   Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z
   Dela Cruz CS, 2018, MITOCHONDRION, V41, P37, DOI 10.1016/j.mito.2017.12.001
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   Di Giorgio E, 2021, GENOME BIOL, V22, P0, DOI 10.1186/s13059-021-02340-z
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Dorward DA, 2015, AM J PATHOL, V185, P1172, DOI 10.1016/j.ajpath.2015.01.020
   Doulamis IP, 2020, AM J PHYSIOL-RENAL, V319, PF403, DOI 10.1152/ajprenal.00255.2020
   Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Escames G, 2010, CURR NEUROPHARMACOL, V8, P182, DOI 10.2174/157015910792246245
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107
   Farfariello V, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28597-x
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Frasca D, 2021, MECH AGEING DEV, V194, P0, DOI 10.1016/j.mad.2020.111428
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gelman SJ, 2018, CELL REP, V22, P512, DOI 10.1016/j.celrep.2017.12.050
   Geng KY, 2018, INT J MOL MED, V42, P3522, DOI 10.3892/ijmm.2018.3917
   Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214
   Ghosh R, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0194611
   Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Grosse L, 2016, EMBO J, V35, P402, DOI 10.15252/embj.201592789
   Guo YY, 2021, REDOX BIOL, V41, P0, DOI 10.1016/j.redox.2021.101915
   Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Hall J, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0184843
   Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446
   Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059
   Harrison CN, 2022, J CLIN ONCOL, V40, P1671, DOI 10.1200/JCO.21.02188
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210
   Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x
   Hoppel CL, 2017, ADV EXP MED BIOL, V982, P451, DOI 10.1007/978-3-319-55330-6_24
   Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041
   Horvath S, 2013, GENOME BIOL, V14, P0, DOI 10.1186/gb-2013-14-10-r115
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Huang LS, 2020, IMMUNITY, V52, P475, DOI 10.1016/j.immuni.2020.02.002
   HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0
   Huo J, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/3181759
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Igelmann S, 2021, MOL CELL, V81, P3848, DOI 10.1016/j.molcel.2021.08.028
   Inukai S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040028
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   James EL, 2015, J PROTEOME RES, V14, P1854, DOI 10.1021/pr501221g
   Jauhari A, 2020, J CLIN INVEST, V130, P3124, DOI 10.1172/JCI135026
   Jensen MB, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.26952
   Jeon OH, 2022, NAT METAB, V4, P995, DOI 10.1038/s42255-022-00609-6
   Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000
   Juricic P, 2022, NATURE AGING, V2, P824, DOI 10.1038/s43587-022-00278-w
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Kornienko JS, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-37972-y
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Krestinina O, 2015, NEUROCHEM INT, V80, P41, DOI 10.1016/j.neuint.2014.09.008
   Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210
   Lama L, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08620-4
   Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312
   Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Lee TY, 2020, KAOHSIUNG J MED SCI, V36, P89, DOI 10.1002/kjm2.12146
   Lightowlers RN, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.202050964
   Lin KY, 2017, CELL, V169, P183, DOI 10.1016/j.cell.2017.03.034
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Malinska D, 2012, MITOCHONDRION, V12, P144, DOI 10.1016/j.mito.2011.06.015
   Mann SN, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.59616
   Marcheggiani F, 2019, AGING-US, V11, P2565, DOI 10.18632/aging.101926
   Martin LJ, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00433
   Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008
   Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015
   Martin-Montalvo A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3192
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Migliavacca E, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13694-1
   Miura S, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18091897
   Mohammed I, 2021, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.718942
   Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001
   Moskowitzova K, 2020, AM J PHYSIOL-LUNG C, V318, PL78, DOI 10.1152/ajplung.00221.2019
   Müller M, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00470
   Muñoz-Najar U, 2011, ANTIOXID REDOX SIGN, V14, P241, DOI 10.1089/ars.2010.3250
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Naresh NU, 2019, CSH PERSPECT BIOL, V11, P0, DOI 10.1101/cshperspect.a033944
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nassour J, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms10399
   Novorolsky RJ, 2020, J CEREBR BLOOD F MET, V40, P1172, DOI 10.1177/0271678X20908523
   OLeary MF, 2013, AM J PHYSIOL-CELL PH, V304, PC422, DOI 10.1152/ajpcell.00240.2012
   OSullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897
   Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811
   Owada T, 2017, CORONARY ARTERY DIS, V28, P33, DOI 10.1097/MCA.0000000000000434
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Padilla-Salinas R, 2020, J ORG CHEM, V85, P1579, DOI 10.1021/acs.joc.9b02666
   Pansarasa O, 2019, AGEING RES REV, V54, P0, DOI 10.1016/j.arr.2019.100935
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, P0, DOI 10.1038/msb.2010.5
   Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734
   Pemmaraju N, 2022, LANCET HAEMATOL, V9, PE434, DOI 10.1016/S2352-3026(22)00116-8
   Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Persengiev S, 2011, NEUROBIOL AGING, V32, P0, DOI 10.1016/j.neurobiolaging.2010.03.014
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, P0, DOI 10.1371/journal.pcbi.1003728
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Pour PA, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.119.014501
   POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595
   Protasoni M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22020586
   Qiang W, 2007, EXP MOL MED, V39, P535, DOI 10.1038/emm.2007.59
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x
   Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007
   Rottenberg H, 1997, BIOCHEM BIOPH RES CO, V240, P68, DOI 10.1006/bbrc.1997.7605
   Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1
   Saha T, 2022, NAT NANOTECHNOL, V17, P98, DOI 10.1038/s41565-021-01000-4
   Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030
   Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384
   Santanasto AJ, 2015, J GERONTOL A-BIOL, V70, P1379, DOI 10.1093/gerona/glu134
   Saresella M, 2016, MOL NEURODEGENER, V11, P0, DOI 10.1186/s13024-016-0088-1
   Schinaman JM, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-44106-5
   Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003
   Schröder N, 2020, J NEUROINFLAMM, V17, P0, DOI 10.1186/s12974-020-01816-2
   Schulz AM, 2015, BBA-BIOENERGETICS, V1847, P1448, DOI 10.1016/j.bbabio.2015.03.008
   Scorrano L, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09253-3
   Sczelecki S, 2014, AM J PHYSIOL-ENDOC M, V306, PE157, DOI 10.1152/ajpendo.00578.2013
   Sen B, 2019, CELL MOL GASTROENTER, V8, P73, DOI 10.1016/j.jcmgh.2019.03.001
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Shum LC, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0155709
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Sitte N, 2001, EXP GERONTOL, V36, P475, DOI 10.1016/S0531-5565(00)00253-9
   Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Summer R, 2019, AM J PHYSIOL-LUNG C, V316, PL1049, DOI 10.1152/ajplung.00244.2018
   Szafranskil K, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00087
   Tait SWG, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a008706
   Tan ZQ, 2016, MOL CANCER THER, V15, P774, DOI 10.1158/1535-7163.MCT-15-0621
   Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016
   Terman Alexei, 2005, HEART LUNG CIRC, V14, P107, DOI 10.1016/j.hlc.2004.12.023
   Tian G, 2014, ANTIOXID REDOX SIGN, V20, P2606, DOI 10.1089/ars.2013.5406
   Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011
   Tigano M, 2021, NATURE, V591, P477, DOI 10.1038/s41586-021-03269-w
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Triggle CR, 2022, METABOLISM, V133, P0, DOI 10.1016/j.metabol.2022.155223
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Van Raamsdonk JM, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000361
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vincent J, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00833-9
   Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200
   Wang ZH, 2019, J GYNECOL ONCOL, V30, P0, DOI 10.3802/jgo.2019.30.e26
   Watroba M, 2016, ADV MED SCI-POLAND, V61, P52, DOI 10.1016/j.advms.2015.09.003
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Wiel C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4792
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wolf AM, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-021-00479-6
   Wong RN, 2012, METHODS MOL BIOL, V810, P235, DOI 10.1007/978-1-61779-382-0_15
   Xia WL, 2016, SEMIN CELL DEV BIOL, V59, P71, DOI 10.1016/j.semcdb.2016.07.020
   Yap Timothy A, 2019, AM SOC CLIN ONCOL EDUC BOOK, V39, P185, DOI 10.1200/EDBK_238473
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yoshino J, 2019, TRENDS ENDOCRIN MET, V30, P229, DOI 10.1016/j.tem.2019.02.002
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yu B, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-16312-7
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zhang B, 2013, AGE, V35, P2237, DOI 10.1007/s11357-013-9520-4
   Zhang DY, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/867293
   Zhang DL, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09014-2
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132
   Zhou J, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19102863
   Zhu XD, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.626011
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Ziegler DV, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-20993-z
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 255
TC 9
Z9 9
U1 3
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1999-4923
J9 PHARMACEUTICS
JI Pharmaceutics
PD FEB 15
PY 2023
VL 15
IS 2
BP 
EP 
DI 10.3390/pharmaceutics15020352
PG 25
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 9L6KT
UT WOS:000941657800001
PM 36839673
DA 2024-11-01
ER

PT J
AU Ghirigato, E
   Terenzi, F
   Baglivo, M
   Zanetti, N
   Baldo, F
   Murru, FM
   Bobbo, M
   Barbi, E
   Zeviani, M
   Bruno, I
   Lamantea, E
AF Ghirigato, Elena
   Terenzi, Francesca
   Baglivo, Mirko
   Zanetti, Nadia
   Baldo, Francesco
   Murru, Flora Maria
   Bobbo, Marco
   Barbi, Egidio
   Zeviani, Massimo
   Bruno, Irene
   Lamantea, Eleonora
TI A new family with a case of severe early-onset muscle fatigue and a peculiar maternally inherited painful swelling in chewing muscles associated with homoplasmic m.15992A &gt; T mutation in mitochondrial tRNA<SUP>Pro</SUP>
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial tRNA; Masseter muscle swelling; Mitochondrial myopathy; MT-TP
ID point mutations; gene; myopathy; patient
AB A 16-year-old boy was evaluated for a history of exercise-induced fatigability associated with nausea even after minimal effort, lower limbs muscle hypotrophy, and swelling of the masseter muscles after chewing. Laboratory tests were remarkable for hyperlactatemia and metabolic acidosis after short physical activity. The muscle biopsy showed non-specific mitochondrial alterations and an increase in intrafibral lipids. Biochemical analysis showed reduced activity of the respiratory chain complexes. Mitochondrial DNA sequencing revealed the presence of a homoplasmic variant m.15992A > T in the MT-TP gene, coding for the mt-tRNA(Pro) in the patient, in his mother and in his brother. Pathogenic or likely pathogenic variants in MT-TP gene are rare. They are responsible for different clinical presentation, almost ever involving the muscle tissue. We report the first family with exercise-induced muscle weakness and swelling of the chewing muscles due to m.15992A > T variant in absence of J1c10 haplogroup, confirming its pathogenicity.(c) 2023 Elsevier B.V. All rights reserved.
C1 [Ghirigato, Elena; Terenzi, Francesca; Barbi, Egidio] Univ Trieste, Trieste, Italy.
   [Baglivo, Mirko; Zanetti, Nadia; Lamantea, Eleonora] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Baldo, Francesco; Murru, Flora Maria; Bobbo, Marco; Barbi, Egidio; Zeviani, Massimo; Bruno, Irene] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Baldo, Francesco] Via Istria 65-1, I-34137 Trieste, Italy.
C3 University of Trieste; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Burlo Garofolo
RP Baldo, F (corresponding author), Via Istria 65-1, I-34137 Trieste, Italy.
EM francesco.baldo@burlo.trieste.it
FU Mariani Foundation; ERA PerMed project PerMiM (Italian Ministry of Health) [ERP-2019-23671048]; Ministry of Health , Rome - Italy; Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste - Italy
CR Auré K, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000480
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Guo H, 2022, AM J HYPERTENS, V35, P96, DOI 10.1093/ajh/hpab123
   Gyimesi G, 2020, BIOMOLECULES, V10, P0, DOI 10.3390/biom10121611
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   IONASESCU VV, 1994, NEUROLOGY, V44, P975, DOI 10.1212/WNL.44.5.975
   Joshi PR, 2020, NEUROMUSCULAR DISORD, V30, P346, DOI 10.1016/j.nmd.2020.02.020
   Legati A, 2021, J MOL DIAGN, V23, P732, DOI 10.1016/j.jmoldx.2021.03.002
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005
   McCann C, 2022, FRONT MOL BIOSCI, V9, P0, DOI 10.3389/fmolb.2022.1037941
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Morel G, 2016, NEUROMUSCULAR DISORD, V26, P885, DOI 10.1016/j.nmd.2016.09.012
   Rusu MC, 2019, ANN ANAT, V224, P117, DOI 10.1016/j.aanat.2019.05.006
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Simon MT, 2017, MITOCHONDRION, V34, P84, DOI 10.1016/j.mito.2017.02.004
   Cardena MMSG, 2013, MITOCHONDR DNA, V24, P46, DOI 10.3109/19401736.2012.717933
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Wong LJC, 2020, GENET MED, V0, P0, DOI DOI 10.1038/s41436-019-0746-0
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 28
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC 15
PY 2023
VL 33
IS 12
BP 972
EP 977
DI 10.1016/j.nmd.2023.11.001
EA DEC 2023
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EC9D3
UT WOS:001136824200001
PM 38030461
DA 2024-11-01
ER

PT J
AU Kumar, M
   Tyagi, N
   Faruq, M
AF Kumar, Manish
   Tyagi, Nishu
   Faruq, Mohammed
TI The molecular mechanisms of spinocerebellar ataxias for DNA repeat expansion in disease
SO EMERGING TOPICS IN LIFE SCIENCES
LA English
DT Review
ID tata-binding protein; neuronal intranuclear inclusions; mitochondrial apoptotic pathway; dominant cerebellar-ataxia; cag trinucleotide repeat; up-regulating bax; clinical-features; mouse model; polyglutamine expansion; nucleolar stress
AB Spinocerebellar ataxias (SCAs) are a heterogenous group of neurodegenerative disorders which commonly inherited in an autosomal dominant manner. They cause muscle incoordination due to degeneration of the cerebellum and other parts of nervous system. Out of all the characterized (>50) SCAs, 14 SCAs are caused due to microsatellite repeat expansion mutations. Repeat expansions can result in toxic protein gain-of-function, protein loss-of-function, and/or RNA gain-of-function effects. The location and the nature of mutation modulate the underlying disease pathophysiology resulting in varying disease manifestations. Potential toxic effects of these mutations likely affect key major cellular processes such as transcriptional regulation, mitochondrial functioning, ion channel dysfunction and synaptic transmission. Involvement of several common pathways suggests interlinked function of genes implicated in the disease pathogenesis. A better understanding of the shared and distinct molecular pathogenic mechanisms in these diseases is required to develop targeted therapeutic tools and interventions for disease management. The prime focus of this review is to elaborate on how expanded 'CAG' repeats contribute to the common modes of neurotoxicity and their possible therapeutic targets in management of such devastating disorders.
C1 [Kumar, Manish; Tyagi, Nishu; Faruq, Mohammed] CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)
RP Faruq, M (corresponding author), CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.
EM faruq.mohd@igib.res.in
FU CSIR; ICMR [5/4-5/5/Ad-hoc/Neuro/220/NCD-I (GAP240)]
CR Abeti R, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.111
   Abramzon Y, 2021, J NEUROL SCI, V430, P0, DOI 10.1016/j.jns.2021.118061
   Adegbuyiro A, 2017, BIOCHEMISTRY-US, V56, P1199, DOI 10.1021/acs.biochem.6b00936
   Ayhan F, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201899023
   Bain PG, 2002, J NEUROL NEUROSUR PS, V72, P0
   Banez-Coronel M, 2019, LAB INVEST, V99, P929, DOI 10.1038/s41374-019-0241-x
   Bañez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038
   Batra R, 2010, HUM MOL GENET, V19, PR77, DOI 10.1093/hmg/ddq132
   Beecroft SJ, 2020, BRAIN, V143, P2673, DOI 10.1093/brain/awaa203
   Beijer D, 2022, EUR J NEUROL, V29, P2156, DOI 10.1111/ene.15310
   Belzil VV, 2013, MOL CELL NEUROSCI, V56, P406, DOI 10.1016/j.mcn.2012.12.006
   Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022
   Berntsson SG, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0180054
   Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314
   Bürk K, 2007, CEREBELLUM, V6, P280, DOI 10.1080/14734220601115924
   Burley SK, 1996, CURR OPIN STRUC BIOL, V6, P69, DOI 10.1016/S0959-440X(96)80097-2
   Bushart DD, 2019, NEUROSCI LETT, V688, P41, DOI 10.1016/j.neulet.2018.02.005
   Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709
   Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110
   CARPENTER NJ, 1994, NEUROL CLIN, V12, P683, DOI 10.1016/S0733-8619(18)30071-9
   Casse F, 2023, MOV DISORD CLIN PRAC, V10, P664, DOI 10.1002/mdc3.13699
   Castelli LM, 2021, MOL NEURODEGENER, V16, P0, DOI 10.1186/s13024-021-00475-y
   Castro AF, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11121418
   Chan HYE, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00431
   Chen WL, 2008, BRAIN RES, V1233, P176, DOI 10.1016/j.brainres.2008.07.096
   Chou AH, 2006, NEUROBIOL DIS, V21, P333, DOI 10.1016/j.nbd.2005.07.011
   Choudhry S, 2001, HUM MOL GENET, V10, P2437, DOI 10.1093/hmg/10.21.2437
   Choudhury S, 2018, MOV DISORD CLIN PRAC, V5, P39, DOI 10.1002/mdc3.12551
   Chow MKM, 2004, J BIOL CHEM, V279, P47643, DOI 10.1074/jbc.M405799200
   Ciesiolka A, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00097
   Coffin SL, 2023, NEURON, V111, P915, DOI 10.1016/j.neuron.2023.02.030
   Conlon EG, 2017, GENE DEV, V31, P1509, DOI 10.1101/gad.304055.117
   Corman A, 2023, TRENDS BIOCHEM SCI, V48, P274, DOI 10.1016/j.tibs.2022.09.006
   Corral-Juan M, 2018, BRAIN, V141, P1981, DOI 10.1093/brain/awy137
   Cortese A, 2020, RFC1 CANVAS/SPECTRUM DISORDER, V0, P0
   Cortese A, 2021, GENEREVIEW SCOPE, V0, P1
   Cortese A, 2019, NAT GENET, V51, P649, DOI 10.1038/s41588-019-0372-4
   Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1
   Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511
   Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502
   Currò R, 2021, BRAIN, V144, P1542, DOI 10.1093/brain/awab072
   Da Silva JD, 2019, NEUROTHERAPEUTICS, V16, P1009, DOI 10.1007/s13311-019-00798-1
   Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200
   Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P739, DOI 10.1001/archneurol.2011.111
   Das MR, 2023, P NATL ACAD SCI USA, V120, P0, DOI 10.1073/pnas.2215071120
   Daughters RS, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000600
   David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165
   David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65
   Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9
   Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649
   de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323
   Doherty KM, 2014, MOVEMENT DISORD, V29, P36, DOI 10.1002/mds.25770
   Dominik N, 2021, J NEUROL, V268, P1119, DOI 10.1007/s00415-020-10183-0
   Du XF, 2018, ADV EXP MED BIOL, V1049, PE1, DOI 10.1007/978-3-319-71779-1_22
   Duan RH, 2014, J GENET GENOMICS, V41, P473, DOI 10.1016/j.jgg.2014.08.003
   Dueñas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081
   Duennwald ML, 2011, PRION, V5, P285, DOI 10.4161/pri.5.4.18071
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030
   Egorova PA, 2016, J NEUROPHYSIOL, V115, P2840, DOI 10.1152/jn.00913.2015
   Eichler L, 2011, AM J NEURORADIOL, V32, P890, DOI 10.3174/ajnr.A2387
   Evers MM, 2014, MOL NEUROBIOL, V49, P1513, DOI 10.1007/s12035-013-8596-2
   Fan HC, 2014, CELL TRANSPLANT, V23, P441, DOI 10.3727/096368914X678454
   Figueiredo AS, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12060826
   Fujino Y, 2022, BIOCHEM SOC T, V50, P119, DOI 10.1042/BST20200143
   Furtado S, 2004, MOVEMENT DISORD, V19, P622, DOI 10.1002/mds.20074
   Gan SR, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0134405
   Ganaraja VH, 2022, TREMOR OTHER HYPERK, V12, P0, DOI 10.5334/tohm.686
   Gao R, 2008, EUR J HUM GENET, V16, P215, DOI 10.1038/sj.ejhg.5201954
   García-Planells J, 1999, J MED GENET, V36, P148
   Garden GA, 2008, CEREBELLUM, V7, P138, DOI 10.1007/s12311-008-0027-y
   GENIS D, 1995, NEUROLOGY, V45, P24, DOI 10.1212/WNL.45.1.24
   Geschwind DH, 1997, AM J HUM GENET, V60, P842
   Ghanekar SD, 2022, EXPERT REV NEUROTHER, V22, P101, DOI 10.1080/14737175.2022.2029703
   Groh M, 2014, BIOCHEM SOC T, V42, P1123, DOI 10.1042/BST20140049
   Hansen ST, 2013, HUM MOL GENET, V22, P271, DOI 10.1093/hmg/dds427
   Havel LS, 2009, MOL BRAIN, V2, P0, DOI 10.1186/1756-6606-2-21
   Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139
   Herrema H, 2014, J NEUROL SCI, V345, P269, DOI 10.1016/j.jns.2014.07.041
   Hoffner G, 2015, MOL NEUROBIOL, V52, P1297, DOI 10.1007/s12035-014-8932-1
   Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913
   Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493
   Holmes SE, 2001, BRAIN RES BULL, V56, P397, DOI 10.1016/S0361-9230(01)00596-2
   Hourez R, 2011, J NEUROSCI, V31, P11795, DOI 10.1523/JNEUROSCI.0905-11.2011
   Hsu JY, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00196
   Hsu TC, 2014, HUM MOL GENET, V23, P6878, DOI 10.1093/hmg/ddu410
   Huang SS, 2015, CELL REP, V13, P196, DOI 10.1016/j.celrep.2015.08.060
   Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677
   Huin V, 2022, BRAIN, V145, P2121, DOI 10.1093/brain/awab449
   Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162
   Ikeda Y, 2008, CEREBELLUM, V7, P150, DOI 10.1007/s12311-008-0010-7
   Ikeda Y, 2012, NEUROLOGY, V79, P333, DOI 10.1212/WNL.0b013e318260436f
   Ishiguro T, 2021, FRONT NEUROSCI-SWITZ, V15, P0, DOI 10.3389/fnins.2021.648133
   Ishiguro T, 2017, NEURON, V94, P108, DOI 10.1016/j.neuron.2017.02.046
   Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0
   Ishikawa K, 2011, NEUROLOGY, V77, P1853, DOI 10.1212/WNL.0b013e3182377e3a
   Ishikawa K, 2023, J HUM GENET, V68, P153, DOI 10.1038/s10038-022-01091-4
   Ishikawa K, 2019, NEUROTHERAPEUTICS, V16, P1106, DOI 10.1007/s13311-019-00804-6
   Ishikawa Kinya, 2009, RINSHO SHINKEIGAKU, V49, P907
   Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386
   Jazurek-Ciesiolka M, 2020, J MOL BIOL, V432, P0, DOI 10.1016/j.jmb.2020.10.033
   Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327
   Johansson J, 1998, HUM MOL GENET, V7, P171, DOI 10.1093/hmg/7.2.171
   Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583
   Kasumu A, 2012, CEREBELLUM, V11, P630, DOI 10.1007/s12311-010-0182-9
   KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221
   Kim JY, 2009, NEUROLOGY, V72, P1385, DOI 10.1212/WNL.0b013e3181a18876
   Kim JM, 2007, ARCH NEUROL-CHICAGO, V64, P1510, DOI 10.1001/archneur.64.10.1510
   Kino Y, 2015, HUM MOL GENET, V24, P740, DOI 10.1093/hmg/ddu492
   Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015
   Koeppen Arnulf H, 2018, HANDB CLIN NEUROL, V154, P129, DOI 10.1016/B978-0-444-63956-1.00008-4
   Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047
   Konno A, 2014, CEREBELLUM, V13, P29, DOI 10.1007/s12311-013-0516-5
   Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080
   Kraus-Perrotta Cara, 2016, CEREBELLUM ATAXIAS, V3, P20
   Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729
   Kumar KR, 2020, BRAIN, V143, PE82, DOI 10.1093/brain/awaa244
   La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6
   Laço MN, 2012, BBA-MOL BASIS DIS, V1822, P139, DOI 10.1016/j.bbadis.2011.10.010
   Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293
   Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038
   Lee J, 2018, WIRES RNA, V9, P0, DOI 10.1002/wrna.1488
   Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101
   Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909
   Li PP, 2021, MOVEMENT DISORD, V36, P2519, DOI 10.1002/mds.28729
   Li PP, 2016, ANN NEUROL, V80, P600, DOI 10.1002/ana.24761
   Li QF, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1314
   Liang XC, 2009, NEUROL INDIA, V57, P578, DOI 10.4103/0028-3886.57803
   Lieberman AP, 2019, ANNU REV PATHOL-MECH, V14, P1, DOI 10.1146/annurev-pathmechdis-012418-012857
   Lilja A, 2005, J NEUROL SCI, V237, P31, DOI 10.1016/j.jns.2005.05.008
   Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101
   Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018
   Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107
   Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965
   Lipinski MM, 2004, CURR OPIN PHARMACOL, V4, P85, DOI 10.1016/j.coph.2003.09.008
   Liu Q, 2019, NEUROTHERAPEUTICS, V16, P1097, DOI 10.1007/s13311-019-00762-z
   Liu W, 2014, EUR J NEUROL, V21, P1377, DOI 10.1111/ene.12491
   Loomis EW, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004294
   Loureiro JR, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11020205
   Lynch DR, 2021, ANN NEUROL, V89, P212, DOI 10.1002/ana.25934
   Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366
   Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X
   Malik I, 2021, EMBO MOL MED, V13, P0, DOI 10.15252/emmm.202114163
   Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0
   Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763
   Martin JJ, 1999, J NEUROL SCI, V168, P37, DOI 10.1016/S0022-510X(99)00176-8
   Martins CR, 2018, J NEUROL, V265, P2949, DOI 10.1007/s00415-018-9087-1
   Martins CR, 2018, ARQ NEURO-PSIQUIAT, V76, P555, DOI 10.1590/0004-282x20180080
   Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998
   Matilla A, 2001, HUM MOL GENET, V10, P2821, DOI 10.1093/hmg/10.24.2821
   Matsumura R, 1997, NEUROLOGY, V49, P1238, DOI 10.1212/WNL.49.5.1238
   Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911
   McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197
   McFarland KN, 2014, NEUROGENETICS, V15, P59, DOI 10.1007/s10048-013-0385-6
   McGurk L, 2021, HUM MOL GENET, V30, P1797, DOI 10.1093/hmg/ddab148
   McLoughlin HS, 2020, NEUROBIOL DIS, V134, P0, DOI 10.1016/j.nbd.2019.104635
   Meijboom KE, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8060161
   Michalik A, 2004, EUR J HUM GENET, V12, P2, DOI 10.1038/sj.ejhg.5201108
   Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439
   Milne SC, 2017, NEUROREHAB NEURAL RE, V31, P609, DOI 10.1177/1545968317712469
   Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827
   Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125
   Murata T, 2008, BIOSCI BIOTECH BIOCH, V72, P2255, DOI 10.1271/bbb.70829
   NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14
   Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437
   Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215
   Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501
   Nalavade R, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.276
   Naruse H, 2019, NEUROGENETICS, V20, P65, DOI 10.1007/s10048-019-00570-9
   Neuenschwander AG, 2014, JAMA NEUROL, V71, P1529, DOI 10.1001/jamaneurol.2014.2082
   Nezhad HG, 2021, AMYOTROPH LAT SCL FR, V22, P579, DOI 10.1080/21678421.2020.1853172
   Niewiadomska-Cimicka A, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.00571
   Nobile V, 2020, HUM GENET, V139, P227, DOI 10.1007/s00439-019-02104-7
   OHearn EE, 2015, MOVEMENT DISORD, V30, P1813, DOI 10.1002/mds.26348
   Onofre I, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep28220
   Orr HT, 2012, PROG NEUROBIOL, V99, P179, DOI 10.1016/j.pneurobio.2012.04.003
   ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221
   Orr HT, 2001, HUM MOL GENET, V10, P2307, DOI 10.1093/hmg/10.20.2307
   Ortiz JMP, 2018, NEUROBIOL DIS, V116, P93, DOI 10.1016/j.nbd.2018.05.002
   Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10
   Özütemiz C, 2020, DIAGN INTERV RADIOL, V26, P596, DOI 10.5152/dir.2020.19607
   Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102
   Pang JT, 2002, BRAIN, V125, P656, DOI 10.1093/brain/awf060
   Paulson Henry, 2018, HANDB CLIN NEUROL, V147, P105, DOI 10.1016/B978-0-444-63233-3.00009-9
   Paulson HL, 2017, NAT REV NEUROSCI, V18, P613, DOI 10.1038/nrn.2017.92
   Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5
   Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269
   Pellerin D, 2023, NEW ENGL J MED, V388, P128, DOI 10.1056/NEJMoa2207406
   Perez BA, 2021, EMBO MOL MED, V13, P0, DOI 10.15252/emmm.202114095
   Polymenidou M, 2018, SCIENCE, V360, P859, DOI 10.1126/science.aat8028
   Rafehi H, 2023, AM J HUM GENET, V110, P105, DOI 10.1016/j.ajhg.2022.11.015
   Rafehi H, 2019, AM J HUM GENET, V105, P151, DOI 10.1016/j.ajhg.2019.05.016
   Rajakulendran Sanjeev, 2010, F1000 BIOL REP, V2, P0, DOI 10.3410/B2-4
   Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014
   Ranum Laura P W, 2010, RINSHO SHINKEIGAKU, V50, P982
   RANUM LPW, 1994, AM J HUM GENET, V55, P244
   Raskin S, 2007, ARCH NEUROL-CHICAGO, V64, P591, DOI 10.1001/archneur.64.4.591
   Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081
   Rodriguez CM, 2019, NEUROBIOL DIS, V130, P0, DOI 10.1016/j.nbd.2019.104515
   Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676
   Rondón AG, 2019, MOL CELL, V76, P529, DOI 10.1016/j.molcel.2019.11.001
   Rossi M, 2023, MOVEMENT DISORD, V38, P368, DOI 10.1002/mds.29278
   Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801
   Rudich P, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0227464
   Sahoo B, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0155747
   Samukawa M, 2019, CEREBELLUM, V18, P76, DOI 10.1007/s12311-018-0955-0
   Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961
   Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019
   Saucier J, 2023, J NEUROL SCI, V444, P0, DOI 10.1016/j.jns.2022.120527
   Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101
   Scoles DR, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0128769
   Scriba CK, 2020, BRAIN, V143, P2904, DOI 10.1093/brain/awaa263
   Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x
   Seixas AI, 2017, AM J HUM GENET, V101, P87, DOI 10.1016/j.ajhg.2017.06.007
   Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016
   Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004
   Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21
   Sen NE, 2016, NEUROBIOL DIS, V96, P115, DOI 10.1016/j.nbd.2016.09.002
   Sen NE, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20235854
   SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6
   Shibata T, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20487-4
   Siddique U, 2021, CLIN PARKINSON RELAT, V5, P0, DOI 10.1016/j.prdoa.2021.100102
   Sisakova A, 2017, BMC BIOL, V15, P0, DOI 10.1186/s12915-017-0429-8
   Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766
   Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790
   Srivastava AK, 2017, BRAIN, V140, P27, DOI 10.1093/brain/aww269
   St George-Hyslop P, 2018, BRAIN RES, V1693, P11, DOI 10.1016/j.brainres.2018.04.036
   Stevanovski I, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abm5386
   Stone J, 2001, J NEUROL, V248, P229, DOI 10.1007/s004150170232
   Stucki DM, 2016, FREE RADICAL BIO MED, V97, P427, DOI 10.1016/j.freeradbiomed.2016.07.005
   Sugihara K, 2012, MOVEMENT DISORD, V27, P1158, DOI 10.1002/mds.25092
   Sullivan R, 2021, J NEUROL NEUROSUR PS, V92, P444, DOI 10.1136/jnnp-2020-325092
   Sullivan R, 2019, J NEUROL, V266, P533, DOI 10.1007/s00415-018-9076-4
   Switonski PM, 2015, NEUROBIOL DIS, V73, P174, DOI 10.1016/j.nbd.2014.09.020
   Takahashi M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0050121
   Tan DD, 2023, MOVEMENT DISORD, V38, P1282, DOI 10.1002/mds.29412
   TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995
   Tazen S, 2013, JAMA NEUROL, V70, P1302, DOI 10.1001/jamaneurol.2013.443
   Teive HAG, 2004, NEUROLOGY, V63, P1509
   Teive HAG, 2011, PARKINSONISM RELAT D, V17, P655, DOI 10.1016/j.parkreldis.2011.04.001
   Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026
   Todd T, 2018, MOL CELLULAR BASIS N, V0, PP441, DOI 10.1016/B978-0-12-811304-2.00015-8
   Todd TW, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107616
   Toyoshima Y, 2018, ADV EXP MED BIOL, V1049, P219, DOI 10.1007/978-3-319-71779-1_10
   Traschütz A, 2021, NEUROLOGY, V96, PE1369, DOI 10.1212/WNL.0000000000011528
   Tsoi H, 2013, CEREBELLUM, V12, P310, DOI 10.1007/s12311-012-0447-6
   Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109
   Tsuchiya M, 2020, J HUM GENET, V65, P1143, DOI 10.1038/s10038-020-0807-x
   Tusi SK, 2021, HUM MOL GENET, V30, P1020, DOI 10.1093/hmg/ddab098
   Tyagi N, 2023, MEDRNV, V0, P0, DOI DOI 10.1101/2023.06.05.23290839
   Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b
   Wang HL, 2006, CELL SIGNAL, V18, P541, DOI 10.1016/j.cellsig.2005.05.024
   Wang YC, 2011, J BIOL CHEM, V286, P21742, DOI 10.1074/jbc.M110.160697
   White MC, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000984
   Wu YR, 2009, HUM GENET, V125, P437, DOI 10.1007/s00439-009-0641-x
   Yang S, 2016, RARE DIS, V4, P0, DOI 10.1080/21675511.2016.1223580
   Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X
   Yu ZM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1001340
   Yvert G, 2001, HUM MOL GENET, V10, P1679, DOI 10.1093/hmg/10.16.1679
   Zhang N, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11091567
   Zhang Q, 2018, RNA, V24, P486, DOI 10.1261/rna.062703.117
   Zhou Chengqian, 2023, BIORXIV, V0, P0, DOI DOI 10.1101/2023.04.02.535298
   Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62
   Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217
   Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247
   Zu T, 2020, P NATL ACAD SCI USA, V117, P18591, DOI 10.1073/pnas.2005748117
   Zu T, 2013, P NATL ACAD SCI USA, V110, PE4968, DOI 10.1073/pnas.1315438110
   Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108
   Zühlke C, 2001, EUR J HUM GENET, V9, P160, DOI 10.1038/sj.ejhg.5200617
   Zühlke C, 2002, EUR J HUM GENET, V10, P204, DOI 10.1038/sj.ejhg.5200788
NR 271
TC 2
Z9 3
U1 1
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 2397-8554
EI 2397-8562
J9 EMERG TOP LIFE SCI
JI Emerg. Top. Life Sci.
PD DEC 15
PY 2023
VL 7
IS 3
BP 289
EP 312
DI 10.1042/ETLS20230013
EA SEP 2023
PG 24
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics
GA CQ8Q8
UT WOS:001078979800001
PM 37668011
DA 2024-11-01
ER

PT J
AU De Paula, IF
   Santos-Araujo, S
   Majerowicz, D
   Ramos, I
   Gondim, KC
AF De Paula, Iron F.
   Santos-Araujo, Samara
   Majerowicz, David
   Ramos, Isabela
   Gondim, Katia C.
TI Knockdown of carnitine palmitoyltransferase I (CPT1) reduces fat body lipid mobilization and resistance to starvation in the insect vector <i>Rhodnius prolixus</i>
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE carnitine palmitoyltransferase I (CPT1); beta-oxidation; starvation; lipid droplet; Rhodnius prolixus
ID malonyl-coa sensitivity; time quantitative pcr; acid oxidation; flight-muscle; coenzyme-a; genome; identification; metabolism; expression; enzyme
AB The energy stored in fatty acids is essential for several critical activities of insects, such as embryogenesis, oviposition, and flight. Rhodnius prolixus is an obligatory hematophagous hemipteran and vector of Chagas disease, and it feeds infrequently on very large blood meals. As digestion slowly occurs, lipids are synthesized and accumulate in the fat body, mainly as triacylglycerol, in lipid droplets. Between feeding bouts, proper mobilization and oxidation of stored lipids are crucial for survival, and released fatty acids are oxidized by mitochondrial beta-oxidation. Carnitine palmitoyl transferase I (CPT1) is the enzyme that catalyzes the first reaction of the carnitine shuttle, where the activated fatty acid, acyl-CoA, is converted to acyl-carnitine to be transported into the mitochondria. Here, we investigated the role of CPT1 in lipid metabolism and in resistance to starvation in Rhodnius prolixus. The expression of the CPT1 gene (RhoprCpt1) was determined in the organs of adult females on the fourth day after a blood meal, and the flight muscle showed higher expression levels than the ovary, fat body, and anterior and posterior midgut. RhoprCpt1 expression in the fat body dramatically decreased after feeding, and started to increase again 10 days later, but no changes were observed in the flight muscle. beta-oxidation rates were determined in flight muscle and fat body homogenates with the use of H-3-palmitate, and in unfed females, they were higher in the flight muscle. In the fat body, lipid oxidation activity did not show any variation before or at different days after feeding, and was not affected by the presence of etomoxir or malonyl-CoA. We used RNAi and generated RhoprCPT1-deficient insects, which surprisingly did not show a decrease in measured H-3-palmitate oxidation rates. However, the RNAi-knockdown females presented increased amounts of triacylglycerol and larger lipid droplets in the fat body, but not in the flight muscle. When subjected to starvation, these insects had a shorter lifespan. These results indicated that the inhibition of RhoprCpt1 expression compromised lipid mobilization and affected resistance to starvation.
C1 [De Paula, Iron F.; Santos-Araujo, Samara; Ramos, Isabela; Gondim, Katia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Majerowicz, David] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut, Rio De Janeiro, Brazil.
   [Majerowicz, David] Univ Estado Rio de Janeiro, Programa Posgrad Biociencias, Rio De Janeiro, Brazil.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro
RP Gondim, KC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
EM katia@bioqmed.ufrj.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Alves-Bezerra M, 2017, BBA-MOL CELL BIOL L, V1862, P324, DOI 10.1016/j.bbalip.2016.12.004
   Alves-Bezerra M, 2016, BBA-MOL CELL BIOL L, V1861, P650, DOI 10.1016/j.bbalip.2016.04.007
   Ameer F, 2014, METABOLISM, V63, P895, DOI 10.1016/j.metabol.2014.04.003
   Antinori S, 2017, EUR J INTERN MED, V43, P6, DOI 10.1016/j.ejim.2017.05.001
   Arêdes DS, 2022, FRONT INSECT SCI, V2, P0, DOI 10.3389/finsc.2022.885172
   Bennick RA, 2019, BIOCHEM BIOPH RES CO, V516, P928, DOI 10.1016/j.bbrc.2019.06.151
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Burns MJ, 2005, BMC BIOTECHNOL, V5, P0, DOI 10.1186/1472-6750-5-31
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012
   CARTER HE, 1952, ARCH BIOCHEM BIOPHYS, V38, P405, DOI 10.1016/0003-9861(52)90047-7
   Chen WB, 2019, INSECT BIOCHEM MOLEC, V110, P112, DOI 10.1016/j.ibmb.2019.05.003
   CHU RY, 1995, J BIOL CHEM, V270, P4908, DOI 10.1074/jbc.270.9.4908
   Cingolani F, 2016, TRENDS ENDOCRIN MET, V27, P696, DOI 10.1016/j.tem.2016.06.003
   Cohen I, 2001, J BIOL CHEM, V276, P5403, DOI 10.1074/jbc.M009555200
   Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x
   Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041
   Defferrari MS, 2016, INSECT BIOCHEM MOLEC, V70, P148, DOI 10.1016/j.ibmb.2015.12.009
   Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   FRAENKEL G, 1948, NATURE, V161, P981, DOI 10.1038/161981a0
   Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711
   Gingras RM, 2014, BIOCHEM BIOPH RES CO, V443, P672, DOI 10.1016/j.bbrc.2013.12.027
   Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200
   Houten SM, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165720
   Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2
   Jackson VN, 1999, BIOCHEM J, V341, P483, DOI 10.1042/0264-6021:3410483
   Kinsella RJ, 2011, DATABASE-OXFORD, V0, P0, DOI DOI 10.1093/database/bar030
   KIORPES TC, 1984, J BIOL CHEM, V259, P9750
   Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107
   Kishita Y, 2012, BIOCHEM BIOPH RES CO, V419, P344, DOI 10.1016/j.bbrc.2012.02.026
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lavarías S, 2009, COMP BIOCHEM PHYS B, V152, P364, DOI 10.1016/j.cbpb.2009.01.004
   Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692
   Leyria J, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67932-4
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOPASCHUK GD, 1990, CIRC RES, V66, P546, DOI 10.1161/01.RES.66.2.546
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu K, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01535
   Luiken JJFP, 2009, BIOCHEM J, V419, P447, DOI 10.1042/BJ20082159
   Lynch SA, 2017, COMPR REV FOOD SCI F, V16, P330, DOI 10.1111/1541-4337.12254
   Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x
   Majerowicz D, 2017, GENE, V596, P27, DOI 10.1016/j.gene.2016.09.045
   MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021
   McGarry JD, 2001, BIOCHEM SOC T, V29, P241, DOI 10.1042/0300-5127:0290241
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112
   Miotto PM, 2017, BIOCHEM J, V474, P557, DOI 10.1042/BCJ20160913
   Mistry J, 2021, NUCLEIC ACIDS RES, V49, PD412, DOI 10.1093/nar/gkaa913
   Moraes B, 2022, FRONT PHYSIOL, V13, P0, DOI 10.3389/fphys.2022.934667
   Morkholt AS, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-02343-6
   Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005
   Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987
   OBrien DM, 2001, J EXP ZOOL, V290, P108, DOI 10.1002/jez.1040
   Oliveira GA, 2006, ARCH INSECT BIOCHEM, V62, P164, DOI 10.1002/arch.20132
   OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918
   Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009
   Pontes EG, 2008, J INSECT PHYSIOL, V54, P790, DOI 10.1016/j.jinsphys.2008.02.003
   Price NT, 2010, J BIOL CHEM, V285, P7857, DOI 10.1074/jbc.M109.072892
   Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845
   Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784
   Rosenfeld JA, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms10164
   Rozen S, 2000, METHODS MOL BIOL, V132, P365
   Rufer AC, 2009, CELL MOL LIFE SCI, V66, P2489, DOI 10.1007/s00018-009-0035-1
   Santos-Araujo S, 2020, INSECT BIOCHEM MOLEC, V127, P0, DOI 10.1016/j.ibmb.2020.103484
   Saraiva FB, 2021, INSECT BIOCHEM MOLEC, V133, P0, DOI 10.1016/j.ibmb.2020.103511
   SELBY PL, 1989, TRENDS PHARMACOL SCI, V10, P495, DOI 10.1016/0165-6147(89)90049-7
   Smith BK, 2012, BIOCHEM J, V448, P13, DOI 10.1042/BJ20121110
   STEVENSON E, 1968, BIOCHEM J, V110, P105, DOI 10.1042/bj1100105
   Strub BR, 2008, GENOME, V51, P409, DOI 10.1139/G08-023
   Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120
   Tawbeh A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22116093
   Terrapon N, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4636
   The International Aphid Genomics Consortium, 2010, PLOS BIOLOGY, V8, P1, DOI 10.1371/journal.pbio.1000313
   Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4
   Toprak U, 2020, ARCH INSECT BIOCHEM, V104, P0, DOI 10.1002/arch.21682
   Velasco G, 1998, J BIOL CHEM, V273, P21497, DOI 10.1074/jbc.273.34.21497
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang XL, 2017, P NATL ACAD SCI USA, V114, PE2709, DOI 10.1073/pnas.1619326114
   WARD JP, 1982, J INSECT PHYSIOL, V28, P527, DOI 10.1016/0022-1910(82)90033-6
   Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260
   Yates AD, 2022, NUCLEIC ACIDS RES, V50, PD996, DOI 10.1093/nar/gkab1007
   Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018
NR 84
TC 3
Z9 3
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD JUL 4
PY 2023
VL 14
IS 
BP 
EP 
DI 10.3389/fphys.2023.1201670
PG 13
WC Physiology
SC Physiology
GA M8BI2
UT WOS:001032409500001
PM 37469565
DA 2024-11-01
ER

PT J
AU Sharma, S
   Kong, ZQ
   Jia, SD
   Iran, P
   Nilsson, AK
   Chabes, A
AF Sharma, Sushma
   Kong, Ziqing
   Jia, Shaodong
   Iran, Phong
   Nilsson, Anna Karin
   Chabes, Andrei
TI Quantitative Analysis of Nucleoside Triphosphate Pools in Mouse Muscle Using Hydrophilic Interaction Liquid Chromatography Coupled with Tandem Mass Spectrometry Detection
SO MITOCHONDRIAL DNA: Methods and Protocols
LA English
DT Article; Book Chapter
DE Deoxyribonucleoside triphosphates; Liquid chromatography; Triple quadrupole mass spectrometry; ZIC-HILIC; Differentiated tissues
ID deoxyribonucleoside triphosphates; ribonucleotide incorporation; dntp pools; dna; mitochondrial; quantification; assay
AB Defects in deoxyribonucleoside triphosphate (dNTP) metabolism are associated with a number of mitochondrial DNA (mtDNA) depletion syndromes (MDS). These disorders affect the muscles, liver, and brain, and the concentrations of dNTPs in these tissues are already normally low and are, therefore, difficult to measure. Thus, information about the concentrations of dNTPs in tissues of healthy animals and animals with MDS are important for mechanistic studies of mtDNA replication, analysis of disease progression, and the development of therapeutic interventions. Here, we present a sensitive method for the simultaneous analysis of all four dNTPs as well as all four ribonucleoside triphosphates (NTPs) in mouse muscles using hydrophilic interaction liquid chromatography coupled with triple quadrupole mass spectrometry. The simultaneous detection of NTPs allows them to be used as internal standards for the normalization of dNTP concentrations. The method can be applied for measuring dNTP and NTP pools in other tissues and organisms.
C1 [Sharma, Sushma; Kong, Ziqing; Jia, Shaodong; Iran, Phong; Nilsson, Anna Karin; Chabes, Andrei] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.
C3 Umea University
RP Sharma, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.
FU Swedish Cancer Society; Swedish Research Council
CR Buckland RJ, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004846
   Cohen S, 2009, J CHROMATOGR B, V877, P3831, DOI 10.1016/j.jchromb.2009.09.030
   DeemA KeszthelyiA, 2011, PLOSBIOL9, V0, P0
   DiPierroD TavazziB, 1995, ANALBIOCHEM231, V0, P0
   Ferraro P, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1141
   GuptaA SharmaS, 2013, TELOMERELENGTHHOMEOSTASISRESPONDSTOCHANGESININTRACELLULARDNTPPOOLS, V0, P0
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   Jia Shaodong, 2015, METHODS MOL BIOL, V1300, P113, DOI 10.1007/978-1-4939-2596-4_8
   KongZ JiaS, 2018, NUCLEICACIDSRES46, V0, P0
   Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200
   McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI 10.1038/nchembio.424
   McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107
   Olafsson S, 2017, J CHROMATOGR B, V1068, P90, DOI 10.1016/j.jchromb.2017.10.008
   PoliJ TsaponinaO, 2012, DNTPPOOLSDETERMINEFORKPROGRESSIONANDORIGINUSAGEUNDERREPLICATIONSTRESS, VEMBOJ31, P883, DOI 10.1038/emboj.2011.470
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Schmidt TT, 2017, P NATL ACAD SCI USA, V114, PE4442, DOI 10.1073/pnas.1618714114
   Sharma S, 2020, NAT METAB, V2, P673, DOI 10.1038/s42255-020-0264-z
   SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X
   SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2
   TecherH SilvaMJ, 2018, SAMHD1ACTSATSTALLEDREPLICATIONFORKSTOPREVENTINTERFERONINDUCTION, V0, P0
   Wanrooij PH, 2020, P NATL ACAD SCI USA, V117, P14306, DOI 10.1073/pnas.1916851117
   WanrooijPH EngqvistMKM, 2017, PROCNATLACADSCIUSA114, V0, P0
   Watt DL, 2016, NUCLEIC ACIDS RES, V44, P1669, DOI 10.1093/nar/gkv1298
   Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37
   Wilson PM, 2011, NUCLEIC ACIDS RES, V39, PE112, DOI 10.1093/nar/gkr350
NR 26
TC 0
Z9 0
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PD JUN 15
PY 2023
VL 2615
IS 
BP 267
EP 280
DI 10.1007/978-1-0716-2922-2_19
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA BW2FG
UT WOS:001116120000020
PM 36807798
DA 2024-11-01
ER

PT J
AU Zelissen, R
   Ahmadian, S
   Montilla-Rojo, J
   Timmer, E
   Ummelen, M
   Hopman, A
   Smeets, H
   van Tienen, F
AF Zelissen, Ruby
   Ahmadian, Somaieh
   Montilla-Rojo, Joaquin
   Timmer, Erika
   Ummelen, Monique
   Hopman, Anton
   Smeets, Hubert
   van Tienen, Florence
TI Fusion of Wild-Type Mesoangioblasts with Myotubes of mtDNA Mutation Carriers Leads to a Proportional Reduction in mtDNA Mutation Load
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mtDNA disease; mtDNA mutation; myogenic stem cell therapy; myotube fusion; mesoangioblast
ID laser capture microdissection; skeletal-muscle; point mutation; cells; expression; patient; fibers
AB In 25% of patients with mitochondrial myopathies, pathogenic mitochondrial DNA (mtDNA) mutation are the cause. For heteroplasmic mtDNA mutations, symptoms manifest when the mutation load exceeds a tissue-specific threshold. Therefore, lowering the mutation load is expected to ameliorate disease manifestations. This can be achieved by fusing wild-type mesoangioblasts with mtDNA mutant myotubes. We have tested this in vitro for female carriers of the m.3271T>C or m.3291T>C mutation (mutation load >90%) using wild-type male mesoangioblasts. Individual fused myotubes were collected by a newly-developed laser capture microdissection (LCM) protocol, visualized by immunostaining using an anti-myosin antibody. Fusion rates were determined based on male-female nuclei ratios by fluorescently labelling the Y-chromosome. Using combined 'wet' and 'air dried' LCM imaging improved fluorescence imaging quality and cell yield. Wild-type mesoangioblasts fused in different ratios with myotubes containing either the m.3271T>C or the m.3291T>C mutation. This resulted in the reduction of the mtDNA mutation load proportional to the number of fused wild-type mesoangioblasts for both mtDNA mutations. The proportional reduction in mtDNA mutation load in vitro after fusion is promising in the context of muscle stem cell therapy for mtDNA mutation carriers in vivo, in which we propose the same strategy using autologous wild-type mesoangioblasts.
C1 [Zelissen, Ruby; Ahmadian, Somaieh; Timmer, Erika; Smeets, Hubert; van Tienen, Florence] Maastricht Univ, Dept Toxicogen, Med Ctr, NL-6229 HX Maastricht, Netherlands.
   [Zelissen, Ruby; Ahmadian, Somaieh; Timmer, Erika; Ummelen, Monique; Hopman, Anton; Smeets, Hubert] Maastricht Univ, Sch Dev Biol & Oncol GROW, Med Ctr, NL-6229 HX Maastricht, Netherlands.
   [Ahmadian, Somaieh; Ummelen, Monique; Hopman, Anton] Maastricht Univ, Dept Mol Cell Biol, Med Ctr, NL-6229 HX Maastricht, Netherlands.
   [Montilla-Rojo, Joaquin] Univ Utrecht, Fac Vet Med, Dept Clin Sci, Anat & Physiol, NL-3584 CS Utrecht, Netherlands.
   [Smeets, Hubert; van Tienen, Florence] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Med Ctr, NL-6229 HX Maastricht, Netherlands.
C3 Maastricht University; Maastricht University; Maastricht University; Utrecht University; Maastricht University
RP van Tienen, F (corresponding author), Maastricht Univ, Dept Toxicogen, Med Ctr, NL-6229 HX Maastricht, Netherlands.; van Tienen, F (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Med Ctr, NL-6229 HX Maastricht, Netherlands.
EM florence.vantienen@maastrichtuniversity.nl
FU Dutch "Prinses Beatrix Spierfonds" [PBS W.0R15-09]
CR Amini P, 2017, BMC MOL BIOL, V18, P0, DOI 10.1186/s12867-017-0099-7
   Berry SE, 2007, REGEN MED, V2, P275, DOI 10.2217/17460751.2.3.275
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chen WJ, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-48316-9
   Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636
   Dellavalle A, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1508
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gautam V, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep21577
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Khodosevich K, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0001151
   Murakami H, 2000, KIDNEY INT, V58, P1346, DOI 10.1046/j.1523-1755.2000.00295.x
   Rai PK, 2018, ESSAYS BIOCHEM, V62, P455, DOI 10.1042/EBC20170113
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   SCHOUTEN HC, 1995, BRIT J HAEMATOL, V91, P162, DOI 10.1111/j.1365-2141.1995.tb05262.x
   Shi X, 2003, WORLD J GASTROENTERO, V9, P1337, DOI 10.3748/wjg.v9.i6.1337
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052
   Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Tayade C, 2014, THE GUIDE TO INVESTIGATION OF MOUSE PREGNANCY, V0, P567
   van Tienen F, 2019, STEM CELL RES THER, V10, P0, DOI 10.1186/s13287-019-1510-8
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Williams DL, 2008, J HISTOCHEM CYTOCHEM, V56, P285, DOI 10.1369/jhc.7A7331.2007
NR 24
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB 15
PY 2023
VL 24
IS 3
BP 
EP 
DI 10.3390/ijms24032679
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 8U1KT
UT WOS:000929711000001
PM 36769001
DA 2024-11-01
ER

PT J
AU Hsu, BY
   Cossin-Sevrin, N
   Stier, A
   Ruuskanen, S
AF Hsu, Bin-Yan
   Cossin-Sevrin, Nina
   Stier, Antoine
   Ruuskanen, Suvi
TI Prenatal thyroid hormones accelerate postnatal growth and telomere shortening in wild great tits
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Developmental programming; Thyroxine; Triiodothyronine; Ageing; Mitochondria; Metabolism; Oxidative stress; Maternal effects
ID oxidative stress; immune function; success; context; muscle; length; tests; birds; dna
AB The early-life environment is known to affect later-life health and disease, which could be mediated by the early-life programming of telomere length, a key hallmark of ageing. According to the fetal programming of telomere biology hypothesis, variation in prenatal exposure to hormones is likely to influence telomere length. Yet, the contribution of key metabolic hormones, i.e. thyroid hormones (THs), has been largely ignored. We recently showed that in contrast to predictions, exposure to elevated prenatal THs increased postnatal telomere length in wild collared flycatchers, but the generality of such effect, the underlying proximate mechanisms and consequences for survival have not been investigated. We therefore conducted a comprehensive study evaluating the impact of THs on potential drivers of telomere dynamics (growth, post-natal THs, mitochondria and oxidative stress), telomere length and medium-term survival using wild great tits as a model system. While prenatal THs did not significantly affect telomere length a week after hatching (i.e. day 7), they influenced postnatal telomere shortening (i.e. shorter telomeres at day 14 and the following winter) but not apparent survival. Circulating THs, mitochondrial density or oxidative stress biomarkers were not significantly influenced, whereas the TH-supplemented group showed accelerated growth, which may explain the observed delayed effect on telomeres. We discuss several alternative hypotheses that may explain the contrast with our previous findings in flycatchers. Given that shorter telomeres in early life tend to be carried until adulthood and are often associated with decreased survival prospects, the effects of prenatal THs on telomeres may have long-lasting effects on senescence.
C1 [Hsu, Bin-Yan; Cossin-Sevrin, Nina; Stier, Antoine; Ruuskanen, Suvi] Univ Turku, Dept Biol, FI-20014 Turku, Finland.
   [Cossin-Sevrin, Nina] Univ Strasbourg, Ctr Natl Rech Sci, UMR 7178, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg, France.
   [Stier, Antoine] Univ Lyon, Univ Claude Bernard Lyon 1, CNRS, UMR 5023,ENTPE,LEHNA, F-69622 Villeurbanne, France.
   [Ruuskanen, Suvi] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland.
C3 University of Turku; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Claude Bernard Lyon 1; University of Jyvaskyla
RP Ruuskanen, S (corresponding author), Univ Turku, Dept Biol, FI-20014 Turku, Finland.; Ruuskanen, S (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland.
EM suvi.k.ruuskanen@gmail.com
FU Academy of Finland [332716, 286278]; Opetushallitus; Ella and Georg Ehrnrooth Foundation; Turku Collegium for Science and Medicine Fellowship; Marie Sklodowska- Curie Postdoctoral Fellowship [894963]; University of Turku; Academy of Finland (AKA) [332716, 286278] Funding Source: Academy of Finland (AKA); Marie Curie Actions (MSCA) [894963] Funding Source: Marie Curie Actions (MSCA)
CR Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692
   [Anonymous], 2017, REV TOXICOL, V0, P0
   Arbeev KG, 2020, JAMA NETW OPEN, V3, P0, DOI 10.1001/jamanetworkopen.2020.0023
   Atema E, 2019, MOL ECOL RESOUR, V19, P648, DOI 10.1111/1755-0998.12996
   Bano A, 2019, PLOS MED, V16, P0, DOI 10.1371/journal.pmed.1002957
   Bano A, 2017, JAMA INTERN MED, V177, P1650, DOI 10.1001/jamainternmed.2017.4836
   Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Bauer CM, 2016, AUK, V133, P649, DOI 10.1642/AUK-16-56.1
   Noguera JC, 2022, MOL ECOL, V31, P6252, DOI 10.1111/mec.15694
   Casagrande S, 2019, BIOL LETTERS, V15, P0, DOI 10.1098/rsbl.2018.0885
   Chang HW, 2008, BMC BIOTECHNOL, V8, P0, DOI 10.1186/1472-6750-8-12
   Cioffi F, 2013, MOL CELL ENDOCRINOL, V379, P51, DOI 10.1016/j.mce.2013.06.006
   Cossin-Sevrin N, 2022, J EXP BIOL, V225, P0, DOI 10.1242/jeb.243414
   Criscuolo F, 2020, J EXP BIOL, V223, P0, DOI 10.1242/jeb.232496
   Eastwood JR, 2019, MOL ECOL, V28, P1127, DOI 10.1111/mec.15002
   Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182
   Entringer S, 2018, PHILOS T R SOC B, V373, P0, DOI 10.1098/rstb.2017.0151
   Godfrey K M, 2001, PUBLIC HEALTH NUTR, V4, P611
   Groothuis TGG, 2020, CURR OPIN BEHAV SCI, V36, P185, DOI 10.1016/j.cobeha.2020.10.006
   Halekoh U, 2014, J STAT SOFTW, V59, P1
   Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913
   Haussmann MF, 2004, ANN NY ACAD SCI, V1019, P186, DOI 10.1196/annals.1297.029
   Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109
   Hsu BY, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-71511-y
   Hsu BY, 2019, AM NAT, V194, PE96, DOI 10.1086/704738
   Hsu BY, 2019, J AVIAN BIOL, V50, P0, DOI 10.1111/jav.01919
   Hsu BY, 2017, GEN COMP ENDOCR, V240, P174, DOI 10.1016/j.ygcen.2016.10.011
   Jetz W, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003261
   Kärkkäinen T, 2022, MOL ECOL, V31, P6339, DOI 10.1111/mec.16155
   Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Liu JS, 2006, J THERM BIOL, V31, P386, DOI 10.1016/j.jtherbio.2006.01.002
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marchetto NM, 2016, AM J OBSTET GYNECOL, V215, P0, DOI 10.1016/j.ajog.2016.01.177
   McNabb FMA, 2007, CRIT REV TOXICOL, V37, P163, DOI 10.1080/10408440601123552
   Medici M, 2013, J CLIN ENDOCR METAB, V0, P0
   Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3
   Mollehave LT, 2020, ENDOCRINE, V68, P358, DOI 10.1007/s12020-020-02216-5
   Monaghan P, 2018, PHILOS T R SOC B, V373, P0, DOI 10.1098/rstb.2016.0446
   Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013
   Muñoz-Lorente MA, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12664-x
   Muriel J, 2015, J EVOLUTION BIOL, V28, P1476, DOI 10.1111/jeb.12668
   Parolini M, 2019, PHYSIOL BIOCHEM ZOOL, V92, P459, DOI 10.1086/705037
   Podmokla E, 2018, BIOL REV, V93, P1499, DOI 10.1111/brv.12406
   Radersma R, 2015, IBIS, V157, P351, DOI 10.1111/ibi.12230
   Reichert S, 2017, BIOL LETTERS, V13, P0, DOI 10.1098/rsbl.2017.0463
   Ruuskanen S, 2022, PHYSIOL BIOCHEM ZOOL, V95, P544, DOI 10.1086/721556
   Ruuskanen S, 2019, ENVIRON POLLUT, V247, P725, DOI 10.1016/j.envpol.2019.01.088
   Ruuskanen S, 2018, J CHROMATOGR B, V1093, P24, DOI 10.1016/j.jchromb.2018.06.052
   Ruuskanen S, 2018, PHYSIOL BIOCHEM ZOOL, V91, P904, DOI 10.1086/697380
   Ruuskanen S, 2016, GEN COMP ENDOCR, V235, P29, DOI 10.1016/j.ygcen.2016.05.026
   Ruuskanen S, 2016, HORM BEHAV, V81, P38, DOI 10.1016/j.yhbeh.2016.03.006
   Salmón P, 2016, BIOL LETTERS, V12, P0, DOI 10.1098/rsbl.2016.0155
   Salmón P, 2017, P ROY SOC B-BIOL SCI, V284, P0, DOI 10.1098/rspb.2017.1349
   Sarraude T, 2020, PEERJ, V8, P0, DOI 10.7717/peerj.10175
   Sarraude T, 2020, PHYSIOL BIOCHEM ZOOL, V93, P255, DOI 10.1086/709030
   Schielzeth H, 2020, METHODS ECOL EVOL, V11, P1141, DOI 10.1111/2041-210X.13434
   Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x
   Smith SM, 2016, ECOL EVOL, V6, P2833, DOI 10.1002/ece3.2080
   Soriano-Redondo A, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-19256-0
   Stier A, 2020, BIOL LETTERS, V16, P0, DOI 10.1098/rsbl.2020.0364
   Stier A, 2020, P ROY SOC B-BIOL SCI, V287, P0, DOI 10.1098/rspb.2020.1378
   Stier A, 2019, BIOL LETTERS, V15, P0, DOI 10.1098/rsbl.2019.0536
   Stier A, 2016, J AVIAN BIOL, V47, P134, DOI 10.1111/jav.00714
   Stier A, 2015, OECOLOGIA, V179, P999, DOI 10.1007/s00442-015-3429-9
   Stier A, 2014, J COMP PHYSIOL B, V184, P1021, DOI 10.1007/s00360-014-0856-6
   Tissier ML, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0097705
   Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x
   Verhulst S, 2020, MOL ECOL RESOUR, V20, P11, DOI 10.1111/1755-0998.13114
   Vrijkotte TGM, 2017, J CLIN ENDOCR METAB, V102, P1059, DOI 10.1210/jc.2016-3452
   Weber K, 2002, ENDOCRINOLOGY, V143, P177, DOI 10.1210/en.143.1.177
   Welcker J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0056229
   Wilbourn RV, 2018, PHILOS T R SOC B, V373, P0, DOI 10.1098/rstb.2016.0447
   Zhang C, 2019, J CLIN ENDOCR METAB, V104, P5853, DOI 10.1210/jc.2019-00390
NR 75
TC 3
Z9 3
U1 1
U2 10
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0022-0949
EI 1477-9145
J9 J EXP BIOL
JI J. Exp. Biol.
PD MAR 15
PY 2023
VL 226
IS 6
BP 
EP 
DI 10.1242/jeb.243875
PG 10
WC Biology; Zoology
SC Life Sciences & Biomedicine - Other Topics; Zoology
GA E4AE1
UT WOS:000974978300018
PM 36714994
DA 2024-11-01
ER

PT J
AU Tomoda, E
   Nagao, A
   Shirai, Y
   Asano, K
   Suzuki, T
   Battersby, BJ
   Suzuki, T
AF Tomoda, Ena
   Nagao, Asuteka
   Shirai, Yuki
   Asano, Kana
   Suzuki, Takeo
   Battersby, Brendan J.
   Suzuki, Tsutomu
TI Restoration of mitochondrial function through activation of hypomodified tRNAs with pathogenic mutations associated with mitochondrial diseases
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID wobble modification deficiency; stroke-like episodes; mutant transfer-rnas; transfer rnaleu(uur) gene; lactic-acidosis; hypertrophic cardiomyopathy; posttranscriptional modifications; modification defect; myoclonic epilepsy; clinical-features
AB Mutations in mitochondrial (mt-)tRNAs frequently cause mitochondrial dysfunction. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), and myoclonus epilepsy associated with ragged red fibers (MERRF) are major clinical subgroups of mitochondrial diseases caused by pathogenic point mutations in tRNA genes encoded in mtDNA. We previously reported a severe reduction in the frequency of 5-taurinomethyluridine (tau m(5)U) and its 2-thiouridine derivative (tau m(5)s(2)U) in the anticodons of mutant mt-tRNAs isolated from the cells of patients with MELAS and MERRF, respectively. The hypomodified tRNAs fail to decode cognate codons efficiently, resulting in defective translation of respiratory chain proteins in mitochondria. To restore the mitochondrial activity of MELAS patient cells, we overexpressed MTO1, a tau m(5)U-modifying enzyme, in patient-derived myoblasts. We used a newly developed primer extension method and showed that MTO1 overexpression almost completely restored the tau m(5)U modification of the MELAS mutant mt-tRNA(Leu(UUR)). An increase in mitochondrial protein synthesis and oxygen consumption rate suggested that the mitochondrial function of MELAS patient cells can be activated by restoring the tau m(5)U of the mutant tRNA. In addition, we confirmed that MTO1 expression restored the tau m(5)s(2)U of the mutant mt-tRNA(Lys) in MERRF patient cells. These findings pave the way for epitranscriptomic therapies for mitochondrial diseases.
C1 [Tomoda, Ena; Nagao, Asuteka; Shirai, Yuki; Asano, Kana; Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138656, Japan.
   [Battersby, Brendan J.] Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland.
   [Suzuki, Takeo] Univ Ryukyus, Grad Sch Med, Dept Med Biochem, 207 Uehara, Nishihara, Okinawa 9030215, Japan.
C3 University of Tokyo; University of Helsinki; University of the Ryukyus
RP Nagao, A; Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, 7 3 1 Hongo,Bunkyo ku, Tokyo 1138656, Japan.
EM asuteka@chemibo.t.u-tokyo.ac.jp; ts@chembio.t.u-tokyo.ac.jp
FU Grants-in-Aid for Scientific Research [21H05280, 22H02208, 23K23475] Funding Source: KAKEN
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   Ayyub SA, 2020, J CELL SCI, V133, P0, DOI 10.1242/jcs.231811
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Bommisetti P, 2022, J BIOL CHEM, V298, P0, DOI 10.1016/j.jbc.2022.102548
   Börner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Campeau E, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006529
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Chujo T, 2021, FEBS J, V288, P7096, DOI 10.1111/febs.15736
   Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112
   Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998
   Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Goto Y, 2000, NEUROPATHOLOGY, V20, P0
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91
   HAYASHI JI, 1993, BIOCHEM BIOPH RES CO, V197, P1049, DOI 10.1006/bbrc.1993.2584
   Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   HO NWY, 1971, BIOCHEMISTRY-US, V10, P3651
   HO NWY, 1967, BIOCHEMISTRY-US, V6, P3632, DOI 10.1021/bi00864a002
   Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202
   Ishitani R, 2008, CURR OPIN STRUC BIOL, V18, P330, DOI 10.1016/j.sbi.2008.05.003
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Karijolich J, 2015, NAT REV MOL CELL BIO, V16, P581, DOI 10.1038/nrm4040
   Kawarada L, 2017, NUCLEIC ACIDS RES, V45, P7401, DOI 10.1093/nar/gkx354
   Keffer-Wilkes LC, 2020, NUCLEIC ACIDS RES, V48, P7981, DOI 10.1093/nar/gkaa548
   Keffer-Wilkes LC, 2016, P NATL ACAD SCI USA, V113, P14306, DOI 10.1073/pnas.1607512113
   Kimura S, 2020, NAT CHEM BIOL, V16, P964, DOI 10.1038/s41589-020-0558-1
   Kimura S, 2012, NUCLEIC ACIDS RES, V40, P4071, DOI 10.1093/nar/gkr1287
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Li XY, 2017, NAT METHODS, V14, P23, DOI 10.1038/NMETH.4110
   Liu CL, 2017, MAR DRUGS, V15, P0, DOI 10.3390/md15060147
   Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, P0, DOI 10.1093/nar/gkl1129
   Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460
   Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022
   Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249
   Ohira T, 2022, NATURE, V605, P372, DOI 10.1038/s41586-022-04677-2
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Okegawa Y, 2015, ANAL BIOCHEM, V486, P51, DOI 10.1016/j.ab.2015.06.031
   Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466
   Perli E, 2020, FASEB J, V34, P7675, DOI 10.1096/fj.201903270R
   Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q
   Rackham O, 2022, NAT REV GENET, V23, P606, DOI 10.1038/s41576-022-00480-x
   Rak R, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2106556118
   Richter U, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06471-z
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Ross RL, 2017, BIOMOLECULES, V7, P0, DOI 10.3390/biom7010021
   Rosselló-Tortella M, 2020, P NATL ACAD SCI USA, V117, P20785, DOI 10.1073/pnas.2003358117
   Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sakaguchi Y, 2015, METHOD ENZYMOL, V560, P19, DOI 10.1016/bs.mie.2015.03.015
   Sakurai M, 2005, FEBS LETT, V579, P2767, DOI 10.1016/j.febslet.2005.04.009
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silva-Pinheiro P, 2022, NAT REV GENET, V23, P199, DOI 10.1038/s41576-021-00432-x
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066
   Su D, 2014, NAT PROTOC, V9, P828, DOI 10.1038/nprot.2014.047
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361
   Suzuki T, 1999, INT J MASS SPECTROM, V46, P168
   Suzuki T, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18068-6
   Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390
   Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8
   Suzuki T, 2021, NAT REV MOL CELL BIO, V22, P375, DOI 10.1038/s41580-021-00342-0
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Urbonavicius J, 2005, NUCLEIC ACIDS RES, V33, P3955, DOI 10.1093/nar/gki703
   VARSHNEY U, 1991, J BIOL CHEM, V266, P24712
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang J, 2021, RNA BIOL, V18, P33, DOI 10.1080/15476286.2020.1790871
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Wolff P, 2020, RNA, V26, P1957, DOI 10.1261/rna.077537.120
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 113
TC 8
Z9 10
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD AUG 11
PY 2023
VL 51
IS 14
BP 7563
EP 7579
DI 10.1093/nar/gkad139
EA MAR 2023
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA O5OX4
UT WOS:000949204100001
PM 36928678
DA 2024-11-01
ER

PT J
AU Yang, H
   Hur, G
   Lee, TK
   Kim, JE
   Kim, JH
   Kim, JR
   Kim, J
   Park, JHY
   Lee, KW
AF Yang, Hee
   Hur, Gihyun
   Lee, Tae Kyung
   Kim, Jong-Eun
   Kim, Jong Hun
   Kim, Jong Rhan
   Kim, Jiyoung
   Park, Jung Han Yoon
   Lee, Ki Won
TI Sulforaphane Mitigates High-Fat Diet-Induced Obesity by Enhancing Mitochondrial Biogenesis in Skeletal Muscle via the HDAC8-PGC1α Axis
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE histone deacetylase 8; mitochondrial biogenesis; obesity; PGC1 alpha; sulforaphane
ID histone deacetylase inhibitors; insulin-resistance; hdac8; pgc-1-alpha; metabolism; mechanisms; expression; nrf2
AB Scope: Histone deacetylases (HDACs) play a crucial role in the transcriptional regulation of various genes which can contribute to metabolic disorders. Although sulforaphane (SFN), a natural HDAC inhibitor, has been reported to alleviate obesity in humans and mice, the specific mechanisms and how HDACs contribute to SFN's anti-obesity effects remain unclear.Methods and results: Oral administration of SFN in mice fed high-fat diet increases peroxisome proliferator activating receptor gamma coactivator (PGC1 alpha)-induced mitochondrial biogenesis in skeletal muscle. Among HDACs, SFN specifically inhibits HDAC8 activity. SFN enhances mitochondrial DNA and adenosine triphosphate (ATP) production in C2C12 myotubes, similar to the action of PCI34051, a synthetic HDAC8-specific inhibitor. These effects are mediated by increased expression of PGC1 alpha via upregulation of cAMP response element binding (CREB, Ser(133)) phosphorylation and p53 (Lys(379)) acetylation. These SFN-induced effects are not observed in cells with a genetic deletion of HDAC8, suggesting the existence of a regulatory loop between HDAC8 and PGC1 alpha in SFN's action.Conclusion: SFN prevents obesity-related metabolic dysregulation by enhancing mitochondrial biogenesis and function via targeting the HDAC8-PGC alpha axis. These results suggest SFN as a beneficial anti-obesity agent providing new insight into the role of HDAC8 in the PGC1 alpha-mediated mitochondrial biogenesis, which may be a novel and promising drug target for metabolic diseases.
C1 [Yang, Hee] Kookmin Univ, Dept Food & Nutr, 77 Jeongneung Ro, Seoul 02707, South Korea.
   [Hur, Gihyun; Lee, Tae Kyung; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.
   [Kim, Jong-Eun] Korea Natl Univ Transportat, Dept Food Sci & Technol, Jeungpyeong, South Korea.
   [Kim, Jong Hun] Sungshin Womens Univ, Dept Food Sci & Biotechnol, Seoul 01133, South Korea.
   [Kim, Jong Rhan] Sungshin Univ, Basic Sci Res Inst, Seoul 01133, South Korea.
   [Kim, Jong Rhan] Korea Inst Sci & Technol Evaluat & Planning, R&D Evaluat Ctr, Eumseong 1339, Chungcheongbug, South Korea.
   [Kim, Jiyoung] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea.
   [Park, Jung Han Yoon; Lee, Ki Won] Seoul Natl Univ, BioMAX Inst, Seoul 08826, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 16229, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea.
C3 Kookmin University; Seoul National University (SNU); Korea National University of Transportation; Sungshin Women's University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)
RP Lee, KW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, BioMAX Inst, Seoul 08826, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 16229, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea.
EM kiwon@snu.ac.kr
FU This project was supported by a National Research Foundation of Korea (NRF) grant (2018R1A2A1A05078707), the K-BIO KIURI Center Program through the Ministry of Science and ICT (2020M3H1A1073304), Korea Institute of Planning and Evaluation for Technology in [2018R1A2A1A05078707, 2020M3H1A1073304]; National Research Foundation of Korea (NRF) [821027]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through Technology Commercialization Support Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA); Brain Korea 21 Plus Program of the Department of Agricultural Biotechnology from Seoul National University, Republic of Korea
CR Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9
   Banerjee S, 2019, EUR J MED CHEM, V164, P214, DOI 10.1016/j.ejmech.2018.12.039
   Çakir I, 2022, ELIFE, V11, P0, DOI 10.7554/eLife.67368
   Chakrabarti A, 2015, TRENDS PHARMACOL SCI, V36, P481, DOI 10.1016/j.tips.2015.04.013
   Clarke JD, 2011, J AGR FOOD CHEM, V59, P10955, DOI 10.1021/jf202887c
   Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100
   Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001
   Dinkova-Kostova AT, 2017, TRENDS FOOD SCI TECH, V69, P257, DOI 10.1016/j.tifs.2017.02.002
   Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548
   Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135
   Gough NR, 2016, SCI SIGNAL, V9, P0
   Greco T, 2011, FREE RADICAL BIO MED, V51, P2164, DOI 10.1016/j.freeradbiomed.2011.09.017
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Harakalova M, 2012, J MED GENET, V49, P539, DOI 10.1136/jmedgenet-2012-100921
   Holmstrom Kira M, 2016, CURRENT OPINION IN TOXICOLOGY, V1, P80, DOI 10.1016/j.cotox.2016.10.002
   Hua WK, 2017, BLOOD, V130, P2619, DOI 10.1182/blood-2017-03-771386
   Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003
   Juengel E, 2018, CANCER LETT, V435, P121, DOI 10.1016/j.canlet.2018.07.017
   Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   King J, 2021, METABOLITES, V11, P0, DOI 10.3390/metabo11110792
   Kobayashi M, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12072054
   Lee S, 2014, PHARMACOL RES, V85, P23, DOI 10.1016/j.phrs.2014.05.003
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Liu YL, 2021, FRONT PHARMACOL, V12, P0, DOI 10.3389/fphar.2021.665894
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marek M, 2018, J MED CHEM, V61, P10000, DOI 10.1021/acs.jmedchem.8b01087
   McIntyre RL, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809854
   Moore MS, 2000, P NUTR SOC, V59, P193, DOI 10.1017/S0029665100000215
   Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje
   Nagata N, 2017, DIABETES, V66, P1222, DOI 10.2337/db16-0662
   Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310
   Ricquier Daniel, 2011, FRONT ENDOCRINOL (LAUSANNE), V2, P85, DOI 10.3389/fendo.2011.00085
   Schell JC, 2017, NAT CELL BIOL, V19, P589, DOI 10.1038/ncb3540
   Sharma BK, 2014, J CELL PHYSIOL, V229, P1901, DOI 10.1002/jcp.24664
   Tian Y, 2015, CANCER RES, V75, P4803, DOI 10.1158/0008-5472.CAN-14-3786
   Vaughan RA, 2014, J PHYSIOL BIOCHEM, V70, P271, DOI 10.1007/s13105-013-0301-4
   Venegas V, 2011, CURR PROTOC HUM GENE, V0, P19
   Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620
   Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426
   Zhang HQ, 2016, MOL NUTR FOOD RES, V60, P2185, DOI 10.1002/mnfr.201500915
NR 44
TC 1
Z9 2
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD DEC 15
PY 2023
VL 67
IS 23
BP 
EP 
DI 10.1002/mnfr.202300149
EA SEP 2023
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA LV3D4
UT WOS:001075108500001
PM 37775334
DA 2024-11-01
ER

PT J
AU Ganguly, A
   Padhan, DK
   Sengupta, A
   Chakraborty, P
   Sen, M
AF Ganguly, Ananya
   Padhan, Deepesh Kumar
   Sengupta, Archya
   Chakraborty, Pritam
   Sen, Malini
TI CCN6 influences transcription and controls mitochondrial mass and muscle organization
SO FASEB JOURNAL
LA English
DT Article
DE CCN6; chondrocyte; mitochondria; transcription; zebrafish
ID progressive pseudorheumatoid dysplasia; dna-damage; wisp3 mutations; gene family; identification; arthropathy; proteins; tarda
AB Mutations in Cellular Communication Network Factor 6 (CCN6) are linked to the debilitating musculoskeletal disease Progressive Pseudo Rheumatoid Dysplasia (PPRD), which disrupts mobility. Yet, much remains unknown about CCN6 function at the molecular level. In this study, we revealed a new function of CCN6 in transcriptional regulation. We demonstrated that CCN6 localizes to chromatin and associates with RNA Polymerase II in human chondrocyte lines. Using zebrafish as a model organism we validated the nuclear presence of CCN6 and its association with RNA Polymerase II in different developmental stages from 10 hpf embryo to adult fish muscle. In concurrence with these findings, we confirmed the requirement of CCN6 in the transcription of several genes encoding mitochondrial electron transport complex proteins in the zebrafish, both in the embryonic stages and in the adult muscle. Reduction in the expression of these genes upon morpholino-mediated knockdown of CCN6 protein expression led to reduced mitochondrial mass, which correlated with defective myotome organization during zebrafish muscle development. Overall, this study suggests that the developmental musculoskeletal abnormalities linked with PPRD could be contributed at least partly by impaired expression of genes encoding mitochondrial electron transport complexes due to defects in CCN6 associated transcriptional regulation.
C1 [Ganguly, Ananya; Padhan, Deepesh Kumar; Sengupta, Archya; Sen, Malini] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India.
   [Chakraborty, Pritam] Southern Illinois Univ, Biochem & Mol Biol, Carbondale, IL USA.
   [Sen, Malini] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4-Raja SC Mullick Rd, Kolkata 700032, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Southern Illinois University System; Southern Illinois University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)
RP Sen, M (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4-Raja SC Mullick Rd, Kolkata 700032, India.
EM msen@iicb.res.in
FU Department of Biotechnology, Ministry of Science and Technology, India (DBT) [BT/PR24244/MED/12/764/2017]; Science and Engineering Research Board [CRG/2019/001933]
CR Al Kaissi A, 2020, CLIN RHEUMATOL, V39, P553, DOI 10.1007/s10067-019-04783-z
   Alawbathani S, 2018, CSH MOL CASE STUD, V4, P0, DOI 10.1101/mcs.a002139
   Arribat Y, 2019, FRONT CELL DEV BIOL, V7, P0, DOI 10.3389/fcell.2019.00282
   Avdesh A, 2012, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/4196
   Aygün O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105
   Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Dalal A, 2012, AM J MED GENET A, V158A, P2820, DOI 10.1002/ajmg.a.35620
   Davis L, 2006, BIOCHEM BIOPH RES CO, V342, P259, DOI 10.1016/j.bbrc.2006.01.132
   Delague V, 2005, AM J MED GENET A, V138A, P118, DOI 10.1002/ajmg.a.30906
   Ekbote AV, 2013, SEMIN ARTHRITIS RHEU, V42, P582, DOI 10.1016/j.semarthrit.2012.09.001
   Engel J, 2004, INT J BIOCHEM CELL B, V36, P997, DOI 10.1016/j.biocel.2003.12.009
   Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008
   Gaboon NEA, 2019, FRONT PEDIATR, V7, P0, DOI 10.3389/fped.2019.00245
   Goody M, 2013, BIOPROTOC, V3, P1
   Hammond-Weinberger DR, 2020, JOVE-J VIS EXP, V155, P1
   Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006
   Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699
   Jaloszynski P, 1997, MUTAT RES-DNA REPAIR, V385, P223, DOI 10.1016/S0921-8777(97)00046-3
   Joshi S, 2017, BASIC SCI METHODS CL, V0, P135
   Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x
   Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106
   Kunowska N, 2015, NUCLEIC ACIDS RES, V43, P1418, DOI 10.1093/nar/gku1350
   Liu LM, 2015, JOINT BONE SPINE, V82, P125, DOI 10.1016/j.jbspin.2014.10.005
   Liu ZQ, 2021, TRANSL PEDIATR, V10, P1932, DOI 10.21037/tp-21-152
   Luo HY, 2015, GENE, V564, P35, DOI 10.1016/j.gene.2015.03.029
   Miller DS, 2007, BIOCHEM BIOPH RES CO, V355, P156, DOI 10.1016/j.bbrc.2007.01.114
   Murray V, 2014, CELL MOL LIFE SCI, V71, P1505, DOI 10.1007/s00018-013-1456-4
   Padhan DK, 2020, FASEB J, V34, P12163, DOI 10.1096/fj.202000405RR
   Patra M, 2016, J CELL SCI, V129, P2841, DOI 10.1242/jcs.186247
   Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717
   Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7
   Pode-Shakked B, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0787-x
   Popgeorgiev N, 2011, DEV CELL, V20, P663, DOI 10.1016/j.devcel.2011.03.016
   Repudi SR, 2013, J CELL SCI, V126, P1650, DOI 10.1242/jcs.119859
   Romanello V, 2016, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00422
   Rosen Jonathan N, 2009, J VIS EXP, V0, P0, DOI DOI 10.3791/1115
   Sailani MR, 2018, CSH MOL CASE STUD, V4, P0, DOI 10.1101/mcs.a001990
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schutze Norbert, 2005, CELL COMMUN SIGNAL, V3, P5, DOI 10.1186/1478-811X-3-5
   Segarra NG, 2012, AM J MED GENET C, V160C, P217, DOI 10.1002/ajmg.c.31333
   Sen M, 2004, ARTHRITIS RHEUM-US, V50, P488, DOI 10.1002/art.20005
   Sengupta A, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.627409
   Shahi P, 2020, BMJ CASE REP, V13, P0, DOI 10.1136/bcr-2020-234461
   Sheth H, 2021, IEEE T PATTERN ANAL, V12, P0
   Sive Hazel L, 2010, COLD SPRING HARB PROTOC, V2010, P0, DOI 10.1101/pdb.prot5537
   Stainier DYR, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1007000
   Sun J, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038643
   Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206
   TEEBI AS, 1986, J MED GENET, V23, P189, DOI 10.1136/jmg.23.2.189-a
   Yan Wenjin, 2016, HUM GENOME VAR, V3, P16041, DOI 10.1038/hgv.2016.41
   Yang X, 2013, JOINT BONE SPINE, V80, P650, DOI 10.1016/j.jbspin.2013.03.006
   Yuan Shiaulou, 2009, J VIS EXP, V0, P0, DOI DOI 10.3791/1113
NR 53
TC 1
Z9 1
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAR 15
PY 2023
VL 37
IS 3
BP 
EP 
DI 10.1096/fj.202201533R
PG 14
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology
GA 9A5DI
UT WOS:000934078000001
PM 36794678
DA 2024-11-01
ER

PT J
AU Picca, A
   Guerra, F
   Calvani, R
   Coelho, HJ
   Leeuwenburgh, C
   Bucci, C
   Marzetti, E
AF Picca, Anna
   Guerra, Flora
   Calvani, Riccardo
   Coelho Jr, Helio Jose
   Leeuwenburgh, Christiaan
   Bucci, Cecilia
   Marzetti, Emanuele
TI The contribution of mitochondrial DNA alterations to aging, cancer, and neurodegeneration
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Review
DE Heteroplasmy; Mitochondrial biogenesis; mtDNA deletions; mtDNA mutations; Mitochondrial diseases; Mitochondrial quality
ID mtdna control-region; copy number; paternal inheritance; transcription factor; oxidative stress; point mutations; calorie restriction; disease; cells; biogenesis
AB Mitochondrial DNA (mtDNA) is as a double-stranded molecule existing in hundreds to thousands copies in cells depending on cell metabolism and exposure to endogenous and/or environmental stressors. The coordination of mtDNA replication and transcription regulates the pace of mitochondrial biogenesis to guarantee the minimum number of organelles per cell. mtDNA inheritance follows a maternal lineage, although bi-parental inheritance has been reported in some species and in the case of mitochondrial diseases in humans. mtDNA mutations (e.g., point mutations, deletions, copy number variations) have been identified in the setting of several human diseases. For instance, sporadic and inherited rare disorders involving the nervous system as well higher risk of developing cancer and neurodegenerative conditions, including Parkinson's and Alzheimer's disease, have been associated with polymorphic mtDNA variants. An accrual of mtDNA mutations has also been identified in several tissues and organs, including heart and muscle, of old experimental animals and humans, which may contribute to the development of aging phenotypes. The role played by mtDNA homeostasis and mtDNA quality control pathways in human health is actively investigated for the possibility of developing targeted therapeutics for a wide range of conditions.
C1 [Picca, Anna] LUM Univ, Dept Med & Surg, I-70100 Casamassima, Italy.
   [Picca, Anna; Calvani, Riccardo; Marzetti, Emanuele] Fdn Policlin Univ Agostino Gemelli IRCCS, I-00168 Rome, Italy.
   [Guerra, Flora; Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol, I-73100 Lecce, Italy.
   [Calvani, Riccardo; Coelho Jr, Helio Jose; Marzetti, Emanuele] Univ Cattolica Sacro Cuore, Dept Geriatr & Orthoped, I-00168 Rome, Italy.
   [Leeuwenburgh, Christiaan] Univ Florida, Dept Physiol & Aging, Gainesville, FL 32601 USA.
   [Calvani, Riccardo] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Md Invecchiamento CeMI, Largo F Vito 1, I-00168 Rome, Italy.
C3 Lum Jean Monnet University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Salento; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Calvani, R (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Md Invecchiamento CeMI, Largo F Vito 1, I-00168 Rome, Italy.
EM riccardo.calvani@unicatt.it
FU Ministero della Salute - Ricerca Corrente 2023, Universita Cattolica del Sacro Cuore [D1.2020, D1.2022]; National Institutes of Health [1RO1 AG075136]; nonprofit research foundation "Centro Studi Achille e Linda Lorenzon", AIRC [25795]; European Commission - Next Generation EU (Age-IT spoke 3)
CR Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   Annis S, 2019, P NATL ACAD SCI USA, V116, P14797, DOI 10.1073/pnas.1821436116
   Area-Gomez E, 2019, J CLIN INVEST, V129, P34, DOI 10.1172/JCI120848
   Arnold RS, 2015, BONE, V78, P81, DOI 10.1016/j.bone.2015.04.046
   Arnold RS, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/239257
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Balciuniene J, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00518
   Bartoletti-Stella A, 2011, ARCH OPHTHALMOL-CHIC, V129, P664, DOI 10.1001/archophthalmol.2011.95
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bianco Angelica, 2018, BMC RES NOTES, V11, P911, DOI 10.1186/s13104-018-4025-y
   Bianco A, 2017, INVEST OPHTH VIS SCI, V58, P2193, DOI 10.1167/iovs.16-20389
   BioRender, 2021, MTDNA HET, V0, P0
   BioRender, 2021, MIT INH, V0, P0
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Caino MC, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13730
   Calabrese C, 2013, CANCER METAB, V1, P0, DOI 10.1186/2049-3002-1-11
   Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009
   Cassarino DS, 1998, BIOCHEM BIOPH RES CO, V248, P168, DOI 10.1006/bbrc.1998.8866
   Chen ZX, 2010, CELL DEATH DIFFER, V17, P408, DOI 10.1038/cdd.2009.132
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   Cormio A, 2009, BIOCHEM BIOPH RES CO, V390, P1182, DOI 10.1016/j.bbrc.2009.10.114
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Courtney KD, 2018, CELL METAB, V28, P793, DOI 10.1016/j.cmet.2018.07.020
   Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617
   Dasgupta S, 2009, INT J CANCER, V125, P2829, DOI 10.1002/ijc.24701
   DeBerardinis RJ, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600200
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Frezza C, 2017, INTERFACE FOCUS, V7, P0, DOI 10.1098/rsfs.2016.0100
   Gan XQ, 2014, FREE RADICAL BIO MED, V75, P230, DOI 10.1016/j.freeradbiomed.2014.07.021
   Gasparre G, 2008, HUM MOL GENET, V17, P986, DOI 10.1093/hmg/ddm371
   Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104
   Gasparre G, 2011, CANCER RES, V71, P6220, DOI 10.1158/0008-5472.CAN-11-1042
   Gasparre G, 2009, HUM MUTAT, V30, P391, DOI 10.1002/humu.20870
   Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034
   Gaude E, 2014, CANCER METAB, V2, P0, DOI 10.1186/2049-3002-2-10
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gopa RK, 2018, CANCER CELL, V34, P242, DOI 10.1016/j.ccell.2018.06.013
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grandhi S, 2017, HUM MOL GENET, V26, P2912, DOI 10.1093/hmg/ddx172
   Guerra F, 2011, HUM, V0, P0
   Guerra F, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00295
   Guerra F, 2017, BBA-BIOENERGETICS, V1858, P686, DOI 10.1016/j.bbabio.2017.01.012
   Guerra F, 2012, J CLIN ONCOL, V30, PE373, DOI 10.1200/JCO.2012.43.5933
   Guha M, 2018, BIOCH BIOPHYS ACTA M, V0, P0
   GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   He XL, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061677
   He YH, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.01.015
   Herrera-Cruz MS, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00105
   Hopkins JF, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00377-y
   HOWELL AN, 1978, P NATL ACAD SCI USA, V75, P2358, DOI 10.1073/pnas.75.5.2358
   Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jiménez-Morales S, 2018, INT J ONCOL, V53, P923, DOI 10.3892/ijo.2018.4468
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kalsbeek AMF, 2017, ONCOTARGET, V8, P71342, DOI 10.18632/oncotarget.19926
   Kalsbeek AMF, 2016, AGING-US, V8, P2702, DOI 10.18632/aging.101044
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Keogh M, 2013, CELL METAB, V18, P463, DOI 10.1016/j.cmet.2013.09.015
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kim HR, 2018, BLOOD RES, V53, P240, DOI 10.5045/br.2018.53.3.240
   Kim S, 2021, HUMAN MTDNA SEQUENCE, V0, P0
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kopinski PK, 2021, NAT REV CANCER, V21, P431, DOI 10.1038/s41568-021-00358-w
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Labuschagne CF, 2019, CELL METAB, V30, P720, DOI 10.1016/j.cmet.2019.07.014
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039
   Letouzé E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Li N, 2018, ONCOL LETT, V16, P3992, DOI 10.3892/ol.2018.9113
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Liou CW, 2016, EUR J NEUROL, V0, P0
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860
   Luo S, 2018, P NATL ACAD SCI US, V0, P0
   Lutz-Bonengel S, 2019, P NATL ACAD SCI USA, V116, P1821, DOI 10.1073/pnas.1820533116
   Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   McWilliams TG, 2019, NATURE, V565, P296, DOI 10.1038/d41586-019-00093-1
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Musicco C, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19072076
   Muyderman H, 2012, MITOCHONDRION, V12, P465, DOI 10.1016/j.mito.2012.06.006
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   Nieborowska-Skorska M, 2012, BLOOD, V119, P4253, DOI 10.1182/blood-2011-10-385658
   Onyango I, 2006, J ALZHEIMERS DIS, V9, P183
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   PAYAMI H, 1993, GENET EPIDEMIOL, V10, P461, DOI 10.1002/gepi.1370100622
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pereira L, 2012, BMC CANCER, V12, P0, DOI 10.1186/1471-2407-12-53
   Perrone AM, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19072048
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Picca A, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11040675
   Picca A, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9030598
   Picca A, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18050933
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Picca A, 2014, BBA-GEN SUBJECTS, V1840, P2184, DOI 10.1016/j.bbagen.2014.03.004
   Picca A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074644
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Piel RB, 2019, MOL GENET METAB, V128, P198, DOI 10.1016/j.ymgme.2019.01.006
   Pinto M, 2017, CELL DEATH DIFFER, V24, P288, DOI 10.1038/cdd.2016.123
   Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726
   Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Rebelo AP, 2011, J INHERIT METAB DIS, V34, P941, DOI 10.1007/s10545-011-9330-8
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Rius R, 2019, GENET MED, V21, P2823, DOI 10.1038/s41436-019-0568-0
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268
   Schmauck-Medina T, 2022, AGING-US, V14, P6829, DOI 10.18632/aging.204248
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353
   Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012
   Silva DF, 2013, CURR ALZHEIMER RES, V10, P180
   Silva DF, 2013, HUM MOL GENET, V22, P3931, DOI 10.1093/hmg/ddt247
   Srivastava S, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8120398
   St John JC, 2004, GENETICS, V167, P897, DOI 10.1534/genetics.103.025049
   Stewart TA, 2015, BBA-BIOMEMBRANES, V1848, P2502, DOI 10.1016/j.bbamem.2014.08.016
   Strobbe D, 2018, NEUROBIOL DIS, V114, P129, DOI 10.1016/j.nbd.2018.02.010
   Swerdlow RH, 2017, PROG MOL BIOL TRANSL, V146, P259, DOI 10.1016/bs.pmbts.2016.12.017
   Swerdlow RH, 2001, EXP NEUROL, V169, P479, DOI 10.1006/exnr.2001.7674
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Thiffault C, 2005, MITOCHONDRION, V5, P109, DOI 10.1016/j.mito.2004.12.002
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyagi A, 2018, MUTAT RES-FUND MOL M, V810, P13, DOI 10.1016/j.mrfmmm.2018.05.002
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vakifahmetoglu-Norberg H, 2017, BIOCHEM BIOPH RES CO, V482, P426, DOI 10.1016/j.bbrc.2016.11.088
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weerts MJA, 2018, CANCERS, V10, P0, DOI 10.3390/cancers10120500
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Wei W, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15336-3
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Xiao JL, 2018, CARCINOGENESIS, V39, P1311, DOI 10.1093/carcin/bgy133
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Yuan Y, 2015, BMC CANCER, V15, P0, DOI 10.1186/s12885-015-1349-z
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
   Zhao X, 2004, HEREDITY, V93, P399, DOI 10.1038/sj.hdy.6800516
NR 188
TC 14
Z9 14
U1 2
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL 15
PY 2023
VL 178
IS 
BP 
EP 
DI 10.1016/j.exger.2023.112203
EA MAY 2023
PG 13
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA J4QG0
UT WOS:001009468200001
PM 37172915
DA 2024-11-01
ER

PT J
AU Mavroudis, I
   Petridis, F
   Kazis, D
AF Mavroudis, Ioannis
   Petridis, Foivos
   Kazis, Dimitrios
TI Inclusion body myositis. Genetics, biomarkers and muscle biopsy
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Review
DE inclusion body myositis; biomarkers; muscle biopsy
ID mitochondrial-dna deletions; rimmed vacuoles; clinical-course; association; epidemiology; proteins; features; cells; mhc
AB Sporadic inclusion body myositis is the most common idiopathic inflammatory myopathy over the age of 50, with a male-to-female ratio of 3:1. Symptoms onset before age of 60 occurs in 18-20% of patients, with a delay in diagnosis of 5 to 8 years.The classic clinical presentation of SIBM consists of proximal leg and distal arm weakness, and most commonly patients present early slowly progressive quadriceps weakness which leads to falls and to difficulties in climbing stairs, while less common the initial complaints refer to finger flexor weakness and atrophy, foot drop, or dysphagia, and rare presentations include prominent forearm weakness, sparing the quadriceps. The aetiopathogenesis of the disease remains unclear and despite some preliminary promising results, to the day there is no effective treatment.The diagnosis of SIBM is based on the clinical presentation and the histopathological findings in muscle biopsy, however increasing evidence on genetics and paraclinical biomarkers has recently come to light giving new insights on the pathogenesis, the diagnosis and the potential treatment of the disease. In the present study we aim to review the histopathological findings, genetics and blood biomarkers, and to review the role of muscle biopsy in the diagnosis of SIBM.
C1 [Mavroudis, Ioannis] Leeds Teaching Hosp, Dept Neurol, Leeds, England.
   [Petridis, Foivos; Kazis, Dimitrios] Aristotle Univ Thessaloniki, Dept Neurol 3, Thessaloniki, Greece.
C3 University of Leeds; Aristotle University of Thessaloniki
RP Mavroudis, I (corresponding author), Leeds Teaching Hosp, Dept Neurol, Leeds, England.
EM ioannis.mavroudis@nhs.net
CR Ahmed M, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aad4583
   Alhammad RM, 2019, NEUROMUSCULAR DISORD, V29, P39, DOI 10.1016/j.nmd.2018.10.007
   Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407
   Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070
   Amlani A, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.00745
   Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Barohn, 2000, CURR TREAT OPTIONS NEUROL, V2, P7, DOI 10.1007/s11940-000-0019-9
   BEYENBURG S, 1993, CLIN INVESTIGATOR, V71, P351
   Brady S, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2013-004552
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe
   Cherin P, 2002, NEUROLOGY, V58, P326, DOI 10.1212/WNL.58.2.326
   Dahlbom K, 2019, ACTA NEUROL SCAND, V139, P177, DOI 10.1111/ane.13040
   Gang Q, 2016, NEUROBIOL AGING, V47, P0, DOI 10.1016/j.neurobiolaging.2016.07.024
   Gang Q, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-88
   Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   Greenberg Steven A, 2016, CONTINUUM (MINNEAP MINN), V22, P1871
   Greenberg SA, 2016, BRAIN, V139, P1348, DOI 10.1093/brain/aww024
   Güttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7
   Ioannis M, 2019, INT J NEUROSCI, V129, P297, DOI 10.1080/00207454.2018.1527329
   Johari M, 2017, EUR J NEUROL, V24, P572, DOI 10.1111/ene.13244
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   Larue S, 2011, J NEUROL NEUROSUR PS, V82, P674, DOI 10.1136/jnnp.2009.190751
   Lilleker JB, 2019, ANN RHEUM DIS, V78, P657, DOI 10.1136/annrheumdis-2018-214644
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lloyd TE, 2014, NEUROLOGY, V83, P426, DOI 10.1212/WNL.0000000000000642
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   Maetzler W, 2011, J NEUROL NEUROSUR PS, V82, P1060, DOI 10.1136/jnnp.2009.197640
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Needham M, 2008, J NEUROL NEUROSUR PS, V79, P1056, DOI 10.1136/jnnp.2007.138891
   Nishino I, 2015, J NEUROL NEUROSUR PS, V86, P385, DOI 10.1136/jnnp-2013-307051
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Phillips BA, 2000, MUSCLE NERVE, V23, P970, DOI 10.1002/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I
   Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076
   Roda RH, 2014, ANN CLIN TRANSL NEUR, V1, P1053, DOI 10.1002/acn3.140
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rothwell S, 2016, ANN RHEUM DIS, V75, P1558, DOI 10.1136/annrheumdis-2015-208119
   Rutkove SB, 2002, NEUROLOGY, V58, P1081, DOI 10.1212/WNL.58.7.1081
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   SAYERS ME, 1992, J RHEUMATOL, V19, P1385
   Tasca G, 2015, MUSCLE NERVE, V52, P956, DOI 10.1002/mus.24661
   Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003
   van der Meulen MFG, 2001, NEUROMUSCULAR DISORD, V11, P447, DOI 10.1016/S0960-8966(00)00219-4
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
   Wilson FC, 2008, J RHEUMATOL, V35, P445
NR 52
TC 2
Z9 2
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD NOV 2
PY 2023
VL 133
IS 11
BP 1211
EP 1217
DI 10.1080/00207454.2020.1763340
EA JUL 2023
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA U8PA5
UT WOS:001031981700001
PM 32364415
DA 2024-11-01
ER

PT J
AU Baslo, SA
   Tekin, B
   Unverengil, GG
   Erdogan, M
   Yusifov, M
   Atakli, D
AF Baslo, Sezin Alpaydin
   Tekin, Betul
   Unverengil, Gokcen Gundogdu
   Erdogan, Mucahid
   Yusifov, Mahir
   Atakli, Dilek
TI Multiple symmetric lipomatosis and MERRF: A case from Turkey
SO NEUROLOGY ASIA
LA English
DT Article
DE lipomatosis; MERRF; mitochondrial disorder; myopathy; MT-TK
ID mitochondrial; prevalence; disorders
AB The association of multiple symmetric lipomatosis (MSL) and mitochondrial disorders is not frequent. We report a male patient with multiple lipomas, hearing loss, progressive limb-girdle muscle weakness, neuropathy and myoclonia. Serum creatinine kinase was mildly elevated. Electromyography revealed sensory axonal polyneuropathy and myopathy with sparse denervation. A muscle biopsy showed ragged-red fibers. Next-generation DNA sequencing revealed a heteroplasmic m.8344A>G mutation in the MT-TK gene. To the best of our knowledge, this is the first patient to be reported from Turkey with a diagnosis of MSL and myoclonic epilepsy with ragged red fibers (MERRF).
C1 [Baslo, Sezin Alpaydin; Tekin, Betul; Erdogan, Mucahid; Yusifov, Mahir; Atakli, Dilek] Univ Hlth Sci, Bakirkoy Prof Dr Mazhar Osman Training & Res Hosp, Dept Neurol, Istanbul, Turkiye.
   [Unverengil, Gokcen Gundogdu] Istanbul Univ, Dept Pathol, Istanbul Fac Med, Istanbul, Turkiye.
C3 University of Health Sciences Turkey; Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital; Istanbul University
RP Baslo, SA (corresponding author), Univ Hlth Sci, Bakirkoy Prof Dr Mazhar Osman Training & Res Hosp, Dept Neurol, Istanbul, Turkiye.
EM sznalpaydin@gmail.com
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519
   Brodie BC, 1846, LECTURES ILLUSTRATIVE OF VARIOUS SUBJECTS IN PATHOLOGY AND SURGERY. M, V0, P275
   Carré F, 2019, EUR ANN OTORHINOLARY, V136, P113, DOI 10.1016/j.anorl.2018.10.015
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chong P Siao Tick, 2003, J CLIN NEUROMUSCUL DIS, V5, P1, DOI 10.1097/00131402-200309000-00001
   Enzi G, 2002, INT J OBESITY, V26, P253, DOI 10.1038/sj.ijo.0801867
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Klopstock T, 1997, MOL CELL BIOCHEM, V174, P271, DOI 10.1023/A:1006877012241
   Launois PE, 1898, B SOC M D H P PARIS, V1, P298
   Madelung OW, 1888, ARCH KLIN CHIR, V37, P106
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Musumeci O, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00160
   Muthusamy K, 2021, ANN NEUROL, V89, P623, DOI 10.1002/ana.25992
   Plummer C, 2013, MITOCHONDRION, V13, P269, DOI 10.1016/j.mito.2013.03.003
   Schutte BC, 1993, GENEREVIEWS(), V0, P0
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ASEAN NEUROLOGICAL ASSOC
PI KUALA LUMPUR
PA UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100, MALAYSIA
SN 1823-6138
EI 
J9 NEUROL ASIA
JI Neurol. Asia
PD DEC 15
PY 2023
VL 28
IS 4
BP 1095
EP 1099
DI 10.54029/2023npx
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA IP0Y8
UT WOS:001167427800038
DA 2024-11-01
ER

PT J
AU Rocha, EBD
   Rodrigues, KD
   Montouro, LAM
   Coelho, EN
   Kouyoumdjian, JA
   Kok, F
   Nóbrega, PR
   Graca, CR
   Morita, MDA
   Estephan, ED
AF Rocha, Emanuelle Bianchi da Silva
   Rodrigues, Ketteny de Lima
   Montouro, Laura Alonso Matheus
   Coelho, erica Nogueira
   Kouyoumdjian, Joao Aris
   Kok, Fernando
   Nobrega, Paulo Ribeiro
   Graca, Carla Renata
   Morita, Maria da Penha Ananias
   Estephan, Eduardo de Paula
TI A case of mitochondrial DNA depletion syndrome type 11-expanding the genotype and phenotype
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial diseases; Chronic progressive external ophthalmoplegia; mtDNA depletion syndrome; MGME1
ID mutations; sequence; mgme1
AB Mitochondrial DNA depletion syndrome type 11 (MTDPS11) is caused by pathogenic variants in MGME1 gene. We report a woman, 40-year-old, who presented slow progressive drop eyelid at 11-year old with, learning difficulty and frequent falls. Phisical examination revealed: mild scoliosis, elbow hyperextensibility, flat feet, chronic progressive external ophthalmoplegia with upper eyelid ptosis, diffuse hypotonia, and weakness of arm abduction and neck flexion. Investigation evidenced mild serum creatine kinase increase and glucose intolerance; second-degree atrioventricular block; mild mixed type respiratory disorder and atrophy and granular appearance of the retinal pigment epithelium. Brain magnetic resonance showed cerebellar atrophy. Muscle biopsy was compatible with mitochondrial myopathy. Genetic panel revealed a homozygous pathogenic variant in the MGME1 gene, consistent with MTDPS11 (c.862C > T; p.Gln288 *). This case of MTDPS11 can contribute to the phenotypic characterization of this ultra-rare mitochondrial disorder, presenting milder respiratory and nutritional involvement than the previously reported cases, with possible additional features.(c) 2023 Elsevier B.V. All rights reserved.
C1 [Rocha, Emanuelle Bianchi da Silva; Rodrigues, Ketteny de Lima; Montouro, Laura Alonso Matheus; Kouyoumdjian, Joao Aris; Graca, Carla Renata; Morita, Maria da Penha Ananias] Fac Estadual Med Sao Jose Do Rio Preto FAMERP, Dept Neurol Sci Psychiat & Med Psychol, Brigadeiro Faria Lima Ave,5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Coelho, erica Nogueira] Fdn Fac Reg Med Sao Jose Do Rio Preto FUNFARME, Dept Neurol Sci Psychiat & Med Psychol, Brigadeiro Faria Lima Ave,5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Kok, Fernando] Univ Sao Paulo FMUSP, Dept Neurol, Fac Med, Ovidio Pires Campos St,225, BR-05403010 Sao Paulo, Brazil.
   [Nobrega, Paulo Ribeiro] Univ Fed Ceara UFC, Dept Neurol, Fac Med, Alexandre Barauna,949, BR-60430160 Fortaleza, CE, Brazil.
   [Estephan, Eduardo de Paula] Hosp Santa Marcelina, Dept Neurol, Sao Paulo, Brazil.
   [Estephan, Eduardo de Paula] Fac Med Santa Marcelina FASM, Dept Med Clin, Sao Paulo, Brazil.
   [Estephan, Eduardo de Paula] Av Dr Eneas Carvalho Aguiar 255,5,Sala 5084, BR-05403900 Sao Paulo, SP, Brazil.
C3 Universidade Federal do Ceara
RP Estephan, ED (corresponding author), Av Dr Eneas Carvalho Aguiar 255,5,Sala 5084, BR-05403900 Sao Paulo, SP, Brazil.
EM eduardo.estephan@santamarcelina.edu.br
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Knizewski L, 2007, BMC STRUCT BIOL, V7, P0, DOI 10.1186/1472-6807-7-40
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382
   Zhu ZH, 2017, ADV EXP MED BIOL, V1038, P219, DOI 10.1007/978-981-10-6674-0_15
NR 10
TC 4
Z9 4
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD AUG 15
PY 2023
VL 33
IS 8
BP 692
EP 696
DI 10.1016/j.nmd.2023.06.004
EA AUG 2023
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA W9CY5
UT WOS:001094547300001
PM 37429773
DA 2024-11-01
ER

PT J
AU Di Pierro, E
   Perrone, M
   Franco, M
   Granata, F
   Duca, L
   Lattuada, D
   De Luca, G
   Graziadei, G
AF Di Pierro, Elena
   Perrone, Miriana
   Franco, Milena
   Granata, Francesca
   Duca, Lorena
   Lattuada, Debora
   De Luca, Giacomo
   Graziadei, Giovanna
TI Mitochondrial DNA Copy Number Drives the Penetrance of Acute Intermittent Porphyria
SO LIFE-BASEL
LA English
DT Article
DE acute intermittent porphyria; heme; mtDNA copy number; mitochondrial biogenesis; PERM1; incomplete penetrance
ID mutations; heme; porphobilinogen; transcription; biogenesis; muscle; model
AB No published study has investigated the mitochondrial count in patients suffering from acute intermittent porphyria (AIP). In order to determine whether mitochondrial content can influence the pathogenesis of porphyria, we measured the mitochondrial DNA (mtDNA) copy number in the peripheral blood cells of 34 patients and 37 healthy individuals. We found that all AIP patients had a low number of mitochondria, likely as a result of a protective mechanism against an inherited heme synthesis deficiency. Furthermore, we identified a close correlation between disease penetrance and decreases in the mitochondrial content and serum levels of PERM1, a marker of mitochondrial biogenesis. In a healthy individual, mitochondrial count is usually modulated to fit its ability to respond to various environmental stressors and bioenergetic demands. In AIP patients, coincidentally, the phenotype only manifests in response to endogenous and exogenous triggers factors. Therefore, these new findings suggest that a deficiency in mitochondrial proliferation could affect the individual responsiveness to stimuli, providing a new explanation for the variability in the clinical manifestations of porphyria. However, the metabolic and/or genetic factors responsible for this impairment remain to be identified. In conclusion, both mtDNA copy number per cell and mitochondrial biogenesis seem to play a role in either inhibiting or promoting disease expression. They could serve as two novel biomarkers for porphyria.
C1 [Di Pierro, Elena; Perrone, Miriana; Granata, Francesca; Duca, Lorena; Lattuada, Debora; Graziadei, Giovanna] Fdn IRCCS CaGranda Osped Maggiore Policlin, I-20122 Milan, Italy.
   [Franco, Milena] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [De Luca, Giacomo] Univ Milan, Sch Internal Med, I-20122 Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pavia; University of Milan
RP Di Pierro, E (corresponding author), Fdn IRCCS CaGranda Osped Maggiore Policlin, I-20122 Milan, Italy.
EM elena.dipierro@policlinico.mi.it; labporfirie@policlinico.mi.it; milena.franco01@universitadipavia.it; francesca.granata@policlinico.mi.it; lorena.duca@policlinico.mi.it; debora.lattuada@policlinico.mi.it; giacomodeluca29@gmail.com; giovanna.graziadei@policlinico.mi.it
FU The authors are grateful to all patients and healthy subjects who donated samples for this study. We also thank the administrative and nursing team for their support in sample collection.
CR Atamna H, 2002, ARCH BIOCHEM BIOPHYS, V397, P345, DOI 10.1006/abbi.2001.2671
   Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799
   Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200
   Bissell DM, 2017, NEW ENGL J MED, V377, P862, DOI 10.1056/NEJMra1608634
   Bissell DM, 2015, J CLIN TRANSL HEPATO, V3, P17, DOI 10.14218/JCTH.2014.00039
   Bonkovsky HL, 2014, AM J MED, V127, P1233, DOI 10.1016/j.amjmed.2014.06.036
   Chen B, 2019, MOL GENET METAB, V128, P382, DOI 10.1016/j.ymgme.2018.12.010
   Chen B, 2016, HUM MUTAT, V37, P1215, DOI 10.1002/humu.23067
   Chien MC, 2012, GENET MOL RES, V11, P3339, DOI 10.4238/2012.September.17.4
   Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Di Pierro E, 2021, DIAGNOSTICS, V11, P0, DOI 10.3390/diagnostics11081343
   Di Pierro E, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21103462
   Dixon N, 2019, MOL GENET METAB, V128, P228, DOI 10.1016/j.ymgme.2019.05.010
   Elder G, 2013, J INHERIT METAB DIS, V36, P849, DOI 10.1007/s10545-012-9544-4
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Mehta RKG, 2021, MUSCLE NERVE, V64, P140, DOI 10.1002/mus.27232
   Gonzalez-Mosquera L F, 2023, ACUTE INTERMITTENT P, V0, P0
   Gouya L, 2020, HEPATOLOGY, V71, P1546, DOI 10.1002/hep.30936
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   He YH, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.01.015
   Homedan C, 2015, HUM MOL GENET, V24, P5015, DOI 10.1093/hmg/ddv222
   Homedan C, 2014, INT J BIOCHEM CELL B, V51, P93, DOI 10.1016/j.biocel.2014.03.032
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Karim Z, 2015, CLIN RES HEPATOL GAS, V39, P412, DOI 10.1016/j.clinre.2015.05.009
   Kazamel M, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.1004125
   Kazamel M, 2020, CURR NEUROL NEUROSCI, V20, P0, DOI 10.1007/s11910-020-01078-8
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Kothadia JP, 2023, ACUTE HEPATIC PORPHYRIA, V0, P0
   Kozhukhar N, 2023, BIOLOGY-BASEL, V12, P0, DOI 10.3390/biology12060823
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Lenglet H, 2018, HUM MOL GENET, V27, P1164, DOI 10.1093/hmg/ddy030
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Liu H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067146
   Longchamps RJ, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0228166
   Ma LY, 2020, INTRACTABLE RARE DIS, V9, P196, DOI 10.5582/irdr.2020.03082
   Marsden JT, 2014, J CLIN PATHOL, V67, P60, DOI 10.1136/jclinpath-2012-201367
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nordmann Y, 1997, J INTERN MED, V242, P213, DOI 10.1046/j.1365-2796.1997.00189.x
   Phillips JD, 2019, MOL GENET METAB, V128, P164, DOI 10.1016/j.ymgme.2019.04.008
   Pischik E, 2009, CELL MOL BIOL, V55, P72
   Pischik E, 2015, APPL CLIN GENET, V8, P201, DOI 10.2147/TACG.S48605
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Popov LD, 2020, J CELL MOL MED, V24, P4892, DOI 10.1111/jcmm.15194
   Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Sardh E, 2022, J INTERN MED, V291, P593, DOI 10.1111/joim.13443
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Stein PE, 2023, J INHERIT METAB DIS, V46, P662, DOI 10.1002/jimd.12612
   Storjord E, 2019, MOL GENET METAB, V128, P254, DOI 10.1016/j.ymgme.2018.12.006
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Venegas Victor, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1907s68
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wang B, 2019, HEPATOL COMMUN, V3, P193, DOI 10.1002/hep4.1297
   Yasuda M, 2019, MOL GENET METAB, V128, P320, DOI 10.1016/j.ymgme.2018.11.012
   Yau WW, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21083020
   Zhang GJ, 2013, DIAGN PATHOL, V8, P0, DOI 10.1186/1746-1596-8-173
NR 63
TC 3
Z9 3
U1 3
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD SEP 15
PY 2023
VL 13
IS 9
BP 
EP 
DI 10.3390/life13091923
PG 12
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA S5QY2
UT WOS:001071722200001
PM 37763326
DA 2024-11-01
ER

PT J
AU Borgione, E
   Lo Giudice, M
   Santa Paola, S
   Giuliano, M
   Di Blasi, FD
   Di Stefano, V
   Lupica, A
   Brighina, F
   Pettinato, R
   Romano, C
   Scuderi, C
AF Borgione, Eugenia
   Lo Giudice, Mariangela
   Santa Paola, Sandro
   Giuliano, Marika
   Di Blasi, Francesco Domenico
   Di Stefano, Vincenzo
   Lupica, Antonino
   Brighina, Filippo
   Pettinato, Rosa
   Romano, Corrado
   Scuderi, Carmela
TI The Mitochondrial tRNA<SUP>Ser(UCN)</SUP> Gene: A Novel m.7484A&gt;G Mutation Associated with Mitochondrial Encephalomyopathy and Literature Review
SO LIFE-BASEL
LA English
DT Review
DE mitochondrial DNA; tRNA(Ser(UCN)); homoplasmic mutation; encephalomyopathy
ID inherited hearing-loss; point mutation; palmoplantar keratoderma; coi/trna(ser(ucn)) genes; 7472insc mutation; chinese pedigrees; g7444a mutation; lactic-acidosis; a1555g mutation; anticodon swap
AB Mitochondrial tRNA(Ser(UCN)) is considered a hot-spot for non-syndromic and aminoglycoside-induced hearing loss. However, many patients have been described with more extensive neurological diseases, mainly including epilepsy, myoclonus, ataxia, and myopathy. We describe a novel homoplasmic m.7484A>G mutation in the tRNA(Ser(UCN)) gene affecting the third base of the anticodon triplet in a girl with profound intellectual disability, spastic tetraplegia, sensorineural hearing loss, a clinical history of epilepsia partialis continua and vomiting, typical of MELAS syndrome, leading to a myoclonic epilepticus status, and myopathy with severe COX deficiency at muscle biopsy. The mutation was also found in the homoplasmic condition in the mother who presented with mild cognitive deficit, cerebellar ataxia, myoclonic epilepsy, sensorineural hearing loss and myopathy with COX deficient ragged-red fibers consistent with MERRF syndrome. This is the first anticodon mutation in the tRNA(Ser(UCN)) and the second homoplasmic mutation in the anticodon triplet reported to date.
C1 [Borgione, Eugenia; Lo Giudice, Mariangela; Santa Paola, Sandro; Giuliano, Marika; Scuderi, Carmela] Oasi Res Inst IRCCS, Unit Neuromuscular Dis, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Di Blasi, Francesco Domenico] Oasi Res Inst IRCCS, Unit Psychol, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Di Stefano, Vincenzo; Lupica, Antonino; Brighina, Filippo] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Unit Neurophysiopathol, I-90129 Palermo, Italy.
   [Pettinato, Rosa] Oasi Res Inst IRCCS, Unit Pediat & Med Genet, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Romano, Corrado] Oasi Res Inst IRCCS, Res Unit Rare Dis & Neurodev Disorders, Via Conte Ruggero 73, I-94018 Troina, Italy.
   [Romano, Corrado] Univ Catania, Dept Biomed & Biotechnol Sci, Sect Med Biochem, Med Genet, I-95123 Catania, Italy.
C3 University of Palermo; University of Catania
RP Di Stefano, V (corresponding author), Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Unit Neurophysiopathol, I-90129 Palermo, Italy.
EM vincenzo19689@gmail.com
FU Italian Ministry of Health [RC2022]
CR Abu-Amero EK, 2006, J CHILD NEUROL, V21, P971, DOI 10.2310/7010.2006.00208
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Bacalhau M, 2018, NEUROMUSCULAR DISORD, V28, P350, DOI 10.1016/j.nmd.2017.11.006
   Bidooki S, 2004, NEUROMUSCULAR DISORD, V14, P417, DOI 10.1016/j.nmd.2004.03.004
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Cardaioli E, 2006, NEUROMUSCULAR DISORD, V16, P26, DOI 10.1016/j.nmd.2005.11.001
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Chen J, 2008, MITOCHONDRION, V8, P285, DOI 10.1016/j.mito.2008.05.002
   Chen Z, 2019, J GENET GENOMICS, V46, P201, DOI 10.1016/j.jgg.2019.03.009
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Ding Y, 2017, AM J TRANSL RES, V9, P2984
   Fetoni V, 2004, NEUROMUSCULAR DISORD, V14, P723, DOI 10.1016/j.nmd.2004.07.002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Grafakou O, 2003, J INHERIT METAB DIS, V26, P593, DOI 10.1023/A:1025960300710
   Hutchin TP, 2001, J MED GENET, V38, P229, DOI 10.1136/jmg.38.4.229
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Imasawa T, 2014, RENAL FAILURE, V36, P1461, DOI 10.3109/0886022X.2014.945181
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Jiang PF, 2020, BIOSCIENCE REP, V40, P0, DOI 10.1042/BSR20201856
   Lindberg C, 2008, ACTA NEUROL SCAND, V117, P128, DOI 10.1111/j.1600-0404.2007.00913.x
   Liu YQ, 2014, BMC MED GENOMICS, V7, P0, DOI 10.1186/s12920-014-0073-x
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Martin L, 2000, BRIT J DERMATOL, V143, P876, DOI 10.1046/j.1365-2133.2000.03797.x
   McCann BJ, 2015, NEUROMUSCULAR DISORD, V25, P262, DOI 10.1016/j.nmd.2014.11.002
   Mkaouar-Rebai E, 2013, BIOCHEM BIOPH RES CO, V430, P585, DOI 10.1016/j.bbrc.2012.11.109
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Müller T, 2005, ACTA NEUROPATHOL, V110, P426, DOI 10.1007/s00401-005-1063-z
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121
   Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Peng W, 2020, MOL MED REP, V22, P77, DOI 10.3892/mmr.2020.11100
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Ramelli GP, 2006, J CHILD NEUROL, V21, P253, DOI 10.2310/7010.2006.00047
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Riley LG, 2020, GENET MED, V22, P1254, DOI 10.1038/s41436-020-0793-6
   Roos S, 2013, EUR J HUM GENET, V21, P571, DOI 10.1038/ejhg.2012.153
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   SCHULMAN LH, 1991, PROG NUCLEIC ACID RE, V41, P23
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.0.CO;2-M
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Souilem S, 2010, DIAGN MOL PATHOL, V19, P28, DOI 10.1097/PDM.0b013e3181b00f02
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001
   Tang XW, 2010, MOL GENET METAB, V100, P57, DOI 10.1016/j.ymgme.2010.01.008
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200
   Uehara DT, 2010, GENET TEST MOL BIOMA, V14, P611, DOI 10.1089/gtmb.2010.0011
   Wong LJC, 2020, GENET MED, V0, P0, DOI DOI 10.1038/s41436-019-0746-0
   Wong LJC, 2002, CLIN CHEM, V48, P1901
   Yan CJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040379
   Yang P, 2020, IRISH J MED SCI, V189, P489, DOI 10.1007/s11845-019-02143-z
   Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952
   Yuan H, 2007, BIOCHEM BIOPH RES CO, V362, P94, DOI 10.1016/j.bbrc.2007.07.161
   Zanssen S, 1997, MOL CELL BIOCHEM, V174, P231, DOI 10.1023/A:1006864709515
   Zaragoza MV, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012295
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
   Zhao Han-Yue, 2008, YICHUAN, V30, P1557, DOI 10.3724/SP.J.1005.2008.01557
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
   Zhu Y, 2006, BIOCHEM BIOPH RES CO, V342, P843, DOI 10.1016/j.bbrc.2006.02.027
NR 69
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD FEB 15
PY 2023
VL 13
IS 2
BP 
EP 
DI 10.3390/life13020554
PG 16
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA 9J3OQ
UT WOS:000940100900001
PM 36836911
DA 2024-11-01
ER

PT J
AU Trayford, C
   Wilhalm, A
   Habibovic, P
   Smeets, H
   van Tienen, F
   van Rijt, S
AF Trayford, Chloe
   Wilhalm, Alissa
   Habibovic, Pamela
   Smeets, Hubert
   van Tienen, Florence
   van Rijt, Sabine
TI One-pot, degradable, silica nanocarriers with encapsulated oligonucleotides for mitochondrial specific targeting
SO DISCOVER NANO
LA English
DT Article
DE Intracellular degradation; Mitochondria targeting; Hollow silica nanoparticles; Large pore silica nanoparticles; Anti-gene therapy
ID mito-porter; nanoparticles; delivery; nanospheres; carrier; functionalization; transfection; glutathione; system
AB Mutations in nuclear and mitochondrial genes are responsible for severe chronic disorders such as mitochondrial myopathies. Gene therapy using antisense oligonucleotides is a promising strategy to treat mitochondrial DNA (mtDNA) diseases by blocking the replication of the mutated mtDNA. However, transport vehicles are needed for intracellular, mitochondria-specific transport of oligonucleotides. Nanoparticle (NP) based vectors such as large pore mesoporous silica nanoparticles (LP) often rely on surface complexation of oligonucleotides exposing them to nucleases and limiting mitochondria targeting and controlled release ability. In this work, stable, fluorescent, hollow silica nanoparticles (HSN) that encapsulate and protect oligonucleotides in the hollow core were synthesized by a facile one-pot procedure. Both rhodamine B isothiocyanate and bis[3-(triethoxysilyl)propyl]tetrasulfide were incorporated in the HSN matrix by co-condensation to enable cell tracing, intracellular-specific degradation and controlled oligonucleotide release. We also synthesized LP as a benchmark to compare the oligonucleotide loading and release efficacy of our HSN. Mitochondria targeting was enabled by NP functionalization with cationic, lipophilic Triphenylphosphine (TPP) and, for the first time a fusogenic liposome based carrier, previously reported under the name MITO-Porter. HSN exhibited high oligonucleotide incorporation ratios and release dependent on intracellular degradation. Further, MITO-Porter capping of our NP enabled delayed, glutathione (GSH) responsive oligonucleotide release and mitochondria targeting at the same efficiency as TPP functionalized NP. Overall, our NP are promising vectors for anti-gene therapy of mtDNA disease as well as many other monogenic disorders worldwide.
C1 [Trayford, Chloe; Wilhalm, Alissa; Habibovic, Pamela; van Rijt, Sabine] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Dept Instruct Biomat Engn, POB 616, NL-6200 MD Maastricht, Netherlands.
   [Wilhalm, Alissa; Smeets, Hubert; van Tienen, Florence] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Toxicogen, POB 616, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University
RP van Rijt, S (corresponding author), Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Dept Instruct Biomat Engn, POB 616, NL-6200 MD Maastricht, Netherlands.; van Tienen, F (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Toxicogen, POB 616, NL-6200 MD Maastricht, Netherlands.
EM florence.vantienen@maastrichtuniversity.nl; s.vanrijt@maastrichtuniversity.nl
FU ZonMw TOP [91217058]; Netherlands Organization for Health Research and Development; United for Metabolic Diseases; Maastricht multimodal molecular imaging Institute
CR Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896
   Ahn J, 2018, J MATER CHEM B, V6, P0, DOI 10.1039/c8tb01358f
   Amin MU, 2021, EUR J PHARM BIOPHARM, V165, P31, DOI 10.1016/j.ejpb.2021.04.020
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X
   Bavnhoj CG, 2019, INT J PHARM-X, V1, P0, DOI 10.1016/j.ijpx.2019.100008
   Blechinger J, 2013, SMALL, V9, P3970, DOI 10.1002/smll.201301004
   Cauda V, 2010, NANO LETT, V10, P2484, DOI 10.1021/nl100991w
   Chaiyana W, 2014, INT J PHARM PHARM SCI, V7, P213
   Chang FP, 2014, SMALL, V10, P4785, DOI 10.1002/smll.201401559
   Chang FP, 2014, ACS APPL MATER INTER, V6, P6883, DOI 10.1021/am500701c
   Chen LJ, 2018, NANOMEDICINE-UK, V13, P1939, DOI 10.2217/nnm-2018-0076
   Chen WD, 2020, CHEMMEDCHEM, V15, P1940, DOI 10.1002/cmdc.202000263
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004
   Ding BB, 2019, NANOSCALE, V11, P14654, DOI 10.1039/c9nr04858h
   Durfee PN, 2016, ACS NANO, V10, P8325, DOI 10.1021/acsnano.6b02819
   El-Sayed A, 2008, J BIOL CHEM, V283, P23450, DOI 10.1074/jbc.M709387200
   Encinas N, 2019, ACTA BIOMATER, V84, P317, DOI 10.1016/j.actbio.2018.12.012
   Fan WP, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09158-1
   Fisichella M, 2010, J NANOSCI NANOTECHNO, V10, P2314, DOI 10.1166/jnn.2010.1917
   Gao F, 2009, J PHYS CHEM B, V113, P1796, DOI 10.1021/jp807956r
   Gonçalves C, 2004, MOL THER, V10, P373, DOI 10.1016/j.ymthe.2004.05.023
   Grogg M, 2018, HELV CHIM ACTA, V101, P0, DOI 10.1002/hlca.201800112
   Guo KL, 2019, J GENE MED, V21, P0, DOI 10.1002/jgm.3084
   Guo ZY, 2020, ACS APPL MATER INTER, V12, P18823, DOI 10.1021/acsami.0c00596
   Han X, 2019, ASIAN J PHARM SCI, V14, P569, DOI 10.1016/j.ajps.2018.06.006
   Hartono SB, 2014, NANOTECHNOLOGY, V25, P0, DOI 10.1088/0957-4484/25/5/055701
   Hosseinpour S, 2021, J MATER CHEM B, V9, P2275, DOI 10.1039/d0tb02756a
   Huang P, 2017, BIOMATERIALS, V125, P23, DOI 10.1016/j.biomaterials.2017.02.018
   Ibragimova AR, 2021, INT J PHARMACEUT, V604, P0, DOI 10.1016/j.ijpharm.2021.120776
   Jatupaiboon N, 2015, J MATER CHEM B, V3, P3130, DOI 10.1039/c5tb00194c
   Kawamura E, 2013, MITOCHONDRION, V13, P610, DOI 10.1016/j.mito.2013.08.010
   Kulkarni CA, 2021, J MED CHEM, V64, P662, DOI 10.1021/acs.jmedchem.0c01671
   Kurtz-Chalot A, 2017, MAT SCI ENG C-MATER, V75, P16, DOI 10.1016/j.msec.2017.02.028
   Kwon D, 2017, NANO LETT, V17, P2747, DOI 10.1021/acs.nanolett.6b04130
   LaBauve AE, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-32033-w
   Li ZY, 2020, J CONTROL RELEASE, V322, P622, DOI 10.1016/j.jconrel.2020.03.021
   Lin CH, 2015, NANOSCALE, V7, P9614, DOI 10.1039/c5nr01395j
   Lin XY, 2018, ACTA BIOMATER, V76, P178, DOI 10.1016/j.actbio.2018.07.007
   Ma X, 2013, CHEM-EUR J, V19, P15593, DOI 10.1002/chem.201302736
   Mandrup OA, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep42230
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI 10.1089/ars.2009.2695
   Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109
   Mudakavi RJ, 2014, RSC ADV, V4, P61160, DOI 10.1039/c4ra12973c
   Nakamura T, 2015, MOL PHARMACEUT, V12, P2791, DOI 10.1021/mp500704e
   Niu DC, 2014, ADV MATER, V26, P4947, DOI 10.1002/adma.201400815
   Qu GJ, 2022, ACS APPL MATER INTER, V14, P2023, DOI 10.1021/acsami.1c21109
   Rahmani S, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24020332
   Rosenbrand R, 2018, INT J NANOMED, V13, P7711, DOI 10.2147/IJN.S182428
   Shahabi S, 2015, ACS APPL MATER INTER, V7, P26880, DOI 10.1021/acsami.5b09483
   Shirley JL, 2020, MOL THER, V28, P709, DOI 10.1016/j.ymthe.2020.01.001
   Smith SA, 2019, BIOCONJUGATE CHEM, V30, P263, DOI 10.1021/acs.bioconjchem.8b00732
   Solberg SM, 2006, J PHYS CHEM B, V110, P15261, DOI 10.1021/jp061691+
   Soldatov VO, 2022, J TRANSL MED, V20, P0, DOI 10.1186/s12967-022-03685-0
   Tonlorenzi Rossana, 2007, CURR PROTOC STEM CELL BIOL, VChapter 2, P0, DOI 10.1002/9780470151808.sc02b01s3
   Trayford C, 2022, ACS APPL NANO MATER, V5, P3237, DOI 10.1021/acsanm.1c03640
   van Tienen F, 2019, STEM CELL RES THER, V10, P0, DOI 10.1186/s13287-019-1510-8
   Wang DD, 2014, ACS APPL MATER INTER, V6, P12600, DOI 10.1021/am502585x
   Wang K, 2016, PHARMACOL RES, V114, P56, DOI 10.1016/j.phrs.2016.10.016
   Wang T, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23102564
   Wu MY, 2015, ADV MATER, V27, P215, DOI 10.1002/adma.201404256
   Xiong L, 2016, SMALL, V12, P4735, DOI 10.1002/smll.201600531
   Xiong L, 2015, SMALL, V11, P5919, DOI 10.1002/smll.201501056
   Yamada Y, 2023, HANDB EXP PHARMACOL, V0, P0
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Zhan ZW, 2017, MATERIALS, V10, P0, DOI 10.3390/ma10070731
   Zhang XD, 2016, J MATER CHEM B, V4, P3916, DOI 10.1039/c6tb00454g
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 71
TC 1
Z9 1
U1 6
U2 12
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 
EI 2731-9229
J9 DISCOV NANO
JI Discov. Nano.
PD DEC 21
PY 2023
VL 18
IS 1
BP 
EP 
DI 10.1186/s11671-023-03926-1
PG 16
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA CS3R1
UT WOS:001127195900001
PM 38127184
DA 2024-11-01
ER

PT J
AU Tyagi, SC
   Pushpakumar, S
   Sen, U
   Akinterinwa, OE
   Zheng, YT
   Mokshagundam, SPL
   Kalra, DK
   Singh, M
AF Tyagi, Suresh C.
   Pushpakumar, Sathnur
   Sen, Utpal
   Akinterinwa, Oluwaseun E.
   Zheng, Yuting
   Mokshagundam, Sri Prakash L.
   Kalra, Dinesh K.
   Singh, Mahavir
TI Role of circadian clock system in the mitochondrial trans-sulfuration pathway and tissue remodeling
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article; Early Access
DE circadian clock; folate 1-carbon metabolism; trans-sulfuration pathway
ID cystathionine beta-synthase; blood-pressure variation; hydrogen-sulfide; dna methylation; homocysteine; risk; dysfunction; expression; disease; mmp-13
AB Previous studies from our laboratory revealed that the gaseous molecule hydrogen sulfide (H2S), a metabolic product of epigenetics, involves trans-sulfuration pathway for ensuring metabolism and clearance of homocysteine (Hcy) from body, thereby mitigating the skeletal muscle's pathological remodeling. Although the master circadian clock regulator that is known as brain and muscle aryl hydrocarbon receptor nuclear translocator like protein 1 (i.e., BMAL 1) is associated with S-adenosylhomocysteine hydrolase (SAHH) and Hcy metabolism but how trans-sulfuration pathway is influenced by the circa-dian clock remains unexplored. We hypothesize that alterations in the functioning of circadian clock during sleep and wake cycle affect skeletal muscle's biology. To test this hypothesis, we measured serum matrix metalloproteinase (MMP) activities using gelatin gels for analyzing the MMP-2 and MMP-9. Further, employing casein gels, we also studied MMP-13 that is known to be influenced by the growth arrest and DNA damage-45 (GADD45) protein during sleep and wake cycle. The wild type and cys-tathionine beta synthase-deficient (CBS-/+) mice strains were treated with H2S and subjected to measurement of trans-sulfuration factors from skeletal muscle tissues. The results suggested highly robust activation of MMPs in the wake mice versus sleep mice, which appears somewhat akin to the "1-carbon metabolic dysregulation", which takes place during remodeling of extracellu-lar matrix during muscular dystrophy. Interestingly, the levels of trans-sulfuration factors such as CBS, cystathionine gamma lyase (CSE), methyl tetrahydrofolate reductase (MTHFR), phosphatidylethanolamine N-methyltransferase (PEMT), and Hcy-protein bound paraoxonase 1 (PON1) were attenuated in CBS-/+ mice. However, treatment with H2S mitigated the attenuation of the trans-sulfuration pathway. In addition, levels of mitochondrial peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC 1-alpha) and mitofusin-2 (MFN-2) were significantly improved by H2S intervention. Our findings suggest participation of the circadian clock in trans-sulfuration pathway that affects skeletal muscle remodeling and mitochondrial regeneration.
C1 [Tyagi, Suresh C.; Pushpakumar, Sathnur; Sen, Utpal; Akinterinwa, Oluwaseun E.; Zheng, Yuting; Singh, Mahavir] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA.
   [Mokshagundam, Sri Prakash L.] Univ Louisville, Div Endocrinol Metab & Diabet, Sch Med, Louisville, KY 40202 USA.
   [Mokshagundam, Sri Prakash L.] Univ Louisville, Robley Rex VA Med Ctr, Sch Med, Louisville, KY 40202 USA.
   [Kalra, Dinesh K.] Univ Louisville, Sch Med, Div Cardiovasc Med, Louisville, KY 40202 USA.
C3 University of Louisville; University of Louisville; University of Louisville; University of Louisville
RP Singh, M (corresponding author), Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA.
EM mahavir.singh@louisville.edu
FU NIH [HL-139047, DK116591, AR-71789]
CR Adamovich Y, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2101115118
   Agrawal A, 2018, J CELL COMMUN SIGNAL, V12, P645, DOI 10.1007/s12079-018-0477-z
   Albano C, 2020, FEMS MICROBIOL LETT, V367, P0, DOI 10.1093/femsle/fnaa059
   Amarnath K, 2003, TALANTA, V60, P1229, DOI 10.1016/S0039-9140(03)00232-7
   Anea CB, 2010, ARTERIOSCL THROM VAS, V30, P2535, DOI 10.1161/ATVBAHA.110.214379
   Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003
   Baribault C, 2018, EPIGENETICS-US, V13, P275, DOI 10.1080/15592294.2018.1445900
   Bremner WF, 2000, AM J CARDIOL, V86, P1153, DOI 10.1016/S0002-9149(00)01181-4
   Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882
   Chen JL, 2017, P NATL ACAD SCI USA, V114, PE5266, DOI 10.1073/pnas.1620013114
   Covic A, 2000, AM J KIDNEY DIS, V35, P617, DOI 10.1016/S0272-6386(00)70007-2
   Day K, 2013, GENOME BIOL, V14, P0, DOI 10.1186/gb-2013-14-9-r102
   Dong YF, 2018, AM J HYPERTENS, V31, PE3, DOI 10.1093/ajh/hpy015
   Dong YF, 2017, AM J HYPERTENS, V30, P1203, DOI 10.1093/ajh/hpx116
   Ellwood RA, 2022, COMMUN BIOL, V5, P0, DOI 10.1038/s42003-022-04212-z
   Ellwood RA, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2018342118
   Gbadegesin MA, 2010, GENET MOL RES, V9, P639, DOI 10.4238/vol9-2gmr713
   Gensous N, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00996
   Greco CM, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.abc5629
   Griñán R, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232012452
   Gwon D, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21072352
   Habibe JJ, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10102611
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Horvath S, 2013, GENOME BIOL, V14, P0, DOI 10.1186/gb-2013-14-10-r115
   Hughes JR, 2009, EPILEPSY BEHAV, V15, P92, DOI 10.1016/j.yebeh.2009.02.037
   Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200
   Jacques M, 2019, EPIGENETICS-US, V14, P633, DOI 10.1080/15592294.2019.1614416
   Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E
   King AL, 2014, P NATL ACAD SCI USA, V111, P3182, DOI 10.1073/pnas.1321871111
   Kishi T, 2001, HYPERTENSION, V38, P896, DOI 10.1161/hyp.38.4.896
   Laha A, 2019, CAN J PHYSIOL PHARM, V97, P1013, DOI 10.1139/cjpp-2019-0227
   Laker RC, 2016, STEM CELLS INT, V2016, P0, DOI 10.1155/2016/5725927
   Lei HQ, 2013, AM J PHYSIOL-CELL PH, V305, PC529, DOI 10.1152/ajpcell.00051.2013
   Majumder A, 2019, CAN J PHYSIOL PHARM, V97, P441, DOI 10.1139/cjpp-2018-0501
   Majumder A, 2018, PHYSIOL REP, V6, P0, DOI 10.14814/phy2.13858
   Majumder A, 2018, AM J PHYSIOL-CELL PH, V315, PC609, DOI 10.1152/ajpcell.00147.2018
   Majumder A, 2017, J CELL BIOCHEM, V118, P2108, DOI 10.1002/jcb.25841
   Meléndez-Fernández OH, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11060883
   Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491
   Moshal KS, 2007, CURR NEUROVASC RES, V4, P289, DOI 10.2174/156720207782446324
   Murphy B, 2019, FASEB J, V33, P13098, DOI 10.1096/fj.201901304R
   Oh G, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0946-8
   Paul BD, 2021, REDOX BIOL, V38, P0, DOI 10.1016/j.redox.2020.101772
   Potabattula R, 2022, AGING-US, V14, P1214, DOI 10.18632/aging.203891
   Qipshidze N, 2011, J CELL PHYSIOL, V226, P2712, DOI 10.1002/jcp.22621
   Rabinovich-Nikitin I, 2023, CAN J CARDIOL, V39, P1772, DOI 10.1016/j.cjca.2023.08.022
   Rabinovich-Nikitin I, 2022, CAN J PHYSIOL PHARM, V0, P0, DOI DOI 10.1139/cjpp-2022-0222
   Rabinovich-Nikitin I, 2024, TRENDS CARDIOVAS MED, V34, P1, DOI 10.1016/j.tcm.2022.09.003
   Rahman FA, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21134575
   Rivers JR, 2012, EXPERT OPIN THER TAR, V16, P439, DOI 10.1517/14728222.2012.673591
   Rodrigo GC, 2016, EXP PHYSIOL, V101, P1030, DOI 10.1113/EP085780
   ROSANSKY SJ, 1995, AM J KIDNEY DIS, V26, P716, DOI 10.1016/0272-6386(95)90433-6
   Sellami M, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.652497
   Sincennes MC, 2016, STEM CELL TRANSL MED, V5, P282, DOI 10.5966/sctm.2015-0266
   Singh M, 2022, PHYSIOL REP, V10, P0, DOI 10.14814/phy2.15422
   Singh M, 2021, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.617953
   Singh M, 2021, CAN J PHYSIOL PHARM, V99, P56, DOI 10.1139/cjpp-2020-0093
   Smith Lucas R, 2020, CELL PHYSIOL BIOCHEM, V54, P333, DOI 10.33594/000000223
   Soni CV, 2016, CELL BIOCHEM BIOPHYS, V74, P59, DOI 10.1007/s12013-015-0711-8
   Theilen NT, 2019, ARCH BIOCHEM BIOPHYS, V666, P138, DOI 10.1016/j.abb.2018.12.015
   Tsuda K, 2018, AM J HYPERTENS, V31, PE1, DOI 10.1093/ajh/hpy002
   Tyagi SC, 1999, CLIN EXP HYPERTENS, V21, P181, DOI 10.3109/10641969909068660
   Tyagi SC, 2021, MOL CELL BIOCHEM, V476, P507, DOI 10.1007/s11010-020-03895-4
   UNGER T, 1984, CIRC RES, V54, P30, DOI 10.1161/01.RES.54.1.30
   Veerabhadrappa P, 2017, AM J HYPERTENS, V30, P1151, DOI 10.1093/ajh/hpx141
   Veeranki S, 2015, BBA-MOL BASIS DIS, V1852, P732, DOI 10.1016/j.bbadis.2015.01.008
   Verhamme FM, 2015, AM J RESP CELL MOL, V52, P653, DOI 10.1165/rcmb.2014-0282RT
   Wang J, 2019, CANCER CELL INT, V19, P0, DOI 10.1186/s12935-019-0902-2
   Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011
   WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585
   Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134
   Yang YL, 2021, NUCLEIC ACIDS RES, V49, P1313, DOI 10.1093/nar/gkaa1203
   Yu HX, 2018, ARTERIOSCL THROM VAS, V38, P555, DOI 10.1161/ATVBAHA.117.310502
   Zhang QQ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074422
   Zhang XY, 2020, NAT METAB, V2, P991, DOI 10.1038/s42255-020-00291-6
   Zhang XY, 2020, NAT METAB, V2, P110, DOI 10.1038/s42255-019-0162-4
   Zhao P, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1951-0
NR 77
TC 0
Z9 0
U1 0
U2 5
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD DEC 21
PY 2023
VL 0
IS 
BP 
EP 
DI 10.1139/cjpp-2023-0186
EA DEC 2023
PG 11
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA CY5V8
UT WOS:001128815000001
PM 37979203
DA 2024-11-01
ER

PT J
AU Almarzooqi, F
   Vallance, H
   Mezei, MM
   Lehman, A
   Horvath, G
   Rakic, B
   Zypchen, L
   Mattman, A
AF Almarzooqi, Farida
   Vallance, Hilary
   Mezei, Michelle M.
   Lehman, Anna
   Horvath, Gabriella
   Rakic, Bojana
   Zypchen, Leslie
   Mattman, Andre
TI Macrocytosis in Mitochondrial DNA Deletion Syndromes
SO ACTA HAEMATOLOGICA
LA English
DT Article
ID disease
AB Large single mtDNA (mitochondrial DNA) deletion syndrome is a rare inborn error of metabolism with variable heteroplasmy levels and clinical phenotype among affected individuals. Chronic progressive external ophthalmoplegia (CPEO) is the most common phenotype in adults with this form of mitochondrial disease [1-2]. The common CPEO clinical manifestations are ptosis and ophthalmoplegia. More variable phenotypic manifestations of CPEO (CPEO plus) include involvement of the peripheral nervous system and myopathy. Here, we describe a 62-year-old female with CPEO and the major mitochondrial DNA deletion present at 40% heteroplasmy, who had a coexistent previously undescribed CPEO phenotypic feature of persistent unexplained macrocytosis without anemia. Building on this case, we reviewed other major mtDNA deletion cases seen in our Adult Metabolic Diseases Clinic (AMDC) at the University of British Columbia, Vancouver, Canada from 2016 to 2022. The major mtDNA deletion cases (n=26) were compared with mtDNA missense variants identified in the clinic over the same period who acted as the comparison group (n=16). Of these, the most frequent diagnosis was maternally inherited diabetes and deafness (MIDD) and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). Ten out of 26 (38%) of mtDNA deletion patients had macrocytosis with elevated MCV (mean corpuscular volume), median (IQR, interquartile range) of 108fl (102-114fl). Seven of the patients with macrocytosis had no pertinent etiology. None of the comparison group had macrocytosis. There was a significant difference (P=0.000) between the MCV & MCH in the mtDNA deletion group compared to the comparison group. This communication sheds light on the association of macrocytosis with the mtDNA deletion syndrome. It would be of great interest to determine if the association is found in other mitochondrial disease clinic populations.
C1 [Almarzooqi, Farida] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Almarzooqi, Farida] UAE Univ, Coll Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates.
   [Almarzooqi, Farida; Rakic, Bojana] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Mezei, Michelle M.] Univ British Columbia, Vancouver Gen Hosp, Adult Metab Dis Clin, Vancouver, BC, Canada.
   [Mezei, Michelle M.] Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC, Canada.
   [Lehman, Anna] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC, Canada.
   [Horvath, Gabriella] Univ British Columbia, Fac Med, Dept Pediat, Div Biochem Dis, Vancouver, BC, Canada.
   [Zypchen, Leslie] Univ British Columbia, Dept Med, Div Hematol, Vancouver, BC, Canada.
   [Mattman, Andre] Univ British Columbia, Vancouver Gen Hosp, Adult Metab Dis Clin, Vancouver, BC, Canada.
   [Mattman, Andre] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Almarzooqi, Farida] Univ British Columbia, Dept Med, British Colombia,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
C3 University of British Columbia; United Arab Emirates University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia
RP Almarzooqi, F (corresponding author), Univ British Columbia, Dept Med, British Colombia,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
EM famarzooqi@uaeu.ac.ae
CR Agodi A, 2014, MUTAGENESIS, V29, P101, DOI 10.1093/mutage/get065
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Dietz JV, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10092198
   Ducamp S, 2019, BLOOD, V133, P59, DOI 10.1182/blood-2018-08-815951
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ormazabal A, 2015, DRUG DISCOV TODAY, V20, P1349, DOI 10.1016/j.drudis.2015.07.002
   Paul BT, 2019, SCI REP-UK, V9, P1
   Schaefer A, 2019, DIAGNOSIS MANAGEMENT, V0, PP63, DOI 10.1007/978-3-030-05517-2_4
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Zegallai HM, 2021, MOL CELL BIOCHEM, V476, P1605, DOI 10.1007/s11010-020-04021-0
   Zhang YC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0128624
NR 17
TC 2
Z9 2
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0001-5792
EI 1421-9662
J9 ACTA HAEMATOL-BASEL
JI Acta Haematol.
PD JUN 15
PY 2023
VL 146
IS 3
BP 220
EP 225
DI 10.1159/000529311
EA FEB 2023
PG 6
WC Hematology
SC Hematology
GA J2IU7
UT WOS:000940716400001
PM 36774923
DA 2024-11-01
ER

PT J
AU Jia, DD
   Tian, ZJ
   Wang, R
AF Jia, Dandan
   Tian, Zhenjun
   Wang, Ru
TI Exercise mitigates age-related metabolic diseases by improving mitochondrial dysfunction
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE Exerkines; Mitochondrial dysfunction; Ageing; Age-related diseases
ID nonalcoholic fatty liver; physical-activity advice; oxidative stress; skeletal-muscle; diabetic cardiomyopathy; molecular-mechanisms; cancer prevention; dna mutations; mouse model; cardiolipin
AB The benefits of regular physical activity are related to delaying and reversing the onset of ageing and age-related disorders, including cardiomyopathy, neurodegenerative diseases, cancer, obesity, diabetes, and fatty liver diseases. However, the molecular mechanisms of the benefits of exercise or physical activity on ageing and agerelated disorders remain poorly understood. Mitochondrial dysfunction is implicated in the pathogenesis of ageing and age-related metabolic diseases. Mitochondrial health is an important mediator of cellular function. Therefore, exercise alleviates metabolic diseases in individuals with advancing ageing and age-related diseases by the remarkable promotion of mitochondrial biogenesis and function. Exerkines are identified as signaling moieties released in response to exercise. Exerkines released by exercise have potential roles in improving mitochondrial dysfunction in response to age-related disorders. This review comprehensive summarizes the benefits of exercise in metabolic diseases, linking mitochondrial dysfunction to the onset of age-related diseases. Using relevant examples utilizing this approach, the possibility of designing therapeutic interventions based on these molecular mechanisms is addressed.
C1 [Jia, Dandan; Wang, Ru] Shanghai Univ Sport, Sch Exercise & Hlth, Shanghai 200438, Peoples R China.
   [Tian, Zhenjun] Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian 710119, Peoples R China.
C3 Shanghai University of Sport; Shaanxi Normal University
RP Jia, DD; Wang, R (corresponding author), Shanghai Univ Sport, Sch Exercise & Hlth, Shanghai 200438, Peoples R China.
EM jiadandan@sus.edu.cn; wangru@sus.edu.cn
FU National Natural Science Foundation of China [31971097, 32271226, 32171128]; National Key R & D Program of China [2020YFA0803800]; Shanghai "Science and Technology Innovation Action Plan" Social Development Science and Technology Reach Project [22dz1204600]; Shanghai Municipal Science and Technology Committee of Shanghai outstanding academic leaders plan [21XD1403200]; Shanghai University of Sport [2023STD023]
CR Abreu A, 2023, EUR HEART J, V44, P4890, DOI 10.1093/eurheartj/ehad136
   Aengevaeren VL, 2023, CIRCULATION, V147, P993, DOI 10.1161/CIRCULATIONAHA.122.061173
   Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009
   Alexandru N, 2022, REV ENDOCR METAB DIS, V23, P309, DOI 10.1007/s11154-021-09664-y
   Alrbyawi H, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms231911763
   Alves RL, 2019, LIFE SCI, V232, P0, DOI 10.1016/j.lfs.2019.116629
   Amorim JA, 2022, NAT REV ENDOCRINOL, V18, P243, DOI 10.1038/s41574-021-00626-7
   Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031
   Andoh M, 2019, CELL REP, V27, P2817, DOI 10.1016/j.celrep.2019.05.015
   Arbeithuber B, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2118740119
   Armstrong A, 2022, OBES REV, V23, P0, DOI 10.1111/obr.13446
   Asokan SM, 2020, AGING-US, V12, P7334, DOI 10.18632/aging.103081
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Balan E, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.01088
   Ballarò R, 2019, CANCERS, V11, P0, DOI 10.3390/cancers11030285
   Bao MHR, 2021, CELL REP, V34, P0, DOI 10.1016/j.celrep.2020.108676
   Barker MM, 2023, DIABETES CARE, V46, P579, DOI 10.2337/dc22-1237
   Bauman AE, 2021, LANCET, V398, P456, DOI 10.1016/S0140-6736(21)01165-X
   Belaya I, 2020, J NEUROINFLAMM, V17, P0, DOI 10.1186/s12974-020-01935-w
   Blandin A, 2023, CELL REP, V42, P0, DOI 10.1016/j.celrep.2023.112169
   Bo H, 2008, FREE RADICAL BIO MED, V44, P1373, DOI 10.1016/j.freeradbiomed.2007.12.033
   Böttner J, 2021, BIOL RES, V54, P0, DOI 10.1186/s40659-021-00354-2
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Bordbar Somayeh, 2012, J CARDIOVASC DIS RES, V3, P22, DOI 10.4103/0975-3583.91599
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Bull FC, 2020, BRIT J SPORT MED, V54, P1451, DOI 10.1136/bjsports-2020-102955
   Burtscher J, 2023, AGING CELL, V22, P0, DOI 10.1111/acel.13770
   Bussard KM, 2017, CANCER RES, V77, P6051, DOI 10.1158/0008-5472.CAN-17-1939
   Campos JC, 2023, P NATL ACAD SCI USA, V120, P0, DOI 10.1073/pnas.2204750120
   Carneros D, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12113472
   Carrière A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885
   Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014
   Cassidy S, 2016, DIABETOLOGIA, V59, P56, DOI 10.1007/s00125-015-3741-2
   Cecconi ADR, 2019, CANCERS, V11, P0, DOI 10.3390/cancers11101541
   Chaudhari SN, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00274-4
   Chen JB, 2022, SIGNAL TRANSDUCT TAR, V7, P0, DOI 10.1038/s41392-022-01233-2
   Chen J, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-34593-y
   Chevalier FP, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11050836
   Chow LS, 2022, NAT REV ENDOCRINOL, V18, P273, DOI 10.1038/s41574-022-00641-2
   Cianciulli A, 2015, INT IMMUNOPHARMACOL, V24, P369, DOI 10.1016/j.intimp.2014.12.035
   Clemente-Suárez VJ, 2023, CANCERS, V15, P0, DOI 10.3390/cancers15030814
   Cluckey TG, 2017, EXP GERONTOL, V96, P7, DOI 10.1016/j.exger.2017.06.003
   Combot Y, 2022, CELL REP, V38, P0, DOI 10.1016/j.celrep.2021.110213
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Conlon KC, 2015, J CLIN ONCOL, V33, P74, DOI 10.1200/JCO.2014.57.3329
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Cramp F, 2008, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD006145.pub2
   Crane JD, 2015, AGING CELL, V14, P625, DOI 10.1111/acel.12341
   Crewe C, 2021, CELL METAB, V33, P1853, DOI 10.1016/j.cmet.2021.08.002
   Crisafulli A, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21082896
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   De Bosscher R, 2023, EUR HEART J, V44, P2388, DOI 10.1093/eurheartj/ehad152
   Neto IVD, 2023, AGEING RES REV, V87, P0, DOI 10.1016/j.arr.2023.101935
   Denham J, 2021, AGEING RES REV, V70, P0, DOI 10.1016/j.arr.2021.101411
   Dillmann WH, 2019, CIRC RES, V124, P1160, DOI 10.1161/CIRCRESAHA.118.314665
   Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X
   Douglas CE, 2023, HYPERTENSION, V80, P1048, DOI 10.1161/HYPERTENSIONAHA.122.20354
   Drake JC, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.732308
   Drake JC, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2025932118
   Drake JC, 2019, CURR OPIN PHYSIOL, V10, P96, DOI 10.1016/j.cophys.2019.05.005
   Drake JC, 2019, CELL CYCLE, V18, P1, DOI 10.1080/15384101.2018.1559556
   Duan JH, 2019, AGING-US, V11, P7307, DOI 10.18632/aging.102247
   Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639
   Ezpeleta M, 2023, CELL METAB, V35, P56, DOI 10.1016/j.cmet.2022.12.001
   Faber C, 2014, J APPL TOXICOL, V34, P1122, DOI 10.1002/jat.3030
   Figueira FR, 2014, SPORTS MED, V44, P1557, DOI 10.1007/s40279-014-0226-2
   Fiuza-Luces C, 2018, NAT REV CARDIOL, V15, P731, DOI 10.1038/s41569-018-0065-1
   Fiuza-Luces C, 2018, MED SCI SPORT EXER, V50, P1142, DOI 10.1249/MSS.0000000000001546
   Flippo KH, 2021, NAT METAB, V3, P309, DOI 10.1038/s42255-021-00354-2
   Fujita Y, 2020, ARCH BIOCHEM BIOPHYS, V696, P0, DOI 10.1016/j.abb.2020.108668
   Fuller OK, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9102182
   Ghosh S, 2020, P NATL ACAD SCI USA, V117, P16383, DOI 10.1073/pnas.2000640117
   Giralt M, 2015, MOL CELL ENDOCRINOL, V418, P66, DOI 10.1016/j.mce.2015.09.018
   Greenhill C, 2021, NAT REV ENDOCRINOL, V17, P637, DOI 10.1038/s41574-021-00563-5
   Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929
   Guan YT, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11050872
   Guan YT, 2019, EXERC SPORT SCI REV, V47, P151, DOI 10.1249/JES.0000000000000192
   Guo YX, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232314701
   Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073
   Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a
   Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029
   He JL, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-24619-2
   Hebert JF, 2021, BBA-MOL BASIS DIS, V1867, P0, DOI 10.1016/j.bbadis.2020.165967
   Hiam D, 2020, AGING-US, V12, P359, DOI 10.18632/aging.102627
   Hoene M, 2021, MOL METAB, V54, P0, DOI 10.1016/j.molmet.2021.101359
   Hojman P, 2018, CELL METAB, V27, P10, DOI 10.1016/j.cmet.2017.09.015
   Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Huang CC, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13093217
   Hwang JH, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28247-2
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Islam MR, 2017, RES PERSPECT END INT, V0, PP93, DOI 10.1007/978-3-319-72790-5_8
   Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991
   Jackisch L, 2020, J CLIN ENDOCR METAB, V105, P2905, DOI 10.1210/clinem/dgaa258
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Javaid HMA, 2021, CELLS, V10, P0
   Jia DD, 2021, MOL THER, V29, P3498, DOI 10.1016/j.ymthe.2021.06.007
   Jia DD, 2019, J CELL PHYSIOL, V234, P23705, DOI 10.1002/jcp.28939
   Jia DD, 2018, LIFE SCI, V193, P77, DOI 10.1016/j.lfs.2017.12.009
   Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586
   Jiang H, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-0787-1
   Jin LG, 2022, CIRCULATION, V146, P1537, DOI 10.1161/CIRCULATIONAHA.122.059631
   Jones RG III, 2023, J PHYSIOL-LONDON, V601, P763, DOI 10.1113/JP283836
   Jusic A, 2022, AGEING RES REV, V77, P0, DOI 10.1016/j.arr.2022.101610
   Kaarniranta K, 2023, AUTOPHAGY, V19, P388, DOI 10.1080/15548627.2022.2069437
   Kammoun HL, 2014, CELL METAB, V19, P1, DOI 10.1016/j.cmet.2013.12.007
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kessas K, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11020257
   Kim HJ, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-1112-x
   Kim S, 2023, MED. SCI. SPORT. EXERC., V0, P0
   Kim SY, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13113927
   Kim SY, 2020, CIRCULATION, V142, P2356, DOI 10.1161/CIRCULATIONAHA.120.047239
   Kim SJ, 2021, GEROSCIENCE, V43, P1113, DOI 10.1007/s11357-020-00262-5
   Kim TW, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23105517
   Klein AB, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-21309-x
   Klein C, 2019, NEUROSCIENCE, V400, P146, DOI 10.1016/j.neuroscience.2018.12.037
   Koelwyn GJ, 2017, NAT REV CANCER, V17, P620, DOI 10.1038/nrc.2017.78
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Kresovich JK, 2023, HYPERTENSION, V80, P1213, DOI 10.1161/HYPERTENSIONAHA.122.20796
   Kruijsen-Jaarsma M, 2013, EXERC IMMUNOL REV, V19, P120
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Kumar AA, 2019, CIRCULATION, V139, P1435, DOI 10.1161/CIRCULATIONAHA.118.036259
   Kwon SM, 2019, BMB REP, V52, P5, DOI 10.5483/BMBRep.2019.52.1.291
   Kyriazis ID, 2021, CIRC RES, V128, P335, DOI 10.1161/CIRCRESAHA.120.316738
   La Colla A, 2023, NUTR RES REV, V36, P281, DOI 10.1017/S0954422422000038
   Laker RC, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00520-9
   Lapatto HAK, 2023, SCI ADV, V9, P0, DOI 10.1126/sciadv.add5163
   Lasón W, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12040660
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee H, 2023, DIABETES CARE, V46, P1085, DOI 10.2337/dc22-2144
   Lee J, 2023, EUR. HEART J., V0, P0
   Lee KJ, 2022, INT J ENV RES PUB HE, V19, P0, DOI 10.3390/ijerph19095463
   Legaki AI, 2022, CURR OBES REP, V11, P126, DOI 10.1007/s13679-022-00473-1
   Lewsey SC, 2020, JCI INSIGHT, V5, P0, DOI 10.1172/jci.insight.141246
   Li J, 2012, P NATL ACAD SCI USA, V109, P6975, DOI 10.1073/pnas.1120043109
   Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003
   Li YL, 2019, CIRCULATION, V140, P751, DOI 10.1161/CIRCULATIONAHA.118.039262
   Lieberman DE, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2107621118
   Lin HR, 2021, CIRCULATION, V143, P2277, DOI 10.1161/CIRCULATIONAHA.120.047000
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Linford NJ, 2006, CANCER RES, V66, P2497, DOI 10.1158/0008-5472.CAN-05-3163
   Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486
   Littlefield AM, 2015, J NEUROINFLAMM, V12, P0, DOI 10.1186/s12974-015-0362-0
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   López-Vicario C, 2023, HEPATOLOGY, V77, P1303, DOI 10.1002/hep.32647
   Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4
   Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395
   Ma LJ, 2023, REDOX BIOL, V62, P0, DOI 10.1016/j.redox.2023.102693
   Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017
   Magkos F, 2020, NAT REV ENDOCRINOL, V16, P545, DOI 10.1038/s41574-020-0381-5
   Mahmoud AM, 2017, ADV EXP MED BIOL, V999, P207, DOI 10.1007/978-981-10-4307-9_12
   Malik N, 2023, SCIENCE, V380, P0, DOI 10.1126/science.abj5559
   Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936
   Margolis LM, 2013, ADV NUTR, V4, P657, DOI 10.3945/an.113.004572
   McGee SL, 2020, NAT REV ENDOCRINOL, V16, P495, DOI 10.1038/s41574-020-0377-1
   McTiernan A, 2019, MED SCI SPORT EXER, V51, P1252, DOI 10.1249/MSS.0000000000001937
   Mee-Inta O, 2019, CELLS-BASEL, V8, P0
   Memme JM, 2021, J PHYSIOL-LONDON, V599, P803, DOI 10.1113/JP278853
   Memon AA, 2022, ANTIOXID REDOX SIGN, V37, P1168, DOI 10.1089/ars.2022.0100
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mercy L, 2005, FEBS J, V272, P5031, DOI 10.1111/j.1742-4658.2005.04913.x
   Millar PR, 2023, ELIFE, V12, P0, DOI 10.7554/eLife.81869
   Miller B, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI158449
   Millichap LE, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222111444
   Milton K, 2023, J SPORT HEALTH SCI, V12, P5, DOI 10.1016/j.jshs.2022.12.006
   Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025
   Mu WJ, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222111512
   Müller S, 2018, ALZHEIMERS DEMENT, V14, P1427, DOI 10.1016/j.jalz.2018.06.3059
   Murphy RM, 2020, NAT METAB, V2, P805, DOI 10.1038/s42255-020-0258-x
   Nambu H, 2021, CARDIOVASC RES, V117, P805, DOI 10.1093/cvr/cvaa127
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, PR505, DOI 10.1152/ajpregu.00208.2003
   Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011
   Nichols E, 2023, LANCET HEALTH LONGEV, V4, PE115, DOI 10.1016/S2666-7568(23)00019-3
   Nigro P, 2021, DIABETES, V70, P1250, DOI 10.2337/db20-0790
   Oh YM, 2023, AUTOPHAGY, V19, P2613, DOI 10.1080/15548627.2023.2175572
   Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841
   Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099
   Opichka M, 2019, CRYOBIOLOGY, V90, P47, DOI 10.1016/j.cryobiol.2019.08.007
   Oppert JM, 2023, REV ENDOCR METAB DIS, V24, P937, DOI 10.1007/s11154-023-09805-5
   Orange ST, 2022, INT J CANCER, V151, P265, DOI 10.1002/ijc.33982
   Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8
   Otaka N, 2018, CIRC RES, V123, P1326, DOI 10.1161/CIRCRESAHA.118.313777
   Pacheco VB, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/3725056
   Panel M, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12793
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Peris E, 2019, J BIOL CHEM, V294, P2340, DOI 10.1074/jbc.RA118.004253
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854
   Prattichizzo F, 2021, DIABETES, V70, P240, DOI 10.2337/db20-0199
   Rangarajan S, 2022, AGING CELL, V21, P0, DOI 10.1111/acel.13674
   Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065
   Raun SH, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22073469
   Reyes LP, 2023, J STEROID BIOCHEM, V225, P0, DOI 10.1016/j.jsbmb.2022.106200
   Reynolds JC, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20790-0
   Roberts FL, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10102639
   Rosa-Caldwell ME, 2022, SPORTS MED HLTH SCI, V4, P183, DOI 10.1016/j.smhs.2022.04.003
   Sabag A, 2017, DIABETES METAB, V43, P195, DOI 10.1016/j.diabet.2016.12.006
   Sabag A, 2020, DIABETES CARE, V43, P2371, DOI 10.2337/dc19-2523
   Safdar A, 2018, CSH PERSPECT MED, V8, P0, DOI 10.1101/cshperspect.a029827
   Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76
   Saito T, 2019, J CLIN INVEST, V129, P802, DOI 10.1172/JCI122035
   Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791
   Salmón P, 2023, AGING CELL, V22, P0, DOI 10.1111/acel.13822
   Sánchez-Sarasúa S, 2022, MOL CELL NEUROSCI, V118, P0, DOI 10.1016/j.mcn.2021.103693
   Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204
   Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schauer T, 2022, BRAIN BEHAV IMMUN-HL, V25, P0, DOI 10.1016/j.bbih.2022.100508
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Semeraro MD, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11101605
   Shannon CE, 2021, MOL METAB, V45, P0, DOI 10.1016/j.molmet.2020.101154
   Sheinboim D, 2022, CANCER RES, V82, P4164, DOI 10.1158/0008-5472.CAN-22-0237
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6
   Shimada K, 2011, INT J CARDIOL, V151, P284, DOI 10.1016/j.ijcard.2010.05.057
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Skuratovskaia D, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8050430
   Son JM, 2019, BMB REP, V52, P13, DOI 10.5483/BMBRep.2019.52.1.300
   Song CJ, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12941
   Song HX, 2021, AUTOPHAGY, V17, P4102, DOI 10.1080/15548627.2021.1904488
   Sorriento D, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.660068
   Spaulding HR, 2022, ANNU REV PHYSIOL, V84, P209, DOI 10.1146/annurev-physiol-060721-095517
   Speisman RB, 2013, BRAIN BEHAV IMMUN, V28, P25, DOI 10.1016/j.bbi.2012.09.013
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Stevanovic J, 2020, MOL METAB, V32, P1, DOI 10.1016/j.molmet.2019.11.015
   Stout R, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020029
   Subbotina E, 2015, P NATL ACAD SCI USA, V112, P16042, DOI 10.1073/pnas.1514250112
   Sun L, 2021, FASEB J, V35, P0, DOI 10.1096/fj.202100868R
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Supruniuk E, 2023, ANTIOXIDANTS-BASEL, V12, P0, DOI 10.3390/antiox12020501
   Taaffe DR, 2023, MED. SCI. SPORT. EXERC., V0, P0
   Tanaka M, 2020, FASEB J, V34, P14389, DOI 10.1096/fj.202001330R
   Tang BL, 2016, MOL CELLS, V39, P87, DOI 10.14348/molcells.2016.2318
   Taylor DF, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23031517
   Tian HL, 2019, AGING-US, V11, P5287, DOI 10.18632/aging.102129
   Toda K, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12010219
   Tokeshi T, 2023, CIRC. J., V0, P0
   Tong MM, 2019, CIRC RES, V124, P1360, DOI 10.1161/CIRCRESAHA.118.314607
   Trigiani LJ, 2019, FASEB J, V33, P13280, DOI 10.1096/fj.201901002R
   Tsai PI, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2119009119
   Tucker WJ, 2022, CIRC-HEART FAIL, V15, P0, DOI 10.1161/CIRCHEARTFAILURE.122.010003
   Tyrrell DJ, 2020, CIRC RES, V126, P298, DOI 10.1161/CIRCRESAHA.119.315644
   Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576
   Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, PC710, DOI 10.1152/ajpcell.00380.2014
   Valente AFD, 2021, EXERC IMMUNOL REV, V27, P42
   Valenzuela PL, 2020, AGEING RES REV, V62, P0, DOI 10.1016/j.arr.2020.101108
   Vernier M, 2021, J MOL ENDOCRINOL, V66, PR1, DOI 10.1530/JME-20-0196
   Vettor R, 2014, AM J PHYSIOL-ENDOC M, V306, PE519, DOI 10.1152/ajpendo.00617.2013
   Viloria MAD, 2022, FRONT CARDIOVASC MED, V9, P0, DOI 10.3389/fcvm.2022.949744
   Vulczak A, 2020, CANCER CELLS, V9, P0
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang L, 2015, HEPATOLOGY, V61, P486, DOI 10.1002/hep.27420
   Wang QY, 2021, J SPORT HEALTH SCI, V10, P201, DOI 10.1016/j.jshs.2020.07.008
   Wang T, 2023, INT. J. MOL. SCI., V24, P0
   Wang Y, 2023, LIFE-BASEL, V13, P0, DOI 10.3390/life13041006
   Wang Y, 2015, SCIENCE, V350, P1204, DOI 10.1126/science.aac4357
   Whelton SP, 2020, DIABETES CARE, V43, P677, DOI 10.2337/dc19-1673
   Whitham M, 2019, PROTEOMICS, V19, P0, DOI 10.1002/pmic.201800154
   Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001
   Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X
   Woo CY, 2019, DIABETES METAB J, V43, P247, DOI 10.4093/dmj.2018.0221
   Wrann Christiane D, 2015, BRAIN PLAST, V1, P55, DOI 10.3233/BPL-150019
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Wu HK, 2020, AUTOPHAGY, V16, P683, DOI 10.1080/15548627.2019.1635380
   Xi Y, 2021, J SPORT HEALTH SCI, V10, P594, DOI 10.1016/j.jshs.2020.11.010
   Xiong Y, 2019, FASEB J, V33, P5876, DOI 10.1096/fj.201801754RR
   Yamamoto-Imoto H, 2022, CELL REP, V38, P0, DOI 10.1016/j.celrep.2022.110444
   Yang J, 2020, FRONT MOL NEUROSCI, V13, P0, DOI 10.3389/fnmol.2020.00020
   Yang YF, 2021, BIOL REV, V96, P1504, DOI 10.1111/brv.12712
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Yoo SZ, 2018, J EXERC REHABIL, V14, P551, DOI 10.12965/jer.1836268.134
   Zanini G, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10102575
   Zarse K, 2015, CELL METAB, V21, P355, DOI 10.1016/j.cmet.2015.02.013
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
   Zeng JL, 2023, NAT COMMUN, V14, P0, DOI 10.1038/s41467-023-38165-6
   Zhang C, 2023, AGEING RES REV, V87, P0, DOI 10.1016/j.arr.2023.101917
   Zhao N, 2023, MOL NEUROBIOL, V60, P277, DOI 10.1007/s12035-022-03035-7
   Zheng A, 2022, DIABETES, V71, P219, DOI 10.2337/db21-0601
   Zheng LD, 2020, AUTOPHAGY, V16, P1366, DOI 10.1080/15548627.2019.1668228
   Zhong HQ, 2017, FREE RADICAL BIO MED, V102, P67, DOI 10.1016/j.freeradbiomed.2016.10.494
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
   Zhu YQ, 2023, J ADV RES, V46, P113, DOI 10.1016/j.jare.2022.06.005
   Zottola ACP, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11162582
NR 289
TC 9
Z9 9
U1 6
U2 41
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD NOV 15
PY 2023
VL 91
IS 
BP 
EP 
DI 10.1016/j.arr.2023.102087
EA OCT 2023
PG 16
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA W7GQ0
UT WOS:001093276000001
PM 37832607
DA 2024-11-01
ER

PT J
AU Ruiz-Pesini, E
   Bayona-Bafaluy, MP
   Sanclemente, T
   Puzo, J
   Montoya, J
   Pacheu-Grau, D
AF Ruiz-Pesini, Eduardo
   Bayona-Bafaluy, Maria Pilar
   Sanclemente, Teresa
   Puzo, Jose
   Montoya, Julio
   Pacheu-Grau, David
TI Mitochondrial Genetic Background May Impact Statins Side Effects and Atherosclerosis Development in Familial Hypercholesterolemia
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE familial hypercholesterolemia; mtDNA; mitochondria; CoQ(10)
ID genome-wide association; dna copy number; coenzyme q(10); susceptibility loci; muscle symptoms; polymorphisms; myopathy; therapy; pharmacogenomics; supplementation
AB Heredity of familial hypercholesterolemia (FH) can present as a dominant monogenic disorder of polygenic origin or with no known genetic cause. In addition, the variability of the symptoms among individuals or within the same families evidence the potential contribution of additional factors than monogenic mutations that could modulate the development and severity of the disease. In addition, statins, the lipid-lowering drugs which constitute the first-line therapy for the disease, cause associated muscular symptoms in a certain number of individuals. Here, we analyze the evidence of the mitochondrial genetic variation with a special emphasis on the role of CoQ(10) to explain this variability found in both disease symptoms and statins side effects. We propose to use mtDNA variants and copy numbers as markers for the cardiovascular disease development of FH patients and to predict potential statin secondary effects and explore new mechanisms to identify new markers of disease or implement personalized medicine strategies for FH therapy.
C1 [Ruiz-Pesini, Eduardo; Bayona-Bafaluy, Maria Pilar; Montoya, Julio; Pacheu-Grau, David] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza 50009, Spain.
   [Ruiz-Pesini, Eduardo; Bayona-Bafaluy, Maria Pilar; Montoya, Julio; Pacheu-Grau, David] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza 50013, Spain.
   [Ruiz-Pesini, Eduardo; Bayona-Bafaluy, Maria Pilar; Montoya, Julio; Pacheu-Grau, David] Inst Invest Sanitaria IIS Aragon, Zaragoza 50009, Spain.
   [Ruiz-Pesini, Eduardo; Bayona-Bafaluy, Maria Pilar; Montoya, Julio; Pacheu-Grau, David] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain.
   [Bayona-Bafaluy, Maria Pilar] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza 50018, Spain.
   [Sanclemente, Teresa] Univ Zaragoza, Fac Ciencias Salud & Deporte, Huesca 22002, Spain.
   [Puzo, Jose] Hosp Gen Univ San Jorge Huesca, Serv Bioquim Clin, Unidad Lipidos, Huesca 22004, Spain.
   [Puzo, Jose] Univ Zaragoza, Dept Med, Zaragoza 50009, Spain.
C3 University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza; University of Zaragoza; University of Zaragoza
RP Pacheu-Grau, D (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza 50009, Spain.; Pacheu-Grau, D (corresponding author), Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza 50013, Spain.; Pacheu-Grau, D (corresponding author), Inst Invest Sanitaria IIS Aragon, Zaragoza 50009, Spain.; Pacheu-Grau, D (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain.
EM dpacheu@unizar.es
FU Instituto de Salud Carlos III [PI21/00229]; European Regional Development Fund (FEDER) [PI21/00229]; MCIN/AEI [PID2020-116970GA-I00, RYC2020-029544-I]; ESF Investing in your future; Gobierno de Aragon (Grupos Consolidados) [B33_20R, LMP22_21]; FEDER 2014-2020 'Construyendo Europa desde Aragon'; Asociacion de Enfermos de Patologia Mitocondrial (AEPMI)
CR Akioyamen LE, 2017, BMJ OPEN, V7, P0, DOI 10.1136/bmjopen-2017-016461
   Al-Furoukh N, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103141
   Alcázar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Antoniazzi L, 2021, NUTR METAB CARDIOVAS, V31, P2014, DOI 10.1016/j.numecd.2021.04.006
   Antons KA, 2006, AM J MED, V119, P400, DOI 10.1016/j.amjmed.2006.02.007
   Arroyo-Olivares R, 2019, PUBLIC HEALTH NUTR, V22, P1433, DOI 10.1017/S1368980018003853
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Beheshti SO, 2020, J AM COLL CARDIOL, V75, P2553, DOI 10.1016/j.jacc.2020.03.057
   Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147
   Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843
   Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004
   Christopher-Stine L, 2006, CURR OPIN RHEUMATOL, V18, P647
   Crane FL, 2007, MITOCHONDRION, V7, PS2, DOI 10.1016/j.mito.2007.02.011
   Degenhardt F, 2016, HUM MOL GENET, V25, P2881, DOI 10.1093/hmg/ddw134
   Fahed AC, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-17374-3
   Fedacko J, 2013, CAN J PHYSIOL PHARM, V91, P165, DOI 10.1139/cjpp-2012-0118
   Fischer Alexandra, 2011, BMC RES NOTES, V4, P245, DOI 10.1186/1756-0500-4-245
   Garcia-Garcia AB, 2011, ATHEROSCLEROSIS, V218, P423, DOI 10.1016/j.atherosclerosis.2011.07.106
   Garrabou G, 2017, ANTIMICROB AGENTS CH, V61, P0, DOI 10.1128/AAC.00542-17
   Gaspar IM, 2019, ATHEROSCLEROSIS SUPP, V36, P28, DOI 10.1016/j.atherosclerosissup.2019.01.006
   GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Gómez-Durán A, 2011, DRUG DISCOV TODAY, V16, P176, DOI 10.1016/j.drudis.2010.11.010
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Gutierrez-Mariscal FM, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10060906
   Hughes K, 2002, FREE RADICAL BIO MED, V32, P132, DOI 10.1016/S0891-5849(01)00783-3
   Kajinami K, 2005, AM J CARDIOL, V96, P65K, DOI 10.1016/j.amjcard.2005.08.011
   KANE JP, 1990, JAMA-J AM MED ASSOC, V264, P3007, DOI 10.1001/jama.264.23.3007
   Kastelein JJP, 2020, J AM COLL CARDIOL, V75, P2567, DOI 10.1016/j.jacc.2020.03.058
   Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327
   Kennedy C, 2020, ATHEROSCLEROSIS, V299, P1, DOI 10.1016/j.atherosclerosis.2020.03.006
   Klopstock T, 2008, CURR OPIN NEUROL, V21, P590, DOI 10.1097/WCO.0b013e32830e2774
   Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643
   Lagos J, 2014, MOL DIAGN THER, V18, P435, DOI 10.1007/s40291-014-0094-3
   Lamhonwah AM, 2006, BIOCHEM BIOPH RES CO, V345, P1315, DOI 10.1016/j.bbrc.2006.05.026
   Liu X, 2021, CELL GENOM, V1, P0, DOI 10.1016/j.xgen.2021.100006
   Lorente L, 2018, ENFERM INFEC MICR CL, V36, P539, DOI 10.1016/j.eimc.2017.08.011
   Lorente L, 2012, CRIT CARE, V16, P0, DOI 10.1186/cc11150
   Luo J, 2021, MEDRXIV, V0, P0, DOI DOI 10.1101/2021.07.01.21259854
   Miles MV, 2003, CLIN CHIM ACTA, V332, P123, DOI 10.1016/S0009-8981(03)00137-2
   Montero R, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-37542-2
   Montoya J, 2009, ADV EXP MED BIOL, V652, P47, DOI 10.1007/978-90-481-2813-6_5
   Morotti A, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms231911446
   Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422
   Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396
   Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273
   Okura T, 2003, HUM GENET, V113, P432, DOI 10.1007/s00439-003-0983-8
   Ordovas JM, 2004, ANNU REV GENOM HUM G, V5, P71, DOI 10.1146/annurev.genom.5.061903.180008
   Pacheu-Grau D, 2018, CELL STRESS, V2, P184, DOI 10.15698/cst2018.07.147
   Pacheu-Grau D, 2013, HUM MOL GENET, V22, P1132, DOI 10.1093/hmg/dds517
   Pacheu-Grau D, 2010, DRUG DISCOV TODAY, V15, P33, DOI 10.1016/j.drudis.2009.10.008
   Päivä H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006
   Paquette M, 2017, J CLIN LIPIDOL, V11, P725, DOI 10.1016/j.jacl.2017.03.019
   Perez-Calahorra S, 2019, ATHEROSCLEROSIS, V284, P245, DOI 10.1016/j.atherosclerosis.2019.02.003
   PULLMAN ME, 1967, ANNU REV BIOCHEM, V36, P539, DOI 10.1146/annurev.bi.36.070167.002543
   Ruiz-Iruela C, 2020, PHARMACOGENOMICS J, V20, P494, DOI 10.1038/s41397-019-0136-7
   Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
   Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002
   Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784
   Skarlovnik A, 2014, MED SCI MONITOR, V20, P2183, DOI 10.12659/MSM.890777
   STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043
   Suárez-Rivero JM, 2018, BBA-MOL BASIS DIS, V1864, P3697, DOI 10.1016/j.bbadis.2018.10.009
   Takahashi M, 2022, NUTRIENTS, V14, P0, DOI 10.3390/nu14132579
   Takahashi M, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10030431
   Taylor BA, 2015, ATHEROSCLEROSIS, V238, P329, DOI 10.1016/j.atherosclerosis.2014.12.016
   Toth Stefan, 2017, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V28, P327, DOI 10.1515/jbcpp-2016-0149
   Villalba JM, 2010, EXPERT OPIN INV DRUG, V19, P535, DOI 10.1517/13543781003727495
   Vilne B, 2022, GENES-BASEL, V13, P0, DOI 10.3390/genes13030516
   Wang J, 2016, ARTERIOSCL THROM VAS, V36, P2439, DOI 10.1161/ATVBAHA.116.308027
   Wilemon KA, 2020, JAMA CARDIOL, V5, P217, DOI 10.1001/jamacardio.2019.5173
   WILLIAMS RR, 1986, JAMA-J AM MED ASSOC, V255, P219, DOI 10.1001/jama.255.2.219
   Zhou Xiaohong, 2020, NAN FANG YI KE DA XUE XUE BAO, V40, P1747, DOI 10.12122/j.issn.1673-4254.2020.12.08
NR 75
TC 4
Z9 4
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 15
PY 2023
VL 24
IS 1
BP 
EP 
DI 10.3390/ijms24010471
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 7R7DP
UT WOS:000910230200001
PM 36613915
DA 2024-11-01
ER

PT J
AU Mullin, NK
   Voigt, AP
   Flamme-Wiese, MJ
   Liu, XY
   Riker, MJ
   Varzavand, K
   Stone, EM
   Tucker, BA
   Mullins, RF
AF Mullin, Nathaniel K.
   Voigt, Andrew P.
   Flamme-Wiese, Miles J.
   Liu, Xiuying
   Riker, Megan J.
   Varzavand, Katayoun
   Stone, Edwin M.
   Tucker, Budd A.
   Mullins, Robert F.
TI Multimodal single-cell analysis of nonrandom heteroplasmy distribution in human retinal mitochondrial disease
SO JCI INSIGHT
LA English
DT Article
ID clinical-features; lactic-acidosis; melas; mutation; deafness; encephalopathy; deficiency; tubulation; myopathy; family
AB Variants within the high copy number mitochondrial genome (mtDNA) can disrupt organelle function and lead to severe multisystem disease. The wide range of manifestations observed in patients with mitochondrial disease results from varying fractions of abnormal mtDNA molecules in different cells and tissues, a phenomenon termed heteroplasmy. However, the landscape of heteroplasmy across cell types within tissues and its influence on phenotype expression in affected patients remains largely unexplored. Here, we identify nonrandom distribution of a pathogenic mtDNA variant across a complex tissue using single-cell RNA-Seq, mitochondrial single-cell ATAC sequencing, and multimodal single-cell sequencing. We profiled the transcriptome, chromatin accessibility state, and heteroplasmy in cells from the eyes of a patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and from healthy control donors. Utilizing the retina as a model for complex multilineage tissues, we found that the proportion of the pathogenic m.3243A>G allele was neither evenly nor randomly distributed across diverse cell types. All neuroectoderm-derived neural cells exhibited a high percentage of the mutant variant. However, a subset of mesoderm-derived lineage, namely the vasculature of the choroid, was near homoplasmic for the WT allele. Gene expression and chromatin accessibility profiles of cell types with high and low proportions of m.3243A>G implicate mTOR signaling in the cellular response to heteroplasmy. We further found by multimodal single-cell sequencing of retinal pigment epithelial cells that a high proportion of the pathogenic mtDNA variant was associated with transcriptionally and morphologically abnormal cells. Together, these findings show the nonrandom nature of mitochondrial variant partitioning in human mitochondrial disease and underscore its implications for mitochondrial disease pathogenesis and treatment.
C1 [Mullin, Nathaniel K.; Voigt, Andrew P.; Flamme-Wiese, Miles J.; Liu, Xiuying; Riker, Megan J.; Varzavand, Katayoun; Stone, Edwin M.; Tucker, Budd A.; Mullins, Robert F.] Univ Iowa, Inst Vis Res, Iowa City, IA USA.
   [Mullin, Nathaniel K.; Voigt, Andrew P.; Flamme-Wiese, Miles J.; Liu, Xiuying; Riker, Megan J.; Varzavand, Katayoun; Stone, Edwin M.; Tucker, Budd A.; Mullins, Robert F.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA.
   [Mullin, Nathaniel K.; Voigt, Andrew P.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA.
   [Mullins, Robert F.] 4130 MERF,375 Newton Rd, Iowa City, IA 52242 USA.
C3 University of Iowa; University of Iowa; University of Iowa
RP Mullins, RF (corresponding author), 4130 MERF,375 Newton Rd, Iowa City, IA 52242 USA.
EM robert-mullins@uiowa.edu
FU NIH [T32GM008629, T32GM139776, F30EY034009, P30EY025580, F30EY031923, R01EY033308]; Research to Prevent Blindness; Elmer and Sylvia Sramek Charitable Trust; Edward N. amp; Della L. Thome Memorial Foundation; University of Iowa Carver College of Medicine; NIH SIG [1 S10 RR018998-01]
CR Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457
   Aryaman J, 2019, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00718
   Barrett A, 2020, PHILOS T R SOC B, V375, P0, DOI 10.1098/rstb.2019.0175
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   Cao DF, 2021, INVEST OPHTH VIS SCI, V62, P0, DOI 10.1167/iovs.62.10.34
   Castro-Mondragon JA, 2022, NUCLEIC ACIDS RES, V50, PD165, DOI 10.1093/nar/gkab1113
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Chung CY, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-26746-2
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Coussa RG, 2021, SURV OPHTHALMOL, V66, P838, DOI 10.1016/j.survophthal.2021.02.008
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   DOLLERY CT, 1969, INVEST OPHTH VISUAL, V8, P588
   Dolz-Marco R, 2017, OPHTHALMOLOGY, V124, P1353, DOI 10.1016/j.ophtha.2017.03.043
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Finsterer J, 2020, AM J CASE REP, V21, P0, DOI 10.12659/AJCR.927938
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004
   Han Ian C, 2020, OPHTHALMOL RETINA, V4, P1102, DOI 10.1016/j.oret.2020.04.027
   Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048
   Hasegawa T, 2007, DEV DYNAM, V236, P2089, DOI 10.1002/dvdy.21231
   Homma K, 2021, REDOX BIOL, V41, P0, DOI 10.1016/j.redox.2021.101921
   Hübner A, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-47570-1
   Iwanicka-Pronicka K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044054
   Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203
   Kanow MA, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.28899
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Lutty GA, 2010, EYE, V24, P408, DOI 10.1038/eye.2009.318
   Lutty GA, 2018, PROG RETIN EYE RES, V62, P58, DOI 10.1016/j.preteyeres.2017.10.001
   Mimitou EP, 2021, NAT BIOTECHNOL, V39, P1246, DOI 10.1038/s41587-021-00927-2
   Moggio Maurizio, 2014, ACTA MYOL, V33, P86
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Scholle LM, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11020212
   Müller PL, 2020, AM J OPHTHALMOL, V213, P134, DOI 10.1016/j.ajo.2020.01.013
   Mullin NK, 2022, HUM MOL GENET, V31, P775, DOI 10.1093/hmg/ddab289
   Oh JK, 2020, INVEST OPHTH VIS SCI, V61, P0, DOI 10.1167/iovs.61.12.12
   Ortolan D, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2117553119
   Pan WW, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-01765-3
   Parakatselaki ME, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11070633
   Pek NMQ, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-2036-9
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Raja MS, 2013, GRAEF ARCH CLIN EXP, V251, P2265, DOI 10.1007/s00417-012-2217-z
   Rao SR, 2021, J LIPID RES, V62, P0, DOI 10.1194/jlr.TR120000979
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schep AN, 2017, NAT METHODS, V14, P975, DOI 10.1038/NMETH.4401
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sreekumar PG, 2016, INVEST OPHTH VIS SCI, V57, P1238, DOI 10.1167/iovs.15-17053
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stone EM, 2017, OPHTHALMOLOGY, V124, P1314, DOI 10.1016/j.ophtha.2017.04.008
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Tripathy K, 2020, INDIAN J OPHTHALMOL, V68, P250, DOI 10.4103/ijo.IJO_577_19
   Viegas FO, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.656000
   Voigt AP, 2019, EXP EYE RES, V184, P234, DOI 10.1016/j.exer.2019.05.001
   Voigt AP, 2021, HUM MOL GENET, V30, P1543, DOI 10.1093/hmg/ddab140
   Voigt AP, 2019, P NATL ACAD SCI USA, V116, P24100, DOI 10.1073/pnas.1914143116
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Xue YL, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.66240
   Yang SH, 2016, CANCER RES, V76, P3838, DOI 10.1158/0008-5472.CAN-15-2841
   Zhou M, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00501
NR 72
TC 8
Z9 8
U1 0
U2 7
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD JUL 24
PY 2023
VL 8
IS 14
BP 
EP 
DI 10.1172/jci.insight.165937
PG 21
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA N9VT0
UT WOS:001040409700001
PM 37289546
DA 2024-11-01
ER

PT J
AU Ferreira, F
   Bacelar, CG
   Lisboa-Gonçalves, P
   Paulo, N
   Quental, R
   Nunes, AT
   Silva, R
   Tavares, I
AF Ferreira, Filipa
   Bacelar, Clara Goncalves
   Lisboa-Goncalves, Pedro
   Paulo, Nuria
   Quental, Rita
   Nunes, Ana Teresa
   Silva, Roberto
   Tavares, Isabel
TI Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A&gt;G pathogenic variant
SO NEFROLOGIA
LA English
DT Review
DE Focal segmental glomerulosclerosis; mtDNA m.3243A > G; MELAS syndrome; Mitochondrial diseases; Renal disease
ID focal segmental glomerulosclerosis; lactic-acidosis; episodes melas; encephalopathy; management; diagnosis; myopathy; mutation; patient; transplantation
AB Mitochondrial diseases are a phenotype and genotype heterogeneous group of disorders that typically have a multisystemic involvement. The m.3243A>G pathogenic variant is the most frequent mitochondrial DNA defect, and it causes several different clinical syndromes, such as mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS), and the maternally inherited diabetes and deafness (MIDD) syndromes. Not frequently reported, renal involvement in these diseases is probably under estimated, yet it increases morbidity. It generally manifests as subnephrotic proteinuria and progressive deterioration of kidney function. Adult presentation of mitochondrial diseases is hard to recognize, especially in oligosymptomatic patients or those with exclusive kidney involvement. However, suspicion should always arise when family history, particularly on the maternal side, and multisystemic symptoms, most often of the central nervous system and skeletal muscles, are present. In this review we discuss the clinical diagnosis and approach of patients with renal manifestations in the context of the mtDNA m.3243A>G pathogenic variant. (c) 2023 Sociedad Espanola de Nefrolog ' ia. Published by Elsevier Espana, S.L.U.
C1 [Ferreira, Filipa; Lisboa-Goncalves, Pedro; Paulo, Nuria; Nunes, Ana Teresa; Tavares, Isabel] Ctr Hosp & Univ Sao Joao, Serv Nefrol, Porto, Portugal.
   [Ferreira, Filipa; Lisboa-Goncalves, Pedro; Paulo, Nuria; Tavares, Isabel] Univ Porto, Dept Med, Fac Med, Porto, Portugal.
   [Bacelar, Clara Goncalves] Univ Porto, Fac Med, Porto, Portugal.
   [Quental, Rita] Ctr Hosp & Univ Sao Joao, Serv Genet Med, Porto, Portugal.
   [Nunes, Ana Teresa; Tavares, Isabel] Univ Porto, I3S Inst Invest Inovacao Saude, Grp Invest & Dev Nefrol & Doencas Infeciosas, Porto, Portugal.
   [Silva, Roberto] Ctr Hosp & Univ Sao Joao, Serv Anat Patol, Porto, Portugal.
C3 Universidade do Porto; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto
RP Ferreira, F (corresponding author), Ctr Hosp & Univ Sao Joao, Serv Nefrol, Porto, Portugal.; Ferreira, F (corresponding author), Univ Porto, Dept Med, Fac Med, Porto, Portugal.
EM filipasilvaf@gmail.com
CR Alcubilla-Prats P, 2017, MED CLIN-BARCELONA, V148, P357, DOI 10.1016/j.medcle.2017.04.002
   Almannai M, 2018, GENEREVIEWS, V0, P0
   Bell JD, 2017, A A CASE REP, V9, P38, DOI 10.1213/XAA.0000000000000520
   Cavero T, 2015, NEFROLOGIA, V35, P6, DOI 10.3265/Nefrologia.pre2014.Sep.12728
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   Chinnery PF, 2021, GENEREVIEWS, V0, P1
   de Laat P, 2019, CLIN KIDNEY J, V12, P840, DOI 10.1093/ckj/sfz020
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   Doorenbos CJ, 2001, PERITON DIALYSIS INT, V21, P518
   Eirin A, 2017, HANDB EXP PHARMACOL, V240, P229, DOI 10.1007/164_2016_6
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emma F, 2017, NEPHROL THER, V13, PS23, DOI 10.1016/j.nephro.2017.01.014
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Godinho I, 2017, CLIN KIDNEY J, V10, P487, DOI 10.1093/ckj/sfx021
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Mima A, 2011, RENAL FAILURE, V33, P622, DOI 10.3109/0886022X.2011.585730
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Narumi K, 2018, NEPHRON, V138, P243, DOI 10.1159/000485109
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Piccoli GB, 2012, BMC NEPHROL, V13, P0, DOI 10.1186/1471-2369-13-9
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Santoro D, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8030303
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Yanagihara C, 2001, INTERNAL MED, V40, P662, DOI 10.2169/internalmedicine.40.662
NR 33
TC 1
Z9 1
U1 1
U2 1
PU SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ
PI SANTANDER
PA C/PASAJE DE PENA 2, 3-C, SANTANDER, SPAIN
SN 0211-6995
EI 1989-2284
J9 NEFROLOGIA
JI Nefrologia
PD DEC 15
PY 2023
VL 43
IS 
BP 1
EP 7
DI 10.1016/j.nefro.2023.03.004
EA DEC 2023
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA IN8J8
UT WOS:001167096100001
PM 38355238
DA 2024-11-01
ER

PT J
AU Grigalioniene, K
   Burnyte, B
   Balkeliene, D
   Ambrozaityte, L
   Utkus, A
AF Grigalioniene, Kristina
   Burnyte, Birute
   Balkeliene, Danute
   Ambrozaityte, Laima
   Utkus, Algirdas
TI Kearns-Sayre syndrome case. Novel 5,9 kb mtDNA deletion
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE Kearns-Sayre syndrome; KSS; mitochondrial disorder; single large-scale mitochondrial DNA deletion syndromes
ID mitochondrial-dna; single; phenotypes; mechanisms
AB Background: Kearns-Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous heteroplasmic single large-scale mitochondrial DNA (mtDNA) deletions. Long-range polymerase chain reaction (LR-PCR), next generation sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA) are the most widely applied methods for the identification of mtDNA deletions. Here, we report the case of 20-year-old male who presented with classic Kearns-Sayre syndrome, confirmed by novel 5,9 kb mtDNA deletion. Methods and results: LR-PCR and MLPA methods were applied to identify the mitochondrial DNA deletion for the patient, but the results were conflicting. Molecular analysis using primer walking and Sanger sequencing identified a novel 5888 base pairs mtDNA deletion (NC_012920.1:m.6069_11956del) with CAAC nucleotides repeat sequence at the breakpoints. Conclusion: Our study enriched the mtDNA variation spectrum associated with KSS and demonstrated the importance of choosing relevant molecular genetic methods.
C1 [Grigalioniene, Kristina; Burnyte, Birute; Balkeliene, Danute; Ambrozaityte, Laima; Utkus, Algirdas] Vilnius Univ, Fac Med, Inst Biomed Sci, Dept Human & Med Genet, Santariskiu Str 2, LT-08661 Vilnius, Lithuania.
C3 Vilnius University
RP Grigalioniene, K (corresponding author), Vilnius Univ, Fac Med, Inst Biomed Sci, Dept Human & Med Genet, Santariskiu Str 2, LT-08661 Vilnius, Lithuania.
EM kristina.grigalioniene@santa.lt
FU Lietuvos Mokslo Taryba [TAP LLT-02/2015]
CR Anteneová N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Goldstein A, 2019, GENEREVIEWS, V0, P0
   Gross-Jendroska M, 1992, EUR J OPHTHALMOL, V2, P15
   Guo L, 2020, DNA CELL BIOL, V39, P1449, DOI 10.1089/dna.2019.5010
   Kisilevsley E, 2020, SURV OPHTHALMOL, V65, P294, DOI 10.1016/j.survophthal.2019.11.001
   Leal M, 2016, OXF MED CASE REP, V0, PP34, DOI 10.1093/omcr/omw007
   Liu R, 2021, TRANSL PEDIATR, V10, P204, DOI 10.21037/tp-20-138
   Luca P, 2020, NEURORADIOLOGY, V62, P1315, DOI 10.1007/s00234-020-02501-0
   Maceluch Jaros Aw, 2006, PEDIATR ENDOCRINOL REV, V4, P117
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mavraki E, 2020, BEST PRACTICE GUIDEL, V0, P0
   Mayorga L, 2016, MITOCHONDRIAL DNA A, V27, P2864, DOI 10.3109/19401736.2015.1053132
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Ruiz-Pesini E, 2010, MITOMAP HUMAN MITOCH, V0, P0
   Sabella-Jiménez V, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1509
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 20
TC 4
Z9 4
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JAN 15
PY 2023
VL 11
IS 1
BP 
EP 
DI 10.1002/mgg3.2059
EA OCT 2022
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 7V9JQ
UT WOS:000862241400001
PM 36181358
DA 2024-11-01
ER

PT J
AU Cadoni, G
   Primiano, G
   Picciotti, PM
   Calandrelli, R
   Galli, J
   Servidei, S
   Conti, G
AF Cadoni, Gabriella
   Primiano, Guido
   Picciotti, Pasqualina M.
   Calandrelli, Rosalinda
   Galli, Jacopo
   Servidei, Serenella
   Conti, Guido
TI Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases
SO JOURNAL OF PERSONALIZED MEDICINE
LA English
DT Article
DE mitochondrial diseases; mtDNA; deafness; cochlear; retrocochlear; MRI; brain changes
ID disorder; mutation; patient; dna
AB Mitochondrial diseases (MDs) are heterogeneous genetic disorders characterized by mitochondrial DNA (mtDNA) defects, involving tissues highly dependent on oxidative metabolism: the inner ear, brain, eye, skeletal muscle, and heart. We describe adult patients with genetically defined MDs, characterizing hearing function and neuroimaging results. We enrolled 34 patients (mean age: 50.02 +/- 15 years, range: 18-75 years; 20 females and 14 males) classified in four groups: MELAS, MIDD, PEO, and Encephalopathy/Polyneuropathy. Audiological evaluations included psychoacoustical tests (pure-tone and speech audiometry), electrophysiological tests (Auditory Brainstem Responses, ABRs), and Impedenzometry. Neuroimaging evaluations considered global MRI abnormalities or structural brain changes. In total, 19/34 patients carried the m.3243A > G mutation (6 affected by MELAS, 12 affected by MIDD, and 1 affected by PEO); 11 had an mtDNA deletion (all affected by PEO); 3 had nuclear genes associated with MDs (POLG1 and OPA1); and 1 patient had an mtDNA deletion without an identified nuclear gene defect (affected by PEO). Sensory neural, bilateral, and symmetrical hearing loss was present in 25 patients (73.5%) to different degrees: 9 mild, 9 moderate, 5 severe, and 2 profound. The severe/profound and mild hearing losses were associated with pantonal and high-frequency audiograms, respectively. Instead, moderate hearing losses were associated with both high-frequency (five cases) and pantonal (five cases) audiogram shapes. In addition, 21/25 patients showed a cochlear site of lesion (84%), and 4/25 (16%) showed a retrocochlear site. We found global MRI abnormalities or structural brain changes in 26/30 subjects (86.6%): 21 had white matter abnormalities, 15 had cortical atrophy, 10 had subcortical atrophy, 8 had basal nuclei involvement or cerebellar atrophy, 4 had stroke-like lesions or laminar necrosis, and 1 had cysts or vacuolated lesions. We concluded that genetic alterations are associated with different clinical presentations for both auditory function and neuroradiological findings. There is no fixed relationship between genotype and phenotype for the clinical conditions analyzed.
C1 [Cadoni, Gabriella; Primiano, Guido; Picciotti, Pasqualina M.; Galli, Jacopo; Servidei, Serenella; Conti, Guido] Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, Rome 00168, Italy.
   [Cadoni, Gabriella; Picciotti, Pasqualina M.; Galli, Jacopo; Conti, Guido] Univ Cattolica Sacro Cuore, Dipartimento Testa Collo & Organi Senso, I-00168 Rome, Italy.
   [Primiano, Guido; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dipartimento Neurosci, I-00168 Rome, Italy.
   [Calandrelli, Rosalinda] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Diagnost Immagini Radioterapia Oncolo, I-00168 Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Picciotti, PM (corresponding author), Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, Rome 00168, Italy.; Picciotti, PM (corresponding author), Univ Cattolica Sacro Cuore, Dipartimento Testa Collo & Organi Senso, I-00168 Rome, Italy.
EM gabriella.cadoni@unicatt.it; guido.primiano@policlinicogemelli.it; pasqualinamaria.picciotti@unicatt.it; rosalinda.calandrelli@policlinicogemelli.it; jacopo.galli@unicatt.it; serenella.servidei@unicatt.it; guido.conti@unicatt.it
CR Alves CAPF, 2023, AM J NEURORADIOL, V44, P602, DOI 10.3174/ajnr.A7837
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Cheng WQ, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.843386
   Elander J, 2022, MOL GENET METAB, V137, P230, DOI 10.1016/j.ymgme.2022.09.002
   Esterhuizen K, 2021, METABOLOMICS, V17, P0, DOI 10.1007/s11306-020-01769-w
   Fancello V, 2023, MEDICINA-LITHUANIA, V59, P0, DOI 10.3390/medicina59030608
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Hougaard DD, 2019, J INT ADV OTOL, V15, P296, DOI 10.5152/iao.2019.5913
   Kanungo S, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.12.13
   Kornblum C, 2005, J NEUROL, V252, P1101, DOI 10.1007/s00415-005-0827-7
   Kullar PJ, 2016, BRAIN, V139, PE33, DOI 10.1093/brain/aww051
   Li DY, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.951185
   Long HS, 2022, EUR J MED RES, V27, P0, DOI 10.1186/s40001-022-00832-7
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Merlini E, 2022, TRENDS NEUROSCI, V45, P53, DOI 10.1016/j.tins.2021.10.014
   Miceli G, 2008, NEUROL SCI, V29, P459, DOI 10.1007/s10072-008-1028-9
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Orsucci D, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10061249
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pinós T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Robinson KN, 2020, ENDOCR PRACT, V26, P241, DOI 10.4158/EP-2019-0270
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P161, DOI 10.1007/978-3-319-95046-4_30
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P163, DOI 10.1007/978-3-319-95046-4_31
   van Kempen CMA, 2022, MOL GENET METAB, V135, P333, DOI 10.1016/j.ymgme.2022.02.003
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
NR 25
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-4426
J9 J PERS MED
JI J. Pers. Med.
PD SEP 15
PY 2023
VL 13
IS 9
BP 
EP 
DI 10.3390/jpm13091329
PG 12
WC Health Care Sciences & Services; Medicine, General & Internal
SC Health Care Sciences & Services; General & Internal Medicine
GA T2TQ9
UT WOS:001076564400001
PM 37763097
DA 2024-11-01
ER

PT J
AU Wang, LT
   Wu, L
   Du, YX
   Wang, X
   Yang, BS
   Guo, S
   Zhou, Y
   Xu, YM
   Yang, SF
   Zhang, YM
   Ren, J
AF Wang, Litao
   Wu, Lin
   Du, Yuxin
   Wang, Xiang
   Yang, Bingsheng
   Guo, Shuai
   Zhou, Yuan
   Xu, Yiming
   Yang, Shuofei
   Zhang, Yingmei
   Ren, Jun
TI DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation
SO REDOX BIOLOGY
LA English
DT Article
DE DNA-PKcs; Vascular remodeling; Drp1; Mitochondrial fragmentation; Hypertension
ID smooth-muscle-cells; dynamin-related protein-1; repair; damage; phosphorylation; hypertension; sensitivity; inhibition; resistance; defects
AB Background: DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a novel instigator for mitochondrial dysfunction, and plays an important role in the pathogenesis of cardiovascular diseases. However, the role and mechanism of DNA-PKcs in angiotensin II (Ang II)-induced vascular remodeling remains obscure.Methods: Rat aortic smooth muscle cells (SMC) and VSMC-specific DNA-PKcs knockout (DNA-PKcs Delta VSMC) mice were employed to examine the role of DNA-PKcs in vascular remodeling and the underlying mechanisms. Blood pressure of mice was monitored using the tail-cuff and telemetry methods. The role of DNA-PKcs in vascular function was evaluated using vascular relaxation assessment.Results: In the tunica media of remodeled mouse thoracic aortas, and renal arteries from hypertensive patients, elevated DNA-PKcs expression was observed along with its cytoplasmic translocation from nucleus, suggesting a role for DNA-PKcs in vascular remodeling. We then infused wild-type (DNA-PKcsfl/fl) and DNA-PKcs Delta VSMC mice with Ang II for 14 days to establish vascular remodeling, and demonstrated that DNA-PKcs Delta VSMC mice displayed attenuated vascular remodeling through inhibition of dedifferentiation of VSMCs. Moreover, deletion of DNAPKcs in VSMCs alleviated Ang II-induced vasodilation dysfunction and hypertension. Mechanistic investigations denoted that Ang II-evoked rises in cytoplasmic DNA-PKcs interacted with dynamin-related protein 1 (Drp1) at its TQ motif to phosphorylate Drp1S616, subsequently promoting mitochondrial fragmentation and dysfunction, as well as reactive oxygen species (ROS) production. Treatment of irbesartan, an Ang II type 1 receptor (AT1R) blocker, downregulated DNA-PKcs expression in VSMCs and aortic tissues following Ang II administration.Conclusion: Our data revealed that cytoplasmic DNA-PKcs in VSMCs accelerated Ang II-induced vascular remodeling by interacting with Drp1 at its TQ motif and phosphorylating Drp1S616 to provoke mitochondrial fragmentation. Maneuvers targeting DNA-PKcs might be a valuable therapeutic option for the treatment of vascular remodeling and hypertension.
C1 [Wang, Litao; Wu, Lin; Du, Yuxin; Wang, Xiang; Zhang, Yingmei; Ren, Jun] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China.
   [Wang, Litao; Wu, Lin; Du, Yuxin; Wang, Xiang; Zhang, Yingmei; Ren, Jun] Natl Clin Res Ctr Intervent Med, Shanghai 200032, Peoples R China.
   [Yang, Bingsheng] Southern Med Univ, Nanfang Hosp, Dept Orthoped, Guangdong Prov Key Lab Bone & Cartilage Regenerat, Guangzhou 510515, Peoples R China.
   [Guo, Shuai; Xu, Yiming] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou 511436, Peoples R China.
   [Zhou, Yuan] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100191, Peoples R China.
   [Yang, Shuofei] Shanghai Jiao Tong Univ, Dept Vasc Surg, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China.
C3 Fudan University; Southern Medical University - China; Guangzhou Medical University; Peking University; Shanghai Jiao Tong University
RP Zhang, YM; Ren, J (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China.; Yang, SF (corresponding author), Shanghai Jiao Tong Univ, Dept Vasc Surg, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China.
EM doctor_yangshuofei@163.com; zhang.yingmei@zs-hospital.sh.cn; ren.jun@zs-hospital.sh.cn
FU National Natural Science Foundation of China [92249301]
CR BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7
   Campbell JH, 2012, ARTERIOSCL THROM VAS, V32, P1784, DOI 10.1161/ATVBAHA.111.243212
   Carneiro L, 2012, ANTIOXID REDOX SIGN, V17, P433, DOI 10.1089/ars.2011.4254
   Chaplin AK, 2021, NAT STRUCT MOL BIOL, V28, P0, DOI 10.1038/s41594-020-00517-x
   Chirinos JA, 2019, J AM COLL CARDIOL, V74, P1237, DOI 10.1016/j.jacc.2019.07.012
   Cristini A, 2016, NUCLEIC ACIDS RES, V44, P1161, DOI 10.1093/nar/gkv1196
   Croom KF, 2008, DRUGS, V68, P1543, DOI 10.2165/00003495-200868110-00008
   Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202
   Deng Y, 2021, BIOMED PHARMACOTHER, V140, P0, DOI 10.1016/j.biopha.2021.111689
   Dibitetto D, 2022, MOL CELL, V82, P3932, DOI 10.1016/j.molcel.2022.08.028
   Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973
   Dylgjeri E, 2022, CANCER RES, V82, P523, DOI 10.1158/0008-5472.CAN-21-1756
   Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fok JHL, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12836-9
   Fonseca TB, 2019, NATURE, V570, PE34, DOI 10.1038/s41586-019-1296-y
   Gao QT, 2022, SIGNAL TRANSDUCT TAR, V7, P0, DOI 10.1038/s41392-022-00933-z
   Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105
   Intengan HD, 1999, CIRCULATION, V100, P2267, DOI 10.1161/01.CIR.100.22.2267
   Kotula E, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0080313
   Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9
   Lacolley P, 2017, PHYSIOL REV, V97, P1555, DOI 10.1152/physrev.00003.2017
   Lees-Miller JP, 2021, PROG BIOPHYS MOL BIO, V163, P87, DOI 10.1016/j.pbiomolbio.2020.09.010
   LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041
   Li GH, 2022, HYPERTENSION, V79, PE116, DOI 10.1161/HYPERTENSIONAHA.122.19126
   Li MX, 2014, FREE RADICAL BIO MED, V76, P278, DOI 10.1016/j.freeradbiomed.2014.08.019
   Li YK, 2013, J BIOL CHEM, V288, P13215, DOI 10.1074/jbc.M113.463679
   Lin QY, 2023, HYPERTENSION, V80, P57, DOI 10.1161/HYPERTENSIONAHA.122.20328
   Liu YY, 2022, RESP RES, V23, P0, DOI 10.1186/s12931-022-02171-x
   Marampon F, 2014, INT J ONCOL, V44, P2121, DOI 10.3892/ijo.2014.2358
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Medunjanin S, 2015, CARDIOVASC RES, V106, P488, DOI 10.1093/cvr/cvv126
   Menolfi D, 2020, CELL BIOSCI, V10, P0, DOI 10.1186/s13578-020-0376-x
   Miller KN, 2021, CELL, V184, P5506, DOI 10.1016/j.cell.2021.09.034
   Morimoto S, 2003, HYPERTENS RES, V26, P315, DOI 10.1291/hypres.26.315
   Park SJ, 2017, CELL METAB, V25, P1135, DOI 10.1016/j.cmet.2017.07.005
   Puustinen P, 2020, AUTOPHAGY, V16, P1871, DOI 10.1080/15548627.2019.1710430
   Rogers MA, 2017, CIRC RES, V121, P220, DOI 10.1161/CIRCRESAHA.116.310293
   Roldán-Montero R, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abm7322
   Romick-Rosendale LE, 2016, CLIN CANCER RES, V22, P2062, DOI 10.1158/1078-0432.CCR-15-2209
   Shi N, 2019, ARTERIOSCL THROM VAS, V39, PE247, DOI 10.1161/ATVBAHA.119.312581
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Song ZQ, 2019, SIGNAL TRANSDUCT TAR, V4, P0, DOI 10.1038/s41392-019-0057-6
   Srinivas US, 2019, REDOX BIOL, V25, P0, DOI 10.1016/j.redox.2018.101084
   Tu Y, 2013, MOL CANCER, V12, P0, DOI 10.1186/1476-4598-12-172
   Umezu R, 2020, ARTERIOSCL THROM VAS, V40, PE214, DOI 10.1161/ATVBAHA.120.314383
   Wang L, 2015, CARDIOVASC RES, V106, P272, DOI 10.1093/cvr/cvv005
   Wang LT, 2021, ACTA PHARMACOL SIN, V42, P2033, DOI 10.1038/s41401-021-00623-6
   Wang LT, 2023, OBES REV, V24, P0, DOI 10.1111/obr.13567
   Wei FX, 2013, BBA-MOL CELL RES, V1833, P90, DOI 10.1016/j.bbamcr.2012.10.016
   Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040
   Wu L, 2023, TRENDS PHARMACOL SCI, V44, P34, DOI 10.1016/j.tips.2022.10.003
   Xia Y, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24043483
   Yang YW, 2023, NAT COMMUN, V14, P0, DOI 10.1038/s41467-023-37043-5
   Yue XQ, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.607428
   Zerihun M, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24065785
   Zhou H, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-019-0773-7
   Zhou H, 2018, J PINEAL RES, V64, P0, DOI 10.1111/jpi.12450
   Zhou P, 2018, NUCLEIC ACIDS RES, V46, PW443, DOI 10.1093/nar/gky357
NR 60
TC 6
Z9 7
U1 7
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
EI 
J9 REDOX BIOL
JI Redox Biol.
PD NOV 15
PY 2023
VL 67
IS 
BP 
EP 
DI 10.1016/j.redox.2023.102893
EA SEP 2023
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA U1BE4
UT WOS:001082218900001
PM 37741045
DA 2024-11-01
ER

PT J
AU Björkman, K
   Vissing, J
   Ostergaard, E
   Bindoff, LA
   de Coo, IFM
   Engvall, M
   Hikmat, O
   Isohanni, P
   Kollberg, G
   Lindberg, C
   Majamaa, K
   Naess, K
   Uusimaa, J
   Tulinius, M
   Darin, N
AF Bjorkman, Kristoffer
   Vissing, John
   ostergaard, Elsebet
   Bindoff, Laurence A.
   de Coo, Irenaeus F. M.
   Engvall, Martin
   Hikmat, Omar
   Isohanni, Pirjo
   Kollberg, Gittan
   Lindberg, Christopher
   Majamaa, Kari
   Naess, Karin
   Uusimaa, Johanna
   Tulinius, Mar
   Darin, Niklas
TI Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE congenital; hereditary; and neonatal diseases and abnormalities; sequence deletion; paediatrics; phenotype; prognosis
ID kearns-sayre syndrome; pearson-syndrome; prevalence; progression; management; disorders; childhood; diagnosis; features; cohort
AB Background Large-scale mitochondrial DNA deletions (LMD) are a common genetic cause of mitochondrial disease and give rise to a wide range of clinical features. Lack of longitudinal data means the natural history remains unclear. This study was undertaken to describe the clinical spectrum in a large cohort of patients with paediatric disease onset. Methods A retrospective multicentre study was performed in patients with clinical onset <16 years of age, diagnosed and followed in seven European mitochondrial disease centres. Results A total of 80 patients were included. The average age at disease onset and at last examination was 10 and 31 years, respectively. The median time from disease onset to death was 11.5 years. Pearson syndrome was present in 21%, Kearns-Sayre syndrome spectrum disorder in 50% and progressive external ophthalmoplegia in 29% of patients. Haematological abnormalities were the hallmark of the disease in preschool children, while the most common presentations in older patients were ptosis and external ophthalmoplegia. Skeletal muscle involvement was found in 65% and exercise intolerance in 25% of the patients. Central nervous system involvement was frequent, with variable presence of ataxia (40%), cognitive involvement (36%) and stroke-like episodes (9%). Other common features were pigmentary retinopathy (46%), short stature (42%), hearing impairment (39%), cardiac disease (39%), diabetes mellitus (25%) and renal disease (19%). Conclusion Our study provides new insights into the phenotypic spectrum of childhood-onset, LMD-associated syndromes. We found a wider spectrum of more prevalent multisystem involvement compared with previous studies, most likely related to a longer time of follow-up.
C1 [Bjorkman, Kristoffer; Tulinius, Mar; Darin, Niklas] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
   [Bjorkman, Kristoffer; Tulinius, Mar; Darin, Niklas] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Sweden.
   [Vissing, John] Rigshosp, Copenhagen Neuromuscular Ctr, Copenhagen, Denmark.
   [ostergaard, Elsebet] Rigshosp, Dept Clin Genet, Copenhagen, Denmark.
   [ostergaard, Elsebet] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
   [Bindoff, Laurence A.; Hikmat, Omar] Univ Bergen, Dept Clin Med K1, Bergen, Norway.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, NeurosysMed, Bergen, Norway.
   [de Coo, Irenaeus F. M.] Maastricht Univ, Dept Toxicogen, Unit Clin Genom, Maastricht, Netherlands.
   [de Coo, Irenaeus F. M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.
   [Engvall, Martin; Naess, Karin] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
   [Engvall, Martin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Hikmat, Omar] Haukeland Hosp, Dept Pediat, Bergen, Norway.
   [Isohanni, Pirjo] Univ Helsinki, Fac Med, Res Programs Unit, Stem Cells & Metab, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Helsinki, Finland.
   [Kollberg, Gittan] Univ Gothenburg, Dept Clin Chem, Gothenburg, Sweden.
   [Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
   [Majamaa, Kari] Oulu Univ, Fac Med, Med Res Ctr, Oulu, Finland.
   [Majamaa, Kari] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
   [Naess, Karin] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Uusimaa, Johanna] Oulu Univ, Fac Med, PEDEGO Res Unit, Oulu, Finland.
   [Uusimaa, Johanna] Oulu Univ Hosp, Clin Children & Adolescents, Oulu, Finland.
   [Darin, Niklas] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
C3 University of Gothenburg; Sahlgrenska University Hospital; Queen Silvia Children's Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Bergen; University of Bergen; Haukeland University Hospital; Maastricht University; Maastricht University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Bergen; Haukeland University Hospital; University of Helsinki; University of Helsinki; University of Gothenburg; Sahlgrenska University Hospital; University of Oulu; University of Oulu; Karolinska Institutet; University of Oulu; University of Oulu; University of Oulu
RP Björkman, K (corresponding author), Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
EM kristoffer.bjorkman@gu.se
FU Queen Silvia Children's Hospital Research Foundation; Swedish government [ALFGBG-718681, ALFGBG-427421]; Swedish country councils [ALFGBG-718681, ALFGBG-427421]; Gothenburg Society of Medicine; NeMO [20_P10]
CR Anteneová N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Cerri C, 1983, MITOCHONDRIAL PATHOL, V0, P141
   Chen J, 2018, ANTIOXID REDOX SIGN, V29, P1361, DOI 10.1089/ars.2017.7346
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Ferrington DA, 2020, TRENDS MOL MED, V26, P105, DOI 10.1016/j.molmed.2019.10.008
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holzer T, 2019, J CELL BIOL, V218, P1853, DOI 10.1083/jcb.201809056
   Karaa A, 2015, PEDIATR DIABETES, V16, P1, DOI 10.1111/pedi.12223
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McDonald DGM, 2002, AM J MED GENET, V111, P191, DOI 10.1002/ajmg.10522
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pijl S, 2008, EAR HEARING, V29, P472, DOI 10.1097/01.aud.0000310791.83193.62
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Quintos JB, 2016, J PEDIATR ENDOCR MET, V29, P1319, DOI 10.1515/jpem-2016-0172
   Rai PK, 2018, ESSAYS BIOCHEM, V62, P455, DOI 10.1042/EBC20170113
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, MUSCLE NERVE, V0, PS159
   Sacher M, 2005, NEURORADIOLOGY, V47, P241, DOI 10.1007/s00234-004-1314-z
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yu M, 2016, CHINESE MED J-PEKING, V129, P1419, DOI 10.4103/0366-6999.183417
NR 47
TC 4
Z9 4
U1 1
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JAN 15
PY 2023
VL 60
IS 1
BP 65
EP 73
DI 10.1136/jmedgenet-2021-108006
EA DEC 2021
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 7O9TO
UT WOS:000728713700001
PM 34872991
DA 2024-11-01
ER

PT J
AU Liao, NY
   Lai, KL
   Liao, YC
   Hsiao, CT
   Lee, YC
AF Liao, Nai-Yi
   Lai, Kuan-Lin
   Liao, Yi-Chu
   Hsiao, Cheng-Tsung
   Lee, Yi-Chung
TI Identification of m.3243A&gt;G mitochondrial DNA mutation in patients with cerebellar ataxia
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE Cerebellar ataxia; m.3243A > G; MELAS
ID heteroplasmy; disease; classification; features; urine
AB Background: The mitochondrial DNA m.3243A>G mutation can affect mitochondrial function and lead to a wide phenotypic spectrum, including mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, diabetes mellitus, hearing impairment, cardiac involvement, epilepsy, migraine, myopathy, and cerebellar ataxia. However, m.3243A>G has been rarely reported in patients with cerebellar ataxia as their predominant manifestation. The aim of this study is to investigate the prevalence and clinical features of m.3243A>G in a Taiwanese cohort of cerebellar ataxia with unknown genetic diagnosis.Methods: This retrospective cohort study conducted the mutation analysis of m.3243A>G by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) in 232 unrelated Han Chinese patients with genetically-undetermined cerebellar ataxia. The clinical presentation and neuroimaging features of patients with m.3243A>G mutation-related cere-bellar ataxia were characterized.Results: We identified two patients harboring m.3243A>G mutation. These patients have suf-fered from apparently sporadic and slowly progressive cerebellar ataxia since age 52 and 35 years, respectively. Both patients had diabetes mellitus and/or hearing impairment. The neu-roimaging studies revealed generalized brain atrophy with predominantly cerebellar involve-ment in both individuals and bilateral basal ganglia calcifications in one of the patients.Conclusion: Mitochondrial m.3243A>G mutation accounted for 0.9% (2/232) of genetically -undetermined cerebellar ataxia in the Han Chinese cohort in Taiwan. These findings highlight the importance of investigating m.3243A>G in patients with genetically-undetermined cere-bellar ataxia.Copyright 2023, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Liao, Nai-Yi] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.
   [Lai, Kuan-Lin; Liao, Yi-Chu; Hsiao, Cheng-Tsung; Lee, Yi-Chung] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Neurol, Taipei, Taiwan.
   [Lai, Kuan-Lin; Liao, Yi-Chu; Hsiao, Cheng-Tsung; Lee, Yi-Chung] Natl Yang Ming Chiao Tung Univ, Brain Res Ctr, Sch Med, Taipei, Taiwan.
   [Hsiao, Cheng-Tsung; Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, 201,Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
C3 Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital
RP Hsiao, CT; Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, 201,Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM cthsiao@vghtpe.gov.tw; ycli@vghtpe.gov.tw
FU Ministry of Science and Technology, Taiwan [109-2314-B-075-044-MY3, 110-2314-B-075-004- MY2]; Taipei Veterans General Hospital [V111C-033]; Brain Research Center of National Yang Ming Chiao Tung University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan
CR Abele M, 2002, BRAIN, V125, P961, DOI 10.1093/brain/awf107
   Almannai M, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.682780
   Ashizawa T, 2018, NAT REV NEUROL, V14, P590, DOI 10.1038/s41582-018-0051-6
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   Chae HW, 2020, EUR J ENDOCRINOL, V183, P505, DOI 10.1530/EJE-20-0189
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gruosso F, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10010094
   Hadjivassiliou M, 2017, J NEUROL NEUROSUR PS, V88, P301, DOI 10.1136/jnnp-2016-314863
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lee YC, 2007, J NEUROL SCI, V254, P65, DOI 10.1016/j.jns.2007.01.005
   Lopriore P, 2022, NEUROL INT, V14, P337, DOI 10.3390/neurolint14020028
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, P0, DOI 10.1007/s11916-016-0583-7
   Scholle LM, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11020212
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Paulson HL, 2017, NAT REV NEUROSCI, V18, P613, DOI 10.1038/nrn.2017.92
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Schöls L, 2000, HUM GENET, V107, P132, DOI 10.1007/s004390000346
   Soong Bing-Wen, 2018, HANDB CLIN NEUROL, V155, P143, DOI 10.1016/B978-0-444-64189-2.00010-X
   Stefanetti RJ, 2022, NEUROLOGY, V98, PE2318, DOI 10.1212/WNL.0000000000200299
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
NR 33
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD OCT 15
PY 2023
VL 122
IS 10
BP 1028
EP 1034
DI 10.1016/j.jfma.2023.05.031
EA SEP 2023
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA W6OV1
UT WOS:001092809400001
PM 37311680
DA 2024-11-01
ER

PT J
AU Shammas, MK
   Nie, Y
   Gilsrud, A
   Huang, XP
   Narendra, DP
   Chinnery, PF
AF Shammas, Mario K.
   Nie, Yu
   Gilsrud, Alexandra
   Huang, Xiaoping
   Narendra, Derek P.
   Chinnery, Patrick F.
TI CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
DE mitochondria; neurodegeneration; mtDNA deletions; mitochondrial DNA; CHCHD10
ID progressive external ophthalmoplegia; multiple mtdna deletions; endonuclease-g; motor neuronopathy; clonal expansion; direct repeats; gene; replication; generation; electron
AB Mutations affecting the mitochondrial intermembrane space protein CHCHD10 cause human disease, but it is not known why different amino acid substitutions cause markedly different clinical phenotypes, including amyotrophic lateral sclerosis-frontotemporal dementia, spinal muscular atrophy Jokela-type, isolated autosomal dominant mitochondrial myopathy and cardiomyopathy. CHCHD10 mutations have been associated with deletions of mitochondrial DNA (mtDNA deletions), raising the possibility that these explain the clinical variability. Here, we sequenced mtDNA obtained from hearts, skeletal muscle, livers and spinal cords of WT and Chchd10 G58R or S59L knockin mice to characterise the mtDNA deletion signatures of the two mutant lines. We found that the deletion levels were higher in G58R and S59L mice than in WT mice in some tissues depending on the Chchd10 genotype, and the deletion burden increased with age. Furthermore, we observed that the spinal cord was less prone to the development of mtDNA deletions than the other tissues examined. Finally, in addition to accelerating the rate of naturally occurring deletions, Chchd10 mutations also led to the accumulation of a novel set of deletions characterised by shorter direct repeats flanking the deletion breakpoints. Our results indicate that Chchd10 mutations in mice induce tissue-specific deletions which may also contribute to the clinical phenotype associated with these mutations in humans.
C1 [Shammas, Mario K.; Nie, Yu; Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.
   [Shammas, Mario K.; Nie, Yu; Chinnery, Patrick F.] Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.
   [Shammas, Mario K.; Gilsrud, Alexandra; Huang, Xiaoping; Narendra, Derek P.] NINDS, Inherited Movement Disorders Unit, Neurogenet Branch, NIH, 35 Convent Dr, Bethesda, MD 20892 USA.
   [Chinnery, Patrick F.] Keith Peters Bldg Rm 3-28,Hills Rd, Cambridge CB2 0XY, England.
C3 University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
RP Chinnery, PF (corresponding author), Keith Peters Bldg Rm 3-28,Hills Rd, Cambridge CB2 0XY, England.
EM pfc25@cam.ac.uk
FU MRC [MR/S005021/1] Funding Source: UKRI
CR Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Anderson CJ, 2019, ACTA NEUROPATHOL, V138, P103, DOI 10.1007/s00401-019-01989-y
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Burstein SR, 2018, HUM MOL GENET, V27, P160, DOI 10.1093/hmg/ddx397
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Genin EC, 2022, BRAIN, V145, P3415, DOI 10.1093/brain/awac197
   Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Guo L, 2021, NEUROMUSCULAR DISORD, V31, P859, DOI 10.1016/j.nmd.2021.06.014
   HeimanPatterson TD, 1997, MUSCLE NERVE, V20, P1219, DOI 10.1002/(SICI)1097-4598(199710)20:10<1219::AID-MUS2>3.0.CO;2-F
   Huang XP, 2018, HUM MOL GENET, V27, P3881, DOI 10.1093/hmg/ddy270
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005
   Ishihara T, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2210730119
   Johnson JO, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu265
   Jokela M, 2011, NEUROLOGY, V77, P334, DOI 10.1212/WNL.0b013e3182267b71
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Keeney PM, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-21
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kurzwelly D, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awv014
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Müller K, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu227
   Nasca A, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11060974
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nie Y, 2022, ACTA NEUROPATHOL, V143, P687, DOI 10.1007/s00401-022-02423-6
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077
   Rackham O, 2022, NAT REV GENET, V23, P606, DOI 10.1038/s41576-022-00480-x
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHATZ G, 1964, BIOCHEM BIOPH RES CO, V15, P127, DOI 10.1016/0006-291X(64)90311-0
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Shammas MK, 2023, BIOCHEM SOC T, V51, P797, DOI 10.1042/BST20221365
   Shammas MK, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI157504
   Shi CH, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.040
   Southwell N, 2023, BIORXIV, V0, P0
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Zambelli F, 2017, EUR J HUM GENET, V25, P1229, DOI 10.1038/ejhg.2017.129
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
NR 66
TC 0
Z9 0
U1 1
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 12
PY 2023
VL 33
IS 1
BP 91
EP 101
DI 10.1093/hmg/ddad161
EA OCT 2023
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CI1N6
UT WOS:001083052700001
PM 37815936
DA 2024-11-01
ER

PT J
AU Li, YJ
   Yang, SJ
   Jin, X
   Li, D
   Lu, J
   Wang, XY
   Wu, M
AF Li, Yujuan
   Yang, Shengjie
   Jin, Xiao
   Li, Dan
   Lu, Jing
   Wang, Xinyue
   Wu, Min
TI Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE atherosclerosis; mitochondria; gut microbiota; metabolism; herbal medicine
ID smooth-muscle-cells; dna copy number; intestinal cholesterol absorption; improves vascular function; induced oxidative stress; vein endothelial-cells; induced apoptosis; prevents atherosclerosis; inflammasome activation; heart-failure
AB Atherosclerosis (AS) is the main cause of cardiovascular disease (CVD) and is characterized by endothelial damage, lipid deposition, and chronic inflammation. Gut microbiota plays an important role in the occurrence and development of AS by regulating host metabolism and immunity. As human mitochondria evolved from primordial bacteria have homologous characteristics, they are attacked by microbial pathogens as target organelles, thus contributing to energy metabolism disorders, oxidative stress, and apoptosis. Therefore, mitochondria may be a key mediator of intestinal microbiota disorders and AS aggravation. Microbial metabolites, such as short-chain fatty acids, trimethylamine, hydrogen sulfide, and bile acids, also affect mitochondrial function, including mtDNA mutation, oxidative stress, and mitophagy, promoting low-grade inflammation. This further damages cellular homeostasis and the balance of innate immunity, aggravating AS. Herbal medicines and their monomers can effectively ameliorate the intestinal flora and their metabolites, improve mitochondrial function, and inhibit atherosclerotic plaques. This review focuses on the interaction between gut microbiota and mitochondria in AS and explores a therapeutic strategy for restoring mitochondrial function and intestinal microbiota disorders using herbal medicines, aiming to provide new insights for the prevention and treatment of AS.
C1 [Li, Yujuan; Yang, Shengjie; Jin, Xiao; Li, Dan; Lu, Jing; Wang, Xinyue; Wu, Min] China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China.
   [Lu, Jing] Beijing Univ Chinese Med, Beijing, Peoples R China.
C3 China Academy of Chinese Medical Sciences; Beijing University of Chinese Medicine
RP Wu, M (corresponding author), China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China.
EM wumin19762000@126.com
FU National Natural Science Foundation of China [81202805, 82074254]; Beijing Natural Science Foundation [7172185]; Science and Technology Innovation Project of China Academy of Chinese Medical Sciences [C12021A01413]
CR Abudureyimu M, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.565751
   Al-Obaide MAI, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6090086
   Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288
   Anhê FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142
   Arbeithuber B, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000745
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Assis LHD, 2022, FRONT MOL BIOSCI, V9, P0, DOI 10.3389/fmolb.2022.839428
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Banoth B, 2018, TRANSL RES, V202, P52, DOI 10.1016/j.trsl.2018.07.014
   Barrington WT, 2017, NAT REV CARDIOL, V14, P699, DOI 10.1038/nrcardio.2017.169
   Bird L, 2012, NAT REV IMMUNOL, V12, P229, DOI 10.1038/nri3195
   Bliksoen M, 2016, BASIC RES CARDIOL, V111, P0, DOI 10.1007/s00395-016-0553-6
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379
   Bogiatzi C, 2018, ATHEROSCLEROSIS, V273, P91, DOI 10.1016/j.atherosclerosis.2018.04.015
   Borisov VB, 2021, BIOCHEMISTRY-MOSCOW+, V86, P22, DOI 10.1134/S000629792101003X
   Boulangé CL, 2016, GENOME MED, V8, P0, DOI 10.1186/s13073-016-0303-2
   Braakhuis AJ, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/8575263
   Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149
   Buskiewicz IA, 2016, SCI SIGNAL, V9, P0, DOI 10.1126/scisignal.aaf1933
   Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026
   Cai XY, 2020, BMJ-BRIT MED J, V370, P0, DOI 10.1136/bmj.m2297
   Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991
   Canugovi C, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101288
   Cao H, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20236093
   Chen J, 2016, GENOME MED, V8, P0, DOI 10.1186/s13073-016-0299-7
   Chen ML, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006347
   Chen ML, 2016, MBIO, V7, P0, DOI 10.1128/mBio.02210-15
   Chen XY, 2021, EUR J PHARMACOL, V911, P0, DOI 10.1016/j.ejphar.2021.174495
   Chen XP, 2020, EUR J PHARMACOL, V868, P0, DOI 10.1016/j.ejphar.2019.172885
   Chen Z, 2022, VASC PHARMACOL, V144, P0, DOI 10.1016/j.vph.2022.106979
   Cheng F, 2013, INT J CARDIOL, V167, P936, DOI 10.1016/j.ijcard.2012.03.090
   Cho YE, 2013, AM J PHYSIOL-CELL PH, V305, PC1033, DOI 10.1152/ajpcell.00234.2013
   Choi SH, 2021, ARTERIOSCL THROM VAS, V41, PE82, DOI 10.1161/ATVBAHA.120.315485
   Chowdhury A, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.796066
   Clark A, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00319
   Cox FF, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11030342
   Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, PH2721, DOI 10.1152/ajpheart.00235.2008
   Csiszar A, 2014, AM J PHYSIOL-HEART C, V307, PH292, DOI 10.1152/ajpheart.00307.2014
   Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, PH13, DOI 10.1152/ajpheart.00368.2009
   Cui JS, 2018, CELL STRESS CHAPERON, V23, P281, DOI 10.1007/s12192-017-0841-6
   Cui L, 2017, VASC PHARMACOL, V88, P21, DOI 10.1016/j.vph.2016.11.006
   Dagenais GR, 2020, LANCET, V395, P785, DOI 10.1016/S0140-6736(19)32007-0
   Davinelli S, 2013, IMMUN AGEING, V10, P0, DOI 10.1186/1742-4933-10-28
   Esposti M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096566
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Ding ZF, 2016, ANTIOXID REDOX SIGN, V25, P997, DOI 10.1089/ars.2016.6631
   Dorighello GG, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11091734
   Duan M, 2022, CELL COMMUN SIGNAL, V20, P0, DOI 10.1186/s12964-022-00858-8
   Dumont A, 2021, MOL ASPECTS MED, V77, P0, DOI 10.1016/j.mam.2020.100922
   Fang CJ, 2016, PROTEIN CELL, V7, P11, DOI 10.1007/s13238-015-0222-9
   Fedotcheva N, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9050558
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Forte M, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-04188-4
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Gioscia-Ryan RA, 2018, J APPL PHYSIOL, V124, P1194, DOI 10.1152/japplphysiol.00670.2017
   Giusti L, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/1026268
   Gkikas I, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.01283
   Gomez-Arango LF, 2018, GUT MICROBES, V9, P189, DOI 10.1080/19490976.2017.1406584
   Granatiero V, 2016, CELL DEATH DIFFER, V23, P231, DOI 10.1038/cdd.2015.84
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Gregory JC, 2015, J BIOL CHEM, V290, P5647, DOI 10.1074/jbc.M114.618249
   Gupta P, 2016, INT J PHARMACEUT, V511, P1012, DOI 10.1016/j.ijpharm.2016.07.071
   Habtemariam S, 2020, PHARMACOL RES, V155, P0, DOI 10.1016/j.phrs.2020.104722
   Han JH, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1753-4
   Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07
   He D, 2002, GASTROENTEROLOGY, V122, P1048, DOI 10.1053/gast.2002.32386
   Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490
   Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161
   Hong T, 2022, NUTRIENTS, V14, P0, DOI 10.3390/nu14091828
   Hotz MJ, 2018, AM J RESP CRIT CARE, V197, P470, DOI 10.1164/rccm.201706-1161OC
   Hu WC, 2022, FRONT CELL INFECT MI, V11, P0, DOI 10.3389/fcimb.2021.743454
   Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009
   Huang Y, 2014, APPL ENVIRON MICROB, V80, P7496, DOI 10.1128/AEM.02926-14
   Hung CH, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22041683
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Jackson DN, 2020, GUT MICROBES, V11, P285, DOI 10.1080/19490976.2019.1592421
   Jenner A, 2022, EMBO J, V41, P0, DOI 10.15252/embj.2021108587
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Jiang YH, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00512
   Jin Y, 2022, CELL DEATH DIS, V13, P0, DOI 10.1038/s41419-022-04966-8
   Jonsson AL, 2017, ATHEROSCLEROSIS, V263, P177, DOI 10.1016/j.atherosclerosis.2017.06.016
   Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183
   Juárez-Fernández M, 2023, HEPATOLOGY, V77, P1654, DOI 10.1002/hep.32705
   Kalghatgi S, 2013, SCI TRANSL MED, V5, P0, DOI 10.1126/scitranslmed.3006055
   Kampa RP, 2021, BIOMED PHARMACOTHER, V142, P0, DOI 10.1016/j.biopha.2021.112039
   Kappel BA, 2020, MOL METAB, V36, P0, DOI 10.1016/j.molmet.2020.100976
   Karunakaran D, 2015, CIRC RES, V117, P266, DOI 10.1161/CIRCRESAHA.117.305624
   Katsnelson MA, 2016, AM J PHYSIOL-CELL PH, V311, PC83, DOI 10.1152/ajpcell.00298.2015
   Khatua Tarak Nath, 2016, BIOCHEM BIOPHYS REP, V5, P77, DOI 10.1016/j.bbrep.2015.11.008
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kim EN, 2018, ATHEROSCLEROSIS, V270, P123, DOI 10.1016/j.atherosclerosis.2018.01.043
   Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011
   Kirichenko TV, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.586189
   Kleele T, 2021, NATURE, V593, P435, DOI 10.1038/s41586-021-03510-6
   Ko J, 2019, FASEB J, V33, P13334, DOI 10.1096/fj.201901148R
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107
   Korytowski W, 2015, ARTERIOSCL THROM VAS, V35, P2104, DOI 10.1161/ATVBAHA.115.306210
   Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819
   Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60
   Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004
   Lawton JS, 2022, CIRCULATION, V145, PE4, DOI 10.1161/CIR.0000000000001039
   Le Roy T, 2022, GUT, V71, P534, DOI 10.1136/gutjnl-2020-323778
   Li C, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00796
   Li JY, 2022, CARDIOVASC RES, V118, P2018, DOI 10.1093/cvr/cvab243
   Li JL, 2021, ARTERIOSCL THROM VAS, V41, P839, DOI 10.1161/ATVBAHA.120.315556
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li M, 2020, BIOMED PHARMACOTHER, V132, P0, DOI 10.1016/j.biopha.2020.110953
   Li SS, 2015, ANTIOXID REDOX SIGN, V23, P630, DOI 10.1089/ars.2014.6186
   Li XX, 2021, NPJ BIOFILMS MICROBI, V7, P0, DOI 10.1038/s41522-021-00205-8
   Li ZQ, 2021, REDOX BIOL, V47, P0, DOI 10.1016/j.redox.2021.102156
   Lian NQ, 2022, INT IMMUNOPHARMACOL, V110, P0, DOI 10.1016/j.intimp.2022.108936
   Liang YM, 2022, ENVIRON POLLUT, V295, P0, DOI 10.1016/j.envpol.2021.118720
   Libiad M, 2019, J BIOL CHEM, V294, P12077, DOI 10.1074/jbc.RA119.009442
   Lim Jong-Hoon, 2009, KOREAN JOURNAL OF INTERNAL MEDICINE, V24, P113, DOI 10.3904/kjim.2009.24.2.113
   Lim S, 2015, J CELL BIOCHEM, V116, P648, DOI 10.1002/jcb.25016
   Liu H, 2020, J LEUKOCYTE BIOL, V108, P253, DOI 10.1002/JLB.3MA0320-358RR
   Liu L, 2013, EUR REV MED PHARMACO, V17, P88
   Liu LL, 2014, EUR J PHARMACOL, V725, P23, DOI 10.1016/j.ejphar.2014.01.010
   Liu QX, 2020, MICROB PATHOGENESIS, V138, P0, DOI 10.1016/j.micpath.2019.103827
   Liu QY, 2018, MOL IMMUNOL, V103, P115, DOI 10.1016/j.molimm.2018.09.010
   Liu Y, 2021, ATHEROSCLEROSIS, V333, P75, DOI 10.1016/j.atherosclerosis.2021.08.029
   Liu YJ, 2017, MOL MED REP, V15, P2457, DOI 10.3892/mmr.2017.6304
   Longchamp A, 2018, CELL, V173, P117, DOI 10.1016/j.cell.2018.03.001
   López-Salazar V, 2021, J NUTR BIOCHEM, V94, P0, DOI 10.1016/j.jnutbio.2021.108751
   Lopresti AL, 2018, ADV NUTR, V9, P41, DOI 10.1093/advances/nmx011
   Lu Y, 2016, EUR REV MED PHARMACO, V20, P1609
   Lv ZY, 2021, BIOMED PHARMACOTHER, V134, P0, DOI 10.1016/j.biopha.2020.111100
   Ma J, 2019, BIOTECHNOL APPL BIOC, V66, P690, DOI 10.1002/bab.1786
   Ma S, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/9286458
   Ma SR, 2022, SIGNAL TRANSDUCT TAR, V7, P0, DOI 10.1038/s41392-022-01027-6
   Ma Y, 2018, FREE RADICAL BIO MED, V129, P463, DOI 10.1016/j.freeradbiomed.2018.10.412
   Mahmud SA, 2022, FEBS J, V289, P7014, DOI 10.1111/febs.16126
   Maimaitijiang A, 2016, BIOCHEM BIOPH RES CO, V471, P474, DOI 10.1016/j.bbrc.2016.02.051
   Makrecka-Kuka M, 2017, TOXICOL LETT, V267, P32, DOI 10.1016/j.toxlet.2016.12.017
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   McFadden RMT, 2015, INFLAMM BOWEL DIS, V21, P2483, DOI 10.1097/MIB.0000000000000522
   Michael DR, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-02889-5
   Mikó E, 2018, BBA-BIOENERGETICS, V1859, P958, DOI 10.1016/j.bbabio.2018.04.002
   Misawa T, 2017, ADV EXP MED BIOL, V997, P187, DOI 10.1007/978-981-10-4567-7_14
   Módis K, 2014, BRIT J PHARMACOL, V171, P2123, DOI 10.1111/bph.12368
   Mohammadi A, 2016, INFLAMMATION, V39, P393, DOI 10.1007/s10753-015-0261-7
   Mohanty A, 2019, J CELL COMMUN SIGNAL, V13, P303, DOI 10.1007/s12079-019-00507-9
   Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924
   Murphy B, 2019, FASEB J, V33, P13098, DOI 10.1096/fj.201901304R
   Najjar RS, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11112712
   Nguyen EK, 2018, ARTERIOSCL THROM VAS, V38, P1333, DOI 10.1161/ATVBAHA.118.310951
   Nie J, 2019, J APPL MICROBIOL, V127, P1824, DOI 10.1111/jam.14441
   Oliveira HCF, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.100840
   Orekhov AN, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9040978
   Orekhov AN, 2020, CURR NEUROPHARMACOL, V18, P1064, DOI 10.2174/1570159X17666191118125018
   Panyod S, 2022, NPJ BIOFILMS MICROBI, V8, P0, DOI 10.1038/s41522-022-00266-3
   Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170
   Paul BD, 2021, REDOX BIOL, V38, P0, DOI 10.1016/j.redox.2020.101772
   Peace CG, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI148548
   Peng X, 2022, INFLAMM RES, V71, P695, DOI 10.1007/s00011-022-01570-6
   Peng X, 2020, CELL BIOL INT, V44, P1481, DOI 10.1002/cbin.11343
   Pham PT, 2021, EUR HEART J, V42, P4336, DOI 10.1093/eurheartj/ehab249
   Picca A, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11040675
   Pollack RM, 2017, J GERONTOL A-BIOL, V72, P1703, DOI 10.1093/gerona/glx041
   Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006
   Primec M, 2019, CLIN NUTR, V38, P1373, DOI 10.1016/j.clnu.2018.06.931
   Pu YF, 2013, CELL PHYSIOL BIOCHEM, V32, P1167, DOI 10.1159/000354516
   Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601
   Pursnani A, 2017, J CLIN ONCOL, V35, P2927, DOI 10.1200/JCO.2016.71.3594
   Qi Y, 2022, FRONT PHARMACOL, V13, P0, DOI 10.3389/fphar.2022.805266
   Querio G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20123045
   Ramachandran RP, 2020, MBIO, V11, P0, DOI 10.1128/mBio.01397-20
   Rassow J, 2011, CELL COMMUN SIGNAL, V9, P0, DOI 10.1186/1478-811X-9-26
   Robert P, 2021, FASEB J, V35, P0, DOI 10.1096/fj.202000238RRR
   Rodrigues RR, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20313-x
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Rong QF, 2022, FRONT PHARMACOL, V12, P0, DOI 10.3389/fphar.2021.729384
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Rossman MJ, 2018, HYPERTENSION, V71, P1056, DOI 10.1161/HYPERTENSIONAHA.117.10787
   Rossmann MP, 2021, DIS MODEL MECH, V14, P0, DOI 10.1242/dmm.048912
   Salnikova D, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22168990
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6934394
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022
   Schneider J, 2018, CHEM RES TOXICOL, V31, P447, DOI 10.1021/acs.chemrestox.7b00329
   Shames SR, 2011, INFECT IMMUN, V79, P4784, DOI 10.1128/IAI.05761-11
   Shen XG, 2013, FREE RADICAL BIO MED, V60, P195, DOI 10.1016/j.freeradbiomed.2013.02.024
   Shi RZ, 2018, LIFE SCI, V207, P442, DOI 10.1016/j.lfs.2018.06.033
   Shi XE, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11122909
   Shi YF, 2018, BIOMED PHARMACOTHER, V107, P1556, DOI 10.1016/j.biopha.2018.08.148
   Song YJ, 2020, CELL COMMUN SIGNAL, V18, P0, DOI 10.1186/s12964-020-00659-x
   Song YJ, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/3960773
   Sprenger HG, 2021, NAT METAB, V3, P636, DOI 10.1038/s42255-021-00385-9
   Springo Z, 2015, J GERONTOL A-BIOL, V70, P1355, DOI 10.1093/gerona/glu244
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054
   Sukumaran SK, 2010, MOL CELL, V37, P768, DOI 10.1016/j.molcel.2010.02.015
   Sun AL, 2016, CELL BIOSCI, V6, P0, DOI 10.1186/s13578-016-0102-x
   Sun Y, 2020, AGING DIS, V11, P269, DOI 10.14336/AD.2019.0524
   Sung MM, 2017, DIABETES, V66, P418, DOI 10.2337/db16-0680
   Swiader A, 2016, ONCOTARGET, V7, P28821, DOI 10.18632/oncotarget.8936
   Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400
   Tang X, 2020, J AGR FOOD CHEM, V68, P6588, DOI 10.1021/acs.jafc.0c01820
   Tian L, 2022, ECOTOX ENVIRON SAFE, V240, P0, DOI 10.1016/j.ecoenv.2022.113663
   Toksoy A, 2017, J BIOL CHEM, V292, P2805, DOI 10.1074/jbc.M116.749473
   Toral M, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201800033
   Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, PH1876, DOI 10.1152/ajpheart.00375.2009
   Untereiner AA, 2016, ANTIOXID REDOX SIGN, V24, P129, DOI 10.1089/ars.2015.6369
   Valente WJ, 2016, NUCLEIC ACIDS RES, V44, P8513, DOI 10.1093/nar/gkw716
   Vecoli C, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20215508
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Vendrov AE, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006775
   Verhaar BJH, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12102982
   Vezza T, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9090848
   Videja M, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.622741
   Wan Q, 2016, BIO-MED MATER ENG, V27, P577, DOI 10.3233/BME-161610
   Wang AL, 2019, PHARMACOL RES, V142, P205, DOI 10.1016/j.phrs.2019.02.018
   Wang J, 2017, AM J PHYSIOL-CELL PH, V312, PC438, DOI 10.1152/ajpcell.00235.2016
   Wang L, 2023, ACTA PHARMACOL SIN, V44, P332, DOI 10.1038/s41401-022-00956-w
   Wang YX, 2018, AM J PHYSIOL-ENDOC M, V315, PE622, DOI 10.1152/ajpendo.00081.2018
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Wang ZC, 2022, FRONT MICROBIOL, V13, P0, DOI 10.3389/fmicb.2022.814855
   Wei T, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006114
   Lian WS, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10040860
   Wellman AS, 2017, GASTROENTEROLOGY, V153, P772, DOI 10.1053/j.gastro.2017.05.022
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973
   Wil DN, 2019, CARDIOVASC DIAGN THE, V9, P545, DOI 10.21037/cdt.2019.12.04
   Witkowski M, 2020, CIRC RES, V127, P553, DOI 10.1161/CIRCRESAHA.120.316242
   Wu D, 2015, NITRIC OXIDE-BIOL CH, V46, P204, DOI 10.1016/j.niox.2014.11.006
   Wu M, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00223
   Wu WW, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132499
   Xian HX, 2022, IMMUNITY, V55, P1370, DOI 10.1016/j.immuni.2022.06.007
   Xie TQ, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.01034
   Xu AJ, 2020, BIOMED PHARMACOTHER, V130, P0, DOI 10.1016/j.biopha.2020.110525
   Xu H, 2022, FRONT PHARMACOL, V13, P0, DOI 10.3389/fphar.2022.919181
   Xu L, 2022, MBIO, V13, P0, DOI 10.1128/mbio.03632-21
   Xue HL, 2022, CIRC RES, V131, P404, DOI 10.1161/CIRCRESAHA.122.321253
   Yang JN, 2019, NUTR METAB, V16, P0, DOI 10.1186/s12986-019-0338-7
   Yang L, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13206
   Yang M, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13113989
   Yang YN, 2022, BIOMED PHARMACOTHER, V155, P0, DOI 10.1016/j.biopha.2022.113749
   Yao SS, 2020, FREE RADICAL BIO MED, V159, P66, DOI 10.1016/j.freeradbiomed.2020.07.028
   Yaron JR, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.277
   Yin Z, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-20942-w
   Yoo JY, 2022, MICROORGANISMS, V10, P0, DOI 10.3390/microorganisms10010108
   Yoshida Y, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-19245-x
   You SB, 2019, PHYTOMEDICINE, V62, P0, DOI 10.1016/j.phymed.2019.152955
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111
   Yu MY, 2021, INT J BIOL SCI, V17, P1693, DOI 10.7150/ijbs.54604
   Zaharuddin L, 2019, BMC GASTROENTEROL, V19, P0, DOI 10.1186/s12876-019-1047-4
   Zhai TY, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/3900835
   Zhang CH, 2020, FASEB J, V34, P10682, DOI 10.1096/fj.202001007R
   Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650
   Zhang JX, 2022, ECOTOX ENVIRON SAFE, V244, P0, DOI 10.1016/j.ecoenv.2022.114057
   Zhang L, 2012, APOPTOSIS, V17, P25, DOI 10.1007/s10495-011-0653-6
   Zhang M, 2017, CELL PHYSIOL BIOCHEM, V41, P2255, DOI 10.1159/000475640
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang SJ, 2021, ADV SCI, V8, P0, DOI 10.1002/advs.202003410
   Zhang X, 2018, BIOCHEM BIOPH RES CO, V495, P454, DOI 10.1016/j.bbrc.2017.11.048
   Zhang YM, 2022, PHARMACOL RES, V186, P0, DOI 10.1016/j.phrs.2022.106530
   Zhang YY, 2017, EUR HEART J, V38, P3443, DOI 10.1093/eurheartj/ehx354
   Zhang YK, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/2876350
   Zhao M, 2021, ACS NANO, V15, P1519, DOI 10.1021/acsnano.0c08947
   Zhao TT, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/1904609
   Zhao YB, 2020, INT J MOL MED, V45, P1514, DOI 10.3892/ijmm.2020.4513
   Zheng MH, 2014, MOL CELL BIOCHEM, V393, P59, DOI 10.1007/s11010-014-2046-y
   Zhou P, 2022, J FOOD BIOCHEM, V46, P0, DOI 10.1111/jfbc.14376
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zhou X, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.530
   Zhou Y, 2021, MOLECULES, V26, P0, DOI 10.3390/molecules26082320
   Zhu L, 2018, ATHEROSCLEROSIS, V268, P117, DOI 10.1016/j.atherosclerosis.2017.11.023
   Zhu N, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00367
   Zhu WZ, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-0861-x
   Ziganshina EE, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164836
   Zou J, 2018, NUTR RES, V56, P32, DOI 10.1016/j.nutres.2018.04.017
NR 279
TC 8
Z9 9
U1 7
U2 31
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JAN 17
PY 2023
VL 14
IS 
BP 
EP 
DI 10.3389/fphar.2023.1082817
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 8H3FT
UT WOS:000920921300001
PM 36733506
DA 2024-11-01
ER

PT J
AU Samanta, A
   Srivastava, A
   Mandal, K
   Sarma, MS
   Poddar, U
AF Samanta, Arghya
   Srivastava, Anshu
   Mandal, Kausik
   Sarma, Moinak Sen
   Poddar, Ujjal
TI MPV17 mutation-related mitochondrial DNA depletion syndrome: A case series in infants
SO INDIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Children; Cholestasis; Fatty liver; Hepato-cerebral form; Hypoketotic hypoglycemia; Infantile liver failure; Liver transplantation; Metabolic liver disease; Mitochondrial hepatopathy; Myopathy; Next-generation sequencing
ID disease
AB MPV17 is a mitochondrial inner membrane protein, involved in transporting deoxynucleotides into the mitochondria. Pathogenic MPV17 mutations can cause mitochondrial deoxyribonucleic acid (DNA) depletion syndrome, which has a varied presentation with neurological, muscular and hepatic involvement. Presentation as liver failure is relatively uncommon. Here, we report four infants from four separate families with pathogenic, homozygous MPV17 mutations. All had predominant hepatic involvement with cholestasis, lactic acidosis and hypoketotic hypoglycemia. Three of them had presented with liver failure. Interestingly, one of them showed fluctuating liver functions, which worsened with infection and improved after aggressive treatment with antibiotics and supplements. Two of the four cases died in infancy, while the other two improved on conservative management with medium-chain triglyceride-based diet, vitamin supplements, co-enzyme Q and carnitine. The two surviving children are alive at 12 and 25 months of age with native liver with normal to mildly deranged liver function and no neurological dysfunction. Next-generation sequencing confirmed the diagnosis in all of our cases. One of the detected mutations, c.55delC (p.Gln19ArgfsTer3) is a novel pathogenic frameshift mutation, while another mutation c.388G>C (p.Ala130Pro), which was previously reported in Single Nucleotide Polymorphism Database in heterozygous form, is being predicted as likely pathogenic in our case series. We, therefore, propose mutation testing for MPV17 gene during evaluation of indeterminate infantile liver failure, especially those with hypoglycemia and raised plasma lactate.
C1 [Samanta, Arghya; Srivastava, Anshu; Sarma, Moinak Sen; Poddar, Ujjal] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Lucknow 226014, India.
   [Mandal, Kausik] Sanjay Gandhi Postgrad Inst Med Sci, Dept Med Genet, Lucknow 226014, India.
C3 Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences
RP Srivastava, A (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Lucknow 226014, India.
EM avanianshu@yahoo.com
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Bijarnia-Mahay S, 2014, INDIAN PEDIATR, V51, P666, DOI 10.1007/s13312-014-0475-z
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   Feldman AG, 2017, J PEDIATR-US, V182, P217, DOI 10.1016/j.jpeds.2016.12.031
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Kamate M, 2021, INDIAN J PEDIATR, V88, P377, DOI 10.1007/s12098-020-03583-7
   McKiernan P, 2016, J PEDIATR GASTR NUTR, V63, P592, DOI 10.1097/MPG.0000000000001345
   Murali CN, 2021, MOL GENET METAB, V132, P146, DOI 10.1016/j.ymgme.2021.01.005
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Shimura M, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-01441-5
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Zweers H, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-01927-w
NR 12
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA
SN 0254-8860
EI 0975-0711
J9 INDIAN J GASTROENTER
JI Indian J. Gastroenterol.
PD AUG 15
PY 2023
VL 42
IS 4
BP 569
EP 574
DI 10.1007/s12664-022-01281-0
EA FEB 2023
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA N5YQ7
UT WOS:000929364000002
PM 36753038
DA 2024-11-01
ER

PT J
AU Scuderi, C
   Santa Paola, S
   Lo Giudice, M
   Blasi, FDD
   Giusto, S
   Di Vita, G
   Pettinato, R
   Vitello, GA
   Romano, C
   Buono, S
   Salpietro, V
   Houlden, H
   Borgione, E
AF Scuderi, Carmela
   Santa Paola, Sandro
   Lo Giudice, Mariangela
   Blasi, Francesco Domenico Di
   Giusto, Stefania
   Di Vita, Giuseppa
   Pettinato, Rosa
   Vitello, Girolamo Aurelio
   Romano, Corrado
   Buono, Serafino
   Salpietro, Vincenzo
   Houlden, Henry
   Borgione, Eugenia
TI Mitochondrial DNA involvement in patients with autism spectrum disorders and intellectual disability
SO RESEARCH IN AUTISM SPECTRUM DISORDERS
LA English
DT Article
DE Autism; Intellectual disability; MtDNA; Mitochondrial disease
ID dysfunction; mutation; disease; abnormality; association; deficiency; genetics
AB Background: Autism spectrum disorders (ASD) are neurodevelopmental disorders, with hetero-geneous etiology, characterized by deficiencies in social interaction, communication, and by repetitive and stereotyped behaviors. Mitochondrial encephalomyopathies are inherited disorders of oxidative metabolism, with a wide clinical, biochemical and genetic heterogeneity, requiring a complex diagnostic flow-chart. In-fantile forms often occur with defects in development, intellectual disabilities and dysmorphisms. ASD has been associated with mitochondrial respiratory chain deficiency and/or mitochondrial DNA (mtDNA) mutations. However, few studies carried out detailed clinical, instrumental, morphological, biochemical investigations, and mtDNA sequencing in ASD patients.Method: The purpose of this study was the identification of mitochondrial dysfunction due to mtDNA variants in 19 selected subjects presenting ASD and clinical features of mitochondrial disease. For these patients we adopted a multidisciplinary approach combining clinical and laboratory investigations on muscle biopsy, with biochemical, histological and genetic techniques.Results: The histological examination showed myogenic or neurogenic changes in 79 % of pa-tients; furthermore, 58 % of the patients had lipid accumulation, mitochondrial proliferation and COX deficient fibers. The biochemical investigations reported in three patients impairments involving one or more of the respiratory chain complexes. In addition, genetic studies revealed in one patient with normal histology and biochemistry multiple mtDNA deletions, and in four pa-tients different mtDNA point mutations.Conclusions: The present study confirms the hypothesis of an association between ASD and mitochondrial dysfunction. However, further studies in a larger group of subjects are needed.
C1 [Scuderi, Carmela; Santa Paola, Sandro; Lo Giudice, Mariangela; Borgione, Eugenia] Oasi Res Inst IRCCS, Unit Neuromuscular Dis, Via Conte Ruggero 73, Troina, Italy.
   [Blasi, Francesco Domenico Di; Buono, Serafino] Oasi Res Inst IRCCS, Unit Psychol, Via Conte Ruggero 73, Troina, Italy.
   [Giusto, Stefania; Di Vita, Giuseppa] Acireale Hosp, Prov Hlth Serv Catania ASP CT, Child & Adolescent Neuropsychiat Unit, Acireale, Italy.
   [Pettinato, Rosa] Oasi Res Inst, Unit Pediat & Med Genet, Via Conte Ruggero 73, Troina, Italy.
   [Vitello, Girolamo Aurelio] Oasi Res Inst IRCCS, Unit Neurol, Via Conte Ruggero 73, Troina, Italy.
   [Romano, Corrado] Oasi Res Inst IRCCS, Res Unit Rare Dis & Neurodev Disorders, Via Conte Ruggero 73, Troina, Italy.
   [Romano, Corrado] Univ Catania, Dept Biomed & Biotechnol Sci, Sect Med Biochem, Med Genet, Catania, Italy.
   [Salpietro, Vincenzo] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16132 Genoa, Italy.
   [Salpietro, Vincenzo] IRCCS Giannina Gaslini Inst, Pediat Neurol & Muscular Dis Unit, I-16147 Genoa, Italy.
   [Salpietro, Vincenzo; Houlden, Henry] UCL, UCL Queen Sq Inst Neurol, Dept Neuromuscular Disorders, London WC1N 3BG, England.
C3 University of Catania; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of London; University College London
RP Scuderi, C (corresponding author), Oasi Res Inst IRCCS, Unit Neuromuscular Dis, Via Conte Ruggero 73, Troina, Italy.
EM cscuderi@oasi.en.it
FU Italian Ministry of Health;  [RC2022]
CR Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   [Anonymous], 2013, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, V0, P0
   Avdjieva-Tzavella D, 2012, BALK J MED GENET, V15, P47, DOI 10.2478/bjmg-2013-0006
   Aydin HI, 2018, INDIAN PEDIATR, V55, P67, DOI 10.1007/s13312-018-1232-5
   Buxbaum Joseph D, 2009, DIALOGUES CLIN NEUROSCI, V11, P35
   Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607
   Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596
   Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559
   Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Gu F, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.68
   Guevara-Campos J, 2015, INT J MOL SCI, V16, P3870, DOI 10.3390/ijms16023870
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76
   Lord C, 2005, AUTISM DIAGNOSTIC OBSERVATION SCHEDULE (ADOS): MANUAL, V0, P0
   Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34
   Manzi B, 2008, J CHILD NEUROL, V23, P307, DOI 10.1177/0883073807308698
   Marin-Garcia J, 1999, PEDIATR NEUROL, V21, P538, DOI 10.1016/S0887-8994(99)00038-7
   Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Napoli E, 2013, MOL AUTISM, V4, P0, DOI 10.1186/2040-2392-4-2
   Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332
   Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018
   Pancrudo J, 2007, NEUROMUSCULAR DISORD, V17, P651, DOI 10.1016/j.nmd.2007.04.005
   Patowary A, 2017, AUTISM RES, V10, P1338, DOI 10.1002/aur.1792
   Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012
   Petek E, 2007, MOL GENET GENOMICS, V277, P71, DOI 10.1007/s00438-006-0173-1
   Piryaei F, 2012, CELL J, V14, P98
   Pons R, 2004, J PEDIATR-US, V144, P81, DOI 10.1016/j.jpeds.2003.10.023
   Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Rose S, 2018, MOL DIAGN THER, V22, P571, DOI 10.1007/s40291-018-0352-x
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Rutter M, 2003, AUTISM DIAGNOSTIC INTERVIEWREVISED (ADI-R), V29, P30
   SANTORELLI FM, 1995, BIOCHEM BIOPH RES CO, V216, P835, DOI 10.1006/bbrc.1995.2697
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shoffner J, 2010, J CHILD NEUROL, V25, P429, DOI 10.1177/0883073809342128
   Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012
   Valiente-Pallejà A, 2018, HUM MOL GENET, V27, P891, DOI 10.1093/hmg/ddy009
   Varga NA, 2018, BEHAV BRAIN FUNCT, V14, P0, DOI 10.1186/s12993-018-0135-x
   Weissman JR, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003815
   Zeidan J, 2022, AUTISM RES, V15, P778, DOI 10.1002/aur.2696
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
NR 50
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1750-9467
EI 1878-0237
J9 RES AUTISM SPECT DIS
JI Res. Autism Spectr. Disord.
PD FEB 15
PY 2023
VL 100
IS 
BP 
EP 
DI 10.1016/j.rasd.2022.102084
EA DEC 2022
PG 9
WC Education, Special; Psychology, Developmental; Psychiatry; Rehabilitation
SC Education & Educational Research; Psychology; Psychiatry; Rehabilitation
GA 7F6PK
UT WOS:000901966800003
DA 2024-11-01
ER

PT J
AU Wu, GP
   Han, YJ
   Zhao, LF
   Zhang, H
   Fan, XZ
   Li, WQ
   Che, XW
   Zhou, Y
AF Wu, Guiping
   Han, Yijun
   Zhao, Lifeng
   Zhang, Hong
   Fan, Xiuzhao
   Li, Weiqin
   Che, Xiaowen
   Zhou, Yun
TI Reversible cardiac function and left ventricular hypertrophy in a Chinese man with mitochondrial myopathy: a case report
SO BMC CARDIOVASCULAR DISORDERS
LA English
DT Article
DE Mitochondrial myopathy; Heart failure; Respiratory failure; Pulmonary artery hypertension; Left ventricular hypertrophy
AB Background Mitochondrial myopathies (MMs) are a group of multi-system diseases caused by abnormalities in mitochondrial DNA (mtDNA) or mutations of nuclear DNA (nDNA). The diagnosis of mitochondrial myopathy (MM) is reliant on the combination of history and physical examination, muscle biopsy, histochemical studies, and next-generation sequencing. Patients with MMs have diverse clinical manifestations. In the contemporary literature, there is a paucity of reports on cardiac structure and function in this rare disease. We report a Chinese man with MM accompanied with both acute right heart failure and left ventricular hypertrophy. Case presentation A 49-year-old man presented with clinical features suggestive of MM, i.e., ophthalmoparesis, weakness of the pharyngeal and extremity muscles, and respiratory muscles which gradually progressed to respiratory insufficiency. He had a family history of mitochondrial myopathy. He had increased levels of serum creatine kinase and lactate. Muscle biopsy of left lateral thigh revealed 8% ragged red fibers (RRF) and 42% COX-negative fibers. Gene sequencing revealed a novel heterozygote TK2 variant (NM_001172644: c.584T>C, p.Leu195Pro) and another heterozygous variant (NM_004614.4:c.156+958G>A; rs1965661603) in the intron of TK2 gene. Based on these findings, we diagnosed the patient as a case of MM. Echocardiography revealed right heart enlargement, pulmonary hypertension, left ventricular hypertrophy, and thickening of the main pulmonary artery and its branches. The patient received non-invasive ventilation and coenzyme Q10 (CoQ10). The cardiac structure and function were restored at 1-month follow-up. Conclusions This is the first report of reversible cardiac function impairment and left ventricular hypertrophy in a case of adult-onset MM, nocturnal hypoxia is a potential mechanism for left ventricular hypertrophy in patients with MM.
C1 [Wu, Guiping; Zhang, Hong] Shanxi Med Univ, Shanxi Prov Peoples Hosp, Dept Cardiol, Hosp 5, Taiyuan 030012, Peoples R China.
   [Han, Yijun] Jining Med Univ, Clin Med Coll, Jining 272000, Peoples R China.
   [Zhao, Lifeng; Che, Xiaowen] Taiyuan Ctr Dis Control & Prevent, Dept Microbiol Test, Taiyuan 030012, Peoples R China.
   [Fan, Xiuzhao; Zhou, Yun] Shanxi Med Univ, Dept Nephrol, Shanxi Prov Peoples Hosp, Hosp 5, Taiyuan 030012, Shanxi, Peoples R China.
   [Li, Weiqin] Shanxi Med Univ, Dept Ultrasound, Hosp 5, Shanxi Prov Peoples Hosp, Taiyuan 030012, Peoples R China.
C3 Shanxi Medical University; Shanxi People's Hospital; Jining Medical University; Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University; Shanxi People's Hospital
RP Che, XW (corresponding author), Taiyuan Ctr Dis Control & Prevent, Dept Microbiol Test, Taiyuan 030012, Peoples R China.; Zhou, Y (corresponding author), Shanxi Med Univ, Dept Nephrol, Shanxi Prov Peoples Hosp, Hosp 5, Taiyuan 030012, Shanxi, Peoples R China.
EM 79410554@qq.com; zhouyun_sx@163.com
FU Natural Science Foundation of Shanxi Province [YDZJSX2021B014]; Development and Reform Commission Foundation of Shanxi Province (Shanxi Genetic Engineering Center for Experimental Animal Models); Research Project of Shanxi Provincial Health Commission [2021111]
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Beshay S, 2020, RESP MED, V171, P0, DOI 10.1016/j.rmed.2020.106099
   Bychkov IO, 2021, MITOCHONDRION, V57, P205, DOI 10.1016/j.mito.2021.01.004
   Dai L F, 2019, ZHONGHUA ER KE ZA ZHI, V57, P211, DOI 10.3760/cma.j.issn.0578-1310.2019.03.011
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   Deng M, 2021, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.608347
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   García-Alvarez M, 2019, MINERVA ENDOCRINOL, V44, P159, DOI 10.23736/S0391-1977.18.02930-9
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0488-x
   GOMEZ A, 1993, CIRCULATION, V87, P247, DOI 10.1161/01.CIR.87.1.247
   Hernandez-Voth A, 2020, BMJ OPEN RESPIR RES, V7, P0, DOI 10.1136/bmjresp-2020-000774
   Hu CP, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.01000
   Nickel NP, 2020, AM J RESP CRIT CARE, V201, P148, DOI 10.1164/rccm.201903-0656CI
   Prados VO, 2020, J BRAS PNEUMOL, V46, P0, DOI 10.36416/1806-3756/e20190136
   Sharp LJ, 2014, NEUROL CLIN, V32, P777, DOI 10.1016/j.ncl.2014.05.001
   Termglinchan T, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000095
NR 16
TC 0
Z9 0
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2261
EI 
J9 BMC CARDIOVASC DISOR
JI BMC Cardiovasc. Disord.
PD SEP 15
PY 2023
VL 23
IS 1
BP 
EP 
DI 10.1186/s12872-023-03444-z
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA S0EP9
UT WOS:001067992500003
PM 37715114
DA 2024-11-01
ER

PT J
AU Danieli, MG
   Antonelli, E
   Piga, MA
   Cozzi, MF
   Allegra, A
   Gangemi, S
AF Danieli, Maria Giovanna
   Antonelli, Eleonora
   Piga, Mario Andrea
   Cozzi, Maria Francesca
   Allegra, Alessandro
   Gangemi, Sebastiano
TI Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies
SO AUTOIMMUNITY REVIEWS
LA English
DT Article
DE Antioxidant; Electron transport chain; Inflammatory myopathies; Inclusion body myositis; Mitochondria; Muscle aging; Nitric oxide; Oxidative stress; Reactive oxygen species; Respiratory chain; Redox
ID inclusion-body myositis; nitric-oxide synthases; skeletal-muscle; dna deletions; histological assessment; autoimmune myositis; hepatic steatosis; potential role; factor-i; kappa-b
AB We investigated the relationship between oxidative stress and inflammatory myopathies. We searched in the current literature the role of mitochondria and respiratory chain defects as sources of oxidative stress and reactive oxygen species production that led to muscle weakness and fatigue. Different molecules and pathways contribute to redox milieu, reactive oxygen species generation, accumulation of misfolded and carbonylated proteins that lose their ability to fulfil cellular activities. Small peptides and physical techniques proved, in mice models, to reduce oxidative stress. We focused on inclusion body myositis, as a major expression of myopathy related to oxidative stress, where mitochondrial abnormalities are causative agents as well. We described the effect of physical exercise in inclusion body myositis that showed to increase strength and to reduce beta amyloid accumulation with subsequent improvement of the mitochondrial functions. We illustrated the influence of epigenetic control on the immune system by non-coding genetic material in the interaction between oxidative stress and inflammatory myopathies.
C1 [Danieli, Maria Giovanna] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Clin Med, Via Tronto 10 A, I-60126 Torrette Di Ancona, Italy.
   [Danieli, Maria Giovanna; Piga, Mario Andrea] Univ Politecn Marche, Postgrad Sch Allergy & Clin Immunol, Via Tronto 10 A, I-60126 Ancona, Italy.
   [Antonelli, Eleonora; Cozzi, Maria Francesca] Univ Politecn Marche, Postgrad Sch Internal Med, Via Tronto 10 A, I-60126 Ancona, Italy.
   [Allegra, Alessandro] Univ Messina, Dept Human Pathol Adulthood & Childhood Gaetano Ba, Div Haematol, Via Consolare Valeria 1, I-98125 Messina, Italy.
   [Gangemi, Sebastiano] Univ Messina, Sch & Operat Unit Allergy & Clin Immunol, Dept Clin & Expt Med, Via Consolare Valeria 1, I-98125 Messina, Italy.
   [Danieli, Maria Giovanna] Clin Med, Dipartimento Sci Clin & Mol, Via Tronto 10A, I-60126 Torrette Di Ancona, Italy.
C3 Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University; University of Messina; University of Messina
RP Danieli, MG (corresponding author), Clin Med, Dipartimento Sci Clin & Mol, Via Tronto 10A, I-60126 Torrette Di Ancona, Italy.
EM m.g.danieli@univpm.it; m.a.piga@pm.univpm.it; alessandro.allegra@unime.it; sebastiano.gangemi@unime.it
CR Alexander Matthew S, 2015, J NEUROMUSCUL DIS, V2, P1
   Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647
   Arenas J, 1996, ARTHRITIS RHEUM, V39, P1869, DOI 10.1002/art.1780391113
   Arnardottir S, 2003, J REHABIL MED, V35, P31, DOI 10.1080/16501970306110
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   Bae SS, 2020, RHEUMATOLOGY, V59, P3515, DOI 10.1093/rheumatology/keaa273
   Bae SS, 2022, RHEUMATOLOGY, V61, P2512, DOI 10.1093/rheumatology/keab795
   Barsotti S, 2019, CLIN EXP RHEUMATOL, V37, P1036
   Basualto-Alarcón C, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0242443
   Vignola MB, 2012, ELECTROMAGN BIOL MED, V31, P320, DOI 10.3109/15368378.2011.641706
   Bertolucci F, 2014, EUR J PHYS REHAB MED, V50, P161
   Bhatt PS, 2019, NEUROMUSCULAR DISORD, V29, P242, DOI 10.1016/j.nmd.2019.02.001
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899
   Boursereau R, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep43437
   Broccolini A, 2000, NEUROSCI LETT, V287, P1, DOI 10.1016/S0304-3940(00)01156-3
   Broccolini A, 2004, J NEUROPATH EXP NEUR, V63, P650, DOI 10.1093/jnen/63.6.650
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   CAMPOS Y, 1995, ANN RHEUM DIS, V54, P491, DOI 10.1136/ard.54.6.491
   Catalán-García M, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9051446
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Charles-Schoeman C, 2018, CLIN RHEUMATOL, V37, P615, DOI 10.1007/s10067-017-3896-y
   Chen J, 2017, EXP THER MED, V14, P2085, DOI 10.3892/etm.2017.4766
   Chen ZB, 2017, INT J NEUROSCI, V127, P617, DOI 10.1080/00207454.2016.1220380
   Cordeiro de Souza Leonardo, 2014, CASE REP CRIT CARE, V2014, P902541, DOI 10.1155/2014/902541
   Coudert JD, 2022, CLIN TRANSL IMMUNOL, V11, P0, DOI 10.1002/cti2.1416
   Cristani M, 2016, CURR MED CHEM, V23, P3862, DOI 10.2174/0929867323666160902154748
   Cron MA, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.01074
   Davila Soledad, 2011, LASER THER, V20, P287
   De Paepe B, 2004, ACTA NEUROPATHOL, V108, P37, DOI 10.1007/s00401-004-0859-6
   Diederichsen LP, 2017, CURR OPIN RHEUMATOL, V29, P598, DOI 10.1097/BOR.0000000000000442
   Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261
   Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104
   Gao SM, 2019, EPIGENOMICS-UK, V11, P23, DOI 10.2217/epi-2018-0064
   Georgantas RW, 2014, ARTHRITIS RHEUMATOL, V66, P1022, DOI 10.1002/art.38292
   Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142
   Gong T, 2012, BIOCHEM BIOPH RES CO, V427, P461, DOI 10.1016/j.bbrc.2012.08.068
   Gualano B, 2010, MED SCI SPORT EXER, V42, P250, DOI 10.1249/MSS.0b013e3181b18fb8
   Haslbeck KM, 2005, ACTA NEUROPATHOL, V110, P247, DOI 10.1007/s00401-005-1043-3
   Hedberg-Oldfors C, 2022, NEUROPATH APPL NEURO, V48, P0, DOI 10.1111/nan.12841
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Ito M, 2011, MED GAS RES, V1, P0, DOI 10.1186/2045-9912-1-24
   Jackson MJ, 2013, ANTIOXID REDOX SIGN, V19, P804, DOI 10.1089/ars.2013.5383
   Jansson M, 2000, ACTA NEUROPATHOL, V100, P23, DOI 10.1007/s004010051188
   Jensen KY, 2019, ARTHRITIS RES THER, V21, P0, DOI 10.1186/s13075-019-2036-2
   Jeong HJ, 2013, BIOCHEM BIOPH RES CO, V434, P503, DOI 10.1016/j.bbrc.2013.03.104
   Jeong JH, 2017, MED SCI SPORT EXER, V49, P1562, DOI 10.1249/MSS.0000000000001286
   Johnson LG, 2007, CLIN NEUROMUSCUL DIS, V8, P187
   Johnson Liam G, 2009, J CLIN NEUROMUSCUL DIS, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   Jorgensen A, 2018, SCAND J RHEUMATOL, V47, P400, DOI 10.1080/03009742.2017.1423109
   Jorgensen AN, 2016, CLIN PHYSIOL FUNCT I, V36, P504, DOI 10.1111/cpf.12259
   Joshi PR, 2014, J CLIN NEUROSCI, V21, P1959, DOI 10.1016/j.jocn.2014.05.051
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Koo JH, 2019, GERONTOLOGY, V65, P240, DOI 10.1159/000494723
   Kwon Insu, 2015, J EXERC NUTRITION BIOCHEM, V19, P225, DOI 10.5717/jenb.2015.15090710
   Li YQ, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-05029-w
   Lightfoot AP, 2015, CURR OPIN RHEUMATOL, V27, P580, DOI 10.1097/BOR.0000000000000212
   Lightfoot AP, 2015, ANN RHEUM DIS, V74, P1340, DOI 10.1136/annrheumdis-2014-207172
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1
   Menzel A, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10030414
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011
   Miquel E, 2014, FREE RADICAL BIO MED, V70, P204, DOI 10.1016/j.freeradbiomed.2014.02.019
   Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51
   Morosetti R, 2010, NEUROBIOL AGING, V31, P1205, DOI 10.1016/j.neurobiolaging.2008.08.011
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Munters LA, 2016, ARTHRITIS RHEUMATOL, V68, P1738, DOI 10.1002/art.39624
   Musolino C, 2018, ANN HEMATOL, V97, P1259, DOI 10.1007/s00277-018-3296-7
   Naddaf E, 2018, NEUROTHERAPEUTICS, V15, P995, DOI 10.1007/s13311-018-0658-8
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200
   Oikawa Y, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0231064
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Olivé M, 2004, MUSCLE NERVE, V29, P261, DOI 10.1002/mus.10550
   Paik JJ, 2023, CLIN EXP RHEUMATOL, V41, P348, DOI 10.55563/clinexprheumatol/hxin6o
   Parkes JE, 2020, BMC RHEUMATOL, V4, P0, DOI 10.1186/s41927-020-00125-8
   Parkes JE, 2015, CURR OPIN RHEUMATOL, V27, P608, DOI 10.1097/BOR.0000000000000225
   Rayavarapu S, 2013, ARTHRITIS RHEUM-US, V65, P3248, DOI 10.1002/art.38180
   Ress AL, 2015, MOL CARCINOGEN, V54, P1442, DOI 10.1002/mc.22218
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Saito Y, 2014, CLIN REV ALLERG IMMU, V47, P128, DOI 10.1007/s12016-013-8401-z
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Santos AR, 2014, BIOL SPORT, V31, P121, DOI 10.5604/20831862.1097479
   Servetto N, 2010, LASER SURG MED, V42, P577, DOI 10.1002/lsm.20910
   Shabrokh E, 2014, OPEN J MOL INTEGR PHYSIOL, V04, P11, DOI 10.4236/ojmip.2014.42002
   Shen QM, 2021, EXP THER MED, V22, P0, DOI 10.3892/etm.2021.10721
   Spector SA, 1997, MUSCLE NERVE, V20, P1242, DOI 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.3.CO;2-X
   Stangel M, 2001, MICROSC RES TECHNIQ, V55, P249, DOI 10.1002/jemt.1174
   Sukkar SG, 2004, AUTOIMMUN REV, V3, P199, DOI 10.1016/j.autrev.2003.09.002
   Terracciano C, 2008, FREE RADICAL BIO MED, V45, P773, DOI 10.1016/j.freeradbiomed.2008.05.030
   Tews DS, 1998, CLIN IMMUNOL IMMUNOP, V87, P240, DOI 10.1006/clin.1998.4527
   van Dooren SHJ, 2011, BIOCHEM CELL BIOL, V89, P545, DOI 10.1139/O11-055
   van Gelder H, 2014, RHEUM DIS CLIN N AM, V40, P1, DOI 10.1016/j.rdc.2013.10.002
   Wanchu A, 1999, NITRIC OXIDE-BIOL CH, V3, P454, DOI 10.1006/niox.1999.0261
   Yamada T, 2022, ARTHRITIS RES THER, V24, P0, DOI 10.1186/s13075-022-02846-2
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
   Yang CC, 1998, NEUROSCI LETT, V254, P77, DOI 10.1016/S0304-3940(98)00657-0
   Yang M, 2023, CLIN EXP RHEUMATOL, V41, P393, DOI 10.55563/clinexprheumatol/jikxzi
   Zamecnik J, 2011, CESK PATOL, V47, P62
   Zhang YK, 2020, AGING-US, V12, P2049, DOI 10.18632/aging.102721
   Zhao YF, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-09943-x
   Zilahi Erika, 2019, EJIFCC, V30, P237
NR 114
TC 24
Z9 25
U1 2
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD MAY 15
PY 2023
VL 22
IS 2
BP 
EP 
DI 10.1016/j.autrev.2023.103308
EA FEB 2023
PG 13
WC Immunology
SC Immunology
GA 9W0EU
UT WOS:000948756300001
PM 36822387
DA 2024-11-01
ER

PT J
AU Wu, YT
   Tay, HY
   Yang, JT
   Liao, HH
   Ma, YS
   Wei, YH
AF Wu, Yu-Ting
   Tay, Hui-Yi
   Yang, Jung-Tse
   Liao, Hsiao-Hui
   Ma, Yi-Shing
   Wei, Yau-Huei
TI Mitochondrial impairment and synaptic dysfunction are associated with neurological defects in iPSCs-derived cortical neurons of MERRF patients
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE AMPARs; Disease modeling; Electrophysiological activity; Excitatory neurons; iPSCs; MERRF syndrome; mtDNA mutation; Neurological defect; Synaptic plasticity; Synaptophysin
ID a8344g mutation; female-patient; dna mutations; plasticity; diseases; generation; line
AB BackgroundMyoclonic epilepsy with ragged-red fibers (MERRF) syndrome is a rare inherited mitochondrial disease mainly caused by the m.8344A > G mutation in mitochondrial tRNA(Lys) gene, and usually manifested as complex neurological disorders and muscle weakness. Currently, the pathogenic mechanism of this disease has not yet been resolved, and there is no effective therapy for MERRF syndrome. In this study, MERRF patients-derived iPSCs were used to model patient-specific neurons for investigation of the pathogenic mechanism of neurological disorders in mitochondrial disease.MethodsMERRF patient-derived iPSCs were differentiated into excitatory glutamatergic neurons to unravel the effects of the m.8344A > G mutation on mitochondrial bioenergetic function, neural-lineage differentiation and neuronal function. By the well-established differentiation protocol and electrophysiological activity assay platform, we examined the pathophysiological behaviors in cortical neurons of MERRF patients.ResultsWe have successfully established the iPSCs-derived neural progenitor cells and cortical-like neurons of patients with MERRF syndrome that retained the heteroplasmy of the m.8344A > G mutation from the patients' skin fibroblasts and exhibited the phenotype of the mitochondrial disease. MERRF neural cells harboring the m.8344A > G mutation exhibited impaired mitochondrial bioenergetic function, elevated ROS levels and imbalanced expression of antioxidant enzymes. Our findings indicate that neural immaturity and synaptic protein loss led to the impairment of neuronal activity and plasticity in MERRF neurons harboring the m.8344A > G mutation. By electrophysiological recordings, we monitored the in vivo neuronal behaviors of MERRF neurons and found that neurons harboring a high level of the m.8344A > G mutation exhibited impairment of the spontaneous and evoked potential-stimulated neuronal activities.ConclusionsWe demonstrated for the first time the link of mitochondrial impairment and synaptic dysfunction to neurological defects through impeding synaptic plasticity in excitatory neurons derived from iPSCs of MERRF patients harboring the m.8344A > G mutation. This study has provided new insight into the pathogenic mechanism of the tRNA(Lys) gene mutation of mtDNA, which is useful for the development of a patient-specific iPSCs platform for disease modeling and screening of new drugs to treat patients with MERRF syndrome.
C1 [Wu, Yu-Ting; Tay, Hui-Yi; Yang, Jung-Tse; Liao, Hsiao-Hui; Ma, Yi-Shing; Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.
   [Wei, Yau-Huei] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei 112, Taiwan.
C3 Changhua Christian Hospital; National Yang Ming Chiao Tung University
RP Wei, YH (corresponding author), Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.; Wei, YH (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei 112, Taiwan.
EM yhweibabi@gmail.com
FU National Science and Technology Council of Taiwan Government (MOST) [MOST 110-2311-B-371-001, MOST 110-2320-B-371-001, MOST 111-2320-B-371-001, 110-CCH-MST-179]; Changhua Christian Hospital, Taiwan [110-CCH-MST-127, 111-CCH-HCR-147, 110-CCH-MST-138];  [MOST 110-2314-B-715-005]
CR Abuhassan K, 2011, IEEE ENG MED BIO, V0, PP2065, DOI 10.1109/IEMBS.2011.6090382
   Bai Xiang, 2014, J BIOCHEM PHARMACOL RES, V2, P185
   Bhattacharya S, 2022, STEM CELL RES THER, V13, P0, DOI 10.1186/s13287-022-02937-6
   Buck SA, 2021, J NEUROSCI, V41, P4937, DOI 10.1523/JNEUROSCI.2770-20.2021
   Chen YC, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-0488-y
   Chou SJ, 2018, STEM CELL RES, V30, P201, DOI 10.1016/j.scr.2018.05.011
   Chou SJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23661
   Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867
   Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X
   Falcicchia C, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21165624
   Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002
   Gunnewiek TMK, 2021, STEM CELL REP, V16, P2197, DOI 10.1016/j.stemcr.2021.07.002
   Hatakeyama H, 2016, STEM CELLS, V34, P801, DOI 10.1002/stem.2292
   Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010
   Holley SM, 2018, CNS NEUROSCI THER, V24, P329, DOI 10.1111/cns.12839
   Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699
   Hsu YH, 2017, STEM CELL RES, V25, P245, DOI 10.1016/j.scr.2017.10.024
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Jurcau A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222111847
   Kang J, 2020, CELL MOL NEUROBIOL, V40, P861, DOI 10.1007/s10571-020-00785-7
   Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI 10.1093/bioinformatics/btp100
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Limanaqi F, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00299
   Liu YY, 2023, MICROSYST NANOENG, V9, P0, DOI 10.1038/s41378-022-00479-8
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lu CY, 2002, CLIN CHIM ACTA, V318, P97, DOI 10.1016/S0009-8981(01)00809-9
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   Nair RR, 2019, MAMM GENOME, V30, P173, DOI 10.1007/s00335-019-09807-2
   Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6
   Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005
   Osimo EF, 2019, MOL PSYCHIATR, V24, P549, DOI 10.1038/s41380-018-0041-5
   Park SY, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00520
   Pelkonen A, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11010106
   Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658
   Peron C, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.648916
   Purkey AM, 2020, FRONT SYNAPTIC NEURO, V12, P0, DOI 10.3389/fnsyn.2020.00008
   Radwitz J, 2022, CELL MOL LIFE SCI, V79, P0, DOI 10.1007/s00018-022-04607-5
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Shen FM, 2021, J ETHNOPHARMACOL, V275, P0, DOI 10.1016/j.jep.2021.114164
   Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516
   Singh Pragya, 2022, METHODS MOL BIOL, V2549, P219, DOI 10.1007/7651_2021_384
   Son G, 2018, BMB REP, V51, P549, DOI 10.5483/BMBRep.2018.51.11.226
   Südhof TC, 2021, J CELL BIOL, V220, P0, DOI 10.1083/jcb.202103052
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tampellini D, 2015, FRONT NEUROSCI-SWITZ, V9, P0, DOI 10.3389/fnins.2015.00423
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Wu YT, 2018, STEM CELL RES, V27, P10, DOI 10.1016/j.scr.2017.12.013
   Yu Q, 2017, J ALZHEIMERS DIS, V59, P223, DOI 10.3233/JAD-170283
   Zalcman G, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00445
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhang XY, 2021, NEURAL REGEN RES, V16, P2446, DOI 10.4103/1673-5374.313056
   Zhao YX, 2015, AM J TRANSL RES, V7, P15
NR 54
TC 5
Z9 5
U1 2
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD AUG 21
PY 2023
VL 30
IS 1
BP 
EP 
DI 10.1186/s12929-023-00966-8
PG 21
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA P7YP8
UT WOS:001052794600001
PM 37605213
DA 2024-11-01
ER

PT J
AU Qi, XL
   Tan, L
   Zhang, X
   Jin, JC
   Kong, WN
   Chen, W
   Wang, JY
   Dong, W
   Gao, LJ
   Luo, LJ
   Lu, D
   Gong, JA
   Guan, FF
   Shu, WJ
   Huang, XX
   Zhang, LF
   Wang, SQ
   Shen, B
   Ma, YW
AF Qi, Xiaolong
   Tan, Lei
   Zhang, Xu
   Jin, Jiachuan
   Kong, Weining
   Chen, Wei
   Wang, Jianying
   Dong, Wei
   Gao, Lijuan
   Luo, Lijun
   Lu, Dan
   Gong, Jianan
   Guan, Feifei
   Shu, Wenjie
   Huang, Xingxu
   Zhang, Lianfeng
   Wang, Shengqi
   Shen, Bin
   Ma, Yuanwu
TI Expanding DdCBE-mediated targeting scope to aC motif preference in rat
SO MOLECULAR THERAPY-NUCLEIC ACIDS
LA English
DT Article
ID mitochondrial transfer-rnas; sporadic patient; mutation; myopathy; disease
AB An animal model harboring pathogenic mitochondrial DNA (mtDNA) mutations is important to understand the biological links between mtDNA variation and mitochondrial diseases. DdCBE, a DddA-derived cytosine base editor, has been utilized in zebrafish, mice, and rats for tC sequence-context targeting and human mitochondrial disease modeling. However, human pathogenic mtDNA mutations other than the tC context cannot be manipulated. Here, we screened the combination of different DdCBE pairs at pathogenic mtDNA mutation sites with nC (n for a, g, or c) context and identified that the left-G1333C (L1333C) + right G1333N (R1333N) pair could mediate C & BULL;G-to-T & BULL;A conversion effectively at aC sites in rat C6 cells. The editing efficiency at disease-associated mtDNA mutation sites within aC context was further confirmed to be up to 67.89% in vivo. Also, the installed disease-associated mtDNA mutations were germline transmittable. Moreover, the edited rats showed impaired cardiac function and mito-chondrial function, resembling human mitochondrial disease symptoms. In summary, for the first time, we expanded the DdCBE targeting scope to an aC motif and installed the path-ogenic mutation in rats to model human mitochondrial dis-eases.
C1 [Qi, Xiaolong; Tan, Lei; Zhang, Xu; Jin, Jiachuan; Kong, Weining; Chen, Wei; Dong, Wei; Gao, Lijuan; Luo, Lijun; Lu, Dan; Gong, Jianan; Guan, Feifei; Zhang, Lianfeng; Ma, Yuanwu] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing Engn Res Ctr Expt Anim Models Human Crit D, Peking Union Med Coll,Natl Hlth Commiss China NHC,, Beijing 100021, Peoples R China.
   [Tan, Lei; Wang, Jianying; Shen, Bin] Nanjing Med Univ, Womens Hosp, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing 211100, Jiangsu, Peoples R China.
   [Jin, Jiachuan] Zhengzhou Univ, Affiliated Hosp 3, Ctr Reprod Med, Zhengzhou 450052, Peoples R China.
   [Shu, Wenjie; Wang, Shengqi] Bioinformat Ctr AMMS, Beijing 100850, Peoples R China.
   [Huang, Xingxu; Shen, Bin] Zhejiang Lab, Hangzhou 311121, Zhejiang, Peoples R China.
   [Zhang, Lianfeng; Ma, Yuanwu] Chinese Acad Med Sci, Neurosci Ctr, Beijing 100730, Peoples R China.
   [Shen, Bin] Nanjing Med Univ, Gusu Sch, Nanjing 215031, Jiangsu, Peoples R China.
   [Shen, Bin] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Nanjing 211100, Jiangsu, Peoples R China.
   [Ma, Yuanwu] Chinese Acad Med Sci, Inst Lab Anim Sci, Peking Union Med Coll, Natl Human Dis Anim Model Resource Ctr, Beijing 100021, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing Medical University; Zhengzhou University; Zhejiang Laboratory; Chinese Academy of Medical Sciences - Peking Union Medical College; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College
RP Ma, YW (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing Engn Res Ctr Expt Anim Models Human Crit D, Peking Union Med Coll,Natl Hlth Commiss China NHC,, Beijing 100021, Peoples R China.; Shen, B (corresponding author), Nanjing Med Univ, Womens Hosp, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing 211100, Jiangsu, Peoples R China.; Wang, SQ (corresponding author), Bioinformat Ctr AMMS, Beijing 100850, Peoples R China.
EM sqwang@bmi.ac.cn; binshen@njmu.edu.cn; mayuanwu@cnilas.org
FU National Key Research and Development Program of China [2021YFC2700600]; Funds for Creative Research Groups of China [82221005]; National Natural Science Foundation of China [31970796]; CAMS Innovation Fund for Medical Sciences of China (CIFMS) [2021-I2M-1-024, 2021-I2M-1- 034, 2021-1-I2M-018]; Beijing Municipal Natural Science Foundation [M21004]; Beijing Nova Program [Z211100002121034]; Leading Talents of Guangdong province program [2016LJ06S386]; 111 Project of Ministry of Education [B20095]
CR Campbell T, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11182835
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010
   Ding Y, 2020, EUR REV MED PHARMACO, V24, P8502, DOI 10.26355/eurrev_202008_22647
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Guo JY, 2022, MOL THER-NUCL ACIDS, V27, P73, DOI 10.1016/j.omtn.2021.11.016
   Guo JY, 2021, CELL DISCOV, V7, P0, DOI 10.1038/s41421-021-00307-9
   Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8090392
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Karadimas CL, 2002, NEUROMUSCULAR DISORD, V12, P865, DOI 10.1016/S0960-8966(02)00072-X
   Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104
   Ling YH, 2022, LIFE SCI, V297, P0, DOI 10.1016/j.lfs.2022.120485
   Liu YQ, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.634137
   Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157
   Mansour HA, 2022, OSLI RETINA, V53, P116, DOI 10.3928/23258160-20220121-04
   Meng FL, 2022, NUCLEIC ACIDS RES, V50, P9453, DOI 10.1093/nar/gkac720
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Bayona-Bafaluy MP, 2020, MUTAT RES-REV MUTAT, V786, P0, DOI 10.1016/j.mrrev.2020.108334
   Qi XL, 2021, CELL DISCOV, V7, P0, DOI 10.1038/s41421-021-00325-7
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   Ronchi D, 2010, J NEUROL SCI, V292, P107, DOI 10.1016/j.jns.2010.01.026
   Sacconi S, 2002, ARCH NEUROL-CHICAGO, V59, P1013, DOI 10.1001/archneur.59.6.1013
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Stewart JB, 2021, J INHERIT METAB DIS, V44, P325, DOI 10.1002/jimd.12324
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Wei YH, 2022, CELL DISCOV, V8, P0, DOI 10.1038/s41421-022-00391-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 30
TC 5
Z9 5
U1 6
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2162-2531
EI 
J9 MOL THER-NUCL ACIDS
JI Mol. Ther.-Nucl. Acids
PD JUN 13
PY 2023
VL 32
IS 
BP 1
EP 12
DI 10.1016/j.omtn.2023.02.028
EA MAR 2023
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA P4CE7
UT WOS:001050134000001
PM 36942261
DA 2024-11-01
ER

PT J
AU Abrishamdar, M
   Jalali, MS
   Farbood, Y
AF Abrishamdar, Maryam
   Jalali, Maryam Sadat
   Farbood, Yaghoob
TI Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Review
DE Parkinson's disease; Mitochondrial dysfunction; Neurodegeneration
ID dna-polymerase-gamma; progressive external ophthalmoplegia; complex-i activity; alpha-synuclein; tauroursodeoxycholic acid; juvenile parkinsonism; familial parkinsonism; dopaminergic-neurons; respiratory-chain; oxidative damage
AB Neurodegeneration is among the most critical challenges that involve modern societies and annually influences millions of patients worldwide. While the pathophysiology of Parkinson's disease (PD) is complicated, the role of mitochondrial is demonstrated. The in vitro and in vivo models and genome-wide association studies in human cases proved that specific genes, including PINK1, Parkin, DJ-1, SNCA, and LRRK2, linked mitochondrial dysfunction with PD. Also, mitochondrial DNA (mtDNA) plays an essential role in the pathophysiology of PD. Targeting mitochondria as a therapeutic approach to inhibit or slow down PD formation and progression seems to be an exciting issue. The current review summarized known mutations associated with both mitochondrial dysfunction and PD. The significance of mtDNA in Parkinson's disease pathogenesis and potential PD therapeutic approaches targeting mitochondrial dysfunction was then discussed.
C1 [Abrishamdar, Maryam; Jalali, Maryam Sadat] Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Dept Physiol, Persian Gulf Physiol Res Ctr, Ahvaz, Iran.
   [Farbood, Yaghoob] Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Fac Med, Dept Physiol,Persian Gulf Physiol Res Ctr, Ahvaz, Iran.
C3 Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS)
RP Jalali, MS (corresponding author), Ahvaz Jundishapur Univ Med Sci, Med Basic Sci Res Inst, Dept Physiol, Persian Gulf Physiol Res Ctr, Ahvaz, Iran.
EM MaryamJalali3231@gmail.com
CR Abdelkader NF, 2016, MOL NEUROBIOL, V53, P810, DOI 10.1007/s12035-014-9043-8
   Abrahams S, 2021, BIOCHEM BIOPHYS REP, V27, P0, DOI 10.1016/j.bbrep.2021.101035
   Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906
   Aman Y, 2020, INT REV NEUROBIOL, V155, P169, DOI 10.1016/bs.irn.2020.02.008
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andres RH, 2005, NEUROSCIENCE, V133, P701, DOI 10.1016/j.neuroscience.2005.03.004
   Anis E, 2020, PHYTOTHER RES, V34, P214, DOI 10.1002/ptr.6523
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Arias-Fuenzalida J, 2017, STEM CELL REP, V9, P1423, DOI 10.1016/j.stemcr.2017.08.026
   Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Barceló-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x
   Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2006, NEUROLOGY, V67, P1262, DOI 10.1212/01.wnl.0000238518.34389.12
   Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004
   Bennett JP, 2020, MITOCHONDRION, V53, P154, DOI 10.1016/j.mito.2020.05.012
   Bentley SR, 2014, MITOCHONDRION, V15, P65, DOI 10.1016/j.mito.2014.01.004
   Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060
   Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483
   Biju KC, 2018, NEUROSCIENCE, V380, P111, DOI 10.1016/j.neuroscience.2018.04.008
   Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200
   Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93
   Boon JY, 2014, FRONT MOL NEUROSCI, V7, P0, DOI 10.3389/fnmol.2014.00064
   Borsche M, 2021, J PARKINSON DIS, V11, P45, DOI 10.3233/JPD-201981
   Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066
   Cannon JR, 2013, EXP NEUROL, V240, P44, DOI 10.1016/j.expneurol.2012.11.007
   Carbone C, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00187
   Castro-Caldas M, 2012, MOL NEUROBIOL, V46, P475, DOI 10.1007/s12035-012-8295-4
   Chakraborty J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809014
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chandra G, 2019, J CHEM NEUROANAT, V95, P29, DOI 10.1016/j.jchemneu.2017.12.004
   Chandra G, 2018, J NEUROIMMUNE PHARM, V13, P143, DOI 10.1007/s11481-017-9771-4
   Chang CY, 2019, TRANSL NEURODEGENER, V8, P0, DOI 10.1186/s40035-019-0158-8
   Chang JL, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-83080-9
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chen C, 2020, NEUROBIOL DIS, V134, P0, DOI 10.1016/j.nbd.2019.104631
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Chun HS, 2012, TOXICOLOGY, V292, P105, DOI 10.1016/j.tox.2011.11.020
   Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Copeland William C, 2003, SCIENTIFICWORLDJOURNAL, V3, P34
   Cornelissen T, 2020, HUM MOL GENET, V29, P1096, DOI 10.1093/hmg/ddaa028
   Costa LG, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/2986796
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Dolhun R, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-92
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3
   East DA, 2016, INT J BIOCHEM CELL B, V79, P382, DOI 10.1016/j.biocel.2016.08.019
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Fares MB, 2021, NAT REV NEUROSCI, V22, P111, DOI 10.1038/s41583-020-00416-6
   Ferreira AFF, 2020, BEHAV BRAIN RES, V387, P0, DOI 10.1016/j.bbr.2020.112607
   Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gerhardt E, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028855
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Giorgio V, 2018, BBA-BIOENERGETICS, V1859, P901, DOI 10.1016/j.bbabio.2018.04.006
   Grassi D, 2018, P NATL ACAD SCI USA, V115, PE2634, DOI 10.1073/pnas.1713849115
   Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865
   Grünewald A, 2019, PROG NEUROBIOL, V177, P73, DOI 10.1016/j.pneurobio.2018.09.003
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Grünewald A, 2013, JAMA NEUROL, V70, P1186, DOI 10.1001/jamaneurol.2013.488
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gui YX, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050086
   Gureev AP, 2019, NEUROCHEM RES, V44, P2273, DOI 10.1007/s11064-018-02711-2
   Haleagrahara N, 2011, NEUROSCI LETT, V500, P139, DOI 10.1016/j.neulet.2011.06.021
   Hallberg BM, 2011, NAT STRUCT MOL BIOL, V18, P1179, DOI 10.1038/nsmb.2167
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   Heo JY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032629
   Ho DH, 2015, MOL BRAIN, V8, P0, DOI 10.1186/s13041-015-0145-7
   Hu QS, 2016, TRANSL NEURODEGENER, V5, P0, DOI 10.1186/s40035-016-0060-6
   Huang XP, 2019, HUM MOL GENET, V28, P349, DOI 10.1093/hmg/ddy340
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Ikeda A, 2019, HUM MOL GENET, V28, P3895, DOI 10.1093/hmg/ddz241
   Inose Y, 2020, NEUROSCI LETT, V736, P0, DOI 10.1016/j.neulet.2020.135268
   Inoue N, 2018, EMBO REP, V19, P0, DOI 10.15252/embr.201744860
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288
   Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034
   Jamebozorgi K, 2019, MOL NEUROBIOL, V56, P4799, DOI 10.1007/s12035-018-1419-8
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Jiang X, 2016, MOL CELL, V63, P229, DOI 10.1016/j.molcel.2016.06.016
   Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Kaidery NA, 2018, NEUROCHEM INT, V117, P91, DOI 10.1016/j.neuint.2018.03.001
   Kakhlon O, 2010, CAN J PHYSIOL PHARM, V88, P187, DOI 10.1139/Y09-128
   Karimi-Moghadam A, 2018, CELL MOL NEUROBIOL, V38, P1153, DOI 10.1007/s10571-018-0587-4
   Kasten M, 2018, MOVEMENT DISORD, V33, P730, DOI 10.1002/mds.27352
   Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334
   Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kim YY, 2019, FASEB J, V33, P9742, DOI 10.1096/fj.201900073R
   Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018
   Klivenyi P, 2004, NEUROBIOL DIS, V15, P610, DOI 10.1016/j.nbd.2003.12.014
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krebiehl G, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0009367
   Kumar N, 2018, J CELL BIOL, V217, P3625, DOI 10.1083/jcb.201807019
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Kwon SH, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20235832
   Lai JH, 2019, BRAIN RES, V1720, P0, DOI 10.1016/j.brainres.2019.146301
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406
   Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044
   Lees AJ, 2015, MOVEMENT DISORD, V30, P19, DOI 10.1002/mds.26120
   Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014
   Li L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0085815
   Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x
   Li YI, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08912-9
   Li ZG, 2015, EUR NEUROL, V73, P205, DOI 10.1159/000377676
   Lin KJ, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20215312
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056
   Liu QQ, 2019, BEHAV BRAIN RES, V367, P10, DOI 10.1016/j.bbr.2019.03.043
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212
   Ludtmann MHR, 2018, NEUROSCI LETT, V663, P86, DOI 10.1016/j.neulet.2017.08.044
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749
   MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033
   Maita C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054087
   Malek N, 2014, ACTA NEUROL SCAND, V130, P59, DOI 10.1111/ane.12247
   Malpartida AB, 2021, TRENDS BIOCHEM SCI, V46, P329, DOI 10.1016/j.tibs.2020.11.007
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Marder KS, 2010, ARCH NEUROL-CHICAGO, V67, P731, DOI 10.1001/archneurol.2010.95
   Martins RD, 2018, CELL BIOL INT, V42, P725, DOI 10.1002/cbin.10969
   Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200
   Matsumine H, 1997, AM J HUM GENET, V60, P588
   Mautone N, 2020, EXPERT OPIN THER PAT, V30, P389, DOI 10.1080/13543776.2020.1749264
   Melrose H, 2006, NEUROSCIENCE, V139, P791, DOI 10.1016/j.neuroscience.2006.01.017
   Meng H, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15500
   Mezzaroba L, 2019, NEUROTOXICOLOGY, V74, P230, DOI 10.1016/j.neuro.2019.07.007
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Minakawa EN, 2013, NEUROSCI RES, V77, P228, DOI 10.1016/j.neures.2013.09.006
   Moors TE, 2017, MOL NEURODEGENER, V12, P0, DOI 10.1186/s13024-017-0154-3
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Mortiboys H, 2013, BRAIN, V136, P3038, DOI 10.1093/brain/awt224
   Müller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036
   Mukai R, 2012, FREE RADICAL RES, V46, P1019, DOI 10.3109/10715762.2012.673720
   Muñoz Y, 2016, PARKINSONS DIS-US, V2016, P0, DOI 10.1155/2016/7049108
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Negida A, 2016, CNS NEUROL DISORD-DR, V15, P45, DOI 10.2174/1871527314666150821103306
   Nieto M, 2006, NEUROBIOL AGING, V27, P848, DOI 10.1016/j.neurobiolaging.2005.04.010
   Nuamnaichati N, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00805
   Obeso JA, 2017, MOVEMENT DISORD, V32, P1, DOI 10.1002/mds.26904
   Okatsu K, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-28656-8
   Okatsu K, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2016
   Orr AL, 2017, NEUROCHEM INT, V109, P106, DOI 10.1016/j.neuint.2017.04.006
   Ouzren N, 2019, ANN NEUROL, V86, P324, DOI 10.1002/ana.25510
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Palle S, 2018, N-S ARCH PHARMACOL, V391, P445, DOI 10.1007/s00210-018-1474-8
   Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   Patel RV, 2018, EUR J MED CHEM, V155, P889, DOI 10.1016/j.ejmech.2018.06.053
   Pereira SS, 2019, J CELL BIOCHEM, V120, P894, DOI 10.1002/jcb.27451
   Pickett SJ, 2022, MITOCHONDRION, V63, P85, DOI 10.1016/j.mito.2022.02.002
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Podlesniy P, 2019, EBIOMEDICINE, V48, P554, DOI 10.1016/j.ebiom.2019.09.015
   Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Prasuhn J, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.615461
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Ramonet D, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018568
   Rappold PM, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6244
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Ren Q, 2018, P NATL ACAD SCI USA, V115, PE5815, DOI 10.1073/pnas.1802179115
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Rizek P, 2016, CAN MED ASSOC J, V188, P1157, DOI 10.1503/cmaj.151179
   Rojas JC, 2009, NEUROSCIENCE, V163, P877, DOI 10.1016/j.neuroscience.2009.07.012
   Rosa AI, 2017, BBA-MOL BASIS DIS, V1863, P2171, DOI 10.1016/j.bbadis.2017.06.004
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Saarni SI, 2006, QUAL LIFE RES, V15, P1403, DOI 10.1007/s11136-006-0020-1
   Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7
   Scorziello A, 2020, FRONT AGING NEUROSCI, V12, P0, DOI 10.3389/fnagi.2020.00100
   Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2
   Shanmughapriya S, 2020, AGEING RES REV, V62, P0, DOI 10.1016/j.arr.2020.101128
   Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
   Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541
   Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Smith ES, 2017, NEUROSCIENCE, V359, P8, DOI 10.1016/j.neuroscience.2017.07.001
   Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148
   Song LK, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0131281
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Steger M, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.12813
   Subramaniam SR, 2014, NEUROBIOL DIS, V70, P204, DOI 10.1016/j.nbd.2014.06.017
   Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Szelechowski M, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6181
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tang BL, 2017, J NEUROSCI RES, V95, P930, DOI 10.1002/jnr.23806
   Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001
   Tapias V, 2017, CELL MOL LIFE SCI, V74, P2851, DOI 10.1007/s00018-017-2541-x
   Tarohda T, 2005, ANAL BIOANAL CHEM, V383, P224, DOI 10.1007/s00216-005-3423-x
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Tomiyama H, 2008, J HUM GENET, V53, P1012, DOI 10.1007/s10038-008-0336-5
   Trinh D, 2021, J NEUROCHEM, V156, P715, DOI 10.1111/jnc.15154
   Trinh J, 2018, MOVEMENT DISORD, V33, P1857, DOI 10.1002/mds.27527
   Tzeng IS, 2022, J CLIN LAB ANAL, V36, P0, DOI 10.1002/jcla.24274
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Uhrbrand A, 2015, J NEUROL SCI, V353, P9, DOI 10.1016/j.jns.2015.04.004
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522
   van der Merwe C, 2017, MOL NEUROBIOL, V54, P2752, DOI 10.1007/s12035-016-9843-0
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wang H, 2018, ANAT REC, V301, P1115, DOI 10.1002/ar.23781
   Wang WW, 2021, AGING-US, V13, P11738, DOI 10.18632/aging.202868
   Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983
   Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003
   Wang YJ, 2019, EUR J MED CHEM, V161, P48, DOI 10.1016/j.ejmech.2018.10.028
   Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001
   Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516
   Xi Y, 2018, BBA-MOL BASIS DIS, V1864, P2859, DOI 10.1016/j.bbadis.2018.05.018
   Xia XY, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00182
   Xu DC, 2016, GENE DEV, V30, P1718, DOI 10.1101/gad.285122.116
   Yan AJ, 2019, FRONT CELL NEUROSCI, V12, P0, DOI 10.3389/fncel.2018.00529
   Yang XF, 2016, CURR TOP MED CHEM, V16, P858, DOI 10.2174/1568026615666150827095252
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   Yoon JH, 2017, BBA-MOL CELL RES, V1864, P2356, DOI 10.1016/j.bbamcr.2017.09.001
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zhou K, 2018, NEURAL REGEN RES, V13, P1552, DOI 10.4103/1673-5374.235299
   Zhu ZG, 2017, NEUROL SCI, V38, P215, DOI 10.1007/s10072-016-2757-9
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
   Zsurka G, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9040175
NR 254
TC 10
Z9 10
U1 2
U2 20
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD MAY 15
PY 2023
VL 43
IS 4
BP 1499
EP 1518
DI 10.1007/s10571-022-01265-w
EA AUG 2022
PG 20
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA F6YP2
UT WOS:000839320400001
PM 35951210
DA 2024-11-01
ER

PT J
AU Gkiourtzis, N
   Tramma, D
   Papadopoulou-Legbelou, K
   Moutafi, M
   Evangeliou, A
AF Gkiourtzis, Nikolaos
   Tramma, Despoina
   Papadopoulou-Legbelou, Kyriaki
   Moutafi, Maria
   Evangeliou, Athanasios
TI Α rare case of myopathy, lactic acidosis, and severe rhabdomyolysis, due to a homozygous mutation of the ferredoxin-2 (<i>FDX2</i>) gene
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE children; FDX2; ferredoxin; lactic acidosis; mitochondrial myopathy; rhabdomyolysis
ID cluster
AB Mitochondrial myopathy is a severe metabolic myopathy related to nuclear or mitochondrial DNA dysfunction. We present a rare case of mitochondrial myopathy, presented with multiple episodes of proximal muscle weakness, lactic acidosis, and severe rhabdomyolysis (CPK 319,990 U/L, lactic acid 22.31 mmol/L, and GFR 3.82 mL/min/1.73m(2)). She was hospitalized in the pediatric intensive care unit due to acute kidney injury, elevated blood pressure, and deterioration of respiratory and cardiac function. Investigation for inherited metabolic disorders showed elevated levels of ammonia, lactic acid to pyruvic acid ratio, and urine ketone bodies. Exome sequencing detected a homozygous pathogenic variant in FDX2 (ENST00000541276:p.Met4Leu/c.10A > T) and a heterozygous variant of uncertain significance in MSTO1 (ENST00000538143:p.Leu137Pro/c.410 T > C). After Sanger sequencing, the p.Met4Leu pathogenic variant in FDX2 (ENST00000541276:p.Met4Leu/c.10A > T) was identified in a heterozygous state in both her parents and sister. Recently, pathogenic variants in the FDX2 gene have been associated with mitochondrial myopathy, lactic acidosis, optic atrophy, and leukoencephalopathy. Only four reports of FDX2-related rhabdomyolysis have been described before, but none of the previous patients had hyperammonemia. This is a rare case of severe mitochondrial myopathy in a pediatric patient related to a pathogenic FDX2 variant, suggesting the need for genetic analysis of the FDX2 gene in cases of suspicion of mitochondrial myopathies.
C1 [Gkiourtzis, Nikolaos; Tramma, Despoina; Papadopoulou-Legbelou, Kyriaki; Moutafi, Maria; Evangeliou, Athanasios] Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Dept Pediat 4, Thessaloniki, Greece.
   [Gkiourtzis, Nikolaos] Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Sch Med, Dept Pediat 4, Thessaloniki, Greece.
C3 Papageorgiou Hospital; Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki
RP Gkiourtzis, N (corresponding author), Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Sch Med, Dept Pediat 4, Thessaloniki, Greece.
EM gkiourtzisnikolaos@gmail.com
CR Aggarwal A, 2022, AM J MED GENET A, V188, P1239, DOI 10.1002/ajmg.a.62608
   Cai K, 2017, BIOCHEMISTRY-US, V56, P487, DOI 10.1021/acs.biochem.6b00447
   Gurgel-Giannetti J, 2018, BRAIN, V141, P2289, DOI 10.1093/brain/awy172
   Lebigot E, 2017, MOL GENET METAB, V122, P85, DOI 10.1016/j.ymgme.2017.08.001
   Lehmann Diana, 2018, J. INBORN ERRORS METAB. SCREEN., V6, P170017
   Li K, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2019.01.013
   Liu LQ, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.947886
   Montealegre S, 2022, NEUROL-GENET, V8, P0, DOI 10.1212/NXG.0000000000000648
   Nance JR, 2015, MUSCLE NERVE, V51, P793, DOI 10.1002/mus.24606
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Perez-Albert Paula, 2018, JIMD REP, V42, P61, DOI 10.1007/8904_2017_78
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Scalco RS, 2015, ORPHANET J RARE DIS, V10, P0, DOI 10.1186/s13023-015-0264-3
   Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
NR 16
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD DEC 15
PY 2023
VL 191
IS 12
BP 2843
EP 2849
DI 10.1002/ajmg.a.63368
EA AUG 2023
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA Y4CT2
UT WOS:001045109100001
PM 37565517
DA 2024-11-01
ER

PT J
AU Naganuma, T
   Imasawa, T
   Nukui, I
   Wakasugi, M
   Kitamura, H
   Yatsuka, Y
   Kishita, Y
   Okazaki, Y
   Murayama, K
   Jinguji, Y
AF Naganuma, Tsukasa
   Imasawa, Toshiyuki
   Nukui, Ikuo
   Wakasugi, Masakiyo
   Kitamura, Hiroshi
   Yatsuka, Yukiko
   Kishita, Yoshihito
   Okazaki, Yasushi
   Murayama, Kei
   Jinguji, Yoshimi
TI Focal segmental glomerulosclerosis with a mutation in the<i> mitochondrially</i> encoded NADH dehydrogenase 5 gene: A case report
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE Focal segmental glomerulosclerosis; Mitochondrial nephropathy; NADH dehydrogenase 5; Podocyte; Case report
ID nd5 gene; fanconi syndrome; leigh-syndrome; dna; melas; c1q; dysfunction; podocyte; disease; binding
AB NADH dehydrogenase 5 (ND5) is one of 44 subunits composed of Complex I in mitochondrial respiratory chain. Therefore, a mitochondrially encoded ND5 (MT-ND5) gene mutation causes mitochondrial oxidative phosphorylation (OXPHOS) disorder, resulting in the development of mitochondrial diseases. Focal segmental glomerulosclerosis (FSGS) which had podocytes filled with abnormal mitochondria is induced by mitochondrial diseases. An MT-ND5 mutation also causes FSGS. We herein report a Japanese woman who was found to have proteinuria and renal dysfunction in an annual health check-up at 29 years old. Because her proteinuria and renal dysfunction were persistent, she had a kidney biopsy at 33 years of age. The renal histology showed FSGS with podocytes filled with abnormal mitochondria. The podocytes also had foot process effacement and cytoplasmic vacuolization. In addition, the renal pathological findings showed granular swollen epithelial cells (GSECs) in tubular cells, age-inappropriately disarranged and irregularly sized vascular smooth muscle cells (AiDIVs), and red-coloured podocytes (ReCPos) by acidic dye. A genetic analysis using peripheral mononuclear blood cells and urine sediment cells detected the m.13513 G > A variant in the MT-ND5 gene. Therefore, this patient was diagnosed with FSGS due to an MT-ND5 gene mutation. Although this is not the first case report to show that an MT-ND5 gene mutation causes FSGS, this is the first to demonstrate podocyte injuries accompanied with accumulation of abnormal mitochondria in the cytoplasm.
C1 [Naganuma, Tsukasa; Nukui, Ikuo; Wakasugi, Masakiyo; Jinguji, Yoshimi] Yamanashi Prefectural Cent Hosp, Dept Internal Med, Div Nephrol, 1-1-1 Fujimi, Kofu, Yamanashi 4000027, Japan.
   [Imasawa, Toshiyuki] Higashi Natl Hosp, Natl Hosp Org Chiba, Dept Nephrol, 673 Nitona Cho,Chuoh Ku, Chiba, Chiba 2068712, Japan.
   [Kitamura, Hiroshi] Higashi Natl Hosp, Natl Hosp Org Chiba, Dept Clin Pathol, 673 Nitona Cho,Chuoh Ku, Chiba, Chiba 2068712, Japan.
   [Yatsuka, Yukiko; Kishita, Yoshihito; Okazaki, Yasushi] Juntendo Univ, Intractable Dis Res Ctr, Grad Sch Med, Diagnost & Therapeut Intractable Dis, 2-1-1 Hongo,Bunkyo Ku, Tokyo 1138421, Japan.
   [Kishita, Yoshihito] Kindai Univ, Fac Sci & Engn, Dept Life Sci, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Ctr Med Genet, Dept Metab, 579-1 Heta Cho,Midori Ku, Chiba 2660007, Japan.
C3 Juntendo University; Kindai University (Kinki University); Chiba Children's Hospital
RP Imasawa, T (corresponding author), Higashi Natl Hosp, Natl Hosp Org Chiba, Dept Nephrol, 673 Nitona Cho,Chuoh Ku, Chiba, Chiba 2068712, Japan.
EM imasawa@nifty.com
FU Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED [19ek0109273, 20ek0109468]
CR Bakis H, 2020, CLIN GENET, V97, P628, DOI 10.1111/cge.13670
   Barone V, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.887696
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Brown EJ, 2014, KIDNEY INT, V85, P1030, DOI 10.1038/ki.2014.48
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   COMIS A, 1985, FEBS LETT, V185, P105, DOI 10.1016/0014-5793(85)80749-3
   DAgati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024
   DAgati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Geng X, 2019, DIABETIC MED, V36, P776, DOI 10.1111/dme.13874
   Ghose A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6090090
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Imasawa T, 2022, KIDNEY INT REP, V7, P580, DOI 10.1016/j.ekir.2021.12.028
   Imasawa T, 2014, DIAGN PATHOL, V9, P0, DOI 10.1186/s13000-014-0181-0
   Imasawa T, 2014, RENAL FAILURE, V36, P1461, DOI 10.3109/0886022X.2014.945181
   Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013
   JENNETTE JC, 1985, AM J KIDNEY DIS, V6, P103, DOI 10.1016/S0272-6386(85)80150-5
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Maeoka Y, 2020, BMC NEPHROL, V21, P0, DOI 10.1186/s12882-020-02040-z
   Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   Motoda Atsuko, 2013, RINSHO SHINKEIGAKU, V53, P446
   Müller-Deile J, 2014, FRONT ENDOCRINOL, V5, P0, DOI 10.3389/fendo.2014.00209
   Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012
   Ng PS, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000314
   Ogawa E, 2020, J INHERIT METAB DIS, V43, P819, DOI 10.1002/jimd.12218
   Olmos PR, 2011, J OTOLARYNGOL-HEAD N, V40, P93, DOI 10.2310/7070.2010.100078
   Pulkes T, 2000, ANN NEUROL, V47, P841
   Rudnicki M, 2016, AM J KIDNEY DIS, V68, P949, DOI 10.1053/j.ajkd.2016.06.027
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Shabaka A, 2020, NEPHRON, V144, P413, DOI 10.1159/000508099
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   STORRS SB, 1981, J BIOL CHEM, V256, P924
   Strassheim D, 2013, J AM SOC NEPHROL, V24, P393, DOI 10.1681/ASN.2012020187
   Sun K, 2021, KIDNEY DIS-BASEL, V7, P350, DOI 10.1159/000517108
   Suzuki S, 2004, ANN NY ACAD SCI, V1011, P185, DOI 10.1196/annals.1293.019
   TEJANI A, 1983, NEPHRON, V35, P1, DOI 10.1159/000183035
   Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010
   THORNER P S, 1985, PEDIATRIC PATHOLOGY, V4, P25
   Tsuchimoto A, 2020, NEPHROL DIAL TRANSPL, V35, P1219, DOI 10.1093/ndt/gfy374
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 52
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD JUN 15
PY 2023
VL 35
IS 
BP 
EP 
DI 10.1016/j.ymgmr.2023.100963
EA MAR 2023
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA N9WU5
UT WOS:001040437200001
PM 36941957
DA 2024-11-01
ER

PT J
AU Chatzovoulou, K
   Mayeur, A
   Cagnard, N
   Zarhrate, M
   Bole, C
   Nitschke, P
   Jabot-Hanin, F
   Rötig, A
   Monnot, S
   Munnich, A
   Frydman, N
   Steffann, J
AF Chatzovoulou, Kalliopi
   Mayeur, Anne
   Cagnard, Nicolas
   Zarhrate, Mohammed
   Bole, Christine
   Nitschke, Patrick
   Jabot-Hanin, Fabienne
   Rotig, Agnes
   Monnot, Sophie
   Munnich, Arnold
   Frydman, Nelly
   Steffann, Julie
TI A shared pattern of altered gene expression in human embryos affected by mitochondrial diseases
SO HUMAN REPRODUCTION
LA English
DT Article
DE mitochondrial mutation; human embryo development; mitochondrial metabolism; transcriptome; RNA sequencing; differential gene expression
ID dna copy number; mutation
AB STUDY QUESTION Does mitochondrial deficiency affect human embryonic preimplantation development? SUMMARY ANSWER The presence of a pathogenic mitochondrial variant triggers changes in the gene expression of preimplantation human embryos, compromising their development, cell differentiation, and survival. WHAT IS KNOWN ALREADY Quantitative and qualitative anomalies of mitochondrial DNA (mtDNA) are reportedly associated with impaired human embryonic development, but the underlying mechanisms remain unexplained. STUDY DESIGN, SIZE, DURATION Taking advantage of the preimplantation genetic testing for mitochondrial disorders in at-risk couples, we have compared gene expression of 9 human embryos carrying pathogenic variants in either mtDNA genes or nuclear genes encoding mitochondrial protein to 33 age-matched control embryos. PARTICIPANTS/MATERIALS, SETTING, METHODS Single-embryo transcriptomic analysis was performed on whole human blastocyst embryos donated to research. MAIN RESULTS AND THE ROLE OF CHANCE Specific pathogenic mitochondrial variants downregulate gene expression in preimplantation human embryos [566 genes in oxidative phosphorylation (OXPHOS)-deficient embryos], impacting transcriptional regulators, differentiation factors, and nuclear genes encoding mitochondrial proteins. These changes in gene expression primarily alter OXPHOS and cell survival pathways. LIMITATIONS, REASONS FOR CAUTION The number of OXPHOS-deficient embryos available for the study was limited owing to the rarity of this material. However, the molecular signature shared by all these embryos supports the relevance of the findings. WIDER IMPLICATIONS OF THE FINDINGS While identification of reliable markers of normal embryonic development is urgently needed in ART, our study prompts us to consider under-expression of the targeted genes reported here, as predictive biomarkers of mitochondrial dysfunction during preimplantation development. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by the 'Association Francaise contre les Myopathies (AFM-Telethon)' and the 'La Fondation Maladies Rares'. No competing interests to declare.
C1 [Chatzovoulou, Kalliopi; Rotig, Agnes; Munnich, Arnold; Steffann, Julie] Paris Cite Univ, Imagine Inst, INSERM UMR 1163, Genet Mitochondrial Disorders, Paris, France.
   [Mayeur, Anne] Paris Saclay Univ, Antoine Beclere Hosp, AP HP, Reprod Biol Dept,CECOS, Clamart, France.
   [Cagnard, Nicolas; Nitschke, Patrick; Jabot-Hanin, Fabienne] Paris Cite Univ, Bioinformat Core Facil, INSERM US24, CNRS UMS3633,Struct Federat Rech Necker, Paris, France.
   [Zarhrate, Mohammed; Bole, Christine] Paris Cite Univ, Inst Imagine Struct Federat Rech Necker, Genom Core Facil, INSERM U1163, Paris, France.
   [Zarhrate, Mohammed; Bole, Christine] Paris Descartes Sorbonne Paris Cite Univ, INSERM US24, CNRS UAR3633, Paris, France.
   [Monnot, Sophie; Munnich, Arnold; Steffann, Julie] Necker Enfants Malad Hosp, AP HP, Genom Med Dept, F-75015 Paris, France.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP
RP Steffann, J (corresponding author), Necker Enfants Malad Hosp, AP HP, Genom Med Dept, F-75015 Paris, France.
EM julie.steffann@aphp.fr
FU 'Association Francaise contre les Myopathies (AFM-Telethon)' [20304]; Fondation Maladies Rares [GenOmics_202003003]; AFM-Telethon [22112]
CR Allshire RC, 2018, NAT REV MOL CELL BIO, V19, P229, DOI 10.1038/nrm.2017.119
   Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, HUM REPROD, V26, P1270, DOI 10.1093/humrep/der037
   Azadi A, 2018, MITOCHONDRIAL DNA A, V29, P674, DOI 10.1080/24701394.2017.1350854
   Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547
   BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0
   Chen SH, 2016, REPROD BIOMED ONLINE, V33, P737, DOI 10.1016/j.rbmo.2016.10.003
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269
   Feeney CL, 2019, BJOG-INT J OBSTET GY, V126, P1380, DOI 10.1111/1471-0528.15667
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Gigarel N, 2005, MOL GENET METAB, V84, P289, DOI 10.1016/j.ymgme.2004.10.008
   Groff AF, 2019, GENOME RES, V29, P1705, DOI 10.1101/gr.252981.119
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kuleva M, 2019, BJOG-INT J OBSTET GY, V126, P1372, DOI 10.1111/1471-0528.15515
   Latham KE, 2001, FRONT BIOSCI, V6, PD748, DOI 10.2741/Latham
   Monnot S, 2013, HUM MOL GENET, V22, P1867, DOI 10.1093/hmg/ddt040
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Nagaraj R, 2017, CELL, V168, P210, DOI 10.1016/j.cell.2016.12.026
   Petropoulos S, 2016, CELL, V165, P1012, DOI 10.1016/j.cell.2016.08.009
   Qi SY, 2022, PLOS BIOL, V20, P0, DOI 10.1371/journal.pbio.3001741
   Schulz KN, 2019, NAT REV GENET, V20, P221, DOI 10.1038/s41576-018-0087-x
   Shaw L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064192
   Sirard MA, 2022, REPROD FERT DEVELOP, V34, P203, DOI 10.1071/RD21266
   Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
NR 26
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD MAY 2
PY 2023
VL 38
IS 5
BP 992
EP 1002
DI 10.1093/humrep/dead052
EA MAR 2023
PG 11
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AJ6V0
UT WOS:000955082300001
PM 36952633
DA 2024-11-01
ER

PT J
AU Wu, SL
   Longley, MJ
   Lujan, SA
   Kunkel, TA
   Copeland, WC
AF Wu, Shilan
   Longley, Matthew J.
   Lujan, Scott A.
   Kunkel, Thomas A.
   Copeland, William C.
TI Mitochondrial DNA Enrichment for Sensitive Next-Generation Sequencing
SO MITOCHONDRIAL DNA: Methods and Protocols
LA English
DT Article; Book Chapter
DE Mitochondrial DNA; DNA deletions; Next-Generation Sequencing; Mitochondrial disease; POLG; Mitochondrial DNA Replication
ID progressive external ophthalmoplegia; deletions; mutations
AB Mitochondrial DNA (mtDNA) encodes components essential for cellular respiration. Low levels of point mutations and deletions accumulate in mtDNA during normal aging. However, improper maintenance of mtDNA results in mitochondrial diseases, stemming from progressive loss of mitochondrial function through the accelerated formation of deletions and mutations in mtDNA. To better understand the molecular mechanisms underlying the creation and propagation of mtDNA deletions, we developed the LostArc next-generation DNA sequencing pipeline to detect and quantify rare mtDNA species in small tissue samples. LostArc procedures are designed to minimize PCR amplification of mtDNA and instead achieve enrichment of mtDNA by selective destruction of nuclear DNA. This approach leads to cost-effective, high-depth sequencing of mtDNA with a sensitivity sufficient to identify one mtDNA deletion per million mtDNA circles. Here, we describe detailed protocols for isolation of genomic DNA from mouse tissues, enrichment of mtDNA through enzymatic destruction of linear nuclear DNA, and preparation of libraries for unbiased next-generation sequencing of mtDNA.
C1 [Wu, Shilan; Longley, Matthew J.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Lujan, Scott A.; Kunkel, Thomas A.] NIEHS, Genome Integr & Struct Biol Lab, DNA Replicat Fidel Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Wu, SL (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, Mitochondrial DNA Replicat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
FU Division of Intramural Research of the NIH, NIEHS [Z01 ES065078, Z01 ES065080, Z01 ES065070]
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NaviauxRK NguyenKV, 2004, ANNNEUROL55, V0, P0
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 23
TC 0
Z9 0
U1 3
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PD JUN 15
PY 2023
VL 2615
IS 
BP 427
EP 441
DI 10.1007/978-1-0716-2922-2_28
PG 15
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA BW2FG
UT WOS:001116120000029
PM 36807807
DA 2024-11-01
ER

PT J
AU Zanini, G
   Selleri, V
   Malerba, M
   Solodka, K
   Sinigaglia, G
   Nasi, M
   Mattioli, AV
   Pinti, M
AF Zanini, Giada
   Selleri, Valentina
   Malerba, Mara
   Solodka, Kateryna
   Sinigaglia, Giorgia
   Nasi, Milena
   Mattioli, Anna Vittoria
   Pinti, Marcello
TI The Role of Lonp1 on Mitochondrial Functions during Cardiovascular and Muscular Diseases
SO ANTIOXIDANTS
LA English
DT Review
DE Lon protease; UPRmt; heart dysfunction; sarcopenia
ID cytochrome-c-oxidase; hypoxia-inducible factor; protein-quality control; age-related-changes; skeletal-muscle; oxidative stress; proteolytic activity; ubiquitin ligases; mitofusin 2; rat-liver
AB The mitochondrial protease Lonp1 is a multifunctional enzyme that regulates crucial mitochondrial functions, including the degradation of oxidized proteins, folding of imported proteins and maintenance the correct number of copies of mitochondrial DNA. A series of recent studies has put Lonp1 at the center of the stage in the homeostasis of cardiomyocytes and muscle skeletal cells. During heart development, Lonp1 allows the metabolic shift from anaerobic glycolysis to mitochondrial oxidative phosphorylation. Knock out of Lonp1 arrests heart development and determines cardiomyocyte apoptosis. In adults, Lonp1 acts as a cardioprotective protein, as its upregulation mitigates cardiac injury by preventing the oxidative damage of proteins and lipids, and by preserving mitochondrial redox balance. In skeletal muscle, Lonp1 is crucial for cell development, as it mediates the activation of PINK1/Parkin pathway needed for proper myoblast differentiation. Skeletal muscle-specific ablation of Lonp1 in mice causes reduced muscle fiber size and strength due to the accumulation of mitochondrial-retained protein in muscle. Lonp1 expression and activity decline with age in different tissues, including skeletal muscle, and are associated with a functional decline and structural impairment of muscle fibers. Aerobic exercise increases unfolded protein response markers including Lonp1 in the skeletal muscle of aged animals and is associated with muscle functional recovery. Finally, mutations of Lonp1 cause a syndrome named CODAS (Cerebral, Ocular, Dental, Auricular, and Skeletal anomalies) characterized by the impaired development of multiple organs and tissues, including myocytes. CODAS patients show hypotonia and ptosis, indicative of skeletal muscle reduced performance. Overall, this body of observations points Lonp1 as a crucial regulator of mitochondrial functions in the heart and in skeletal muscle.
C1 [Zanini, Giada; Selleri, Valentina; Malerba, Mara; Solodka, Kateryna; Sinigaglia, Giorgia; Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy.
   [Selleri, Valentina; Solodka, Kateryna; Mattioli, Anna Vittoria] Ist Nazl Ric Cardiovascolari, I-40126 Bologna, Italy.
   [Nasi, Milena] Univ Modena & Reggio Emilia, Morphol Sci Related Transplant Oncol & Regenerat, Surg Med & Dent Dept, I-41125 Modena, Italy.
   [Mattioli, Anna Vittoria] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, I-41124 Modena, Italy.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia
RP Mattioli, AV (corresponding author), Ist Nazl Ric Cardiovascolari, I-40126 Bologna, Italy.; Mattioli, AV (corresponding author), Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, I-41124 Modena, Italy.
EM annavittoria.mattioli@unimore.it
FU Department of Life Sciences, UNIMORE (FAR Dipartimentale 2020); AIRC; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Istituto Nazionale per le Ricerche Cardiovascolari (INRC);  [813863];  [19786]
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Anderson NS, 2020, TRENDS CELL BIOL, V30, P428, DOI 10.1016/j.tcb.2020.03.001
   Baechler BL, 2019, AUTOPHAGY, V15, P1606, DOI 10.1080/15548627.2019.1591672
   Baggio F, 2014, NUCLEIC ACIDS RES, V42, P13920, DOI 10.1093/nar/gku1132
   Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Bar-Ziv R, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.202050094
   Barbieri Elena, 2011, J AGING RES, V2011, P845379, DOI 10.4061/2011/845379
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Borghetti G, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01514
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031
   Bratic A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002324
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   Bruneau BG, 2020, DEVELOPMENT, V147, P0, DOI 10.1242/dev.194233
   Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035
   Cantu D, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007095
   Chandel NS, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-34
   Chen SH, 2008, NUCLEIC ACIDS RES, V36, P1273, DOI 10.1093/nar/gkm1140
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Cheng CW, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.204
   Chou HC, 2010, FREE RADICAL BIO MED, V49, P96, DOI 10.1016/j.freeradbiomed.2010.04.001
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   Cocchi C, 2021, FUTUR CARDIOL, V17, P487, DOI 10.2217/fca-2021-0011
   Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467
   Cordeiro AV, 2020, J GERONTOL A-BIOL, V75, P2258, DOI 10.1093/gerona/glaa059
   Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127
   Crewe C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077280
   De Gaetano A, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10050794
   De Gaetano A, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9061783
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Delbridge LMD, 2017, NAT REV CARDIOL, V14, P412, DOI 10.1038/nrcardio.2017.35
   Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029
   Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004
   Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516
   Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291
   Erjavec N, 2013, FREE RADICAL BIO MED, V56, P9, DOI 10.1016/j.freeradbiomed.2012.11.019
   ERMINI M, 1976, GERONTOLOGY, V22, P301, DOI 10.1159/000212145
   Ferrara D, 2019, J CELL PHYSIOL, V234, P21630, DOI 10.1002/jcp.28821
   Fragasso G, 2011, HEART, V97, P1495, DOI 10.1136/hrt.2011.226332
   Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047
   Fukui T, 2002, J BACTERIOL, V184, P3689, DOI 10.1128/JB.184.13.3689-3698.2002
   Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Gibellini L, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-14860-0
   Gibellini L, 2020, INT REV CEL MOL BIO, V354, P1, DOI 10.1016/bs.ircmb.2020.02.005
   Gibellini L, 2014, MITOCHONDRION, V18, P76, DOI 10.1016/j.mito.2014.08.001
   Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8
   Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198
   Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458
   Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14
   Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001
   Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x
   Guo QQ, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abo0340
   Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384
   Gurusamy N, 2009, J CELL MOL MED, V13, P373, DOI 10.1111/j.1582-4934.2008.00495.x
   Hannah-Shmouni F, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00981
   He LH, 2016, INFECT IMMUN, V84, P1387, DOI 10.1128/IAI.00076-16
   Henning RJ, 2018, FUTUR CARDIOL, V14, P0, DOI 10.2217/fca-2018-0045
   Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje
   Hoshino A, 2014, CIRC-HEART FAIL, V7, P500, DOI 10.1161/CIRCHEARTFAILURE.113.001062
   Hsieh SR, 2013, J BIOMED SCI, V20, P0, DOI 10.1186/1423-0127-20-86
   Huang SY, 2020, AM J PHYSIOL-CELL PH, V319, PC1020, DOI 10.1152/ajpcell.00589.2019
   Huang SY, 2018, AM J PHYSIOL-CELL PH, V315, PC474, DOI 10.1152/ajpcell.00112.2018
   Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Inui T, 2017, J HUM GENET, V62, P653, DOI 10.1038/jhg.2017.11
   Kadenbach B, 2011, MITOCHONDRION, V11, P700, DOI 10.1016/j.mito.2011.06.001
   Kao TY, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.9
   Kaspar S, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abf0971
   Keipert S, 2021, TRENDS ENDOCRIN MET, V32, P904, DOI 10.1016/j.tem.2021.08.008
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Koltai E, 2012, AM J PHYSIOL-REG I, V303, PR127, DOI 10.1152/ajpregu.00337.2011
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kuo CY, 2015, MITOCHONDRION, V23, P7, DOI 10.1016/j.mito.2015.04.004
   Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156
   LaFrance R, 2005, AGING CELL, V4, P139, DOI 10.1111/j.1474-9726.2005.00156.x
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Leduc-Gaudet JP, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22158179
   Lee YG, 2021, ONCOGENESIS, V10, P0, DOI 10.1038/s41389-021-00306-1
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13
   Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14
   Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009
   Lopez-Crisosto C, 2017, NAT REV CARDIOL, V14, P342, DOI 10.1038/nrcardio.2017.23
   Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Marlin S, 2010, AM J MED GENET A, V152A, P1510, DOI 10.1002/ajmg.a.33242
   Maroli G, 2021, CARDIOVASC RES, V117, P712, DOI 10.1093/cvr/cvaa159
   Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Masoud WGT, 2014, CARDIOVASC RES, V101, P30, DOI 10.1093/cvr/cvt216
   Matsushima Y, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-02498-z
   Mattioli AV, 2021, VASC HEALTH RISK MAN, V17, P729, DOI 10.2147/VHRM.S242636
   Menendez-Montes I, 2016, DEV CELL, V39, P724, DOI 10.1016/j.devcel.2016.11.012
   Miller MS, 2008, BIOPHYS J, V95, P2391, DOI 10.1529/biophysj.108.130005
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004
   Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015
   Nimmo GAM, 2019, HUM MOL GENET, V28, P290, DOI 10.1093/hmg/ddy351
   Nouri K, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-03062-z
   OLeary MF, 2013, AM J PHYSIOL-CELL PH, V304, PC422, DOI 10.1152/ajpcell.00240.2012
   Onat UI, 2019, J AM COLL CARDIOL, V73, P1149, DOI 10.1016/j.jacc.2018.12.055
   Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012
   Paolisso P, 2020, FRONT PHARMACOL, V10, P0, DOI 10.3389/fphar.2019.01606
   Pareek G, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-1213-6
   Pareek G, 2018, CELL DEATH DISCOV, V4, P0, DOI 10.1038/s41420-018-0110-1
   Pasupathy S, 2005, EUR J VASC ENDOVASC, V29, P106, DOI 10.1016/j.ejvs.2004.11.005
   Pinti M, 2016, BBA-BIOENERGETICS, V1857, P1300, DOI 10.1016/j.bbabio.2016.03.025
   Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3
   Pinti M, 2011, MITOCHONDRION, V11, P200, DOI 10.1016/j.mito.2010.09.010
   Polo M, 2017, BRIT J PHARMACOL, V174, P4409, DOI 10.1111/bph.14045
   Pomatto LCD, 2017, CURR BIOL, V27, P1, DOI 10.1016/j.cub.2016.10.044
   Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758
   Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200
   Qiao L, 2021, AM J HUM GENET, V108, P1964, DOI 10.1016/j.ajhg.2021.08.011
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Quirós PM, 2014, MOL CELL ONCOL, V1, P0, DOI 10.4161/23723548.2014.968505
   Quirós PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018
   Rackham O, 2016, CELL REP, V16, P1874, DOI 10.1016/j.celrep.2016.07.031
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Rüegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537
   SACHS HG, 1977, AM J ANAT, V150, P63, DOI 10.1002/aja.1001500105
   Schilling JD, 2015, ANTIOXID REDOX SIGN, V22, P1515, DOI 10.1089/ars.2015.6294
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Sedlic F, 2017, J CELL PHYSIOL, V232, P216, DOI 10.1002/jcp.25413
   Sepuri NBV, 2017, BBA-BIOENERGETICS, V1858, P519, DOI 10.1016/j.bbabio.2017.04.003
   Shin CS, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20597-z
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172
   Stadtman E R, 1992, EXS, V62, P64
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Stanyer L, 2008, NEUROCHEM INT, V53, P95, DOI 10.1016/j.neuint.2008.06.004
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7
   Takahashi R, 2006, BBA-GEN SUBJECTS, V1760, P1293, DOI 10.1016/j.bbagen.2006.06.006
   Tang Y, 2023, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.1031856
   Taouktsi E, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11081363
   Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110
   Terman A, 2004, EXP GERONTOL, V39, P701, DOI 10.1016/j.exger.2004.01.005
   Thomas RE, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004279
   Vainshtein A, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0033-y
   Venkatesh S, 2020, MITOCHONDRION, V51, P46, DOI 10.1016/j.mito.2019.10.004
   Venkatesh S, 2019, J MOL CELL CARDIOL, V128, P38, DOI 10.1016/j.yjmcc.2018.12.017
   Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003
   Vijayasarathy C, 2003, EUR J BIOCHEM, V270, P871, DOI 10.1046/j.1432-1033.2003.03447.x
   Wang DD, 2021, NAT REV ENDOCRINOL, V17, P592, DOI 10.1038/s41574-021-00529-7
   WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247
   Wang XA, 2023, ACTA HISTOCHEM, V125, P0, DOI 10.1016/j.acthis.2022.151986
   Welle S, 2003, PHYSIOL GENOMICS, V12, P71, DOI 10.1152/physiolgenomics.00177.2002
   Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111
   Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412
   Xu ZS, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28557-5
   Zanini G, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11233940
   Zhao K, 2022, DEVELOPMENT, V149, P0, DOI 10.1242/dev.200458
   Zhao QC, 2019, J AM HEART ASSOC, V8, P0, DOI 10.1161/JAHA.119.012731
NR 169
TC 10
Z9 11
U1 5
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD MAR 15
PY 2023
VL 12
IS 3
BP 
EP 
DI 10.3390/antiox12030598
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology
GA A8DI9
UT WOS:000957365700001
PM 36978846
DA 2024-11-01
ER

PT J
AU Shafique, A
   Arif, B
   Chu, ML
   Moran, E
   Hussain, T
   Zamora, FM
   Wohler, E
   Sobreira, N
   Klein, C
   Lohmann, K
   Naz, S
AF Shafique, Anum
   Arif, Beenish
   Chu, Mary Lynn
   Moran, Ellen
   Hussain, Tooba
   Zamora, Francisca Millan
   Wohler, Elizabeth
   Sobreira, Nara
   Klein, Christine
   Lohmann, Katja
   Naz, Sadaf
TI <i>MRM2</i> variants in families with complex dystonic syndromes: evidence for phenotypic heterogeneity
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE movement disorders; human genetics; gene expression profiling; germ-line mutation; high-throughput nucleotide sequencing
ID ribosomal-rna; large subunit; mutation; donor; site
AB Background Dystonia involves repetitive movements and muscle contractions leading to abnormal postures. We investigated patients in two families, DYAF11 and M, exhibiting dystonic or involuntary movement disorders. Methods Clinical investigations were performed for all patients. Genetic analyses included genome-wide linkage analysis and exome sequencing followed by Sanger sequencing validation. MRM2-specific transcripts were analysed from participants' blood samples in Family DYAF11 after cloning of gene-specific cDNA. Results Four affected siblings in Family DYAF11 had progressive dystonic features. Two patients in Family M exhibited a neurodevelopmental disorder accompanied by involuntary movements. In Family DYAF11, linkage was detected to the telomere at chromosome 7p22.3, spanning <2 Mb. Exome sequencing identified a donor splice-site variant, c.8+1G>T in MRM2, which segregated with the phenotype, corresponding to the linkage data since all affected individuals were homozygous while the obligate unaffected carriers were heterozygous for the variant. In the MRM2 c.8+1G>T allele, an aberrant alternative acceptor splice-site located within exon 2 was used in a subset of the transcripts, creating a frameshift in the open reading frame. Exome sequencing in Family M revealed a rare missense variant c.242C>T, p.(Ala81Val), which affected a conserved amino acid. Conclusions Our results expand the clinical and allelic spectrum of MRM2 variants. Previously, these descriptions were based on observations in a single patient, diagnosed with mitochondrial DNA depletion syndrome 17, in whom movement disorder was accompanied by recurrent strokes and epilepsy. We also demonstrate a subset of correctly spliced tt-ag MRM2 transcripts, raising the possibility to develop treatment by understanding the disease mechanism.
C1 [Shafique, Anum; Arif, Beenish; Hussain, Tooba; Naz, Sadaf] Univ Punjab, Sch Biol Sci, Quaid i Azam Campus, Lahore, Pakistan.
   [Chu, Mary Lynn] NYU, Grossman Sch Med, Dept Neurol, New York, NY 10016 USA.
   [Chu, Mary Lynn] NYU, Langone Orthoped Hosp, New York, NY USA.
   [Moran, Ellen] NYU, Hassenfeld Childrens Hosp, Ctr Children, Clin Genet, New York, NY USA.
   [Zamora, Francisca Millan] GeneDx, Gaithersburg, MD USA.
   [Wohler, Elizabeth; Sobreira, Nara] Johns Hopkins Univ, McKusick Nathans Dept Genet Med, Baltimore, MD USA.
   [Klein, Christine; Lohmann, Katja] Univ Lubeck, Inst Neurogenet, Lubeck, Germany.
C3 University of Punjab; New York University; New York University; New York University; Johns Hopkins University; University of Lubeck
RP Naz, S (corresponding author), Univ Punjab, Sch Biol Sci, Quaid i Azam Campus, Lahore, Pakistan.
EM naz.sbs@pu.edu.pk
FU Baylor-Hopkins Center for Mendelian Genomics, USA; DFG, Germany [LO 1555/8-1, FOR 2488]; Damp Foundation, Germany and Higher Education Commission, Pakistan [2877]
CR Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475
   Amir El-Ad David, 2010, HUM GENOMICS, V4, P394
   Capuano A, 2020, APPL CLIN GENET, V13, P71, DOI 10.2147/TACG.S210325
   Charlesworth G, 2013, CURR OPIN NEUROL, V26, P406, DOI 10.1097/WCO.0b013e3283633696
   Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670
   Erro R, 2019, J NEUROL NEUROSUR PS, V90, P227, DOI 10.1136/jnnp-2018-318932
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016
   Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006
   Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137
   Lange LM, 2022, MOVEMENT DISORD, V37, P905, DOI 10.1002/mds.28982
   Lee HH, 2001, J ENDOCRINOL, V171, P397, DOI 10.1677/joe.0.1710397
   Lee KW, 2014, J BIOL CHEM, V289, P24936, DOI 10.1074/jbc.C114.581868
   Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692
   Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009
   Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139
   Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148
   Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014
   Rowlands CF, 2022, AM J HUM GENET, V109, P210, DOI 10.1016/j.ajhg.2021.12.014
   Sacoto MJG, 2020, AM J HUM GENET, V107, P352, DOI 10.1016/j.ajhg.2020.06.013
   Seelow D, 2009, NUCLEIC ACIDS RES, V37, PW593, DOI 10.1093/nar/gkp369
   Sobreira Nara, 2015, HUM MUTAT, V36, P928, DOI 10.1002/humu.22844
   Zech M, 2020, LANCET NEUROL, V19, P908, DOI 10.1016/S1474-4422(20)30312-4
NR 23
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD APR 15
PY 2023
VL 60
IS 4
BP 352
EP 358
DI 10.1136/jmg-2022-108521
EA AUG 2022
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA L4ZI5
UT WOS:000844724100001
PM 36002240
DA 2024-11-01
ER

PT J
AU Wu, G
   Shen, YG
   Zhu, F
   Tao, WW
   Zhou, YL
   Ke, SF
   Jiang, HH
AF Wu, Gang
   Shen, Yuguang
   Zhu, Feng
   Tao, Weiwei
   Zhou, Yuanlin
   Ke, Shaofa
   Jiang, Huihua
TI Comprehensive Diagnostic Criteria for MELAS Syndrome; a Case Study Involving an Elderly Patient With MT-TWm.5541C&gt;T Mutation
SO NEUROLOGIST
LA English
DT Article
DE MELAS; recurrent stroke; MRI; lactate; MT-TW mutation
ID stroke-like episodes; mitochondrial encephalomyopathy; lactic-acidosis
AB Introduction:The mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a matrilineal hereditary multisystem disease caused by mutations in the mitochondrial DNA. Although the initial diagnostic criteria correlate with a range of clinical phenotypes, including clinical onset after the age of 40, there is still lack of a unified single diagnostic standard for MELAS. Case Report:A 71-year-old female patient with recurrent stroke was reported. Magnetic resonance imaging showed a cerebral gyrus-like diffusion weighted imaging high signal lesion in the parietal-occipital lobe and the area of this lesion expanded with disease progression. The MRS result showed significantly inverted Lac/Lip peaks. The nucleic acid sequencing result displayed a MT-TWm.5541C>T mutation, and a 12.86% mutation rate in the blood sample. The patient had a 6-year history of type 2 diabetes. Conclusion:Patients with the MELAS syndrome may present with a variety of clinical manifestations. Our data demonstrated that, for patients with atypical cerebral infarction and suspected MELAS syndrome, gene sequencing and muscle biopsy should be performed in time. This case provides a reference for the diagnostic criteria of MELAS syndrome.
C1 [Wu, Gang; Shen, Yuguang; Zhu, Feng; Tao, Weiwei; Zhou, Yuanlin; Ke, Shaofa; Jiang, Huihua] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Neurol, Linhai, Zhejiang, Peoples R China.
   [Wu, Gang] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Pharm, Linhai, Zhejiang, Peoples R China.
   [Jiang, Huihua] Taizhou Hosp Zhejiang Prov, Taizhou, Zhejiang, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University
RP Jiang, HH (corresponding author), Taizhou Hosp Zhejiang Prov, Taizhou, Zhejiang, Peoples R China.
EM wug5937@enzemed.com; shenyg@enzemed.com; zhufeng@enzemed.com; taoww1594@enzemed.com; zyl@enzemed.com; kesf@enzemed.com; jianghh@enzemed.com
CR Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fang GL, 2018, CLIN INTERV AGING, V13, P2421, DOI 10.2147/CIA.S186636
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, P0, DOI 10.1186/s40478-015-0227-x
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Ikeda T, 2018, HUM GENOME VAR, V5, P0, DOI 10.1038/s41439-018-0026-6
   Ji KQ, 2022, J MED GENET, V59, P79, DOI 10.1136/jmedgenet-2020-107323
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Li WW, 2015, INT J CLIN EXP PATHO, V8, P7022
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, P0, DOI 10.1007/s11916-016-0583-7
   Scaglia F, 2018, PEDIATR CLIN N AM, V0, P0
   Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 16
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1074-7931
EI 2331-2637
J9 NEUROLOGIST
JI Neurologist
PD MAY 15
PY 2023
VL 28
IS 3
BP 190
EP 194
DI 10.1097/NRL.0000000000000457
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA F3YW5
UT WOS:000981746000011
PM 36125978
DA 2024-11-01
ER

PT J
AU Phan, HTL
   Lee, HYJ
   Kim, K
AF Phan, Hong Thi Lam
   Lee, Hyunji
   Kim, Kyoungmi
TI Trends and prospects in mitochondrial genome editing
SO EXPERIMENTAL AND MOLECULAR MEDICINE
LA English
DT Review
ID zinc-finger proteins; sequence-specific modification; 5s ribosomal-rna; selective degradation; restriction enzymes; dna heteroplasmy; mutant mtdna; elimination; mutations; expression
AB Mitochondria are of fundamental importance in programmed cell death, cellular metabolism, and intracellular calcium concentration modulation, and inheritable mitochondrial disorders via mitochondrial DNA (mtDNA) mutation cause several diseases in various organs and systems. Nevertheless, mtDNA editing, which plays an essential role in the treatment of mitochondrial disorders, still faces several challenges. Recently, programmable editing tools for mtDNA base editing, such as cytosine base editors derived from DddA (DdCBEs), transcription activator-like effector (TALE)-linked deaminase (TALED), and zinc finger deaminase (ZFD), have emerged with considerable potential for correcting pathogenic mtDNA variants. In this review, we depict recent advances in the field, including structural biology and repair mechanisms, and discuss the prospects of using base editing tools on mtDNA to broaden insight into their medical applicability for treating mitochondrial diseases. Gene editing: moving into mitochondriaApplying gene editing techniques to the DNA found within mitochondria, the intracellular energy-producing organelles, is being explored as an approach to treating various diseases. Most of the cell's genetic information is found in the nucleus, but mitochondria carry their own set of genes. Hong Thi Lam Phan Korea University, Seoul, South Korea, and coworkers review current trends and prospects in mitochondrial gene editing. Genetic defects in mitochondria have been implicated in many diseases, mainly affecting muscle and nervous tissues. A variety of methods for editing mitochondrial DNA are being explored, both as possible treatments and as methods to create animal models of human mitochondrial diseases. Challenges yet to be overcome, initially in animal studies, including finding effective means to deliver the molecular editing tools into mitochondria and achieving therapeutic results without harmful side effects.
C1 [Phan, Hong Thi Lam; Kim, Kyoungmi] Korea Univ, Coll Med, Dept Physiol, Seoul 02841, South Korea.
   [Lee, Hyunji] Korea Res Inst Biosci & Biotechnol, Lab Anim Resource & Res Ctr, Cheongju 28116, South Korea.
   [Lee, Hyunji] Sungkyunkwan Univ, Sch Med, Suwon 16419, South Korea.
   [Kim, Kyoungmi] Korea Univ, Coll Med, Dept Biomed Sci, Seoul 02841, South Korea.
C3 Korea University; Korea University Medicine (KU Medicine); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Sungkyunkwan University (SKKU); Korea University; Korea University Medicine (KU Medicine)
RP Kim, K (corresponding author), Korea Univ, Coll Med, Dept Physiol, Seoul 02841, South Korea.; Lee, HYJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Lab Anim Resource & Res Ctr, Cheongju 28116, South Korea.; Lee, HYJ (corresponding author), Sungkyunkwan Univ, Sch Med, Suwon 16419, South Korea.; Kim, K (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul 02841, South Korea.
EM hjlee102@kribb.re.kr; kim0912@korea.ac.kr
FU Bio & Medical Technology Development Program of the National Research Foundation (NRF) of Korea [NRF-2020M3A9D5A01082439, NRF-2019R1A2C2087198]; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antón Z, 2020, J CELL SCI, V133, P0, DOI 10.1242/jcs.248468
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Banskota S, 2022, CELL, V185, P250, DOI 10.1016/j.cell.2021.12.021
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628
   Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697
   Bian WP, 2019, ACS SYNTH BIOL, V8, P621, DOI 10.1021/acssynbio.8b00411
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Cho SI, 2022, CELL, V185, P1764, DOI 10.1016/j.cell.2022.03.039
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   Filippi MD, 2019, BLOOD, V133, P1943, DOI 10.1182/blood-2018-10-808873
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034
   Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Guo JY, 2022, MOL THER-NUCL ACIDS, V27, P73, DOI 10.1016/j.omtn.2021.11.016
   Guo JY, 2021, CELL DISCOV, V7, P0, DOI 10.1038/s41421-021-00307-9
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530
   Hussain SRA, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.627050
   Jo A, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/305716
   Kang BC, 2021, NAT PLANTS, V7, P899, DOI 10.1038/s41477-021-00943-9
   Kaniak-Golik A, 2015, FREE RADICAL BIO MED, V82, P73, DOI 10.1016/j.freeradbiomed.2015.01.013
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249, DOI 10.1007/BF01694557
   Lee H, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-21464-1
   Lei ZX, 2022, NATURE, V606, P804, DOI 10.1038/s41586-022-04836-5
   Lim K, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-27962-0
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mangeot PE, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-018-07845-z
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moraes CT, 2014, EMBO MOL MED, V6, P434, DOI 10.1002/emmm.201303769
   Nakazato I, 2021, NAT PLANTS, V7, P906, DOI 10.1038/s41477-021-00954-6
   Pereira CV, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708084
   Perez-Quintero AL, 2019, ANNU REV PHYTOPATHOL, V57, P459, DOI 10.1146/annurev-phyto-082718-100026
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001
   Qi XL, 2021, CELL DISCOV, V7, P0, DOI 10.1038/s41421-021-00325-7
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Richter A, 2016, METHODS MOL BIOL, V1338, P9, DOI 10.1007/978-1-4939-2932-0_2
   Sabharwal A, 2021, CRISPR J, V4, P799, DOI 10.1089/crispr.2021.0061
   Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silva-Pinheiro P, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28358-w
   Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208
   Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711
   Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tang SH, 2015, BIOCHEM BIOPH RES CO, V458, P186, DOI 10.1016/j.bbrc.2015.01.092
   Tonin Y, 2014, J BIOL CHEM, V289, P13323, DOI 10.1074/jbc.M113.528968
   Towheed A, 2014, NEUROBIOL DIS, V69, P15, DOI 10.1016/j.nbd.2014.04.017
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607
   Wang YJ, 2022, CELL REP, V40, P0, DOI 10.1016/j.celrep.2022.111418
   Wei YH, 2022, CELL DISCOV, V8, P0, DOI 10.1038/s41421-022-00391-5
   Wei YH, 2022, CELL DISCOV, V8, P0, DOI 10.1038/s41421-021-00372-0
   Wu ZW, 2021, NAT CHEM BIOL, V17, P1132, DOI 10.1038/s41589-021-00868-6
   Xiong H, 2004, NEUROBIOL AGING, V25, P349, DOI 10.1016/S0197-4580(03)00123-4
   Yahata N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15871-y
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasukawa K, 2009, SCI SIGNAL, V2, P0, DOI 10.1126/scisignal.2000287
   Yin T, 2022, FRONT PHYSIOL, V13, P0, DOI 10.3389/fphys.2022.883459
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Zelenka J, 2016, METHODS MOL BIOL, V1351, P175, DOI 10.1007/978-1-4939-3040-1_13
NR 84
TC 9
Z9 9
U1 2
U2 18
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1226-3613
EI 2092-6413
J9 EXP MOL MED
JI Exp. Mol. Med.
PD MAY 15
PY 2023
VL 55
IS 5
BP 871
EP 878
DI 10.1038/s12276-023-00973-7
EA MAY 2023
PG 8
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA H7IM4
UT WOS:000978586000005
PM 37121968
DA 2024-11-01
ER

PT J
AU Conti, F
   Di Martino, S
   Drago, F
   Bucolo, C
   Micale, V
   Montano, V
   Siciliano, G
   Mancuso, M
   Lopriore, P
AF Conti, Federica
   Di Martino, Serena
   Drago, Filippo
   Bucolo, Claudio
   Micale, Vincenzo
   Montano, Vincenzo
   Siciliano, Gabriele
   Mancuso, Michelangelo
   Lopriore, Piervito
TI Red Flags in Primary Mitochondrial Diseases: What Should We Recognize?
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE primary mitochondrial diseases; red flags; mitochondria; rare diseases
ID encephalomyopathy (mngie)-like phenotype; progressive external ophthalmoplegia; differentiation factor 15; kearns-sayre-syndrome; optic neuropathy; peripheral neuropathy; cancer cachexia; lactic-acidosis; dna depletion; m.3243a-greater-than-g mutation
AB Primary mitochondrial diseases (PMDs) are complex group of metabolic disorders caused by genetically determined impairment of the mitochondrial oxidative phosphorylation (OXPHOS). The unique features of mitochondrial genetics and the pivotal role of mitochondria in cell biology explain the phenotypical heterogeneity of primary mitochondrial diseases and the resulting diagnostic challenges that follow. Some peculiar features ("red flags") may indicate a primary mitochondrial disease, helping the physician to orient in this diagnostic maze. In this narrative review, we aimed to outline the features of the most common mitochondrial red flags offering a general overview on the topic that could help physicians to untangle mitochondrial medicine complexity.
C1 [Conti, Federica; Di Martino, Serena; Drago, Filippo; Bucolo, Claudio; Micale, Vincenzo] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, I-95123 Catania, Italy.
   [Bucolo, Claudio] Univ Catania, Ctr Res Ocular Pharmacol CERFO, I-95213 Catania, Italy.
   [Montano, Vincenzo; Siciliano, Gabriele; Mancuso, Michelangelo; Lopriore, Piervito] Univ Pisa, Neurol Inst, Dept Clin & Expt Med, I-56126 Pisa, Italy.
C3 University of Catania; University of Catania; University of Pisa
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Inst, Dept Clin & Expt Med, I-56126 Pisa, Italy.
EM conti.federica1@hotmail.it; serena.dm.92@gmail.com; claudio.bucolo@unict.it; vincenzomicale@inwind.it; michelangelo.mancuso@unipi.it; piervito.lopriore@gmail.com
FU Telethon
CR Akaike M, 1997, CLIN CARDIOL, V20, P239, DOI 10.1002/clc.4960200310
   Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   Alharbi Hana, 2021, CLIN LIVER DIS (HOBOKEN), V18, P243, DOI 10.1002/cld.1133
   Ali AS, 2021, ENDOCR. METAB. SCI., V2, P0
   Almannai M, 2020, MOL GENET METAB, V131, P1, DOI 10.1016/j.ymgme.2020.10.002
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   Argilés JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829
   Aversa Z, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30340
   Ayers M, 2022, CLIN LIVER DIS, V26, P421, DOI 10.1016/j.cld.2022.03.006
   BAGNASCO S, 1985, AM J PHYSIOL, V248, PF522, DOI 10.1152/ajprenal.1985.248.4.F522
   Baldacci J, 2022, HEALTHCARE-BASEL, V10, P0, DOI 10.3390/healthcare10030574
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Boenzi S, 2018, ESSAYS BIOCHEM, V62, P443, DOI 10.1042/EBC20170111
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   Borrelli E, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep37332
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232
   Brunetti D, 2016, EMBO MOL MED, V8, P176, DOI 10.15252/emmm.201505894
   Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295
   Busquets S, 2007, CLIN NUTR, V26, P614, DOI 10.1016/j.clnu.2007.06.005
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Castro-Gago M, 2010, ACTA PAEDIATR, V99, P796, DOI 10.1111/j.1651-2227.2010.01738.x
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chang XL, 2020, MEDICINE, V99, P0, DOI 10.1097/MD.0000000000018634
   Chen XH, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00341
   Cheng WQ, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.843386
   Chinnery PF, 2001, GUT, V48, P121, DOI 10.1136/gut.48.1.121
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Coin A, 2000, J CLIN NEUROMUSCUL DIS, V1, P124, DOI 10.1097/00131402-200003000-00002
   Fontes-Oliveira CC, 2013, BBA-GEN SUBJECTS, V1830, P2770, DOI 10.1016/j.bbagen.2012.11.009
   Crow Y, 2020, J MED GENET, V57, P475, DOI 10.1136/jmedgenet-2019-106457
   dAlmeida OC, 2018, GRAEF ARCH CLIN EXP, V256, P2341, DOI 10.1007/s00417-018-4153-z
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   de Laat P, 2015, NETH J MED, V73, P30
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Distelmaier Felix, 2023, HANDB CLIN NEUROL, V194, P173, DOI 10.1016/B978-0-12-821751-1.00016-6
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   El-Hattab AW, 2012, GENEREVIEWS, V0, P0
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Enns GM, 2017, CURR OPIN PEDIATR, V29, P541, DOI 10.1097/MOP.0000000000000535
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7110389
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2017, SEIZURE-EUR J EPILEP, V50, P166, DOI 10.1016/j.seizure.2017.06.010
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Gandhi SS, 2017, J INHERIT METAB DIS, V40, P673, DOI 10.1007/s10545-017-0046-2
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gilhuis HJ, 2006, NEUROMUSCULAR DISORD, V16, P394, DOI 10.1016/j.nmd.2006.03.006
   Glamuzina E, 2012, J INHERIT METAB DIS, V35, P459, DOI 10.1007/s10545-011-9413-6
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Grattagliano I, 2011, CURR DRUG TARGETS, V12, P879, DOI 10.2174/138945011795528877
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Harris SR, 2008, DEV MED CHILD NEUROL, V50, P889, DOI 10.1111/j.1469-8749.2008.03097.x
   Hassan S, 2020, PEDIATR TRANSPLANT, V24, P0, DOI 10.1111/petr.13714
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   Hikmat O, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18091845
   Hikmat O, 2017, J INHERIT METAB DIS, V40, P861, DOI 10.1007/s10545-017-0084-9
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Hong CM, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00267
   Horvath Rita, 2023, HANDB CLIN NEUROL, V194, P99, DOI 10.1016/B978-0-12-821751-1.00014-2
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hutchesson A, 1997, CLIN CHEM, V43, P158
   Inak G, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-22117-z
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7
   KALIMO H, 1979, ANN NEUROL, V6, P200, DOI 10.1002/ana.410060304
   Kang YL, 2017, MOL CELL, V67, P457, DOI 10.1016/j.molcel.2017.06.014
   Karaa A, 2015, PEDIATR DIABETES, V16, P1, DOI 10.1111/pedi.12223
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kennedy H, 2016, AM J HUM GENET, V99, P674, DOI 10.1016/j.ajhg.2016.06.027
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   KLOPSTOCK T, 1994, NEUROLOGY, V44, P862, DOI 10.1212/WNL.44.5.862
   Koenig MK, 2016, MITOCHONDRIAL CASE STUDIES, V0, P69
   Kullar PJ, 2016, BRAIN, V139, PE33, DOI 10.1093/brain/aww051
   La Morgia C, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-116
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   LANG CJG, 1995, EUR J NEUROL, V2, P171, DOI 10.1111/j.1468-1331.1995.tb00112.x
   Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Lee S, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00496
   Lee YS, 2001, PEDIATR NEPHROL, V16, P710, DOI 10.1007/s004670100637
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lim A, 2020, EUR J PAEDIATR NEURO, V24, P47, DOI 10.1016/j.ejpn.2019.12.021
   Liu K, 2022, FRONT NEUROSCI-SWITZ, V16, P0, DOI 10.3389/fnins.2022.902405
   Lopriore P, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232113216
   Lopriore P, 2022, NEUROL INT, V14, P337, DOI 10.3390/neurolint14020028
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lynch DR, 2023, MOVEMENT DISORD, V38, P313, DOI 10.1002/mds.29286
   Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Majander A, 2017, MITOCHONDRION, V36, P138, DOI 10.1016/j.mito.2017.07.006
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Marotta R, 2020, MITOCHONDRION, V54, P128, DOI 10.1016/j.mito.2020.08.007
   Marques-Matos C, 2016, JAMA NEUROL, V73, P604, DOI 10.1001/jamaneurol.2015.5061
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Matsuzaki M, 2002, NEUROPEDIATRICS, V33, P271, DOI 10.1055/s-2002-36742
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Montano V, 2022, J NEUROL, V269, P1413, DOI 10.1007/s00415-021-10697-1
   Moore HL, 2020, EUR J NEUROL, V27, P3, DOI 10.1111/ene.14068
   Moore HL, 2019, ANN CLIN TRANSL NEUR, V6, P826, DOI 10.1002/acn3.736
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451
   Musumeci O, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00160
   NAKAGAWA E, 1994, BRAIN DEV-JPN, V16, P416, DOI 10.1016/0387-7604(94)90133-3
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Nelis E, 1996, EUR J HUM GENET, V4, P25
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Newman NJ, 2020, J NEURO-OPHTHALMOL, V40, P547, DOI 10.1097/WNO.0000000000001045
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Nomura T, 1993, RINSHO SHINKEIGAKU, V33, P1198
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Orsucci D, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10061249
   Orsucci Daniele, 2019, DRUGS CONTEXT, V8, P212588, DOI 10.7573/dic.212588
   Ozaltin F, 2014, PEDIATR NEPHROL, V29, P961, DOI 10.1007/s00467-013-2482-z
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pajares S, 2013, MOL GENET METAB, V108, P119, DOI 10.1016/j.ymgme.2012.11.283
   Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236
   PoggiTravert F, 1996, J INHERIT METAB DIS, V19, P478, DOI 10.1007/BF01799109
   Porporato PE, 2016, ONCOGENESIS, V5, P0, DOI 10.1038/oncsis.2016.3
   Prasun P, 2014, J NEUROL, V261, P1818, DOI 10.1007/s00415-014-7428-2
   Primiano G, 2022, NEUROL SCI, V43, P6955, DOI 10.1007/s10072-022-06391-3
   Quadir A, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000339
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rahman Shamima, 2023, HANDB CLIN NEUROL, V194, P43, DOI 10.1016/B978-0-12-821751-1.00015-4
   Rahman S, 2019, EPILEPSY BEHAV, V101, P0, DOI 10.1016/j.yebeh.2019.106546
   Rahman S, 2018, EPILEPSIA, V59, P70, DOI 10.1111/epi.14485
   Rahman S, 2013, PEDIATR NEPHROL, V28, P357, DOI 10.1007/s00467-012-2362-y
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   Sako S, 2003, GENEREVIEWS, V0, P0
   Samocha-Bonet D, 2021, AGEING RES REV, V71, P0, DOI 10.1016/j.arr.2021.101423
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Santarelli R, 2015, BRAIN, V138, P563, DOI 10.1093/brain/awu378
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Saporta MA, 2015, EXP NEUROL, V263, P190, DOI 10.1016/j.expneurol.2014.10.005
   Sawyer SL, 2015, HUM MOL GENET, V24, P5109, DOI 10.1093/hmg/ddv229
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Sharma C, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094850
   Sharma N, 2023, CLIN GENET, V103, P16, DOI 10.1111/cge.14228
   Shayota BJ, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.973
   Shemesh A, 2023, STATPEARLS, V0, P0
   SHIRAIWA N, 1993, J NEUROL SCI, V120, P174, DOI 10.1016/0022-510X(93)90270-9
   Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215
   Shum AMY, 2012, AGING-US, V4, P133, DOI 10.18632/aging.100436
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008
   Soldath P, 2017, BMC MUSCULOSKEL DIS, V18, P0, DOI 10.1186/s12891-017-1781-0
   Soldatov VO, 2022, J TRANSL MED, V20, P0, DOI 10.1186/s12967-022-03685-0
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stamate Alina-Cristina, 2016, ROM J OPHTHALMOL, V60, P47
   Suomalainen Anu, 2013, EXPERT OPIN MED DIAGN, V7, P313, DOI 10.1517/17530059.2013.812070
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Surana S, 2020, EPILEPSIA, V61, P2224, DOI 10.1111/epi.16650
   Suzuki-Hatano S, 2019, HUM GENE THER, V30, P139, DOI 10.1089/hum.2018.020
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Tann A, 2019, AM J MED GENET A, V179, P1015, DOI 10.1002/ajmg.a.61104
   Thanh Hai N, 2021, CLIN TER, V172, P500, DOI 10.7417/CT.2021.2364
   Thobois S, 1997, REV NEUROL, V153, P595
   Ticci C, 2020, NEUROGENETICS, V21, P87, DOI 10.1007/s10048-019-00601-5
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Urano F, 2016, CURR DIABETES REP, V16, P0, DOI 10.1007/s11892-015-0702-6
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Vergara RC, 2019, FRONT COMPUT NEUROSC, V13, P0, DOI 10.3389/fncom.2019.00049
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vollono C, 2018, CEPHALALGIA, V38, P1093, DOI 10.1177/0333102417723568
   Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013
   Wesol-Kucharska D, 2021, CHILDREN-BASEL, V8, P0, DOI 10.3390/children8070532
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Wong SC, 2016, ENDOCR REV, V37, P62, DOI 10.1210/er.2015-1026
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Yamada K, 2012, BRAIN DEV-JPN, V34, P92, DOI 10.1016/j.braindev.2011.08.004
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yorns WR, 2013, SEMIN PEDIATR NEUROL, V20, P188, DOI 10.1016/j.spen.2013.09.002
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Yu-Wai-Man P, 2013, OPHTHALMOLOGY, V120, P1712, DOI 10.1016/j.ophtha.2013.04.022
   Zhang JJ, 2021, INVEST OPHTH VIS SCI, V62, P0, DOI 10.1167/iovs.62.9.38
   Zhang JJ, 2013, MITOCHONDRION, V13, P772, DOI 10.1016/j.mito.2013.05.002
   Zou TY, 2022, FRONT NEUROSCI-SWITZ, V16, P0, DOI 10.3389/fnins.2022.998507
NR 241
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC 15
PY 2023
VL 24
IS 23
BP 
EP 
DI 10.3390/ijms242316746
PG 28
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AC1Z6
UT WOS:001116183200001
PM 38069070
DA 2024-11-01
ER

PT J
AU Yu, WF
   Li, ZX
   Wu, WJ
   Zhao, DD
   Yan, CZ
   Lin, PF
AF Yu, Wenfei
   Li, Zhuxun
   Wu, Wenjing
   Zhao, Dandan
   Yan, Chuanzhu
   Lin, Pengfei
TI Insights into the mechanisms of telbivudine-induced myopathy associated with mitochondrial dysfunction
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Telbivudine; Mitochondrial dysfunction; Myotoxicity; Oxidative stress
ID hepatitis-b; complex-i; neuropathy; efficacy; mutation; therapy; damage; ros
AB As a nucleotide analogue (NA), telbivudine was widely used in the treatment for chronic hepatitis B (CHB) by interfering with reverse transcriptase of hepatitis B virus. However, the use of NAs for hepatitis B treatment has been accompanied by numerous reports highlighting the occurrence of neuromyopathy, particularly in the case of telbivudine. This study aimed to investigate the underlying mechanisms responsible for telbivudine-induced myopathy. We established animal and cell models of telbivudine-induced myopathy using C57BL/6 mice and C2C12 cells, respectively. Our findings revealed that telbivudine significantly reduced mitochondrial DNA (mtDNA) copy number and caused increase of oxidative stress. Telbivudine treatment significantly inhibited mitochondrial complex I and IV expression, impairing the oxidative phosphorylation function of the respiratory chain. Modified Gomori trichrome (MGT) staining of the muscle sections displayed an increase in ragged red fibers (RRFs), indicating abnormal mitochondrial accumulation. In conclusion, our study provides compelling evidence suggesting that telbivudine-induced myopathy is associated with mitochondrial toxicity and impaired energy metabolism. The observed muscle pathology, depletion of mtDNA, elevation of oxidative stress and altered mitochondrial function support the hypothesis that telbivudine disrupts mitochondrial homeostasis, ultimately leading to muscle damage. This may be also a common mechanism for NAs to cause neuromyopathy.
C1 [Yu, Wenfei; Wu, Wenjing; Zhao, Dandan; Yan, Chuanzhu; Lin, Pengfei] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250012, Shandong, Peoples R China.
   [Yu, Wenfei] Univ Hlth & Rehabil Sci, 17, Shandong Rd, Qingdao, Shandong, Peoples R China.
   [Li, Zhuxun] Shandong Univ, Cheeloo Coll Med, Jinan 250012, Shandong, Peoples R China.
   [Lin, Pengfei] Shandong Univ, Dept Neurol, Qilu Hosp, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; University of Health & Rehabilitation Sciences; Shandong University; Shandong University
RP Lin, PF (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.
EM lpfsdu@foxmail.com
FU National Natural Science Foundation of China [82271436]; young Taishan Scholars Program of Shandong Province; National Key Ramp;D Program of China [2021YFC2700904]
CR Ambang T, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0162760
   Bridges EG, 2008, ANTIMICROB AGENTS CH, V52, P2521, DOI 10.1128/AAC.00029-08
   Brody H, 2022, NATURE, V603, PS45, DOI 10.1038/d41586-022-00811-2
   Chen J, 2019, INT IMMUNOPHARMACOL, V74, P0, DOI 10.1016/j.intimp.2019.105683
   Chen J, 2018, INT IMMUNOPHARMACOL, V55, P1, DOI 10.1016/j.intimp.2017.11.043
   Cronin-Furman EN, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-6
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Finsterer J, 2010, VIROL J, V7, P0, DOI 10.1186/1743-422X-7-323
   Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011
   Fontana RJ, 2009, HEPATOLOGY, V49, PS185, DOI 10.1002/hep.22885
   Fung S, 2022, HEPATOLOGY, V76, P233, DOI 10.1002/hep.32314
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009
   Gureev AP, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00435
   Hernández-Laín A, 2015, J NEUROL SCI, V358, P481, DOI 10.1016/j.jns.2015.08.1550
   Hernandez-Santiago B, 2002, ANTIMICROB AGENTS CH, V46, P1728, DOI 10.1128/AAC.46.6.1728-1733.2002
   Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010
   Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14
   Kuroda Y, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67336-4
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lan MY, 2023, J CLIN NEUROL, V19, P52, DOI 10.3988/jcn.2023.19.1.52
   Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026
   Liochev SI, 2013, FREE RADICAL BIO MED, V65, P232, DOI 10.1016/j.freeradbiomed.2013.06.027
   Long JF, 2017, BIOCHEM PHARMACOL, V146, P224, DOI 10.1016/j.bcp.2017.10.005
   Mak LY, 2019, DIGEST DIS SCI, V64, P3630, DOI 10.1007/s10620-019-05717-0
   Mak LY, 2016, EXPERT OPIN DRUG SAF, V15, P383, DOI 10.1517/14740338.2016.1139573
   MITA S, 1995, MUSCLE NERVE, V0, PS113
   MIZUSAWA H, 1988, J NEUROL SCI, V86, P171, DOI 10.1016/0022-510X(88)90096-2
   Nash K, 2009, ADV THER, V26, P155, DOI 10.1007/s12325-009-0004-y
   Nolan D, 2004, ANTIVIR THER, V9, P849
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Papaconstantinou J, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8111383
   Perazella MA, 2010, KIDNEY INT, V78, P1060, DOI 10.1038/ki.2010.344
   Pereira CV, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201910674
   Schieber M, 2014, CURR BIOL, V24, PR453, DOI 10.1016/j.cub.2014.03.034
   Tanji N, 2001, HUM PATHOL, V32, P734, DOI 10.1053/hupa.2001.25586
   Thelen MP, 2020, ACTA NEUROPATHOL COM, V8, P0, DOI 10.1186/s40478-020-01101-6
   Van Linthout S, 2018, ESC HEART FAIL, V5, P818, DOI 10.1002/ehf2.12341
   Xu HL, 2014, J CLIN PATHOL, V67, P999, DOI 10.1136/jclinpath-2013-202069
   Xu J, 2019, J MED VIROL, V91, P2153, DOI 10.1002/jmv.25566
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
   Zhang JJ, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-05571-y
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
   Zoulim F, 2006, J HEPATOL, V44, PS95, DOI 10.1016/j.jhep.2005.11.020
NR 45
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD SEP 25
PY 2023
VL 383
IS 
BP 
EP 
DI 10.1016/j.cbi.2023.110692
EA SEP 2023
PG 11
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA S3HO8
UT WOS:001070115400001
PM 37659625
DA 2024-11-01
ER

PT J
AU Serrano, RJ
   Oorschot, V
   Palipana, D
   Calcinotto, V
   Sonntag, C
   Ramm, G
   Bryson-Richardson, RJ
AF Serrano, Rita J.
   Oorschot, Viola
   Palipana, Dashika
   Calcinotto, Vanessa
   Sonntag, Carmen
   Ramm, Georg
   Bryson-Richardson, Robert J.
TI Genetic model of UBA5 deficiency highlights the involvement of both peripheral and central nervous systems and identifies widespread mitochondrial abnormalities
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE UBA5; ufmylation; encephalopathy; mitochondria; zebrafish
ID biallelic variants; zebrafish models; ufm1; reveal
AB Variants in UBA5 have been reported to cause neurological disease with impaired motor function, developmental delay, intellectual disability and brain pathology as recurrent clinical manifestations. UBA5 encodes a ubiquitin-activating-like enzyme that activates ufmylation, a post-translational ubiquitin-like modification pathway, which has been implicated in neurodevelopment and neuronal survival. The reason behind the variation in severity and clinical manifestations in affected individuals and the signal transduction pathways regulated by ufmylation that compromise the nervous system remains unknown. Zebrafish have emerged as a powerful model to study neurodegenerative disease due to its amenability for in vivo analysis of muscle and neuronal tissues, high-throughput examination of motor function and rapid embryonic development allowing an examination of disease progression. Using clustered regularly interspaced short palindromic repeats-associated protein 9 genome editing, we developed and characterized zebrafish mutant models to investigate disease pathophysiology. uba5 mutant zebrafish showed a significantly impaired motor function accompanied by delayed growth and reduced lifespan, reproducing key phenotypes observed in affected individuals. Our study demonstrates the suitability of zebrafish to study the pathophysiology of UBA5-related disease and as a powerful tool to identify pathways that could reduce disease progression. Furthermore, uba5 mutants exhibited widespread mitochondrial damage in both the nervous system and the skeletal muscle, suggesting that a perturbation of mitochondrial function may contribute to disease pathology.
C1 [Oorschot, Viola] European Mol Biol Lab, Electron Microscopy Core Facil, D-69117 Heidelberg, Germany.
   [Serrano, Rita J.; Palipana, Dashika; Calcinotto, Vanessa; Sonntag, Carmen; Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, Melbourne 3800, Australia.
   [Oorschot, Viola; Ramm, Georg] Monash Univ, Monash Ramaciotti Ctr Cryoelectron Microscopy, Melbourne 3800, Australia.
   [Ramm, Georg] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne 3800, Australia.
   [Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, 25 Rainforest Walk, Melbourne, Vic 3800, Australia.
C3 European Molecular Biology Laboratory (EMBL); Monash University; Monash University; Monash University; Monash University
RP Bryson-Richardson, RJ (corresponding author), Monash Univ, Sch Biol Sci, 25 Rainforest Walk, Melbourne, Vic 3800, Australia.
EM robert.bryson-richardson@monash.edu
FU Monash University through a Monash Graduate Scholarship (MGS); Monash International Postgraduate Research Scholarship (MIPRS); National Health and Medical Research Council [1080587]
CR Al-Saady ML, 2021, NEUROPEDIATRICS, V52, P489, DOI 10.1055/s-0041-1724130
   Arnadottir GA, 2017, BMC MED GENET, V18, P0, DOI 10.1186/s12881-017-0466-8
   Briere LC, 2021, COLD SPRING HARB MOL CASE STUD, V7, P0
   Cabrera-Serrano M, 2020, J MED GENET, V57, P835, DOI 10.1136/jmedgenet-2019-106496
   Chitre M, 2018, J MED GENET, V55, P803, DOI 10.1136/jmedgenet-2018-105288
   Colin E, 2016, AM J HUM GENET, V99, P695, DOI 10.1016/j.ajhg.2016.06.030
   Daida A, 2018, EPILEPTIC DISORD, V20, P313, DOI 10.1684/epd.2018.0981
   Dark C, 2020, TRANSL PSYCHIAT, V10, P0, DOI 10.1038/s41398-020-01077-w
   Duan RH, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0149039
   Gannavaram S, 2012, MOL MICROBIOL, V86, P187, DOI 10.1111/j.1365-2958.2012.08183.x
   Gannavaram S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016156
   Guo S, 2009, EXPERT OPIN DRUG DIS, V4, P715, DOI 10.1517/17460440902988464
   Gupta T, 2018, METHODS, V150, P49, DOI 10.1016/j.ymeth.2018.06.008
   Hamilton EMC, 2017, NEUROLOGY, V89, P1821, DOI 10.1212/WNL.0000000000004578
   Homrich M, 2014, EXP CELL RES, V324, P192, DOI 10.1016/j.yexcr.2014.04.003
   Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205
   Lange M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0070172
   Low KJ, 2019, EUR J MED GENET, V62, P97, DOI 10.1016/j.ejmg.2018.06.009
   Mignon-Ravix C, 2018, HUM MUTAT, V39, P934, DOI 10.1002/humu.23534
   Montague TG, 2014, NUCLEIC ACIDS RES, V42, PW401, DOI 10.1093/nar/gku410
   Muona M, 2016, AM J HUM GENET, V99, P683, DOI 10.1016/j.ajhg.2016.06.020
   Nahorski MS, 2018, BRAIN, V141, P1934, DOI 10.1093/brain/awy135
   Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898
   Quinn PMJ, 2020, ACTA NEUROPATHOL COM, V8, P0, DOI 10.1186/s40478-020-01062-w
   Rangaraju V, 2019, J NEUROSCI, V39, P8200, DOI 10.1523/JNEUROSCI.1157-19.2019
   Ruparelia AA, 2012, HUM MOL GENET, V21, P4073, DOI 10.1093/hmg/dds231
   Soudah N, 2019, J MOL BIOL, V431, P463, DOI 10.1016/j.jmb.2018.10.007
   Sztal TE, 2016, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/54431
   Sztal TE, 2015, ACTA NEUROPATHOL, V130, P389, DOI 10.1007/s00401-015-1430-3
   Tatsumi K, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1182
   Tumiene B, 2018, CLIN GENET, V93, P1057, DOI 10.1111/cge.13203
   Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791
NR 32
TC 0
Z9 0
U1 1
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD NOV 1
PY 2023
VL 5
IS 6
BP 
EP 
DI 10.1093/braincomms/fcad317
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CR2H5
UT WOS:001126899900004
PM 38046095
DA 2024-11-01
ER

PT J
AU Denham, J
AF Denham, Joshua
TI Canonical and extra-telomeric functions of telomerase: Implications for healthy ageing conferred by endurance training
SO AGING CELL
LA English
DT Review
DE epigenetics; exercise; metabolism; oxidative stress; telomeres; TERT
ID tert promoter mutations; dna-damage response; messenger-rna expression; human skeletal-muscle; mouse cells lacking; reverse-transcriptase; terminal transferase; length maintenance; alzheimers-disease; metabolic disease
AB Telomerase preserves genomic integrity by maintaining and protecting the telomeres. Seminal findings from 1985 revealed the canonical role of telomerase and motivated investigations into potential therapeutic strategies to combat one of the hallmarks of ageing-telomere attrition. Since then, the field of telomere biology has rapidly expanded, with telomerase serving essential roles in cancer and cell development through its canonical function. However, telomerase also exerts critical extra-telomeric functions through its protein (telomerase reverse transcriptase, TERT) and RNA components (telomerase RNA component, TERC). Telomerase re-activation or ectopic expression promotes survival and permits unlimited proliferation in tumours and healthy non-malignant cells. TERT gene therapies improve health and lifespan in ageing mice and mouse models of age-related diseases. The extra-telomeric functions of telomerase are critical to ageing. These include protection against oxidative stress, orchestration of chromatin modifications and transcription, and regulation of angiogenesis and metabolism (e.g. mitochondrial function and glucose control). Given these biological functions are key adaptations to endurance training and the recent meta-analytical findings that indicate exercise up-regulates TERT and telomerase, a comprehensive discussion on the implications of the canonical and extra-telomeric roles of telomerase is warranted. This review highlights the therapeutic benefits of telomerase-based treatments for idiopathic and chronic diseases that are linked to ageing. Discussion on the canonical and extra-telomeric roles of telomerase are presented, followed by a detailed summary of the evidence on how exercise influences telomerase. Finally, the potential cell signalling underpinning the exercise-induced modulation of telomerase are discussed with directions for future research.
C1 [Denham, Joshua] Univ Southern Queensland, Sch Hlth & Med Sci, Toowoomba, Qld, Australia.
   [Denham, Joshua] Inst Resilient Reg, Ctr Hlth Res, Toowoomba, Qld, Australia.
   [Denham, Joshua] Univ Southern Queensland, Sch Hlth & Med Sci, Room 111,Bldg P Ipswich Campus, Ipswich, Qld 4305, Australia.
C3 University of Southern Queensland; University of Southern Queensland; University of Southern Queensland
RP Denham, J (corresponding author), Univ Southern Queensland, Sch Hlth & Med Sci, Room 111,Bldg P Ipswich Campus, Ipswich, Qld 4305, Australia.
EM josh.denham@usq.edu.au
CR Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Akiyama M, 2004, BIOCHEM BIOPH RES CO, V316, P528, DOI 10.1016/j.bbrc.2004.02.080
   Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269
   Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246
   Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092
   Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399
   Bär C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6863
   Bandaria JN, 2016, CELL, V164, P735, DOI 10.1016/j.cell.2016.01.036
   Bär C, 2016, BLOOD, V127, P1770, DOI 10.1182/blood-2015-08-667485
   Bell RJA, 2016, MOL CANCER RES, V14, P315, DOI 10.1158/1541-7786.MCR-16-0003
   Bennudez Y, 2007, GYNECOL ONCOL, V106, P526, DOI 10.1016/j.ygyno.2007.05.005
   de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245
   Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019
   Beyer AM, 2016, CIRC RES, V118, P856, DOI 10.1161/CIRCRESAHA.115.307918
   BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104
   Blasco MA, 2002, SPRINGER SEMIN IMMUN, V24, P75, DOI 10.1007/s00281-001-0096-1
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763
   Chakravarti D, 2021, CELL, V184, P306, DOI 10.1016/j.cell.2020.12.028
   Chen SF, 2014, AGING-US, V6, P414, DOI 10.18632/aging.100671
   Cheng FF, 2021, LANCET DIABETES ENDO, V9, P117, DOI 10.1016/S2213-8587(20)30365-X
   Chilton WL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092088
   Choi JK, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.0040010
   Cluckey TG, 2017, EXP GERONTOL, V96, P7, DOI 10.1016/j.exger.2017.06.003
   Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566
   Coffey VG, 2017, J PHYSIOL-LONDON, V595, P2883, DOI 10.1113/JP272270
   Daniali L, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2602
   De Cecco M, 2019, NATURE, V572, PE5, DOI 10.1038/s41586-019-1350-9
   de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882
   de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921
   Denham J, 2021, AGEING RES REV, V70, P0, DOI 10.1016/j.arr.2021.101411
   Denham J, 2020, AM J PHYSIOL-ENDOC M, V319, PE320, DOI 10.1152/ajpendo.00215.2020
   Denham J, 2016, SPORTS MED, V46, P1213, DOI 10.1007/s40279-016-0482-4
   Denham J, 2016, J APPL PHYSIOL, V120, P148, DOI 10.1152/japplphysiol.00587.2015
   Denham J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069377
   Derevyanko A, 2017, AGING CELL, V16, P1353, DOI 10.1111/acel.12677
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Diman A, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600031
   Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433
   Drevytska TI, 2014, CELL BIOCHEM FUNCT, V32, P565, DOI 10.1002/cbf.3051
   Eitan E, 2016, CEREBELLUM, V15, P509, DOI 10.1007/s12311-015-0720-6
   Eitan E, 2012, EMBO MOL MED, V4, P313, DOI 10.1002/emmm.201200212
   Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639
   Forero DA, 2016, J GERONTOL A-BIOL, V71, P1069, DOI 10.1093/gerona/glw053
   Gala K, 2021, CANCER LETT, V502, P120, DOI 10.1016/j.canlet.2020.12.036
   Gao JX, 2022, NAT REV CANCER, V22, P515, DOI 10.1038/s41568-022-00490-1
   García-Castillo J, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2015528118
   Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959
   Gioscia-Ryan RA, 2016, AGING-US, V8, P2897, DOI 10.18632/aging.101099
   Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x
   González-Suárez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002
   Gorbunova V, 2009, MECH AGEING DEV, V130, P3, DOI 10.1016/j.mad.2008.02.008
   Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y
   GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0
   GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   Guo N, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017858
   Guterres AN, 2020, ONCOGENE, V39, P5811, DOI 10.1038/s41388-020-01405-w
   Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3
   Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003
   Haendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9
   Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546
   Hagman M, 2020, PROG CARDIOVASC DIS, V63, P738, DOI 10.1016/j.pcad.2020.05.009
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hawley JA, 2018, CELL METAB, V27, P962, DOI 10.1016/j.cmet.2018.04.014
   Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029
   Haycock PC, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g4227
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018
   Heidenreich B, 2017, MUTAT RES-REV MUTAT, V771, P15, DOI 10.1016/j.mrrev.2016.11.002
   Hendrickse PW, 2021, EUR J APPL PHYSIOL, V121, P3161, DOI 10.1007/s00421-021-04768-4
   Henstridge DC, 2016, J APPL PHYSIOL, V120, P683, DOI 10.1152/japplphysiol.00811.2015
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370
   Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117
   Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062
   Hu B, 2020, SIGNAL TRANSDUCT TAR, V5, P0, DOI 10.1038/s41392-020-0207-x
   Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259
   Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010
   Jaijyan DK, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2121499119
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626
   Jurk D, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5172
   Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321
   Kim W, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.2000016
   Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010
   Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007
   Lansdorp PM, 2022, BLOOD, V139, P813, DOI 10.1182/blood.2021014299
   LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Lassmann T, 2015, INT J MOL SCI, V16, P1192, DOI 10.3390/ijms16011192
   Laudadio I, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201845969
   Laye MJ, 2012, J APPL PHYSIOL, V112, P773, DOI 10.1152/japplphysiol.00997.2011
   Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013
   Leung FP, 2008, SPORTS MED, V38, P1009, DOI 10.2165/00007256-200838120-00005
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   Li J, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9080656
   Li XJ, 2020, NAT CELL BIOL, V22, P282, DOI 10.1038/s41556-020-0471-6
   Lim CJ, 2021, NAT REV MOL CELL BIO, V22, P283, DOI 10.1038/s41580-021-00328-y
   Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7
   Liu BC, 2022, NATURE, V604, P578, DOI 10.1038/s41586-022-04582-8
   Liu N, 2016, NUCLEIC ACIDS RES, V44, P8693, DOI 10.1093/nar/gkw549
   Liu TJ, 2019, J BIOL CHEM, V294, P8861, DOI 10.1074/jbc.RA118.006615
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ludlow AT, 2017, EXP PHYSIOL, V102, P397, DOI 10.1113/EP086189
   Ludlow AT, 2012, J APPL PHYSIOL, V113, P1737, DOI 10.1152/japplphysiol.00200.2012
   Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa
   Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283
   Mandal S, 2022, PFLUG ARCH EUR J PHY, V474, P1159, DOI 10.1007/s00424-022-02745-0
   Mangaonkar AA, 2018, MAYO CLIN PROC, V93, P904, DOI 10.1016/j.mayocp.2018.03.020
   Povedano JM, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.31299
   Martínez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111
   Martínez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x
   Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102
   McAllister RM, 2008, APPL PHYSIOL NUTR ME, V33, P173, DOI 10.1139/H07-146
   McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908
   Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719
   Memme JM, 2021, J PHYSIOL-LONDON, V599, P803, DOI 10.1113/JP278853
   Miao Guo-Ying, 2016, ASIAN PAC J CANCER PREV, V17, P1993
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Miwa S, 2016, AGING-US, V8, P2551, DOI 10.18632/aging.101089
   Morland C, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15557
   Mundstock E, 2015, OBESITY, V23, P2165, DOI 10.1002/oby.21183
   Mundstock E, 2015, AGEING RES REV, V22, P72, DOI 10.1016/j.arr.2015.02.004
   Muñoz-Lorente MA, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12664-x
   Murphy RM, 2020, NAT METAB, V2, P805, DOI 10.1038/s42255-020-0258-x
   Nickels M, 2020, HELIYON, V6, P0, DOI 10.1016/j.heliyon.2020.e04151
   Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580
   Ogasawara R, 2019, EXERC SPORT SCI REV, V47, P188, DOI 10.1249/JES.0000000000000189
   Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072
   Pallini R, 2001, J NEUROSURG, V94, P961, DOI 10.3171/jns.2001.94.6.0961
   Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137
   Perera ON, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav4409
   Pérez-Rivero G, 2006, CIRCULATION, V114, P309, DOI 10.1161/CIRCULATIONAHA.105.611111
   Perry CGR, 2018, CSH PERSPECT MED, V8, P0, DOI 10.1101/cshperspect.a029686
   Pestana A, 2017, J MOL ENDOCRINOL, V58, PR129, DOI 10.1530/JME-16-0195
   Pickett HA, 2015, NAT STRUCT MOL BIOL, V22, P875, DOI 10.1038/nsmb.3106
   Ponsot E, 2012, EXP PHYSIOL, V97, P774, DOI 10.1113/expphysiol.2011.063818
   Roake CM, 2020, NAT REV MOL CELL BIO, V21, P384, DOI 10.1038/s41580-020-0234-z
   Rossiello F, 2022, NAT CELL BIOL, V24, P135, DOI 10.1038/s41556-022-00842-x
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1
   Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715
   Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x
   Saraswati S, 2021, NATURE AGING, V1, P269, DOI 10.1038/s43587-021-00040-8
   Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498
   Shaheen F, 2014, BBA-MOL BASIS DIS, V1842, P1762, DOI 10.1016/j.bbadis.2014.06.018
   Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758
   Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1
   Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Shim HS, 2021, NATURE AGING, V1, P1162, DOI 10.1038/s43587-021-00146-z
   Singhapol C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0052989
   Slusher AL, 2022, MED SCI SPORT EXER, V54, P931, DOI 10.1249/MSS.0000000000002868
   Smith EM, 2020, CELL MOL LIFE SCI, V77, P61, DOI 10.1007/s00018-019-03369-x
   Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985
   Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015
   Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11
   Sun LL, 2019, P NATL ACAD SCI USA, V116, P18983, DOI 10.1073/pnas.1907199116
   Sundin T, 2012, EXPERT REV MOL MED, V14, P0, DOI 10.1017/erm.2012.1
   Suvorava T, 2018, CURR MED CHEM, V25, P4457, DOI 10.2174/0929867325666180307112557
   Nguyen THD, 2018, NATURE, V557, P190, DOI 10.1038/s41586-018-0062-x
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Toupance S, 2017, HYPERTENSION, V70, P420, DOI 10.1161/HYPERTENSIONAHA.117.09354
   Trotter Kevin W, 2008, NUCL RECEPT SIGNAL, V6, Pe004, DOI 10.1621/nrs.06004
   Valente C, 2021, J AM GERIATR SOC, V69, P3285, DOI 10.1111/jgs.17334
   Vidal-Cardenas SL, 2010, NUCLEIC ACIDS RES, V38, P60, DOI 10.1093/nar/gkp855
   Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454
   Wang JF, 2016, J INT MED RES, V44, P1156, DOI 10.1177/0300060516667132
   Wariyar SS, 2022, EXP NEUROL, V353, P0, DOI 10.1016/j.expneurol.2022.114029
   Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034
   Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005
   Werner CM, 2019, EUR HEART J, V40, P34, DOI 10.1093/eurheartj/ehy585
   Whittemore K, 2019, AGING-US, V11, P2916, DOI 10.18632/aging.101982
   Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379
   Widegren U, 2000, PFLUG ARCH EUR J PHY, V441, P317, DOI 10.1007/s004240000417
   Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019
   WYNFORDTHOMAS D, 1997, NATURE, V389, P551, DOI 10.1038/39207
   Xiong SQ, 2015, CELL REP, V12, P1391, DOI 10.1016/j.celrep.2015.07.047
   Yeh JK, 2019, JACC-BASIC TRANSL SC, V4, P855, DOI 10.1016/j.jacbts.2019.05.009
   Yu JY, 2018, CANCER LETT, V434, P33, DOI 10.1016/j.canlet.2018.07.013
   Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x
   Zaccagnini G, 2005, J BIOL CHEM, V280, P14790, DOI 10.1074/jbc.M414644200
   Zhao L, 2019, LAB INVEST, V99, P1661, DOI 10.1038/s41374-019-0290-1
   Zheng Q, 2019, PROTEIN CELL, V10, P631, DOI 10.1007/s13238-019-0612-5
   Zietzer A, 2017, ACTA PHYSIOL, V220, P251, DOI 10.1111/apha.12820
   Zinder JC, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2201662119
NR 194
TC 7
Z9 7
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN 15
PY 2023
VL 22
IS 6
BP 
EP 
DI 10.1111/acel.13836
EA APR 2023
PG 18
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA I9NV0
UT WOS:000969086100001
PM 37041671
DA 2024-11-01
ER

PT J
AU Faria, R
   Boisguérin, P
   Sousa, A
   Costa, D
AF Faria, Ruben
   Boisguerin, Prisca
   Sousa, Angela
   Costa, Diana
TI Delivery Systems for Mitochondrial Gene Therapy: A Review
SO PHARMACEUTICS
LA English
DT Review
DE gene therapy; mitochondria; mitochondria-targeted delivery systems; mitochondrial diseases; mitochondrial gene therapy
ID mito-porter; complex-i; ceria nanoparticles; skeletal-muscle; dna mutations; cancer; drug; membrane; triphenylphosphonium; efficient
AB Mitochondria are membrane-bound cellular organelles of high relevance responsible for the chemical energy production used in most of the biochemical reactions of cells. Mitochondria have their own genome, the mitochondrial DNA (mtDNA). Inherited solely from the mother, this genome is quite susceptible to mutations, mainly due to the absence of an effective repair system. Mutations in mtDNA are associated with endocrine, metabolic, neurodegenerative diseases, and even cancer. Currently, therapeutic approaches are based on the administration of a set of drugs to alleviate the symptoms of patients suffering from mitochondrial pathologies. Mitochondrial gene therapy emerges as a promising strategy as it deeply focuses on the cause of mitochondrial disorder. The development of suitable mtDNA-based delivery systems to target and transfect mammalian mitochondria represents an exciting field of research, leading to progress in the challenging task of restoring mitochondria's normal function. This review gathers relevant knowledge on the composition, targeting performance, or release profile of such nanosystems, offering researchers valuable conceptual approaches to follow in their quest for the most suitable vectors to turn mitochondrial gene therapy clinically feasible. Future studies should consider the optimization of mitochondrial genes' encapsulation, targeting ability, and transfection to mitochondria. Expectedly, this effort will bring bright results, contributing to important hallmarks in mitochondrial gene therapy.
C1 [Faria, Ruben; Sousa, Angela; Costa, Diana] Univ Beira Interior, Hlth Sci Res Ctr, CICS UBI, P-6201506 Covilha, Portugal.
   [Boisguerin, Prisca] Univ Montpellier, INSERM, CNRS, PhyMedExp, F-34295 Montpellier, France.
C3 Universidade da Beira Interior; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier
RP Costa, D (corresponding author), Univ Beira Interior, Hlth Sci Res Ctr, CICS UBI, P-6201506 Covilha, Portugal.
EM dcosta@fcsaude.ubi.pt
FU FEDER [POCI-01-0145-FEDER-007491]; National Funds by FCT-Foundation for Science and Technology [UID/Multi/00709/2019]; CICS-UBI projects [UIDB/00709/2020, UIDP/00709/2020]; national funds through Portuguese Foundation for Science and Technology/MCTES; "Agence National de la Recherche" (ANR NanoCard) [ANR-21-CE18-0022-01]; "Centre National de la Recherche Scientifique" (CNRS); Agence Nationale de la Recherche (ANR) [ANR-21-CE18-0022] Funding Source: Agence Nationale de la Recherche (ANR)
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Akita H, 2009, BIOMATERIALS, V30, P2940, DOI 10.1016/j.biomaterials.2009.02.009
   Allemailem KS, 2021, INT J NANOMED, V16, P3907, DOI 10.2147/IJN.S303832
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Ammar M, 2016, BIOCHEM BIOPH RES CO, V474, P702, DOI 10.1016/j.bbrc.2016.05.014
   Arafa KK, 2022, RSC ADV, V12, P21690, DOI 10.1039/d2ra03240f
   Athanasopoulos T, 2017, HEMATOL ONCOL CLIN N, V31, P753, DOI 10.1016/j.hoc.2017.06.007
   Aversa R, 2016, AM. J. ENG. APPL. SCI., V9, P991, DOI 10.3844/ajeassp.2016.991.1002
   Avula S, 2014, CURR TREAT OPTION NE, V16, P0, DOI 10.1007/s11940-014-0292-7
   Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544
   Bae Y, 2019, MACROMOL RES, V27, P1071, DOI 10.1007/s13233-019-7153-x
   Bae Y, 2018, EUR J PHARM BIOPHARM, V124, P104, DOI 10.1016/j.ejpb.2017.12.013
   Bae Y, 2017, MITOCHONDRION, V37, P27, DOI 10.1016/j.mito.2017.06.005
   Baertling F, 2018, J PEDIATR-US, V196, P309, DOI 10.1016/j.jpeds.2017.12.043
   Ban R, 2018, CHINESE MED J-PEKING, V131, P1569, DOI 10.4103/0366-6999.235120
   Batabyal S, 2017, J BIOMED OPT, V22, P0, DOI 10.1117/1.JBO.22.6.060504
   Battogtokh G, 2018, FRONT PHARMACOL, V9, P0, DOI 10.3389/fphar.2018.00922
   Bayda S, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25010112
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bi R, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2014.10.009
   Birk AV, 2014, BRIT J PHARMACOL, V171, P2017, DOI 10.1111/bph.12468
   Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032
   Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1
   Bonnefoy Nathalie, 2007, METHODS MOL BIOL, V372, P153, DOI 10.1007/978-1-59745-365-3_11
   Bordoni L, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9080764
   Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148335
   Buneeva O, 2020, BIOMEDICINES, V8, P0, DOI 10.3390/biomedicines8120591
   Bykov YS, 2020, TRENDS BIOCHEM SCI, V45, P650, DOI 10.1016/j.tibs.2020.04.001
   Carreño-Gago L, 2017, BBA-MOL BASIS DIS, V1863, P182, DOI 10.1016/j.bbadis.2016.09.002
   Chen HC, 2017, J MATER CHEM B, V5, P972, DOI 10.1039/c6tb02714h
   Chokchaiwong S, 2018, FREE RADICAL RES, V52, P1445, DOI 10.1080/10715762.2018.1500695
   Chu QH, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17170
   Cordani M, 2019, CELL MOL LIFE SCI, V76, P1215, DOI 10.1007/s00018-018-2973-y
   Costa D, 2017, BIOMACROMOLECULES, V18, P2928, DOI 10.1021/acs.biomac.7b00877
   Coutinho E, 2017, MOL PHARMACEUT, V14, P626, DOI 10.1021/acs.molpharmaceut.6b00823
   DSouza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   DSouza GGM, 2005, MITOCHONDRION, V5, P352, DOI 10.1016/j.mito.2005.07.001
   Dafinca R, 2020, STEM CELL REP, V14, P892, DOI 10.1016/j.stemcr.2020.03.023
   de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019
   Dolatabadi JEN, 2015, ADV PHARM BULL, V5, P151, DOI 10.15171/apb.2015.022
   Du XF, 2018, DRUG DELIV, V25, P1516, DOI 10.1080/10717544.2018.1480674
   Elorza AA, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.625020
   Lopes AFC, 2020, CLIN EPIGENETICS, V12, P0, DOI 10.1186/s13148-020-00976-5
   Fan XX, 2020, NANO-MICRO LETT, V12, P0, DOI 10.1007/s40820-020-0410-x
   Faria R, 2022, PHARMACEUTICS, V14, P0, DOI 10.3390/pharmaceutics14040757
   Faria R, 2021, POLYMERS-BASEL, V13, P0, DOI 10.3390/polym13111836
   Faria R, 2020, J MOL LIQ, V316, P0, DOI 10.1016/j.molliq.2020.113873
   Farrar GJ, 2013, TRENDS GENET, V29, P488, DOI 10.1016/j.tig.2013.05.005
   Fontaine F, 2015, EMPIR SOFTW ENG, V0, PP1, DOI 10.1007/s10658-015-0770-0/
   Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267
   Ganly I, 2019, THYROID, V29, P471, DOI 10.1089/thy.2019.0088
   Ganly I, 2018, CANCER CELL, V34, P256, DOI 10.1016/j.ccell.2018.07.002
   Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gruntman AM, 2018, FASEB J, V32, P1733, DOI 10.1096/fj.201700982R
   Guo Y, 2018, INT J DEV NEUROSCI, V71, P172, DOI 10.1016/j.ijdevneu.2018.09.007
   Guzman-Villanueva D, 2019, METHODS MOL BIOL, V2000, P183, DOI 10.1007/978-1-4939-9516-5_12
   Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8090392
   Han L, 2013, SMALL, V9, P3647, DOI 10.1002/smll.201300279
   Hebert-Chatelain E, 2016, NATURE, V539, P555, DOI 10.1038/nature20127
   Henry C, 2017, OCHSNER J, V17, P296
   Herrera Arturo S, 2015, CENTRAL NERVOUS SYSTEM AGENTS IN MEDICINAL CHEMISTRY, V15, P32
   Herrero MJ, 2017, SAF EFFIC GENE BASED, V0, PP113, DOI 10.1007/978-3-319-53457-2_6
   Horten P, 2020, BIOMOLECULES, V10, P0, DOI 10.3390/biom10071008
   Huang RQ, 2008, BIOMATERIALS, V29, P238, DOI 10.1016/j.biomaterials.2007.09.024
   Huang SX, 2013, ACS NANO, V7, P2860, DOI 10.1021/nn400548g
   Indoria S, 2020, INT J PHARMACEUT, V582, P0, DOI 10.1016/j.ijpharm.2020.119314
   Ishikawa T, 2018, J CONTROL RELEASE, V274, P109, DOI 10.1016/j.jconrel.2018.02.005
   Jang YH, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23092316
   Jedynak-Slyvka M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22157999
   Jerome MS, 2022, BIOCHIMIE, V198, P96, DOI 10.1016/j.biochi.2022.03.013
   Johnston IG, 2016, CELL SYST, V2, P101, DOI 10.1016/j.cels.2016.01.013
   Kawamura E, 2020, MOL THER-NUCL ACIDS, V20, P687, DOI 10.1016/j.omtn.2020.04.004
   Kawamura E, 2019, MITOCHONDRION, V49, P178, DOI 10.1016/j.mito.2019.08.004
   Kawamura E, 2013, MITOCHONDRION, V13, P610, DOI 10.1016/j.mito.2013.08.010
   Khair SZNM, 2021, DIS MARKERS, V2021, P0, DOI 10.1155/2021/7675269
   Khalil IA, 2007, GENE THER, V14, P682, DOI 10.1038/sj.gt.3302910
   Kim H, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17122049
   Kinnear C, 2017, CHEM REV, V117, P11476, DOI 10.1021/acs.chemrev.7b00194
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   Kotrys AV, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010017
   Kulkarni CA, 2021, J MED CHEM, V64, P662, DOI 10.1021/acs.jmedchem.0c01671
   Lalrohlui F, 2020, MITOCHONDRION, V51, P7, DOI 10.1016/j.mito.2019.12.001
   Lalrohlui F, 2016, GENES ENVIRON, V38, P0, DOI 10.1186/s41021-016-0034-z
   Lang M, 2015, MODERN PATHOL, V28, P1458, DOI 10.1038/modpathol.2015.101
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Li HR, 2020, INT J NANOMED, V15, P7199, DOI 10.2147/IJN.S270229
   Li JM, 2018, BIOMATER SCI-UK, V6, P2998, DOI 10.1039/c8bm00889b
   Li LY, 2021, CLIN TRANSL MED, V11, P0, DOI 10.1002/ctm2.529
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Ma JC, 2018, CANCER-AM CANCER SOC, V124, P2289, DOI 10.1002/cncr.31248
   Maksum IP, 2017, BIOINFORM BIOL INSIG, V11, P0, DOI 10.1177/1177932217728515
   Mallick S, 2019, INT J BIOL MACROMOL, V132, P451, DOI 10.1016/j.ijbiomac.2019.03.215
   Marrache S, 2013, ACS NANO, V7, P7392, DOI 10.1021/nn403158n
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Moslemi AR, 2008, NEUROPEDIATRICS, V39, P24, DOI 10.1055/s-2008-1076739
   Muramatsu H, 2019, FORENS SCI INT-GEN S, V7, P698, DOI 10.1016/j.fsigss.2019.10.143
   Nikzamir M, 2021, J INORG ORGANOMET P, V31, P2246, DOI 10.1007/s10904-021-01925-2
   Nissanka N, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949612
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Nolfi-Donegan D, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101674
   Nomikou N, 2018, J TISSUE ENG REGEN M, V12, PE250, DOI 10.1002/term.2406
   Obrador E, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126352
   Oddone N, 2016, J NANOBIOTECHNOL, V14, P0, DOI 10.1186/s12951-016-0197-6
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pearce Erika L, 2013, SCIENCE, V342, P1242454, DOI 10.1126/science.1242454
   Picard M, 2018, PSYCHOSOM MED, V80, P141, DOI 10.1097/PSY.0000000000000545
   Polyakova T, 2017, IEEE MAGN LETT, V8, P0, DOI 10.1109/LMAG.2017.2732361
   Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566
   Prasai Kanchanjunga, 2017, PATHOPHYSIOLOGY, V24, P107, DOI 10.1016/j.pathophys.2017.03.001
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Saki M, 2017, FREE RADICAL BIO MED, V107, P216, DOI 10.1016/j.freeradbiomed.2016.11.050
   Salvado R, 2015, COLLOID SURFACE A, V480, P287, DOI 10.1016/j.colsurfa.2014.12.013
   Santos J, 2014, COLLOID SURFACE B, V121, P129, DOI 10.1016/j.colsurfb.2014.06.003
   Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schwarz D, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-017-02560-7
   Seeman NC, 2018, NAT REV MATER, V3, P0, DOI 10.1038/natrevmats.2017.68
   Sharma A, 2018, THERANOSTICS, V8, P5529, DOI 10.7150/thno.29039
   Sharma S, 2021, MOL NEUROBIOL, V58, P65, DOI 10.1007/s12035-020-02080-4
   Smith ALM, 2022, MOL ONCOL, V16, P3276, DOI 10.1002/1878-0261.13291
   Smolina N, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165745
   Solmonson A, 2018, J BIOL CHEM, V293, P7522, DOI 10.1074/jbc.TM117.000259
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Sun YJ, 2021, FRONT BIOENG BIOTECH, V9, P0, DOI 10.3389/fbioe.2021.755727
   Surekha B, 2021, COLLOID SURFACE B, V204, P0, DOI 10.1016/j.colsurfb.2021.111837
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Tarnopolsky MA, 2011, AMINO ACIDS, V40, P1397, DOI 10.1007/s00726-011-0876-4
   Thapa S, 2016, BREAST CANCER-TOKYO, V23, P607, DOI 10.1007/s12282-015-0611-1
   Tian HY, 2013, SMALL, V9, P2034, DOI 10.1002/smll.201202485
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Trecarichi A, 2022, PLOS ONE, V17, P0, DOI 10.1371/journal.pone.0262544
   van Horssen J, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.050
   Wang F, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.675465
   Wang XY, 2014, J MATER CHEM B, V2, P2546, DOI 10.1039/c3tb21348j
   Weissig V, 2020, TRENDS MOL MED, V26, P40, DOI 10.1016/j.molmed.2019.09.002
   Weissig V, 2014, INT J NANOMED, V9, P4357, DOI 10.2147/IJN.S46900
   Wolfram RK, 2018, EUR J MED CHEM, V152, P21, DOI 10.1016/j.ejmech.2018.04.031
   Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2020, NUCLEOS NUCLEOT NUCL, V39, P141, DOI 10.1080/15257770.2019.1675167
   Yamada Y, 2015, J CONTROL RELEASE, V213, P86, DOI 10.1016/j.jconrel.2015.06.037
   Yamada Y, 2012, METHOD ENZYMOL, V509, P301, DOI 10.1016/B978-0-12-391858-1.00015-0
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yang P, 2020, BIOMATERIALS, V238, P0, DOI 10.1016/j.biomaterials.2020.119844
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Yu H, 2020, THERANOSTICS, V10, P2342, DOI 10.7150/thno.40395
   Yuan Y, 2019, SMALL, V15, P0, DOI 10.1002/smll.201900172
   Zhang LF, 2020, ANN TRANSL MED, V8, P0, DOI 10.21037/atm.2019.10.113
   Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200
   Zheng FF, 2019, NANOPHOTONICS-BERLIN, V8, P391, DOI 10.1515/nanoph-2018-0219
   Zhou W, 2017, NANOSCALE, V9, P17044, DOI 10.1039/c7nr06130g
   Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042
NR 162
TC 7
Z9 7
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1999-4923
J9 PHARMACEUTICS
JI Pharmaceutics
PD FEB 15
PY 2023
VL 15
IS 2
BP 
EP 
DI 10.3390/pharmaceutics15020572
PG 25
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 9L6AK
UT WOS:000941630400001
PM 36839894
DA 2024-11-01
ER

PT J
AU Giannese, D
   Montano, V
   Lopriore, P
   Nesti, C
   LoGerfo, A
   Caligo, MA
   Dal Canto, F
   Pasquinelli, G
   Bonadio, AG
   Moriconi, D
   Siciliano, G
   Mancuso, M
AF Giannese, Domenico
   Montano, Vincenzo
   Lopriore, Piervito
   Nesti, Claudia
   LoGerfo, Annalisa
   Caligo, Maria Adelaide
   Dal Canto, Flavio
   Pasquinelli, Gianandrea
   Bonadio, Angelo Giovanni
   Moriconi, Diego
   Siciliano, Gabriele
   Mancuso, Michelangelo
TI A Multisystem Mitochondrial Disease Caused by a Novel <i>MT-TL1</i> <i>mtDNA</i> Variant: A Case Report
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE mtDNA; mitochondrial diseases; mitochondrial myopathies; glomerulosclerosis; kidney disease
ID follow-up; mutation; kidney; phenotype; gene
AB Background: Mitochondrial tRNA (MTT) genes are hotspot for mitochondrial DNA mutation and are responsible of half mitochondrial disease. MTT mutations are associated with a broad spectrum of phenotype often with complex multisystem involvement and complex genotype-phenotype correlations. MT-TL1 mutations, among which the m.3243A>G mutation is the most frequent, are associated with myopathy, maternal inherited diabetes and deafness, MELAS, cardiomyopathy, and focal segmental glomerulosclerosis. Case study: Here we report the case of an Italian 49-years old female presenting with encephalomyopathy, chronic proteinuric kidney disease and a new heteroplasmic m.3274 3275delAC MT-TL1 gene mutation. Conclusions: Our case demonstrates a systemic mitochondrial disease caused by the heteroplasmic m.3274 3275delAC MT-TL1 gene mutation, not yet described in the literature. A mitochondrial disease should be suspected in case of complex multisystem phenotypes, including steroid-resistant nephrotic syndrome with multisystemic involvement.
C1 [Giannese, Domenico] Univ Hosp Pisa, Dept Clin & Expt Med, Nephrol Transplant & Dialysis Div, Pisa, Italy.
   [Montano, Vincenzo; Lopriore, Piervito; Siciliano, Gabriele; Mancuso, Michelangelo] Univ Pisa, Dept Clin & Expt Med, Neurol Clin, Pisa, Italy.
   [Nesti, Claudia; Dal Canto, Flavio] IRCCS Fdn Stella Maris, Mol Med, Pisa, Italy.
   [LoGerfo, Annalisa; Caligo, Maria Adelaide] Azienda Osped Univ Pisana, Lab Mol Genet, Pisa, Italy.
   [Pasquinelli, Gianandrea] Univ Bologna, Dept Expt Biotechnol & Methods Lab Med Diagnost &, Bologna, Italy.
   [Pasquinelli, Gianandrea] IRCCS Azienda Osped Univ Bologna, Pathol Unit, Subcellular Nephrovasc Diagnost Program, Bologna, Italy.
   [Bonadio, Angelo Giovanni] Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy.
   [Moriconi, Diego] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy.
C3 University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; IRCCS Fondazione Stella Maris; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Pisa; University of Pisa
RP Mancuso, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Neurol Inst, Pisa, Italy.
EM michelangelo.mancuso@unipi.it
FU Telethon [GUP09004, GSP16001]; EJP RD Joint Transnational Call (JTC2019) GENOMIT
CR Atmaca M, 2019, TURKISH J PEDIATR, V61, P657, DOI 10.24953/turkjped.2019.05.003
   Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107
   de Laat P, 2019, CLIN KIDNEY J, V12, P840, DOI 10.1093/ckj/sfz020
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Eirin A, 2015, HYPERTENSION, V65, P264, DOI 10.1161/HYPERTENSIONAHA.114.04598
   Emma F, 2006, PEDIATR NEPHROL, V21, P355, DOI 10.1007/s00467-005-2092-5
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Govers LP, 2021, PEDIATR NEPHROL, V36, P9, DOI 10.1007/s00467-019-04404-6
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Iwasaki N, 2001, J HUM GENET, V46, P330, DOI 10.1007/s100380170068
   Jaksch M, 2001, NEUROLOGY, V57, P1930, DOI 10.1212/WNL.57.10.1930
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Piccoli GB, 2012, BMC NEPHROL, V13, P0, DOI 10.1186/1471-2369-13-9
   Preston R, 2019, PEDIATR NEPHROL, V34, P195, DOI 10.1007/s00467-017-3838-6
   Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489
   Schijvens AM, 2020, KIDNEY INT REP, V5, P2146, DOI 10.1016/j.ekir.2020.09.044
   Smeitink Jan, 2019, JIMD REP, V46, P52, DOI 10.1002/jmd2.12017
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 19
TC 0
Z9 0
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PD JUN 15
PY 2023
VL 10
IS 1
BP 119
EP 123
DI 10.3233/JND-221526
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 7P0JM
UT WOS:000908400700010
PM 36404555
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Phenotypic Heterogeneity of the Mitochondrial DNA Variant m.13513 G &gt; A
SO JOURNAL OF PEDIATRIC GENETICS
LA English
DT Review; Early Access
DE mtDNA; Leigh's syndrome; MELAS; heteroplasmy; m.13513G > A
ID leigh-syndrome; g13513a mutation; overlap syndrome; complex-i; nd5 gene; m.13513g-greater-than-a mutation; frequent cause; melas
AB The mitochondrial DNA (mtDNA) variant m.13513G > A is increasingly recognized as a cause of syndromic and nonsyndromic mitochondrial disorders (MIDs). This minireview aims a summarizing and discussing recent and previous findings about the phenotypic heterogeneity of this variant. A systematic literature review using the databases PubMed and Google Scholar by application of specific search terms was performed. As per the end of July 2021, at least 50 patients carrying the mtDNA variant m.13513G > A have been reported. Age ranged between 0 and 63 years, and of these patients, 28 were male and 22 were female. The phenotype was highly variable. The most common phenotypes were Leigh syndrome (LS) ( n = 25), mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) ( n = 11), Leigh-like syndrome ( n = 4), MELAS/LS ( n = 3), progressive external ophthalmoplegia ( n = 3), MELAS/Leber's hereditary optic neuropathy (LHON) ( n = 1), and LHON ( n = 1). More rarely are nonsyndromic phenotypes. Heteroplasmy rates were highly variable ranging from 0 to 86% depending on the investigated tissue. The outcome was reported in only a few cases but was worse in patients with LS compared with those with MELAS. The variant m.13513G > A is responsible for syndromic or nonsyndromic MIDs. Syndromic MIDs in which this variant should be particularly considered include LS, MELAS, and LHON and their overlaps. Patients with suspected MID and maternal inheritance should undergo sequencing of the entire mtDNA not to miss rare mtDNA variants.
C1 [Finsterer, Josef] Messerli Inst, Neurol Dept, Klin Landstr, Vienna, Austria.
   [Finsterer, Josef] Postfach 20, A-1180 Vienna, Austria.
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   Hsieh YT, 2011, OPHTHALMIC GENET, V32, P31, DOI 10.3109/13816810.2010.531880
   Jiménez-Legido M, 2019, REV NEUROLOGIA, V68, P312, DOI 10.33588/rn.6807.2018393
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Liang JM, 2021, FRONT PEDIATR, V9, P0, DOI 10.3389/fped.2021.700898
   Penisson-Besnier I, 2000, NEUROLOGY, V55, P317, DOI 10.1212/WNL.55.2.317
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   van Karnebeek CDM, 2011, DEV MED CHILD NEUROL, V53, P565, DOI 10.1111/j.1469-8749.2010.03907.x
   Vázquez-Justes D, 2019, J PEDIATR GENET, V8, P231, DOI 10.1055/s-0039-1691812
   Wang Shi-Bing, 2008, PEDIATRICS AND NEONATOLOGY, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Wei YP, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.648740
   Yahata N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15871-y
NR 21
TC 1
Z9 1
U1 0
U2 2
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2146-4596
EI 2146-460X
J9 J PEDIATR GENET
JI J. Pediatr. Genet.
PD APR 27
PY 2023
VL 0
IS 
BP 
EP 
DI 10.1055/s-0043-1768474
EA APR 2023
PG 5
WC Pediatrics
SC Pediatrics
GA F1AD8
UT WOS:000979734800001
DA 2024-11-01
ER

PT J
AU Rimoldi, M
   Magri, F
   Antognozzi, S
   Ripolone, M
   Salani, S
   Piga, D
   Bertolasi, L
   Zanotti, S
   Ciscato, P
   Fortunato, F
   Moggio, M
   Corti, S
   Comi, GP
   Ronchi, D
AF Rimoldi, Martina
   Magri, Francesca
   Antognozzi, Sara
   Ripolone, Michela
   Salani, Sabrina
   Piga, Daniela
   Bertolasi, Letizia
   Zanotti, Simona
   Ciscato, Patrizia
   Fortunato, Francesco
   Moggio, Maurizio
   Corti, Stefania
   Comi, Giacomo Pietro
   Ronchi, Dario
TI Prominent muscle involvement in a familial form of mitochondrial disease due to a <i>COA8</i> variant
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitochondrial myopathy; cytochrome c oxidase deficiency; COA8; mitochondrial encefalomyopathies; whole exome sequencing
ID mutations; protein
AB Isolated mitochondrial respiratory chain Complex IV (Cytochrome c Oxidase or COX) deficiency is the second most frequent isolated respiratory chain defect. Causative mutations are mainly identified in structural COX subunits or in proteins involved in the maturation and assembly of the COX holocomplex. We describe an Italian familial case of mitochondrial myopathy due to a variant in the COX assembly factor 8 gene (COA8). Patient 1 is a 52-year-old woman who presented generalized epilepsy and retinitis pigmentosa at 10 years of age. From her early adulthood she complained about cramps and myalgia after exercise, and bilateral hearing loss emerged. Last neurological examination (52 years of age) showed bilateral ptosis, muscle weakness, peripheral neuropathy, mild dysarthria and dysphonia, cognitive impairment. Muscle biopsy had shown the presence of ragged-red fibers. Patient 2 (Patient 1's sister) is a 53-year-old woman presenting fatigability, myalgia, and hearing loss. Neurological examination showed ptosis and muscle weakness. Muscle biopsy displayed a diffuse reduction of COX activity staining and ragged-red fibers. Both sisters presented secondary amenorrhea. After ruling out mtDNA mutations, Whole Exome Sequencing analysis identified the novel homozygous COA8 defect c.170_173dupGACC, p.(Pro59fs) in the probands. Loss-of-function COA8 mutations have been associated with cavitating leukoencephalopathy with COX deficiency in 9 reported individuals. Disease course shows an early-onset rapid clinical deterioration, affecting both cognitive and motor functions over months, followed by stabilization and slow improvement over several years. Our findings expand the clinical spectrum of COA8-related disease. We confirm the benign course of this rare disorder, highlighting its (intrafamilial) clinical variability.
C1 [Rimoldi, Martina; Ripolone, Michela; Zanotti, Simona; Ciscato, Patrizia; Moggio, Maurizio; Corti, Stefania] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Magri, Francesca; Antognozzi, Sara; Salani, Sabrina; Piga, Daniela; Bertolasi, Letizia; Fortunato, Francesco; Comi, Giacomo Pietro; Ronchi, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Corti, Stefania; Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Ronchi, D (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.; Ronchi, D (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
EM dario.ronchi@unimi.it
FU Italian Ministry of Health-Current research IRCCS Ca' Granda Ospedale Maggiore Policlinico
CR Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148335
   Brischigliaro M, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.01143
   Chapleau A, 2023, FRONT CELL NEUROSCI, V17, P0, DOI 10.3389/fncel.2023.1216487
   Chinnery PF, 1993, MITOCHONDRIAL DISORD, V0, P0
   Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, PC1129, DOI 10.1152/ajpcell.00233.2006
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000464
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Melchionda L, 2014, AM J HUM GENET, V95, P315, DOI 10.1016/j.ajhg.2014.08.003
   Mu WY, 2019, J NEUROGENET, V33, P21, DOI 10.1080/01677063.2018.1555249
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Richman TR, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11884
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sferruzza G, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000573
   Sharma S, 2018, J CHILD NEUROL, V33, P428, DOI 10.1177/0883073818760875
   Signes A, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809582
   Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Sun X, 2008, BIOCHEM BIOPH RES CO, V377, P1097, DOI 10.1016/j.bbrc.2008.10.109
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Yasuda O, 2006, J BIOL CHEM, V281, P23899, DOI 10.1074/jbc.M512610200
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 23
TC 2
Z9 2
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD NOV 30
PY 2023
VL 14
IS 
BP 
EP 
DI 10.3389/fgene.2023.1278572
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA CJ5Z6
UT WOS:001124911700001
PM 38098475
DA 2024-11-01
ER

PT J
AU Hines, TJ
   Bailey, J
   Liu, HD
   Guntur, AR
   Seburn, KL
   Pratt, SL
   Funke, JR
   Tarantino, LM
   Burgess, RW
AF Hines, Timothy J.
   Bailey, Janice
   Liu, Hedi
   Guntur, Anyonya R.
   Seburn, Kevin L.
   Pratt, Samia L.
   Funke, Jonathan R.
   Tarantino, Lisa M.
   Burgess, Robert W.
TI A Novel ENU-Induced <i>Mfn2</i> Mutation Causes Motor Deficits in Mice without Causing Peripheral Neuropathy
SO BIOLOGY-BASEL
LA English
DT Article
DE Charcot-Marie-Tooth disease; CMT2A; mitofusin 2; neuromuscular disease
ID marie-tooth-disease; mitochondrial fusion; mitofusin 2; dynamics; expression; features; defects; health; model; gene
AB Simple Summary The fission and fusion of mitochondria are important processes for maintaining mitochondrial health. One of the proteins responsible for mediating mitochondrial fusion, mitofusin 2 (MFN2), has over 100 known mutations that cause Charcot-Marie-Tooth disease type 2A (CMT2A). This disease causes the nerves that control your muscles to degenerate, leading to muscle atrophy and weakness, problems walking, and other related symptoms. In this paper, we describe a mouse line with a recessive mutation in the Mfn2 gene (Leu643Pro) that causes a similar set of symptoms, including abnormal gait, weight loss, and decreased muscular endurance. However, further analysis of these mice revealed signs of skeletal muscle dysfunction (including smaller mitochondria) and bone abnormalities, with little evidence of axon degeneration typical of CMT2A. While this makes these mice a poor model for CMT2A, they are the first reported mouse line with a mutation in the transmembrane domain, a region critical for MFN2 & PRIME;s role in mitochondrial fusion. For this reason, we believe these mice will be a valuable tool for scientists interested in studying the biological functions of MFN2. Mitochondrial fission and fusion are required for maintaining functional mitochondria. The mitofusins (MFN1 and MFN2) are known for their roles in mediating mitochondrial fusion. Recently, MFN2 has been implicated in other important cellular functions, such as mitophagy, mitochondrial motility, and coordinating endoplasmic reticulum-mitochondria communication. In humans, over 100 MFN2 mutations are associated with a form of inherited peripheral neuropathy, Charcot-Marie-Tooth disease type 2A (CMT2A). Here we describe an ENU-induced mutant mouse line with a recessive neuromuscular phenotype. Behavioral screening showed progressive weight loss and rapid deterioration of motor function beginning at 8 weeks. Mapping and sequencing revealed a missense mutation in exon 18 of Mfn2 (T1928C; Leu643Pro), within the transmembrane domain. Compared to wild-type and heterozygous littermates, Mfn2(L643P/L643P) mice exhibited diminished rotarod performance and decreases in activity in the open field test, muscular endurance, mean mitochondrial diameter, sensory tests, mitochondrial DNA content, and MFN2 protein levels. However, tests of peripheral nerve physiology and histology were largely normal. Mutant leg bones had reduced cortical bone thickness and bone area fraction. Together, our data indicate that Mfn2(L643P) causes a recessive motor phenotype with mild bone and mitochondrial defects in mice. Lack of apparent nerve pathology notwithstanding, this is the first reported mouse model with a mutation in the transmembrane domain of the protein, which may be valuable for researchers studying MFN2 biology.
C1 [Hines, Timothy J.; Seburn, Kevin L.; Pratt, Samia L.; Funke, Jonathan R.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA.
   [Bailey, Janice; Liu, Hedi; Tarantino, Lisa M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.
   [Guntur, Anyonya R.] Maine Hlth Inst Res, Ctr Mol Med, Scarborough, ME 04074 USA.
   [Pratt, Samia L.; Funke, Jonathan R.; Burgess, Robert W.] Tufts Univ, Grad Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA.
C3 Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill; Tufts University
RP Burgess, RW (corresponding author), Jackson Lab, Bar Harbor, ME 04609 USA.; Burgess, RW (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA.
EM robert.burgess@jax.org
CR Abati E, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-10220-0
   Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Ballard Anna, 2020, J BIOL CHEM, V295, P6629, DOI 10.1074/jbc.RA119.012023
   Bannerman P, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167573
   Bertholet AM, 2016, NEUROBIOL DIS, V90, P3, DOI 10.1016/j.nbd.2015.10.011
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Brozková DS, 2013, MOL MED REP, V8, P1779, DOI 10.3892/mmr.2013.1730
   Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082
   Chandhok G, 2018, BIOL REV, V93, P933, DOI 10.1111/brv.12378
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Cohen S, 2018, CURR OPIN CELL BIOL, V53, P84, DOI 10.1016/j.ceb.2018.06.003
   Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   De Gioia R, 2020, MOL NEUROBIOL, V57, P5121, DOI 10.1007/s12035-020-02081-3
   Deng LD, 2022, STEM CELL RES THER, V13, P0, DOI 10.1186/s13287-022-02836-w
   Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098
   Dorn GW, 2013, CIRC J, V77, P1370, DOI 10.1253/circj.CJ-13-0453
   Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Filadi R, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0023-6
   Gerlinger-Romero F, 2019, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/58696
   Gomez CM, 1997, J NEUROSCI, V17, P4170
   Hikiami R, 2018, J HUM GENET, V63, P89, DOI 10.1038/s10038-017-0353-3
   Hsu YH, 2019, ANN CLIN TRANSL NEUR, V6, P1090, DOI 10.1002/acn3.50797
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Luo NJ, 2021, FASEB J, V35, P0, DOI 10.1096/fj.202002464R
   Ma Y, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.757518
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012
   Mottie S, 2018, J CELL BIOL, V217, P507, DOI 10.1083/jcb.201611194
   Quiros Pedro M, 2017, CURR PROTOC MOUSE BIOL, V7, P47, DOI 10.1002/cpmo.21
   Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Santel A, 2001, J CELL SCI, V114, P867
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Spaulding EL, 2016, J NEUROSCI, V36, P3254, DOI 10.1523/JNEUROSCI.1762-15.2016
   Strickland AV, 2014, J PERIPHER NERV SYST, V19, P152, DOI 10.1111/jns5.12066
   Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Yu R, 2020, FRONT ENDOCRINOL, V11, P0, DOI 10.3389/fendo.2020.00374
   Zaman M, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.858286
   Zarei A, 2021, BONE, V148, P0, DOI 10.1016/j.bone.2021.115941
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
   Zhou YQ, 2019, J CLIN INVEST, V129, P1756, DOI 10.1172/JCI124194
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 60
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD JUL 15
PY 2023
VL 12
IS 7
BP 
EP 
DI 10.3390/biology12070953
PG 22
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA N1RC5
UT WOS:001034857900001
PM 37508383
DA 2024-11-01
ER

PT J
AU Lindgren, U
   Hedberg-Oldfors, C
   Pullerits, R
   Lindberg, C
   Oldfors, A
AF Lindgren, Ulrika
   Hedberg-Oldfors, Carola
   Pullerits, Rille
   Lindberg, Christopher
   Oldfors, Anders
TI Inclusion body myositis with early onset: a population-based study
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Inclusion body myositis; Inflammatory myopathy; Muscular weakness; Mitochondrial DNA; Epidemiology
ID mitochondrial
AB IntroductionInclusion body myositis (IBM), an inflammatory myopathy with progressive weakness without efficient treatment, typically presents after 45 years of age and younger patients are sparsely studied.MethodsIn a population-based study during a 33-year period, 142 patients with IBM were identified in western Sweden. Six patients fell outside the European Neuromuscular Centre 2011 criteria for IBM due to young age at symptom onset, verified by a muscle biopsy < 50 years of age. These were defined as early-onset IBM and included in this study. Medical records, muscle strength, comorbidities, muscle biopsies, and nuclear- and mitochondrial DNA were examined and compared with patients with IBM and age matched controls from the same population.ResultsThe median age at symptom onset was 36 (range 34-45) years and at diagnosis 43 (range 38-58) years. Four patients were deceased at a median age of 59 (range 50-75) years. The median survival from diagnosis was 14 (range 10-18) years. The prevalence December 31 2017 was 1.2 per million inhabitants and the mean incidence 0.12 patients per million inhabitants and year. The mean decline in quadriceps strength & PLUSMN; 1 standard deviation was 1.21 & PLUSMN; 0.2 Newton or 0.91 & PLUSMN; 0.2% per month and correlated to time from diagnosis (p < 0.001). Five patients had swallowing difficulties. All patients displayed mitochondrial changes in muscle including cytochrome c oxidase deficiency and the mitochondrial DNA mutation load was high.ConclusionsEarly-onset IBM is a severe disease, causing progressive muscle weakness, high muscle mitochondrial DNA mutation load and a reduced cumulative survival in young and middle-aged individuals.
C1 [Lindgren, Ulrika; Hedberg-Oldfors, Carola; Oldfors, Anders] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden.
   [Lindgren, Ulrika; Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
   [Pullerits, Rille] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.
   [Pullerits, Rille] Sahlgrens Univ Hosp, Dept Clin Immunol & Transfus Med, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital
RP Lindgren, U (corresponding author), Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden.; Lindgren, U (corresponding author), Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
EM ulrika.lindgren@gu.se
CR Alamr M, 2022, MUSCLE NERVE, V66, P686, DOI 10.1002/mus.27716
   Askanas Valerie, 2011, PRESSE MED, V40, Pe219, DOI 10.1016/j.lpm.2010.11.024
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Carpenter S, 1975, RECENT ADV MYOLOGY, V0, P374
   Danckert B, 2019, NORDCAN: CANCER INCIDENCE, V0, P0
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Dobloug GC, 2015, EUROPEAN JOURNAL OF NEUROLOGY, V22, P672, DOI 10.1111/ene.12627
   Dobloug GC, 2015, SEMIN ARTHRITIS RHEU, V45, P301, DOI 10.1016/j.semarthrit.2015.06.005
   Dubowitz V, 2021, MUSCLE BIOPSY A PRAC, V0, P0
   Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002
   Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017
   Felice KJ, 2001, MEDICINE, V80, P320, DOI 10.1097/00005792-200109000-00006
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Jeppesen TD, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.547638
   Lindberg C, 2012, ACTA NEUROL SCAND, V125, P353, DOI 10.1111/j.1600-0404.2011.01584.x
   Lindgren S, 1991, DYSPHAGIA, V6, P187
   Lindgren U, 2022, ANN NEUROL, V92, P201, DOI 10.1002/ana.26412
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   Michelle EH, 2023, NEUROLOGY, V100, PE1406, DOI 10.1212/WNL.0000000000206777
   Naddaf E, 2022, RHEUMATOLOGY, V61, P2016, DOI 10.1093/rheumatology/keab716
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Richards Sue, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Shelly S, 2021, NEUROLOGY, V96, PE2653, DOI 10.1212/WNL.0000000000012004
NR 30
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD NOV 15
PY 2023
VL 270
IS 11
BP 5483
EP 5492
DI 10.1007/s00415-023-11878-w
EA JUL 2023
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA W0FA5
UT WOS:001034417500001
PM 37498322
DA 2024-11-01
ER

PT J
AU Miyahara, H
   Tamai, C
   Inoue, M
   Sekiguchi, K
   Tahara, D
   Tahara, N
   Takeda, K
   Arafuka, S
   Moriyoshi, H
   Koizumi, R
   Akagi, A
   Riku, Y
   Sone, J
   Yoshida, M
   Ihara, K
   Iwasaki, Y
AF Miyahara, Hiroaki
   Tamai, Chisato
   Inoue, Masanori
   Sekiguchi, Kazuhito
   Tahara, Daisuke
   Tahara, Nao
   Takeda, Kazuhiro
   Arafuka, Shusei
   Moriyoshi, Hideyuki
   Koizumi, Ryuichi
   Akagi, Akio
   Riku, Yuichi
   Sone, Jun
   Yoshida, Mari
   Ihara, Kenji
   Iwasaki, Yasushi
TI Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G mutation
SO BRAIN PATHOLOGY
LA English
DT Article
DE choroidal epithelial cell swelling; MELAS; mitochondrial 3243A>G mutation; mitochondrial vasculopathy; mtDNA heteroplasmy; stroke-like episodes
ID stroke-like episodes; growth-factor 21; dna; melas; pathogenesis; biomarker; fgf-21; health
AB The mitochondrial (m.) 3243A>G mutation is known to be associated with various mitochondrial diseases including mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Their clinical symptoms have been estimated to occur with an increased mitochondrial DNA (mtDNA) heteroplasmy and reduced activity of oxidative phosphorylation (OXPHOS) complexes, but their trends in the central nervous system remain unknown. Six autopsied mutant cases and three disease control cases without the mutation were enrolled in this study. The mutant cases had a disease duration of 1-27 years. Five of six mutant cases were compatible with MELAS. In the mutant cases, cortical lesions including a laminar necrosis were frequently observed in the parietal, lateral temporal, and occipital lobes; less frequently in the frontal lobe including precentral gyrus; and not at all in the medial temporal lobe. The mtDNA heteroplasmy in brain tissue samples of the mutant cases was strikingly high, ranging from 53.8% to 85.2%. The medial temporal lobe was preserved despite an inhospitable environment having high levels of mtDNA heteroplasmy and lactic acid. OXPHOS complex I was widely decreased in the mutant cases. The swelling of smooth muscle cells in the vessels on the leptomeninges, with immunoreactivity (IR) against mitochondria antibody, and a decreased nuclear/cytoplasmic ratio of choroidal epithelial cells were observed in all mutant cases but in none without the mutation. Common neuropathological findings such as cortical laminar necrosis and basal ganglia calcification were not always observed in the mutant cases. A high level of mtDNA heteroplasmy was observed throughout the brain in spite of heterogeneous cortical lesions. A lack of medial temporal lesion, mitochondrial vasculopathy in vessels on the leptomeninges, and an increased cytoplasmic size of epithelial cells in the choroid plexus could be neuropathological hallmarks helpful in the diagnosis of mitochondrial diseases.
C1 [Miyahara, Hiroaki; Tamai, Chisato; Tahara, Daisuke; Tahara, Nao; Takeda, Kazuhiro; Arafuka, Shusei; Moriyoshi, Hideyuki; Koizumi, Ryuichi; Akagi, Akio; Riku, Yuichi; Sone, Jun; Yoshida, Mari; Iwasaki, Yasushi] Aichi Med Univ, Inst Med Res Aging, Dept Neuropathol, Nagakute, Aichi, Japan.
   [Inoue, Masanori; Sekiguchi, Kazuhito; Ihara, Kenji] Oita Univ, Dept Pediat, Fac Med, Oita, Japan.
   [Miyahara, Hiroaki] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.
C3 Aichi Medical University; Oita University; Aichi Medical University
RP Miyahara, H (corresponding author), Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.
EM miyahara.hiroaki.926@mail.aichi-med-u.ac.jp
CR Almudares F, 2023, PEDIATR PULM, V58, P271, DOI 10.1002/ppul.26197
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Cheng XB, 2011, ENDOCR RES, V36, P142, DOI 10.3109/07435800.2011.558550
   Clark BJ, 2013, CRIT CARE, V17, P0, DOI 10.1186/cc12737
   Conte M, 2022, AGEING RES REV, V75, P0, DOI 10.1016/j.arr.2022.101569
   Feigenbaum A, 1996, AM J MED GENET, V62, P404, DOI 10.1002/(SICI)1096-8628(19960424)62:4<404::AID-AJMG14>3.0.CO;2-S
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Hirano M, 2020, NEUROPATHOLOGY, V40, P515, DOI 10.1111/neup.12668
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Kawahara Y, 2020, HELICOBACTER, V25, P0, DOI 10.1111/hel.12732
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Koga Y, 2021, J INHERIT METAB DIS, V44, P358, DOI 10.1002/jimd.12317
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Koga Yasutoshi, 2008, RINSHO SHINKEIGAKU, V48, P1010
   Kralisch S, 2011, CURR OPIN CLIN NUTR, V14, P354, DOI 10.1097/MCO.0b013e328346a326
   Love Seth, 2014, AM J NEURODEGENER DIS, V3, P19
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
   Nishiuchi M, 2018, BIOSCI BIOTECH BIOCH, V82, P2168, DOI 10.1080/09168451.2018.1516543
   Nishiumi S, 2017, ONCOTARGET, V8, P17115, DOI 10.18632/oncotarget.15081
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Pang CY, 2001, DIABETES RES CLIN PR, V54, PS45, DOI 10.1016/S0168-8227(01)00335-7
   Phadwal K, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.611922
   Riley LG, 2022, MOL GENET METAB, V135, P63, DOI 10.1016/j.ymgme.2021.12.001
   Rochette L, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22168889
   Rochette L, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165798
   Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911
   Scholle LM, 2018, CURR MED CHEM, V25, P2070, DOI 10.2174/0929867325666180111094336
   Sekiguchi K, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13093026
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Xie T, 2017, AM J PHYSIOL-ENDOC M, V313, PE292, DOI 10.1152/ajpendo.00101.2017
NR 39
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD NOV 15
PY 2023
VL 33
IS 6
BP 
EP 
DI 10.1111/bpa.13199
EA AUG 2023
PG 11
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA U7RU1
UT WOS:001039828700001
PM 37534760
DA 2024-11-01
ER

PT J
AU Erdinc, D
   Macao, B
   Valenzuela, S
   Lesko, N
   Naess, K
   Peter, B
   Bruhn, H
   Wedell, A
   Wredenberg, A
   Falkenberg, M
AF Erdinc, Direnis
   Macao, Bertil
   Valenzuela, Sebastian
   Lesko, Nicole
   Naess, Karin
   Peter, Bradley
   Bruhn, Helene
   Wedell, Anna
   Wredenberg, Anna
   Falkenberg, Maria
TI The disease-causing mutation p.F907I reveals a novel pathogenic mechanism for POL?-related diseases
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE DNA polymerase & gamma;; TWINKLE helicase; mtDNA; Mitochondrial replication; Disease
ID dna-polymerase-gamma; mitochondrial rna-polymerase; replication; maintenance; stability; subunit; binding
AB Mutations in the catalytic domain of mitochondrial DNA polymerase ? (POL?) cause a broad spectrum of clinical conditions. POL? mutations impair mitochondrial DNA replication, thereby causing deletions and/or depletion of mitochondrial DNA, which in turn impair biogenesis of the oxidative phosphorylation system. We here identify a patient with a homozygous p.F907I mutation in POL?, manifesting a severe clinical phenotype with develop-mental arrest and rapid loss of skills from 18 months of age. Magnetic resonance imaging of the brain revealed extensive white matter abnormalities, Southern blot of muscle mtDNA demonstrated depletion of mtDNA and the patient deceased at 23 months of age. Interestingly, the p.F907I mutation does not affect POL? activity on single-stranded DNA or its proofreading activity. Instead, the mutation affects unwinding of parental double-stranded DNA at the replication fork, impairing the ability of the POL? to support leading-strand DNA synthesis with the TWINKLE helicase. Our results thus reveal a novel pathogenic mechanism for POL?-related diseases.
C1 [Erdinc, Direnis; Macao, Bertil; Valenzuela, Sebastian; Peter, Bradley; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.
   [Lesko, Nicole; Naess, Karin; Bruhn, Helene; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.
   [Wedell, Anna; Wredenberg, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Lesko, Nicole; Naess, Karin; Bruhn, Helene; Wedell, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
C3 University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital
RP Falkenberg, M (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden.; Wredenberg, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.
EM anna.wredenberg@ki.se; maria.falkenberg@medkem.gu.se
FU Swedish Research Council [2021-00932, 2020.0228]; Wallenberg Clinical Scholar [NNF18OC0032200]; NovoNordisk Foundation [KAW2019.0109]; Knut and Alice Wallenberg Foundation [2017.0080, 2018.0204]; Wallenberg Scholar [ALFGBG-965954]; Swedish Cancer Foundation; IngaBritt and Arne Lundberg Research Foundation; Vastra Gotalandsregionen;  [2016-02179]; Swedish Research Council [2021-00932] Funding Source: Swedish Research Council
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Darin N, 2021, NEUROMUSCULAR DISORD, V31, P348, DOI 10.1016/j.nmd.2021.01.004
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Foster BM, 2019, BIOCHEMISTRY-US, V58, P4466, DOI 10.1021/acs.biochem.9b00525
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000391
   Hikmat O, 2019, GENET MED, V21, P1027, DOI 10.1038/s41436-018-0098-1
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v
   Meng EC, 2006, BMC BIOINFORMATICS, V7, P0, DOI 10.1186/1471-2105-7-339
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Qian YF, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00135
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Siibak T, 2017, HUM MOL GENET, V26, P2515, DOI 10.1093/hmg/ddx146
   Silva-Pinheiro P, 2021, NUCLEIC ACIDS RES, V49, P5230, DOI 10.1093/nar/gkab282
   Stranneheim H, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-1090
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524
NR 32
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD OCT 15
PY 2023
VL 1869
IS 7
BP 
EP 
DI 10.1016/j.bbadis.2023.166786
EA JUN 2023
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA Q9WA8
UT WOS:001060935900001
PM 37302426
DA 2024-11-01
ER

PT J
AU Sadeesh, EM
   Singla, N
   Lahamge, MS
   Kumari, S
   Ampadi, AN
   Anuj, M
AF Sadeesh, E. M.
   Singla, Nancy
   Lahamge, Madhuri S.
   Kumari, Sweta
   Ampadi, A. N.
   Anuj, M.
TI Tissue heterogeneity of mitochondrial activity, biogenesis and mitochondrial protein gene expression in buffalo
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Buffalo; Tissue-specific; Mitochondria; OXPHOS complexes; Mitochondria protein coding gene
ID dna copy number; liver mitochondrial; dysfunction; mechanisms; disease; catfish; muscle
AB BackgroundCellular metabolism is most invariant process, occurring in all living organisms, which involves mitochondrial proteins from both nuclear and mitochondrial genomes. The mitochondrial DNA (mtDNA) copy number, protein-coding genes (mtPCGs) expression, and activity vary between various tissues to fulfill specific energy demands across the tissues.Methods and ResultsIn present study, we investigated the OXPHOS complexes and citrate synthase activity in isolated mitochondria from various tissues of freshly slaughtered buffaloes (n = 3). Further, the evaluation of tissue-specific diversity based on the quantification of mtDNA copy numbers was performed and also comprised an expression study of 13 mtPCGs. We found that the functional activity of individual OXPHOS complex I was significantly higher in the liver compared to muscle and brain. Additionally, OXPHOS complex III and V activities was observed significantly higher levels in liver compared to heart, ovary, and brain. Similarly, CS-specific activity differs between tissues, with the ovary, kidney, and liver having significantly greater. Furthermore, we revealed the mtDNA copy number was strictly tissue-specific, with muscle and brain tissues exhibiting the highest levels. Among 13 PCGs expression analyses, mRNA abundances in all genes were differentially expressed among the different tissue.ConclusionsOverall, our results indicate the existence of a tissue-specific variation in mitochondrial activity, bioenergetics, and mtPCGs expression among various types of buffalo tissues. This study serves as a critical first stage in gathering vital comparable data about the physiological function of mitochondria in energy metabolism in distinct tissues, laying the groundwork for future mitochondrial based diagnosis and research.
C1 [Sadeesh, E. M.; Singla, Nancy; Lahamge, Madhuri S.; Kumari, Sweta; Ampadi, A. N.; Anuj, M.] ICAR Natl Dairy Res Inst, Anim Biochem Div, Lab Mitochondrial Biol Farm Anim, Karnal, Haryana, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute
RP Sadeesh, EM (corresponding author), ICAR Natl Dairy Res Inst, Anim Biochem Div, Lab Mitochondrial Biol Farm Anim, Karnal, Haryana, India.
EM sadeeshcirb@gmail.com
CR 20th Livestock census, 2019, ALL INDIA REPORT, V0, P0
   Al-Kafaji G, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/754946
   Alex AP, 2015, J DAIRY SCI, V98, P4439, DOI 10.3168/jds.2014-8917
   Annesley SJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070680
   Basu U, 2020, J BIOL CHEM, V295, P18406, DOI 10.1074/jbc.REV120.011202
   Benard G, 2006, AM J PHYSIOL-CELL PH, V291, PC1172, DOI 10.1152/ajpcell.00195.2006
   Bujan N, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11040741
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013
   Dorji J, 2020, BMC GENOMICS, V21, P0, DOI 10.1186/s12864-020-07018-7
   Eigentler A, 2020, MITOCHONDRIAL PHYSIOL NETW, V17, P1
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Fukunaga H, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126634
   Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003
   Gureev AP, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00435
   Hebert JF, 2021, BBA-MOL BASIS DIS, V1867, P0, DOI 10.1016/j.bbadis.2020.165967
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Hood WR, 2018, INTEGR COMP BIOL, V58, P480, DOI 10.1093/icb/icy089
   Jezek P, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10121921
   Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, PC698, DOI 10.1152/ajpcell.00109.2006
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kennedy KM, 2021, J DAIRY SCI, V104, P9287, DOI 10.3168/jds.2020-20031
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Laubenthal L, 2016, J DAIRY SCI, V99, P1571, DOI 10.3168/jds.2015-9847
   Lee JY, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/586017
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x
   Marí M, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10020314
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Protasoni M, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019102817
   Qu B, 2012, ACTA HISTOCHEM, V114, P448, DOI 10.1016/j.acthis.2011.08.007
   Ramanathan R, 2021, MEAT AND MUSCLE BIOLOGY, V5, P0, DOI 10.22175/MMB.11705
   Sanglard LP, 2022, J ANIM SCI, V100, P0, DOI 10.1093/jas/skac059
   Spehar Marija, 2017, AGRICULTURAE CONSPECTUS SCIENTIFICUS, V82, P263
   Uittenbogaard M, 2014, CURR PHARM DESIGN, V20, P5574, DOI 10.2174/1381612820666140305224906
   Vaughan OR, 2016, REPROD DOMEST ANIM, V51, P25, DOI 10.1111/rda.12797
   Vuda M, 2016, MITOCHONDRION, V31, P63, DOI 10.1016/j.mito.2016.10.005
   Weikard R, 2018, MOL BIOL REP, V45, P1209, DOI 10.1007/s11033-018-4273-x
   Yan YL, 2015, COMP BIOCHEM PHYS A, V183, P64, DOI 10.1016/j.cbpa.2014.12.011
   Yan YL, 2011, CURR ZOOL, V57, P109, DOI 10.1093/czoolo/57.1.109
NR 47
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JUN 15
PY 2023
VL 50
IS 6
BP 5255
EP 5266
DI 10.1007/s11033-023-08416-2
EA MAY 2023
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA F8W6Y
UT WOS:000980316900001
PM 37140692
DA 2024-11-01
ER

PT J
AU Gupta, R
   Kanai, M
   Durham, TJ
   Tsuo, K
   McCoy, JG
   Kotrys, AV
   Zhou, W
   Chinnery, PF
   Karczewski, KJ
   Calvo, SE
   Neale, BM
   Mootha, VK
AF Gupta, Rahul
   Kanai, Masahiro
   Durham, Timothy J.
   Tsuo, Kristin
   McCoy, Jason G.
   Kotrys, Anna V.
   Zhou, Wei
   Chinnery, Patrick F.
   Karczewski, Konrad J.
   Calvo, Sarah E.
   Neale, Benjamin M.
   Mootha, Vamsi K.
TI Nuclear genetic control of mtDNA copy number and heteroplasmy in humans
SO NATURE
LA English
DT Article
ID mitochondrial-dna; control region; association; mutations; sequence; tissue; variant; muscle; rna; heritability
AB Mitochondrial DNA (mtDNA) is a maternally inherited, high-copy-number genome required for oxidative phosphorylation(1). Heteroplasmy refers to the presence of a mixture of mtDNA alleles in an individual and has been associated with disease and ageing. Mechanisms underlying common variation in human heteroplasmy, and the influence of the nuclear genome on this variation, remain insufficiently explored. Here we quantify mtDNA copy number (mtCN) and heteroplasmy using blood-derived whole-genome sequences from 274,832 individuals and perform genome-wide association studies to identify associated nuclear loci. Following blood cell composition correction, we find that mtCN declines linearly with age and is associated with variants at 92 nuclear loci. We observe that nearly everyone harbours heteroplasmic mtDNA variants obeying two principles: (1) heteroplasmic single nucleotide variants tend to arise somatically and accumulate sharply after the age of 70 years, whereas (2) heteroplasmic indels are maternally inherited as mixtures with relative levels associated with 42 nuclear loci involved in mtDNA replication, maintenance and novel pathways. These loci may act by conferring a replicative advantage to certain mtDNA alleles. As an illustrative example, we identify a length variant carried by more than 50% of humans at position chrM:302 within a G-quadruplex previously proposed to mediate mtDNA transcription/replication switching(2,3). We find that this variant exerts cis-acting genetic control over mtDNA abundance and is itself associated in-trans with nuclear loci encoding machinery for this regulatory switch. Our study suggests that common variation in the nuclear genome can shape variation in mtCN and heteroplasmy dynamics across the human population.
C1 [Gupta, Rahul; Durham, Timothy J.; McCoy, Jason G.; Kotrys, Anna V.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.
   [Gupta, Rahul; Durham, Timothy J.; McCoy, Jason G.; Kotrys, Anna V.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Gupta, Rahul; Kanai, Masahiro; Durham, Timothy J.; Tsuo, Kristin; McCoy, Jason G.; Kotrys, Anna V.; Zhou, Wei; Karczewski, Konrad J.; Calvo, Sarah E.; Neale, Benjamin M.; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Gupta, Rahul; Kanai, Masahiro; Tsuo, Kristin; Zhou, Wei; Karczewski, Konrad J.; Neale, Benjamin M.] Massachusetts Gen Hosp, Ctr Genom Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
C3 Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Cambridge; University of Cambridge; Harvard University; Harvard Medical School
RP Gupta, R; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Gupta, R; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Gupta, R; Neale, BM; Mootha, VK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Gupta, R; Neale, BM (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
EM rahul_gupta@hms.harvard.edu; bneale@broadinstitute.org; vamsi_mootha@hms.harvard.edu
FU National Institutes of Health; Novo Nordisk Foundation; Jane Coffin Childs Memorial Fund for Medical Research fellowship; Wellcome Trust [5R35GM122455, 5R37MH107649, 5R01MH101244, 5F30AG074507, K99HG012222]; UK NIHR [NNF21SA0072102]; Medical Research Council (MRC) Mitochondrial Biology Unit; MRC International Centre for Genomic Medicine in Neuromuscular Disease [212219/Z/18/Z]; Leverhulme Trust; MRC [MC_UU_00028/7]; Alzheimer's Society Project Grant [MR/S005021/1]; NIHR Cambridge Biomedical Research Centre [RPG-2018-408]; National Institutes of Health, Office of the Director [MR/S035699/1];  [AS-PG-18b-022];  [BRC-1215-20014];  [1 OT2 OD026549];  [1 OT2 OD026554];  [1 OT2 OD026557];  [1 OT2 OD026556];  [1 OT2 OD026550];  [1 OT2 OD 026552];  [1 OT2 OD026553];  [1 OT2 OD026548];  [1 OT2 OD026551];  [1 OT2 OD026555];  [AOD 16037];  [HHSN 263201600085U];  [5 U2C OD023196];  [1 U24 OD023121];  [U24 OD023176];  [1 U24 OD023163];  [3 OT2 OD023205];  [3 OT2 OD023206];  [1 OT2 OD025277];  [3 OT2 OD025315];  [1 OT2 OD025337];  [1 OT2 OD025276]
CR Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776
   All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Binder JX, 2014, DATABASE-OXFORD, V0, P0, DOI DOI 10.1093/database/bau012
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Byrska-Bishop M, 2022, CELL, V185, P3426, DOI 10.1016/j.cell.2022.08.004
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-S4-S15
   CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0
   Chong MR, 2022, NEUROLOGY, V98, PE470, DOI 10.1212/WNL.0000000000013165
   COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616
   Cui R, 2022, BIORXIV, V0, P0, DOI DOI 10.1101/2022.10.21.513123
   Danecek P, 2021, GIGASCIENCE, V10, P0, DOI 10.1093/gigascience/giab008
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   de Bakker PIW, 2008, HUM MOL GENET, V17, PR122, DOI 10.1093/hmg/ddn288
   Deming WE, 1943, STAT ADJUSTMENT DATA, V0, P0
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Falah M, 2017, CLIN INTERV AGING, V12, P459, DOI 10.2147/CIA.S123278
   Falkenberg M, 2020, CRIT REV BIOCHEM MOL, V55, P509, DOI 10.1080/10409238.2020.1818684
   Fazzini F, 2021, J INTERN MED, V290, P190, DOI 10.1111/joim.13242
   Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4
   Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404
   Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954
   Gopal RK, 2018, P NATL ACAD SCI USA, V115, PE6283, DOI 10.1073/pnas.1711888115
   Gupta R, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.68610
   Hägg S, 2021, HUM GENET, V140, P849, DOI 10.1007/s00439-020-02249-w
   Halldorsson BV, 2022, NATURE, V607, P732, DOI 10.1038/s41586-022-04965-x
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003
   Hurtado-Roca Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163770
   Kanai M, 2021, PREPRINT, V0, P0, DOI DOI 10.1101/2021.09.03.21262975
   Kanai M, 2022, CELL GENOM, V2, P0, DOI 10.1016/j.xgen.2022.100210
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Karczewski KJ, 2022, CELL GENOM, V2, P0, DOI 10.1016/j.xgen.2022.100168
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kerimov N, 2021, NAT GENET, V53, P1290, DOI 10.1038/s41588-021-00924-w
   Laricchia KM, 2022, GENOME RES, V32, P569, DOI 10.1101/gr.276013.121
   Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li MK, 2012, NUCLEIC ACIDS RES, V40, P0, DOI 10.1093/nar/gks499
   Liu YW, 2020, J AM STAT ASSOC, V115, P393, DOI 10.1080/01621459.2018.1554485
   Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071
   Longchamps RJ, 2022, HUM GENET, V141, P127, DOI 10.1007/s00439-021-02394-w
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354
   Marchington DR, 1997, AM J HUM GENET, V60, P408
   McLaren W, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0974-4
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Pan-UKB team, 2020, PAN UK BIOB, V0, P0
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Ratnaike TE, 2021, NUCLEIC ACIDS RES, V49, P9686, DOI 10.1093/nar/gkab726
   Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993
   Sanchez MIGL, 2021, AM J HUM GENET, V108, P2159, DOI 10.1016/j.ajhg.2021.09.015
   Sang Y, 2022, MOL THER, V30, P2844, DOI 10.1016/j.ymthe.2022.04.012
   Sherry ST, 1999, GENOME RES, V9, P677
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Sudlow C, 2015, PLOS MED, V12, P0, DOI 10.1371/journal.pmed.1001779
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Tan BG, 2016, NUCLEIC ACIDS RES, V44, P7817, DOI 10.1093/nar/gkw648
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Venables WN, 2002, MODERN APPL STAT S, V0, P0, DOI DOI 10.1007/978-0-387-21706-2
   VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang G, 2020, J R STAT SOC B, V82, P1273, DOI 10.1111/rssb.12388
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107
   Wei W, 2022, NATURE, V611, P105, DOI 10.1038/s41586-022-05288-7
   Weissensteiner H, 2021, GENOME RES, V31, P309, DOI 10.1101/gr.256545.119
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW58, DOI 10.1093/nar/gkw233
   Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029
   Yang SY, 2021, GENOME RES, V31, P349, DOI 10.1101/gr.269381.120
   Zhou W, 2022, CELL GENOM, V2, P0, DOI 10.1016/j.xgen.2022.100192
   Zhou W, 2022, NAT GENET, V54, P1466, DOI 10.1038/s41588-022-01178-w
   Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y
NR 88
TC 39
Z9 43
U1 5
U2 29
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD AUG 15
PY 2023
VL 620
IS 7975
BP 
EP 
DI 10.1038/s41586-023-06426-5
EA AUG 2023
PG 33
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO5S6
UT WOS:001049978000003
PM 37587338
DA 2024-11-01
ER

PT J
AU Ikonen, L
   Pirnes-Karhu, S
   Pradhan, S
   Jacobs, HT
   Szibor, M
   Suomalainen, A
AF Ikonen, Lilli
   Pirnes-Karhu, Sini
   Pradhan, Swagat
   Jacobs, Howard T.
   Szibor, Marten
   Suomalainen, Anu
TI Alternative oxidase causes cell type- and tissue-specific responses in mutator mice
SO LIFE SCIENCE ALLIANCE
LA English
DT Article
ID skeletal-muscle; stress responses; mitochondria; expression; defects; understand; activation; mutations; deletions; pathway
AB Energetic insufficiency, excess production of reactive oxygen species (ROS), and aberrant signaling partially account for the diverse pathology of mitochondrial diseases. Whether interventions affecting ROS, a regulator of stem cell pools, could modify somatic stem cell homeostasis remains unknown. Previous data from mitochondrial DNA mutator mice showed that increased ROS leads to oxidative damage in erythroid progenitors, causing lifespan-limiting anemia. Also unclear is how ROStargeted interventions affect terminally differentiated tissues. Here, we set out to test in mitochondrial DNA mutator mice how ubiquitous expression of the Ciona intestinalis alternative oxidase (AOX), which attenuates ROS production, affects murine stem cell pools. We found that AOX does not affect neural stem cells but delays the progression of mutator-driven anemia. Furthermore, when combined with the mutator, AOX potentiates mitochondrial stress and inflammatory responses in skeletal muscle. These differential cell type-specific findings demonstrate that AOX expression is not a global panacea for curing mitochondrial dysfunction. ROS attenuation must be carefully studied regarding specific underlying defects before AOX can be safely used in therapy.
C1 [Ikonen, Lilli; Pradhan, Swagat; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, Helsinki, Finland.
   [Pirnes-Karhu, Sini] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland.
   [Jacobs, Howard T.; Szibor, Marten] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.
   [Szibor, Marten] Friedrich Schiller Univ Jena, Jena Univ Hosp, Ctr Sepsis Control & Care, Dept Cardiothorac Surg, Jena, Germany.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Tampere University; Friedrich Schiller University of Jena; University of Helsinki; Helsinki University Central Hospital
RP Ikonen, L; Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, HUSLAB, Helsinki, Finland.
EM lilli.ikonen@helsinki.fi; anu.wartiovaara@helsinki.fi
FU Biomedicum Helsinki Foundation; Finnish Medical Foundation; Academy of Finland; Sigrid Juselius Foundation; University of Helsinki; European Research Council; Bio-center Finland
CR Aarreberg LD, 2019, MOL CELL, V74, P801, DOI 10.1016/j.molcel.2019.02.038
   Abdel-Nour M, 2019, SCIENCE, V365, P47, DOI 10.1126/science.aaw4144
   Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657
   Ahlqvist KJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7494
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   AZZARELLO G, 1987, J CANCER RES CLIN, V113, P417, DOI 10.1007/BF00390035
   Bloemberg D, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035273
   Cannino G, 2012, J BIOL CHEM, V287, P38729, DOI 10.1074/jbc.M112.386060
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chin AC, 2019, J NEUROPHYSIOL, V121, P1087, DOI 10.1152/jn.00848.2018
   Cláudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80
   Coleman V, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20901-4
   Dassa EP, 2009, PHYSIOL PLANTARUM, V137, P427, DOI 10.1111/j.1399-3054.2009.01248.x
   Dhandapani PK, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-49231-9
   Dhandapani PK, 2019, PHYSIOL REP, V7, P0, DOI 10.14814/phy2.14159
   DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   El-Khoury R, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003182
   Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Fessler E, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-29479-y
   Giordano L, 2019, AM J RESP CELL MOL, V60, P515, DOI 10.1165/rcmb.2018-0261OC
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Hämäläinen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009
   Jones TR, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-482
   Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x
   Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lei YJ, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abe7548
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768
   Mayer-Barber KD, 2017, CELL MOL IMMUNOL, V14, P22, DOI 10.1038/cmi.2016.25
   McQuin C, 2018, PLOS BIOL, V16, P0, DOI 10.1371/journal.pbio.2005970
   Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064
   Mito T, 2022, CELL METAB, V34, P197, DOI 10.1016/j.cmet.2021.12.017
   Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1
   Newman LE, 2018, J CELL BIOL, V217, P3327, DOI 10.1083/jcb.201808118
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Pierre P, 2019, SCIENCE, V365, P28, DOI 10.1126/science.aay0987
   Piltti K, 2006, ONCOGENE, V25, P4880, DOI 10.1038/sj.onc.1209492
   Rajendran J, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809456
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107
   Rustin P, 2009, PHYSIOL PLANTARUM, V137, P362, DOI 10.1111/j.1399-3054.2009.01249.x
   SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810
   Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Szibor M, 2020, BBA-BIOENERGETICS, V1861, P0, DOI 10.1016/j.bbabio.2019.148137
   Szibor M, 2017, DIS MODEL MECH, V10, P163, DOI 10.1242/dmm.027839
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yi YS, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22147580
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
NR 66
TC 1
Z9 1
U1 0
U2 0
PU LIFE SCIENCE ALLIANCE LLC
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 
EI 2575-1077
J9 LIFE SCI ALLIANCE
JI Life Sci. Alliance
PD NOV 15
PY 2023
VL 6
IS 11
BP 
EP 
DI 10.26508/lsa.202302036
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA Y9VL9
UT WOS:001108664200009
PM 37657934
DA 2024-11-01
ER

PT J
AU Scarcella, S
   Dell'Arti, L
   Gagliardi, D
   Magri, F
   Govoni, A
   Velardo, D
   Mainetti, C
   Minorini, V
   Ronchi, D
   Piga, D
   Comi, GP
   Corti, S
   Meneri, M
AF Scarcella, Simone
   Dell'Arti, Laura
   Gagliardi, Delia
   Magri, Francesca
   Govoni, Alessandra
   Velardo, Daniele
   Mainetti, Claudia
   Minorini, Valeria
   Ronchi, Dario
   Piga, Daniela
   Comi, Giacomo Pietro
   Corti, Stefania
   Meneri, Megi
TI Ischemic optic neuropathy as first presentation in patient with m.3243 A &gt; G MELAS classic mutation
SO BMC NEUROLOGY
LA English
DT Article
DE Optic neuropathy; Mitochondrial disease; MELAS; Stroke-like episodes; NAION
ID lactic-acidosis; mitochondrial
AB BackgroundMitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a systemic disorder in which multi-organ dysfunction may occur from mitochondrial metabolism failure. Maternally inherited mutations in the MT-TL1 gene are the most frequent causes for this disorder. Clinical manifestations may include stroke-like episodes, epilepsy, dementia, headache and myopathy. Among these, acute visual failure, usually in association with cortical blindness, can occur because of stroke-like episodes affecting the occipital cortex or the visual pathways. Vision loss due to optic neuropathy is otherwise considered a typical manifestation of other mitochondrial diseases such as Leber hereditary optic neuropathy (LHON).Case presentationHere we describe a 55-year-old woman, sister of a previously described patient with MELAS harbouring the m.3243A > G (p.0, MT-TL1) mutation, with otherwise unremarkable medical history, that presented with subacute, painful visual impairment of one eye, accompanied by proximal muscular pain and headache. Over the next weeks, she developed severe and progressive vision loss limited to one eye. Ocular examination confirmed unilateral swelling of the optic nerve head; fluorescein angiography showed segmental perfusion delay in the optic disc and papillary leakage. Neuroimaging, blood and CSF examination and temporal artery biopsy ruled out neuroinflammatory disorders and giant cell arteritis (GCA). Mitochondrial sequencing analysis confirmed the m.3243A > G transition, and excluded the three most common LHON mutations, as well as the m.3376G > A LHON/MELAS overlap syndrome mutation. Based on the constellation of clinical symptoms and signs presented in our patient, including the muscular involvement, and the results of the investigations, the diagnosis of optic neuropathy as a stroke-like event affecting the optic disc was performed. L-arginine and ubidecarenone therapies were started with the aim to improve stroke-like episode symptoms and prevention. The visual defect remained stable with no further progression or outbreak of new symptoms.ConclusionsAtypical clinical presentations must be always considered in mitochondrial disorders, even in well-described phenotypes and when mutational load in peripheral tissue is low. Mitotic segregation of mitochondrial DNA (mtDNA) does not allow to know the exact degree of heteroplasmy existent within different tissue, such as retina and optic nerve. Important therapeutic implications arise from a correct diagnosis of atypical presentation of mitochondrial disorders.
C1 [Scarcella, Simone; Gagliardi, Delia; Govoni, Alessandra; Velardo, Daniele; Ronchi, Dario; Comi, Giacomo Pietro; Corti, Stefania; Meneri, Megi] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat DEPT, Neurosci Sect, Via Francesco Sforza 35, I-20122 Milan, Italy.
   [Scarcella, Simone; Gagliardi, Delia; Piga, Daniela; Corti, Stefania; Meneri, Megi] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Dell'Arti, Laura; Minorini, Valeria] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ophthalmol Unit, Milan, Italy.
   [Magri, Francesca; Mainetti, Claudia; Ronchi, Dario; Comi, Giacomo Pietro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, I-20122 Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Meneri, M (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat DEPT, Neurosci Sect, Via Francesco Sforza 35, I-20122 Milan, Italy.; Meneri, M (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
EM megi.meneri@unimi.it
FU Universita degli Studi di Milano within the CRUI-CARE Agreement; Italian Ministry of Health (Ministero della Salute); Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant Ricerca Corrente 2022
CR Biousse V, 2015, NEW ENGL J MED, V372, P2428, DOI 10.1056/NEJMra1413352
   Birtel J, 2022, OPHTHALMOL RETINA, V6, P65, DOI 10.1016/j.oret.2021.02.017
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Cho KJ, 2015, CAN J OPHTHALMOL, V50, PE85, DOI 10.1016/j.jcjo.2015.05.019
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2019, J NEUROL SCI, V400, P135, DOI 10.1016/j.jns.2019.03.021
   Gagliardi D, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00038
   Kisilevsley E, 2020, SURV OPHTHALMOL, V65, P294, DOI 10.1016/j.survophthal.2019.11.001
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Mack HG, 2018, CAN J OPHTHALMOL, V53, PE208, DOI 10.1016/j.jcjo.2017.11.010
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Shinkai A, 2021, MITOCHONDRION, V56, P47, DOI 10.1016/j.mito.2020.11.003
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Tournaire-Marques E, 2020, J FR OPHTALMOL, V43, P552, DOI 10.1016/j.jfo.2019.10.020
NR 15
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD APR 24
PY 2023
VL 23
IS 1
BP 
EP 
DI 10.1186/s12883-023-03198-3
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA E9QE1
UT WOS:000978792900001
PM 37095452
DA 2024-11-01
ER

PT J
AU Almeida, CM
   Rodrigues, E
   Campos, TA
   Vilarinho, L
   Teles, EL
AF Almeida, Catarina Maria
   Rodrigues, Esmeralda
   Campos, Teresa Almeida
   Vilarinho, Laura
   Teles, Elisa Leao
TI Novel MTO1 mutations associated with an intrafamilial phenotypic variability
SO EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS
LA English
DT Article
DE Mitochondrial disease; Mitochondrial translation optimization 1; Lactic acidosis
AB BackgroundMitochondrial diseases are a group of rare inborn metabolic disorders with multi-systemic manifestations. MTO1 gene mutations are associated with MTO1 (Mitochondrial tRNA Translation Optimization 1) protein deficiency, a mitochondrial disorder, which commonly presents with lactic acidosis and hypertrophic cardiomyopathy.Case presentationThe authors describe two siblings with mitochondrial cytopathy and distinct outcomes. The index case, a female born in 1989, presented hypotonia and lactic acidosis since birth. She developed a severe myoclonic encephalopathy, movement disorder and psychomotor and growth delay. Respiratory chain enzyme complex measurement in muscle revealed a partial deficiency of complex III and IV. Throughout the years she had multiple decompensations with severe acidemia and died at age of 16, due to a respiratory infection. She never presented cardiac alterations. The younger sibling, a male born in 2002, had a less severe clinical presentation. He presented hypotonia and lactic acidosis at birth. Metabolic study performed in the first days of life revealed elevated plasma alanine and hyperlactacidemia. At 8 months of age a partial deficiency of complex IV was reported. He had a mild persistent hyperlactacidemia, psychomotor development delay, generalized hypotonia, dilated cardiomyopathy and epilepsy. In 2017, at 15 years of age, a genetic study confirmed the mitochondrial disease with identification of two MTO1 likely pathogenic variants [c.413delT (p.M138Sfs*6) / c.1450C > T (p.R484W)]. Currently, he is clinically stable, maintaining a multidisciplinary follow up. The same genotype was confirmed in his sister's stored DNA.ConclusionsWith this case, report the authors emphasize mitochondrial diseases' phenotypic heterogeneity, even in the same family, and the significance of the new genetic diagnostic techniques. The authors also report a novel MTO1 likely pathogenic variant not described to date.
C1 [Almeida, Catarina Maria; Rodrigues, Esmeralda; Campos, Teresa Almeida; Teles, Elisa Leao] Ctr Hospitalar Univ Sao Joao, Reference Ctr Inherited Metab Dis, Serv Cardiol Pediat, Inborn Errors Metab Unit, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.
   [Almeida, Catarina Maria] Ctr Hospitalar Univ Sao Joao, Pediat Cardiol Dept, Porto, Portugal.
   [Vilarinho, Laura] Inst Nacl Saude Doutor Ricardo Jorge, Human Genet Dept, Lisbon, Portugal.
C3 Instituto Nacional de Saude Dr. Ricardo Jorge
RP Almeida, CM (corresponding author), Ctr Hospitalar Univ Sao Joao, Reference Ctr Inherited Metab Dis, Serv Cardiol Pediat, Inborn Errors Metab Unit, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.; Almeida, CM (corresponding author), Ctr Hospitalar Univ Sao Joao, Pediat Cardiol Dept, Porto, Portugal.
EM catarinalmeidalmeida@live.com.pt
CR Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Martín MA, 2017, CLIN GENET, V91, P46, DOI 10.1111/cge.12815
   OByrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Saudubray JM, 2016, INBORN METABOLIC DISEASES: DIAGNOSIS AND TREATMENT, V6th, P0
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743
NR 8
TC 0
Z9 0
U1 1
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1110-8630
EI 2090-2441
J9 EGYPTIAN J MED HUMAN
JI Egypt. J. Med. Human Genet.
PD JAN 20
PY 2023
VL 24
IS 1
BP 
EP 
DI 10.1186/s43042-023-00387-0
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA 7W8JK
UT WOS:000913753500001
DA 2024-11-01
ER

PT J
AU Girard, A
   Heindl, B
   Clarkson, S
   Litovsky, S
   Ubogu, E
   Schwartzlow, C
   Tallaj, J
AF Girard, Andrew
   Heindl, Brittain
   Clarkson, Stephen
   Litovsky, Silvio
   Ubogu, Eroboghene
   Schwartzlow, Coreen
   Tallaj, Jose
TI Cardiogenic shock in a woman with a mitochondrial cardiomyopathy: a case report
SO EUROPEAN HEART JOURNAL-CASE REPORTS
LA English
DT Article
DE Mitochondrial cardiomyopathy; Mitochondrial DNA disease; Advanced heart failure; Mechanical circulatory support device; Case report
ID clinical spectrum; disease; disorders; trial
AB Background Mitochondrial cardiomyopathy (MCM) is an alteration in cardiac structure and function caused by gene mutations or deletions affecting components of the mitochondrial respiratory chain. We report a case of MCM presenting as cardiogenic shock, ultimately requiring left ventricular assist device (LVAD) placement. Case summary A 35-year-old woman with chronic weakness and non-ischaemic cardiomyopathy, on home dobutamine, was referred to our institution for heart transplantation evaluation. She was admitted to the hospital for suspected cardiogenic shock after laboratory tests revealed a lactate level of 5.4 mmol/L (ref: 0.5-2.2 mmol/L). Her hospital course was complicated by persistently undulating lactate levels (0.2-8.6 mmol/L) that increased with exertion and did not correlate with mixed venous oxygen saturation measurements obtained from a pulmonary artery catheter. Electrodiagnostic testing demonstrated a proximal appendicular and axial myopathy. A left deltoid muscle biopsy was performed that demonstrated evidence of a mitochondrial disease on light and electron microscopy. Muscle genetic testing revealed two large-scale mitochondrial deoxyribonucleic acid sequence deletions, confirming the diagnosis of MCM. She subsequently underwent LVAD placement, which was complicated by significant right ventricular failure requiring early mechanical support. She was ultimately discharged home with chronic inotropic support. Discussion Mitochondrial cardiomyopathy in adults is a diagnostic and therapeutic challenge. Prompt diagnosis should be made in patients with unknown causes of heart failure via skeletal muscle histopathology guided by electrodiagnostic studies, and targeted genetic testing in affected tissue. Outcomes in adult MCM patients who receive an LVAD are unknown and warrant further investigation.
C1 [Girard, Andrew] Univ Alabama Birmingham, Dept Med, 1720 2nd Ave S, BDB 327, Birmingham, AL 35233 USA.
   [Heindl, Brittain; Clarkson, Stephen; Tallaj, Jose] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35233 USA.
   [Litovsky, Silvio] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35233 USA.
   [Ubogu, Eroboghene; Schwartzlow, Coreen] Univ Alabama Birmingham, Dept Neurol, Div Neuromuscular Dis, Birmingham, AL 35233 USA.
C3 University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham
RP Girard, A (corresponding author), Univ Alabama Birmingham, Dept Med, 1720 2nd Ave S, BDB 327, Birmingham, AL 35233 USA.
EM aagirard@uabmc.edu
CR Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Imai-Okazaki A, 2021, INT J CARDIOL, V341, P48, DOI 10.1016/j.ijcard.2021.06.042
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Ochiai Y, 2002, CIRCULATION, V106, PI198, DOI 10.1161/01.cir.0000032906.33237.1c
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Weiner JG, 2020, J PEDIATR-US, V217, P46, DOI 10.1016/j.jpeds.2019.10.016
NR 18
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2514-2119
J9 EUR HEART J-CASE REP
JI Eur. Heart J.-Case Rep.
PD APR 10
PY 2023
VL 7
IS 4
BP 
EP 
DI 10.1093/ehjcr/ytad183
EA APR 2023
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA F0VZ8
UT WOS:000979623600004
PM 37123653
DA 2024-11-01
ER

PT J
AU Wang, W
   Zhao, YY
   Xu, XB
   Ma, XT
   Sun, Y
   Lin, Y
   Zhao, Y
   Xu, ZH
   Wang, JY
   Ren, H
   Wang, B
   Zhao, DD
   Wang, DD
   Liu, FC
   Li, W
   Yan, CZ
   Ji, KQ
AF Wang, Wei
   Zhao, Yuying
   Xu, Xuebi
   Ma, Xiaotian
   Sun, Yuan
   Lin, Yan
   Zhao, Ying
   Xu, Zhihong
   Wang, Jiayin
   Ren, Hong
   Wang, Bin
   Zhao, Dandan
   Wang, Dongdong
   Liu, Fuchen
   Li, Wei
   Yan, Chuanzhu
   Ji, Kunqian
TI A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt-ND variants
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID complex i deficiency; mitochondrial-dna; lactic-acidosis; diagnostic-criteria; chinese patients; common-cause; mutation; gene; cohort; encephalomyopathy
AB Objective: To explore the clinical characteristics of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) caused by mitochondrial DNA-encoded complex I subunit (mt-ND) variants. Methods: In this retrospective study, the clinical, myopathological and brain MRI features of patients with MELAS caused by mt-ND variants (MELAS-mtND) were collected and compared with those of MELAS patients carrying the m.3243A > G variant (MELAS-A3243G). Result: A total of 18 MELAS-mtND patients (female: 7; median age: 24.5 years) represented 15.9% (n = 113) of all patients with MELAS caused by mtDNA variants in our neuromuscular center from January 2012 to June 2022. In this MELAS-mtND cohort, the two most common variants were m.10191 T > C (4/18, 22.2%) and m.13513 G > A (3/18, 16.7%). The most frequent symptoms were seizures (14/18, 77.8%) and muscle weakness (11/18, 61.1%). Compared with 87 MELAS-A3243G patients, MELASmtND patients were significantly more likely to have a variant that was absent in blood cells (40% vs. 1.4%). Furthermore, MELAS-mtND patients had a significantly lower MDC score (7.8 +/- 2.7 vs. 9.8 +/- 1.9); less hearing loss (27.8% vs. 54.0%), diabetes (11.1% vs. 37.9%), and migraine (33.3% vs. 62.1%); less short stature (males <= 165 cm; females <= 155 cm; 23.1% vs. 60.8%) and higher body mass index (20.4 +/- 2.5 vs. 17.8 +/- 2.7). MELAS-mtND patients had significantly more normal muscle pathology (31.3% vs. 4.1%) and fewer RRFs/ RBFs (62.5% vs. 91.9%), COX-deficient fibers/blue fibers (25.0% vs. 85.1%) and SSVs (50.0% vs. 81.1%). Moreover, brain MRI evaluated at the first strokelike episode showed significantly more small cortical lesions in MELAS-mtND patients (66.7% vs. 12.2%). Interpretation: Our results suggested that MELASmtND patients have distinct clinical, myopathological and brain MRI features compared with MELAS-A3243G patients.
C1 [Wang, Wei; Zhao, Yuying; Lin, Yan; Zhao, Ying; Xu, Zhihong; Wang, Jiayin; Ren, Hong; Wang, Bin; Zhao, Dandan; Wang, Dongdong; Liu, Fuchen; Li, Wei; Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, Jinan 250012, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Ma, Xiaotian] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Med Expt Ctr, Qingdao 266035, Shandong, Peoples R China.
   [Sun, Yuan] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept neurol, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Wenzhou Medical University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University
RP Yan, CZ; Ji, KQ (corresponding author), Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM czyan@sdu.edu.cn; jikunqian@email.sdu.edu.cn
FU National Key Research and Development Program of China [2021YFC2700904]; National Natural Science Foundation of China [82171394]; Taishan Scholars Program of Shandong Province; Qingdao Key Health Discipline Development Fund
CR Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Flaquer A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0105116
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Hou Y, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0219628
   Ji KQ, 2022, NEUROLOGY, V98, P80, DOI 10.1212/WNL.0000000000013015
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Li YX, 2018, J MAGN RESON IMAGING, V47, P583, DOI 10.1002/jmri.25736
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Lin Y, 2020, MITOCHONDRION, V54, P57, DOI 10.1016/j.mito.2020.06.011
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lu YY, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116499
   Lyu JW, 2019, CHINESE MED J-PEKING, V132, P805, DOI 10.1097/CM9.0000000000000144
   Matsumoto M, 2017, NEUROMUSCULAR DISORD, V27, P1023, DOI 10.1016/j.nmd.2017.06.007
   Mick E, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.49178
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Oldfors A, 2013, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   PEARL GS, 1995, ARCH PATHOL LAB MED, V119, P303
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tatlisumak T, 2016, J NEUROL, V263, P257, DOI 10.1007/s00415-015-7969-z
   Valentino ML, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.037507
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wang W, 2021, NEUROMUSCULAR DISORD, V31, P558, DOI 10.1016/j.nmd.2021.02.020
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Xu XB, 2019, CHINESE MED J-PEKING, V132, P716, DOI 10.1097/CM9.0000000000000139
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yu HO, 2019, J NEUROL, V266, P1459, DOI 10.1007/s00415-019-09283-3
   Zhang Z, 2018, J NEUROL SCI, V385, P151, DOI 10.1016/j.jns.2017.12.033
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 48
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JUN 15
PY 2023
VL 10
IS 6
BP 1035
EP 1045
DI 10.1002/acn3.51787
EA MAY 2023
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA J2HB8
UT WOS:000994028900001
PM 37221696
DA 2024-11-01
ER

PT J
AU Latchman, K
   Saporta, M
   Moraes, CT
AF Latchman, Kumarie
   Saporta, Mario
   Moraes, Carlos T.
TI Mitochondrial dysfunction characterized in human induced pluripotent stem cell disease models in MELAS syndrome: A brief summary
SO MITOCHONDRION
LA English
DT Article
ID mutation
AB Human induced pluripotent stem cells (hiPSCs) for MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes) may allow deeper understanding of how tissue-specific mitochondrial dysfunction result in multi-systemic disease. Here, we summarize how the m.3243G mtDNA mutation affects mitochondrial function in different tissues using iPSC and iPSC-differentiated cell type disease models and what significant findings have been replicated in the independent studies. Through this brief review and with a focus on mitochondrial dysfunction in iPSC-differentiated cell types, namely fibroblast, neuron, and retinal pigment epithelium cells, we aim to bring awareness of hiPSC as a robust mitochondrial disease model even if many unanswered questions remain.
C1 [Latchman, Kumarie] Univ Miami, Dept Clin & Translat Genet, Miller Sch Med, Miami, FL 33136 USA.
   [Saporta, Mario; Moraes, Carlos T.] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL USA.
C3 University of Miami; University of Miami
RP Latchman, K (corresponding author), Univ Miami, Dept Clin & Translat Genet, Miller Sch Med, Miami, FL 33136 USA.
EM o604@med.miami.edu
CR Bhattacharya S, 2022, STEM CELL RES THER, V13, P0, DOI 10.1186/s13287-022-02937-6
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gunnewiek TMK, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107538
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Homma K, 2021, REDOX BIOL, V41, P0, DOI 10.1016/j.redox.2021.101921
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Lin DS, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8010065
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
NR 12
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2023
VL 72
IS 
BP 102
EP 105
DI 10.1016/j.mito.2023.08.003
EA AUG 2023
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA T1JR2
UT WOS:001075623200001
PM 37633406
DA 2024-11-01
ER

PT J
AU Ohwada, W
   Kouzu, H
   Sato, T
   Sazawa, K
   Matsui, A
   Nagano, N
   Koyama, M
   Ogasawara, N
   Takada, A
   Yano, T
   Furuhashi, M
AF Ohwada, Wataru
   Kouzu, Hidemichi
   Sato, Tatsuya
   Sazawa, Kahomi
   Matsui, Azumi
   Nagano, Nobutaka
   Koyama, Masayuki
   Ogasawara, Noriko
   Takada, Akifumi
   Yano, Toshiyuki
   Furuhashi, Masato
TI Case report: Transient lactate elevation by intravenous insulin infusion therapy for diabetic ketoacidosis in a patient with mitochondrial DNA 3243 A &gt; G mutation: A glycolysis rebooting syndrome?
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Article
DE mitochondrial disease; cardiomyopathy; lactate metabolism; glycolysis; diabetic ketoacidosis; case report
AB Mitochondrial disease, most cases of which are caused by mitochondrial DNA (mtDNA) mutation, is present with multiple phenotypes including diabetes mellitus, sensorineural hearing loss, cardiomyopathy, muscle weakness, renal dysfunction, and encephalopathy, depending on the degree of heteroplasmy. While mitochondria play an important role in intracellular glucose and lactate metabolism in insulin-sensitive tissues such as muscles, appropriate strategies for glycemic control have not yet been established in a patient with mitochondrial disease, which is often complicated by myopathy. Here, we describe the history of a 40-year-old man with mtDNA 3243A > G who had sensorineural hearing loss, cardiomyopathy, muscle wasting, and diabetes mellitus with stage 3 chronic kidney disease. He developed mild diabetic ketoacidosis (DKA) in the process of treatment for poor glycemic control with severe latent hypoglycemia. According to the standard therapy for DKA, he was treated with continuous intravenous insulin infusion therapy, which unexpectedly resulted in an abrupt and transient elevation in blood lactate levels without exacerbation of heart failure and kidney function. Since blood lactate levels are determined by the balance between lactate production and consumption, an abrupt and transient lactate elevation following intravenous insulin injection therapy may reflect not only enhanced glycolysis in insulin-sensitive tissues with mitochondrial dysfunction but also decreased lactate consumption in the sarcopenic skeletal muscle and failing heart. Intravenous insulin infusion therapy in patients with mitochondrial disease may unmask derangements of intracellular glucose metabolism in response to insulin signaling.
C1 [Ohwada, Wataru; Kouzu, Hidemichi; Sato, Tatsuya; Sazawa, Kahomi; Matsui, Azumi; Nagano, Nobutaka; Koyama, Masayuki; Yano, Toshiyuki; Furuhashi, Masato] Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sch Med, Sapporo, Japan.
   [Sato, Tatsuya] Sapporo Med Univ, Dept Cellular Physiol & Signal Transduct, Sch Med, Sapporo, Japan.
   [Koyama, Masayuki] Sapporo Med Univ, Dept Publ Hlth, Sch Med, Sapporo, Japan.
   [Ogasawara, Noriko] Sapporo Med Univ, Dept Microbiol, Sch Med, Sapporo, Japan.
   [Ogasawara, Noriko] Sapporo Med Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Sapporo, Japan.
   [Takada, Akifumi] Steel Mem Muroran Hosp, Dept Cardiol Diabetic Internal Med, Muroran, Japan.
C3 Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University
RP Sato, T (corresponding author), Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sch Med, Sapporo, Japan.; Sato, T (corresponding author), Sapporo Med Univ, Dept Cellular Physiol & Signal Transduct, Sch Med, Sapporo, Japan.
EM sato.tatsuya@sapmed.ac.jp
FU Sapporo Medical University
CR Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   de Boer IH, 2022, KIDNEY INT, V102, PS1, DOI 10.1016/j.kint.2022.06.008
   ElSayed NA, 2023, DIABETES CARE, V46, PS267, DOI 10.2337/dc23-S016
   Hou Y, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0219628
   Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, PE578, DOI 10.1152/ajpendo.00093.2009
   Keidai Y, 2019, J DIABETES INVEST, V10, P1116, DOI 10.1111/jdi.12992
   Legouis D, 2020, NAT METAB, V2, P732, DOI 10.1038/s42255-020-0238-1
   Li DY, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.951185
   Li XL, 2022, SIGNAL TRANSDUCT TAR, V7, P0, DOI 10.1038/s41392-022-01151-3
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Rabinowitz JD, 2020, NAT METAB, V2, P566, DOI 10.1038/s42255-020-0243-4
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Stahn A, 2014, DIABETES CARE, V37, P516, DOI 10.2337/dc13-0600
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Yeung RO, 2018, REV ENDOCR METAB DIS, V19, P35, DOI 10.1007/s11154-018-9446-3
NR 17
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
EI 
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD APR 17
PY 2023
VL 10
IS 
BP 
EP 
DI 10.3389/fcvm.2023.1144925
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA E6BG8
UT WOS:000976368800001
PM 37139126
DA 2024-11-01
ER

PT J
AU Popoiu, TA
   Dudek, J
   Maack, C
   Bertero, E
AF Popoiu, Tudor-Alexandru
   Dudek, Jan
   Maack, Christoph
   Bertero, Edoardo
TI Cardiac Involvement in Mitochondrial Disorders
SO CURRENT HEART FAILURE REPORTS
LA English
DT Article
DE Mitochondrial disease; Cardiomyopathy; Mitochondrial DNA; Cardiolipin; Electron transport chain
ID kearns-sayre syndrome; clinical-features; skeletal-muscle; leigh-syndrome; cardiolipin biosynthesis; dilated cardiomyopathy; lactic-acidosis; barth-syndrome; heart-failure; ataxia
AB Purpose of ReviewWe review pathophysiology and clinical features of mitochondrial disorders manifesting with cardiomyopathy.Recent FindingsMechanistic studies have shed light into the underpinnings of mitochondrial disorders, providing novel insights into mitochondrial physiology and identifying new therapeutic targets.Mitochondrial disorders are a group of rare genetic diseases that are caused by mutations in mitochondrial DNA (mtDNA) or in nuclear genes that are essential to mitochondrial function. The clinical picture is extremely heterogeneous, the onset can occur at any age, and virtually, any organ or tissue can be involved. Since the heart relies primarily on mitochondrial oxidative metabolism to fuel contraction and relaxation, cardiac involvement is common in mitochondrial disorders and often represents a major determinant of their prognosis.
C1 [Popoiu, Tudor-Alexandru; Dudek, Jan; Maack, Christoph; Bertero, Edoardo] Univ Clin Wurzburg, Comprehens Heart Failure Ctr, Dept Translat Res, Wurzburg, Germany.
   [Popoiu, Tudor-Alexandru] Victor Babes Univ Med & Pharm, Timisoara, Romania.
   [Bertero, Edoardo] Univ Genoa, Dept Internal Med & Specialties Di MI, Genoa, Italy.
C3 University of Wurzburg; Victor Babes University of Medicine & Pharmacy, Timisoara; University of Genoa
RP Bertero, E (corresponding author), Univ Clin Wurzburg, Comprehens Heart Failure Ctr, Dept Translat Res, Wurzburg, Germany.; Bertero, E (corresponding author), Univ Genoa, Dept Internal Med & Specialties Di MI, Genoa, Italy.
EM edo.bertero@gmail.com
CR Abeti R, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.111
   Al Tuwaijri A, 2022, MOL GENET GENOM MED, V10, P0, DOI 10.1002/mgg3.1969
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Anheim M, 2012, ARCH NEUROL-CHICAGO, V69, P912, DOI 10.1001/archneurol.2011.834
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bayeva M, 2014, CIRC-HEART FAIL, V7, P680, DOI 10.1161/CIRCHEARTFAILURE.113.000912
   Benson MD, 2017, OPHTHALMIC GENET, V38, P88, DOI 10.3109/13816810.2015.1137327
   Bertero E, 2021, CIRCULATION, V144, P1694, DOI 10.1161/CIRCULATIONAHA.121.053755
   Bertero E, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165803
   Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Brambilla A, 2019, INT J CARDIOL, V276, P14, DOI 10.1016/j.ijcard.2018.10.051
   Brandes R, 1997, CIRC RES, V80, P82, DOI 10.1161/01.RES.80.1.82
   Byers SL, 2014, WORLD J CARDIOL, V6, P1149, DOI 10.4330/wjc.v6.i11.1149
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   CHANNER KS, 1988, BRIT HEART J, V59, P486
   Chatfield KC, 2014, J MOL CELL CARDIOL, V74, P251, DOI 10.1016/j.yjmcc.2014.06.002
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chowdhury S, 2022, PEDIATR CARDIOL, V43, P1251, DOI 10.1007/s00246-022-02846-8
   Chu B, 2021, FRONT CELL DEV BIOL, V9, P1
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cook A, 2017, BRIT MED BULL, V124, P19, DOI 10.1093/bmb/ldx034
   Cotticelli MG, 2019, J PHARMACOL EXP THER, V369, P47, DOI 10.1124/jpet.118.252759
   Das AM, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/340849
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Delatycki MB, 2019, NEUROBIOL DIS, V132, P0, DOI 10.1016/j.nbd.2019.104606
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   EI-Gharbawy A, 2018, PEDIATR CLIN N AM, V65, P317, DOI 10.1016/j.pcl.2017.11.006
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Fsadni MG, 1900, V90, V0, PP249, DOI 10.1111/j.1755-3768.2012.T132.x
   Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gasanoff ES, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071721
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009
   Inak G, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-22117-z
   Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296
   Jackson TD, 2021, MOL BIOL CELL, V32, P475, DOI 10.1091/mbc.E20-06-0390
   Janz A, 2020, STEM CELL RES, V46, P0, DOI 10.1016/j.scr.2020.101856
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jeukendrup AE, 1998, INT J SPORTS MED, V19, P293, DOI 10.1055/s-2007-971921
   Jiang HJ, 2020, BLOOD, V136, P119, DOI 10.1182/blood.2019003851
   Jiang XJ, 2021, NAT REV MOL CELL BIO, V22, P266, DOI 10.1038/s41580-020-00324-8
   Johnson JM, 2018, J MOL CELL CARDIOL, V121, P94, DOI 10.1016/j.yjmcc.2018.07.001
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kalkhoran S, 2018, J AM COLL CARDIOL, V72, P2964, DOI 10.1016/j.jacc.2018.10.020
   Kazuhito T, 2020, J BIOCHEM, V168, P435, DOI 10.1093/jb/mvaa098
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koeppen AH, 2017, J NEUROPATH EXP NEUR, V76, P101, DOI 10.1093/jnen/nlw111
   KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lee JS, 2016, J CLIN NEUROL, V12, P181, DOI 10.3988/jcn.2016.12.2.181
   Lemieux H, 2011, MITOCHONDRION, V11, P97, DOI 10.1016/j.mito.2010.07.014
   Liu XJ, 2021, CIRCULATION, V143, P1894, DOI 10.1161/CIRCULATIONAHA.120.048698
   Machiraju P, 2022, J INHERIT METAB DIS, V45, P366, DOI 10.1002/jimd.12441
   Martin-Perez M, 2020, NAT METAB, V2, P0, DOI 10.1038/s42255-020-00319-x
   Martinez ARM, 2017, CEREBELLUM, V16, P253, DOI 10.1007/s12311-015-0755-8
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Meyers DE, 2013, TEX HEART I J, V40, P385
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   Moreira JD, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12111668
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   ORourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562
   Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92
   Orssaud C, 2018, J NEURO-OPHTHALMOL, V38, P466, DOI 10.1097/WNO.0000000000000623
   Orsucci D, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10061249
   Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Petit PX, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9102333
   Pousset F, 2015, JAMA NEUROL, V72, P1334, DOI 10.1001/jamaneurol.2015.1855
   Quadir A, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000339
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Ranea-Robles P, 2022, CARDIOVASC RES, V267, P36
   Reetz K, 2015, LANCET NEUROL, V14, P174, DOI 10.1016/S1474-4422(14)70321-7
   Regner SR, 2012, AM J CARDIOL, V109, P401, DOI 10.1016/j.amjcard.2011.09.025
   Thompson WR, 2021, GENET MED, V23, P471, DOI 10.1038/s41436-020-01006-8
   Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016
   Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705
   Rubio-Gozalbo ME, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P521, DOI 10.1016/j.mam.2004.06.007
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun Alfredo A, 2002, TRANS AM OPHTHALMOL SOC, V100, P169
   Sadun AA, 2011, CURR TREAT OPTION NE, V13, P109, DOI 10.1007/s11940-010-0100-y
   Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schlame M, 1999, J LIPID RES, V40, P1585
   Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sehgal Swati, 2016, BMJ CASE REP, V2016, P0, DOI 10.1136/bcr-2015-213813
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537
   Sharma P, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8020100
   Sinha D, 2016, J BIOL CHEM, V291, P17345, DOI 10.1074/jbc.M116.738146
   Smith EC, 2011, RHEUM DIS CLIN N AM, V37, P201, DOI 10.1016/j.rdc.2011.01.004
   SO N, 1989, BRAIN, V112, P1261, DOI 10.1093/brain/112.5.1261
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sorajja P, 2003, HEART, V89, P791, DOI 10.1136/heart.89.7.791
   Sparkes R, 2007, CARDIOL YOUNG, V17, P215, DOI 10.1017/S1047951107000042
   Spencer CT, 2006, PEDIATRICS, V118, PE337, DOI 10.1542/peds.2005-2667
   Spencer CT, 2011, AM J PHYSIOL-HEART C, V301, PH2122, DOI 10.1152/ajpheart.00479.2010
   Spencer CT, 2005, PEDIATR CARDIOL, V26, P632, DOI 10.1007/s00246-005-0873-z
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Towbin JA, 2018, HEART FAILURE IN THE CHILD AND YOUNG ADULT, V0, P269
   Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang SY, 2020, CIRC RES, V126, P1024, DOI 10.1161/CIRCRESAHA.119.315956
   Weidemann F, 2013, J NEUROCHEM, V126, P88, DOI 10.1111/jnc.12217
   Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI 10.1038/nchembio.2113
   Yan CJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040379
   Yoon J-Y, 2022, CLIN TRANSL MED, V141, P70
NR 132
TC 4
Z9 4
U1 1
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1546-9530
EI 1546-9549
J9 CURR HEART FAIL REP
JI Curr. Heart Fail. Rep.
PD FEB 15
PY 2023
VL 20
IS 1
BP 76
EP 87
DI 10.1007/s11897-023-00592-3
EA FEB 2023
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 9I0YK
UT WOS:000934848900001
PM 36802007
DA 2024-11-01
ER

PT J
AU Moore, J
   Ewoldt, J
   Venturini, G
   Pereira, AC
   Padilha, K
   Lawton, M
   Lin, WW
   Goel, R
   Luptak, I
   Perissi, V
   Seidman, CE
   Seidman, J
   Chin, MT
   Chen, C
   Emili, A
AF Moore, Jarrod
   Ewoldt, Jourdan
   Venturini, Gabriela
   Pereira, Alexandre C. C.
   Padilha, Kallyandra
   Lawton, Matthew
   Lin, Weiwei
   Goel, Raghuveera
   Luptak, Ivan
   Perissi, Valentina
   Seidman, Christine E. E.
   Seidman, Jonathan
   Chin, Michael T. T.
   Chen, Christopher
   Emili, Andrew
TI Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation-Contraction Coupling
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE hypertrophic cardiomyopathy; human induced pluripotent stem-cell-derived cardiomyocytes; myectomy; liquid chromatography-tandem mass spectrometry; phosphoproteomics; metabolomics; network systems biology
ID light-chain phosphatase; base excision-repair; oxidative stress; sarcomere function; phosphorylation; dysfunction; energetics; fission; muscle; dna
AB Hypertrophic cardiomyopathy is one of the most common inherited cardiomyopathies and a leading cause of sudden cardiac death in young adults. Despite profound insights into the genetics, there is imperfect correlation between mutation and clinical prognosis, suggesting complex molecular cascades driving pathogenesis. To investigate this, we performed an integrated quantitative multi-omics (proteomic, phosphoproteomic, and metabolomic) analysis to illuminate the early and direct consequences of mutations in myosin heavy chain in engineered human induced pluripotent stem-cell-derived cardiomyocytes relative to late-stage disease using patient myectomies. We captured hundreds of differential features, which map to distinct molecular mechanisms modulating mitochondrial homeostasis at the earliest stages of pathobiology, as well as stage-specific metabolic and excitation-coupling maladaptation. Collectively, this study fills in gaps from previous studies by expanding knowledge of the initial responses to mutations that protect cells against the early stress prior to contractile dysfunction and overt disease.
C1 [Moore, Jarrod; Lawton, Matthew; Lin, Weiwei; Goel, Raghuveera; Perissi, Valentina; Emili, Andrew] Boston Univ, Ctr Network Syst Biol, Dept Biochem, Sch Med, Boston, MA 02118 USA.
   [Ewoldt, Jourdan; Chen, Christopher] Boston Univ, Dept Biomed Engn, Boston, MA 02218 USA.
   [Venturini, Gabriela; Pereira, Alexandre C. C.; Seidman, Christine E. E.; Seidman, Jonathan] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.
   [Padilha, Kallyandra] Univ Sao Paulo, Clin Hosp, Fac Med, Lab Genet & Mol Cardiol, BR-05508000 Sao Paulo, Brazil.
   [Luptak, Ivan] Boston Univ, Myocardial Biol Unit, Sch Med, Boston, MA 02118 USA.
   [Seidman, Christine E. E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.
   [Seidman, Christine E. E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Chin, Michael T. T.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02145 USA.
   [Chen, Christopher] Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA.
C3 Boston University; Boston University; Harvard University; Harvard Medical School; Universidade de Sao Paulo; Boston University; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Tufts Medical Center; Harvard University
RP Emili, A (corresponding author), Boston Univ, Ctr Network Syst Biol, Dept Biochem, Sch Med, Boston, MA 02118 USA.
EM aemili@bu.edu
FU National Science Foundation Engineering Research Center on Cellular Metamaterials grant [HL080494]; National Institution of Health National Heart Lung and Blood Institute [DGE-1840990]; Engineering Research Centers Program of the National Science Foundation NSF Cooperative Agreement; National Science Foundation Graduate Research Fellowship [F31 HL158195-03]; Boston University; Howard Hughes Medical Institute; National Institute of Health National Heart Lung and Blood; BioDesign Center
CR Adebayo M, 2021, FASEB J, V35, P0, DOI 10.1096/fj.202100067R
   Aiken CT, 2011, MOL CELL PROTEOMICS, V10, P0, DOI 10.1074/mcp.M110.006924
   Akhtar Mohammed, 2018, GLOB CARDIOL SCI PRACT, V2018, P36, DOI 10.21542/gcsp.2018.36
   Ambruso DR, 2013, METHOD ENZYMOL, V527, P145, DOI 10.1016/B978-0-12-405882-8.00008-8
   Anderson RL, 2018, P NATL ACAD SCI USA, V115, PEB143, DOI 10.1073/pnas.1809540115
   Arimura T, 2001, J BIOL CHEM, V276, P6073, DOI 10.1074/jbc.M008566200
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Baier MJ, 2021, FEBS OPEN BIO, V11, P2756, DOI 10.1002/2211-5463.13274
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147
   Blighe K, 2023, ENHANCEDVOLCANO: PUBLICATION-READY VOLCANO PLOTS WITH ENHANCED COLOURING AND LABELING, V0, P0
   Blum BC, 2021, BIOINFORM ADV, V1, P0, DOI 10.1093/bioadv/vbab024
   Blum BC, 2022, MOL CELL PROTEOMICS, V21, P0, DOI 10.1016/j.mcpro.2021.100189
   Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028
   Campalans A, 2013, NUCLEIC ACIDS RES, V41, P3115, DOI 10.1093/nar/gkt025
   Candasamy AJ, 2014, J BIOL CHEM, V289, P1282, DOI 10.1074/jbc.M113.479030
   Cantin GT, 2007, ANAL CHEM, V79, P4666, DOI 10.1021/ac0618730
   Chaanine AH, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9113582
   Chang AN, 2016, J MOL CELL CARDIOL, V101, P35, DOI 10.1016/j.yjmcc.2016.10.004
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen XR, 2015, P NATL ACAD SCI USA, V112, P12687, DOI 10.1073/pnas.1512464112
   Cho E, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-43410-4
   Codden Christina J, 2022, CARDIOL CARDIOVASC MED, V6, P398, DOI 10.26502/fccm.92920277
   Codden CJ, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23020946
   Cohn R, 2019, STEM CELL REP, V12, P71, DOI 10.1016/j.stemcr.2018.11.015
   Coppini R, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01391
   Fan TWM, 2008, MOL CANCER, V7, P0, DOI 10.1186/1476-4598-7-79
   Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163
   Frohman MA, 2015, J MOL MED, V93, P263, DOI 10.1007/s00109-014-1237-z
   Gansemer ER, 2020, ISCIENCE, V23, P0, DOI 10.1016/j.isci.2020.101116
   Gao J, 2014, J CELL BIOL, V207, P213, DOI 10.1083/jcb.201403129
   Ge TX, 2020, FRONT ENDOCRINOL, V11, P0, DOI 10.3389/fendo.2020.00365
   GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I
   Geske JB, 2018, JACC-HEART FAIL, V6, P364, DOI 10.1016/j.jchf.2018.02.010
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018
   Grynberg A, 1996, J CARDIOVASC PHARM, V28, P0
   Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009
   Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047
   Jung WI, 1998, CIRCULATION, V97, P2536, DOI 10.1161/01.CIR.97.25.2536
   Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002
   Knöll R, 2011, CIRC RES, V109, P758, DOI 10.1161/CIRCRESAHA.111.245787
   Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098
   Korotkevich G, 2019, BIORXIV, V0, P0, DOI DOI 10.1101/060012
   Kraft LJ, 2016, AUTOPHAGY, V12, P1660, DOI 10.1080/15548627.2016.1199299
   Kraus I, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep12767
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012583
   Kudin AP, 2012, BBA-BIOENERGETICS, V1817, P1901, DOI 10.1016/j.bbabio.2012.02.023
   Kuzmanov U, 2020, NAT BIOMED ENG, V4, P889, DOI 10.1038/s41551-020-0585-y
   Kwon SH, 2003, J MOL CELL CARDIOL, V35, P615, DOI 10.1016/S0022-2828(03)00084-1
   Landstrom AP, 2010, CIRCULATION, V122, P2441, DOI 10.1161/CIRCULATIONAHA.110.954446
   Larson A, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-08561-x
   Larson A, 2021, BMC MED GENOMICS, V14, P0, DOI 10.1186/s12920-021-01011-z
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, PE1848, DOI 10.1073/pnas.1200250109
   Liu MR, 2022, REDOX BIOL, V53, P0, DOI 10.1016/j.redox.2022.102323
   Lu Fujian, 2020, BIOPHYS REV, V12, P1007, DOI 10.1007/s12551-020-00729-x
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Lynch TL, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/424751
   Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059
   Mattiazzi A, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00005
   McDonald TS, 2017, ENEURO, V4, P0, DOI 10.1523/ENEURO.0341-16.2017
   McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116
   McNamara JW, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0180064
   Michas C, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abm3791
   Moore J, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222413644
   Nakamura K, 2005, J CARD FAIL, V11, P117, DOI 10.1016/j.cardfail.2004.05.005
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Ommen SR, 2020, CIRCULATION, V142, Pe558, DOI 10.1161/CIR.0000000000000937
   Pangou E, 2021, CELL REP, V35, P0, DOI 10.1016/j.celrep.2021.109129
   Paradies G, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070728
   Perdiz D, 2017, CELL SIGNAL, V39, P32, DOI 10.1016/j.cellsig.2017.07.020
   Pla-Martin D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019102731
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Ranjbarvaziri S, 2021, CIRCULATION, V144, P1714, DOI 10.1161/CIRCULATIONAHA.121.053575
   Ribas V, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00151
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, P0, DOI 10.1093/nar/gkv007
   Roe AJ, 2018, BIOCHEM BIOPH RES CO, V496, P706, DOI 10.1016/j.bbrc.2018.01.114
   Ronson GE, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03159-2
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Ruiz DG, 2022, BIOCHEMISTRY-US, V61, P2165, DOI 10.1021/acs.biochem.2c00349
   Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560
   Sang LJ, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12239
   Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009
   Schmidt TA, 1998, CARDIOVASC RES, V37, P335, DOI 10.1016/S0008-6363(97)00261-7
   Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200
   Seco-Cervera M, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9121257
   Senthil V, 2005, CIRC RES, V97, P285, DOI 10.1161/01.RES.0000177090.07296.ac
   Sequeira V, 2019, FEBS LETT, V593, P1616, DOI 10.1002/1873-3468.13496
   Sharma Arun, 2018, CURR PROTOC HUM GENET, V96, P0, DOI 10.1002/cphg.52
   Sheikh F, 2015, GENE, V569, P14, DOI 10.1016/j.gene.2015.06.027
   Shimada YJ, 2021, CIRC-HEART FAIL, V14, P777, DOI 10.1161/CIRCHEARTFAILURE.120.007849
   Singh Gyanesh, 2015, F1000RES, V4, P176, DOI 10.12688/f1000research.6665.1
   Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szygula-Jurkiewicz B, 2022, MEDICINA-LITHUANIA, V58, P0, DOI 10.3390/medicina58010031
   Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100
   Toepfer CN, 2020, CIRCULATION, V141, P828, DOI 10.1161/CIRCULATIONAHA.119.042339
   Toepfer CN, 2019, CIRC RES, V124, P1172, DOI 10.1161/CIRCRESAHA.118.314505
   Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, PH2181, DOI 10.1152/ajpheart.00554.2011
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   van der Velden J, 2018, CARDIOVASC RES, V114, P1273, DOI 10.1093/cvr/cvy147
   Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002
   Viola HM, 2019, ARCH BIOCHEM BIOPHYS, V665, P166, DOI 10.1016/j.abb.2019.03.006
   Wakim J, 2017, J CELL SCI, V130, P1940, DOI 10.1242/jcs.201616
   Wang WM, 2022, NAT CARDIOVASC RES, V1, P445, DOI 10.1038/s44161-022-00057-1
   Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202
   Watanabe K, 2021, BIOCHEM BIOPH RES CO, V534, P687, DOI 10.1016/j.bbrc.2020.11.018
   Wijnker PJM, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165774
   Wijnker PJM, 2019, ANTIOXID REDOX SIGN, V31, P318, DOI 10.1089/ars.2017.7236
   Winn LM, 2003, J PHARMACOL EXP THER, V306, P523, DOI 10.1124/jpet.103.052639
   Witjas-Paalberends ER, 2014, J PHYSIOL-LONDON, V592, P3257, DOI 10.1113/jphysiol.2014.274571
   Yamada T, 2019, AUTOPHAGY, V15, P2012, DOI 10.1080/15548627.2019.1643185
   Yang H, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-29071-4
   Yu R, 2021, BMC BIOL, V19, P0, DOI 10.1186/s12915-021-01161-7
   Yuan M, 2019, NAT PROTOC, V14, P313, DOI 10.1038/s41596-018-0102-x
   Zhang C, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-03484-3
   Zhang KH, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abh3995
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
NR 120
TC 7
Z9 7
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR 15
PY 2023
VL 24
IS 5
BP 
EP 
DI 10.3390/ijms24054724
PG 24
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 9U7EF
UT WOS:000947869100001
PM 36902152
DA 2024-11-01
ER

PT J
AU Wang, A
   Zhao, J
   Zhao, Y
   Yan, Y
AF Wang, Ai
   Zhao, Ji
   Zhao, Yun
   Yan, Yan
TI Late-onset MELAS syndrome in a 46-year-old man with initial symptom of chest tightness: a case report
SO EUROPEAN HEART JOURNAL-CASE REPORTS
LA English
DT Article
DE Cardiomyopathy; MELAS syndrome; Mitochondrial disease; Case report
ID stroke-like-episodes; mitochondrial-myopathy; lactic-acidosis; encephalopathy; prevalence; disease; adults
AB Background Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) syndrome is a rare mitochondrial disorder caused by mutations in mitochondrial DNA, resulting in impaired energy production and affecting multiple organs. We present a suspected MELAS syndrome case with the initial symptom of chest tightness.Case summary A 46-year-old man sought medical attention due to progressively worsening chest tightness during physical activity. He had been receiving treatment for type 2 diabetes for 15 years. One year ago, he presented with symptoms of hearing impairment. Transthoracic echocardiography revealed increased thickness of the left ventricular wall. Serum protein electrophoresis showed no evidence of light-chain amyloidosis, and the 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scan showed no definite uptake in the heart muscle. The patient's head magnetic resonance imaging (MRI) indicated lacunar infarcts. The lactate threshold test was positive. The biopsy of the skeletal muscle showed broken red fibre infiltration on modified Gomori trichrome staining, and electron microscopy revealed signs of mitochondrial cardiomyopathy, including mild mitochondrial swelling, lipid accumulation, and myofibril damage. A whole-exome genetic test was used to detect the m.3243A>G mutation in the MT-TL1 gene. Based on these findings, MELAS syndrome was the most probable diagnosis.Discussion The patient presented with chest tightness in adulthood, without any accompanying psychoneurological symptoms. However, the patient presented with other symptoms, including diabetes mellitus, hearing loss, abnormal lactate levels, ischaemic lesions on head MRI, and left ventricular hypertrophy. By identifying a mutation in the MT-TL1 gene and conducting a muscle biopsy, the diagnosis of MELAS syndrome was definitively confirmed.
C1 [Wang, Ai; Zhao, Ji; Yan, Yan] Fudan Univ, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
   [Zhao, Yun] Shanghai Geriatr Med Ctr, Dept Cardiovasc Surg, 2560 Chunshen Rd, Shanghai 201104, Peoples R China.
C3 Fudan University
RP Yan, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.
EM yan.yan@zhongshan-hospital.sh.cn
FU National Natural Science Foundation of China [81873538, 82070463]
CR Brambilla A, 2019, INT J CARDIOL, V276, P14, DOI 10.1016/j.ijcard.2018.10.051
   Di Toro A, 2022, J AM COLL CARDIOL, V80, P1431, DOI 10.1016/j.jacc.2022.04.067
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lee SH, 2023, EUR HEART J-CASE REP, V7, P0
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Salpeter SR, 2010, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD002967.pub3
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Sunde K, 2016, MOL GENET METAB REP, V9, P94, DOI 10.1016/j.ymgmr.2016.11.002
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Wu G, 2023, NEUROLOGIST, V28, P190, DOI 10.1097/NRL.0000000000000457
NR 16
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2514-2119
J9 EUR HEART J-CASE REP
JI Eur. Heart J.-Case Rep.
PD SEP 1
PY 2023
VL 7
IS 9
BP 
EP 
DI 10.1093/ehjcr/ytad441
EA SEP 2023
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA S8XJ5
UT WOS:001073939700002
PM 37767231
DA 2024-11-01
ER

PT J
AU Zhao, MM
   Zuo, C
   Hao, HY
   Xing, X
   Zhao, L
   Li, N
AF Zhao, Mingmin
   Zuo, Chun
   Hao, Hongyu
   Xing, Xing
   Zhao, Lei
   Li, Na
TI A patient with MELAS syndrome combined with autoimmune abnormalities: a case report
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE MELAS; mitochondrial encephalomyopathy; autoimmune abnormalities; antinuclear antibodies (ANA); antimetabolic glutamate receptor 5 encephalitis
ID metabotropic glutamate-receptor; mitochondrial myopathy; lactic-acidosis; encephalopathy; episodes
AB BackgroundMitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is a group of maternally inherited disorders caused by mutations or deletions in mitochondrial genes with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes as the main clinical manifestations.Case presentationWe reported a 20-year-old female patient with MELAS syndrome combined with autoimmune abnormalities. She suffered from an intermittent headache in the right temporal region with no obvious cause, and then, after strenuous exercise in dance class, the headache became aggravated, accompanied by unresponsiveness, blurred vision, and diplopia. Her blood lactate levels were elevated, her antinuclear antibodies were positive, and the antimetabolic glutamate receptors 5 in her serum were positive. Brain DWI showed a hypertensive signal in the right temporo-parietal-occipital cortex and subcortical area. Brain MRS showed decreased NAA peak and increased Lac peak. Muscle biopsy showed myogenic damage, and the modified Gomori trichrome (MGT) staining showed ragged red fibers (RRF). A genetic study revealed a mitochondrial DNA A3243G mutation.ConclusionMitochondrial encephalomyopathy is a rare clinical condition; however, the association with autoimmune diseases is not yet clear and still needs further research and analysis.
C1 [Zhao, Mingmin; Zuo, Chun] Hebei North Univ, Grad Sch, Zhangjiakou, Hebei, Peoples R China.
   [Zhao, Mingmin; Zuo, Chun; Hao, Hongyu; Xing, Xing; Zhao, Lei; Li, Na] Hebei Gen Hosp, Neurol Intens Care Unit, Shijiazhuang, Hebei, Peoples R China.
   [Hao, Hongyu; Xing, Xing; Zhao, Lei; Li, Na] Hebei Prov Key Lab Cerebral Networks & Cognit Diso, Shijiazhuang, Hebei, Peoples R China.
C3 Hebei North University
RP Li, N (corresponding author), Hebei Gen Hosp, Neurol Intens Care Unit, Shijiazhuang, Hebei, Peoples R China.; Li, N (corresponding author), Hebei Prov Key Lab Cerebral Networks & Cognit Diso, Shijiazhuang, Hebei, Peoples R China.
EM lihaiying119@sina.com
FU Project of Clinical Medicine Excellent Talents Government-funded Project of Hebei Province, China [ZF2023186]; Medical Science Research Project of Hebe Province [20230314]
CR Chen SX, 2023, BRAIN BEHAV, V13, P0, DOI 10.1002/brb3.3003
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Faas MM, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165845
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Guevara C, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.02568
   Hemphill S, 2019, BRIT J ANAESTH, V122, P448, DOI 10.1016/j.bja.2018.12.025
   Hortová-Kohoutková M, 2021, BIOESSAYS, V43, P0, DOI 10.1002/bies.202000067
   Hu CP, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.01000
   Ikawa M, 2020, CURR OPIN CLIN NUTR, V23, P17, DOI 10.1097/MCO.0000000000000610
   Irure-Ventura J, 2022, DIAGNOSTICS, V12, P0, DOI 10.3390/diagnostics12030647
   Lancaster E, 2011, NEUROLOGY, V77, P1698, DOI 10.1212/WNL.0b013e3182364a44
   Makowski L, 2020, IMMUNOL REV, V295, P5, DOI 10.1111/imr.12858
   Marques-Matos C, 2016, JAMA NEUROL, V73, P604, DOI 10.1001/jamaneurol.2015.5061
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Seo KS, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00552
   SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   SWEENEY MG, 1993, Q J MED, V86, P709
NR 19
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD AUG 24
PY 2023
VL 14
IS 
BP 
EP 
DI 10.3389/fneur.2023.1239664
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA Q8DY5
UT WOS:001059785700001
PM 37693769
DA 2024-11-01
ER

PT J
AU Harada, N
   Nagasaki, H
   Yamamoto, H
   Matsubara, K
   Suzuki, T
   Gomori, A
   Yokogawa, T
   Matsuo, K
   Miyadera, K
AF Harada, Naomoto
   Nagasaki, Haruka
   Yamamoto, Hiromi
   Matsubara, Kenji
   Suzuki, Takamasa
   Gomori, Akira
   Yokogawa, Tatsushi
   Matsuo, Kenichi
   Miyadera, Kazutaka
TI Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID uridine phosphorylase; neurogastrointestinal encephalomyopathy; deoxynucleotide pools; kinase 2; expression; dna; gene; nucleoside; deletion; triphosphate
AB Plasma thymidine levels in rodents are higher than in other mammals including humans, possibly due to a different pattern and lower level of thymidine phosphorylase expression. Here, we generated a novel knock-in (KI) mouse line with high systemic expression of human thymidine phosphorylase to investigate this difference in nucleotide metabolism in rodents. The KI mice showed growth retardation around weaning and died by 4 weeks of age with a decrease in plasma thymidine level compared with the litter-control WT mice. These phenotypes were completely or partially rescued by administration of the thymidine phosphorylase inhibitor 5-chloro-6-(2drochloride or thymidine, respectively. Interestingly, when thymidine phosphorylase inhibitor administration was discontinued in adult animals, KI mice showed deteriorated grip strength and locomotor activity, decreased bodyweight, and subsequent hind-limb paralysis. Upon histological analyses, we observed axonal degeneration in the spinal cord, muscular atrophy with morphologically abnormal mitochondria in quadriceps, retinal degeneration, and abnormality in the exocrine pancreas. Moreover, we detected mitochondrial DNA depletion in multiple tissues of KI mice. These results indicate that the KI mouse represents a new animal model for mitochondrial diseases and should be applicable for the study of differences in nucleotide metabolism between humans and mice.
C1 [Harada, Naomoto; Nagasaki, Haruka; Yamamoto, Hiromi; Matsubara, Kenji; Suzuki, Takamasa; Gomori, Akira; Yokogawa, Tatsushi; Matsuo, Kenichi; Miyadera, Kazutaka] Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan.
C3 Taiho Pharmaceutical
RP Harada, N (corresponding author), Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan.
EM nm-harada@taiho.co.jp
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104
   Barboni P, 2004, GRAEF ARCH CLIN EXP, V242, P878, DOI 10.1007/s00417-004-0914-y
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Brown NS, 1998, BIOCHEM J, V334, P1
   Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200
   Dobrovolsky VN, 2003, MOL GENET METAB, V78, P1, DOI 10.1016/S1096-7192(02)00224-X
   ELKOUNI MH, 1993, CANCER RES, V53, P3687
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   FRIEDKIN M, 1954, J BIOL CHEM, V207, P245
   Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   Hurwitz Selwyn J, 2005, ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, V16, P117
   ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0
   JACKMAN AL, 1984, BIOCHEM PHARMACOL, V33, P3269, DOI 10.1016/0006-2952(84)90089-3
   Koszalka GW, 1993, ANTIVIRAL RESEARCH, V20, P143
   KRENITSKY TA, 1964, J BIOL CHEM, V239, P805
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mazat JP, 2001, BBA-BIOENERGETICS, V1504, P20, DOI 10.1016/S0005-2728(00)00236-X
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Mikhailopulo IA, 2010, ACTA NATURAE, V2, P36, DOI 10.32607/20758251-2010-2-2-36-58
   MIYADERA K, 1995, CANCER RES, V55, P1687
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Pacitti D, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00669
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SMITH GK, 1995, CANCER RES, V55, P6117
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Stevenson DP, 1998, AM J PATHOL, V152, P1641
   TAX WJM, 1976, BIOCHEM PHARMACOL, V25, P2025, DOI 10.1016/0006-2952(76)90425-1
   TAYLOR GA, 1984, ADV EXP MED BIOL, V165, P379
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   van der Wilt CL, 2001, CANCER RES, V61, P3675
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918
   YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X
   Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 42
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 15
PY 2023
VL 299
IS 3
BP 
EP 
DI 10.1016/j.jbc.2023.103002
EA MAR 2023
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA J1AV3
UT WOS:001007010500001
PM 36773803
DA 2024-11-01
ER

PT J
AU Bottoni, P
   Gionta, G
   Scatena, R
AF Bottoni, Patrizia
   Gionta, Giulia
   Scatena, Roberto
TI Remarks on Mitochondrial Myopathies
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondria; oxidative metabolism; electron respiratory chain; mutations; mitochondrial DNA; reactive oxygen species
ID dysfunction; drugs; disorders; complexes; diagnosis; disease; safety
AB Mitochondrial myopathies represent a heterogeneous group of diseases caused mainly by genetic mutations to proteins that are related to mitochondrial oxidative metabolism. Meanwhile, a similar etiopathogenetic mechanism (i.e., a deranged oxidative phosphorylation and a dramatic reduction of ATP synthesis) reveals that the evolution of these myopathies show significant differences. However, some physiological and pathophysiological aspects of mitochondria often reveal other potential molecular mechanisms that could have a significant pathogenetic role in the clinical evolution of these disorders, such as: i. a deranged ROS production both in term of signaling and in terms of damaging molecules; ii. the severe modifications of nicotinamide adenine dinucleotide (NAD)+/NADH, pyruvate/lactate, and alpha-ketoglutarate (alpha-KG)/2- hydroxyglutarate (2-HG) ratios. A better definition of the molecular mechanisms at the basis of their pathogenesis could improve not only the clinical approach in terms of diagnosis, prognosis, and therapy of these myopathies but also deepen the knowledge of mitochondrial medicine in general.
C1 [Bottoni, Patrizia] Univ Cattolica Sacro Cuore, Dipartimento Sci Biotecnol Base Clin Intens & Peri, Largo Francesco Vito 1, I-00168 Rome, Italy.
   [Gionta, Giulia] Univ Roma La Sapienza, Dipartimento Sci Anatom Istolog Med Legali & Appar, Sez Anat Umana, Via Alfonso Borelli 50, I-00161 Rome, Italy.
   [Scatena, Roberto] Madre Giuseppina Vannini Hosp, Dipartimento Med Lab, Via Acqua Bullicante 4, I-00177 Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome
RP Scatena, R (corresponding author), Madre Giuseppina Vannini Hosp, Dipartimento Med Lab, Via Acqua Bullicante 4, I-00177 Rome, Italy.
EM roberto.scatena@unicatt.it
CR Abramov AY, 2019, BIOCHEM SOC T, V47, P1963, DOI 10.1042/BST20191042
   Arena IG, 2022, J CLIN MED, V11, P0, DOI 10.3390/jcm11030632
   Barajas MB, 2022, PEDIATR RES, V92, P1341, DOI 10.1038/s41390-022-01985-1
   Bargiela D, 2015, NEUROLOGY, V85, P1195, DOI 10.1212/WNL.0000000000001995
   Bottoni P, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11071169
   Brunmair B, 2004, J PHARMACOL EXP THER, V311, P109, DOI 10.1124/jpet.104.068312
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Chiaratti MR, 2022, PHARMACOL RES, V185, P0, DOI 10.1016/j.phrs.2022.106466
   De Paepe B, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9010015
   DiMauro S, 2014, NEUROMUSCULAR DISORDERS IN CLINICAL PRACTICE, V0, PP1335, DOI 10.1007/978-1-4614-6567-6_64
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Finsterer J, 2010, DRUG CHEM TOXICOL, V33, P138, DOI 10.3109/01480540903207076
   Gayathri N, 2021, MITOCHONDRION, V61, P69, DOI 10.1016/j.mito.2021.09.007
   Hargreaves IP, 2016, DRUG SAFETY, V39, P661, DOI 10.1007/s40264-016-0417-x
   Hernansanz-Agustín P, 2022, ANTIOXID REDOX SIGN, V37, P290, DOI 10.1089/ars.2021.0262
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Holder Kathryn, 2016, FP ESSENT, V440, P23
   Hussain Y, 2020, NEUROL CLIN, V38, P619, DOI 10.1016/j.ncl.2020.04.002
   Law M, 2006, AM J CARDIOL, V97, P52C, DOI 10.1016/j.amjcard.2005.12.010
   Legro NR, 2022, AM J MED GENET A, V188, P896, DOI 10.1002/ajmg.a.62568
   Lemoine S, 2018, AM J KIDNEY DIS, V71, P754, DOI 10.1053/j.ajkd.2017.09.020
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Li DY, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.951185
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mastrangelo M, 2022, MOL GENET METAB, V135, P3, DOI 10.1016/j.ymgme.2021.12.014
   Mitsui T, 2002, J NEUROL, V249, P1004, DOI 10.1007/s00415-002-0774-5
   Morén C, 2016, CURR DRUG METAB, V17, P648, DOI 10.2174/1389200217666160322143631
   Nadanaciva S, 2011, CURR DRUG TARGETS, V12, P774, DOI 10.2174/138945011795528985
   Nagasaka S, 2002, DIABETIC MED, V19, P347, DOI 10.1046/j.1464-5491.2002.00712_4.x
   Riess ML, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010252
   Robinson KN, 2020, ENDOCR PRACT, V26, P241, DOI 10.4158/EP-2019-0270
   Sato T, 2015, EUR J PEDIATR, V174, P1593, DOI 10.1007/s00431-015-2576-7
   Scatena R, 2004, BIOCHEM BIOPH RES CO, V319, P967, DOI 10.1016/j.bbrc.2004.05.072
   Scatena R, 2012, ADV EXP MED BIOL, V942, P329, DOI 10.1007/978-94-007-2869-1_15
   Seed LM, 2022, MOL GENET GENOM MED, V10, P0, DOI 10.1002/mgg3.1955
   Setoguchi S, 2010, AM HEART J, V159, P428, DOI 10.1016/j.ahj.2009.12.008
   Shemesh A, 2022, KEARNS SAYRE SYNDROME, V0, P0
   Shoop WK, 2022, J BIOL CHEM, V298, P0, DOI 10.1016/j.jbc.2022.102574
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P161, DOI 10.1007/978-3-319-95046-4_30
   Varga ZV, 2015, AM J PHYSIOL-HEART C, V309, PH1453, DOI 10.1152/ajpheart.00554.2015
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wessels B, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0100525
   Yang MG, 2021, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.728043
   Yoshimi A, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02538-9
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Zeviani M, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11040637
NR 49
TC 4
Z9 4
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 15
PY 2023
VL 24
IS 1
BP 
EP 
DI 10.3390/ijms24010124
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 7P8OL
UT WOS:000908958900001
PM 36613565
DA 2024-11-01
ER

PT J
AU Kashio, A
   Yamada, C
   Yasuhara, K
   Kamogashira, T
   Someya, S
   Yamasoba, T
AF Kashio, Akinori
   Yamada, Chikako
   Yasuhara, Kazuo
   Kamogashira, Teru
   Someya, Shinichi
   Yamasoba, Tatsuya
TI Taurine, Coenzyme Q 10, and Hydrogen Water Prevents Germanium Dioxide-Induced Mitochondrial Dysfunction and Associated Sensorineural Hearing Loss in mouse
SO HEARING RESEARCH
LA English
DT Article
DE Germanium dioxide; Hearing loss; Mitochondrial dysfunction; Taurine; Coenzyme Q10; Hydrogen water
ID oxidative stress; dna mutations; induced apoptosis; cell-line; gene; myopathy; model; mice; ischemia/reperfusion; nephrotoxicity
AB Mitochondrial dysfunction has been implicated in numerous common diseases as well as aging and plays an important role in the pathogenesis of sensorineural hearing loss (SNHL). In the current study, we showed that supplementation with germanium dioxide (GeO 2 ) in CBA/J mice resulted in SNHL due to the degeneration of the stria vascularis and spiral ganglion, which were associated with down-regulation of mitochondrial respiratory chain associated genes and up-regulation in apoptosis associated genes in the cochlea. Supplementation with taurine, coenzyme Q10, or hydrogen-rich water, attenuated the cochlear degeneration and associated SNHL induced by GeO 2 . These results suggest that daily supplements or consumption of antioxidants, such as taurine, coenzyme Q10, and hydrogen-rich water, may be a promising intervention to slow SNHL associated with mitochondrial dysfunction.(c) 2022 Elsevier B.V. All rights reserved.
C1 [Kashio, Akinori; Yamada, Chikako; Yasuhara, Kazuo; Kamogashira, Teru; Yamasoba, Tatsuya] Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Tokyo, Japan.
   [Someya, Shinichi] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
C3 University of Tokyo; State University System of Florida; University of Florida
RP Yamasoba, T (corresponding author), Univ Tokyo, Fac Med, Dept Otolaryngol & Head & Neck Surg, Tokyo, Japan.
EM tyamasoba-tky@umin.ac.jp
FU Government of Japan Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [JP20H00546, JP20K21646JP]; Government of Japan Ministry of Labour and Welfare [20FC1019]; Grants-in-Aid for Scientific Research [20K21646, 21K16853, 20H00546] Funding Source: KAKEN
CR Affymetrix, 2004, EXPR AN TECHN MAN, V0, P0
   Alam SS, 2011, ENVIRON TOXICOL PHAR, V31, P143, DOI 10.1016/j.etap.2010.10.001
   ASAKA T, 1995, J NEUROL SCI, V130, P220, DOI 10.1016/0022-510X(95)00032-W
   Böttger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006
   Bustamante J, 1997, TOXICOLOGY, V118, P129, DOI 10.1016/S0300-483X(96)03607-4
   Chang KL, 2003, TOXICOL APPL PHARM, V193, P209, DOI 10.1016/j.taap.2003.07.004
   Chou CT, 2015, AMINO ACIDS, V47, P735, DOI 10.1007/s00726-014-1901-1
   Cortes NG, 2012, HUM MUTAT, V33, P681, DOI 10.1002/humu.22023
   Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171
   Dennis G, 2003, GENOME BIOL, V4, P0, DOI 10.1186/gb-2003-4-9-r60
   Dereköy FS, 2004, LARYNGOSCOPE, V114, P1775, DOI 10.1097/00005537-200410000-00019
   Erdem A, 2000, NEPHROL DIAL TRANSPL, V15, P1175, DOI 10.1093/ndt/15.8.1175
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fransson AE, 2021, FRONT CELL NEUROSCI, V15, P0, DOI 10.3389/fncel.2021.658662
   Fujimoto C, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8040109
   Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088
   Gopinath B, 2009, STROKE, V40, P1496, DOI 10.1161/STROKEAHA.108.535682
   Hargreaves I P, 2014, INT J BIOCHEM CELL BIOL, V49, P105, DOI 10.1016/j.biocel.2014.01.020
   Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165
   HIGUCHI I, 1989, ACTA NEUROPATHOL, V79, P300, DOI 10.1007/BF00294665
   HIGUCHI I, 1991, ACTA NEUROPATHOL, V82, P55, DOI 10.1007/BF00310923
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Hosack DA, 2003, GENOME BIOL, V4, P0, DOI 10.1186/gb-2003-4-10-r70
   Hoya N, 2004, NEUROREPORT, V15, P1597, DOI 10.1097/01.wnr.0000133226.94662.80
   Hu XM, 2003, CANCER CHEMOTH PHARM, V52, P47, DOI 10.1007/s00280-003-0629-5
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264
   Kim KM, 1998, NEPHROL DIAL TRANSPL, V13, P3218, DOI 10.1093/ndt/13.12.3218
   Kinoshita M, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/325702
   Koh JH, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/397307
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Li Xiaodong, 2001, CHINESE MEDICAL SCIENCES JOURNAL, V16, P157
   Lin CH, 2006, NEUROTOXICOLOGY, V27, P1052, DOI 10.1016/j.neuro.2006.05.018
   Lin Y, 2011, NEUROSCI LETT, V487, P12, DOI 10.1016/j.neulet.2010.09.064
   Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x
   Milton AG, 2004, BIOMETALS, V17, P707, DOI 10.1007/s10534-004-1210-3
   Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2
   Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043
   Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577
   Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156
   Okamoto Y, 2005, AUDIOL NEURO-OTOL, V10, P220, DOI 10.1159/000084843
   Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200
   Qiao M, 2015, BIOTECHNOL LETT, V37, P1579, DOI 10.1007/s10529-015-1846-9
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Roy Anandita, 2012, PATHOPHYSIOLOGY, V19, P137, DOI 10.1016/j.pathophys.2012.05.001
   SANAI T, 1990, TOXICOL APPL PHARM, V103, P345, DOI 10.1016/0041-008X(90)90234-L
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Shen ZY, 2003, INT J MOL MED, V11, P479
   Shoubridge EA, 2001, SEMIN NEUROL, V21, P261, DOI 10.1055/s-2001-17943
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Sikorska M, 2014, NEUROBIOL AGING, V35, P2329, DOI 10.1016/j.neurobiolaging.2014.03.032
   Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090
   Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024
   Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106
   TAKEUCHI A, 1992, NEPHRON, V60, P436, DOI 10.1159/000186805
   Wang W, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aac7410
   WU CM, 1992, MUSCLE NERVE, V15, P1258, DOI 10.1002/mus.880151107
   Yamada Y, 2015, J CONTROL RELEASE, V213, P86, DOI 10.1016/j.jconrel.2015.06.037
   Yamasoba T, 2006, NEUROSCI LETT, V395, P18, DOI 10.1016/j.neulet.2005.10.045
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yoshida A, 2012, CARDIOVASC DRUG THER, V26, P217, DOI 10.1007/s10557-012-6381-5
NR 66
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-5955
EI 1878-5891
J9 HEARING RES
JI Hear. Res.
PD FEB 15
PY 2023
VL 428
IS 
BP 
EP 
DI 10.1016/j.heares.2022.108678
EA DEC 2022
PG 11
WC Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology
GA 7W6BP
UT WOS:000913597300001
PM 36577362
DA 2024-11-01
ER

PT J
AU Borgione, E
   Lo Giudice, M
   Santa Paola, S
   Giuliano, M
   Lanza, GSP
   Cantone, M
   Ferri, R
   Scuderi, C
AF Borgione, Eugenia
   Lo Giudice, Mariangela
   Santa Paola, Sandro
   Giuliano, Marika
   Lanza, Giuseppe
   Cantone, Mariagiovanna
   Ferri, Raffaele
   Scuderi, Carmela
TI The Y831C Mutation of the <i>POLG</i> Gene in Dementia
SO BIOMEDICINES
LA English
DT Article
DE neurodegeneration; movement disorders; dementia; POLG; Y831C
ID dna-polymerase-gamma; mitochondrial-dna; neurodegeneration; alzheimers; variants; diseases
AB Background: The POLG gene encodes the catalytic subunit of DNA polymerase gamma, which is crucial for mitochondrial DNA (mtDNA) repair and replication. Gene mutation alters the stability of mtDNA and is associated with several clinical presentations, such as dysarthria and ophthalmoplegia (SANDO), progressive external ophthalmoplegia (PEO), spinocerebellar ataxia and epilepsy (SCAE), Alpers syndrome, and sensory ataxic neuropathy. Recent evidence has also indicated that POLG mutations may be involved in some neurodegenerative disorders, although systematic screening is currently lacking. Methods: To investigate the frequency of POLG gene mutations in neurodegenerative disorders, we screened a group of 33 patients affected by neurodegenerative diseases, including Parkinson's disease, some atypical parkinsonisms, and dementia of different types. Results: Mutational analysis revealed the presence of the heterozygous Y831C mutation in two patients, one with frontotemporal dementia and one with Lewy body dementia. The allele frequency of this mutation reported by the 1000 Genomes Project in the healthy population is 0.22%, while in our group of patients, it was 3.03%, thus showing a statistically significant difference between the two groups. Conclusions: Our results may expand the genotype-phenotype spectrum associated with mutations in the POLG gene and strengthen the hypothesis of a pathogenic role of the Y831C mutation in neurodegeneration.
C1 [Borgione, Eugenia; Lo Giudice, Mariangela; Santa Paola, Sandro; Giuliano, Marika; Lanza, Giuseppe; Ferri, Raffaele; Scuderi, Carmela] IRCCS, Oasi Res Inst, I-94018 Troina, Italy.
   [Lanza, Giuseppe] Univ Catania, Dept Surg & Med Surg Specialties, I-95123 Catania, Italy.
   [Cantone, Mariagiovanna] Univ Hosp Policlin G Rodol San Marco, Neurol Unit, I-95123 Catania, Italy.
C3 University of Catania
RP Borgione, E (corresponding author), IRCCS, Oasi Res Inst, I-94018 Troina, Italy.
EM eborgione@oasi.en.it
FU Italian Ministry of Health; Ricerca Corrente
CR Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Barthélémy C, 2002, HUM GENET, V110, P479, DOI 10.1007/s00439-002-0708-4
   Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138
   Briston T, 2018, BIOCHEM SOC T, V46, P829, DOI 10.1042/BST20180025
   Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412
   Cantone M, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.721906
   Caruso G, 2022, NUTRIENTS, V14, P0, DOI 10.3390/nu14040819
   Da Pozzo P, 2017, NEUROL SCI, V38, P563, DOI 10.1007/s10072-016-2734-3
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Gui YX, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050086
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hsieh PC, 2019, BRAIN BEHAV, V9, P0, DOI 10.1002/brb3.1281
   Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164
   Kasahara T, 2017, PSYCHIAT CLIN NEUROS, V71, P518, DOI 10.1111/pcn.12496
   Kiaei M, 2013, BASIC CLIN NEUROSCI, V4, P3
   Lanza G, 2020, J INT MED RES, V48, P0, DOI 10.1177/0300060519854626
   Lanza G, 2018, COMPLEMENT THER MED, V38, P74, DOI 10.1016/j.ctim.2018.04.013
   Lanza G, 2018, J NEUROL, V265, P968, DOI 10.1007/s00415-018-8795-x
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Ma L, 2020, INT J NEUROSCI, V130, P319, DOI 10.1080/00207454.2019.1681422
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Marambaud P, 2009, MOL NEURODEGENER, V4, P0, DOI 10.1186/1750-1326-4-20
   Min J, 2014, J STROKE CEREBROVASC, V1, P1021
   Muddapu VR, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.00213
   Ortega-Moreno L, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0188978
   Russo SN, 2022, MOL GENET METAB REP, V32, P0, DOI 10.1016/j.ymgmr.2022.100890
   Salemi M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23031535
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Spracklen TF, 2021, CIRC-GENOM PRECIS ME, V14, P0, DOI 10.1161/CIRCGEN.120.003138
   Stopinska K, 2006, ACTA BIOCHIM POL, V53, P591
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
   Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004
NR 41
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD APR 15
PY 2023
VL 11
IS 4
BP 
EP 
DI 10.3390/biomedicines11041172
PG 11
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy
GA E9YR2
UT WOS:000979014500001
PM 37189790
DA 2024-11-01
ER

PT J
AU Wang, XM
   Yu, QX
   Liao, XM
   Fan, MY
   Liu, XB
   Liu, Q
   Wang, MR
   Wu, XY
   Huang, CK
   Tan, RB
   Yuan, JX
AF Wang, Xiaomei
   Yu, Qianxue
   Liao, Xuemei
   Fan, Mengying
   Liu, Xibin
   Liu, Qian
   Wang, Manru
   Wu, Xinyu
   Huang, Chun-Kai
   Tan, Rubin
   Yuan, Jinxiang
TI Mitochondrial Dysfunction in Arrhythmia and Cardiac Hypertrophy
SO REVIEWS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE mitochondria; dysfunction; heart; arrhythmias; cardiac hypertrophy
ID oxidative stress; sarcoplasmic-reticulum; reactive oxygen; posttranslational modifications; diabetic cardiomyopathy; molecular-mechanisms; calcium-channel; down-regulation; failing hearts; ca2+ uptake
AB Arrhythmia and cardiac hypertrophy are two very common cardiovascular diseases that can lead to heart failure and even sudden death, thus presenting a serious threat to human life and health. According to global statistics, nearly one million people per year die from arrhythmia, cardiac hypertrophy and other associated cardiovascular diseases. Hence, there is an urgent need to find new treatment targets and to develop new intervention measures. Recently, mitochondrial dysfunction has been examined in relation to heart disease with a view to lowering the incidence of arrhythmia and cardiac hypertrophy. The heart is the body's largest energy consuming organ, turning over about 20 kg of adenosine triphosphate (ATP) per day in the mitochondria. Mitochondrial oxidative phosphorylation (OXPHOS) produces up to 90% of the ATP needed by cardiac muscle cells for contraction and relaxation. Dysfunction of heart mitochondria can therefore induce arrhythmia, cardiac hypertrophy and other cardiovascular diseases. Mitochondrial DNA (mtDNA) mutations cause disorders in OXPHOS and defects in the synthesis of muscle contraction proteins. These lead to insufficient production of secondary ATP, increased metabolic requirements for ATP by the myocardium, and the accumulation of reactive oxygen species (ROS). The resulting damage to myocardial cells eventually induces arrhythmia and cardiac hypertrophy. Mitochondrial damage decreases the efficiency of energy production, which further increases the production of ROS. The accumulation of ROS causes mitochondrial damage and eventually leads to a vicious cycle of mitochondrial damage and low efficiency of mitochondrial energy production. In this review, the mechanism underlying the development of arrhythmia and cardiac hypertrophy is described in relation to mitochondrial energy supply, oxidative stress, mtDNA mutation and Mitochondrial dynamics. Targeted therapy for arrhythmia and cardiac hypertrophy induced by mitochondrial dysfunction is also discussed in terms of its potential clinical value. These strategies should improve our understanding of mitochondrial biology and the pathogenesis of arrhythmia and cardiac hypertrophy. They may also identify novel strategies for targeting mitochondria in the treatment of these diseases.
C1 [Wang, Xiaomei; Yu, Qianxue; Liu, Xibin; Liu, Qian] Jining Med Univ, Coll Basic Med, Jining 272067, Shandong, Peoples R China.
   [Yu, Qianxue; Liao, Xuemei; Fan, Mengying; Liu, Xibin; Liu, Qian; Wang, Manru; Wu, Xinyu; Yuan, Jinxiang] Jining Med Univ, Collaborat Innovat Ctr Birth Defect Res & Transfo, Jining 272067, Shandong, Peoples R China.
   [Liao, Xuemei; Fan, Mengying; Wang, Manru; Wu, Xinyu] Jining Med Univ, Coll Clin Med 2, Jining 272067, Shandong, Peoples R China.
   [Huang, Chun-Kai] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Cardiol, Shanghai 200025, Peoples R China.
   [Tan, Rubin] Xuzhou Med Univ, Coll Basic Med, Xuzhou 221004, Jiangsu, Peoples R China.
   [Yuan, Jinxiang] Jining Med Univ, Lin Hes Academician Workstn New Med & Clin Transl, Jining 272067, Shandong, Peoples R China.
C3 Jining Medical University; Jining Medical University; Jining Medical University; Shanghai Jiao Tong University; Xuzhou Medical University; Jining Medical University
RP Yuan, JX (corresponding author), Jining Med Univ, Collaborat Innovat Ctr Birth Defect Res & Transfo, Jining 272067, Shandong, Peoples R China.; Huang, CK (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Cardiol, Shanghai 200025, Peoples R China.; Tan, RB (corresponding author), Xuzhou Med Univ, Coll Basic Med, Xuzhou 221004, Jiangsu, Peoples R China.; Yuan, JX (corresponding author), Jining Med Univ, Lin Hes Academician Workstn New Med & Clin Transl, Jining 272067, Shandong, Peoples R China.
EM chun-kai-huang@outlook.com; tanrubin11@126.com; yuanjinxiang18@163.com
FU National Natural Science Foundation of China [82100522, JYHL2021MS10]; Research Start-up Fund of Jining Medical University [600791001]; Research Fund for Lin He's Academician Workstation of New Medicine and Clinical Translation in Jining Medical University [81700055]
CR Abumayyaleh M, 2023, DIABETES OBES METAB, V25, P2999, DOI 10.1111/dom.15198
   Alharbi Hajed O, 2022, CLIN SCI (LOND), V136, P1661, DOI 10.1042/CS20220607
   Andreadou I, 2021, BASIC RES CARDIOL, V116, P0, DOI 10.1007/s00395-021-00885-5
   Ashrafian H, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001000
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108
   Boardman NT, 2021, BBA-MOL BASIS DIS, V1867, P0, DOI 10.1016/j.bbadis.2020.165982
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Borer JS, 2004, J AM COLL CARDIOL, V44, P406, DOI 10.1016/j.jacc.2004.04.023
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Caterine MR, 1996, J AM COLL CARDIOL, V28, P1598, DOI 10.1016/S0735-1097(96)00333-6
   Chang YW, 2013, MOL CELL PROTEOMICS, V12, P3094, DOI 10.1074/mcp.M113.027649
   Chen D, 2018, J CELL BIOCHEM, V119, P0, DOI 10.1002/jcb.27068
   Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723
   Comità S, 2021, BASIC RES CARDIOL, V116, P0, DOI 10.1007/s00395-021-00898-0
   CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001
   Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306
   García-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932
   Dia M, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-00835-7
   Disatnik MH, 2013, J AM HEART ASSOC, V2, P0, DOI 10.1161/JAHA.113.000461
   Du ZH, 2022, J CELL MOL MED, V26, P5054, DOI 10.1111/jcmm.17532
   Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313
   Eisner DA, 2017, CIRC RES, V121, P181, DOI 10.1161/CIRCRESAHA.117.310230
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Emelyanova L, 2016, AM J PHYSIOL-HEART C, V311, PH54, DOI 10.1152/ajpheart.00699.2015
   Fang L, 2007, LIFE SCI, V80, P2154, DOI 10.1016/j.lfs.2007.04.003
   Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729
   Gallo S, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20092164
   Gao J, 2020, PHARMACOL RES, V155, P0, DOI 10.1016/j.phrs.2020.104739
   Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351
   Hamilton S, 2021, J MOL CELL CARDIOL, V156, P105, DOI 10.1016/j.yjmcc.2021.04.002
   Hamilton S, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-0797-z
   Han K, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-02339-2
   Han WH, 2022, JACC-BASIC TRANSL SC, V7, P820, DOI 10.1016/j.jacbts.2022.03.006
   Hasan P, 2018, J MOL CELL CARDIOL, V121, P103, DOI 10.1016/j.yjmcc.2018.07.004
   Holmberg M, 1999, AM J CARDIOL, V83, P0
   Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x
   Hou CL, 2022, COMMUN BIOL, V5, P0, DOI 10.1038/s42003-022-03414-9
   Huizar JF, 2019, J AM COLL CARDIOL, V73, P2328, DOI 10.1016/j.jacc.2019.02.045
   Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Ishaq L, 2015, ROLE OF MITOFUSIN-2 AND MITOCHONDRIA-ASSOCIATED MEMBRANE IN ARRHYTHMOGENESIS, V0, P0
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Jeong K, 2009, EXP MOL MED, V41, P226, DOI 10.3858/emm.2009.41.4.025
   Ji LL, 2017, DIABETES, V66, P1586, DOI 10.2337/db16-1237
   Kanaan GN, 2019, CAN J DIABETES, V43, P67, DOI 10.1016/j.jcjd.2018.05.007
   Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359
   Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x
   Koentges C, 2015, BASIC RES CARDIOL, V110, P0, DOI 10.1007/s00395-015-0493-6
   Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346
   Lahnwong S, 2020, CARDIOVASC DIABETOL, V19, P0, DOI 10.1186/s12933-020-01066-9
   LAMPERTH L, 1991, LAB INVEST, V65, P742
   LaRocca TJ, 2012, AM J PHYSIOL-HEART C, V303, PH353, DOI 10.1152/ajpheart.01198.2011
   Lauritzen KH, 2015, AM J PHYSIOL-HEART C, V309, PH434, DOI 10.1152/ajpheart.00253.2014
   Lemieux H, 2009, J BIOENERG BIOMEMBR, V41, P99, DOI 10.1007/s10863-009-9211-0
   Li RJ, 2015, J HAZARD MATER, V287, P392, DOI 10.1016/j.jhazmat.2015.02.006
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   Lippi G, 2021, INT J STROKE, V16, P217, DOI 10.1177/1747493019897870
   Liu J, 2014, AM J PHYSIOL-HEART C, V307, PH598, DOI 10.1152/ajpheart.00058.2014
   Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673
   Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919
   Liu T, 2021, CIRC RES, V128, P1191, DOI 10.1161/CIRCRESAHA.120.318562
   Liu XX, 2023, CELL STRESS CHAPERON, V28, P133, DOI 10.1007/s12192-023-01321-4
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Lucas AM, 2017, CHEM-BIOL INTERACT, V261, P50, DOI 10.1016/j.cbi.2016.11.012
   Maack C, 2007, BASIC RES CARDIOL, V102, P369, DOI 10.1007/s00395-007-0666-z
   Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011
   Mammucari C, 2018, PFLUG ARCH EUR J PHY, V470, P1165, DOI 10.1007/s00424-018-2123-2
   Maneechote C, 2022, ACTA PHARMACOL SIN, V43, P26, DOI 10.1038/s41401-021-00626-3
   Maneechote C, 2018, CLIN SCI, V132, P1669, DOI 10.1042/CS20180510
   MARAS P, 1986, EUR HEART J, V7, P23
   Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650
   Mesubi OO, 2016, CARDIOVASC RES, V109, P542, DOI 10.1093/cvr/cvw002
   Mitra A, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.114
   Montaigne D, 2013, J AM COLL CARDIOL, V62, P1466, DOI 10.1016/j.jacc.2013.03.061
   Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, PH769, DOI 10.1152/ajpheart.1997.272.2.H769
   Morales PE, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.09.006
   Murphy KR, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.01277
   Neumann JT, 2011, MOL PHARMACOL, V79, P141, DOI 10.1124/mol.110.067165
   Ni YJ, 2021, J CELL MOL MED, V25, P203, DOI 10.1111/jcmm.15904
   Nikolaienko R, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01775
   NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0
   ORourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005
   Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610
   Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498
   Park HW, 2007, J CLIN PATHOL, V60, P948, DOI 10.1136/jcp.2007.047134
   Pathak T, 2018, PHARMACOL THERAPEUT, V192, P112, DOI 10.1016/j.pharmthera.2018.07.001
   Protasoni M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22020586
   Redout EM, 2010, AM J PHYSIOL-HEART C, V298, PH1038, DOI 10.1152/ajpheart.00097.2009
   Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002
   Rossi A, 2019, BBA-MOL CELL RES, V1866, P1068, DOI 10.1016/j.bbamcr.2018.10.016
   Ruiz-Meana M, 2010, CARDIOVASC RES, V88, P30, DOI 10.1093/cvr/cvq225
   Sabbah HN, 2018, CARDIOVASC DRUG THER, V32, P319, DOI 10.1007/s10557-018-6805-y
   Samak M, 2016, MED SCI MONIT BASIC, V22, P75, DOI 10.12659/MSMBR.900437
   Samuel TJ, 2022, JCI INSIGHT, V7, P0, DOI 10.1172/jci.insight.157557
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041
   Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Shao QM, 2019, CARDIOVASC DIABETOL, V18, P0, DOI 10.1186/s12933-019-0964-4
   Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221
   Sheeran FL, 2017, ADV EXP MED BIOL, V982, P65, DOI 10.1007/978-3-319-55330-6_4
   Sheeran FL, 2016, AM J PHYSIOL-ENDOC M, V311, PE449, DOI 10.1152/ajpendo.00127.2016
   Shires SE, 2015, CIRC RES, V117, P0
   Sivakumar B, 2022, INHAL TOXICOL, V34, P107, DOI 10.1080/08958378.2022.2049931
   Sommese L, 2016, INT J CARDIOL, V202, P394, DOI 10.1016/j.ijcard.2015.09.022
   Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011
   Stram AR, 2016, CELL MOL LIFE SCI, V73, P4063, DOI 10.1007/s00018-016-2280-4
   Sun DD, 2019, DNA CELL BIOL, V38, P796, DOI 10.1089/dna.2019.4731
   Supinski GS, 2009, AM J PHYSIOL-REG I, V297, PR1095, DOI 10.1152/ajpregu.90902.2008
   Sygitowicz G, 2022, FRONT BIOSCI-LANDMRK, V27, P0, DOI 10.31083/j.fbl2703096
   Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tahrir FG, 2019, J CELL PHYSIOL, V234, P8122, DOI 10.1002/jcp.27597
   Tong MM, 2019, CIRC RES, V124, P1360, DOI 10.1161/CIRCRESAHA.118.314607
   Tsai MS, 2014, ACAD EMERG MED, V21, P257, DOI 10.1111/acem.12335
   Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, PH2181, DOI 10.1152/ajpheart.00554.2011
   Tu T, 2014, CIRC J, V78, P993, DOI 10.1253/circj.CJ-13-1365
   Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465
   Venetucci LA, 2008, CARDIOVASC RES, V77, P285, DOI 10.1093/cvr/cvm009
   Vona R, 2021, CANCERS, V13, P0, DOI 10.3390/cancers13225812
   Wang HY, 2022, FRONT CARDIOVASC MED, V9, P0, DOI 10.3389/fcvm.2022.808163
   Wang JQ, 2022, FRONT IMMUNOL, V13, P0, DOI 10.3389/fimmu.2022.883116
   Wang SJ, 2018, J CELL MOL MED, V22, P5132, DOI 10.1111/jcmm.13802
   Wang SY, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.848214
   Wang YX, 2022, J CARDIOVASC PHARM, V80, P430, DOI 10.1097/FJC.0000000000001301
   Xie LJ, 2019, EUR J MED GENET, V62, P0, DOI 10.1016/j.ejmg.2019.01.018
   Xu X, 2021, CARDIOVASC TOXICOL, V21, P759, DOI 10.1007/s12012-021-09667-w
   Yan CJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040379
   Yan ML, 2022, CELL DEATH DISCOV, V8, P0, DOI 10.1038/s41420-022-01046-w
   Yang KC, 2014, FREE RADICAL BIO MED, V71, P351, DOI 10.1016/j.freeradbiomed.2014.03.033
   Yang RL, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.118.008939
   Yang Y, 2021, AGING-US, V13, P493, DOI 10.18632/aging.202159
   Yoo S, 2020, CIRCULATION, V142, P1261, DOI 10.1161/CIRCULATIONAHA.119.044127
   Zang QS, 2012, AM J PHYSIOL-HEART C, V302, PH1847, DOI 10.1152/ajpheart.00203.2011
   Zhao D, 2020, BMC MED, V18, P0, DOI 10.1186/s12916-020-01715-6
   Zhu R, 2016, MITOCHONDRIAL DNA A, V27, P1165, DOI 10.3109/19401736.2014.936420
NR 139
TC 0
Z9 0
U1 3
U2 13
PU IMR PRESS
PI ROBINSON
PA 112 ROBINSON RD, ROBINSON, SINGAPORE
SN 1530-6550
EI 2153-8174
J9 REV CARDIOVASC MED
JI Rev. Cardiovasc. Med.
PD DEC 15
PY 2023
VL 24
IS 12
BP 
EP 
DI 10.31083/j.rcm2412364
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FF5E2
UT WOS:001144352600008
PM 39077079
DA 2024-11-01
ER

PT J
AU Kim, HC
   Zhang, Y
   King, PH
   Lu, L
AF Kim, Han-Cheon
   Zhang, Yan
   King, Peter H. H.
   Lu, Liang
TI MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE aggregation; amyotrophic lateral sclerosis (ALS); microRNAs; neurotoxicity; SQSTM1; p62; TAR DNA-binding protein 43 (TDP-43)
ID noncoding rnas; tdp-43; aggregation; mechanism; biology; disease; mirnas; p62
AB Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that selectively attacks motor neurons, and leads to progressive muscle weakness and death. A common pathological feature is the misfolding, aggregation, and cytoplasmic mislocalization of TAR DNA-binding protein 43 (TDP-43) proteins in more than 95% of ALS patients, suggesting a universal role TDP-43 proteinopathy in ALS. Mutations in SQSTM1/p62 have been identified in familial and sporadic cases of ALS. MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate their target genes. Emerging evidence indicates that miRNA dysregulation is associated with neuronal toxicity and mitochondrial dysfunction, and also plays a pivotal role in ALS pathogenesis. Here, we report the first evidence that miR-183-5p is aberrantly upregulated in spinal cords of patients with ALS. Using luciferase reporter assays and miR-183-5p agomirs, we demonstrate that miR-183-5p regulates the SQSTM1/p62 3 & PRIME;-untranslated region to suppress expression. A miR-183-5p agomir attenuated SOSTM1/p62 expression and led to an increase in TDP-43 protein levels in neuronal and non-neuronal cells. In contrast, a miR-183-5p antagomir decreased TDP-43 but increased SQSTM1/p62 protein levels. The antagomir repressed formation of stress granules and aggregated TDP43 protein in neuronal cells under stress-induced conditions and protected against cytotoxicity. Knockdown of SQSTM1/p62 decreased total ubiquitination and increased TDP-43 protein aggregation, indicating that SQSTM1/p62 may play a protective role in cells. In summary, our study reveals a novel mechanism of TDP-43 proteinopathy mediated by the miR-183-5p and provides a molecular link between aberrant RNA processing and protein degradation, two major pillars in ALS pathogenesis.
C1 [Kim, Han-Cheon; Zhang, Yan; Lu, Liang] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.
   [Kim, Han-Cheon; Zhang, Yan; Lu, Liang] Michael E DeBakey VA Med Ctr, Dept Neurol, Houston, TX USA.
   [King, Peter H. H.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL USA.
   [King, Peter H. H.] Birmingham VA Med Ctr, Birmingham, AL USA.
C3 Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham
RP Kim, HC; Lu, L (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.
EM hancheon.kim@bcm.edu; liang.lu@bcm.edu
FU National Institute of Health (NIH)/Veterans Affairs (VA) [5I01BX003035-03, I01BX004419, R01NS092651, R21NS111275]; MEDVAMC Bridge and Seed Award Program the Michael E. DeBakey VA Medical Center
CR Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6
   Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x
   Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Chen ML, 2021, THERANOSTICS, V11, P2395, DOI 10.7150/thno.47408
   Chu CT, 2019, NEUROBIOL DIS, V122, P23, DOI 10.1016/j.nbd.2018.07.015
   Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565
   Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004
   Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029
   de Boer EMJ, 2021, J NEUROL NEUROSUR PS, V92, P86, DOI 10.1136/jnnp-2020-322983
   De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Foster AD, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-90822-2
   Gregory JM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031899
   Gupta R, 2021, CELL MOL LIFE SCI, V78, P8001, DOI 10.1007/s00018-021-04004-4
   Hadano S, 2016, HUM MOL GENET, V25, P3321, DOI 10.1093/hmg/ddw180
   Kaur P, 2012, J TOXICOL-US, V2012, P0, DOI 10.1155/2012/870150
   Kosik KS, 2018, ANNU REV NEUROSCI, V41, P119, DOI 10.1146/annurev-neuro-080317-061822
   Lin XL, 2013, DNA CELL BIOL, V32, P220, DOI 10.1089/dna.2012.1915
   Lin YC, 2017, ASIAN J SURG, V40, P396, DOI 10.1016/j.asjsur.2016.07.001
   Liu WJ, 2016, CELL MOL BIOL LETT, V21, P0, DOI 10.1186/s11658-016-0031-z
   Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Pham J, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21103464
   Prasad A, 2019, FRONT MOL NEUROSCI, V12, P0, DOI 10.3389/fnmol.2019.00025
   Rajgor Dipen, 2018, NONCODING RNA RES, V3, P154, DOI 10.1016/j.ncrna.2018.07.001
   Ravnik-Glavac M, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21051714
   Rothstein JD, 2009, ANN NEUROL, V65, PS3, DOI 10.1002/ana.21543
   Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Saucier D, 2019, BRAIN RES, V1708, P100, DOI 10.1016/j.brainres.2018.12.016
   Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748
   Soliman AM, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00038
   Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184
   Tal TL, 2012, NEUROTOXICOLOGY, V33, P530, DOI 10.1016/j.neuro.2012.02.013
   Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0
   Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001
   Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012
   Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, P0, DOI 10.1186/1750-1172-4-3
   Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200
   Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076
NR 43
TC 3
Z9 3
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD MAR 15
PY 2023
VL 164
IS 5
BP 643
EP 657
DI 10.1111/jnc.15744
EA JAN 2023
PG 15
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 9U5VG
UT WOS:000920538700001
PM 36527420
DA 2024-11-01
ER

PT J
AU Di Leo, V
   Gomes, TMB
   Vincent, AE
AF Di Leo, Valeria
   Gomes, Tiago M. Bernardino
   Vincent, Amy E.
TI Interactions of mitochondrial and skeletal muscle biology in mitochondrial myopathy
SO BIOCHEMICAL JOURNAL
LA English
DT Review
ID amino-acid-metabolism; c-oxidase deficiency; cytochrome-c; respiratory-chain; dna deletions; reactive oxygen; fiber types; external ophthalmoplegia; therapeutic targets; lactic-acidosis
AB Mitochondrial dysfunction in skeletal muscle fibres occurs with both healthy aging and a range of neuromuscular diseases. The impact of mitochondrial dysfunction in skeletal muscle and the way muscle fibres adapt to this dysfunction is important to understand disease mechanisms and to develop therapeutic interventions. Furthermore, interactions between mitochondrial dysfunction and skeletal muscle biology, in mitochondrial myopathy, likely have important implications for normal muscle function and physiology. In this review, we will try to give an overview of what is known to date about these interactions including metabolic remod-elling, mitochondrial morphology, mitochondrial turnover, cellular processes and muscle cell structure and function. Each of these topics is at a different stage of understanding, with some being well researched and understood, and others in their infancy. Furthermore, some of what we know comes from disease models. Whilst some findings are confirmed in humans, where this is not yet the case, we must be cautious in interpreting findings in the context of human muscle and disease. Here, our goal is to discuss what is known, highlight what is unknown and give a perspective on the future direction of research in this area.
C1 [Di Leo, Valeria; Gomes, Tiago M. Bernardino; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.
   [Di Leo, Valeria; Gomes, Tiago M. Bernardino; Vincent, Amy E.] NIHR Newcastle Biomed Res Ctr, Biomed Res Bldg, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, England.
   [Gomes, Tiago M. Bernardino] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Dis, Newcastle Upon Tyne NE2 4HH, England.
   [Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne NE2 4HH, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.; Vincent, AE (corresponding author), NIHR Newcastle Biomed Res Ctr, Biomed Res Bldg, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, England.; Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne NE2 4HH, England.
EM amy.vincent@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research; NIHR Newcastle Biomedical Research Centre, a Sir Henry Wellcome Postdoctoral Fellowship [215888/Z/19/Z]; Newcastle University
CR Ahmed ST, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-14623-2
   Ajayi PT, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-30401-9
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   ARPE J, 1994, ACTA NEUROL SCAND, V90, P281
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Avellaneda J, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-22058-7
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Baldelli S, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.458
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015
   Bhosale G, 2017, BBA-MOL CELL RES, V1864, P1009, DOI 10.1016/j.bbamcr.2017.01.015
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309
   Bottoni P, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24010124
   Bouchez C, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040287
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Britti Elena, 2018, NEURONAL SIGNAL, V2, PNS20180061, DOI 10.1042/NS20180061
   Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen ZK, 2023, SCI ADV, V9, P0, DOI 10.1126/sciadv.add3216
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Collier JJ, 2021, NEW ENGL J MED, V384, P2406, DOI 10.1056/NEJMoa1915722
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cordero MD, 2016, J MED GENET, V53, P113, DOI 10.1136/jmedgenet-2015-103392
   Cornelissen T, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.35878
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x
   Dai ZW, 2020, NAT REV GENET, V21, P737, DOI 10.1038/s41576-020-0270-8
   Deng JW, 2020, BIOCHEM BIOPH RES CO, V523, P91, DOI 10.1016/j.bbrc.2019.12.005
   Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005
   Di Giovanni S, 2001, MOL CELL NEUROSCI, V17, P696, DOI 10.1006/mcne.2001.0970
   Di Leo V, 2022, UNDERSTANDING THE EFFECTS OF RESISTANCE EXERCISE TRAINING ON MITOCHONDRIAL MYOPATHY IN MITOCHONDRIAL MYOPATHY AND MYOTONIC DYSTROPHY TYPE 1 PATIENTS, V0, P0
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004
   DiMauro S, 2010, ACTA MYOL, V29, P333
   Djouadi F, 2008, J INHERIT METAB DIS, V31, P217, DOI 10.1007/s10545-008-0844-7
   Dogan SA, 2022, ANTIOXID REDOX SIGN, V37, P301, DOI 10.1089/ars.2021.0266
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Faitg J, 2020, J MICROSC-OXFORD, V278, P89, DOI 10.1111/jmi.12891
   Farge G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112770
   FASSATI A, 1994, J NEUROL SCI, V123, P140, DOI 10.1016/0022-510X(94)90216-X
   Favaro G, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-10226-9
   Ferrari M, 2017, P NATL ACAD SCI USA, V114, PE4241, DOI 10.1073/pnas.1621511114
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   Formichi P, 2003, JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, V35, P29
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y
   Fulle S, 2005, ARCH ITAL BIOL, V143, P229
   García-Pérez C, 2011, AM J PHYSIOL-HEART C, V301, PH1907, DOI 10.1152/ajpheart.00397.2011
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0488-x
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Glancy B, 2021, J PHYSIOL-LONDON, V599, P863, DOI 10.1113/JP278930
   Glancy B, 2017, CELL REP, V19, P487, DOI 10.1016/j.celrep.2017.03.063
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Gobin-Limballe S, 2007, AM J HUM GENET, V81, P1133, DOI 10.1086/522375
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gottschalk B, 2022, CELL CALCIUM, V101, P0, DOI 10.1016/j.ceca.2021.102517
   Gumeni S, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-03952-w
   HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   HARATI Y, 1979, ARCH NEUROL-CHICAGO, V36, P454, DOI 10.1001/archneur.1979.00500430084024
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Hepple RT, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9081821
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057
   Hunt M, 2022, AIDS, V36, P1927, DOI 10.1097/QAD.0000000000003334
   Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Irazoki A, 2023, NAT COMMUN, V14, P0, DOI 10.1038/s41467-022-35732-1
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005
   Katti P, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-34445-9
   Katti P, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-33678-y
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011
   Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162
   KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107
   Kowald A, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Leduc-Gaudet JP, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22158179
   Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Leo D, 2023, THE EFFECTS OF RESISTANCE EXERCISE TRAINING ON MITOCHONDRIAL DYSFUNCTION IN MITOCHONDRIAL MYOPATHY AND MYOTONIC DYSTROPHY TYPE 1 PATIENTS, V0, P0
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   LEXELL J, 1991, J ANAT, V174, P239
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lin DS, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8010065
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Liu C C, 2001, CURR RHEUMATOL REP, V3, P325, DOI 10.1007/s11926-001-0037-y
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Liu G, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044375
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Long Q, 2015, BIOPHYS J, V109, P892, DOI 10.1016/j.bpj.2015.07.039
   Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309
   Mbaya E, 2010, CELL DEATH DIFFER, V17, P1855, DOI 10.1038/cdd.2010.51
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391
   McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X
   MERIKANGAS JR, 1995, AM J PSYCHIAT, V152, P142, DOI 10.1176/ajp.152.1.142
   Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Mito T, 2022, CELL METAB, V34, P197, DOI 10.1016/j.cmet.2021.12.017
   Moreno-Justicia R, 2023, MYOSIN HEAVY CHAINS, V0, P0, DOI DOI 10.1101/2023.09.07.556665
   Moss T, 2021, CSH MOL CASE STUD, V7, P0, DOI 10.1101/mcs.a006081
   Mposhi A, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23042197
   Murgia M, 2019, CELL REP, V29, P3825, DOI 10.1016/j.celrep.2019.11.055
   Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nielsen J, 2017, J PHYSIOL-LONDON, V595, P2839, DOI 10.1113/JP273040
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   OHKOSHI N, 1995, MUSCLE NERVE, V18, P1265, DOI 10.1002/mus.880181108
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901
   Pascale RM, 2020, CANCERS, V12, P0, DOI 10.3390/cancers12102819
   Payne BAI, 2015, JAMA NEUROL, V72, P603, DOI 10.1001/jamaneurol.2015.0150
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7
   PETTE D, 1986, FED PROC, V45, P2910
   Pette D, 1997, INT REV CYTOL, V170, P143, DOI 10.1016/S0074-7696(08)61622-8
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2013, AM J PHYSIOL-REG I, V304, PR393, DOI 10.1152/ajpregu.00584.2012
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Picard M, 2012, AM J PHYSIOL-CELL PH, V302, PC629, DOI 10.1152/ajpcell.00368.2011
   Picca A, 2023, SEMIN CELL DEV BIOL, V143, P37, DOI 10.1016/j.semcdb.2022.03.023
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Protasoni M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22020586
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Romanello V, 2021, CELL MOL LIFE SCI, V78, P1305, DOI 10.1007/s00018-020-03662-0
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Sánchez-González C, 2022, CELL DEATH DIS, V13, P0, DOI 10.1038/s41419-022-05016-z
   Santos JH, 2021, FREE RADICAL BIO MED, V170, P59, DOI 10.1016/j.freeradbiomed.2020.11.016
   Satrústegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schiaffino S, 2020, HISTOL HISTOPATHOL, V35, P239, DOI 10.14670/HH-18-170
   Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2
   Sekler I, 2015, BIOCHEM BIOPH RES CO, V460, P50, DOI 10.1016/j.bbrc.2015.02.170
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shuler KT, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9122544
   Si HB, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0225214
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Southwell N, 2023, EMBO MOL MED, V15, P0, DOI 10.15252/emmm.202216951
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taivassalo T, 2012, BRAIN, V135, P53, DOI 10.1093/brain/awr293
   Takao M, 1996, J NEUROL SCI, V139, P111
   Takeuchi A, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23147948
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tomar D, 2016, CELL REP, V15, P1673, DOI 10.1016/j.celrep.2016.04.050
   Trumpff C, 2021, MITOCHONDRION, V59, P225, DOI 10.1016/j.mito.2021.04.002
   Tu MK, 2016, CELL CALCIUM, V59, P91, DOI 10.1016/j.ceca.2016.02.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Umaki Y, 2002, ACTA NEUROPATHOL, V103, P163
   Varughese JT, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071737
   Vincent AE, 2019, CELL REP, V27, P321, DOI 10.1016/j.celrep.2019.03.051
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Vincent AE, 2017, TRENDS CELL BIOL, V27, P797, DOI 10.1016/j.tcb.2017.08.009
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287
   Wagenmakers AJM, 1998, ADV EXP MED BIOL, V441, P307
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850
   Wang T, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201947892
   Warren C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-70885-3
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   Willingham TB, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-17579-6
   Wilson RJ, 2019, MITOCHONDRION, V44, P20, DOI 10.1016/j.mito.2017.12.008
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
   Wu Z, 2019, NAT METAB, V1, P1209, DOI 10.1038/s42255-019-0150-8
   Xian HX, 2022, IMMUNITY, V55, P1370, DOI 10.1016/j.immuni.2022.06.007
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Yuan JH, 2013, J CLIN PATHOL, V66, P659, DOI 10.1136/jclinpath-2012-201431
   Yuan YX, 2017, MOL MED REP, V16, P7361, DOI 10.3892/mmr.2017.7554
   Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239
   Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1
   Zhang XN, 2020, ADV EXP MED BIOL, V1207, P103, DOI 10.1007/978-981-15-4272-5_6
   Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
   Zulian A, 2016, PHARMACOL RES, V113, P563, DOI 10.1016/j.phrs.2016.09.043
NR 225
TC 2
Z9 2
U1 3
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD NOV 15
PY 2023
VL 480
IS 21
BP 1767
EP 1789
DI 10.1042/BCJ20220233
PG 23
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA Y2TE5
UT WOS:001103833500001
PM 37965929
DA 2024-11-01
ER

PT J
AU Erdinc, D
   Rodríguez-Luis, A
   Fassad, MR
   Mackenzie, S
   Watson, CM
   Valenzuela, S
   Xie, X
   Menger, KE
   Sergeant, K
   Craig, K
   Hopton, S
   Falkous, G
   Poulton, J
   Garcia-Moreno, H
   Giunti, P
   Aschoff, CAD
   Saute, JAM
   Kirby, AJ
   Toro, C
   Wolfe, L
   Novacic, D
   Greenbaum, L
   Eliyahu, A
   Barel, O
   Anikster, Y
   McFarland, R
   Gorman, GS
   Schaefer, AM
   Gustafsson, CM
   Taylor, RW
   Falkenberg, M
   Nicholls, TJ
AF Erdinc, Direnis
   Rodriguez-Luis, Alejandro
   Fassad, Mahmoud R.
   Mackenzie, Sarah
   Watson, Christopher M.
   Valenzuela, Sebastian
   Xie, Xie
   Menger, Katja E.
   Sergeant, Kate
   Craig, Kate
   Hopton, Sila
   Falkous, Gavin
   Poulton, Joanna
   Garcia-Moreno, Hector
   Giunti, Paola
   Aschoff, Carlos A. de Moura
   Saute, Jonas A. Morales
   Kirby, Amelia J.
   Toro, Camilo
   Wolfe, Lynne
   Novacic, Danica
   Greenbaum, Lior
   Eliyahu, Aviva
   Barel, Ortal
   Anikster, Yair
   McFarland, Robert
   Gorman, Grainne S.
   Schaefer, Andrew M.
   Gustafsson, Claes M.
   Taylor, Robert W.
   Falkenberg, Maria
   Nicholls, Thomas J.
TI Pathological variants in <i>TOP3A</i> cause distinct disorders of mitochondrial and nuclear genome stability
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE Bloom syndrome; mitochondrial disease; mtDNA; TOP3A
ID topoisomerase-iii-alpha; impair mtdna replication; syndrome gene-product; d-loop; essential component; syndrome protein; dna; mutations; duplication; deletions
AB Topoisomerase 3 alpha (TOP3A) is an enzyme that removes torsional strain and interlinks between DNA molecules. TOP3A localises to both the nucleus and mitochondria, with the two isoforms playing specialised roles in DNA recombination and replication respectively. Pathogenic variants in TOP3A can cause a disorder similar to Bloom syndrome, which results from bi-allelic pathogenic variants in BLM, encoding a nuclear-binding partner of TOP3A. In this work, we describe 11 individuals from 9 families with an adult-onset mitochondrial disease resulting from bi-allelic TOP3A gene variants. The majority of patients have a consistent clinical phenotype characterised by bilateral ptosis, ophthalmoplegia, myopathy and axonal sensory-motor neuropathy. We present a comprehensive characterisation of the effect of TOP3A variants, from individuals with mitochondrial disease and Bloom-like syndrome, upon mtDNA maintenance and different aspects of enzyme function. Based on these results, we suggest a model whereby the overall severity of the TOP3A catalytic defect determines the clinical outcome, with milder variants causing adult-onset mitochondrial disease and more severe variants causing a Bloom-like syndrome with mitochondrial dysfunction in childhood.
C1 [Erdinc, Direnis; Valenzuela, Sebastian; Xie, Xie; Gustafsson, Claes M.; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Rodriguez-Luis, Alejandro; Fassad, Mahmoud R.; Menger, Katja E.; Craig, Kate; Hopton, Sila; Falkous, Gavin; McFarland, Robert; Gorman, Grainne S.; Schaefer, Andrew M.; Taylor, Robert W.; Nicholls, Thomas J.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, England.
   [Rodriguez-Luis, Alejandro; Menger, Katja E.; Nicholls, Thomas J.] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, England.
   [Fassad, Mahmoud R.; McFarland, Robert; Gorman, Grainne S.; Taylor, Robert W.] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, England.
   [Mackenzie, Sarah] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, England.
   [Watson, Christopher M.] St James Univ Hosp, North East & Yorkshire Genom Lab Hub, Cent Lab, Leeds, England.
   [Watson, Christopher M.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Med Res, Leeds, England.
   [Sergeant, Kate] Oxford Univ Hosp NHS Fdn Trust, Oxford Genet Labs, Oxford, England.
   [Craig, Kate; Hopton, Sila; Falkous, Gavin; Schaefer, Andrew M.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, England.
   [Poulton, Joanna] Univ Oxford, Womens Ctr, Nuffield Dept Womens & Reprod Hlth, Oxford, England.
   [Garcia-Moreno, Hector; Giunti, Paola] UCL Queen Sq Inst Neurol, Ataxia Ctr, Dept Clin & Movement Neurosci, London, England.
   [Aschoff, Carlos A. de Moura; Saute, Jonas A. Morales] Hosp Clin Porto Alegre HCPA, Med Genet Serv, Porto Alegre, Brazil.
   [Saute, Jonas A. Morales] Univ Fed Rio Grande do Sul, Dept Internal Med, Porto Alegre, Brazil.
   [Saute, Jonas A. Morales] Univ Fed Rio Grande do Sul, Grad Program Med Med Sci, Porto Alegre, Brazil.
   [Kirby, Amelia J.] Wake Forest Sch Med, Dept Pediat, Winston Salem, NC USA.
   [Toro, Camilo; Wolfe, Lynne; Novacic, Danica] Natl Human Genome Res Inst, Undiagnosed Dis Program, NIH, Bethesda, MD USA.
   [Greenbaum, Lior; Eliyahu, Aviva] Sheba Med Ctr, Danek Gertner Inst Human Genet, Tel Hashomer, Israel.
   [Greenbaum, Lior] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel.
   [Greenbaum, Lior; Eliyahu, Aviva; Anikster, Yair] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Barel, Ortal] Sheba Med Ctr, Ctr Canc Res, Genom Unit, Tel Hashomer, Israel.
   [Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Metab Dis Unit, Tel Hashomer, Israel.
   [Gustafsson, Claes M.] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden.
C3 University of Gothenburg; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; Oxford University Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Oxford; University of London; University College London; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Sahlgrenska University Hospital
RP Nicholls, TJ (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, England.; Nicholls, TJ (corresponding author), Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, England.
EM thomas.nicholls@newcastle.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Mitochondrial Disease Patient Cohort (UK) [G0800674]; UK National Institute for Health Research (NIHR) Biomedical Research Centre for Ageing; Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust; UK NHS Specialist Commissioners - Wellcome Trust; Royal Society [213464/Z/18/Z]; Rosetrees and Stoneygate Trust Research Fellowship [M811]; Swedish Research Council; Swedish Cancer Foundation; IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenberg Foundation [ALFGBG-965954, ALFGBG-966275]; Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease [MR/S005021/1]; Lily Foundation; Medical Research Council; Pathological Society - Lily Foundation; Angus Memorial Mitochondrial Fund - National Institute for Health Research; NHS England; Wellcome Trust; Cancer Research UK; MRC [MR/S005021/1, MR/W019027/1] Funding Source: UKRI
CR Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Bizard AH, 2020, J BIOL CHEM, V295, P7138, DOI 10.1074/jbc.REV120.008286
   Bizard AH, 2019, NAT STRUCT MOL BIOL, V26, P267, DOI 10.1038/s41594-019-0201-6
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Bocquet N, 2014, NAT STRUCT MOL BIOL, V21, P261, DOI 10.1038/nsmb.2775
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   Cao N, 2020, NUCLEIC ACIDS RES, V48, P4448, DOI 10.1093/nar/gkaa201
   Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065
   Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hagström E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969
   Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653
   Hangas A, 2022, NUCLEIC ACIDS RES, V50, P8733, DOI 10.1093/nar/gkac660
   Jiang WJ, 2021, BBA-MOL BASIS DIS, V1867, P0, DOI 10.1016/j.bbadis.2021.166106
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Langmead B, 2012, NAT METHODS, V9, P357, DOI 10.1038/NMETH.1923
   Li MX, 2012, NUCLEIC ACIDS RES, V40, P0, DOI 10.1093/nar/gkr1257
   Li Q, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23092270
   Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010
   LLAURADO A, 2022, GENES-BASEL, V103, P492
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   MANFREDI G, 1995, NEUROLOGY, V45, P762, DOI 10.1212/WNL.45.4.762
   Martin CA, 2018, AM J HUM GENET, V103, P456, DOI 10.1016/j.ajhg.2018.08.012
   Menger KE, 2022, NUCLEIC ACIDS RES, V50, P11154, DOI 10.1093/nar/gkac857
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Oláhová M, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-21279-0
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200
   Primiano G, 2022, NEUROL-GENET, V8, P0, DOI 10.1212/NXG.0000000000200007
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108
   Smedley D, 2021, NEW ENGL J MED, V385, P1868, DOI 10.1056/NEJMoa2035790
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sugrañes TA, 2022, GENET MED, V24, P1476, DOI 10.1016/j.gim.2022.03.008
   Tan KM, 2015, NUCLEIC ACIDS RES, V43, P0, DOI 10.1093/nar/gkv1073
   TORRONI A, 1994, AM J HUM GENET, V55, P760
   Tsai HZ, 2016, J BIOMED SCI, V23, P0, DOI 10.1186/s12929-016-0255-2
   Turnbull C, 2018, BMJ-BRIT MED J, V361, P0, DOI 10.1136/bmj.k1687
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wu JH, 2010, P NATL ACAD SCI USA, V107, P6228, DOI 10.1073/pnas.1001855107
   Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103
   Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636
   Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608
   Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216
   Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-09258-2
NR 65
TC 8
Z9 8
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD MAY 8
PY 2023
VL 15
IS 5
BP 
EP 
DI 10.15252/emmm.202216775
EA APR 2023
PG 21
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA F1VJ3
UT WOS:000962771600001
PM 37013609
DA 2024-11-01
ER

PT J
AU Haque, S
   Crawley, K
   Shrestha, R
   Schofield, D
   Sue, CM
AF Haque, Sameen
   Crawley, Karen
   Shrestha, Rupendra
   Schofield, Deborah
   Sue, Carolyn M.
TI Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Mitochondrial diseases; Mitochondrial disorders; Health care costs; Health services; Health resources; Outpatients
ID diagnosis; spectrum; defects
AB Background and objectivesMitochondrial diseases present as multi-system disorders requiring a comprehensive multidisciplinary approach. The data on healthcare resource utilization associated with mitochondrial diseases and the clinical drivers of these costs are limited including for the out-patient setting where the majority of the clinical care for mitochondrial disease patients occurs. We performed a cross-sectional retrospective study of out-patient healthcare resource utilization and costs for patients with a confirmed diagnosis of mitochondrial disease.MethodsWe recruited participants from the Mitochondrial Disease Clinic in Sydney and stratified them into three groups: those with mitochondrial DNA (mtDNA) mutations (Group 1), those with nuclear DNA (nDNA) mutations and the predominant phenotype of chronic progressive external ophthalmoplegia (CPEO) or optic atrophy (Group 2) and those without a confirmed genetic diagnosis but clinical criteria and muscle biopsy findings supportive of a diagnosis of mitochondrial disease (Group 3). Data was collected through retrospective chart review and out-patient costs were calculated using the Medicare Benefits Schedule.ResultsWe analyzed the data from 91 participants and found that Group 1 had the greatest average out-patient costs per person per annum ($838.02; SD 809.72). Neurological investigations were the largest driver of outpatient healthcare costs in all groups (average costs per person per annum:-Group 1: $364.11; SD 340.93, Group 2: $247.83; SD 113.86 and Group 3: $239.57; SD 145.69) consistent with the high frequency (94.5%) of neurological symptoms. Gastroenterological and cardiac-related out-patient costs were also major contributors to out-patient healthcare resource utilization in Groups 1 and 3. In Group 2, ophthalmology was the second-most resource intensive specialty ($136.85; SD 173.35). The Group 3 had the greatest average healthcare resource utilization per person over the entire duration of out-patient clinic care ($5815.86; SD 3520.40) most likely due to the lack of a molecular diagnosis and a less customized management approach.ConclusionThe drivers of healthcare resource utilization are dependent on the phenotype-genotype characteristics. Neurological, cardiac, and gastroenterological costs were the top three drivers in the out-patient clinics unless the patient had nDNA mutations with predominant phenotype of CPEO and/or optic atrophy wherein ophthalmological-related costs were the second most resource intensive driver.
C1 [Haque, Sameen] Nepean Hosp, Derby St, Kingswood, NSW 2747, Australia.
   [Haque, Sameen; Crawley, Karen; Sue, Carolyn M.] Royal North Shore Hosp, Kolling Inst, Reserve Rd, St Leonards, NSW 2065, Australia.
   [Shrestha, Rupendra; Schofield, Deborah] Macquarie Univ, Ctr Econ Impacts Genom Med GenIMPACT, Macquarie Business Sch, Eastern Rd, Macquarie Pk, NSW 2109, Australia.
   [Sue, Carolyn M.] Univ New South Wales, Neurosci Res Australia, Sydney, Australia.
C3 Nepean Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Macquarie University; Neuroscience Research Australia; University of New South Wales Sydney
RP Haque, S (corresponding author), Nepean Hosp, Derby St, Kingswood, NSW 2747, Australia.; Haque, S (corresponding author), Royal North Shore Hosp, Kolling Inst, Reserve Rd, St Leonards, NSW 2065, Australia.
EM sameenhaque@hotmail.com
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   Buajitti E, 2022, PLOS ONE, V17, P0, DOI 10.1371/journal.pone.0265744
   Chinnery PF, 1997, QJM-INT J MED, V90, P657, DOI 10.1093/qjmed/90.11.657
   Cohen B, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0949-5
   Davis RL, 2022, NEUROLOGY, V99, PE730, DOI 10.1212/WNL.0000000000200745
   Davis Ryan L, 2018, HANDB CLIN NEUROL, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   Doherty M, 2013, ORBIT, V32, P12, DOI 10.3109/01676830.2012.736599
   Eshaghi M, 2021, EUR J OPHTHALMOL, V31, P2064, DOI 10.1177/1120672120952344
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Guo Yi, 2018, ZHONGGUO DANG DAI ER KE ZA ZHI, V20, P887
   Hom XB, 2004, MITOCHONDRION, V4, P601, DOI 10.1016/j.mito.2004.07.014
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Klopstock T, 2021, DTSCH ARZTEBL INT, V118, P741, DOI 10.3238/arztebl.m2021.0251
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nolte E, 2008, CARING FOR PEOPLE WITH CHRONIC CONDITIONS: A HEALTH SYSTEM PERSPECTIVE, V0, P0
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parsons T, 2010, ARCH NEUROL-CHICAGO, V67, P976, DOI 10.1001/archneurol.2010.174
   Sue CM, 2022, INTERN MED J, V52, P110, DOI 10.1111/imj.15505
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
NR 33
TC 2
Z9 2
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD MAY 29
PY 2023
VL 18
IS 1
BP 
EP 
DI 10.1186/s13023-023-02746-x
PG 9
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA H3HL7
UT WOS:000994909200001
PM 37246228
DA 2024-11-01
ER

PT J
AU Houshmand, M
   Zeinali, V
   Hosseini, A
   Seifi, A
   Danaei, B
   Kamfar, S
AF Houshmand, Massoud
   Zeinali, Vahide
   Hosseini, Amirhossein
   Seifi, Atena
   Danaei, Bardia
   Kamfar, Sharareh
TI Investigation of FGF21 mRNA levels and relative mitochondrial DNA copy number levels and their relation in nonalcoholic fatty liver disease: a case-control study
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE fibroblast growth factor 21; mitochondrial DNA; nonalcoholic fatty liver disease; FGF21; NAFLD
ID growth-factor 21; insulin-resistance; oxidative stress; skeletal-muscle; gene-expression; impact; nash; age; steatohepatitis; association
AB Background: Although the exact mechanisms of nonalcoholic fatty liver disease (NAFLD) are not fully understood, numerous pieces of evidence show that the variations in mitochondrial DNA (mtDNA) level and hepatic Fibroblast growth factor 21 (FGF21) expression may be related to NAFLD susceptibility.Objectives: The main objective of this study was to determine relative levels of mtDNA copy number and hepatic FGF21 expression in a cohort of Iranian NAFLD patients and evaluate the possible relationship.Methods: This study included 27 NAFLD patients (10 with nonalcoholic fatty liver (NAFL) and 17 with non-alcoholic steatohepatitis (NASH)) and ten healthy subjects. Total RNA and genomic DNA were extracted from liver tissue samples, and then mtDNA copy number and FGF21 expression levels were assessed by quantitative real-time PCR.Results: The relative level of hepatic mtDNA copy number was 3.9-fold higher in patients than in controls (p < 0.0001). NAFLD patients showed a 2.9-fold increase in hepatic FGF21 expression compared to controls (p < 0.013). Results showed that hepatic FGF21 expression was positively correlated with BMI, serum ALT, and AST levels (p < 0.05). The level of mitochondrial copy number and hepatic FGF21 expression was not significantly associated with stages of change in hepatic steatosis. Finally, there was a significant correlation between FGF21 expression and mitochondrial copy number in NAFLD patients (p = 0.027).Conclusion: Our findings suggest a considerable rise of hepatic FGF21 mRNA levels and mtDNA-CN and show a positive correlation between them in the liver tissue of NAFLD patients.
C1 [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.
   [Zeinali, Vahide] Shahid Beheshti Univ Med Sci, Res Inst Childrens Hlth, Tehran, Iran.
   [Hosseini, Amirhossein] Shahid Beheshti Univ Med Sci, Res Inst Childrens Hlth, Pediat Gastroenterol Hepatol & Nutr Res Ctr, Tehran, Iran.
   [Seifi, Atena] Shahid Beheshti Univ Med Sci, Res Inst Childrens Hlth, Pediat Nephrol Res Ctr, Tehran, Iran.
   [Danaei, Bardia] Shahid Beheshti Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran.
   [Kamfar, Sharareh] Shahid Beheshti Univ Med Sci, Res Inst Childrens Hlth, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences
RP Kamfar, S (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Childrens Hlth, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran.
EM kamfarsharareh@gmail.com
FU Shahid Beheshti University of Medical Sciences, Tehran, Iran
CR Acierno C, 2020, EXPLOR. MED, V1, P287, DOI 10.37349/EMED.2020.00019
   Alisi A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067160
   Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527
   Bao LC, 2018, BRIT J PHARMACOL, V175, P3379, DOI 10.1111/bph.14383
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793
   Bayoumi A, 2021, ADV SCI, V8, P0, DOI 10.1002/advs.202004168
   Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004
   Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491
   Boparai RK, 2015, INT J ENDOCRINOL, V2015, P0, DOI 10.1155/2015/282375
   Cao K, 2020, FOOD FUNCT, V11, P9624, DOI 10.1039/D0FO01545H
   Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004
   Caturano A, 2021, PROCESSES, V9, P0, DOI 10.3390/pr9010135
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Chiappini F, 2006, LAB INVEST, V86, P154, DOI 10.1038/labinvest.3700374
   Cuevas-Ramos D, 2009, CURR DIABETES REV, V5, P216, DOI 10.2174/157339909789804396
   Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015
   Dabravolski SA, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094459
   Diba LZ, 2016, MITOCHONDRIAL DNA A, V27, P3008, DOI 10.3109/19401736.2015.1063046
   Dornas W, 2020, AM J PHYSIOL-GASTR L, V319, PG400, DOI 10.1152/ajpgi.00121.2020
   Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054
   Falamarzi K, 2022, FRONT MED-LAUSANNE, V9, P0, DOI 10.3389/fmed.2022.967375
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Flisiak-Jackiewicz M, 2019, ADV MED SCI-POLAND, V64, P280, DOI 10.1016/j.advms.2019.02.005
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Francque S, 2019, ADV THER, V36, P1052, DOI 10.1007/s12325-019-00898-6
   Greenbaum D, 2003, GENOME BIOL, V4, P0, DOI 10.1186/gb-2003-4-9-117
   Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x
   Henkel J, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11112709
   Jensen EC, 2012, ANAT REC, V295, P1, DOI 10.1002/ar.21487
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   Kamfar S, 2016, HEPAT MON, V16, P0, DOI 10.5812/hepatmon.40774
   Köroglu E, 2016, TURK J GASTROENTEROL, V27, P361, DOI 10.5152/tjg.2016.16106
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lee JH, 2016, AM J TRANSL RES, V8, P4750
   Lee K, 2018, MOL CELL PROTEOMICS, V17, P2371, DOI 10.1074/mcp.RA118.000961
   Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018
   Lin Y, 2020, ANN CLIN TRANSL NEUR, V7, P1204, DOI 10.1002/acn3.51104
   Liu C, 2023, ELIFE, V12, P0, DOI 10.7554/eLife.83075
   Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009
   Lonardo A, 2017, WORLD J GASTROENTERO, V23, P6571, DOI 10.3748/wjg.v23.i36.6571
   Ma CF, 2020, FRONT MED-LAUSANNE, V7, P0, DOI 10.3389/fmed.2020.00536
   Malik AN, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8101222
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   Mitra S, 2020, TRANSL GASTROENT HEP, V5, P0, DOI 10.21037/tgh.2019.09.08
   Nakanishi K, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-02075-8
   Nusrat S, 2014, WORLD J GASTROENTERO, V20, P5442, DOI 10.3748/wjg.v20.i18.5442
   Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Pirola CJ, 2015, MEDICINE, V94, P0, DOI 10.1097/MD.0000000000001480
   Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084
   Reinehr T, 2012, J CLIN ENDOCR METAB, V97, P2143, DOI 10.1210/jc.2012-1221
   Rusli F, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30484
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Shakhssalim N, 2013, CANCER CELL INT, V13, P0, DOI 10.1186/1475-2867-13-120
   Shami GJ, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-82884-z
   Silva GM, 2016, MOL SYST BIOL, V12, P0, DOI 10.15252/msb.20167325
   Skuratovskaia D, 2019, BMC MED GENOMICS, V12, P0, DOI 10.1186/s12920-019-0485-8
   Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927
   Tan HL, 2023, INT J BIOL SCI, V19, P66, DOI 10.7150/ijbs.73936
   Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012
   Tapia MAP, 2018, FASEB J, V32, P0
   Tillman EJ, 2020, FRONT ENDOCRINOL, V11, P0, DOI 10.3389/fendo.2020.601290
   Toshikuni N, 2014, WORLD J GASTROENTERO, V20, P8393, DOI 10.3748/wjg.v20.i26.8393
   Tucker B, 2019, METABOLISM, V101, P0, DOI 10.1016/j.metabol.2019.153994
   Tyynismaa H, 2011, J CLIN ENDOCR METAB, V96, PE351, DOI 10.1210/jc.2010-1326
   van der Windt Dirk J, 2018, GENE EXPRESSION, V18, P89, DOI 10.3727/105221617X15124844266408
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wang J, 2020, LIPIDS HEALTH DIS, V19, P0, DOI 10.1186/s12944-020-01210-0
   Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800
   Watanabe M, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12072141
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Xu JQ, 2021, FRONT PHARMACOL, V12, P0, DOI 10.3389/fphar.2021.796207
   Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060
   Ye J, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-134
   Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Zhang ZJ, 2022, J CELL MOL MED, V26, P4157, DOI 10.1111/jcmm.17262
NR 78
TC 2
Z9 2
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD JUN 6
PY 2023
VL 10
IS 
BP 
EP 
DI 10.3389/fmolb.2023.1203019
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA K2YH1
UT WOS:001015141100001
PM 37347041
DA 2024-11-01
ER

PT J
AU Ardissone, A
   Ferrera, G
   Lamperti, C
   Tiranti, V
   Ghezzi, D
   Moroni, I
   Lamantea, E
AF Ardissone, Anna
   Ferrera, Giulia
   Lamperti, Costanza
   Tiranti, Valeria
   Ghezzi, Daniele
   Moroni, Isabella
   Lamantea, Eleonora
TI Phenotyping mitochondrial DNA-related diseases in childhood: A cohort study of 150 patients
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE mitochondrial disorder; mitochondrial DNA; pediatric; phenotypes
ID cytochrome-c-oxidase; clinical spectrum; cavitating leukoencephalopathy; pediatric-patients; mutations; children; features; disorders; mortality; variant
AB Background and purpose: Mitochondrial diseases (MDs) are heterogeneous disorders caused by mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA) associated with specific syndromes. However, especially in childhood, patients often display heterogeneity. Several reports on the biochemical and molecular profiles in children have been published, but studies tend not to differentiate between mtDNA- and nDNA-associated diseases, and focus is often on a specific phenotype. Thus, large cohort studies specifically focusing on mtDNA defects in the pediatric population are lacking. Methods: We reviewed the clinical, metabolic, biochemical, and neuroimaging data of 150 patients with MDs due to mtDNA alterations collected at our neurological institute over the past 20 years. Results: mtDNA impairment is less frequent than nDNA impairment in pediatric MDs. Ocular involvement is extremely frequent in our cohort, as is classical Leber hereditary optic neuropathy, especially with onset before 12 years of age. Extraneurological manifestations and isolated myopathy appear to be rare, unlike adult phenotypes. Deep gray matter involvement, early disease onset, and specific phenotypes, such as Pearson syndrome and Leigh syndrome, represent unfavorable prognostic factors. Phenotypes related to single large scale mtDNA deletions appear to be very frequent in the pediatric population. Furthermore, we report for the first time an mtDNA pathogenic variant associated with cavitating leukodystrophy. Conclusions: We report on a large cohort of pediatric patients with mtDNA defects, adding new data on the phenotypical characterization of mtDNA defects and suggestions for diagnostic workup and therapeutic approach.
C1 [Ardissone, Anna; Ferrera, Giulia; Moroni, Isabella] Fdn IRCCS Ist Neurol Carlo Besta, Dept Pediat Neurosci, Child Neurol Unit, Milan, Italy.
   [Lamperti, Costanza; Tiranti, Valeria; Ghezzi, Daniele; Lamantea, Eleonora] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Ghezzi, Daniele] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Ardissone, Anna] Fdn IRCCS Ist Neurol Carlo Besta, Dept Pediat Neurosci, Child Neurol Unit, Via Celoria 11, I-20133 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Milan; Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Ardissone, A (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Pediat Neurosci, Child Neurol Unit, Via Celoria 11, I-20133 Milan, Italy.
EM anna.ardissone@istituto-besta.it
FU Italian Ministry of Health [RF-2016-02361241, RF-2016-02361495]; (Ricerca Corrente); European Joint Programme on Rare Diseases project GENOMIT (Italian Ministry of Health) [ERP-2019-23671045]; ERA PerMed project PerMiM (Italian Ministry of Health) [ERP-2019-23671048]; Mariani Foundation; BIBLIOSAN
CR Al-Hassnan ZN, 2015, J MED GENET, V52, P186, DOI 10.1136/jmedgenet-2014-102592
   Anteneová N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   Ardissone A, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-02029-3
   Ardissone A, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0788-4
   Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328
   Biancheri R, 2010, AJNR AM J NEURORADIOL, V31, PE78, DOI 10.3174/ajnr.A2182
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cruz S, 2017, MUSCLE NERVE, V56, P868, DOI 10.1002/mus.25593
   Dallabona C, 2016, BRAIN, V139, P782, DOI 10.1093/brain/awv392
   Danhelovska T, 2020, BMC PEDIATR, V20, P0, DOI 10.1186/s12887-020-1912-x
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   de Laat P, 2021, J MED GENET, V58, P48, DOI 10.1136/jmedgenet-2019-106800
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Fang F, 2017, SCI CHINA LIFE SCI, V60, P746, DOI 10.1007/s11427-017-9080-y
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Hu CP, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2020.103898
   Invernizzi F, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00412
   Lee JS, 2020, CLIN GENET, V97, P586, DOI 10.1111/cge.13713
   Legati A, 2021, J MOL DIAGN, V23, P732, DOI 10.1016/j.jmoldx.2021.03.002
   Loos MA, 2021, MOL GENET METAB REP, V27, P0, DOI 10.1016/j.ymgmr.2021.100733
   Lyseng-Williamson KA, 2016, DRUGS, V76, P805, DOI 10.1007/s40265-016-0574-3
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marco M, 2022, NEUROL SCI, V43, P2081, DOI 10.1007/s10072-022-05881-8
   Melchionda L, 2014, AM J HUM GENET, V95, P315, DOI 10.1016/j.ajhg.2014.08.003
   Naess K, 2021, J PEDIATR-US, V228, P240, DOI 10.1016/j.jpeds.2020.08.025
   Ogawa E, 2020, J INHERIT METAB DIS, V43, P819, DOI 10.1002/jimd.12218
   Puoti G, 2003, J MED GENET, V40, P858, DOI 10.1136/jmg.40.11.858
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Shinagawa Austin, 2020, RADIOL CASE REP, V15, P908, DOI 10.1016/j.radcr.2020.04.042
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Torraco A, 2017, J NEUROL, V264, P102, DOI 10.1007/s00415-016-8312-z
   Verity CM, 2010, DEV MED CHILD NEUROL, V52, P434, DOI 10.1111/j.1469-8749.2009.03463.x
   Wang W, 2021, NEUROMUSCULAR DISORD, V31, P558, DOI 10.1016/j.nmd.2021.02.020
   Zanolini A, 2017, MOL GENET METAB REP, V10, P24, DOI 10.1016/j.ymgmr.2016.11.009
NR 50
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD JUL 15
PY 2023
VL 30
IS 7
BP 2079
EP 2091
DI 10.1111/ene.15814
EA APR 2023
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA I1CO0
UT WOS:000979070900001
PM 37038312
DA 2024-11-01
ER

PT J
AU Siri, B
   D'Alessandro, A
   Maiorana, A
   Porzio, O
   Ravà, L
   Dionisi-Vici, C
   Cappa, M
   Martinelli, D
AF Siri, Barbara
   D'Alessandro, Annamaria
   Maiorana, Arianna
   Porzio, Ottavia
   Rava, Lucilla
   Dionisi-Vici, Carlo
   Cappa, Marco
   Martinelli, Diego
TI Adrenocortical function in patients with Single Large Scale Mitochondrial DNA Deletions: a retrospective single centre cohort study
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
DE single large scale mtDNA deletions; primary adrenal insufficiency; ACTH stimulation tests; glucocorticoid replacement therapy
ID kearns-sayre-syndrome; adrenal insufficiency; pearson-syndrome; acth; disorders; evolution; diagnosis; myopathy; spectrum; disease
AB Objective Single Large Scale Mitochondrial DNA Deletions (SLSMDs), Pearson Syndrome (PS) and Kearns-Sayre Syndrome (KSS), are systemic diseases with multiple endocrine abnormalities. The adrenocortical function has not been systematically investigated with a few anecdotal reports of overt adrenal insufficiency (AI). The study aimed to assess the adrenocortical function in a large cohort of SLSMDs.Design and methods A retrospective monocentric longitudinal study involved a cohort of 18 SLSMDs patients. Adrenocortical function was evaluated by baseline adrenocorticotrophic hormone (ACTH) and cortisol measurements and by high- (HDT) and low-dose (LDT) ACTH stimulation tests and compared with 92 healthy controls (HC).Results Baseline adrenocortical function was impaired in 39% of patients and by the end of the study, 66% of PS and 25% of KSS showed an insufficient increase after ACTH stimulation, with cortisol deficiency due to primary AI in most PS and subclinical AI in KSS. Symptomatic AI was recorded in 44% of patients. Peak cortisol levels after ACTH stimulation tests were significantly lower in patients than in HC (P < .0001), with a more reduced response to LDT vs HDT (P < .05).Conclusions Our study highlights that cortisol deficiency due to primary AI represents a relevant part of the clinical spectrum in SLSMDs, with more severe impairment in PS than in KSS. Basal and after-stimulus assessment of adrenocortical axis should be early and regularly investigated to identify any degree of adrenocortical dysfunction. The study allowed the elaboration of a diagnostic process designed for the diagnosis, treatment, and follow-up of adrenocortical abnormalities in SLSMDs.
C1 [Siri, Barbara; Maiorana, Arianna; Dionisi-Vici, Carlo; Martinelli, Diego] IRCCS, Bambino Gesu Childrens Hosp, Div Metab Dis & Hepatol, I-00165 Rome, Italy.
   [Siri, Barbara] Univ Turin, Dept Paediat, Citta Salute & Sci, OIRM, I-10126 Turin, Italy.
   [D'Alessandro, Annamaria] IRCCS, Bambino Gesu Childrens Hosp, Clin Biochem Lab, I-00165 Rome, Italy.
   [Rava, Lucilla] IRCCS, Bambino Gesu Childrens Hosp, Clin Epidemiol Unit, I-00165 Rome, Italy.
   [Cappa, Marco] IRCCS, Bambino Gesu Childrens Hosp, Res Area Innovat Therapies Endocrinopathies, I-00165 Rome, Italy.
   [Martinelli, Diego] Osped Pediatr Bambino Gesu, Div Metab Dis & Hepatol, Piazza St Onofrio 4, I-00165 Rome, Italy.
C3 IRCCS Bambino Gesu; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu
RP Siri, B; Martinelli, D (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Div Metab Dis & Hepatol, I-00165 Rome, Italy.; Martinelli, D (corresponding author), Osped Pediatr Bambino Gesu, Div Metab Dis & Hepatol, Piazza St Onofrio 4, I-00165 Rome, Italy.
EM barbara.siri@opbg.net; diego.martinelli@opbg.net
FU Istituto Superiore di Sanita [GR-2018-12368395]; Italian Ministry of Health
CR Artuch R, 1998, HORM RES, V50, P99, DOI 10.1159/000023243
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Biousse V, 2001, SEMIN NEUROL, V21, P275, DOI 10.1055/s-2001-17945
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   Bornstein SR, 2016, J CLIN ENDOCR METAB, V101, P364, DOI 10.1210/jc.2015-1710
   BROIDE J, 1995, J CLIN ENDOCR METAB, V80, P1243, DOI 10.1210/jc.80.4.1243
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   CROWLEY S, 1991, J ENDOCRINOL, V130, P475, DOI 10.1677/joe.0.1300475
   DAIDOH H, 1995, CLIN ENDOCRINOL, V43, P311, DOI 10.1111/j.1365-2265.1995.tb02037.x
   Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009
   Duran GP, 2012, JIMD REP, V3, P5, DOI 10.1007/8904_2011_33
   Gill H, 2019, J CLIN ENDOCR METAB, V104, P4587, DOI 10.1210/jc.2019-00295
   Giordano R, 2004, J CLIN ENDOCR METAB, V89, P675, DOI 10.1210/jc.2003-030814
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   GRAYBEAL ML, 1985, ACTA ENDOCRINOL-COP, V108, P401, DOI 10.1530/acta.0.1080401
   Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710
   Laureti S, 2000, CLIN ENDOCRINOL, V53, P107, DOI 10.1046/j.1365-2265.2000.01050.x
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014
   Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   North K, 1996, J PEDIATR-US, V128, P688, DOI 10.1016/S0022-3476(96)80136-3
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Prasad R, 2014, J ENDOCRINOL, V221, PR63, DOI 10.1530/JOE-13-0346
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   TORDJMAN K, 1995, J CLIN ENDOCR METAB, V80, P1301, DOI 10.1210/jc.80.4.1301
   Tzoufi M, 2013, EUR J PEDIATR, V172, P557, DOI 10.1007/s00431-012-1798-1
   Weintrob N, 1998, J CLIN ENDOCR METAB, V83, P88, DOI 10.1210/jc.83.1.88
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 37
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD NOV 8
PY 2023
VL 189
IS 5
BP 485
EP 494
DI 10.1093/ejendo/lvad137
EA NOV 2023
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA Y3GJ6
UT WOS:001104184200001
PM 37815532
DA 2024-11-01
ER

PT J
AU Gedikbasi, A
   Toksoy, G
   Karaca, M
   Gulec, C
   Balci, MC
   Gunes, D
   Gunes, S
   Aslanger, AD
   Unverengil, G
   Karaman, B
   Basaran, S
   Demirkol, M
   Gokcay, GF
   Uyguner, ZO
AF Gedikbasi, Asuman
   Toksoy, Guven
   Karaca, Meryem
   Gulec, Cagri
   Balci, Mehmet Cihan
   Gunes, Dilek
   Gunes, Seda
   Aslanger, Ayca Dilruba
   Unverengil, Gokcen
   Karaman, Birsen
   Basaran, Seher
   Demirkol, Mubeccel
   Gokcay, Gulden Fatma
   Uyguner, Zehra Oya
TI Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitochondrial diseases; mtDNA; bi-genomic sequencing; exome sequencing; differential diagnosis
ID deficiency; classification; mutations; diagnosis
AB Background: Mitochondrial diseases are the most common group of inherited metabolic disorders, causing difficulties in definite diagnosis due to clinical and genetic heterogeneity. Clinical components are predominantly associated with pathogenic variants shown in nuclear or mitochondrial genomes that affect vital respiratory chain function. The development of high-throughput sequencing technologies has accelerated the elucidation of the genetic etiology of many genetic diseases that previously remained undiagnosed. Methods: Thirty affected patients from 24 unrelated families with clinical, radiological, biochemical, and histopathological evaluations considered for mitochondrial diseases were investigated. DNA isolated from the peripheral blood samples of probands was sequenced for nuclear exome and mitochondrial DNA (mtDNA) analyses. MtDNA sequencing was also performed from the muscle biopsy material in one patient. For segregation, Sanger sequencing is performed for pathogenic alterations in five other affected family members and healthy parents. Results: Exome sequencing revealed 14 different pathogenic variants in nine genes encoding mitochondrial function peptides (AARS2, EARS2, ECHS1, FBXL4, MICOS13, NDUFAF6, OXCT1, POLG, and TK2) in 12 patients from nine families and four variants in genes encoding important for muscle structure (CAPN3, DYSF, and TCAP) in six patients from four families. Three probands carried pathogenic mtDNA variations in two genes (MT-ATP6 and MT-TL1). Nine variants in five genes are reported for the first time with disease association: (AARS2: c.277C>T/p.(R93*), c.845C>G/p.(S282C); EARS2: c.319C>T/p.(R107C), c.1283delC/p.(P428Lfs*); ECHS1: c.161G>A/p.(R54His); c.202G>A/p.(E68Lys); NDUFAF6: c.479delA/p.(N162Ifs*27); and OXCT1: c.1370C>T/p.(T457I), c.1173-139G>T/p.(?). Conclusion: Bi-genomic DNA sequencing clarified genetic etiology in 67% (16/24) of the families. Diagnostic utility by mtDNA sequencing in 13% (3/24) and exome sequencing in 54% (13/24) of the families prioritized searching for nuclear genome pathologies for the first-tier test. Weakness and muscle wasting observed in 17% (4/24) of the families underlined that limb-girdle muscular dystrophy, similar to mitochondrial myopathy, is an essential point for differential diagnosis. The correct diagnosis is crucial for comprehensive genetic counseling of families. Also, it contributes to making treatment-helpful referrals, such as ensuring early access to medication for patients with mutations in the TK2 gene.
C1 [Gedikbasi, Asuman; Karaman, Birsen] Istanbul Univ, Dept Pediat Basic Sci, Inst Child Hlth, Istanbul, Turkiye.
   [Gedikbasi, Asuman; Karaca, Meryem; Balci, Mehmet Cihan; Gunes, Dilek; Gunes, Seda; Demirkol, Mubeccel; Gokcay, Gulden Fatma] Istanbul Univ, Istanbul Fac Med, Dept Pediat, Div Pediat Nutr & Metab, Istanbul, Turkiye.
   [Toksoy, Guven; Gulec, Cagri; Aslanger, Ayca Dilruba; Karaman, Birsen; Basaran, Seher; Uyguner, Zehra Oya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkiye.
   [Unverengil, Gokcen] Istanbul Univ, Istanbul Fac Med, Dept Pathol, Istanbul, Turkiye.
C3 Istanbul University; Istanbul University; Istanbul University; Istanbul University
RP Uyguner, ZO (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkiye.
EM o.uyguner@istanbul.edu.tr
FU Scientific Research Projects Coordination Unit of Istanbul University [TDK-2018-32544]
CR Boczonadi V, 2018, FEBS LETT, V592, P703, DOI 10.1002/1873-3468.12962
   Catania A, 2018, J HUM GENET, V63, P563, DOI 10.1038/s10038-018-0423-1
   Desmet FO, 2009, NUCLEIC ACIDS RES, V37, P0, DOI 10.1093/nar/gkp215
   Dogan T, 2016, BIOINFORMATICS, V32, P2264, DOI 10.1093/bioinformatics/btw114
   Domínguez-González C, 2022, J NEUROL, V269, P3550, DOI 10.1007/s00415-021-10957-0
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Fernandez-Eulate G, 2022, J NEUROL NEUROSUR PS, V93, P413, DOI 10.1136/jnnp-2021-328045
   Ferreira CR, 2021, J INHERIT METAB DIS, V44, P164, DOI 10.1002/jimd.12348
   Fitzsimons PE, 2018, AM J MED GENET A, V176, P1115, DOI 10.1002/ajmg.a.38658
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Gödiker J, 2018, J HUM GENET, V63, P707, DOI 10.1038/s10038-018-0442-y
   Grünert SC, 2021, BIOCHIMIE, V183, P55, DOI 10.1016/j.biochi.2021.02.003
   Haack TB, 2015, ANN CLIN TRANSL NEUR, V2, P492, DOI 10.1002/acn3.189
   Hamosh A, 2005, NUCLEIC ACIDS RES, V33, P0
   Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739
   Kanehisa M, 2023, NUCLEIC ACIDS RES, V51, PD587, DOI 10.1093/nar/gkac963
   Kerr M, 2020, MOL GENET METAB, V131, P66, DOI 10.1016/j.ymgme.2020.08.009
   Kose M, 2021, J PEDIATR ENDOCR MET, V34, P417, DOI 10.1515/jpem-2020-0410
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Liu FC, 2016, INT J NEUROSCI, V126, P499, DOI 10.3109/00207454.2015.1034801
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Nigro Vincenzo, 2014, ACTA MYOL, V33, P1
   Orsucci D, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10061249
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Puusepp S, 2018, MOL GENET METAB REP, V15, P80, DOI 10.1016/j.ymgmr.2018.03.004
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, PD886, DOI 10.1093/nar/gky1016
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   Roux CJ, 2021, MOL GENET METAB, V133, P222, DOI 10.1016/j.ymgme.2021.04.004
   Sasai H, 2017, J INHERIT METAB DIS, V40, P845, DOI 10.1007/s10545-017-0065-z
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Stelzer G, 2016, CURR PROTOC BIOINFOR, V54, P1.30.1, DOI 10.1002 / cpbi.5
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Turvey AK, 2022, FRONT PHYSIOL, V13, P0, DOI 10.3389/fphys.2022.1029218
   Wang L, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0859-6
   Webb Bryn D, 2020, J TRANSL GENET GENOM, V4, P71, DOI 10.20517/jtgg.2020.11
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 46
TC 2
Z9 2
U1 11
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JUN 12
PY 2023
VL 14
IS 
BP 
EP 
DI 10.3389/fgene.2023.1191159
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA L0II9
UT WOS:001020172900001
PM 37377599
DA 2024-11-01
ER

PT J
AU Ewert, R
   Elhadad, MA
   Habedank, D
   Heine, A
   Stubbe, B
AF Ewert, Ralf
   Elhadad, Mohamed A. A.
   Habedank, Dirk
   Heine, Alexander
   Stubbe, Beate
TI Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation - a case report
SO BMC PULMONARY MEDICINE
LA English
DT Article
DE Case report; Dyspnea; Invasive cardiopulmonary exercise testing; Lactate; Metabolic myopathy; Mitochondriopathy
ID exercise; statement
AB BackgroundPrimary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findings that can be classified in the known pathologies of mitochondrial deletion syndrome.Case presentationThe patient presented to us at 29 years of age, having had tachycardia, dyspnea, and functional impairment since childhood. She had been diagnosed with bronchial asthma and mild left ventricular hypertrophy and treated accordingly, but her symptoms had worsened. After more than 20 years of progressive physical and social limitations was a mitochondrial disease suspected in the exercise testing. We performed cardiopulmonary exercise testing (CPET) with right heart catheterization showed typical signs of mitochondrial myopathy. Genetic testing confirmed the presence of a similar to 13 kb deletion in mitochondrial DNA from the muscle. The patient was treated with dietary supplements for 1 year. In the course of time, the patient gave birth to a healthy child, which is developing normally.ConclusionCPET and lung function data over 5 years demonstrated stable disease. We conclude that CPET and lung function analysis should be used consistently to evaluate the cause of dyspnea and for long-term observation.
C1 [Ewert, Ralf; Elhadad, Mohamed A. A.; Habedank, Dirk; Heine, Alexander; Stubbe, Beate] Univ Hosp Greifswald, Dept Internal Med B Pneumol, F Sauerbruchstr, D-17475 Greifswald, Germany.
   [Habedank, Dirk] Hosp Berlin, DRK, Berlin, Germany.
RP Stubbe, B (corresponding author), Univ Hosp Greifswald, Dept Internal Med B Pneumol, F Sauerbruchstr, D-17475 Greifswald, Germany.
EM beate.stubbe@med.uni-greifswald.de
FU Ernst-Moritz-Arndt University (Greifswald, Germany)
CR Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BOGAARD JM, 1988, EUR RESPIR J, V1, P445
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Das AM, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/340849
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Karaa A, 2019, MITOCHONDRION, V46, P214, DOI 10.1016/j.mito.2018.06.007
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST
   Riley MS, 2017, ANN AM THORAC SOC, V14, PS129, DOI 10.1513/AnnalsATS.201701-014FR
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Wasserman K, 2002, AM J RESP CRIT CARE, V166, P118
NR 15
TC 1
Z9 1
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2466
EI 
J9 BMC PULM MED
JI BMC Pulm. Med.
PD MAR 29
PY 2023
VL 23
IS 1
BP 
EP 
DI 10.1186/s12890-023-02391-x
PG 6
WC Respiratory System
SC Respiratory System
GA C2RY6
UT WOS:000960463300002
PM 36991405
DA 2024-11-01
ER

PT J
AU Smith, IC
   Chakraborty, S
   Bourque, PR
   Sampaio, ML
   Melkus, G
   Lochmüller, H
   Woulfe, J
   Parks, RJ
   Brais, B
   Warman-Chardon, J
AF Smith, Ian C.
   Chakraborty, Shaoni
   Bourque, Pierre R.
   Sampaio, Marcos L.
   Melkus, Gerd
   Lochmueller, Hanns
   Woulfe, John
   Parks, Robin J.
   Brais, Bernard
   Warman-Chardon, Jodi
TI Emerging and established biomarkers of oculopharyngeal muscular dystrophy
SO NEUROMUSCULAR DISORDERS
LA English
DT Review
DE Neuromuscular disorders; Biomarker discovery; Clinical; Biochemical; Imaging; Pathology
ID mitochondrial-dna deletions; qol outcomes tool; nuclear inclusions; oropharyngeal dysphagia; swal-qol; neuromuscular diseases; ambulatory capacity; poly(a) polymerase; monozygotic twins; muscle weakness
AB Oculopharyngeal muscular dystrophy (OPMD) is a rare, primarily autosomal dominant, late onset muscular dystrophy commonly presenting with ptosis, dysphagia, and subsequent weakness of proximal muscles. Although OPMD diagnosis can be confirmed with high confidence by genetic testing, the slow progression of OPMD poses a significant challenge to clinical monitoring and a barrier to assessing the efficacy of treatments during clinical trials. Accordingly, there is a pressing need for more sensitive measures of OPMD progression, particularly those which do not require a muscle biopsy. This review provides an overview of progress in OPMD biomarkers from clinical assessment, quantitative imaging, histological assessments, and genomics, as well as hypothesis-generating "omics" approaches. The ongoing search for biomarkers relevant to OPMD progression needs an integrative, longitudinal approach combining validated and experimental approaches which may include clinical, imaging, demographic, and biochemical assessment methods. A multi-omics approach to biochemical biomarker discovery could help provide context for differences found between individuals with varying levels of disease activity and provide insight into pathomechanisms and prognosis of OPMD.(c) 2023 Published by Elsevier B.V.
C1 [Smith, Ian C.; Lochmueller, Hanns; Woulfe, John; Parks, Robin J.; Warman-Chardon, Jodi] Ottawa Hosp Res Inst, Ottawa, ON K1Y 4E9, Canada.
   [Chakraborty, Shaoni] Univ Ottawa, Fac Sci, Ottawa, ON K1N 9B4, Canada.
   [Bourque, Pierre R.; Sampaio, Marcos L.; Melkus, Gerd; Lochmueller, Hanns; Warman-Chardon, Jodi] Univ Ottawa, Fac Med, Ottawa, ON K1H 8M5, Canada.
   [Bourque, Pierre R.; Lochmueller, Hanns; Parks, Robin J.; Warman-Chardon, Jodi] Univ Ottawa, Ottawa Hosp, Dept Med, Ottawa, ON K1H 8L6, Canada.
   [Bourque, Pierre R.; Sampaio, Marcos L.; Melkus, Gerd; Lochmueller, Hanns; Woulfe, John; Parks, Robin J.; Warman-Chardon, Jodi] Univ Ottawa, Eric Poulin Ctr Neuromuscular Dis, Ottawa, ON, Canada.
   [Sampaio, Marcos L.; Melkus, Gerd] Ottawa Hosp, Dept Med Imaging, Ottawa, ON K1Y 4E9, Canada.
   [Sampaio, Marcos L.] Univ Ottawa, Dept Radiol Radiat Oncol & Med Phys, Ottawa, ON K1N 6N5, Canada.
   [Melkus, Gerd] Carleton Univ, Dept Phys, Ottawa, ON K1S 5B6, Canada.
   [Lochmueller, Hanns; Warman-Chardon, Jodi] Childrens Hosp Eastern Ontario, Genet, Ottawa, ON K1H 8L1, Canada.
   [Woulfe, John] Ottawa Hosp, Dept Pathol & Lab Med, Ottawa, ON K1Y 4E9, Canada.
   [Brais, Bernard; Warman-Chardon, Jodi] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada.
   [Warman-Chardon, Jodi] Ottawa Hosp Res Inst, NeuroMuscular Ctr, Civ Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.
C3 University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Carleton University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute; McGill University; University of Ottawa; Ottawa Hospital Research Institute
RP Warman-Chardon, J (corresponding author), Ottawa Hosp Res Inst, NeuroMuscular Ctr, Civ Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.
EM jwarman@toh.ca
FU Eric Poulin ALS Translational Research Fund; University of Ottawa Department of Radiology; Canadian Institutes of Health Research [INS-464765, FDN-167281, FRN-142316, PJT-178120, FRN-175428, PJT-186267]; Canadian Institutes of Health Research and Muscular Dystrophy Canada; Canada Foundation for Innovation [CFI-JELF 38412]; Canada Research Chairs program (Canada Research Chair in Neuromuscular Genomics and Health) [950-232279]; Natural Sciences and Engineering Research Council [RGPIN-2019-04786]; Department of Medicine University of Ottawa Clinical Research Chair; Physician Services Incorporated [19-28]; Muscular Dystrophy Canada [932196]
CR Abu-Baker A, 2018, NEUROLOGY, V91, PE551, DOI 10.1212/WNL.0000000000005942
   Alghadir AH, 2017, AFR HEALTH SCI, V17, P133, DOI 10.4314/ahs.v17i1.17
   Alonso-Jimenez A, 2019, J NEUROL NEUROSUR PS, V90, P576, DOI 10.1136/jnnp-2018-319578
   Alonso-Perez J, 2022, EUR J NEUROL, V29, P1488, DOI 10.1111/ene.15252
   Anvar SY, 2013, AGING-US, V5, P412, DOI 10.18632/aging.100567
   Anvar SY, 2011, SKELET MUSCLE, V1, P0, DOI 10.1186/2044-5040-1-15
   Apponi LH, 2013, SKELET MUSCLE, V3, P0, DOI 10.1186/2044-5040-3-23
   Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569
   Argov Z, 2016, NEUROLOGY, V86, P0
   Aryani O, 2017, IRAN J NEUROL, V16, P98
   Acosta-Mérida MA, 2016, REV ESP ENFERM DIG, V108, P843, DOI 10.17235/reed.2016.4266/2016
   Baird MF, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/960363
   Banerjee A, 2019, J BIOL CHEM, V294, P7360, DOI 10.1074/jbc.RA118.007287
   Banerjee A, 2013, FEBS J, V280, P4230, DOI 10.1111/febs.12294
   Bann CM, 2015, NEUROLOGY, V84, P1034, DOI 10.1212/WNL.0000000000001336
   Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109
   Barp A, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11081246
   Becher MW, 2001, JAMA-J AM MED ASSOC, V286, P2437, DOI 10.1001/jama.286.19.2437
   Bérard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004
   Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101
   BLUMEN SC, 1993, NEUROMUSCULAR DISORD, V3, P575, DOI 10.1016/0960-8966(93)90119-5
   Blumen SC, 2000, NEUROLOGY, V55, P1267, DOI 10.1212/WNL.55.9.1267
   Blumen SC, 1999, ANN NEUROL, V46, P115, DOI 10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.0.CO;2-O
   Bouazza B, 2008, MYOLOGY 2008, V0, P0
   Bouazza B, 2009, NEUROMUSCULAR DISORD, V19, P199, DOI 10.1016/j.nmd.2008.12.003
   Bouchard JP, 1997, NEUROMUSCULAR DISORD, V7, PS5, DOI 10.1016/S0960-8966(97)00074-6
   Brais B, 1997, NEUROMUSCULAR DISORD, V7, PS70, DOI 10.1016/S0960-8966(97)00086-2
   Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164
   Brais B, 2009, CURR NEUROL NEUROSCI, V9, P76, DOI 10.1007/s11910-009-0012-y
   Brisson JD, 2020, MUSCLE NERVE, V62, P201, DOI 10.1002/mus.26888
   Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924
   Carlier Pierre G, 2016, J NEUROMUSCUL DIS, V3, P1
   Carr SJ, 2018, PROTEOM CLIN APPL, V12, P0, DOI 10.1002/prca.201700071
   Catoire H, 2008, HUM MOL GENET, V17, P2108, DOI 10.1093/hmg/ddn109
   Chardon JW, 2019, NEUROMUSCULAR DISORD, V29, P827, DOI 10.1016/j.nmd.2019.08.011
   Chardon JW, 2015, CURR NEUROL NEUROSCI, V15, P0, DOI 10.1007/s11910-015-0584-7
   Chartier A, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005092
   Conklin LS, 2018, STEROIDS, V140, P159, DOI 10.1016/j.steroids.2018.10.008
   Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019
   Cortese A, 2020, NAT GENET, V52, P473, DOI 10.1038/s41588-020-0615-4
   Côté C, 2022, QUAL LIFE RES, V31, P293, DOI 10.1007/s11136-021-02915-0
   Dahlqvist JR, 2020, ANN NEUROL, V88, P669, DOI 10.1002/ana.25804
   Dang UJ, 2020, HUM MOL GENET, V29, P2481, DOI 10.1093/hmg/ddaa132
   Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422
   Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242
   de Swart BJM, 2006, J NEUROL NEUROSUR PS, V77, P266, DOI 10.1136/jnnp.2005.062521
   Dion P, 2005, NEUROBIOL DIS, V18, P528, DOI 10.1016/j.nbd.2004.09.021
   Dionne A, 2011, NEUROL PRACT, V0, P87
   Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2
   Gadesmann M, 2008, INT J LANG COMM DIS, V43, P41, DOI 10.1080/13682820701234444
   Galimberti V, 2020, EUR J NEUROL, V27, P709, DOI 10.1111/ene.14131
   Gambelli S, 2004, EUR NEUROL, V51, P144, DOI 10.1159/000077070
   Gidaro T, 2013, J NEUROPATH EXP NEUR, V72, P234, DOI 10.1097/NEN.0b013e3182854c07
   Glinge C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0167969
   Gloor M, 2011, J MAGN RESON IMAGING, V33, P203, DOI 10.1002/jmri.22431
   Goemans N, 2017, NEUROMUSCULAR DISORD, V27, P203, DOI 10.1016/j.nmd.2016.11.013
   Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006
   Grewal RP, 1999, ARCH NEUROL-CHICAGO, V56, P1378, DOI 10.1001/archneur.56.11.1378
   GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818
   Harish P, 2023, METABOLITES, V13, P0, DOI 10.3390/metabo13060769
   Harish P, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00184
   Harish P, 2019, J CACHEXIA SARCOPENI, V10, P1016, DOI 10.1002/jcsm.12438
   Hathout Y, 2015, P NATL ACAD SCI USA, V112, P7153, DOI 10.1073/pnas.1507719112
   Hebbar S, 2007, NEUROMUSCULAR DISORD, V17, P254, DOI 10.1016/j.nmd.2006.11.009
   Helmy H, 2018, EGYPT J NEUROL PSYCH, V54, P0, DOI 10.1186/s41983-018-0039-6
   Herbison GJ, 1996, SPINAL CORD, V34, P543, DOI 10.1038/sc.1996.98
   Huang J, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.659760
   Huang SH, 2021, AESTHET SURG J, V41, PNP260, DOI 10.1093/asj/sjaa429
   Hutcheson KA, 2017, CANCER-AM CANCER SOC, V123, P62, DOI 10.1002/cncr.30283
   Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5
   Jordan DR, 2022, OPHTHAL PLAST RECONS, V38, P535, DOI 10.1097/IOP.0000000000002118
   Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347
   Kroon R, 2021, IMAGING, V31, P0
   Kroon RHMJM, 2021, NEUROLOGY, V97, PE1475, DOI 10.1212/WNL.0000000000012640
   Kroon RHMJM, 2020, J NEUROMUSCULAR DIS, V7, P483, DOI 10.3233/JND-200511
   Kühn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226
   Kurtz NS, 2019, MUSCLE NERVE, V60, P724, DOI 10.1002/mus.26712
   Leonard R, 2011, DYSPHAGIA, V26, P13, DOI 10.1007/s00455-009-9258-4
   Leung DG, 2017, J NEUROL, V264, P1320, DOI 10.1007/s00415-016-8350-6
   Lezza AMS, 1997, FEBS LETT, V418, P167, DOI 10.1016/S0014-5793(97)01374-4
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   Li SX, 2022, CURR OPIN STRUC BIOL, V75, P0, DOI 10.1016/j.sbi.2022.102430
   Maksimova NR, 2008, ZH NEVROL PSIKHIATR, V108, P52
   Malerba A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14848
   Malerba A, 2019, HUM MOL GENET, V28, P1694, DOI 10.1093/hmg/ddz007
   Mancopes Renata, 2021, OBM GERIAT, V5, P0, DOI 10.21926/obm.geriatr.2101153
   Manjaly JG, 2012, DYSPHAGIA, V27, P216, DOI 10.1007/s00455-011-9356-y
   Marusin A V, 2016, GENETIKA, V52, P376
   Matsubara S, 2016, NEUROMUSCULAR DISORD, V26, P436, DOI 10.1016/j.nmd.2016.05.001
   McHorney CA, 2000, DYSPHAGIA, V15, P115, DOI 10.1007/s004550010012
   McHorney CA, 2000, DYSPHAGIA, V15, P122, DOI 10.1007/s004550010013
   McHorney CA, 2002, DYSPHAGIA, V17, P97, DOI 10.1007/s00455-001-0109-1
   Melkus G, 2023, NEUROMUSCULAR DISORD, V33, P24, DOI 10.1016/j.nmd.2022.09.010
   Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006
   Mihaylova V, 2008, J NEUROL, V255, P609, DOI 10.1007/s00415-008-0769-y
   Mubeen S, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.01203
   Muqit MMK, 2008, J NEUROL NEUROSUR PS, V79, P68, DOI 10.1136/jnnp.2006.112250
   Nishii YS, 2021, BMC NEUROL, V21, P0, DOI 10.1186/s12883-021-02300-x
   Noreau L, 1998, SPINAL CORD, V36, P716, DOI 10.1038/sj.sc.3100646
   OBrien J, 2018, FRONT ENDOCRINOL, V9, P0, DOI 10.3389/fendo.2018.00402
   Obert LA, 2021, TOXICOL PATHOL, V49, P996, DOI 10.1177/0192623320985045
   Olie CS, 2019, ISCIENCE, V12, P318, DOI 10.1016/j.isci.2019.01.024
   Oppenheim JJ, 2018, CSH PERSPECT BIOL, V10, P0, DOI 10.1101/cshperspect.a028498
   Park RB, 2023, ORBIT-ABINGDON, V42, P11, DOI 10.1080/01676830.2022.2122514
   Peek K, 2014, JBI DATABASE OF SYSTEMATIC REVIEWS AND IMPLEMENTATION REPORTS, V12, P349, DOI 10.11124/JBISRIR-2014-1503
   Périé S, 2014, MOL THER, V22, P219, DOI 10.1038/mt.2013.155
   Pillen S, 2008, MUSCLE NERVE, V37, P679, DOI 10.1002/mus.21015
   Pinu FR, 2019, METABOLITES, V9, P0, DOI 10.3390/metabo9060108
   Prasad A, 2019, FRONT MOL NEUROSCI, V12, P0, DOI 10.3389/fnmol.2019.00025
   Rådjursöga M, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10081063
   Raz V, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21176059
   Raz V, 2013, NEUROMUSCULAR DISORD, V23, P516, DOI 10.1016/j.nmd.2013.03.001
   Raz V, 2011, AM J PATHOL, V179, P1988, DOI 10.1016/j.ajpath.2011.06.044
   Raz V, 2011, NUCLEUS-PHILA, V2, P208, DOI 10.4161/nucl.2.3.15736
   Riaz M, 2016, HUM MOL GENET, V25, P4282, DOI 10.1093/hmg/ddw259
   Richard P, 2017, NEUROLOGY, V88, P359, DOI 10.1212/WNL.0000000000003554
   Roberts TC, 2023, NAT REV DRUG DISCOV, V22, P917, DOI 10.1038/s41573-023-00775-6
   Robinson DO, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.037598
   Robinson DO, 2005, HUM GENET, V116, P267, DOI 10.1007/s00439-004-1235-2
   Roos A, 2018, PROTEOM CLIN APPL, V12, P0, DOI 10.1002/prca.201700073
   Schranner D, 2020, SPORTS MED-OPEN, V6, P0, DOI 10.1186/s40798-020-0238-4
   Semmler A, 2007, MUSCLE NERVE, V35, P681, DOI 10.1002/mus.20726
   Senior JR, 2014, DRUG SAFETY, V37, PS9, DOI 10.1007/s40264-014-0182-7
   Serradell AP, 2004, NEUROLOGIA, V19, P239
   Sethi PK, 2016, PEDIATR RES, V79, P409, DOI 10.1038/pr.2015.237
   Shan JL, 2014, NEUROMOL MED, V16, P782, DOI 10.1007/s12017-014-8327-5
   Spriggs BL, 2004, ASHG ANN M, V0, P0
   Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025
   Strings-Ufombah V, 2021, MOL THER-NUCL ACIDS, V24, P67, DOI 10.1016/j.omtn.2021.02.017
   Tabor LC, 2018, NEUROGASTROENT MOTIL, V30, P0, DOI 10.1111/nmo.13251
   Thompson R, 2020, LANCET NEUROL, V19, P522, DOI 10.1016/S1474-4422(20)30028-4
   TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226
   Tondo M, 2012, J NEUROL, V259, P1546, DOI 10.1007/s00415-011-6374-5
   Trollet C, 1993, GENEREVIEWS R, V0, P0
   Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098
   Uppot RN, 2018, BRIT J RADIOL, V91, P0, DOI 10.1259/bjr.20170931
   Urtizberea JA, 2004, OCULOPHARYNGEAL MUSCULAR DYSTROPHY, V0, P0
   Uyama E, 2000, MUSCLE NERVE, V23, P1549, DOI 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0
   van der Sluijs BM, 2017, NEUROMUSCULAR DISORD, V27, P1099, DOI 10.1016/j.nmd.2017.09.010
   van der Sluijs B M, 2016, J NEUROMUSCUL DIS, V3, P101
   Vest KE, 2017, HUM MOL GENET, V26, P3235, DOI 10.1093/hmg/ddx206
   VICTOR M, 1962, NEW ENGL J MED, V267, P1267, DOI 10.1056/NEJM196212202672501
   WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J
   Waito AA, 2018, DYSPHAGIA, V33, P789, DOI 10.1007/s00455-018-9904-9
   Wallace AL, 2000, GASTROENTEROLOGY, V118, P678, DOI 10.1016/S0016-5085(00)70137-5
   Walters J, 2022, PRACT NEUROL, V22, P358, DOI 10.1136/pn-2022-003422
   Wang Z, 2015, ANAL BIOCHEM, V490, P1, DOI 10.1016/j.ab.2015.08.024
   Warman-Chardon J, 2020, NEUROMUSCULAR DISORD, V30, P938, DOI 10.1016/j.nmd.2020.08.360
   Werling S, 2015, ANN GASTROENTEROL, V28, P291
   Yamashita S, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10071375
   Young SP, 2009, GENET MED, V11, P536, DOI 10.1097/GIM.0b013e3181a87867
   Youssof S, 2014, MUSCLE NERVE, V49, P601, DOI 10.1002/mus.24123
   Zaidman CM, 2021, MUSCLE NERVE, V64, P6, DOI 10.1002/mus.27258
NR 153
TC 0
Z9 0
U1 3
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD NOV 15
PY 2023
VL 33
IS 11
BP 824
EP 834
DI 10.1016/j.nmd.2023.09.010
EA NOV 2023
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CU2A1
UT WOS:001127673700001
PM 37926637
DA 2024-11-01
ER

PT J
AU Magistrati, M
   Gilea, AI
   Gerra, MC
   Baruffini, E
   Dallabona, C
AF Magistrati, Martina
   Gilea, Alexandru Ionut
   Gerra, Maria Carla
   Baruffini, Enrico
   Dallabona, Cristina
TI Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast <i>Saccharomyces cerevisiae</i>
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE drug drop test; yeast model; Saccharomyces cerevisiae; drug repurposing; mitochondrial diseases
ID dynamin-related gtpase; dna-polymerase-gamma; progressive external ophthalmoplegia; kinase-associated neurodegeneration; adenine-nucleotide translocator; dominant optic atrophy; respiratory-chain supercomplexes; complex-iii deficiency; to-c mutation; atp synthase
AB Mitochondrial diseases (MDs) refer to a group of clinically and genetically heterogeneous pathologies characterized by defective mitochondrial function and energy production. Unfortunately, there is no effective treatment for most MDs, and current therapeutic management is limited to relieving symptoms. The yeast Saccharomyces cerevisiae has been efficiently used as a model organism to study mitochondria-related disorders thanks to its easy manipulation and well-known mitochondrial biogenesis and metabolism. It has been successfully exploited both to validate alleged pathogenic variants identified in patients and to discover potential beneficial molecules for their treatment. The so-called "drug drop test", a phenotype-based high-throughput screening, especially if coupled with a drug repurposing approach, allows the identification of molecules with high translational potential in a cost-effective and time-saving manner. In addition to drug identification, S. cerevisiae can be used to point out the drug's target or pathway. To date, drug drop tests have been successfully carried out for a variety of disease models, leading to very promising results. The most relevant aspect is that studies on more complex model organisms confirmed the effectiveness of the drugs, strengthening the results obtained in yeast and demonstrating the usefulness of this screening as a novel approach to revealing new therapeutic molecules for MDs.
C1 [Magistrati, Martina; Gilea, Alexandru Ionut; Gerra, Maria Carla; Baruffini, Enrico; Dallabona, Cristina] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
C3 University of Parma
RP Dallabona, C (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM martina.magistrati@unipr.it; alexandruionut.gilea@unipr.it; mariacarla.gerra@unipr.it; enrico.baruffini@unipr.it; cristina.dallabona@unipr.it
FU COMP-HUB Initiative; Departments of Excellence' program of the Italian Ministry for Education, University and Research; Consorzio Interuniversitario per le Biotecnologie (CIB); MUR [1059-09/08/2021]; Italian "Fondazione Telethon" [GGP19287A]
CR Aiyar RS, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6585
   Aleo SJ, 2020, HUM MOL GENET, V29, P3631, DOI 10.1093/hmg/ddaa244
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alfonso-Pecchio A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0049509
   AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439
   Alvarez-Córdoba M, 2019, MOL NEUROBIOL, V56, P3638, DOI 10.1007/s12035-018-1333-0
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   Amemiya A, 1993, POLG RELATED DISORDE, V0, P0
   Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   [Anonymous], 1909, KLIN MON AUGENHEILKD, V0, P0
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855
   Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005
   Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733
   Barboni P, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws280
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   Baumann M, 2019, CLIN GENET, V95, P182, DOI 10.1111/cge.13462
   Berti CC, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12020300
   Binieda K, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22020914
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   BOTSTEIN D, 1991, HOSP PRACT, V26, P157
   Bottani E, 2020, PHARMACEUTICS, V12, P0, DOI 10.3390/pharmaceutics12111083
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   Brunetti D, 2014, BRAIN, V137, P57, DOI 10.1093/brain/awt325
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awu234
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Berti CC, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22010293
   Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011
   Chang XT, 2020, CNS NEUROSCI THER, V26, P754, DOI 10.1111/cns.13294
   Christou YP, 2017, CASE REP NEUROL MED, V2017, P0, DOI 10.1155/2017/3247034
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dallabona C, 2017, BIOCHEM BIOPH RES CO, V493, P909, DOI 10.1016/j.bbrc.2017.09.122
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   de Tilques MD, 2018, MICROB CELL, V5, P220, DOI 10.15698/mic2018.05.629
   de Tilques MD, 2017, DIS MODEL MECH, V10, P439, DOI 10.1242/dmm.027540
   deCoo IFM, 1996, AM J HUM GENET, V58, P636
   Del Dotto V, 2018, BBA-MOL BASIS DIS, V1864, P3496, DOI 10.1016/j.bbadis.2018.08.004
   Del Dotto V, 2018, PHARMACOL RES, V131, P199, DOI 10.1016/j.phrs.2018.02.018
   Delerue T, 2019, DIS MODEL MECH, V12, P0, DOI 10.1242/dmm.036558
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Di Meo I, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-11564-8
   di Punzio G, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222212223
   di Punzio G, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094461
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Ding QJ, 2020, LIFE-BASEL, V10, P0, DOI 10.3390/life10090215
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   DRGON T, 1992, FEBS LETT, V304, P277, DOI 10.1016/0014-5793(92)80637-V
   Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005
   Duina AA, 2014, GENETICS, V197, P33, DOI 10.1534/genetics.114.163188
   Dujon B, 2020, YEAST, V37, P191, DOI 10.1002/yea.3445
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Facchinello N, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-020-03359-z
   Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Fernández-Vizarra E, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00134
   Ferri L, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-27
   Figuccia S, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094524
   Fink GR, 1991, GUIDE YEAST GENETICS, V0, P0
   Finsterer J, 2018, NEUROPEDIATRICS, V49, P231, DOI 10.1055/s-0037-1609039
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friggeri L, 2019, J MED CHEM, V62, P10391, DOI 10.1021/acs.jmedchem.9b01485
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   Gilberti M, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0205014
   Gilea AI, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12121866
   Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546
   Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8
   Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929
   Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x
   GUAN KL, 1993, CURR GENET, V24, P141, DOI 10.1007/BF00324678
   Guthrie C, 2002, PART B METHODS ENZYM, V0, P0
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817
   HIGGINS JJ, 1992, NEUROLOGY, V42, P194, DOI 10.1212/WNL.42.1.194
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021
   Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534
   Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200
   Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006
   Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100
   Hörtnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026
   Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jeong SY, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201910489
   Johnson MA, 2004, ANN NY ACAD SCI, V1012, P282, DOI 10.1196/annals.1306.023
   JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   JONES BA, 1992, GENE DEV, V6, P380, DOI 10.1101/gad.6.3.380
   Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaminska J, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23095106
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   King MS, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000256
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Klopstock T, 2019, LANCET NEUROL, V18, P631, DOI 10.1016/S1474-4422(19)30142-5
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005
   Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132
   Kruer MC, 2011, BRAIN, V134, P947, DOI 10.1093/brain/awr042
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   LAWSON JE, 1988, J BIOL CHEM, V263, P14812
   Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200
   Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x
   Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200
   LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034
   Lodi T, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00106
   Löllgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   Luna-Sanchez M, 2020, MOL THER, V28, P1918, DOI 10.1016/j.ymthe.2020.06.010
   Lynch DS, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000188
   Magistrati M, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24032178
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Martorano L, 2019, DIS MODEL MECH, V12, P0, DOI 10.1242/dmm.037226
   Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015
   Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012
   Miller-Fleming Leonor, 2008, BIOTECHNOL J, V3, P325, DOI 10.1002/biot.200700217
   Moreno SNJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P15, DOI 10.1006/abbi.1996.0041
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nasca A, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0641-1
   Nolli C, 2015, MITOCHONDRION, V25, P38, DOI 10.1016/j.mito.2015.10.002
   Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1
   Orellana DI, 2016, EMBO MOL MED, V8, P1197, DOI 10.15252/emmm.201606391
   Ostojic J, 2013, CELL METAB, V18, P567, DOI 10.1016/j.cmet.2013.08.017
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Panozzo C, 2017, BBA-MOL CELL RES, V1864, P2297, DOI 10.1016/j.bbamcr.2017.09.003
   Pellecchia MT, 2005, NEUROLOGY, V64, P1810, DOI 10.1212/01.WNL.0000161843.52641.EC
   Pelloquin L, 1998, BIOCHEM BIOPH RES CO, V251, P720, DOI 10.1006/bbrc.1998.9539
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107
   Reeder NL, 2011, ANTIMICROB AGENTS CH, V55, P5753, DOI 10.1128/AAC.00724-11
   Reinhold R, 2012, MOL CELL BIOL, V32, P5009, DOI 10.1128/MCB.00843-12
   Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103
   Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Santambrogio P, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21103664
   Sarzi E, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20838-8
   SCHLAME M, 1993, J BIOL CHEM, V268, P74
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015
   Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200
   Selvaag E, 2000, EUR J DERMATOL, V10, P91
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Siddiqi S, 2013, J HUM GENET, V58, P819, DOI 10.1038/jhg.2013.101
   Soczewka P, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22052248
   Soczewka P, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11070828
   Soczewka P, 2019, DIS MODEL MECH, V12, P0, DOI 10.1242/dmm.036830
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   St Onge R, 2012, MOLECULES, V17, P13098, DOI 10.3390/molecules171113098
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Su X, 2021, HUM MOL GENET, V30, P381, DOI 10.1093/hmg/ddab043
   Talevi A, 2020, EXPERT OPIN DRUG DIS, V15, P397, DOI 10.1080/17460441.2020.1704729
   Tan J, 2020, EBIOMEDICINE, V54, P0, DOI 10.1016/j.ebiom.2020.102730
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491
   THOMAS PK, 1984, J NEUROL SCI, V64, P137, DOI 10.1016/0022-510X(84)90032-7
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Tibbetts AS, 2002, ARCH BIOCHEM BIOPHYS, V406, P96, DOI 10.1016/S0003-9861(02)00419-8
   Tribouillard-Tanvier Deborah, 2022, METHODS MOL BIOL, V2497, P221, DOI 10.1007/978-1-0716-2309-1_14
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Voisset C, 2014, DIS MODEL MECH, V7, P435, DOI 10.1242/dmm.014308
   Votruba M, 1998, HUM GENET, V102, P79, DOI 10.1007/s004390050657
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Wen SZ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36313
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015
   Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341
   Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zara V, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms231810537
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572
NR 258
TC 4
Z9 4
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 15
PY 2023
VL 24
IS 13
BP 
EP 
DI 10.3390/ijms241310696
PG 34
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA M5TU1
UT WOS:001030848700001
PM 37445873
DA 2024-11-01
ER

PT J
AU Sturm, G
   Karan, KR
   Monzel, AS
   Santhanam, B
   Taivassalo, T
   Bris, C
   Ware, SA
   Cross, M
   Towheed, A
   Higgins-Chen, A
   McManus, MJ
   Cardenas, A
   Lin, J
   Epel, ES
   Rahman, S
   Vissing, J
   Grassi, B
   Levine, M
   Horvath, S
   Haller, RG
   Lenaers, G
   Wallace, DC
   St-Onge, MP
   Tavazoie, S
   Procaccio, V
   Kaufman, BA
   Seifert, EL
   Hirano, M
   Picard, M
AF Sturm, Gabriel
   Karan, Kalpita R.
   Monzel, Anna S.
   Santhanam, Balaji
   Taivassalo, Tanja
   Bris, Celine
   Ware, Sarah A.
   Cross, Marissa
   Towheed, Atif
   Higgins-Chen, Albert
   McManus, Meagan J.
   Cardenas, Andres
   Lin, Jue
   Epel, Elissa S.
   Rahman, Shamima
   Vissing, John
   Grassi, Bruno
   Levine, Morgan
   Horvath, Steve
   Haller, Ronald G.
   Lenaers, Guy
   Wallace, Douglas C.
   St-Onge, Marie-Pierre
   Tavazoie, Saeed
   Procaccio, Vincent
   Kaufman, Brett A.
   Seifert, Erin L.
   Hirano, Michio
   Picard, Martin
TI OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases
SO COMMUNICATIONS BIOLOGY
LA English
DT Article
ID c-oxidase deficiency; energy-expenditure; metabolic-rate; stress-response; dna deletions; exercise; dysfunction; mutations; myopathy; mechanism
AB A meta-analysis of 17 cohorts of mitochondrial disease patients reveals that OxPhos defects are associated with signs of hypermetabolism. Experiments in patient-derived fibroblast show that mitochondrial OxPhos defects trigger hypermetabolism in a cell-autonomous manner and this is linked to accelerated telomere shortening and epigenetic aging. Patients with primary mitochondrial oxidative phosphorylation (OxPhos) defects present with fatigue and multi-system disorders, are often lean, and die prematurely, but the mechanistic basis for this clinical picture remains unclear. By integrating data from 17 cohorts of patients with mitochondrial diseases (n = 690) we find evidence that these disorders increase resting energy expenditure, a state termed hypermetabolism. We examine this phenomenon longitudinally in patient-derived fibroblasts from multiple donors. Genetically or pharmacologically disrupting OxPhos approximately doubles cellular energy expenditure. This cell-autonomous state of hypermetabolism occurs despite near-normal OxPhos coupling efficiency, excluding uncoupling as a general mechanism. Instead, hypermetabolism is associated with mitochondrial DNA instability, activation of the integrated stress response (ISR), and increased extracellular secretion of age-related cytokines and metabokines including GDF15. In parallel, OxPhos defects accelerate telomere erosion and epigenetic aging per cell division, consistent with evidence that excess energy expenditure accelerates biological aging. To explore potential mechanisms for these effects, we generate a longitudinal RNASeq and DNA methylation resource dataset, which reveals conserved, energetically demanding, genome-wide recalibrations. Taken together, these findings highlight the need to understand how OxPhos defects influence the energetic cost of living, and the link between hypermetabolism and aging in cells and patients with mitochondrial diseases.
C1 [Sturm, Gabriel; Karan, Kalpita R.; Monzel, Anna S.; Cross, Marissa; Towheed, Atif; Picard, Martin] Columbia Univ Irving Med Ctr, Dept Psychiat, Div Behav Med, New York, NY 10032 USA.
   [Sturm, Gabriel; Lin, Jue] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA.
   [Santhanam, Balaji; Tavazoie, Saeed] Columbia Univ, New York, NY USA.
   [Taivassalo, Tanja] Univ Florida, Dept Physiol & Funct Genom, Clin & Translat Res Bldg, Gainesville, FL USA.
   [Bris, Celine; Lenaers, Guy; Procaccio, Vincent] Angers Hosp, Dept Genet & Neurol, Angers, France.
   [Bris, Celine; Lenaers, Guy; Procaccio, Vincent] Univ Angers, Angers, France.
   [Ware, Sarah A.; Kaufman, Brett A.] Univ Pittsburgh, Vasc Med Inst, Ctr Metab & Mitochondrial Med, Dept Med, Pittsburgh, PA USA.
   [Towheed, Atif] Univ Pittsburgh Med Ctr, Internal Med Pediat Residency Program, Pittsburgh, PA USA.
   [Higgins-Chen, Albert] Yale Univ Sch Med, Dept Psychiat, New Haven, CT USA.
   [McManus, Meagan J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA USA.
   [McManus, Meagan J.; Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA USA.
   [Cardenas, Andres] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA USA.
   [Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA USA.
   [Rahman, Shamima] Great Ormond St Hosp Children NHS Fdn Trust, UCL Great Ormond St Inst Child Hlth, Metab Unit, Mitochondrial Res Grp, London, England.
   [Vissing, John] Univ Copenhagen, Copenhagen Neuromuscular Ctr, Dept Neurol, Rigshospitalet, Copenhagen, Denmark.
   [Grassi, Bruno] Univ Udine, Dept Med, Udine, Italy.
   [Levine, Morgan; Horvath, Steve] Altos Labs, San Diego, CA USA.
   [Haller, Ronald G.] Univ Texas Southwestern Med Ctr, Inst Exercise & Environm Med Texas Hlth Resources, Neuromuscular Ctr, Dept Neurol, Dallas, TX USA.
   [St-Onge, Marie-Pierre] Columbia Univ Irving Med Ctr, Ctr Excellence Sleep & Circadian Res, Dept Med, Div Gen Med, New York, NY USA.
   [Seifert, Erin L.] Thomas Jefferson Univ, MitoCare Ctr, Dept Pathol & Genom Med, Philadelphia, PA USA.
   [Hirano, Michio; Picard, Martin] Columbia Univ Irving Med Ctr, H Houston Merritt Ctr, Dept Neurol, Columbia Translat Neurosci Initiat, New York, NY 10032 USA.
   [Picard, Martin] New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
C3 NewYork-Presbyterian Hospital; University of California System; University of California San Francisco; Columbia University; State University System of Florida; University of Florida; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Stanford University; University of California System; University of California San Francisco; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Copenhagen; University of Udine; University of Texas System; University of Texas Southwestern Medical Center Dallas; NewYork-Presbyterian Hospital; Jefferson University; NewYork-Presbyterian Hospital; New York State Psychiatry Institute
RP Picard, M (corresponding author), Columbia Univ Irving Med Ctr, Dept Psychiat, Div Behav Med, New York, NY 10032 USA.; Picard, M (corresponding author), Columbia Univ Irving Med Ctr, H Houston Merritt Ctr, Dept Neurol, Columbia Translat Neurosci Initiat, New York, NY 10032 USA.; Picard, M (corresponding author), New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
EM martin.picard@columbia.edu
FU NIH [R01AG066828, R01GM123771]; Baszucki Brain Research Fund; J. Willard and Alice S. Marriott Foundation; Muscular Dystrophy Association; Nicholas Nunno Foundation; JDF Fund for Mitochondrial Research; Shuman Mitochondrial Disease Fund
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Apabhai S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022294
   Barends M, 2016, JIMD REP, V26, P103, DOI 10.1007/8904_2015_449
   Basan M, 2015, NATURE, V528, P99, DOI 10.1038/nature15765
   Basisty N, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000599
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Becker C, 2018, EMBO REP, V19, P0, DOI 10.15252/embr.201745126
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Bobba-Alves N, 2022, METABOLOMICS, V146, P105951, DOI 10.1016/j.psyneuen.2022.105951
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519
   Bris C, 2021, GENET MED, V23, P1769, DOI 10.1038/s41436-021-01206-w
   Brydges CR, 2019, INNOV AGING, V3, P0, DOI 10.1093/geroni/igz036
   BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163
   Cao YS, 2015, NAT PHYS, V11, P772, DOI 10.1038/NPHYS3412
   Caporali L, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007210
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/30.10.e47
   Celotto AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025823
   Chen DP, 2016, BRIEF FUNCT GENOMICS, V15, P485, DOI 10.1093/bfgp/elw018
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   Delaney NF, 2017, P NATL ACAD SCI USA, V114, P8402, DOI 10.1073/pnas.1703338114
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Galna B, 2014, J NEUROL, V261, P73, DOI 10.1007/s00415-013-7129-2
   Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050
   Ganetzky RD, 2022, NEW ENGL J MED, V387, P1395, DOI 10.1056/NEJMoa2202949
   Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931
   Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708
   Grassi B, 2009, MED SCI SPORT EXER, V41, P2120, DOI 10.1249/MSS.0b013e3181aae96b
   Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011
   Guimier A, 2021, GENET MED, V23, P2415, DOI 10.1038/s41436-021-01296-6
   Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2
   Gutierrez JM, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13867-y
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heinicke K, 2011, AM J PHYSIOL-REG I, V301, PR873, DOI 10.1152/ajpregu.00001.2011
   Higgins-Chen AT, 2022, NATURE AGING, V2, P644, DOI 10.1038/s43587-022-00248-2
   Hoitzing H, 2019, PLOS COMPUT BIOL, V15, P0, DOI 10.1371/journal.pcbi.1007023
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Hou Y, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0219628
   Inak G, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-22117-z
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, PE972, DOI 10.1210/jc.2010-2944
   Kafri M, 2016, CELL REP, V14, P22, DOI 10.1016/j.celrep.2015.12.015
   Karan KR, 2020, BRAIN BEHAV IMMUN-HL, V5, P0, DOI 10.1016/j.bbih.2020.100080
   Kaspar S, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abf0971
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Keshavan N, 2018, ESSAYS BIOCHEM, V62, P423, DOI 10.1042/EBC20170108
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klein HU, 2021, MOL NEURODEGENER, V16, P0, DOI 10.1186/s13024-021-00495-8
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kühl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lan G, 2012, NAT PHYS, V8, P422, DOI 10.1038/NPHYS2276
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Lozoya OA, 2020, CELL REP, V32, P0, DOI 10.1016/j.celrep.2020.108131
   Lozoya OA, 2018, PLOS BIOL, V16, P0, DOI 10.1371/journal.pbio.2005707
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Mehta NM, 2015, CLIN NUTR, V34, P151, DOI 10.1016/j.clnu.2014.02.008
   Mick E, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.49178
   Molenaar D, 2009, MOL SYST BIOL, V5, P0, DOI 10.1038/msb.2009.82
   Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Newman Jane, 2015, J NEUROMUSCUL DIS, V2, P151
   Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Picard M, 2015, P NATL ACAD SCI USA, V112, PE6614, DOI 10.1073/pnas.1515733112
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Pontzer H, 2021, SCIENCE, V373, P808, DOI 10.1126/science.abe5017
   Pontzer H, 2018, PHYSIOLOGY, V33, P384, DOI 10.1152/physiol.00027.2018
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Qian W, 2019, P NATL ACAD SCI USA, V116, P18435, DOI 10.1073/pnas.1910574116
   Quadalti C, 2018, BBA-MOL BASIS DIS, V1864, P2131, DOI 10.1016/j.bbadis.2018.03.021
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Rabenstein A, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-01724-5
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Ratheiser KM, 1998, AM J CLIN NUTR, V68, P1046, DOI 10.1093/ajcn/68.5.1046
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruggiero C, 2008, J GERONTOL A-BIOL, V63, P698, DOI 10.1093/gerona/63.7.698
   Saleem A, 2015, MITOCHONDRION, V21, P19, DOI 10.1016/j.mito.2014.12.001
   Schmidt CA, 2021, J BIOL CHEM, V297, P0, DOI 10.1016/j.jbc.2021.101140
   Schrack JA, 2014, J AM GERIATR SOC, V62, P667, DOI 10.1111/jgs.12740
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   SHELMET JJ, 1988, J CLIN INVEST, V81, P1137, DOI 10.1172/JCI113428
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Sturm G, 2022, SCI DATA, V9, P0, DOI 10.1038/s41597-022-01852-y
   Sturm G, 2019, EPIGENETICS-US, V14, P961, DOI 10.1080/15592294.2019.1626651
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   SUTER PM, 1992, NEW ENGL J MED, V326, P983, DOI 10.1056/NEJM199204093261503
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Takauji Y, 2016, EXP CELL RES, V345, P239, DOI 10.1016/j.yexcr.2016.06.011
   Takauji Y, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep18722
   Tanaka T, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12799
   Tencerova M, 2019, CELL REP, V27, P2050, DOI 10.1016/j.celrep.2019.04.066
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vincent AE, 2018, J PATHOL, V246, P261, DOI 10.1002/path.5146
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   Ware SA, 2020, J BIOL CHEM, V295, P15677, DOI 10.1074/jbc.RA120.015237
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-96
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Yang XB, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2026786118
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 127
TC 34
Z9 37
U1 5
U2 20
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2399-3642
J9 COMMUN BIOL
JI Commun. Biol.
PD JAN 12
PY 2023
VL 6
IS 1
BP 
EP 
DI 10.1038/s42003-022-04303-x
PG 22
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics
GA 9E1GU
UT WOS:000936542400004
PM 36635485
DA 2024-11-01
ER

PT J
AU Serag, M
   Plutino, M
   Charles, P
   Azulay, JP
   Chaussenot, A
   Paquis-Flucklinger, V
   Saadi, SAE
   Rouzier, C
AF Serag, Mounir
   Plutino, Morgane
   Charles, Perrine
   Azulay, Jean-Philippe
   Chaussenot, Annabelle
   Paquis-Flucklinger, Veronique
   Saadi, Samira Ait-El-Mkadem
   Rouzier, Cecile
TI A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations
SO GENES
LA English
DT Article
DE WES; array-CGH; SYNE1; mitochondrial disorder
ID newly discovered form; mutations; dna; nesprin-1; features; criteria; defects; ataxia; muscle; lead
AB Mitochondrial disorders are characterized by a huge clinical, biochemical, and genetic heterogeneity, which poses significant diagnostic challenges. Several studies report that more than 50% of patients with suspected mitochondrial disease could have a non-mitochondrial disorder. Thus, only the identification of the causative pathogenic variant can confirm the diagnosis. Herein, we describe the diagnostic journey of a family suspected of having a mitochondrial disorder who were referred to our Genetics Department. The proband presented with the association of cerebellar ataxia, COX-negative fibers on muscle histology, and mtDNA deletions. Whole exome sequencing (WES), supplemented by a high-resolution array, comparative genomic hybridization (array-CGH), allowed us to identify two pathogenic variants in the non-mitochondrial SYNE1 gene. The proband and her affected sister were found to be compound heterozygous for a known nonsense variant (c.13258C>T, p.(Arg4420Ter)), and a large intragenic deletion that was predicted to result in a loss of function. To our knowledge, this is the first report of a large intragenic deletion of SYNE1 in patients with cerebellar ataxia (ARCA1). This report highlights the interest in a pangenomic approach to identify the genetic basis in heterogeneous neuromuscular patients with the possible cause of mitochondrial disease. Moreover, even rare copy number variations should be considered in patients with a phenotype suggestive of SYNE1 deficiency.
C1 [Serag, Mounir; Plutino, Morgane; Chaussenot, Annabelle; Paquis-Flucklinger, Veronique; Saadi, Samira Ait-El-Mkadem; Rouzier, Cecile] Hop Archet 2, Serv Genet Medicale, Serv Genet Med, 151 Route St Antoine Ginestiere, F-06202 Nice, France.
   [Serag, Mounir; Plutino, Morgane; Chaussenot, Annabelle; Paquis-Flucklinger, Veronique; Saadi, Samira Ait-El-Mkadem; Rouzier, Cecile] Univ Cote Azur, CNRS UMR7284 INSERM U1081, Fac Med, F-06107 Nice, France.
   [Charles, Perrine] La Pitie Salpetriere, Pitie Salpetriere, AP HP, F-75610 Paris, France.
   [Azulay, Jean-Philippe] Serv Neurol, F-13005 Marseille, France.
C3 CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP
RP Rouzier, C (corresponding author), Hop Archet 2, Serv Genet Medicale, Serv Genet Med, 151 Route St Antoine Ginestiere, F-06202 Nice, France.; Rouzier, C (corresponding author), Univ Cote Azur, CNRS UMR7284 INSERM U1081, Fac Med, F-06107 Nice, France.
EM serag.m@chu-nice.fr; plutino.m@chu-nice.fr; perrine.charles@aphp.fr; jean-philippe.azulay@ap-hm.fr; chaussenot.a@chu-nice.fr; veronique.paquis@unice.fr; saadi.s@chu-nice.fr; rouzier.c@chu-nice.fr
FU Fondation Maladies Rares
CR Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024
   Arias M, 2022, NEUROLOGIA, V37, P257, DOI 10.1016/j.nrl.2019.01.004
   Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bris C, 2021, GENET MED, V23, P1769, DOI 10.1038/s41436-021-01206-w
   BYRNE E, 1992, MUTAT RES, V275, P125, DOI 10.1016/0921-8734(92)90017-J
   Chen ZZ, 2017, BMC MED GENET, V18, P0, DOI 10.1186/s12881-017-0424-5
   COLLINS S, 1995, ACTA NEUROL SCAND, V91, P287, DOI 10.1111/j.1600-0404.1995.tb07007.x
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Duan XH, 2021, CEREBELLUM, V20, P74, DOI 10.1007/s12311-020-01186-8
   Dupré N, 2007, M S-MED SCI, V23, P261, DOI 10.1051/medsci/2007233261
   Frascarelli C, 2023, FRONT GENET, V14, P0, DOI 10.3389/fgene.2023.1089956
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927
   Indelicato E, 2019, PARKINSONISM RELAT D, V62, P210, DOI 10.1016/j.parkreldis.2018.12.007
   Izumi Y, 2013, NEUROLOGY, V80, P600, DOI 10.1212/WNL.0b013e3182815529
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Legati A, 2021, J MOL DIAGN, V23, P732, DOI 10.1016/j.jmoldx.2021.03.002
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Mademan I, 2016, BRAIN, V139, P0, DOI 10.1093/brain/aww115
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Ngo KJ, 2020, HUM MUTAT, V41, P487, DOI 10.1002/humu.23946
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Schon KR, 2021, BMJ-BRIT MED J, V375, P0, DOI 10.1136/bmj-2021-066288
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Swan L, 2018, CLINICS PRACT, V8, P91, DOI 10.4081/cp.2018.1071
   Synofzik M, 2016, BRAIN, V139, P1378, DOI 10.1093/brain/aww079
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238
   Zhou C, 2017, HUM MOL GENET, V26, P2258, DOI 10.1093/hmg/ddx116
NR 39
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD DEC 15
PY 2023
VL 14
IS 12
BP 
EP 
DI 10.3390/genes14122154
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA DM2U8
UT WOS:001132403200001
PM 38136976
DA 2024-11-01
ER

PT J
AU Polosa, PL
   Capriglia, F
   Bruni, F
AF Loguercio Polosa, Paola
   Capriglia, Francesco
   Bruni, Francesco
TI Molecular Investigation of Mitochondrial RNA19 Role in the Pathogenesis of MELAS Disease
SO LIFE-BASEL
LA English
DT Article
DE mt-RNA processing; RNA19; MELAS; trans-mitochondrial cybrids; mitochondrial translation; mitoribosome; LARS2; Cterm; mitochondrial disease
ID lactic-acidosis; mutation; encephalopathy; synthetase; myopathy; domain; model
AB In mammalian mitochondria, the processing of primary RNA transcripts involves a coordinated series of cleavage and modification events, leading to the formation of processing intermediates and mature mt-RNAs. RNA19 is an unusually stable unprocessed precursor, physiologically polyadenylated, which includes the 16S mt-rRNA, the mt-tRNALeuUUR and the mt-ND1 mRNA. These peculiarities, together with the alteration of its steady-state levels in cellular models with defects in mitochondrial function, make RNA19 a potentially important molecule for the physiological regulation of mitochondrial molecular processes as well as for the pathogenesis of mitochondrial diseases. In this work, we quantitatively and qualitatively examined RNA19 in MELAS trans-mitochondrial cybrids carrying the mtDNA 3243A>G transition and displaying a profound mitochondrial translation defect. Through a combination of isokinetic sucrose gradient and RT-qPCR experiments, we found that RNA19 accumulated and co-sedimented with the mitoribosomal large subunit (mt-LSU) in mutant cells. Intriguingly, exogenous expression of the isolated LARS2 C-terminal domain (Cterm), which was shown to rescue defective translation in MELAS cybrids, decreased the levels of mt-LSU-associated RNA19 by relegating it to the pool of free unbound RNAs. Overall, the data reported here support a regulatory role for RNA19 in mitochondrial physiopathological processes, designating this RNA precursor as a possible molecular target in view of therapeutic strategy development.
C1 [Loguercio Polosa, Paola; Capriglia, Francesco; Bruni, Francesco] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Environm, I-70125 Bari, Italy.
   [Capriglia, Francesco] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield S10 2HQ, England.
C3 Universita degli Studi di Bari Aldo Moro; University of Sheffield
RP Bruni, F (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Environm, I-70125 Bari, Italy.
EM paolaannamaria.loguerciopolosa@uniba.it; f.capriglia@sheffield.ac.uk; francesco.bruni@uniba.it
FU Fondi di Ateneo "Contributo Ordinario di Supporto alla Ricerca" 2017/18 [Bruni11906Ricat17_18]
CR Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026
   Bruni F, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11090991
   Bruni F, 2021, FEBS J, V288, P437, DOI 10.1111/febs.15342
   Bruni F, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064670
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Capriglia F, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11070674
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872
   Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202
   Jedynak-Slyvka M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22157999
   Jiang S, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201948101
   Jones CN, 2008, RNA, V14, P862, DOI 10.1261/rna.909208
   Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5
   KOGA Y, 1993, NUCLEIC ACIDS RES, V21, P657, DOI 10.1093/nar/21.3.657
   Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008
   Sanchez MIGL, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22083827
   Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727
   Metodiev MD, 2016, AM J HUM GENET, V98, P993, DOI 10.1016/j.ajhg.2016.03.010
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Peng GX, 2022, NUCLEIC ACIDS RES, V50, P12951, DOI 10.1093/nar/gkac1141
   Perks KL, 2018, CELL REP, V23, P127, DOI 10.1016/j.celrep.2018.03.033
   Perli E, 2020, FASEB J, V34, P7675, DOI 10.1096/fj.201903270R
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Rackham O, 2016, CELL REP, V16, P1874, DOI 10.1016/j.celrep.2016.07.031
   Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627
   Remes C, 2023, NUCLEIC ACIDS RES, V51, P891, DOI 10.1093/nar/gkac1233
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/0005-2728(92)90226-R
   Siira SJ, 2018, EMBO REP, V19, P0, DOI 10.15252/embr.201846198
   Siira SJ, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-01221-z
   Singh V, 2023, BIORXIV, V0, P0, DOI DOI 10.1101/2023.05.24.542018
   Su ZL, 2020, ANNU REV GENET, V54, P47, DOI 10.1146/annurev-genet-022620-101840
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tani H, 2022, NUCLEIC ACIDS RES, V50, P9382, DOI 10.1093/nar/gkac699
   Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036
   Zuccotti P, 2016, METHODS MOL BIOL, V1358, P59, DOI 10.1007/978-1-4939-3067-8_4
NR 49
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD SEP 15
PY 2023
VL 13
IS 9
BP 
EP 
DI 10.3390/life13091863
PG 16
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA T2VF9
UT WOS:001076605800001
PM 37763267
DA 2024-11-01
ER

PT J
AU Boran, T
   Zengin, OS
   Seker, Z
   Akyildiz, AG
   Oztas, E
   Özhan, G
AF Boran, Tugce
   Zengin, Ozge Sultan
   Seker, Zehra
   Akyildiz, Aysenur Gunaydin
   Oztas, Ezgi
   Ozhan, Gul
TI Ripretinib induced skeletal muscle toxicity through mitochondrial impairment in C2C12 myotubes
SO TOXICOLOGY
LA English
DT Article
DE Ripretinib; Kinase inhibitors; Myotoxicity; Mitochondrial damage; C2C12 myotubes
ID kinase inhibitors; accurate docking; mitophagy; glide; metabolism; decline; disease; protein; death
AB Ripretinib is a multikinase inhibitor drug approved in 2020 by the FDA and in 2021 by EMA for use in the treatment of advanced gastrointestinal stromal tumors (GIST) which have not adequately responded to previous treatments with kinase inhibitors. The most common side effects of the drug are myalgia and fatigue, which likely causes interruption of the treatment or reduction of the dose. Skeletal muscle cells highly depend on ATP to perform their functions and mitochondrial damage may play a role in skeletal muscle toxicity induced by kinase inhibitors. However, the molecular mechanism has not been clearly identified in the literature yet. In this study, it has been aimed to elucidate the role of mitochondria in the toxic effect of ripretinib on skeletal muscle using the mouse C2C12 myoblast-derived myotubes. The myotubes were exposed to ripretinib at the range of 1-20 mu M concentrations for 24 h. To determine the potential role of mitochondrial impairment in ripretinib-induced skeletal muscle toxicity, intracellular ATP level, mitochondrial membrane potential (MMP), mitochondrial ROS production (mtROS), mitochondrial DNA (mtDNA) copy number, and mitochondrial mass were examined after ripretinib treatment. Furthermore, changes in PGC 1 alpha/NRF 1/NRF 2 expression levels that play a role in mitochondrial biogenesis and mitophagy were investigated. Additionally, the mitochondrial electron transport chain (ETC) enzyme activities were evaluated. Lastly, a molecular docking study was done to see ripretinib's possible interaction with DNA polymerase gamma (POLG) which is important for DNA replication in the mitochondria. According to the findings, ripretinib decreases the ATP level and mtDNA copy number, induces loss of MMP, and reduces mitochondrial mass. The activities of the ETC complexes were inhibited with ripretinib exposure which is in line with the observed ATP depletion and MMP loss. The molecular docking study revealed that ripretinib has inhibitory potential against POLG which supports the observed inhibition of mtDNA. The expression of PGC 1 alpha was reduced in the nuclear fraction indicating that PGC-1 alpha was not activated since the NRF 1 expression was reduced and NRF 2 level did not show significant change. Consequently, mtROS production increased in all treatment groups and mitophagy-related gene expressions and Parkin protein expression level were up-regulated at high doses. In conclusion, mitochondrial damage/loss can be one of the underlying causes of ripretinib-induced skeletal muscle toxicity. However, further studies are needed to confirm the results in vivo.
C1 [Boran, Tugce; Zengin, Ozge Sultan; Oztas, Ezgi; Ozhan, Gul] Istanbul Univ, Fac Pharm, Dept Pharmaceut Toxicol, TR-34116 Istanbul, Turkiye.
   [Boran, Tugce] Istanbul Univ Cerrahpasa, Fac Pharm, Dept Pharmaceut Toxicol, TR-34500 Istanbul, Turkiye.
   [Zengin, Ozge Sultan; Seker, Zehra] Istanbul Univ, Inst Grad Studies Hlth Sci, TR-34116 Istanbul, Turkiye.
   [Seker, Zehra; Akyildiz, Aysenur Gunaydin] Bezmialem Vakif Univ, Fac Pharm, Dept Pharmaceut Toxicol, TR-34093 Istanbul, Turkiye.
C3 Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Bezmialem Vakif University
RP Özhan, G (corresponding author), Istanbul Univ, Fac Pharm, TR-34116 Istanbul, Turkiye.
EM gulozhan@istanbul.edu.tr
FU Scientific Research Project Coordina- tion Unit of Istanbul University [TSA-2021 -37953, FBG-2021 -37896]
CR Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103
   Anflous-Pharayra K, 2011, BBA-BIOENERGETICS, V1807, P150, DOI 10.1016/j.bbabio.2010.09.007
   Atashbar S, 2022, J BIOCHEM MOL TOXIC, V36, P0, DOI 10.1002/jbt.22934
   Bouitbir J, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.01106
   Carson JA, 2016, SEMIN CELL DEV BIOL, V54, P53, DOI 10.1016/j.semcdb.2015.11.005
   Damaraju VL, 2018, BIOCHEM PHARMACOL, V155, P162, DOI 10.1016/j.bcp.2018.07.001
   Drake JC, 2017, J PHYSIOL-LONDON, V595, P6391, DOI 10.1113/JP274337
   EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023
   FDA and CDER, 2020, HIGHL PRESCR INF, V0, P0
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   GIST Support International, 2020, SWITCH POCK KIN INH, V0, P0
   Gouspillou G, 2016, FRONT PHYSIOL, V7, P0, DOI 10.3389/fphys.2016.00446
   Guan YT, 2019, EXERC SPORT SCI REV, V47, P151, DOI 10.1249/JES.0000000000000192
   Gureev AP, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00435
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Harris J, 2018, MITOCHONDRION, V41, P2, DOI 10.1016/j.mito.2017.10.009
   Hartmann JT, 2009, CURR DRUG METAB, V10, P470, DOI 10.2174/138920009788897975
   Huot JR, 2019, CANCERS, V11, P0, DOI 10.3390/cancers11040571
   Jung S, 2014, INTEGR MED RES, V3, P155, DOI 10.1016/j.imr.2014.09.004
   Kaminski J, 2012, BIOCHEM PHARMACOL, V84, P1251, DOI 10.1016/j.bcp.2012.08.023
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Kunz WS, 2001, BBA-BIOENERGETICS, V1504, P12, DOI 10.1016/S0005-2728(00)00235-8
   Leermakers PA, 2016, CURR OPIN CLIN NUTR, V19, P427, DOI 10.1097/MCO.0000000000000319
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martinez MS, 2018, VESSEL, V2, P32, DOI 10.20517/2574-1209.2018.68
   Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Napolitano G, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10111824
   Negrette-Guzmán M, 2015, EVID-BASED COMPL ALT, V2015, P0, DOI 10.1155/2015/917435
   Okada N, 2021, J PHARMACOL SCI, V147, P367, DOI 10.1016/j.jphs.2021.09.001
   Okamoto S, 2019, METABOLISM, V90, P52, DOI 10.1016/j.metabol.2018.10.003
   Panajatovic MV, 2020, BIOMEDICINES, V8, P0, DOI 10.3390/biomedicines8090351
   Pavithran K, 2021, CANC RES STAT TREAT, V4, P93, DOI 10.4103/crst.crst_308_20
   Popov LD, 2020, J CELL MOL MED, V24, P4892, DOI 10.1111/jcmm.15194
   Quan Y, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/9423593
   Quiros Pedro M, 2017, CURR PROTOC MOUSE BIOL, V7, P47, DOI 10.1002/cpmo.21
   Rao JY, 2022, BRAIN SCI, V12, P0, DOI 10.3390/brainsci12070868
   Rinninella E, 2021, INTERN EMERG MED, V16, P1341, DOI 10.1007/s11739-020-02589-5
   Romanello V, 2016, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00422
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Saito T, 2015, CIRC RES, V116, P1477, DOI 10.1161/CIRCRESAHA.116.303790
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Schneider AM, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/9151169
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shoshan-Barmatz V, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00060
   Sivandzade F, 2019, BIO-PROTOCOL, V9, P0, DOI 10.21769/BioProtoc.3128
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087
   Warren C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-70885-3
   Wong CY, 2020, J PHARM PHARMACOL, V72, P1667, DOI 10.1111/jphp.13359
   Wu KLH, 2016, FREE RADICAL BIO MED, V97, P58, DOI 10.1016/j.freeradbiomed.2016.05.012
   Yue P, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0206003
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 57
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0300-483X
EI 1879-3185
J9 TOXICOLOGY
JI Toxicology
PD MAY 1
PY 2023
VL 489
IS 
BP 
EP 
DI 10.1016/j.tox.2023.153489
EA MAR 2023
PG 13
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA C1IR1
UT WOS:000959544200001
PM 36933644
DA 2024-11-01
ER

PT J
AU Bhattacharya, D
   Slavin, MB
   Hood, DA
AF Bhattacharya, Debasmita
   Slavin, Mikhaela B.
   Hood, David A.
TI Muscle mitochondrial transplantation can rescue and maintain cellular homeostasis
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE lysosomes; mitochondrial DNA defects; mitochondrial dynamics; mitochondrial transplantation; oxygen consumption
ID mesenchymal stem-cells; tunneling nanotubes; cancer-cells; dysfunction; protects; diseases
AB Mitochondria control cellular functions through their metabolic role. Recent research that has gained considerable attention is their ability to transfer between cells. This has the potential of improving cellular functions in pathological or energy-deficit conditions, but little is known about the role of mitochondrial transfer in sustaining cellular homeostasis. Few studies have investigated the potential of skeletal muscle as a source of healthy mitochondria that can be transferred to other cell types. Thus, we isolated intermyofibrillar mitochondria from murine skeletal muscle and incubated them with host cells. We observed dose- and time-dependent increases in mitochondrial incorporation into myoblasts. This resulted in elongated mitochondrial networks and an enhancement of bioenergetic profile of the host cells. Mitochondrial donation also rejuvenated the functional capacities of the myoblasts when respiration efficiency and lysosomal function were inhibited by complex I inhibitor rotenone and bafilomycin A, respectively. Mitochondrial transfer was accomplished via tunneling nanotubes, extracellular vesicles, gap junctions, and by macropinocytosis internalization. Murine muscle mitochondria were also effectively transferred to human fibroblast cells having mitochondrial DNA mutations, resulting in augmented mitochondrial dynamics and metabolic functions. This improved cell function by diminishing reactive oxygen species (ROS) emission in the diseased cells. Our findings suggest that mitochondria from donor skeletal muscle can be integrated in both healthy and functionally compromised host cells leading to mitochondrial structural refinement and respiratory boost. This mitochondrial trafficking and bioenergetic reprogramming to maintain and revitalize tissue homeostasis could be a useful therapeutic strategy in treating diseases. NEW & NOTEWORTHY In our study, we have shown the potential of mouse skeletal muscle intermyofibrillar mitochondria to be transplanted in myoblasts and human fibroblast cells having mitochondrial DNA mutations. This resulted in an augmentation of mitochondrial dynamics and enhancement of bioenergetic profile in the host cells. Our findings suggest that mitochondria from donor skeletal muscle can be integrated into both healthy and functionally compromised host cells leading to mitochondrial structural refinement and respiratory boost.
C1 [Bhattacharya, Debasmita; Slavin, Mikhaela B.; Hood, David A.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.
C3 York University - Canada
RP Hood, DA (corresponding author), York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.
EM dhood@yorku.ca
FU The graphical abstract was created with BioRender.com and used with permission.
CR Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Alway SE, 2023, J CACHEXIA SARCOPENI, V14, P493, DOI 10.1002/jcsm.13153
   Amorim JA, 2022, NAT REV ENDOCRINOL, V18, P243, DOI 10.1038/s41574-021-00626-7
   Antanaviciute I, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0099196
   Bajzikova M, 2019, CELL METAB, V29, P399, DOI 10.1016/j.cmet.2018.10.014
   Berardi MJ, 2011, CURR OPIN GENET DEV, V21, P59, DOI 10.1016/j.gde.2010.10.001
   Boukelmoune N, 2018, ACTA NEUROPATHOL COM, V6, P0, DOI 10.1186/s40478-018-0644-8
   Brestoff JR, 2021, CELL METAB, V33, P270, DOI 10.1016/j.cmet.2020.11.008
   Cabrera F, 2019, BMC BIOTECHNOL, V19, P0, DOI 10.1186/s12896-019-0534-6
   Caicedo A, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09073
   Chandel NS, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-34
   Chen J, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.771298
   Cheng XY, 2020, TRANSL NEURODEGENER, V9, P0, DOI 10.1186/s40035-020-00190-6
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Cho YM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032778
   CLARK MA, 1982, NATURE, V295, P605, DOI 10.1038/295605a0
   COGSWELL AM, 1993, AM J PHYSIOL, V264, PC383, DOI 10.1152/ajpcell.1993.264.2.C383
   Court AC, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201948052
   Crewe C, 2021, CELL METAB, V33, P1853, DOI 10.1016/j.cmet.2021.08.002
   Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111
   Deus CM, 2020, TRENDS MOL MED, V26, P71, DOI 10.1016/j.molmed.2019.10.009
   Dong LF, 2023, J CELL BIOL, V222, P0, DOI 10.1083/jcb.202211044
   Driscoll J, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23105487
   Elliott RL, 2012, BREAST CANCER RES TR, V136, P347, DOI 10.1007/s10549-012-2283-2
   English AM, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.202002144
   Gäbelein CG, 2022, PLOS BIOL, V20, P0, DOI 10.1371/journal.pbio.3001576
   Golan K, 2020, BLOOD, V136, P2607, DOI 10.1182/blood.2020005399
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Guariento A, 2021, J THORAC CARDIOV SUR, V162, P992, DOI 10.1016/j.jtcvs.2020.10.151
   Hayakawa K, 2018, STEM CELLS, V36, P1404, DOI 10.1002/stem.2856
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Herst PM, 2017, FRONT ENDOCRINOL, V8, P0, DOI 10.3389/fendo.2017.00296
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310
   Hough KP, 2018, REDOX BIOL, V18, P54, DOI 10.1016/j.redox.2018.06.009
   Hsu CC, 2016, EXP BIOL MED, V241, P1281, DOI 10.1177/1535370216641787
   Ippolito L, 2019, ONCOGENE, V38, P5339, DOI 10.1038/s41388-019-0805-7
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jackson MV, 2016, STEM CELLS, V34, P2210, DOI 10.1002/stem.2372
   Johnson J, 2021, ARCH BIOCHEM BIOPHYS, V702, P0, DOI 10.1016/j.abb.2020.108698
   Katrangi E, 2007, REJUV RES, V10, P561, DOI 10.1089/rej.2007.0575
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Kesner EE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26057
   Kim MJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-21539-y
   KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0
   Kitani T, 2014, J CELL MOL MED, V18, P1694, DOI 10.1111/jcmm.12316
   Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC
   Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y
   Lin HY, 2015, MITOCHONDRION, V22, P31, DOI 10.1016/j.mito.2015.02.006
   Liu DL, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-020-00440-z
   Macheiner T, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep35571
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   McCully JD, 2016, CLIN TRANSL MED, V5, P0, DOI 10.1186/s40169-016-0095-4
   Mistry JJ, 2019, P NATL ACAD SCI USA, V116, P24610, DOI 10.1073/pnas.1913278116
   Moschoi R, 2016, BLOOD, V128, P253, DOI 10.1182/blood-2015-07-655860
   Moskowitzova K, 2019, J HEART LUNG TRANSPL, V38, P92, DOI 10.1016/j.healun.2018.09.025
   Norris RP, 2021, TRAFFIC, V22, P174, DOI 10.1111/tra.12786
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pasquier J, 2013, J TRANSL MED, V11, P0, DOI 10.1186/1479-5876-11-94
   Patel D, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-13227-0
   Phinney DG, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9472
   Pluchino S, 2016, SWISS MED WKLY, V146, P0, DOI 10.4414/smw.2016.14374
   Rodriguez AM, 2018, CELL CYCLE, V17, P712, DOI 10.1080/15384101.2018.1445906
   Rodríguez-Sinovas A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094413
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Saleem A, 2014, AM J PHYSIOL-CELL PH, V306, PC241, DOI 10.1152/ajpcell.00270.2013
   Schulz R, 2015, PHARMACOL THERAPEUT, V153, P90, DOI 10.1016/j.pharmthera.2015.06.005
   Sergi D, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00532
   Sinclair KA, 2016, STEM CELL RES THER, V7, P0, DOI 10.1186/s13287-016-0354-8
   Slavin Mikhaela B, 2022, MOL METAB, V66, P101623, DOI 10.1016/j.molmet.2022.101623
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Suomalainen A, 2019, CELL METAB, V30, P231, DOI 10.1016/j.cmet.2019.07.009
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Takahashi M, 1996, J BIOL CHEM, V271, P27285, DOI 10.1074/jbc.271.44.27285
   Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003
   Valsecchi F, 2013, MITOCHONDRION, V13, P436, DOI 10.1016/j.mito.2012.12.001
   Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P1041, DOI 10.1016/j.bbadis.2007.05.004
   Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009
   Vincent AE, 2019, CELL REP, V26, P996, DOI 10.1016/j.celrep.2019.01.010
   Weissig V, 2020, TRENDS MOL MED, V26, P40, DOI 10.1016/j.molmed.2019.09.002
   Wu TH, 2016, CELL METAB, V23, P921, DOI 10.1016/j.cmet.2016.04.007
   Yasuda K, 2011, AGING-US, V3, P597, DOI 10.18632/aging.100341
   Zhang TG, 2023, ACTA PHARM SIN B, V13, P1028, DOI 10.1016/j.apsb.2022.10.008
   Zhang ZQ, 2019, BEHAV BRAIN RES, V356, P322, DOI 10.1016/j.bbr.2018.09.005
NR 85
TC 9
Z9 9
U1 1
U2 6
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0363-6143
EI 1522-1563
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD OCT 14
PY 2023
VL 325
IS 4
BP C862
EP C884
DI 10.1152/ajpcell.00212.2023
PG 23
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA U1LD7
UT WOS:001082478900001
PM 37575060
DA 2024-11-01
ER

PT J
AU Headley, CA
   Tsao, PS
AF Headley, Colwyn A. A.
   Tsao, Philip S. S.
TI Building the case for mitochondrial transplantation as an anti-aging cardiovascular therapy
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE aging; mitochondrial stress; ROS; oxidative stress; cardiovascular system; endothelial cells; vascular smooth muscle cells
ID oxidative stress; dna-polymerase; endothelial dysfunction; copy number; transcription; inflammation; damage; translation; mutations; capacity
AB Mitochondrial dysfunction is a common denominator in both biological aging and cardiovascular disease (CVD) pathology. Understanding the protagonist role of mitochondria in the respective and independent progressions of CVD and biological aging will unravel the synergistic relationship between biological aging and CVD. Moreover, the successful development and implementation of therapies that can simultaneously benefit mitochondria of multiple cell types, will be transformational in curtailing pathologies and mortality in the elderly, including CVD. Several works have compared the status of mitochondria in vascular endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in CVD dependent context. However, fewer studies have cataloged the aging-associated changes in vascular mitochondria, independent of CVD. This mini review will focus on the present evidence related to mitochondrial dysfunction in vascular aging independent of CVD. Additionally, we discuss the feasibility of restoring mitochondrial function in the aged cardiovascular system through mitochondrial transfer.
C1 [Headley, Colwyn A. A.; Tsao, Philip S. S.] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA.
C3 Stanford University
RP Tsao, PS (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA.
EM ptsao@stanford.edu
FU National Heart, Lung, and Blood Institute [1T32HL098049]; Stanford University's Propel Post-Doctoral Fellowship; California Tobacco Related Disease Research Program of the University of California [T29IR0636]
CR Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   Bektas A, 2019, AGING-US, V11, P9234, DOI 10.18632/aging.102438
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Caicedo A, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/7610414
   Carvalho G, 2022, ANTIOXID REDOX SIGN, V36, P885, DOI 10.1089/ars.2021.0091
   Castegna A, 2015, PHYSIOL GENOMICS, V47, P299, DOI 10.1152/physiolgenomics.00096.2014
   Chang JC, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-90094-w
   Chew K, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12081246
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Cooper HA, 2021, CARDIOVASC RES, V117, P971, DOI 10.1093/cvr/cvaa133
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11
   Coronado F, 2022, PREV CHRONIC DIS, V19, P0, DOI 10.5888/pcd19.220347
   DSouza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Dela Cruz CS, 2018, MITOCHONDRION, V41, P37, DOI 10.1016/j.mito.2017.12.001
   Desdín-Micó G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563
   Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021
   Fernández-Ruiz I, 2016, NAT REV CARDIOL, V13, P503, DOI 10.1038/nrcardio.2016.127
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Foote K, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12773
   Garcia GC, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-54159-1
   Geto Z, 2020, J INFLAMM RES, V13, P97, DOI 10.2147/JIR.S232009
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Gioscia-Ryan RA, 2014, J PHYSIOL-LONDON, V592, P2549, DOI 10.1113/jphysiol.2013.268680
   Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295
   Golledge J, 2010, ARTERIOSCL THROM VAS, V30, P1075, DOI 10.1161/ATVBAHA.110.206573
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Habbane M, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9101364
   Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8090392
   Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123
   Headley CA, 2016, BIOCHEM PHARMACOL, V104, P108, DOI 10.1016/j.bcp.2016.01.005
   Ikeda G, 2021, J AM COLL CARDIOL, V77, P1073, DOI 10.1016/j.jacc.2020.12.060
   Ikeda M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0119687
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Janikiewicz J, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0105-5
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Katewa SD, 2014, CELL METAB, V20, P8, DOI 10.1016/j.cmet.2014.06.013
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kondadi AK, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20174311
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lee Y, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12020284
   Li XY, 2013, J HEMATOL ONCOL, V6, P0, DOI 10.1186/1756-8722-6-19
   Lightowlers RN, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.202050964
   Liu DL, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-020-00440-z
   Liu X, 2021, CELL GENOM, V1, P0, DOI 10.1016/j.xgen.2021.100006
   Liu ZH, 2022, CELL BIOSCI, V12, P0, DOI 10.1186/s13578-022-00805-7
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lorenz Carmen, 2016, STEM CELL INVESTIG, V3, P43, DOI 10.21037/sci.2016.08.09
   Martín-Fernández B, 2016, AGE, V38, P225, DOI 10.1007/s11357-016-9933-y
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   Martins SG, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.673002
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918
   Miwa S, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI158447
   Napolitano G, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10111824
   Nicolás-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031
   Nielsen J, 2017, J PHYSIOL-LONDON, V595, P2839, DOI 10.1113/JP273040
   Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005
   Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Poznyak AV, 2020, BIOLOGY-BASEL, V9, P0, DOI 10.3390/biology9060137
   Radak D, 2016, CURR VASC PHARMACOL, V14, P196, DOI 10.2174/1570161113666150529125127
   Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101
   Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010
   Saha T, 2022, NAT NANOTECHNOL, V17, P98, DOI 10.1038/s41565-021-01000-4
   Santos JH, 2021, FREE RADICAL BIO MED, V170, P59, DOI 10.1016/j.freeradbiomed.2020.11.016
   Schmauck-Medina T, 2022, AGING-US, V14, P6829, DOI 10.18632/aging.204248
   Scott J, 2004, CURR OPIN GENET DEV, V14, P271, DOI 10.1016/j.gde.2004.04.012
   Sercel AJ, 2021, TRENDS CELL BIOL, V31, P311, DOI 10.1016/j.tcb.2020.12.009
   Sercel AJ, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.63102
   Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055
   Stamerra CA, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/9530007
   Stefano GB, 2017, MED SCI MONITOR, V23, P2732, DOI 10.12659/MSM.902515
   Sun JY, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abp9245
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Toleikis A, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9020340
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyrrell DJ, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.120.017820
   Tyrrell DJ, 2020, CIRC RES, V126, P298, DOI 10.1161/CIRCRESAHA.119.315644
   Ungvari Z, 2008, AM J PHYSIOL-HEART C, V294, PH2121, DOI 10.1152/ajpheart.00012.2008
   van Beek AA, 2019, TRENDS IMMUNOL, V40, P113, DOI 10.1016/j.it.2018.12.007
   Vassalle C, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25112653
   Vendrov AE, 2015, ANTIOXID REDOX SIGN, V23, P1389, DOI 10.1089/ars.2014.6221
   Wang LL, 2021, DIS MARKERS, V2021, P0, DOI 10.1155/2021/7157109
   Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x
   Yao CH, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.41351
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yoshinaga N, 2022, ACS BIOMATER SCI ENG, V8, P348, DOI 10.1021/acsbiomaterials.1c01114
   Yusoff AAM, 2019, ONCOL REV, V13, P54, DOI 10.4081/oncol.2019.409
   Zhang ZQ, 2021, SHOCK, V56, P108, DOI 10.1097/SHK.0000000000001681
   Zhao LL, 2020, CHEM RES TOXICOL, V33, P2491, DOI 10.1021/acs.chemrestox.0c00083
NR 101
TC 4
Z9 5
U1 1
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
EI 
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD MAY 9
PY 2023
VL 10
IS 
BP 
EP 
DI 10.3389/fcvm.2023.1141124
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA G9IY8
UT WOS:000992219300001
PM 37229220
DA 2024-11-01
ER

PT J
AU Guerrero-Molina, MP
   Morales-Conejo, M
   Delmiro, A
   Morán, M
   Domínguez-González, C
   Arranz-Canales, E
   Ramos-González, A
   Arenas, J
   Martín, MA
   de la Aleja, JG
AF Paz Guerrero-Molina, Maria
   Morales-Conejo, Montserrat
   Delmiro, Aitor
   Moran, Maria
   Dominguez-Gonzalez, Cristina
   Arranz-Canales, Elena
   Ramos-Gonzalez, Ana
   Arenas, Joaquin
   Martin, Miguel A.
   Gonzalez de la Aleja, Jesus
TI High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE glutamate; glutamine supplementation; MELAS syndrome; mitochondrial disease
ID melas syndrome; brain; encephalopathy; metabolism; pathogenesis; dysfunction; transport; myopathy; blood; gaba
AB Background and PurposeMitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is a genetically heterogeneous disorder caused by mitochondrial DNA mutations. There are no disease-modifying therapies, and treatment remains mainly supportive. It has been shown previously that patients with MELAS syndrome have significantly increased cerebrospinal fluid (CSF) glutamate and significantly decreased CSF glutamine levels compared to controls. Glutamine has many metabolic fates in neurons and astrocytes, and the glutamate-glutamine cycle couples with many metabolic pathways depending on cellular requirements. The aim was to compare CSF glutamate and glutamine levels before and after dietary glutamine supplementation. It is postulated that high-dose oral glutamine supplementation could reduce the increase in glutamate levels. MethodThis open-label, single-cohort study determined the safety and changes in glutamate and glutamine levels in CSF after 12 weeks of oral glutamine supplementation. ResultsNine adult patients with MELAS syndrome (66.7% females, mean age 35.8 +/- 3.2 years) were included. After glutamine supplementation, CSF glutamate levels were significantly reduced (9.77 +/- 1.21 vs. 18.48 +/- 1.34 mu mol/l, p < 0.001) and CSF glutamine levels were significantly increased (433.66 +/- 15.31 vs. 336.31 +/- 12.92 mu mol/l, p = 0.002). A side effect observed in four of nine patients was a mild sensation of satiety. One patient developed mild and transient elevation of transaminases, and another patient was admitted for an epileptic status without stroke-like episode. DiscussionThis study demonstrates that high-dose oral glutamine supplementation significantly reduces CSF glutamate and increases CSF glutamine levels in patients with MELAS syndrome. These findings may have potential therapeutic implications in these patients. Trial Registration Information Identifier: NCT04948138. Initial release 24 June 2021, first patient enrolled 1 July 2021. .
C1 [Paz Guerrero-Molina, Maria; Dominguez-Gonzalez, Cristina] Univ Hosp, Neuromuscular Disorders Unit, Neurol Dept, Madrid, Spain.
   [Morales-Conejo, Montserrat; Arranz-Canales, Elena] Univ Hosp, Dept Internal Med, Madrid, Spain.
   [Morales-Conejo, Montserrat; Arranz-Canales, Elena; Gonzalez de la Aleja, Jesus] Univ Hosp, Natl Reference Ctr Congenital Errors Metab CSUR, Madrid, Spain.
   [Morales-Conejo, Montserrat; Arranz-Canales, Elena; Gonzalez de la Aleja, Jesus] Univ Hosp, European Reference Ctr Inherited Metab Dis MetabE, Madrid, Spain.
   [Morales-Conejo, Montserrat; Delmiro, Aitor; Moran, Maria; Dominguez-Gonzalez, Cristina; Arenas, Joaquin; Martin, Miguel A.] Spanish Network Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Delmiro, Aitor; Moran, Maria; Arenas, Joaquin; Martin, Miguel A.] Inst Invest Sanitaria Hosp 12 Octubre Imas12, Mitochondrial & Neuromuscular Dis Lab, Madrid, Spain.
   [Delmiro, Aitor; Moran, Maria; Dominguez-Gonzalez, Cristina; Arenas, Joaquin; Martin, Miguel A.] Univ Hosp, Res Inst Imas12, Madrid, Spain.
   [Ramos-Gonzalez, Ana] Univ Hosp, Dept Neuroradiol, Madrid, Spain.
   [Gonzalez de la Aleja, Jesus] Univ Hosp, Epilepsy Unit, Neurol Dept, Madrid, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP Guerrero-Molina, MP (corresponding author), Univ Hosp 12 Octubre, Neurol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
EM maripazguerrero@gmail.com
FU Fundacion Eugenio Rodriguez Pascual; Fundacion Mutua Madrilena
CR Almannai M, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.682780
   Andersen JV, 2021, NEUROPHARMACOLOGY, V196, P0, DOI 10.1016/j.neuropharm.2021.108719
   Apostolopoulou A, 2020, NUTRITION, V78, P0, DOI 10.1016/j.nut.2020.110960
   Bagga P, 2014, J CEREBR BLOOD F MET, V34, P1666, DOI 10.1038/jcbfm.2014.129
   Bélanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Bellusci M, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12101590
   Berg A, 2006, INTENS CARE MED, V32, P1741, DOI 10.1007/s00134-006-0375-3
   Çavus I, 2016, ANN NEUROL, V80, P35, DOI 10.1002/ana.24673
   Chan F, 2019, BRAIN, V142, P391, DOI 10.1093/brain/awy320
   Chen JM, 2016, MOL NEURODEGENER, V11, P0, DOI 10.1186/s13024-016-0127-y
   Chen JM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033177
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Coqueiro AY, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11040863
   Cruzat V, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10111564
   Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339
   DiFrancesco JC, 2008, EXP NEUROL, V212, P152, DOI 10.1016/j.expneurol.2008.03.015
   Divakaruni AS, 2017, J CELL BIOL, V216, P1091, DOI 10.1083/jcb.201612067
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Engström ER, 2005, NEUROSCI LETT, V384, P7, DOI 10.1016/j.neurlet.2005.04.030
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Gleeson M, 2008, J NUTR, V138, P2045S, DOI 10.1093/jn/138.10.2045S
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Jafari-Vayghan H, 2020, NUTR METAB, V17, P0, DOI 10.1186/s12986-020-00503-6
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, P0, DOI 10.3389/fnins.2015.00469
   McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444
   McKenna MC, 1996, J NEUROCHEM, V66, P386
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Guerrero-Molina MP, 2022, J NEUROL, V269, P3238, DOI 10.1007/s00415-021-10942-7
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Ribeiro PFM, 2013, FRONT NEUROANAT, V7, P0, DOI 10.3389/fnana.2013.00028
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2
   Tao KM, 2014, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD010050.pub2
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   Vohra R, 2017, MITOCHONDRION, V36, P52, DOI 10.1016/j.mito.2017.02.003
   Wang L, 2007, FASEB J, V21, P1227, DOI 10.1096/fj.06-7495com
   Wu YT, 2010, ANN NY ACAD SCI, V1201, P147, DOI 10.1111/j.1749-6632.2010.05631.x
   Xiang JM, 2003, NEUROCHEM INT, V43, P279, DOI 10.1016/S0197-0186(03)00013-5
   Zaragozá R, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00973
   ZIEGLER TR, 1990, JPEN-PARENTER ENTER, V14, PS137, DOI 10.1177/0148607190014004201
   Zielman R, 2017, BRAIN, V140, P1859, DOI 10.1093/brain/awx130
NR 47
TC 9
Z9 10
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD FEB 15
PY 2023
VL 30
IS 2
BP 538
EP 547
DI 10.1111/ene.15626
EA NOV 2022
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 9X2ND
UT WOS:000888923700001
PM 36334048
DA 2024-11-01
ER

PT J
AU Gill, EL
   Wang, J
   Viaene, AN
   Master, SR
   Ganetzky, RD
AF Gill, Emily L.
   Wang, Jing
   Viaene, Angela N.
   Master, Stephen R.
   Ganetzky, Rebecca D.
TI Methodologies in Mitochondrial Testing: Diagnosing a Primary Mitochondrial Respiratory Chain Disorder
SO CLINICAL CHEMISTRY
LA English
DT Review
ID skeletal-muscle; 3-methylglutaconic aciduria; coenzyme q(10); disease; mutations; dehydrogenase; maintenance; dysfunction; deficiency; biomarker
AB Background Mitochondria are cytosolic organelles within most eukaryotic cells. Mitochondria generate the majority of cellular energy in the form of adenosine triphosphate (ATP) through oxidative phosphorylation (OxPhos). Pathogenic variants in mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) lead to defects in OxPhos and physiological malfunctions (Nat Rev Dis Primer 2016;2:16080.). Patients with primary mitochondrial disorders (PMD) experience heterogeneous symptoms, typically in multiple organ systems, depending on the tissues affected by mitochondrial dysfunction. Because of this heterogeneity, clinical diagnosis is challenging (Annu Rev Genomics Hum Genet 2017;18:257-75.). Laboratory diagnosis of mitochondrial disease depends on a multipronged analysis that can include biochemical, histopathologic, and genetic testing. Each of these modalities has complementary strengths and limitations in diagnostic utility. Content The primary focus of this review is on diagnosis and testing strategies for primary mitochondrial diseases. We review tissue samples utilized for testing, metabolic signatures, histologic findings, and molecular testing approaches. We conclude with future perspectives on mitochondrial testing. This review offers an overview of the current biochemical, histologic, and genetic approaches available for mitochondrial testing. For each we review their diagnostic utility including complementary strengths and weaknesses. We identify gaps in current testing and possible future avenues for test development.
C1 [Gill, Emily L.; Wang, Jing; Viaene, Angela N.; Master, Stephen R.; Ganetzky, Rebecca D.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA USA.
   [Gill, Emily L.; Viaene, Angela N.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.
   [Ganetzky, Rebecca D.] Childrens Hosp Philadelphia, Mitochondrial Med Frontier Program, Div Human Genet, Philadelphia, PA USA.
   [Ganetzky, Rebecca D.] Univ Penn, Dept Pediat, Philadelphia, PA USA.
   [Ganetzky, Rebecca D.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia
RP Ganetzky, RD (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM ganetzkyr@chop.edu
FU NIDDK; NIH
CR Abela L, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176363
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012
   Arias A, 2012, J CHROMATOGR B, V908, P23, DOI 10.1016/j.jchromb.2012.09.027
   Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328
   Barshop BA, 2004, MITOCHONDRION, V4, P521, DOI 10.1016/j.mito.2004.07.010
   Bedoyan Jirair K, 2020, JIMD REP, V56, P70, DOI 10.1002/jmd2.12153
   Bedoyan JK, 2017, MOL GENET METAB, V120, P342, DOI 10.1016/j.ymgme.2017.02.002
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Broberg K, 2021, BIOESSAYS, V43, P0, DOI 10.1002/bies.202000299
   Buján N, 2014, J INHERIT METAB DIS, V37, P53, DOI 10.1007/s10545-013-9620-4
   Charles-Schoeman C, 2012, J RHEUMATOL, V39, P94, DOI 10.3899/jrheum.110739
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Davis RL, 2022, NEUROLOGY, V99, PE730, DOI 10.1212/WNL.0000000000200745
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Djafarzadeh S, 2017, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/54985
   El-Hattab AW, 2017, GENEREVIEWS, V0, P0
   Enns GM, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6050050
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Forny P, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000597
   Frazier AE, 2020, METHOD CELL BIOL, V155, P121, DOI 10.1016/bs.mcb.2019.11.007
   Ganetzky R, 2019, GENEREVIEWS, V0, P1993
   GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219
   HORAK V, 1983, HISTOCHEMISTRY, V78, P545, DOI 10.1007/BF00496207
   Hu QX, 2021, CELL REP METHODS, V1, P0, DOI 10.1016/j.crmeth.2021.100116
   Imasawa T, 2022, KIDNEY INT REP, V7, P580, DOI 10.1016/j.ekir.2021.12.028
   Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0
   KOWALOFF EM, 1977, P NATL ACAD SCI USA, V74, P5368, DOI 10.1073/pnas.74.12.5368
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lu WY, 2018, ANTIOXID REDOX SIGN, V28, P167, DOI 10.1089/ars.2017.7014
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Marin-Garcia J, 1999, PEDIATRICS, V103, P456, DOI 10.1542/peds.103.2.456
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Moore T, 2013, J CHROMATOGR B, V929, P51, DOI 10.1016/j.jchromb.2013.04.004
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   Mudhar HS, 2001, J CLIN PATHOL, V54, P321, DOI 10.1136/jcp.54.4.321
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Neergheen Viruna, 2017, J. INBORN ERRORS METAB. SCREEN., V5, P0
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Oglesbee D, 2006, PEDIATR NEUROL, V35, P289, DOI 10.1016/j.pediatrneurol.2006.05.007
   Pajares S, 2013, MOL GENET METAB, V108, P119, DOI 10.1016/j.ymgme.2012.11.283
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Peretz RH, 2021, MOL GENET METAB, V134, P37, DOI 10.1016/j.ymgme.2021.06.007
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   PRICE HM, 1967, J NEUROPATH EXP NEUR, V26, P475, DOI 10.1097/00005072-196707000-00009
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rahman S, 2012, NEUROMUSCULAR DISORD, V22, P76, DOI 10.1016/j.nmd.2011.05.001
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Seymour Christopher W, 2011, BMC RES NOTES, V4, P169, DOI 10.1186/1756-0500-4-169
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Takemura G, 2016, CIRC-HEART FAIL, V9, P0, DOI 10.1161/CIRCHEARTFAILURE.116.003283
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, P0, DOI 10.5936/csbj.201301012
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001
   Wang J, 2022, MOL GENET METAB, V135, P93, DOI 10.1016/j.ymgme.2021.12.006
   Wang YD, 2019, J BIOL CHEM, V294, P12380, DOI 10.1074/jbc.RA119.008680
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Yamada K, 2012, BRAIN DEV-JPN, V34, P92, DOI 10.1016/j.braindev.2011.08.004
   Yamada K, 2014, MOLEC GENET METAB RE, V1, P455, DOI 10.1016/j.ymgmr.2014.10.003
   Zhang FF, 2015, MOL ENDOCRINOL, V29, P1400, DOI 10.1210/me.2015-1155
NR 77
TC 3
Z9 3
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD JUN 1
PY 2023
VL 69
IS 6
BP 564
EP 582
DI 10.1093/clinchem/hvad037
EA APR 2023
PG 19
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA I1MG2
UT WOS:000976642100001
PM 37099687
DA 2024-11-01
ER

PT J
AU Wu, YT
   Huang, SC
   Shiao, YM
   Syu, WC
   Wei, YH
   Hsu, YC
AF Wu, Yu-Ting
   Huang, Szu-Chuan
   Shiao, Yu-Ming
   Syu, Wei-Chi
   Wei, Yau-Huei
   Hsu, Yi-Chao
TI Identification of new variants in MTRNR1 and MTRNR2 genes using whole mitochondrial genome sequencing in a Taiwanese family with MERRF (myoclonic epilepsy with ragged-red fibers) syndrome
SO HEARING RESEARCH
LA English
DT Article
DE MERRF; Mitochondrial DNA; Next generation sequencing; Sensorineural hearing loss; MTRNR1; MTRNR2
ID inherited hearing-loss; ribosomal-rna gene; mutational analysis; diabetes-mellitus; dna mutation; phenotype; melas; impairment
AB Mitochondrial encephalomyopathy is a multi-system disorder mostly caused by inborn errors of the oxidative phosphorylation (OXPHOS) system and usually manifested as complex neurological disorder and muscle weakness. Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome is one of the major subtypes of mitochondrial disease associated with the m.8344A>G mutation in mitochondrial tRNA(Lys )gene. In addition to the symptoms in central nervous and muscle systems, a portion of the patients may develop hearing loss, which has been linked to the genetic mutations of mitochondrial DNA (mtDNA) especially in the mitochondrial ribosome RNA (rRNA) gene. Despite a great number of studies focusing on the consequences of mtDNA mutations, the mechanism of pathogenesis of these overt diseases has remained unclear, and there is no specific and effective treatment for MERRF syndromes. In this study, we developed a high-quality mtDNA sequencing method by next generation sequencing technology to search for the additional pathogenic variations of mtDNA from skin fibroblasts of four members in a Taiwanese family with MERRF syndrome. Through uncovering the signatures of all mtDNA variants in the MERRF family, we identified novel mtDNA variants in the genes encoding mitochondrial 12S and 16S rRNAs. The finding from this study will give us further insight into the molecular mechanisms driving the phenotypic variability and timing of onset of the MERRF syndrome.
C1 [Wu, Yu-Ting; Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.
   [Huang, Szu-Chuan; Shiao, Yu-Ming; Syu, Wei-Chi] Union Clin Lab, Taipei 10665, Taiwan.
   [Hsu, Yi-Chao] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City 25245, Taiwan.
   [Hsu, Yi-Chao] Mackay Med Coll, Inst Biomed Sci, New Taipei City 25245, Taiwan.
C3 Changhua Christian Hospital; Mackay Medical College; Mackay Medical College
RP Wei, YH (corresponding author), Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua 50046, Taiwan.; Hsu, YC (corresponding author), Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City 25245, Taiwan.; Hsu, YC (corresponding author), Mackay Med Coll, Inst Biomed Sci, New Taipei City 25245, Taiwan.
FU Ministry of Science and Technology of Taiwan Government [MOST 110-2314-B-715-005, 111-2314-B-715-009-MY3]; Ministry of Science and Technology of Taiwan Government [MOST 110-2314-B-715-005, 111-2314-B-715-009-MY3, NSTC 112-2321-B-715-001, MOST 110-2311-B-371-001, MOST 110-2320-B-371-001, NSTC 112-2320-B-371-001]; Mackay Medical College [MMC-RD-111-CF-G002-03, MMC-RD-110-1B-P030, MMC-RD-111-1E-P002]; Changhua Christian Hospital, Taiwan [110-CCH-MST-179, 110-CCH-MST-127, 111-CCH-HCR-147]
CR Abe S, 2014, OTOL NEUROTOL, V35, P1087, DOI 10.1097/MAO.0000000000000350
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040
   Crimi M, 2003, NEUROLOGY, V60, P1200, DOI 10.1212/01.WNL.0000055865.30580.39
   de Wit HM, 2012, NETH J MED, V70, P460
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692
   Iwanicka-Pronicka K, 2015, MED SCI MONITOR, V21, P694, DOI 10.12659/MSM.890965
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kloss-Brandstätter A, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0135643
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Levin BC, 2003, MITOCHONDRION, V2, P387, DOI 10.1016/S1567-7249(03)00010-2
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lu CY, 2002, CLIN CHIM ACTA, V318, P97, DOI 10.1016/S0009-8981(01)00809-9
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lv ZY, 2017, MEDICINE, V96, P0, DOI 10.1097/MD.0000000000008869
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Park SY, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00520
   Riman S, 2017, FORENSIC SCI INT-GEN, V29, P181, DOI 10.1016/j.fsigen.2017.04.005
   Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3
   Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905
   Tang J, 1997, PEDIATR NEUROL, V17, P327, DOI 10.1016/S0887-8994(97)00151-3
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Tsutsumi T, 2001, J LARYNGOL OTOL, V115, P777
   Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753
   Wu YT, 2014, CURR PHARM DESIGN, V20, P5510, DOI 10.2174/1381612820666140306103401
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
NR 38
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-5955
EI 1878-5891
J9 HEARING RES
JI Hear. Res.
PD OCT 15
PY 2023
VL 438
IS 
BP 
EP 
DI 10.1016/j.heares.2023.108876
EA SEP 2023
PG 9
WC Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology
GA U1DA9
UT WOS:001082267600001
PM 37683310
DA 2024-11-01
ER

